                         SEQUENCE LISTING

<110>  VANDERBILT UNIVERSITY
 
<120>  HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME 
       CORONAVIRUS 2 (SARS-COV- 2)

<130>  VBLT.P0307WO4

<150>  US 63/000,299
<151>  2020-03-26

<150>  US 63/003,716
<151>  2020-04-01

<150>  US 63/024,204
<151>  2020-05-13

<150>  US 63/040,224
<151>  2020-06-17

<160>  7160  

<170>  PatentIn version 3.5

<210>  1
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ccccatcagc agtagtcgtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atctccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgaactctgt gaccgccgca gacacggctg tgtattattg tgcgagacat      300

gatgggtcgg gggagatgga tacaattaca tgggggccca tttactacta catggacgtc      360

tggggcaaag ggaccacggt caccgtctcc tca                                   393


<210>  2
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagct ggtaccagca gaagccagga      120

caggcccctg tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg tcaggtgtgg gacagcagca ctgtggtatt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  3
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3
caggtgctcc tggtggagtc tgggggaggc gtggtccagc ctgggacgtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagc agtcatgctt tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atagcaattg atgtaaatag gaaattctac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga acagcctgag agttgaggac acggctgtgt attactgtgc gagagatcaa      300

ggaattgctt tcacggacat tgactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  4
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcgccgtc       60

tcctgcactg gaaccaccag tgatgttggt ggttatgact atgtctcctg gtatcaacag      120

cacccaggca aagcccccaa actcctgatt tatgaagtca ctaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga atactactgc tgctcatatg caggcaacta cattcgggtg      300

ttcggcggag ggaccaggct gaccgtccta                                       330


<210>  5
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcactt atatcatctg atgggggtaa taaattctac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatgtc      300

ccgactacgg tgactgcttt caccgttttt acctactggg gccagggaac cctggtcacc      360

gtctcctca                                                              369


<210>  6
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagcctagac      240

cctgaagatt ttgcagttta ttactgtcac aagcgtagca actggcctcc ttcgctcact      300

ttcggcggag ggaccaaggt ggagatcaaa c                                     331


<210>  7
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7
cagctgcagt tgcaggagtc gggcccaggg ctagtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctagtgg ctccattagg agcgataata tctactggga ctggatccgc      120

cagtccccag ggaaggggct ggagtggata gggagtattt attatagtgg aaccacctac      180

tacaatccgt ccctcaagag tcgagtcacc atatctgtag acacgtccaa caaccagttc      240

tccctgaagc tgagttctgt gaccgccgca gacacggcta tgtattattg tgcgagacaa      300

aagggctggg ttagtatggt ccagggagtc cctcaataca acttcgacgg tatggacgtc      360

tggggccaag ggaccacggt caccgtctcc tca                                   393


<210>  8
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  8
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttccc agcacctatt tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctac gctgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtata ttactgtcaa cactatggtg gttcaccgag aatcagcttc      300

ggccaaggga cacgactgga gattaaa                                          327


<210>  9
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  9
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg tttctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg atgaacccta acagtggtca cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accaggaaca cctccataag cacagcctac      240

atggagctga gcagcctgag atatgaggac acggccgtgt attactgtgc gagaggctac      300

ggcctcacct actacatgga cgtctggggc aaagggacca cggtcaccgt ctcctca         357


<210>  10
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  10
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa aatgtgcact ggtaccagca gaagccaggc      120

caggcccctg tactggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagtt attatcatcc tgtcgtattc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  11
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  11
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ccccatcagc agtagtcgtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atctccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgaactctgt gaccgccgca gacacggctg tgtattattg tgcgagacat      300

gatgggtcgg gggagatgga tacaattaca tgggggccca tttactacta catggacgtc      360

tggggcaaag ggaccacggt caccgtctcc tca                                   393


<210>  12
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  12
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aggcccccaa actcatgatt tattatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cactctactt      300

tatgtcttcg gaactgggac caaggtcacc gtcctag                               337


<210>  13
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  13
gaagagcaac tggtggagtc tgggggaggc tcggtacagc ctggcaggtc cctgaggctc       60

tcctgtgcag tcactggatt caactttaat gaacatgcca tgcactgggt ccggcaacct      120

ccagggaagg gcctggagtg ggtctcaggt atcagtggga gtagtgatta catagtctac      180

gcggactctg tgaagggccg attcatcgtc tccagagaca acgccaagaa ttccctgtat      240

ctacaaatga acaatctgag acctgaggac acggccttct attactgtgc aaaaggtgta      300

gatgaaggag ggctgatcgc ctacttccag cgctggggcc agggcaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  14
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  14
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagccg gagcctcctg cgtagtaatg gatacaacta tttggcttgg      120

tatctgcaga agccagggca gtctccacag ctcctgatct atttgggttc tgctcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt gggtcaggca cagattttac actgagaatc      240

agcaaagtgg aggctgagga tgttggggtt tattactgca tgcaagctct ccagaccccc      300

ctcactttcg gcggagggac caaggtggag atcaaac                               337


<210>  15
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  15
caggtgcagc tggcgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg ctgctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatggggtgg atgaacccta acagtggtaa cgcaggctat      180

gcacagaagt tccagggcag agtcactatg accagggaca cctccataag tacagcctac      240

atggagttga gcagcctgag atctgaggac acggccgtgt attattgtgc gagaatgcgc      300

agtggctggc ccacacatgg ccgcccggat gacttctggg ggcggggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  16
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  16
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcaactc caacatcgga agttatactg taaactggta ccagcagttc      120

ccaggaacgg cccccaaact cctcatttat gataataatc agcggacctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctaatta ttactgttta gtatgggatg acagcctgaa tggcctggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  17
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  17
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact acctatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcaa cacggcattt      240

ctgcatatcg gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagagatcag      300

gacagtggct acccaactta ctactactac tacctggacg tctggggcaa agggaccacg      360

gtcaccgtct cctc                                                        374


<210>  18
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  18
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tttattaact ccaatcggcc ctcaggggtc      180

cctgaccgat tctctgactc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc ctgtcctatg acagcagcct gggtgccttg      300

ttcggcggag ggaccatgct gacc                                             324


<210>  19
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  19
gaggtgcagc tgttggagtc ggggggtggc ttggtacagc ctggacagtc cctgagactc       60

tcctgtgcag cctctggatt cagcttcagc aactatgcca tgacctgggt ccgccaggct      120

ccagggcagg gactggagtg ggtctccgga atcagtggta ccggtagtgg gtatagtggg      180

ggtagcacat actatgcagg ctccgtgaag ggccggttca ccatctccag agacgactcc      240

aagaagacag tggttttgca catgaacagc ctgagagtcg aggacacggc cgtgtattac      300

tgcgcgaagg ttcgggtgag tgacggaggg agctacggcg gtttggacgt ctggggccaa      360

gggaccacgg tcaccgtctc c                                                381


<210>  20
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  20
tacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtcggaga cacagtcacc       60

atcacttgcc gggcaggtca gcccattagc aactttttaa attggtatca acagacaccg      120

ggcaaagccc ctaaactcct gatctactct gcgtccattt tgcaaagtgg agtcccatca      180

aggttcagtg ccagtggatc tgggacagat ttcactctca ccatctacag tctgcaacct      240

gaagattttg caacttatta ctgtcaccag agttacttta cccctcaaac ttttggccag      300

gggaccaacc tggagatc                                                    318


<210>  21
<211>  371
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  21
gaggtgcagc tgttgcagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagg aactatgcca tgagttgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtac cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgcgc gaaaaacgag      300

cggattacta tgctagtagt agttaccctc tttgactact ggggccaggg aaccctggtc      360

accgtctcct c                                                           371


<210>  22
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  22
cagtctgtgt tgacgcagcc gccctcagtg tctgcggccc caggacagaa ggtcaccatc       60

tcctgctctg gaagcagctc caacattgga aataattata tatcctggta ccagcaactc      120

ccaggaacag cccccaaact cctcatttat gacaataata agcgaccctc agggattcct      180

gaccgattct ctggctccaa gtctggcacg tcagccaccc tgggcatcac cggactccag      240

actggggacg aggccgatta ttactgcgga acatgggata gcagcctgag tgctgtggtt      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  23
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  23
caaatgcaat tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgaaggtc       60

tcctgttcgg cctctggatt cccctttagt tcgtctgcta tccagtgggt gcgacaggct      120

cgtggacaag gccttgagtg gataggatgg gtcgtcgttg gcagtggtaa cacaaactac      180

gcacagaagt tccaagaaag agtcaccatc accagagaca tgtccacaag tacagcctcc      240

atggagctgc gcagcctgag gtccgaggac acggccgtat attattgtgc ggcatcaaga      300

tattgtacta gttacgcctg tcacgggagt tacggtgcgg acgtctgggg ccaagggacc      360

aaggtcaccg tctcctca                                                    378


<210>  24
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  24
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga tagcgtcacc       60

atctcttgtc gggcgagtga ggacattaga aattatgtga cgtggtatca gcagaaacca      120

gggaaacttc ctaaggtctt gatctatgct gcatccactc tgtattcagg ggtcccatct      180

cggttccgtg gcagtggatc tgggactgat ttctctctca ccatcaccgg cctgcagcct      240

gacgattttg caacttacta ctgtcaaaac tatatcagtg cccctcaaac tttcggccct      300

gggaccaaag tggatgtcaa ac                                               322


<210>  25
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  25
cagggtcagc tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacctttatc agttatggtg tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcagccctt acagtagtaa cacaaactat      180

ccacagaagt tccagggcag agtcaccatg accacagtca catccacgag cacagtctac      240

atggagctga ggagcctgag atttgacgac acggccgtgt attactgtgc gagagatctg      300

gcgcggtatt gtagaagtgc cagctgctcc aacaaagggg ttgactactg gggccaggga      360

accctggtca ccgtcttctc ag                                               382


<210>  26
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  26
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagtattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc agagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcag caatcatgtg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  27
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  27
gaggtgcagt tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccgtcagt ggcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctt      240

caaatgaaca gcccgagagc tgaggacacg gctgtgtatt actgtgcgag agatccgtcg      300

gcgtattacg atattctgac tggttattcg ggggacgtct ggggcaaagg gaccacggtc      360

accgtctcct cag                                                         373


<210>  28
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  28
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattaat agctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tatagtattt attcgtggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  29
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  29
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgcag cctctggatc cacctttagt agctattgga tgacatgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcagatga acagcctgag agccgaggac acggctgttt attactgcgc gagtcgccgt      300

tgcagtgtta gcggctgcta tatggcgtcc tactactaca tggacgtctg gggcaaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  30
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  30
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataact atgtctcctg gtaccaacaa      120

tacccaggca aagcccccaa actcatgatt tatgatgtca ataagtggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcagcta cactttggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  31
<211>  385
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  31
gaggtgcagc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc ccttagactc       60

tcctgtgcag cctctggatt cactttcagt aacgcctgga tgagctgggt ccgccaggct      120

ccagggaagg gactggagtg ggttggccgt attaaaggca aaactgatgg tgggacaaca      180

gactacgctg cacccgtgaa aggcagattc accatctcaa aagatgattc aaaaaatacg      240

ctgtatctgc aaatgagcag cctgaatacc gaggacacag ccgtgtattg gtgtaccacc      300

cttacgtatt attatgatag tagtgcttat ctcaatgatg cttttgatat ctggggccaa      360

gggacaatgg tcaccgtctc ttcag                                            385


<210>  32
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  32
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtgttagt acctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcaccctca ccatcaatag cctggaagct      240

gaagatgctg caacttatta ctgtcatcag agtagtagtt tacctcccac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  33
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  33
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cagcttcagt agctatgtta tgaactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcag taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa tacactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagacatt      300

gatagtggct acgatcctac ccccgttttt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  34
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  34
gacatccaga tgacccagtc tccatcctcc ctgtctgcat gtgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaaggcc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagac ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta ccccgtggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  35
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  35
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggggac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agtagtaact ggtggacttg ggtccgccag      120

cccccaggga aggggctgga gtggattggg gaaatctatc atagtgggag caccaactac      180

aacccgtccc tcaagagtcg agtcaccatc tcagtagaca agtccaagaa ccagttctcc      240

ctgaagctga gctctgtgac cgccgcggac acggccgtgt attattgtgc gagtcggtgg      300

ggggattatt ttgatagtag tggtgcctat gactcctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  36
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  36
gacatccaga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggtattagc agctggttag cctggtatca gcagaaacca      120

gggaaagccc ctaaactcct gatctatgct gcatccagtt tgcaacgtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct      240

gaagattttg caacttacta ttgtcaacag gctaacagtt tacctctcac tttcggcgga      300

gggaccaagg tggaggtcaa ac                                               322


<210>  37
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  37
cgggtccaat tagtacagtc tggggctgag gtgaggaagc ctggggcctc agtgagggtc       60

tcctgtaagg tgtccgggta ctccctcagt gaattatcca tgcactgggt gcgacaggct      120

cctggaaaag ggcttgagtg gatgggaggc tttgatcctg aagatggtga aacagtctac      180

gcacagaggt tccaaggcag agtctccatg accgaggaca tatctacaga cacagcccac      240

atggagctga gcagcctgag atctgacgac acggccgtct attactgtgc atccgggggt      300

ctcaacggtg actacgtcac gggtggggcc tactactatt acatggacgt ctggggcaag      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  38
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  38
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagtctcctg catagtaatg gatacaacta cttggattgg      120

tatctgcaga agccaggaca gtctccacaa ctcctgttct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

cggacattcg gccaagggac acgactggag attaaac                               337


<210>  39
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  39
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac agcaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aacccacgag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaaaagga      300

tggggacaca gttatggtta cgtcgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  40
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  40
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcacaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcac tataataact ggcctccgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  41
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  41
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatagca tgaactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcag taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac atggctgtgt attactgtgc gagaggtttg      300

gtgggacgca tcgacccctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  42
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  42
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacaatc aatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtcc gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcattta caagtcgagg cgccctcgtc      300

ctcttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  43
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  43
gaggtgcagc tggtggagtc tgggggaggc ctggtcaagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcatgc attagtagta gtagtagttt catatactac      180

gcagactcag tgaagggccg gttcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagatccc      300

gtttgggtgg atggggagct actttccggt ggcattccct ttgactactg gggccaggga      360

accctggtca ccgtctcctc a                                                381


<210>  44
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  44
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgaa agtaatagtg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tggactccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tggtgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  45
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  45
cagctgcagc tgcaggagtc gggcccggga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaga agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gcgagtatct attatagtgg gagcacctac      180

tacaactcgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccagttc      240

tccctgaagg tgaactctat gaccgccgca gacacggctg tgtattactg tgcgatactc      300

tggcggggca gcagctgggc cgacagacac tactactact acagtatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  46
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  46
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcacctc caacatcgga agtaatactg taaactggta ccagcaactc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcccc tcagcctccc tggccatcag tgggctccag      240

tctgtggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tggttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  47
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  47
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtag catagcctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagcctgag agccgaggac acggcactat attactgcgc gcgagagtac      300

catgatggtg ccaattggtc gggtgccttt gatgtctggg gccaagggac atgggtcacc      360

gtctcttcag                                                             370


<210>  48
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  48
gatgttgtga tgactcagtc tccactctcc ctgcccgtca cccttggaca gccggcctcc       60

atctcctgca ggtctagtca aagcctcgta tacagtgatg gaaacaccta cttgaattgg      120

tttctgcaga ggccaggcca atctccaagg cgcctaattt ataaggtttc taaccgtgac      180

tctggggtcc cagacagatt cagcggcagt gggtcaggca ctgattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

ctcactttcg gcggagggac caaggtagag atcaaac                               337


<210>  49
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  49
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtacag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcactt atatcatatg atggaaacaa taaatactac      180

gcagactccg cgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag aagtgaggac acggctgtct attactgtgc gagagatctg      300

gggcggggtc tcgacccctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  50
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  50
tcctatgagc tgactcagtc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagca gaggccaggc      120

cagtcccctg tgctggtcat ctatcaagat agccagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctgcggtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  51
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  51
gaggtgcaac tgttggagtc tgggggaggc ttgatacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc aactatgcca tgtcctgggt ccgccaggcc      120

ccagggaagg ggctggagtg ggtctcaggt attattagta gcagtggtgg tgccacatat      180

aacgcagact ccgtgagggg ccggttcacc acctccaggg acaattccaa gaacatactg      240

tatctgcaaa tgaacagcct cagaggcgag gacacggccg tttattactg tgtgaaaggt      300

ctctttgact ggttcccgct ctggggccaa gggacaatgg tcaccgtctc ttcag           355


<210>  52
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  52
gacatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccatc       60

ctctcctgca gggccagtca gagtgttaga agcaatttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctctggt gcatccacca gggccactgc tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcaccag cctgcagtct      240

gaagattgtg cagtttatta ctgtcaccag tataataact ggcctcagac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  53
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  53
cagggacagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgtgagg cttctggata cacctttctc agttatgata tcaactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcagcgctt acacaggaaa cacaaactat      180

gcacagaagt tccagggcag aatgaccatg accacagaca catccacggg aacaggttat      240

atggaactga ggagcctgag atctgacgac acggccgtgt attactgtgc gagagtacaa      300

cgacgtcgac ttgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  54
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  54
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaccaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctcagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg gacagcagcc ttgtggtatt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  55
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  55
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcgctg tctctggtgc ctccatcagc agtggtagtt actactggag ctggatccgg      120

cagcccgccg ggaagggact ggagtggatt gggcgtatct ataccagtgg gaacaccaac      180

tacaacccct ccctcaagag tcgagtcacc atatcagtag acacgtccaa gaaccagttc      240

tccctgaagc tgagttctgt gaccgccgca gacacggccg tgtattactg tgcgacaggt      300

tatattggta cctactacta ctacatggac gtctggggca aagggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  56
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  56
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc acttatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacca ctgtcaacag agttacagta ccctcacttt cggcggaggg      300

accaaggtgg agatcaaac                                                   319


<210>  57
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  57
gaggggcagc tgttggagtc cgggggaggc ctgctacagc ctggggggtc cctgagactc       60

tcttgtgcag cctctggatt cacgtttagc gactatgcca tgagctgggt ccgccaggct      120

ccggggaagg ggctggaatg ggtctcaaca attagtaaat ttggtagtac cttctacgca      180

gactccgtga agggccactt caccatctcc agagacaatt ttaagaacac actgtatctg      240

caaatgaata gcctgagcgc cgacgacacg gccgtctatc actgtgcgaa ggaacctcag      300

cagtggggtc ttaatgcttt tgaaatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  58
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  58
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccaacag cgatgttggt ggttataatt atgtctcgtg gtaccaacag      120

tacccaggca aagcccccaa actcatgatt tatgatgtca ttaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgacg atgaggctga ttattactgc tgttcatatg caggcaccca tgtggctttc      300

ggcggaggga ccaaggtgac cgtccta                                          327


<210>  59
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  59
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtga atccttcagt ggttactact ggagctggat ccgccagccc      120

ccagggaggg gcctggagtg gattggggaa atcaatcaaa gtggaaacaa caactacaac      180

ccgtccctca agagtcgagt caccatatcc attgacacgt ccaacaaccg gttctccctg      240

agggtgagct ctgtgaccgc cgcggacacg gctgtctatt actgtgcgag agacaccagc      300

aagtactact ttgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  60
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  60
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaaggcc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gatgattttg caacttacta ctgtcaacag agttacagta cccccacttt cggcggaggg      300

accaaggtgg agatcaaac                                                   319


<210>  61
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  61
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtag cataggctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctatat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagtgtcg      300

tccattacta gcctattggg atactacttt gactcctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  62
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  62
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcac cgtagcaact ggcctccgag gctcactttc      300

ggcggaggga ccaaggtgga gatcaaac                                         328


<210>  63
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  63
aacgtgcaat tagtggagtc tgggggaggc ttggttcagc ctggcgggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttcat cattatgcca tgcactgggt ccgacaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagtggga gtagtgatta cagagcctat      180

gcggactctc tgaagggccg attcaccatc tccagagact acgccaagaa ctccctgtgg      240

ctgcaaatga acagtctgac atctgaggac acggccttct attactgtgc aaagggcgtt      300

gactatggcg gcaaacttgc ctactttgac tcctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  64
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  64
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtcttg gatacaactc tttgagttgg      120

tacctgcaga agccagggca gtctccacac ctcctgatct atttgggctc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcagcca cagactttac actgaaaatc      240

agcagattgg aggctgagga tgttggcgtt tattactgca tgcaagctct acaaactccc      300

ctcaccttcg gccaagggac acgactggag attaaac                               337


<210>  65
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  65
caggtgcagc tggtgcaatc tgggcctgag ttgaaggagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccctcacg actacttcta tggattgggt gcgacaggtc      120

cctggacagg gacttgagtg gatgggatgg atgcgtcccg gcaccgggag cccaacatat      180

gtcgagggct tcagaggacg gtttgtcttt tctttggaca cctcgctcaa tacggcctac      240

ctgcagatca gtggcctcaa ggccgaggac actgccgttt attactgcgc gagagtgggg      300

gacaagtcgg aagagtttga ctactggggc caaggaaccc tggtcagcgt ctcctcag        358


<210>  66
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  66
gaaattgtga tgacacagtc tccggccacc ctgtcgctgt ctccagggga tagagccacc       60

ctctattgta aggccagcca gaatgttggc aactacttag cctggttcca acagaaacct      120

ggccagcctc ccaggctcgt catctttggt gtatccaaca gggcctctgg catcccactc      180

aggttcagtg gcggtggctc tgggacagat ttcactctca ccatcagcag cctagagccc      240

gaagattttg gaatttatta ctgtcaacag cgtcgccact ggcggacgtt cggccaaggg      300

accagggtgg aaatcaaac                                                   319


<210>  67
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  67
caggtccagc tggttcaatc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaaga cttctggaga cacctccagc agttatactg tcggctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat agcatactcc      180

gcacagaagt tccagggcag actcacgatt accgcggaca aatccacgag cacatcctac      240

atggagctga gcagcctgag atctgaggac acggccgttt attactgtgc gagaggggtg      300

gtagctgcta ctccgggttg gttcgacccc tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  68
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  68
cagcctgtgc tgactcagcc accttctgca tcagcctccc tgggagcctc ggtcacactc       60

acctgcaccc tgagcagcgg ctacagtaat tataaagtgg actggtacca gcagagacca      120

gggaagggcc cccggtttgt gatgcgagtg ggcactggtg ggattgtggg atccaagggg      180

gatggcatcc ctgatcgctt ctcagtcttg ggctcaggcc tgaatcggta cctgaccatc      240

aagaacatcc aggaagagga tgagagtgac taccactgtg gggcagacca tggcagtggg      300

agcaacttcg tttttgtggt tttcggcgga gggaccaggc tgaccgtcct ag              352


<210>  69
<211>  396
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  69
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcacc acaagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ctctgaagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtcctcgcaa tgaccaacat ggaccctgtg gacacagcca catactactg tgcacgggta      300

gtcgttaggt gtcctggtac tggtgatgtc tgctcgacgt actactatca aagcatggac      360

gtctggggcc aggggaccac ggtcaccgtc tcctca                                396


<210>  70
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  70
cagtctgccc tgactcagcc tccctccgcg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataagt atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgaggtca ataagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccgt ctctgggctc      240

caggctgagg atgaggctga ttattactgc agctcatttg caggcagcaa catcccttat      300

gtcttcggaa ctgggaccaa ggtcaccgtc ctag                                  334


<210>  71
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  71
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctctcactg       60

acctgcacct tctctgggtt ctcactcggc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ctctgaagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacggggg      300

gtggttactt atgactattg gggccaggga accctggtca ccgtctcctc ag              352


<210>  72
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  72
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtgacc       60

atcacttgcc gggcaagtca gagcattgcc ggctatttaa actggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatggt acaaccagtt tgcaaagtgg ggtcccagta      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccctggcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  73
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  73
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcacc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataagtac      180

tacagcacat ctctgcagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggaa      300

actccggtga ctgctattga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  74
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  74
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tttattaact ccaatcggcc ctcaggggtc      180

cctgaccgct tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagaactct gagtgtggta      300

ttcggcggag ggaccaaact gaccgtccta                                       330


<210>  75
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  75
caggtgcagc tgcgggagtc gggcccagga ctggtgaggc cttcggagac cctgtccctc       60

aagtgcactg tctctggaga ctccgtcagc ggtaattctc acttctggac gtggatccgg      120

cagcccccag ggaagggact ggagtggatt gggtacatct ataatagtgt gtccaccgcc      180

tacaacgcct ccctcaagag tcgagtgacc atatcagtag actcgtccaa gaacctattc      240

tccctggaac tgacctctgt caccgctgcg gacacggccg tctatttttg tgcgggaggt      300

ttcgacgacg cgtgggagcc ccaggtctac tggggcctgg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  76
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  76
gacatcgtga tgacgcagtc tccagacttc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgttttc aacaccgtca accataggga ctacttaggg      120

tggtaccagc agaaaccagg acagcctcct aagttactct tttactgggc ctcaagtcgg      180

agatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcaacaata tcacaatatg      300

gtcacttttg gccaggggac caagctggag atcaaac                               337


<210>  77
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  77
caggtcacct tgaaagaatc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcaccc tctctggctt cgcagtcctc aaagccagaa tgggtgtgag ctggatccgt      120

cagtccccag ggaaggccct ggaatggctt gcacacactt tttcgggtga cgaagaatcc      180

tacaacccat ctctgaggac cagactcacc atctccacgg acacctccag aaggcaggtg      240

gtccttacca tgagcaacgt ggaccctgtg gacacagcca cttatttctg tgctcgagtc      300

aagacttatt acacctcgac gagacggatc ctctggttcg acccctgggg ccagggaatc      360

ctggtcaccg tctcctcag                                                   379


<210>  78
<211>  332
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  78
aattttattc tgactcagcc ccactctgtc tcggcgtctc cgggggagac ggtgaacatc       60

tcctgcaccc gcagcagtgg cgacattgcc cgcaactctg tgcagtggta ccaacagcgc      120

ccggactgtg cccccaccgt tctcatcttt gaggatgacc agagaccctc agcggtccct      180

gatcggttct ctggctccat cgacaggtcc tccaacactg cctccctcac catctctggg      240

ctgacgcctg aggacgaggc tgactactac tgtcactctt atgatgacaa ttatcaagcc      300

ttcttcggcg gagggaccag actgaccgtc ct                                    332


<210>  79
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  79
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aactatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggactg ggtggcagtt atatcatatg atggcagtaa tagatactac      180

gcagcctccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctacaaatga acagcctgag aactgaggac acggctgtgt atttctgtgc gagaggcgat      300

ggatatagat cccagttcga cccctggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  80
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  80
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcgtacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  81
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  81
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc acctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagatattgg      300

ttcggggacc catactacta ctacggtatg gacgtctggg gccaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  82
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  82
gagatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag actggagcct      240

gaagattttg cagtgtatta ctgtcagcaa tatactaact tcctcacctt cggccaaggg      300

acacgactgg agattaaac                                                   319


<210>  83
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  83
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtga ctccatcaac agtggtggtt actcctggag ttggctccgg      120

cagcccgccg ggaagggact ggagtgggtt gggcgtatct atagcagtgg gaacacccac      180

tacaacccct ccctcaagag tcgagtcaca atatccagag acacgtccaa gaaccagttc      240

tccctgaacc tgaactttgt gatcgccgca gacacggccg tgtacttctg cgcgagagat      300

agaaacggga tagctgctac tgacttctgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  84
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  84
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttgac agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctaa ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcag cgtagcaact ggcctccgga cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  85
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  85
cagatcacct tcaaggagtc tggtcctacg ctggtgaaac ccacagagac cctcacgctg       60

acctgcacct tctctgggtt ctcagtcagc actagtggag agggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcagtcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaggg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagg      300

ctttggttca gggatgcttt tgatatttgg ggccaaggga caacggtcac cgtctcctca      360

g                                                                      361


<210>  86
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  86
gacatccaga tgacccagtc tccatcgtcc ctgtctgcat ctgtaggaga cagagtcaca       60

atcacttgcc gggcacgtca gagcattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcacagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag acttacagta ccttctggac gttcggccaa      300

gggaccaacg tggaaatcaa ac                                               322


<210>  87
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  87
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcactctg       60

acctgcacct tttctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcagtcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagaa caggctcacc atcaccaagg acacctccca aatacaggtg      240

atccttacaa tgaccaacat ggaccctgtg gacacaggca catattactg tgcacacaga      300

cgagagtggg agccttaccg ttactggggc cagggcaccc tggtcaccgt ctcttcag        358


<210>  88
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  88
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgttttt tacagctcca acaagaagaa ctacttagct      120

tggttccagc aaaaaccagg gcaggctcct aagctgctcg tttactgggc atctgcccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggcg gtttattact gtcaacaata ttatagcact      300

cctcagactt tcggccctgg gaccaaagtg gatatcaaac                            340


<210>  89
<211>  385
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  89
gaggtgcagc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc ccttagactc       60

tcctgtgcag cctctggatt cactttcagt aacgcctgga tgagctgggt ccgccaggct      120

ccagggaagg gactggagtg ggttggccgt attaaaggca aaactgatgg tgggacaaca      180

gactacgctg cacccgtgaa aggcagattc accatctcaa aagatgattc aaaaaatacg      240

ctgtatctgc aaatgagcag cctgaatacc gaggacacag ccgtgtattg gtgtaccacc      300

cttacgtatt attatgatag tagtgcttat ctcaatgatg cttttgatat ctggggccaa      360

gggacaatgg tcaccgtctc ttcag                                            385


<210>  90
<211>  317
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  90
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tttgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tactggtcat ctatgaagat ttcaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctggagtctt cggaactggg      300

accaaggtca ccgtcct                                                     317


<210>  91
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  91
cagatcacct tgaaggagtc tgggcctccg ctggtggaac ccaaacagac cctcactctg       60

acctgcacct tctctgggtt ctcactcaca actagtggag aggctgtggg ctggatccgt      120

cagccccccg gaaaggccct ggagtggctc gctctcattt attgggatga tgataagcac      180

tacagcccgt ctctgaggaa cagactcacc atcaccaggg acacctccaa aaaccaggtt      240

gtccttaccc tgaccaacgt ggaccctgcg gacacaggca catattactg tgcacacagg      300

gcagttatct taaactttga tcactggggc cagggatttc tggtcaccgt ctcctcag        358


<210>  92
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  92
ttctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccggcatc       60

acctgctctg gagataaatt gggacataaa tatgcttatt ggtatcaaca aaagccaggc      120

cagtccccta tactgctcat ctatcaggat gacaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gactatagcc actctgacca tcagcgggac ccagcctgtg      240

gatgaggctg actattactg tcaggcgtgg gacaacgacg ctggggtagt gttcggcgga      300

gggaccaagc tgaccgtcct                                                  320


<210>  93
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  93
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaatcaa taaatactac      180

gcagacgccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaggccacga      300

agtgggagct actacgccta ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  94
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  94
gacatccaga tgacccagtc tccatcctca ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggcattagc aattatttag cctggtttca gcagaaacca      120

gggaaagccc ctaagtccct gatctatgct gcatccagtt tacaaagtgg ggtcccatca      180

aagttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct      240

gaagatgttg caacttatta ctgccaacag tataatagtc accctcccac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  95
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  95
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggaag tataggctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagtgggg      300

tatacgatca gtcgtcagtg gctggtagga gagtttgact actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  96
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  96
cagtctgccc tgactcagcc tccctccgcg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgacgttggt acttataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccgt ctctgggctc      240

caggctgagg atgaggctga atattactgc agcgcatatg caggcagcaa caatttggta      300

ttcggcggag ggaccaaatt gaccgtccta g                                     331


<210>  97
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  97
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcgactgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atttatcctg gtgactctga taccagatat      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccaccag caccgcctac      240

ctgcagtgga gcagcttgaa ggcctcggac accgccatgt attactgtgc gagacgtgga      300

gaagcagctg gtatttggta cttcgatctc tggggccgtg gcaccctggt cactgtctcc      360

tcag                                                                   364


<210>  98
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  98
cagcctgtgc tgactcagcc accttctgca tcagcctccc tgggagcctc ggtcacactc       60

acctgcaccc tgagcagcgg ctacagtaat tataaagtgg actggtacca gcagagacca      120

gggaagggcc cccggtttgt gatgcgagtg ggcactggtg ggattgtggg atccaagggg      180

gatggcatcc ctgatcgctt ctcagtcttg ggctcaggcc tgaatcggta tctgacaatc      240

aagaacatcc aagaagagga tgagagtgac taccactgtg gggcagacca tggcagtggg      300

agcaacttcg agtatgtggt attcggcgga gggaccaagc tgaccgtcct ag              352


<210>  99
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  99
caggtgcact tacagcagtg gggcgcgggg ctattgaagc cttcggagac cctgtccctc       60

acctgcgatg tctatggtgg gtccttcagc ggttactact ggagctggat ccgccagccc      120

ccaggaaagg ggctggagtg gattggggaa atcactcgta gtggaagcac cgactacaac      180

ccgtccctca ggagtcgagt caccatgtca gtagacacgt ccaagaacca gttctccctg      240

aacctgaggt ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag aggcttcgat      300

tccgcgtggg aactacagtt cctctggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  100
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  100
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcacctgca agtccagcca gagtgtttta caccgcccca acaatatgaa ctacttagct      120

tggtaccagc agaaaccagg acagccccct aagttgctca tttactgggc gtctacccgg      180

gcatccgggg tccctgaccg attcagtggc agcgggtctg agacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttatttct gtcagcaata tgaaattact      300

cctcgcacat tcggccacgg gaccaaggtg gaaatcaaac                            340


<210>  101
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  101
caactgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgcccctc       60

acctgcactg tctctggtgg ctccattagt agtagcagtt actactgggg ctggatccgc      120

cagcccccag ggaagggact gcagtggatt gggaatattt attatagtgg gagcacctac      180

tacaattcgt ccctcaagag tcgagtcacc atatctgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctccgt gaccgccgca gacacggctg tgtattactg tgcgagacaa      300

tctcgtggat acagttatgc ttggtctttt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  102
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  102
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc atggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ttcaggggtt      180

tctaatcgct tctctggctc cacgtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggtattgt gctattcggc      300

ggagggacca aggtgaccgt cctag                                            325


<210>  103
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  103
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagaagga      300

caagggacct accttgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  104
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  104
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattagt agctggttgg cctggtatca gcagaaacca      120

gggaaacttc ctaaggtctt gatctatgct gcatccactc tgtattcagg ggtcccatct      180

cggttccgtg gcagtggatc tgggactgat ttctctctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatagtt attctccgga cacctttggc      300

caggggacca agctggagat caaac                                            325


<210>  105
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  105
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt aactatggca tacactgggt ccgccaggct      120

ccaggccagg ggctggaatg ggtggcaggc atatggtatg atggaagtaa taaatactat      180

gtagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtat attactgtgc gggatccagt      300

ggagagggtg gtctctacta ctactacggt atggacgtct ggggccaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  106
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  106
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac gaccaggatc       60

acctgctctg gagatgcatt gccaaagcaa tatggttatt ggtaccagca gaaggcaggc      120

caggccccta tactggtgat atataaagac agcgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctc actattactg tcaatcagga gacagcagtg gtacttatgt ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  107
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  107
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc ggaagtgatt ccttctgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct ctgatagtgg gaccacctac      180

tacaatccgt ccctcaacag tcgagtcacc atatccgttg acacgtccag gaaccagttc      240

tccctgaagt tgaggtctgt gaccgccgca gacacggctg tgtattattg tgtgagaggt      300

cggaacttga gtggtcatgg gtggctcgac ccctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  108
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  108
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccagggtcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagacttcg caatttatta ctgtcagcag cgtcgcagct ggcctctcac attcggcgga      300

gggaccaggg tggagatcaa ac                                               322


<210>  109
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  109
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt cacactcagc actagtggag tgggtgtggc ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacttaccat ctctaaagag taggctcacc atcagcaagg acacccccaa aaaccaggtg      240

atcctcacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagg      300

ggacgatggt tcggggaatt gtcctttgac tactggggcc agggagccct ggtcaccgtc      360

tcctcag                                                                367


<210>  110
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  110
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagtca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aggttgctct tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

ccgctcactt tcggcggagg gaccaaggtg gagatcaaac                            340


<210>  111
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  111
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcgat agctatggtg tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaacactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

gtgcaaatga acagcctgag aactgaggac acggctgtgt attactgtgc gagagattcg      300

gggggtaact acggtgactc atactttgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  112
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  112
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gtcaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagta gacaggagtg gtacttattt taattgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  113
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  113
gaagagcatc tggtggagtc tgggggaggc tcggtacagc ctggcgggtc cctgaggctc       60

tcctgtgcag gcgctggatt caaatttggt gattatgcca tgcattgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagtggga gtagtgatta catagtctat      180

gcggactctg tgaggggccg atgcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag accagaggac acggccttct actactgtgc aaaaggtgtt      300

gatcaaggag gggtgatcgc ctacttccac cactggggcc cgggcaccct agtcaccgtc      360

tccgcag                                                                367


<210>  114
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  114
tatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg cgtagtaatg gatacaacta tttgagttgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tattgggctt tattactgca tgcaagctct acgaaccccc      300

ctcactttcg gcggagggac caaggtggag atcaaac                               337


<210>  115
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  115
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggcgtg ggtggcactt atatcatatg atggatataa taaatactac      180

gcagactccg tgaggggccg attcaccatc tccagaatca attccaagaa cacgctgtct      240

ctgcagatga acagcctgag agctgaggac acggctgtct attactgtgc gagagggtca      300

gctggaaact actactacgg tatggacgtc tggggccagg ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  116
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  116
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gaccattacc aactatttaa attggtatca gctgaaatca      120

gggagagccc ccaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cgccgtacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  117
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  117
caggtcacct tgaaggagtc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcgccg tctctgggtt ctcactcagc aatgctaaaa tgggtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgaatga cgaaaaagct      180

tacagtacat ctctgaagac caggctcacc atctccaagg acacctccaa aagccaggtg      240

gtccttaccg tgaccaacat ggaccctgtg gacacagcca catattactg tgcacggata      300

gtcttaggag cttcggggac ttatccctct ccggggttcg acccctgggg ccagggaacc      360

ctggtcaccg tctcctcag                                                   379


<210>  118
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  118
cagactgtgg tgactcagga gccctcactg actgtgtccc caggagggac agtcactctc       60

acctgtgctt ccagtgctgg agcagtcacc agtggttact atccaaactg gttccagcag      120

aaacctggac aagcacccag ggcactgatt tatagtacag ccaacaaaca ctcctggacc      180

cttgcccggt tctcaggctc cctccttggg ggcaaagctg ccctgacact gtcaggtgtg      240

cagcctgagg acgaggctga gtattactgc ctgctctact atggtggtgc ttgggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  119
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  119
gaggagcaac tggtggagtc tgggggcggc ttggtacagc cagggcggtc cctgagactc       60

tcctgtacag cctctggatt cacctttggc gattataaaa tggcgtgggt ccgccaggct      120

ccagggaggg ggccggagtg ggttggtctc attcgaagca gagctaacgg tgagtcaaca      180

gaatactccg cgtctgtaaa aggcagattc accgtctcca gagatgattc caaaggcatc      240

gcctatctgc aaatgtacaa cctacaaact gaggacacag ccatatatta ctgtactagg      300

gatcctacct tgtggccctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  120
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  120
gacatccaga tgacccagtc tccttccacc ctgtctacat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattggt ccctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgag acctctcgtt tacataatgg agtcccatca      180

aggttcagcg gcagtggttc tgggacagac ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caaattatta ttgtcatcaa tatatggctt tctggacgtt cggccaaggg      300

accagggtgg aaatcaaac                                                   319


<210>  121
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  121
gaggtgcagc tggtggagtc cgggggaggc ttagttcagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctactgga tgcactgggt ccgccaagtt      120

ccagggaagg ggctggtgtg ggtctcacgt attaatagtg atgggagtag cacaagctac      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa cacgctgtat      240

ctggaaatga acagtctgag agcccaggac acggctgttt attactgtgc aggttccccg      300

tggctacgag gcgacattga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  122
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  122
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaaggccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctggg      240

ctgatgactg aggacgaggc tgactactac tgtcagtctt atgatggcag caatcatgct      300

gtggtattcg gcggagggac caagctgacc gtcctag                               337


<210>  123
<211>  385
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  123
gaggtgcagc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc ccttagactc       60

tcctgtgcag cctctggatt cactttcagt aacgcctgga tgagctgggt ccgccaggct      120

ccagggaagg gactggagtg ggttggccgt attaaaggca aaactgatgg tgggacaaca      180

gactacgctg cacccgtgaa aggcagattc accatctcaa aagatgattc aaaaaatacg      240

ctgtatctgc aaatgagcag cctgaatacc gaggacacag ccgtgtattg gtgtaccacc      300

cttacgtatt attatgatag tagtgcttat ctcaatgatg cttttgatat ctggggccaa      360

gggacaatgg tcaccgtctc ttcag                                            385


<210>  124
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  124
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcaaaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac cggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagcctgcag      240

cctgatgatt ttgcaactta ttactgtcaa cagagttaca gtacccctgg caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  125
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  125
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcacc agctactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtggtggtag cacaagctac      180

gcacagaagt tccagggcag agtcaccatt accagggaca catccgcgag tacagtctac      240

atggagctga gcagcctgag atttgaagac acggctgtgt attactgtgc gagtatgacc      300

cggaggtcac accaaaccta cttcggtatg gacgtctggg gccaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  126
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  126
gacatcgtga tgacccaatc tccagagtcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtctttta tacagctccg acaataagaa ctacttagct      120

tggtatcaac agaaaccagg acagcctcct aagctactca tttactgggc gtctatccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagac tggagcctga agattttgca gtgtattact gccagcagta tggtcgctca      300

ccgatcacct tcggccacgg gacacgactg gagattaaac                            340


<210>  127
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  127
caggtgcagc tggtgcaatc tgggtctgag ttgacgaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact agctatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacaccg acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtat actactgtgc gagagatccc      300

tcctattgta gtagtactag atgctatact gtaggctggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  128
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  128
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa aatgtgcact ggtaccagca gaagccaggc      120

caggcccctg tggtggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcctgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  129
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  129
caggtgcagc tacaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtga ctccatcaac agtggtaatt actactggag ctggatccgg      120

cagcccgccg ggaagggact ggagtggatt gggcgtatgt ttaccagtgg gagcaccaac      180

tacaacccct ccctcacgag tcgagtcacc atgtcaatag acacgtccaa gaaccagttc      240

tccctgaacc tgaactcggt gaccgccgca gacacggcca tgtattactg tgcgaggggt      300

cacgtcgcag cctgggagag ctgctactac tggggccagg gaatcctagt caccgtctcc      360

tcag                                                                   364


<210>  130
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  130
aatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg aatagtaatg gactcaccta tttggattgg      120

tacctgcaga agccagggca gtctccacag ttgttgatct atttcgtttc taatcgggcc      180

tccggggtct ctgacaggtt cagtggcagt gggtcaggcg cagattttac actgacaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

cagacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  131
<211>  391
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  131
gaggtgcagc tggtggagtc tgggggaggt gtagtacggc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacccttgat gattatggct tgagctgggt ccgccacgct      120

ccagggaagg ggctggagtg ggtctctggt attaattgga atggtggtcg cacagcttat      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agccgaggac acggccttgt atcactgtgc gagagccaga      300

ggcccatcgg aacaatatta cgatcttttg actggttatt atgatgcttt tgatatctgg      360

ggccaaggga caatggtcac cgtctcttca g                                     391


<210>  132
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  132
gaaattgtgc tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgcg gggccagtca gagtattagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccgc tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta tttctgtcag caatatggtg gctcgctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  133
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  133
gaggtgcaac tgttggagtc tgggggaggc ttgatacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc aactatgcca tgtcctgggt ccgccaggcc      120

ccagggaagg ggctggagtg ggtctcaggt attattagta ccagtggtgg tgccacatac      180

aacgcagact ccgtgagggg ccggttcacc acctccaggg acaattccaa gaacatactg      240

tatctgcaaa tgaacagcct cagaggcgag gacacggccg tttattactg tgtgaaaggt      300

ctctttgact ggttcccgct ctggggccaa gggacaatgg tcaccgtctc ttcag           355


<210>  134
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  134
tcctatgagc tgactcagtc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgtt ggtaccaaca gaggccaggc      120

cagtcccctg tgctggtcat ctatcaagat agtaagcggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg gacagcagca cccatgtggt attcggcgga      300

gggaccaagc tgaccgtcct ag                                               322


<210>  135
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  135
gaggtgcagc tgttggagtc tgggggaggc ttggtacatc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc agctatgcct tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acaggctgag agccgaggac acggccgtat attactgtgc gcaaatgggc      300

cccctgggta gtaccagctc cgcggcggac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  136
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  136
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaaat gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tggtggtcat ctatgaagat aacaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagcc ttgtggtatt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  137
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  137
gaggtgaagc tattggagtc tgggggaggc ttggtacagc cgggggggtc cctgagactc       60

tcctgcgaaa cgtctggatt cagttttagt agttatgaca tgaattgggt tcgccaggct      120

ccagagaagg ggccggagtg ggtcgcagtt atcactgtta gtggtgacac agaatacgca      180

gactccgtga agggccggtt caccatctcc agagacaatt cccagaacaa ggtctttcta      240

caaatggaca gtctgaccgc cgaggacacg gccacatatt tttgtgcgaa agatttcaca      300

gcctggtatg cggtgggctt ctggggccaa gggaccacgg tcatcgtctc ctca            354


<210>  138
<211>  314
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  138
gacatccagt tgacccagtc tccatcctcg gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca ggacattggc cattttttag cctggtttca gcagacgcca      120

gggaaagccc ctaagcccct aatatatgct acgagtaaaa tgcagcgtgg ggtcccgtca      180

cagttcagtg gcagtggctc tgggacagat ttcactctca ccatcagcag cctgcatcct      240

gacgatttcg caacttatta ctgccaacaa tatgacagtt atccgtggac gttcggccaa      300

gggaccaggg tgga                                                        314


<210>  139
<211>  390
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  139
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg atgaatccta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accaggaaca cctccataag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccctgt attactgtgc gagagaggca      300

cgatattttg actggatatt cgaggggtcg gattactact actacggtat ggacgtctgg      360

ggccaaggga ccacggtcac cgtctcctca                                       390


<210>  140
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  140
cagtctgccc tgactcagcc tccctccgtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgacgttggt agttataacc gtgtctcctg gtaccagcag      120

cccccaggca cagcccccaa actcatgatt tatgaggtca gtaatcggcc ctcaggggtc      180

cctgatcgct tctctgggtc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag ccttagggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  141
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  141
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggagggtc cctgagactc       60

tcctgtgaag cctctggatt caccttcagt agttctgaaa tcaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcacac attagtagta gtggtagtat catatactac      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgttt attactgtgc gaggagatct      300

tatagaagca gctggtacta ctactacggt atggacgtct ggggccaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  142
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  142
gacatccagt tgacccagtc tccatccttc ctgtctgctt ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct      240

gaagattttg caacttatta ctgtcaacag cttaatagtt accccgtgac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  143
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  143
caggtgcaac tggtgcagtc tggggctgag atgaagaagc ctgggtcctc ggtgaaagtc       60

tcctgcaggg cttctagagg caccttcaat acccacgcta tcagctgggt gcgacaggcc      120

cctggacaag gtcttacatg gatgggaggg atcatcccca tctttgccac gacaaactac      180

gctcacaact tccagggcag aatcaccatt accgcggacg actccacgac cacagcctac      240

atggaactga gcagcctgac atccgcggac acggccgtct attactgtgc gagagtgggc      300

gggggtaatt cgtattctta ttatggaatg gacgtctggg gccctgggac cacggtcatc      360

gtctcctca                                                              369


<210>  144
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  144
gagattatga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catacgagtg gacataatct tttggattgg      120

tacctgcaga aaccagggca gtctccacag ctcctgatct acttgggttc taagcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggagcaggca cagattttac actgaaaatc      240

agtagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

ccaacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  145
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  145
gacgtgcaat tggtggagtc cgggggaggc ttggttcagc cgggggggtc cctgagactc       60

tcctgtgtgg cctctggatt caccctcggc aacttttgga tgcactgggt ccgccaggct      120

ccagggaggg ggcttgaatg ggtctctcgt gtgaacactg ccggaactac cacatattac      180

gcggattccg tgaagggccg attcaccatc tccagagaca acgccaagaa tacgctgttt      240

ctgcaaatca gtagtgtgag agtcgacgat tcgggaattt attattgtgc aagagacggg      300

agtggtggaa gctggggctg gctcgacccc tggggccagg gcgtcctggt caccgtctcc      360

tcag                                                                   364


<210>  146
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  146
tcctatgaac tgactcagcc accctcactg tccgtgtccc caggacagac agccagaatc       60

acctgctctg gaaataactt gggggataga tatgccttct ggtatcgtca gaggccaggc      120

cagtcccctc ttttaatcat ctatcaagat aataaccggc cctctggaat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc actctgacca tcaccgggac ccaggctctc      240

gatgaggctg actatttctg tcaggcgtgg gatggcggca ctgtggtgtt cggcggaggg      300

accagattga ccgtcctag                                                   319


<210>  147
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  147
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc cagggcggtc cctgagactc       60

tcctgtactg cctctggatt catctttggt gattatgcta tgggctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtaggtttc attagaggca aagcttatga tgggacaaca      180

gaatacgccg cgtctgtgaa aggcagattc accatctcaa gagatgattc caaatacatc      240

gcccatctgc aaatgaacag cctgaaaacc gaggacacag ccgtgtatta ctgtattaga      300

gactacgatt tttggggtgg ttattattat catccattgc gtgcttttga tatctggggc      360

cgagggacaa tggtcaccgt ctcttcag                                         388


<210>  148
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  148
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataatt atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca ctaagaggcc ctcaggggtc      180

cctgagcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttactcctgc tgctcatatg ctggcagcta cacctatgtc      300

ttcggaactg ggaccaaggt caccgtccta g                                     331


<210>  149
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  149
caggtgcact tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgcca tgcactgggt ccgccagtct      120

ccaggcaagg gactggagtg ggtggcattc ataacacatg atggaagtaa gcaagaatat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgttgtat      240

ttgcaaatga accgcctgag agcagaggac acgactgtgt attactgtgc gaaaggagtc      300

actgagggca gctggagttt tgactcctgg ggccagggaa cccaggtcag cgtctcctca      360

g                                                                      361


<210>  150
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  150
aatattgtgc tgacccagag tccactcttt ctgtccgtca cccctggaca gccggcctcc       60

atctcctgca ggtctagtca gagactcata aatgattatg gacggacctt tttgtattgg      120

tatctgcaga agccaggcca gtctccacag ctcctgatct ctgaagtttc caagcggttc      180

tctggagtgc cagataggtt cagtggcagc gggtcaggga cagatttcac actgcaaatc      240

agacgggtgg aggctgagga tgtgggcgtt tattactgca tgcaaagtgc gtcccttccc      300

actttcggcc ctgggaccaa agtgaatgtc aaac                                  334


<210>  151
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  151
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcagc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca catattactg tgcacgccac      300

cagatagtag tcctttttga tatgtggggc caagggacaa gggtcaccgt ctcttcag        358


<210>  152
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  152
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccggcag tgacgttggt ggttctaact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag caccctagtg      300

ctattcggcg gagggaccaa gctgtccgtc ctag                                  334


<210>  153
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  153
caggtccaat ttgcgcaatc cggggctgag gtgaagaggc ctggggcctc agtgaagatt       60

tcctgtaagg cttctggatt caccttcact aactatgcag tccactgggt gcgccaggcc      120

cccggacaaa gtcctgagtg gatgggatgg atcaacgctg gcaatggcaa cacaaaatac      180

tcagagaagt tcaagggcag agtcaccatt actagagaca cgtctgcgaa cacagcctac      240

atggagctga gcagcctgac atctgaagac acggctgtgt tttactgtgc gagactactc      300

tataccgcag tgggttatta ttatgattat tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  154
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  154
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtcggaga cagaattacc       60

atcacttgcc gggcaaacca gaccattgcc aactctttaa attggtatca acaaaaacca      120

gggaaagccc ctgcactctt gatctatctt tcaagcaact tacacagcgg ggtcccatca      180

aggttcagtg gcagtggttc tgggacagac tttactctca ccattagtag tctgcaacct      240

gaggattttg cgacttactt ctgtcagcag ggtgccacta ccccgggcac ctttggccag      300

gggaccacgg ttgacatcaa ac                                               322


<210>  155
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  155
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac agcaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gattacgtat      300

tactatgata gtagtggtta ttggtgggac gactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  156
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  156
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcag cgtagcaact ggcctccttc gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  157
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  157
gaagtggagg tggtagagtc gggcgggggc ttagtccacc caggggggtc ccggagactc       60

tcctgtgtag cctctggatt ctcttttagt acttcgtgga tgacctgggt ccgccaggct      120

ccagggaggg ggccggagtg ggtggccagc attaaggacg atggaaatga gaagcagtat      180

ttggactctg tgaggggccg attcagcatc tctagagaca acggcaacaa cctagtgttt      240

ctgcaaatgg acagcctgag agccgaggac acggctgtct actactgtgc gagaagtctc      300

agcttccacc cctacgcctt cttttattac atggacgtct ggggcaaggg gaccacggtc      360

accgtctcct ca                                                          372


<210>  158
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  158
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgctctg ggggcacctc taatatcggg tcaggttatc atgttcactg gtacaaacag      120

cttccagaag aagcccccaa actcctcatc tttggcaaca gccatcggcc ttcaggggtc      180

cctgaccgat tttctggctc caagtctggg aacacagcct ccctggtcat cactggcctc      240

cagagtgacg atgaggctga ttacttctgc cagtcgtatg acggctacct gactgcttat      300

gtcttcggaa gtgggaccaa actcaccgtc ctag                                  334


<210>  159
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  159
caggtgcaac tggtgcagtc tggggctgag gtgaagaagc ctggggcctc aatgaaggtc       60

tcctgcaagg cttctggata catcttcgcc aattatgata tcaactgggt gcgacaggcc      120

actggacacg ggcttgagtg gatggggtgg atgaacccta gtagtactaa cacaggctat      180

gcacagaagt tccagggcag ggtcaccctg accacgaaca cctccatggg cacagcctac      240

atggagctga gcggcctgac atctgaggac acggccgtat attactgtgc gcgaggacgt      300

cagtggagta cctggtcgga gcactggttc gacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  160
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  160
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact taacctggta tcagcacaaa      120

cccggccagg ctcccaggct cctcatgtac agtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgcgaca gacttcactc tcaccatcaa cagactggag      240

cctgaagatt ttgcagtata ttactgtcaa caatatgttg agcccccgtt cacttttggc      300

caggggacca ggctggagat caaac                                            325


<210>  161
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  161
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggactatct attatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaagcagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattattg tgcgggggag      300

gaggttcggg gagttaaact gtactactac tatgctatgg acgtctgggg ccaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  162
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  162
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacattggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcatcag cacttgggtg      300

ttcggcggag ggaccaaggt gaccgtccta g                                     331


<210>  163
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  163
gaggtgcagc tggtggagtc tgggggacgc ttggtcctgc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt gtttatgaaa tgaactgggt ccgccaggct      120

ccagggaagg gactggagtg gctttcatac attggcacta gtggtagtcc catatactat      180

gcagactctg tgaagggccg attcaccgtc tccagagaca acgccaaaaa ctcactatat      240

ctgcaaatga acagcctgag agtcgaggac acggctcttt actactgtgc gagagatagg      300

ggctggaact acggtcttga ttactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  164
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  164
tcctatgagc tgacacagcc atcatcggtg tcagtgtccc caggacaaac ggccagaatc       60

acctgctctg gagatgcatt gccaaaaaga tatgcttatt ggtaccggca gaagtcaggc      120

caggcccctg tgttggtcat ccatgaggac agtaaacgac cctccgggat ccctgagaga      180

ttctctggct ccacctcagg gacaatggcc actttgacta tcactggggc ccagctggaa      240

gatgaagctg actactattg tttttcaatg gacagcagtg gtgatcttag ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  165
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  165
caggtgcagc tacagcagtg gggcgcagga ctgttgaggc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg gtccttcagt gatttcttct ggacctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcagacgaa gtggactcac cacctacaac      180

tcgtccctca agagtcgagt caccatatca atagacacgt ccaggaacca gttctccctg      240

aggctggact ctgtgaccgc cgcggacacg gctatgtatt actgtgcggg aggcgactct      300

cgcgtgtggg aggcattaat tgactggggc cagggaaccc aggtcgccgt ctcctcag        358


<210>  166
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  166
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtaagctg gtaccaccag      120

cttccaggaa cagcccccaa actcctcatc tatggtaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cagtgggctc      240

cagtctgagg atgaggctga ttattactgt cagtcttatg atggcagcaa tcatgctgtg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  167
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  167
caggtgcagc tgctgcagtc tggggctgag gtgaagaagc ctggggcctc tgtgagggtt       60

tcctgcaacc cgtctggata caccttcacc acttactata tccactgggt acgacaggcc      120

cctggacaag ggctagagtg gatgggaata atcaacccta atagtagtga cacaatgtac      180

gcacagaagt tccaggacag agtcaccatg accagggaca cgtccacgag aacagtctac      240

atggacctga gcagcctgag atctgaggac acggccttat attactgtgc gagagattcc      300

gggggggggc gcggtgactt ctctaacggt atggacgtct ggggtcaagg gaccacggtc      360

accgtctcct cag                                                         373


<210>  168
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  168
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatt       60

acctgctctg gagacgcatt gccaaagaaa tatgcttatt ggtaccagca gaaggtaggc      120

caggcccctg tgttgatgat atataaagac actgagaggg cctcagggat ccctgagcga      180

ttctctggct ccagtagaga cacaaaagtc acattgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcaaca gacagcagtg gtgtctatag ggttttcggc      300

ggagggacca ggctgaccgt cctag                                            325


<210>  169
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  169
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcactt atatcatctg atgggggtaa taaattctac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatgtc      300

ccgactacgg tgactgcttt caccgttttt acctactggg gccagggaac cctggtcacc      360

gtctcctca                                                              369


<210>  170
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  170
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggtga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc acctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattatg caacttacta ctgtcaacag agttacagta cccctgggct cactttcggc      300

ggagggacca aggtggagat caaac                                            325


<210>  171
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  171
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctctcactg       60

acctgcacct tctctgggtt ctcactcggc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ctctgaagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtcttactg tgcacggggg      300

gtggatactt atgactattg gggccaggga accctggtca ccgtctcctc ag              352


<210>  172
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  172
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtgacc       60

atcacttgcc gggcaagtca gagcattgcc ggctatttaa actggtatca gcagaaacca      120

gggaaagccc ctaacctcct gatctatgag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccctcagcag tctgcaacct      240

gaagattttg caacttactc ctgtcaacag agttacagta cccctggcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  173
<211>  385
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  173
gaggtgcagc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc ccttagactc       60

tcctgtgcag cctctggatt cactttcagt aacgcctgga tgagctgggt ccgccaggct      120

ccagggaagg gactggagtg ggttggccgt attaaaggca aaactgatgg tgggacaaca      180

gactacgctg cacccgtgaa aggcagattc accatctcaa aagatgattc aaaaaatacg      240

ctgtatctgc aaatgagcag cctgaatacc gaggacacag ccgtgtattg gtgtaccacc      300

cttacgtatt attatgatag tagtgcttat ctcaatgatg cttttgatat ctggggccaa      360

gggacaatgg tcaccgtctc ttcag                                            385


<210>  174
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  174
tcccaacttg tgactcaatc gccctctgcc tctgcctccc tgggagcctc ggtcaagctc       60

acctgcactc tgagtagtgg gcacaccaat tacgccatcg catggcatca gcaggagcca      120

gagaagggcc ctcggttctt gatgaaggtt aacagtgatg gcagccacaa caagggggac      180

gggatccctg atcgcttctc aggctccagc tccggggctg agcgctacct caccatctcc      240

agcctccagt ctgaggatga ggctgattat tactgtcaga cctggggccc tggcattcgg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  175
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  175
gaggtgcgac tggtgcagtc tggaccagag gtgaaggagc ccggggagtc tctgaagatc       60

tcctgtaagg gatctggata caactttgcc gactactggg tcggctgggt gcgccagatg      120

tccggcggag gcctggagtg gatggggatc atccatcctc ctgactctca aaccagactc      180

agtccgtcct tccaaggcca ggtcaccatg tcagtcgaca agtccatcaa caccgcctac      240

ctgcagtgga gcagcctgac ggcctcggac accgccatat attactgtgc gaggcgcctt      300

tctcctcttc agttgctaag cggtggattc tactcctttg actactgggg ccagggaacc      360

cgcgtcaccg tctcctcag                                                   379


<210>  176
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  176
gaaattgtgt tgacacagtc tccagccacc ctatctttgt ctccagggga aggagcctcc       60

ctctcttgta gggccagtca gagtgttggc accttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgag ggctccaacc gggccactgg cattccaggc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcac cctggagcct      240

gaagattttg cagtttatta ctgtcagcag cgttacggct ggcctcccac tttcggcggg      300

gggaccaagg tggagatcaa ac                                               322


<210>  177
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  177
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cgccttcagt aactatgcta tacactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaaacaa taaagactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagtccct      300

gttatggttc ggggagttta ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  178
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  178
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttgtt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtcc gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttatttctgc atctcatata caagcagccg cactctggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  179
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  179
caggtgcagc tacagcagtg gggcgcagga ctgttgaggc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg gtccttcagt gatttcttct ggacctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcagacgaa gtggactcac cacctacaac      180

tcgtccctca agagtcgagt caccatatca atagacacgt ccaggaacca gttctccctg      240

aggctggact ctgtgaccgc cgcggacacg gctatgtatt actgtgcggg aggcgactct      300

cgcgtgtggg aggcattaat tgactggggc cagggaaccc aggtcgccgt ctcctcag        358


<210>  180
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  180
gacatcgtga tgacccagtc tccagattcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgttttt aacatccaca acaataggga ctacttaggc      120

tggtaccagc agaaaccggg acagcctcct aaactagtca tttactgggc atctacccgg      180

gaatccgggg tccccgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcgccggcc tgcaggtcga agatgtggca gtttattact gtcagcaaat gtatagtcct      300

ccgcgaacat tcggccaagg gaccagggtg gaaatcaaac                            340


<210>  181
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  181
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggact caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac atactacgca      180

gactccgtga agggcagatt caccatctcc ggagacaatt ccaagaacac gctgtatctt      240

caaatgaaca gcctgagagt cgatgacacg gctgtgtatt actgtgcgag agatccgggt      300

tcccgataca gtggtggctg gtacgactac tactacgcta tggacgtctg gggccaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  182
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  182
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctcc gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  183
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  183
gaagtgcagc tggtggagtc cgggggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgtag cctccgaatt cacctttagt agctattgga tgagctggtt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtca gaaatactat      180

gtggactctg caaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agtcgaggat acggctgtgt attactgtgc gagtcgcctt      300

tgtagttctt ccggctgcta tgcggcgtcc taccactaca tggacgtctg gggcaaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  184
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  184
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataatt atgtctcttg gtaccaacat      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtcagcggcc ctcaggggtc      180

cctgatagct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcagcta cactttggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  185
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  185
gaggtgcagc tggtggagtc cgggggaggc ttagttcagc ctggggggtc cctgacactc       60

tcctgtgcag cctctggatt ccccttcagt acttactgga tacactgggt ccgccaggcg      120

ccagggaagg ggctggtgtg ggtctccagt attaaggatg atgcgactaa cacatactac      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgcccagaa cacggtacat      240

ctgcaaatga acagtctcag aggcgaggac acggctgtgt attactgtgc aagagatgag      300

ggccgactta atatggttcg ggggtatgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  186
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  186
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagccg gagtctttta tccaagaata agaacttctt agcctggtac      120

cagcagaaac caggacagcc tcctaagctg ctcacttact gggcatccac ccgggcatcc      180

ggggtccctg accgattcgc tggcagcggg tctgggacag atttcactct caccatcagc      240

agcctgcagg ctgaagatgt ggcagtttat tactgtcaac aatattatag tagtcctttc      300

actttcggcg gagggaccaa ggtggagatc aaac                                  334


<210>  187
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  187
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctcaagatc       60

tcctgtaagg cttctggata cagctttacc agctactgga ttggctgggt gcgccagaag      120

cccgggaaag gcctggaatg gatggggatc atctatccta gtgattctga aaccagatac      180

agcccgtcct tccagggcca ggtcagcatc tcagccgaca agtccatcaa caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccacct attattgtgc gagacactgg      300

tgtagtggtg gtagttgcta ctacggaatg gacgtctggg gccaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  188
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  188
gaaattgttt tgacgcagtc tccaaccacg ctgtctttgt ctccggggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcggctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatcaat gctgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcac cagactggag      240

cctgaagact ttgcagtcta ttactgtcag gagtatggta gctcggcgat caccttcggc      300

caagggacac gactggacat taaac                                            325


<210>  189
<211>  399
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  189
caggtgcaac tggtggagtc tgggggaggc ttggtcaagc ctggagggtc cctgagactt       60

tcctgtgcag cctctggatt cacactcagt gacttctaca tgagctggat ccgccaggct      120

ccagggaagg ggctggagtg gatttcatac tttagtagtg gtaggagtag cacatactac      180

ggagactctg tgaagggccg attcaccatc tccagggaca ccgccaagaa ttcactgtat      240

ttgcaaatga acgacctgag agccgaggac acggccgtgt attactgtgc gagagatacg      300

cgcaaggctt attactatga tagtcgtggt tataacccat tctaccatta ttacggtatg      360

gacgtctggg gccaagggac cacggtcacc gtctcctca                             399


<210>  190
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  190
gaaattgtga tgactcagtc tccactctcc ctgtccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctc catagtaatg gatacaacta tttggattgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc tgatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagc ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgaaga tgttgggatt tactactgca tgcaagctct agacactctg      300

ttcactttcg gccctgggac caaagtggat atcaaac                               337


<210>  191
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  191
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttccc acctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

ggcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagacgtgac      300

accgattttg actactgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  192
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  192
cagcctgtgc tgactcagcc accttctgca tcagcctccc tgggagcctc ggtcacactc       60

acctgcaccc tgagcagcgg ctacagtaat tataaagtgg actggttcca gcagagacca      120

gggaagggcc cccggtttgt gatgcgagtg ggcaccggtg ggattgtggg atccaagggg      180

gatggcatcc ctgatcgctt ctcagtcttg ggctcaggcc tgaatcggta cctgaccatc      240

aagaacatcc aggaagagga tgagagtgac taccactgtg gggcagacca tggcagtggg      300

agcaacttcg tctatgtggt attcggcgga gggaccaagc tgaccgtcct ag              352


<210>  193
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  193
gaggtgcaac tattggagtc tgggggaggc ttggcacagc cgggggggtc cctgagactc       60

tcgtgtgtag cctctggatt cagctttagt tcttatggca tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagta atggatggta gtgctggaaa catatactac      180

gcagacgccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacactgtat      240

ctgcaaatga acagcctgag acccgaagac acggccgcat atttctgtgc gaaagattcg      300

ggagcgcttt gcagtggtgg tgattgcttg agggggtact tcgatctctg gggccgaggc      360

accctggtca ctgtctcctc ag                                               382


<210>  194
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  194
gacatcgtaa tgacccagtc tccagaatcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtctttta tacagctccg acaataagaa ctacttagct      120

tggtatcaac agaaaccagg acagcctcct aagctactca tttactgggc gtctatccgg      180

gaatccgggg tccctgaccg attcaggggg agcgggtctg ggacagattt cactctcacc      240

atcagcggcc tgcaggctga agatgtggcg gtttattatt gtcagcagta ttatggtact      300

ccgtacactt ttggccaggg gaccaggctg gagatcaaac                            340


<210>  195
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  195
caggtgcaac tggtgcagtc tggggctgag gtgaagaagc ctggggcctc aatgaaggtc       60

tcctgcaagg cttctggata catcttcgcc aattatgata tcaactgggt gcgacaggcc      120

actggacacg ggcttgagtg gatggggtgg atgaacccta gtagtactaa cacaggctat      180

gcacagaagt tccagggcag ggtcaccatg accaggaaca cctccatagg cacagcctac      240

atggagctga gcggcctgac atctgaggac acggccgtat attactgtgc gcgaggacgt      300

cagtggagta cctggtcgga gcactggttc gacccctggg gccagggaac cctggtcacc      360

gtctccgcag                                                             370


<210>  196
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  196
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gtgaaactca gagtataagt acctatttaa attggtatca acagaaacca      120

gggaaagccc ctaaactcct aatctatgct gcgtccagtt tgcaaagtgg ggtcccaccg      180

aggttcagtg gccgtggatc tgggacagat ttcactctca ccatcagcag cctagaccct      240

gaagattttg cagtttatta ctgtcacaag cgtagcaact ggcctccttc gctcactttc      300

ggcggaggga ccaaggtgga gatcaaac                                         328


<210>  197

<400>  197
000

<210>  198

<400>  198
000

<210>  199
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  199
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgtag cctctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatttg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt tttactgtgc gaaagatttg      300

cctccgtatg ctagtggctg gtacgagggg ggctttgact actggggccg gggaacccag      360

gtcaccgtct cctcag                                                      376


<210>  200
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  200
cagactgtgg tgactcagga gccctcactg actgtgtccc caggagggac agtcactctc       60

acctgtgctt ccagcactgg agcagtcacc agtggttact ttccaaactg gttccagcag      120

aaacctggac aagcacccag ggcactgatt tttagtacaa acaacagaca ctcctggacc      180

cctgcccggt tctcaggctc cctccttggg gacaaagctg ccctgacact gtcaggtgtg      240

cagcctgagg acgaggctga atattactgc ctgctctact atggtggtcc ttgggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  201
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  201
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt gtatcatatg atggaagtaa caaatactat      180

acagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgttt      240

ctgcaaatga tcggcctgag agaagaggac acggctgtgt attactgtgc gcaaggccga      300

ggtggttatt actccccctt tgacgactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  202
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  202
gaaatagtga tgacgcagtc tccaggcacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gactcttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatca ctgtcagcag tataataact ggcctctggc gttcggccaa      300

gggacgaagg tggaaatcaa ac                                               322


<210>  203
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  203
caggtcacct tgaaggagtc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcaccg tctctgggtt ctcactcagc aatgctagaa tgggtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgggtga cgaaaaatcc      180

tacagcacat ctctgaagag caggctcacc atctccaagg acacctccaa gagccaggtg      240

gtccttacca tgaccaacat ggaccctctg gacacagcca catattactg tgcacggacg      300

acgtggggga cgtggataca agcctggtac ttcgatatct ggggccgtgg caccctggtc      360

actgtctcct cag                                                         373


<210>  204
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  204
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatattggg agttataacc ttgtctcctg gtaccaacag      120

tacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggtggtaa cacttttgtg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  205
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  205
caaatgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgaaggtt       60

tcctgcaagg cttctggatt cacctttact aggtctgctg tgcagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gataggatgg atcgtcgttg gcagtggtaa cacaaactac      180

gcacagaagt ttcaggaaag agtcaccatt accagggaca tgtccacaag cacagcctac      240

ctggagctgg gcagcctgag atccgacgac acggccgtgt attactgtgc ggcagtgtgc      300

gagtggttat gtgacttctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  206
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  206
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggac      240

gatgaggctg actattactg ttactctgcg gctgacaaca aaggggtatt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  207
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  207
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agttatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtttg atggaagtaa taaacactat      180

gcagattcag tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagagggc      300

gatttttgga gtggttatta tacaggctgg ttcgacccct ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  208
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  208
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgta gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcctcggac gttcggccaa      300

gggaacaggg tggaaatcaa                                                  320


<210>  209
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  209
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cacgttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatctc      300

acaattgtag taataccagc tgccccaaat tttgactact ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  210
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  210
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caggtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cactcctgtg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  211
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  211
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc agctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctagagtg ggtctcattt attagtggta ctggtgatag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gaaagatcaa      300

gcccgagtcc aggattacat ttgggggagt tatcgctcct acggtatgga cgtctggggc      360

ctagggacca cggtcaccgt ctcctca                                          387


<210>  212
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  212
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacctgcaga agccagggca gtctccacat ctcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

cggacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  213
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  213
gaagtgcaac tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcattgggt ccggcaagct      120

ccagggaagg gcctagagtg ggtctcaggt atcagttgga acagtggtac cataggctat      180

gcggactctg tgaagggccg attcatcatc tccagagaca acgccaagaa ctccttgtat      240

ctgcaaatga acagtctgag acctgaggac acggccttgt attactgtgc aaaagatata      300

atacgtcagg gcgaagacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  214
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  214
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gaacattgcc agctatttga attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc ggggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagagtttg caacttacta ctgtcaacag agttacagta ccccgtggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  215
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  215
caggtgcagc tgcgggagtc gggcccagga ctggtgaggc cttcggagac cctgtccctc       60

aagtgcactg tctctggtga ctccgtcagc ggtaattccc acttctggac gtggatccgg      120

cagcccccag ggaagggact ggagtggatt gggtacatct ttaatagtgt gtccaccgcc      180

tacaacgcct ccctcaggag tcgagtgacc atatcagtag acacatccaa gaaccaattc      240

tccctggaac tgacctctgt caccgctgcg gacacggccg tgtattattg tgcgggaggt      300

ttcggcgacg cgtgggagcc ccagggctac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  216
<211>  335
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  216
gacatcgtga tgacccagtc tccagacttc ctggctgtgt ctctgggcga gagggccacc       60

atcagctgca agtccagcca gactgttttc aacagcgcca accataggaa ctacttaggg      120

tggtaccagc agaaaccagg acagcctcct aagttgctca tttactgggc ctcaacccgg      180

agatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata tcacaatatg      300

gtcacttttg gccaggggac caagctggag atcaa                                 335


<210>  217

<400>  217
000

<210>  218

<400>  218
000

<210>  219
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  219
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc agctatgcct tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagta atggatggta gtgctggaaa catatactac      180

gcagacgccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gcaaatgggc      300

cccctgggta gtaccagctc cgcggcggac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  220
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  220
gaaattgtgt tgacacagtc tccagccatt ttgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gggccactgg catcccagac      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaaaac tatatcagtg cccctcaaac tttcggccct      300

gggaccaaag tggatgtcaa ac                                               322


<210>  221
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  221
caggtgcagc tgcaggagtc gggcccagga ctggtgaagg cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtc actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtattt cttatagagg gaccacccac      180

cagaacccgt ccctcaagag tcgagccatc atatctattg acacgtccaa gaaccacttc      240

tccctgatcc tgagctctct gaccgccgct gatacggctg tttattattg tgcgagatac      300

actacgatgg taggggagtt tgactcttgg ggccagggaa ccctggtcgc cgtctcctca      360

g                                                                      361


<210>  222
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  222
tcctatgaac tgacacagac accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccagaccaa tatgcttttt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac actgagaggc cctcagggat ccctgatcga      180

ttctctggtt ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcggca gacagcagtg gaactaaccc tgtggtattc      300

ggcggaggga ccacgctgac cgtccta                                          327


<210>  223
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  223
gaggtgcagc tggtggagtc tgggggaggc ctggtcaagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cactttcagt ggctatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcatcc attagtagta gtagtagtta catatactac      180

gcagactcag tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag ggccgaggac acggctgtgt attactgtgc gagatggcta      300

cagttaagat cagactacta ttacttcggt atggacgtct ggggccaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  224
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  224
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc aacaacttag cctggtacca gcacaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctacagtct      240

gaagattttg cagtttattt ctgtcagcag tgttataact ggcctccgtg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  225
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  225
gaggtgcagc tggtggagtc tgggggaggc ctggtcaagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcatcc attagtagta gtagtcgtta catatactac      180

gcagactcag tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagaggcccc      300

cgtgggtaca gttatggtta ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  226
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  226
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgta gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gggccactgg catcccagac      180

aggttcagtg gcactgagtc tgggacagac ttcactctca ccatcagcag actggagcct      240

gaagattttg cagtgtatta ctgtcagcag tatggtagct cactgctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  227
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  227
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc acttttggag tgggtgtggg ctgggtccgt      120

cagcccccag gaaaggccct ggagtgcctt gcactcattt attgggatga tgatgagcgc      180

tatagcccgt ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggta      240

gtccttacaa tgaccaacat ggaccctgca gacacaggca catattactg tgcacacagg      300

aaaaaagcga gcagtggctg gcagacattt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  228
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  228
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttct tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac cggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gatcatcagg gacgttcggc      300

caagggaccc gactggacat taaac                                            325


<210>  229
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  229
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgtag cctctggatt cacctttagt ttctattgga tgagctgggt ccgccaggct      120

ccaggaaagg ggctcgagtg ggtggccaac ataaagcaag atggaggtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagactgtct      300

ggcagcagct gggactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  230
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  230
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgtt ggtaccaaca gaggccaggc      120

cagtcccctg tgctggtcat ctatcaagat agtaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctggagtctt cggaactggg      300

accaaggtca ccgtcctag                                                   319


<210>  231
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  231
gaggtgcagt tggtgcagtc tgggggaggc ttagtaaagc ctggggggtc cctcagactc       60

tcctgtgcag cctctggatt ccctttcagt aacatctgga tgagttgggt ccgccaggct      120

ccaggaaagg ggctggagtg ggttgcccgt attaaaagca agactgctgg tgagatcaca      180

gactatgctg cacccgtaaa ggacagattc aacatttcaa gagatgattc acaaaaaatg      240

ctgtttctgc aaatgaacag cctgaaaacc gaggacacag gcatgtatta ctgtatcaca      300

gattggcgcg ttgactactg gggccaggga gccctggtca ccgtctcctc ag              352


<210>  232
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  232
tcctatgagc tgactcagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaaaaaaa tatgcttatt ggtaccagca gaagtcgggc      120

caggtccctg tgttggtcat ctttgaggac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagttcagg gacaatggcc accttgacca tcagtggggc ccaggtggcg      240

gatgaaggtg actactattg ttactcaaca gacagcagtg gtgaccaaag ggtgttcggc      300

ggagggacca agctgaccgt cct                                              323


<210>  233
<211>  343
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  233
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cagcgtcagt accaactaca tgagttgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagtac attctacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctt      240

cagatgaata gcctgagagc tgaggacacg gctgtgtatt actgtgcgag agactacagg      300

gattggatct ggggccaggg aaccctggtc accgtctcct cag                        343


<210>  234
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  234
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca agacattagc aagtatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaagagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcaggct      240

gaagatattg caacatatta ctgtcaacag tatcataatc tgcctcggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  235
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  235
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacaac      300

cgtttccaat attgtagtag tactacctgc tataccctac ttccctttga ctactggggc      360

cagggaaccc tggtcaccgt ctcctcag                                         388


<210>  236
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  236
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaagaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct      240

gaagattttg caacttatta ctgtcaacag cttaatagtt acccattcac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  237
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  237
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgctc tgttctgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atttcatatg atggaaataa taaatactac      180

gcagactccg tgaggggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag acctgaggac acggctgtgt attactgtgc gagaccatat      300

actgggagct acaagagcta catggacgtc tggggcaaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  238
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  238
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctccttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtatattact gtcagcaata ttatagtatt      300

tcttggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  239
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  239
caggtgcagt tggtggagtc tgggggaggc ttggtcaagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt ggctactaca tgagctggat ccgccagact      120

ccagggaagg gactggaaca tatttcatac atcagtggag atggtagtga caaaatctac      180

gcagactctg tgaagggccg attctccatc tccagggaca acgccaagaa ctcactgtat      240

ctccaaatga acagcctgcg agccgaggac acggccgtgt attactgtgc gactgctgct      300

cgcacagcgc caaactgggg ccagggaacc ctggtctccg tctcctcag                  349


<210>  240
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  240
gatgttgtgg tgactcagtc tccactctcc ctgcccgtca ttcttggaca gccggcctcc       60

atctcctgca ggtctagtca aagcctcgta tacagtgatg gaaacaccta cttgaattgg      120

tttcagcaga ggccaggcca atctccaagg cgcctaattt ataaggtttc taaccgggac      180

tctggggtcc cagatagatt cagcggcagt gggtcaggca ctgatttcac actggaaatc      240

agcagagtgg aggctgggga tgttgggatt tattactgca tgcaagctac acactggccg      300

ttcacttttg gccaggggac caagctggag atcaaac                               337


<210>  241
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  241
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggaatg ggtggcagtt atatcatatg atggaagtaa taaatattac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactgtat      240

cttcaaatga gcagcctgag agctgaggac acggctgttt tttactgtgc gagaggggat      300

ggagatgtct acaatttcct cctcgttcgt aactggttcg acccctgggg ccagggaacc      360

ctggtcaccg tctcctcag                                                   379


<210>  242
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  242
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtcg gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cactctctat      300

gtcttcggaa ctgggaccaa ggtcaccgtc ctag                                  334


<210>  243
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  243
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggaatg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca acaccaagaa cacggtgtgg      240

ctacaaatga acagcctgag agtcgaggac acggctgtct atttttgtgc aagagttttt      300

gactgggtct tatatgatta ttggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  244
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  244
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacattggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat cgctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggctgcta cactttggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  245
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  245
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtttct attatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccagttc      240

tccctgaacc tgagctctgt gaccgccgca gacacggctg tatattcctg tgcgagttta      300

tggttcgggg acttatactc ttttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  246
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  246
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

ttcacctgcc gggcgagtca gggcatcagc aattatttag cctggtatca gcagaagcca      120

gggaaagttc ctaagctcct gatctatgct gcatccactt tgcaatcagg ggtcccatct      180

cggttcagcg gcattggatc tgggacagat ttcactctca ccatcagcag cctgcagcct      240

gaagatgttg caacttatta ctgtcaaaag tataacagtg ccccttggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  247
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  247
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctgggggttc cctgagactc       60

tcctgtgcag actctgcatt cacctttagt agtttttgga tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaattctat      180

ttggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagactaggt      300

cgcagcagct ggaactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  248
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  248
tcctatgaac tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataag tttgtttgct ggtatcagca gaagccaggc      120

cagtcccctg tcctggtcat ctatcaagat aacaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctctg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctggggtatt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  249
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  249
caggtccagc tggttcaatc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaaga cttctggaga cacctccagc agttatactg tcggctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat agcatactcc      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgac cacagcctac      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagagaggac      300

tactatggtt cggggagctt agtcgacccg tactactact accgtatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  250
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  250
gacatccaga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggtattagc agctggctag cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctactt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag actggagcct      240

gaagattttg cagtgtatta ctgtcagcag tatggtagct cacctaggct cactttcggc      300

ggagggacca aggtggagat caaac                                            325


<210>  251
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  251
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtga ctccatcagc agtggtagtt actactggag ctggatccgg      120

cagcccgccg ggaagggact ggagtggatt gggcgtatct ataccagtgg gagcaccacc      180

tacaacccct ccctcaagag tcgagtcacc atatcagtaa acacgtccaa gaatcagttc      240

tccctgaacc tgagctctgt gaccgccgca gacacggccg tgtattactg tgcgagagtg      300

ggcggtatat caccttacta ctactactac tacatggacg tctggggcaa agggaccacg      360

gtcaccgtct cctca                                                       375


<210>  252
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  252
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgttggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatgtatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcaacac cctgcagcct      240

gaagattttg caacttatta ctgtcaacag cttaatagtt accccatcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  253
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  253
caggtgcacc tggtggagtc tggaggaggc gtggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agatttggcg tgcactgggt ccgccaggct      120

ccaggcaagg gcctggagtg ggtgactctc atatcgtttg atggaaggaa taaaaattat      180

gcaggctccg tgaggggccg cttcaccatc tccagagaca gttccaagag tacggtgtat      240

ctgcaaatga acagcctgag agccgaggac acggcactat attactgcgc gcgagagtac      300

catgatggtg ccaattggtc gggtgccttt gatgtctggg gccaagggac atgggtcacc      360

gtctcttcag                                                             370


<210>  254
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  254
cagtctgtgc tgagtcagcc accctcaacg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcacctc caacatcgga aggaatactc taaactggta tcagcagcgc      120

ccaggaacgg cccccaaact actcatctat attaataacc ggcggccctc aggggtccct      180

gaccgagtct ctggctccaa gtctggcacc tcaggttccc tggccatcag tgggctgcag      240

tctgacgatg aggctgatta ctactgtgca gcatgggatg acgtattgca ggggtgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  255
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  255
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat ccggcagccc      120

gccgggaagg gactggagtg gattgggcgt atctatacca gtgggagcac caactacaac      180

ccctccctca agagtcgagt caccatttca gttgacacgt ccaagaacca gttctccctg      240

aaactgacgt ctgtgaccgc cgcggacacg gccgtctatt actgtgcgag agacgtgccg      300

gcagctgacg gtatggacgt ctggggccaa gggaccacgg tcaccgtctc ctca            354


<210>  256
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  256
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tttgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tactggtcat ctatgaagat ttcaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca attgggtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  257
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  257
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat tcggcagccc      120

ccagggaagg gactggagtg gattgggtat atctactaca gtgggagcac caagtacaac      180

ccctccctca agagtcgagt caccatgtca gtagacacgt ccaagagcca gttctccctg      240

aagctgggct ctgtgaccgc tgcggacacg gccatgtatt actgtgcgag agtcgggagc      300

attggctggt atcactattt tgagtactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  258
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  258
gatattgtga tgactcagtc cccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactccg      300

acgttcggcc aagggaccaa ggtggaaatc aaac                                  334


<210>  259
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  259
cagggacagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgtgagg cttctggata cacctttctc agttatgata tcaactgggt gcgacaggcc      120

cctggacaag ggcctgagtg gatgggatgg atgagcccaa ccagtggtta cacagactct      180

gcaccgaagt tccagggcag actcaccatg accaggagca cctccataag cacagcctat      240

atggaactga gcggcctaac atctgacgat acggccgtgt attactgtgc gagaggcaaa      300

ccgcttgact actggggcca gggaaccctg gtcaccgtct cctcag                     346


<210>  260
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  260
gacatcgtga tgacccagtc tcctgactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gactctttta tacagttcca ataataaggc ttgcttagct      120

tggtaccagc agaaaccagg gcagcctcct aagttgctca ttttctgggc atccacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcaggc tgcaggctga agatgtggcg cattattatt gtcagcaata ctgttcttct      300

cctcggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  261
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  261
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatggggtgg atgaacccta acagtggtaa cgcaggctat      180

ggacagaagt tccagggcag agtcactatg accaggaaca cctccataag cacagcctac      240

atggagttga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaatgcgc      300

agtggctggc ccactcatgg ccgcccggat gactactggg gccggggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  262
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  262
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccttc       60

tcttgttctg gaagcaactc caacatcgga agttatactg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatttat gataataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gtatgggatg acagcctgaa tggcctggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  263
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  263
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc acttttggag tgggtgtggg ctgggtccgt      120

cagcccccag gaaaggccct ggagtgcctt gcactcattt attgggatga tgatgagcgc      180

tatagcccgt ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggta      240

gtccttacaa tgaccaacat ggaccctgca gacacaggca catattactg tgcacacagg      300

aaaaaagcga gcagtggctg gcagacattt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  264
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  264
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaccaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg gacagcagca ctggagtctt cggaactggg      300

accaaggtca ccgtcctag                                                   319


<210>  265
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  265
gaggtgcaac ttttggagtc tgggggagac ttggtacagc ctgggggttc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctacgcca tgacttgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcaagt attagtggaa gtggtggaaa cacacactac      180

gcagagtccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacggtgttt      240

ttgcaaatga gcagcctgag agccgaggac acggccgtgt attattgtgc gaaagataaa      300

ccggatacta gtagtactac cctaaacatg gacgcctggg gcaaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  266
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  266
tcccatgagc tgacacagcc atcctcagtg tcagtgtctc cgggacagac agccaggatc       60

acctgctcag gaaatatatt gacaaaaaaa tatgctcggt ggttccaaca gagacctggc      120

caggcccctg ttcttctaat ttataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctccggct ccagctcagg gaccacagtc accttgacca tcaccggggc ccaggttgag      240

gacgaggctg actattactg ttactctgtg gctgacaaca accgggtctt cggaactggg      300

accaaggtca ccgtcctag                                                   319


<210>  267
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  267
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtggtt actactggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggtacatct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagttacc atatcagtag acacgtctaa gaaccagttc      240

tccctgaagc tgagctctgt gactgccgcg gacacggccg tgtattactg tgcgagcgca      300

aaactagtgg ctacgattag ctactttgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  268
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  268
cagtctgtgc tgactcagcc accctcggtg tctgaagccc ccaggcagag ggtcaccatc       60

tcctgttctg gaagcagctc caacatcgga aataatgctg taaactggta ccagcagctc      120

ccaggaaagg ctcccaaact cctcatctat tatgatgatc tgctgccctc aggggtctct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tggtgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  269
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  269
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggttactact ggaactggct ccgccagccc      120

ccagggaagg ggctagagtg gattggggaa atcaatcata gtggaagcac caactacaac      180

ccgtccctca agagtcgagt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag agtgggggga      300

tactactact actacatgga cgtctggggc aaagggacca cggtcaccgt ctcctca         357


<210>  270
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  270
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattacc agctatttaa attggtatca gcagagacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca gcatcagcag tctgcaacct      240

gaggattttg caacttacta ctgtcaacag agttacacta cccttctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  271
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  271
gaagtgcagc tggtggagtc tgggggagac ttggttcagc ctggcaggtc cctgagactc       60

tcctgtgcaa cctccggatt cacctttaat cgtcatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagtggga gtagtgatta catagtctat      180

gcggactctg tgaagggccg attcaccatc tccagagact acgccaagaa ctccctgtat      240

ctggacttga acagtctgag agttgaggac acggcctttt atttctgtgc aaagggagtg      300

gatatgacgg gtcgactagc ctactttgac cactggggcc agggaaccct ggccaccgtc      360

tcctcag                                                                367


<210>  272
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  272
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatactacca tttggcttgg      120

tacctgcaga agccagggca gtctccacag ctcctcatct acttggcttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggttcaggca cagattttac actgaagatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

ctcactttcg gccctgggac caaagtggat atcaaac                               337


<210>  273
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  273
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt catcttcagt acctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggagacaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca actccaagaa cacgctgtat      240

ctggaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagaccccgg      300

ggggggagct atcaaacttg ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  274
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  274
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggccagggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  275
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  275
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact agccacacta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaatgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctggcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagatggggg      300

cctgactacg gtgactacgc ctccaatgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  276
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  276
tcctatgagc tgacacagcc atcctcagtg tcagtgtctc cgggacagac agccaggatc       60

acctgctcag gagatgtact ggcaaaaaac tatgctcggt ggttccagca gaagccaggc      120

caggcccctg tgttggtgat ttataaagac agtgagcggc cctcagggat ccctaagcga      180

ttttccggct ccagctcagg gaccacagtc accttgacca tcagcggggc ccaggttgag      240

gatgaggctg actattactg ttactctgcg gctgacaaca atcgggtatt cggcggaggg      300

accaagctga ctgtcctag                                                   319


<210>  277
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  277
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcagct tctctgggtt ctcactcacc actagtggag tgggtgtggg ctggatccgt      120

cagtccccag gaaaggccct ggagtggctt gcactcattt attgggataa tgataagcgc      180

tacagtccat ctctgaagag cagggtcacc atcaccaagg gaacctccaa aaaccaggtg      240

gtcttcacaa tgaccaatat ggagtctgtg gacacagcca catattactg tgcacacaac      300

acttattcca acggtgtgga cgtctggggc cgagggacca cggtcaccgt ctcctca         357


<210>  278
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  278
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttaac ggcttcttgg cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg cgtcccagcc      180

aggttcagtg gcggtgggtc taggacagac ttcaccctca ccatcagcgg cctagagcct      240

gaagattttg gaatttatta ctgtcaacag cgtagcaact ggttgtacac ttttggccag      300

gggaccaaac tggagatcaa ac                                               322


<210>  279
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  279
gaggagcagt tggtggagtc tgggggaggc ttggtggagc ctggagggtc cctgagactc       60

tcctgtggag cctctggatt catcttcagt aactatgatc tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg gctttcatac attagtcata gtggccgtac cacatggtac      180

gcagactctg tgaagggccg attcaccatt tccagagaca acgccaagaa gtcactgcac      240

ctgcaaatga acagcctgag agtcgaggac acggctgttt atttctgtgc gagagattcg      300

gattactatg ataatagtgg ttatcctgat gcttttgata tctggggcca agggacaatg      360

gtcaccgtca cctcag                                                      376


<210>  280
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  280
tcctctgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaagtcaa tatgtttatt ggtaccaaca gaggccaggc      120

caggcccctg tgttggtgat atataaagac actgagaggc cctcagggat ccctgagcga      180

ttctctggcg ccagctcagg gacaacagtc acgttgacca tccgtggagc ccaggcagaa      240

gacgaggctg actatcactg tcaatcagca gacagcactg gtacctttgt ggtgttcggc      300

ggcgggaccc atctgaccgt cctag                                            325


<210>  281
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  281
gaagcgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattctgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtaa cgtaggctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtac aaaagcctct      300

cgatattgta gtagtaccat ctgctattgg aactggttcg acccctgggg ccagggaacc      360

ctggtcaccg tctcctcag                                                   379


<210>  282
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  282
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatggt gcatccagtt tgcaaactgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagaag tctgcaacct      240

gaagattttg caagttacta ctgtcaacag agttacagta cccccacttt cggcggaggg      300

accaaggtgg agatcaaac                                                   319


<210>  283

<400>  283
000

<210>  284

<400>  284
000

<210>  285
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  285
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact acctatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccaggact tcacaggacg gtttgtcttc tccttggaca cctctgtcag tacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagaggtttg      300

gtgggacgca tcgacccctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  286
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  286
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactctttaa gttggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tgaaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tcctcttatt cactttcggc      300

cctgggacca aagtggatat caaac                                            325


<210>  287
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  287
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcacc aactactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatggggata ctcaaccctg gtgctggtag cacaagctac      180

gcacagaagt tccagggcag agtcaccatg accagtgaca cgtccacgaa cacagtctac      240

atgcagctga gcagcctgaa atctgaagac acggccgttt attactgtgc gagagatcag      300

caaatcgtcc cccatgccga tggttttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttcag                                                                367


<210>  288
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  288
gaaattgtgt tgacacagtc tccggccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcag cgtagcaact ggcctccgag gacgtggacg      300

ttcggccaag ggaccaaggt ggaaatcaaa c                                     331


<210>  289
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  289
caggtgcagc tggtgcagtc tggggctgag gtgaggaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcggcaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatccctg tctttggtac agcaaactac      180

gcacagaagt tccagggccg agtcacgatt accgcggaca aatccacgag cacagccttc      240

atggagctga acagcctgag atctgaggac acggccgtct attactgtgc gagaattggg      300

agctaccctg aatacttcca gcactggggc cagggcaccc tggtcaccgt ctcctcag        358


<210>  290
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  290
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcactac cgtagcaact ggcctccggt tctcactttc      300

ggcggaggga ccaaggtgga gatcgaac                                         328


<210>  291
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  291
gaagtgcaac tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcattgggt ccggcaagct      120

ccagggaagg gcctagagtg ggtctcaggt atcagttgga acagtggtac cataggctat      180

gcggactctg tgaagggccg attcatcatc tccagagaca acgccaagaa ctccttgtat      240

ctgcaaatga acagtctgag acctgaggac acggccttgt attactgtgc aaaagatata      300

atacgtcagg gcgaagacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  292
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  292
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gtaacgccgt ggtattcggc      300

ggagggacca agctgaccgt c                                                321


<210>  293
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  293
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcactctg       60

acctgcacct tttctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcagtcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagaa caggctcacc atcaccaagg acacctccca aatacaggtg      240

atccttacaa tgaccaacat ggaccctgtg gacacaggca catattactg tgcacacaga      300

cgagagtggg agccttaccg ttactggggc cagggcaccc tggtcaccgt ctcttcag        358


<210>  294
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  294
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtctttta tacacctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctccg aagttgctct tttattgggc atctacgcgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtcct      300

ccgtggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  295
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  295
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt agctattgga tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaaggaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt actactgtgc gagagatgtt      300

gggggatata gtggctacga tttgggtttt gactactact actacatgga cgtctggggc      360

aaagggacca cggtcaccgt ctcctca                                          387


<210>  296
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  296
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaaact ggtaccagca gaagccagga      120

caggcccctg tagttgtcat ctttggtaag aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccaactcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gttacatctg gggttggatg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  297
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  297
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

gcctgtgcag cctctggatt caccttcagt agttatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaaataa taaatactat      180

gcagactctc tgaagggccg attcaccatc tccagagacg attccaagaa cacgctgtat      240

ctgcagatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatcgg      300

acagctgtgt ttctattctt cggcctagga gatgcttttg atatctgggg ccaagggaca      360

atggtcaccg tctcttcag                                                   379


<210>  298
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  298
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tggttgtcgt ctatgatgat agcgaccggc cctcagggct ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcattg ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  299
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  299
caggtgcagc tggtgcagtc tggggctgcg gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcgtcccta tctttggcac agcaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgac cacagcctac      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagagaggac      300

tactatggtt cggggagctt agtcgacccg tactactact accgtatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  300
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  300
gaaatagtgc tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcac cgtagcaact ggcctccgag gctcactttc      300

ggcggaggga ccaaggtgga gatcaaac                                         328


<210>  301
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  301
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcagtg tatctggtgg ctccatcagg agttacttct ggaactgggt ccggcagccc      120

ccagggaagg gactggagtg gattgggtat atctattaca gtgggagcac caactacaaa      180

ccctccttca agagtcgagt caccatctcc ttagacacgt ccaagaacca gatctccctg      240

aagctgagct ctgtgaccgc tgcggacacg gccgtgtatt actgcgcgag agcaacatgg      300

ctgcgggatg cttttggtat ctggggccaa gggacaatgg tcaccgtctc ttcag           355


<210>  302
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  302
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcagctgca agtccagtca gagtgtttta aacagccaga acaataggga ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aaactactca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcagtctga agattttgca ctttattact gtcagcagta taataactgg      300

tggcgcacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  303
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  303
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agtcactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatat      180

agcccgtcct tccaagggca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagtgccctc      300

agagagcgag gcgtacagct gtggtcagtt tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  304
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  304
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tttattaact ccaatcggcc ctcaggggtc      180

cctgaccgct tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gggtgccttg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  305
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  305
gaggtgcgac tgttggagtc tgggggaggc ttggtacagc cgggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttacc agctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctgcagtg ggtctcaact attagtgtta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gaaagatcct      300

gcgtcgggga tagtgggacc tactcacttt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  306
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  306
cagcttgtac tgactcaatc gccctctgcc tctgcctccc tgggagcctc ggtcaagctc       60

acctgcactc tgagcagtgg gcacaccacc tacgccatcg catggcatca gcagcagcca      120

gagaagggcc ctcggtactt gatgaagctt aacagtgatg gcagccacac caggggggac      180

gggatccctg atcgcttctc aggctccagc tctggggctg agcgctacct caccatctcc      240

agcctccagt ctgaggatga ggctgactat tactgtcagt cctgggacac tggcataggg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  307
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  307
caggtccagc tggtacagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg tttccggata caccctcact gaactatcca tacactgggt gcgacaggct      120

cctggaaaag ggcttgagtg gatgggaggt tttgatcctg aagatgctga aacaatctac      180

gcacagcagt tccagggcag agtcaccatg accgaggaca catctacaga cacagcctac      240

atggagctga gcagcctgaa atctgaggac acggccctgt attactgtgc aacagggttc      300

gcggtgtttg ggagggcagc agttccctac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  308
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  308
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctttg gagataaatt gggggataaa tatgcttgct ggtttcagca gaagccaggc      120

cagtcccctg tgctgatcat ctatcaaggt gccaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctgtggtttt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  309
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  309
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtgatt actactggag ttggatccgc      120

cagcccccag ggaagggcct ggagtggatt gggtacatct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagttacc atatcagtag acacgtccaa gaaccaggtc      240

tccctgaagc tgagttctgt gactgccgca gacacggccg tgtattactg tgccagattc      300

cgacgcagct atggttcagg gagttattat aatataagct ttgactactg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  310
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  310
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg taggtagtag cacttatgtg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  311
<211>  395
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  311
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcacc acaagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ctctgaagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtcctcgcaa tgaccaacat ggaccctgtg gacacagcca catactactg tgcacgggta      300

gtcgttaggt gtcctggtac tggtgatgtc tgctcgacgt actactatca aagcatggac      360

gtctggggcc aggggaccac ggtcaccgtc tcctc                                 395


<210>  312
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  312
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctacc tagcctggta ccagcagaaa      120

cgtggccagg ctcccaggct cctcatcttt ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gagttcactc tcaccatcag cagcctgcag      240

tctgaagatt ttgcagttta ttactgtcag caaatgtata gtcctccgcg aacattcggc      300

caagggacca gggtggaaat caaac                                            325


<210>  313
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  313
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact aggcatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg atttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgt gagagagtat      300

ggcagtggcc acccactccc gatctggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  314
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  314
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg cagatgcatt gtcaaaacaa tatgcttatt ggtatcagca gaagccaggc      120

caggcccctg tggtggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtt cccattgggt gttcggcgga      300

gggaccaagc tgaccgtcct ag                                               322


<210>  315
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  315
caggtgcagt tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agtggcagtt actggtggag ctggatccgg      120

cagtccgccg ggaagggact ggagtggatt ggacatacat atatcagtgg gagcaccaac      180

tacaatcctt ccctcaagag tcgcgtctac atatcagaag acacgtccaa gaaccagttc      240

tccctgaaaa tgaactctgt gaccgcccga gacacggccg tgtattattg cgcgagaatc      300

gtccgcccct gtagttatcc cagctgctct ggttacaact tcttctacta cttggacgtc      360

tggggcaaag ggaccacggt caccgtctcc tca                                   393


<210>  316
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  316
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga attaatactg tgaactggta tcaacaagtc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tgggcatcag tggggtccac      240

tctgaggatg aggctgatta ttactgtgca gcctgggatg acagcctgaa tggtccggtg      300

ttcggcggag ggaccaaggt gaccgtcct                                        329


<210>  317
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  317
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcagtg tatctggtgg ctccatcagg agttacttct ggaactgggt ccggcagccc      120

ccagggaagg gactggagtg gattgggtat atctattaca gtgggagcac caactacaaa      180

ccctccttca agagtcgagt caccatctcc ttagacacgt ccaagaacca gatctccctg      240

aagctgagct ctgtgaccgc tgcggacacg gccgtgtatt actgcgcgag agcaacatgg      300

ctgcgggatg cttttggtat ctggggccaa gggacaatgg tcaccgtctc ttcag           355


<210>  318
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  318
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcaacagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggatagcc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt ttgatagcgg caatgtggtc      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  319
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  319
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgagggtt       60

tcctgcaagg cacctggata caccttcacc acctactata tacactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtgctggtag tacaacctac      180

gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaggattc      300

catgtaccag ctgctcttcg gaactggttc gacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  320
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  320
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaatactg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctat aataataatc agcggccctc aggggtccct      180

gaccgactct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgtg gcatgggatg acagccggaa tggcctggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  321
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  321
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtggtt actactggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggtacatct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagttacc atatcagtag acacgtctaa gaaccagttc      240

tccctgaagc tgacctctgt gactgccgcg gacacggccg tgtattactg tgcgagagag      300

gctaatgatt cggggagttt ttataacggc ccctttgact actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  322
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  322
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

cggacttttg gccaggggac caagctggag atcaaac                               337


<210>  323
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  323
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac actgtccctc       60

acctgcactg tctatggtgg gtccttcagt gactacttct tgacctgggt ccgccagccc      120

cccgggaagg gtctggagtg gattggggaa gtcactcata ttgggagcat ctactacaac      180

acgtccctcc agagtcgact caccatatca atggacgcgt ccaagaatca gtttttactc      240

aagctggctt ctgtgtccgc cgcggacacg gctgtttatt actgtgcgaa aggcaccgcc      300

tacgcatggg aagtcctcca tgcctggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  324
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  324
gacatcgtga tgacccagtc tccagacttc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgttttc aacagcgaaa accattacaa ctacttagct      120

tggtatcaac aaaaaccagg acaggtccct aaattgctcg tttactgggc atctacccgg      180

gaagccgggg tccctgagcg attcagtggc agcgggtctg cgacagattt cactctcaca      240

atcagcaccc tgcaggctga agatgtggca gtttattatt gtcagcaata ctatggtgct      300

cctcggacgt tcggccgagg gaccaaggtg gaaatcaaac                            340


<210>  325
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  325
caggtgcagc tgcaggagtc gggcccagga ctggtgaaac cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcggt agttactact ggagctgggt ccggctgccc      120

cccggaaggg gactggaatg gattgggcat atctcttaca gtgggaacac caactacaat      180

ccctccctca agagtcgact ctccatatca gtagacacgt ccaagaacct gttttccctg      240

aaactgaatt ctgtgaccgc tgcggacacg ggcatttatt attgtgcgag agttttcccc      300

cgtaagcagt ggctggtacg ggggtactgg tacttcgatg tctggggccg gggcactctg      360

gtcactgtct cctcag                                                      376


<210>  326
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  326
gacatccaga tgacccagtc tccatcgtcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacataaag aactttttaa attggtatca gaagaaacca      120

ggggaagccc ctaagctcct gatctacgat gcatccaatt tgaaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttga ccatcaacag cctgcagcct      240

gaagatactg cgacatattt ttgtcagcag tatgataatc tcctattcac tttcggctct      300

gggaccaaag tggatatcaa ac                                               322


<210>  327
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  327
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtagtt actactggag ctggatccgg      120

cagcccgccg ggaagggact ggagtggatt gggcgtatct ttaccagtgg gagcaccaac      180

tacaacccct ccctcaagag tcgagtcacc atatcagtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggccg tgtattactg tgcgaggggt      300

ggcttactat ggttcggggg ggcggggaac tacatggacg tctggggcaa agggaccacg      360

gtcaccgtct cctca                                                       375


<210>  328
<211>  343
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  328
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

cctccgtaca cttttggcca ggggaccaag gtggagatca aac                        343


<210>  329
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  329
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcag taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa tacgctgtat      240

ctgcaaatga gcagcctgag agctgaggac acggctgtat attactgtgc gaaagaagga      300

gagtgggaac tacgggggaa tgctcttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttcag                                                                367


<210>  330
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  330
gacatcgtga tgacccagtc tccagattcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgttttt aattgggaca accataggga ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

ggatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaccg tagcaactgg      300

cctccgaggc tcactttcgg cggagggacc aaggtggaga tcaaac                     346


<210>  331
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  331
caagtgcagc tggtgcagtc tggggctgaa gtaaagacgc ctggggcctc agtgatggtc       60

tcctgcaggg tttcgggata caccttcacc agccttgata tcaactgggt acgacagacc      120

actgcacaag gactggagtg gatgggatgg atgacccccc ggaacggtaa tacaggctat      180

gcacagaagt ttcagggcag agtcatcatg accagggaca ccgccattaa caccgcctac      240

atggaactca ctggcctgaa ctctgaggac acggccatat attattgtgc gagaggtgtt      300

gccgctggcg ttgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  332
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  332
caggctgtgc tgactcagcc gtctgccctg tctgcatctc ctggagcatc agccaggatc       60

acctgctcct caggcagtgg catcgatatt aaaatgtaca ggatatattg gtatcaacag      120

aagccaggga gtcctccccg gtatctcctg agctacaagt cagactcaga taaacagcag      180

ggctctggag tccccagccg cttctctgga tcgaaagatg cttcggccaa tgcaggggtt      240

ctattcatct ctggactcca gtctgaggat gaggctgact attattgttt gatttggcac      300

atcaacgctt atgtcttcgg gactgggacc aaggtcaccg tcctag                     346


<210>  333
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  333
caggtgcagc tggcgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg ctggtggata caccttcacc agttatgata tcaattgggt gcgacaggcc      120

actggacaag ggcttgagtg gatggggtgg atgaattcta acagcggtaa cgcaggctac      180

gcacagaagt tccagggcag agtcactatg accagggaca cctccataag tacagcctac      240

atggagttga gcagcctgag atctgaggac acggccgtgt attattgtgc gagaatgcgc      300

actggctggc ccacacatgg ccgcccggat gacttctggg ggcggggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  334
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  334
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcaactc caacatcgga agttatactg taaactggta ccagcagttc      120

ccaggaacgg cccccaaact cctcatttat gataataatc agcggacctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctagtta ttattgttta gcatgggatg acagcctgaa tggcctggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  335
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  335
gaagtgcagc tggtggagtc cgggggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgtag cctccgaatt cacctttagt agctattgga tgagctggtt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agtcgaggat acggctgtgt attactgtgc gagtcgcctt      300

tgtagttctt ccggctgcta tgcggcgtcc taccactaca tggacgtctg gggcaaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  336
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  336
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gtaacgccgt ggtattcggc      300

ggagggacca aactgaccgt cctag                                            325


<210>  337
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  337
caggagcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtctctc       60

atctgcactg tctctggtgg ctccatcagt agttactact ggaactggat ccggcagccc      120

ccagggaagg gactggagtg gattgggtat atctattata gtgggcgcac caactacaac      180

ccctccctca agagtcgagt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aagctgaact ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag agcccctccc      300

cccccctcga agtggttact taactactac tacatggacg tctggggcaa agggaccccg      360

gtcaccgtct cctca                                                       375


<210>  338
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  338
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagccc caacatcgga agtagtacta taaactggta tcagcagctc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgacta ttactgtgca tcatgggatg acagcctaaa tggccatgtg      300

gttttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  339
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  339
caggtgctcc tgcaggagtc gggcccaggg ctggtgaagc cttcggggac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agcagtaact ggtggagttg ggtccgccag      120

cccccaggga agggtctgga atggattgga gaaatctatc ataggggcca aaccggctac      180

aacccgtccc tcaagaggcg agtcaccata tcattagaca agtctcagaa ccagttttcc      240

ctgaaactga cctctgtgac cgccgcggac acggccgtgt attactgtgc gagagatcgt      300

agggagtctt cgccatatca cttctactac ggagtggacg tctggggcca agggaccacg      360

gtcaccgtct cctca                                                       375


<210>  340
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  340
cagcctgtgg tgactcaatc gccctctgcc tctgcctccc tgggagcctc ggtcaagctc       60

acctgcactc tggatagtgg gcacagaagc tacgccatcg catggcatca gcagcggcca      120

gagaagggcc ctcgcttctt gatgaggatt accactgatg gcaggcacac caagggggac      180

gggatccccg atcgcttctc aggctccggg tctgggactg agcgctacct caccatctcc      240

agcctccagt ctgaggatga ggctgactat tactgtcaga cttggggcac tttcggcgga      300

gggaccaggc tgaccgtcct ag                                               322


<210>  341
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  341
caggtgcagt tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcattgggt ccggcaagct      120

ccagggaagg gcctagagtg ggtctcaggt atcagttgga acagtggtac cataggctat      180

gcggactctg tgaagggccg attcatcatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaggccacga      300

agtgggagct actacgccta ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  342
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  342
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttactcaaca gacagcagtg gtaatgtctt cggaactggg      300

accaaggtca ccgtcctag                                                   319


<210>  343
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  343
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc cgggggggtc cctgagactc       60

tcatgtgaag cctttggatt cacatttggt acttattgga tgagttgggt ccgtcaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaaaccag atggaagtga caaatactat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaggga ctcagtggac      240

ctgcaaatga acaacgtgag agccgaggac acggctgtct attattgtgc gagaggggtc      300

tatgacagtg gttggtacat ggataacttt gactactggg gccagggaat cctggtcacc      360

gccgcctcag                                                             370


<210>  344
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  344
cagtctgccc tgactcaacc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagaga tgatgttggt cgttacaacc atgtctcctg gtatcaacaa      120

caaccaggca aagccccccg actcatgatt tatgatgtca ataagcggcc ctcaggggtc      180

cctgatcgct tctctgggtc caagtctggc aatacggcct ccctgaccat ctatgggctc      240

caggctgagg atgaggctga ttattcctgc tgctcatatg cggaggggta cattctcgtg      300

ttcggcggag ggacccgggt gaccgtccta g                                     331


<210>  345
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  345
caggtgcaga tacagcagtg gggcgcagga gtgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggtcactact ggagctggat ccgtcagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagtac caagtacaac      180

ccgtccctca agagtcgagt caccatttca gtagacacgt ccaagaacca gttctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag agggcctccg      300

gtgactacct tttttgtctt tagtttgttg ttcgacccct ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  346
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  346
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg ggagcagctc caacatcgga agtaattatg tatactggta tcagcaactc      120

ccaggaacgg cccccaaact cctcatctat agtagtaatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccgg      240

tccgaggatg aggctgatta ttactgtgca gcatgggatg ccagcctgag tggttgggtg      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  347
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  347
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cacattcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atgggaggaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa tacgctgtat      240

ctgcaaatga gcagcctgag agctgaggac acggctgtat attactgtgc gaaagaagga      300

gagtgggaac tacgggggaa tgctcttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttcag                                                                367


<210>  348
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  348
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg cagatgcatt gccaaagcat tatgcttatt ggtaccagca gaggccaggc      120

caggcccctg tactggtgat atataaagac attgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcactggagc ccaggcagaa      240

gacgaggctg actattactg tcaatcagta gacggcagtg gttcctccgt ggtgttcggc      300

ggagggacca agctggccgt cctag                                            325


<210>  349
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  349
gaggtgcagc tggtggagtc tgggggagtc ttggcccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt agttattgga tgagttgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaaggaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca atgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagaggaatt      300

agcagcggct actggggcca gggaaccctg gtcaccgtct cctcag                     346


<210>  350
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  350
gaaatagtga tgacgcagtc tccagtcacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcctccgtg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  351
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  351
gaggtgcggc tggtggaatc cgggggaggg ttagttcagc cgggggggtc cctgagactc       60

tcctgtgtag cctctggatt caccttcggc tcctacgtga tgcactgggt ccgccaagtt      120

ccagggaagg ggctggtgtg ggtctcacgt attagtcatg acgcaacaag cacaacttac      180

acggactccg tgcagggccg attcaccgtt tccagagaca acgccaggaa cactctgttt      240

ttgcaaatga atagtctcag agtcgacgat acggctgtat attattgtgc aagagacgtc      300

aactacgtct tttacgattt ttggggccag ggatccctgg tcaccgtctc ctcag           355


<210>  352
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  352
caggctgtgc tgactcagcc gccttccctc tctgcatctc ctggagcatc aaccagtctc       60

acctgcacct tacacagtgg catcaatgtt gaaacctacc cgatctactg gtaccagcag      120

aagccaggga gtcctccccg gtatctcctg cagtacaatt cagactcaca taaacagcag      180

ggttctggag tccccagccg cttctctgga tccaaagatg cttcggccaa tgcagggatc      240

ttactcatct ctgggctcca gtctgaggat gaggctgact atcactgtat gatttggcac      300

aacgacgctg cggttttcgg cggagggacc aagctgaccg tcctag                     346


<210>  353
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  353
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccagacaagg ggctggagtg ggtggcagtt atatggtatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctacaaatga acagcctgag agccgaggac acggctgtat attattgtgc gagagagggg      300

cagtggccga accaagcttt tgacatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  354
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  354
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagtatc       60

acctgctcgg gagataaatt gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tgctggtcat ccatcaagat agtcagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca cccatgtggt attcggcgga      300

gggaccaagc tgaccgtcct ag                                               322


<210>  355
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  355
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagac cactctggat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagctggg      300

ggtgggagct accgggggcc ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  356
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  356
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtgacc       60

atcacttgcc gggcaagtca gagcattgcc ggctatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcgccag cctgcaggct      240

gaagatgtgg cagtttttta ctgtcagcta tattatagta ctcctttaac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  357
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  357
caggtgcagc tgcaagagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaagggact ggagtggatt gggagtatct attatagtgg gagctcctac      180

tacagtccgt ctctcaagag tcgagtcacc atatccgcag acacgtccaa gaaccagttc      240

tccctgaacc tgaggtctgt gaccgccgca gacacggctg tgtattactg tgcgagtggg      300

cccccctaca tggctacatt ttcgtactac tttgactact ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  358
<211>  332
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  358
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gttccaacac      120

cacccagaca aagcccccag actcatgatt tatgatgtca gcaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cacccccttt      300

gtcttcggaa ctgggaccaa ggtcaccgtc ct                                    332


<210>  359
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  359
caggtgcagc tggtggagtc tgggggaggc ttggtcaagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt gactactaca tgagctggat ccgccaggct      120

ccagggaagg ggctggagtg tgtttcatac attagtagta gtggtagtac catatactac      180

gcagactctg tgaagggccg attcaccatc tccagggaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtgt attactgtgc gagagaccca      300

atccgcgacg gggtttgggg acttaacgag aatgactact ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  360
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  360
cagcctgtgc tgactcaatc atcctctgcc tctgcttccc tgggatcctc ggtcaagctc       60

acctgcactc tgagcagtgg gcacagtagc tacatcatcg catggcatca gcagcagcca      120

gggaaggccc ctcggtactt gatgaagctt gaaggtagtg gaagctacaa caaggggagc      180

ggagttcctg atcgcttctc aggctccagc tctggggctg actgctacct caccatctcc      240

aacctgcagt ctgaggatga ggctgattat tactgtgaga cctgggacag taacactcgg      300

gtgttcgccg gagggaccaa gctgaccgtc ctag                                  334


<210>  361
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  361
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtctctc       60

acctgcactg tctctgatgg ctccatcagc agtggaagtt actgctggag ctggatccgg      120

cagcccgccg ggaagggact ggagtggatt gggcgtgtct atatatatag cagtgggagt      180

accaactaca acccctccct caagagtcga gtcaccatat cagtagacac gtccaagaac      240

cagttctccc tgaagctgag ctctgtgacc gctgcggaca cggccgtgta ttactgtgcg      300

agagatgggg aaacaactgc aacgtctgcg aggggctcct cctgctacta catggacgtc      360

tggggcaaag ggaccacggt caccgtctcc tca                                   393


<210>  362
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  362
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattaat agctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag actggagcct      240

gaagattttg cagtgtatta ctgtcagcag tatggtagct cacctaggct cactttcggc      300

ggagggacca aggtggagat caaac                                            325


<210>  363
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  363
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtggtt actactggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggtacatct cttacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgacttacc atatcagtag acacgtctaa gaaccagttc      240

tccctgaaac tgagctctgt gactgccgcg gacacggccg tctattactg tgcgagagat      300

ctgggagatg gctacaattt gagggttccg gcctacttcg atctctgggg ccgtggcacc      360

ctggtcactg tctcctcag                                                   379


<210>  364
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  364
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gcctaaccaa tatgcttatt ggtaccacca gaagccaggc      120

caggcccctg tggtggtgat atataaagac agtgagaggc cctcagggat ccctcagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg gttatgtctt cggaactggg      300

accaaggtca ccgtcctag                                                   319


<210>  365
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  365
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggggac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agtagtaact ggtggagttg ggtccgccag      120

cccccaggga aggggctgga gtggattggg gaaatctatc atggtgggag caccgactac      180

aacccgtccc tcaagagtcg agtcaccata tcagtagaca agtccaagaa ccagttctcc      240

ctgaaactga cctctgtgac cgccgcggac acggccgtgt attattgtgc gagggtggac      300

catgtaaacg tgcgtgacta ctggggcccg ggaaccctgg tcaccgtctc ctcag           355


<210>  366
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  366
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cattccctat      300

gtcttcggaa ctgggaccaa ggtcaccgtc ctag                                  334


<210>  367
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  367
gaggtgcagc tggtggagtc tgggggaggc ctggtcaagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcatcc ataagtaata gtaatagttt catatactac      180

gcagactcaa tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gcgagttaac      300

ggcaactcaa actggaactt tgggtcttac tactactact acatggacgt ctggggcaaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  368
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  368
gaaattgtgt tgacacagtc tccagccatt ttgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagt agctacttag cctggtacca acagaagcct      120

ggccaggctc ccaggctcct catctatgat acatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ctatcagcag cctagagcct      240

gaagattttg cattttatta ctgtcagcag cgtggcaact ggtggacgtt cgcccaaggg      300

accaaggtgg aaatcaaac                                                   319


<210>  369
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  369
cgggtccagt tggtacagtc tggggctgag gtgaggaagc ctggggcctc agtgagggtc       60

tcctgcaagg tgtccgggta ctccctcagt gaattatcca tgcactgggt gcgacaggct      120

cctggaaaag ggcttgagtg gatgggaggc tttgatcctg aagatggtga aacagtctac      180

gcacagaggt tccaaggcag agtctccatg accgaggaca tatctacaga cacagcccac      240

atggagctga gcagcctgag atctgacgac acggccgtct attactgtgc atccgggggt      300

ctcaacggtg actacgtcac gggtggggcc tactactatt acatggacgt ctggggcaag      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  370
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  370
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattacc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

cggttcagtg gaagtggatc tgggacagat tttattttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaccag tatgattatc tcccgtacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  371
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  371
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcagc aactaccata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtgc agcaaactac      180

gcacagaact tccagggcag agtcacgatt accgcggacg aatccacgag cacaggctac      240

atgcaactga gcagcctgag atttgaggac acggccgtgt attactgtgc gagaggtgca      300

gcgtcctttg actactgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  372
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  372
cagtctgccc tgactcagcc tccctccgcg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataagt atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgaggtca ataagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccgt ctctgggctc      240

caggctgagg atgaggctga ttattactgc agctcatata caagcagcag cacccccttt      300

gtcttcggaa ctgggaccaa ggtcaccgt                                        329


<210>  373
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  373
caggtgcacc tacaacagtg gggcgcagga ctgttgaagc cttcagagac cctgtccctc       60

acgtgcactg tctctggtac ctccttcagc gattatttct ggacgtggat ccgccagccc      120

ccagggaagg gactagagtg gattggggaa atcagggaga tgggaaccat caactacaat      180

tcgtccctcg agagtcgagc cgtcatttca atggacacgt cccggagtca gttctccctg      240

agtctgaggt ctgtgaccgc cgcggacacg gctgtatatt attgcgcggg aggcgattct      300

cgcgtgtggg aggccctagt tgtctcgggc ccgggaacgc aggtcaccgt ttcctcag        358


<210>  374
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  374
gacatcgtga tgacccagtc tccagattcc ctgggtgtgc ctctgggcgg gagggccacc       60

atcaactgca agtccagcca gaatgttttc aacagccaca acaataggga ctacttggct      120

tggtaccagc agagaccagg acagcctcct aagttactta tttactgggc atctacgcgg      180

gacttcgggg tccctgaccg cttcagtggc agcgggtctg ggacggattt cactctcacc      240

atcgccagcc tgcaggctga agatgtggca gtctactact gtcaacaata tcatgctgcc      300

ccgcgaacgt tcggccaggg gaccaaggtg gaaatcaaac                            340


<210>  375
<211>  368
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  375
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgccc tgcactgggt ccgccagtct      120

ccaggcaagg gactggagtg ggtggcattc ataacacatg atggaagtaa gcaagaatat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgcgc gaaaaacgag      300

cggattacta tgctagtagt agttaccctc tttgactact ggggccaggg aaccctggtc      360

tccgtctc                                                               368


<210>  376
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  376
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagtctcctg catagtaatg gatacaacta cttggattgg      120

tatctgcaga agccaggaca atctccacaa ctcctgttct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgacga tgttggggtt tattactgca tgcaagctct acaaactcct      300

ttcactttcg gccctgggac cagagtggat atcaaac                               337


<210>  377
<211>  353
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  377
gaggtgcagc tgttggagtc tggaggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgcag cgtctggatt cacctttagt acctatgcca tacactgggt ccgccaggcc      120

ccagggaagg ggctggagtg gatctcaggc attagcggga atggttattt tacattctac      180

gcagactccg tgaagggccg gttctccatc tccagagaca attccaggga cacgctgtat      240

ctccaaatga acagcctgcg cgccgaagac acggccattt attactgtgc gaagaccggt      300

cttcttactc ttaaaccgtt ctggggcaag ggaaccctgg tcaccgtctc ctc             353


<210>  378
<211>  308
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  378
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgttggaga cagagtcacc       60

atcacttgcc gggcaagtca gactattagt aactttttaa gttggtatca gtacattcca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tacaaagtgg ggtcccatca      180

agattcagtg gcagtgggtc tgggacagtt ttcactctca ccatcactag tctgcaacct      240

gaggattttg cgacttacta ctgtcaacag acttacactg acacgtggac cttcggccaa      300

ggaaccaa                                                               308


<210>  379
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  379
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact aactatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcttat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgcgt atttctgtgc gcaagtactt      300

tgtagtagta ccagctgcca ctactactac ggtatggacg tctggggcca agggaccacg      360

gtcaccgtct cctca                                                       375


<210>  380
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  380
tcctatgagc tgactcagcc actctcagtg tcagtggccc tgggacagac ggccaggatt       60

tcctgtgggg gaaacaaaat tggaagaata catgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcat ctatagggat agcaaccggc cctctgggat ccctgagcga      180

ttctctggct ccaactcggg gaacacggcc accctgacca tcagcagagc ccaagccggg      240

gatgaggctg actattactg tcaggtgtgg gacagcagca ctgtggtatt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  381
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  381
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctaagactc       60

tcctgtgcag cgtctggatt caccttcagt aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atttattatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatt tccagagaca attccaagaa cacgctctat      240

ctgcaaatcc acagcctgag agccgaggac acggctgtgt attactgtgc gagagagggg      300

cagatggctg caactaccgg aattgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  382
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  382
tcctatgagc tgacacagcc accctcggtg tcagtgtccc cacgacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaaaaaaa tatgcttatt ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcat ctatgaggac agcaagcgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttactcaaca gacaccagtg gtaatcattg ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  383
<211>  385
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  383
gaggtgcagc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc ccttagactc       60

tcctgtgcag cctctggatt cactttcagt aacgcctgga tgagctgggt ccgccaggct      120

ccagggaagg gactggagtg ggttggccgt attaaaggca aaactgatgg tgggacaaca      180

gactacgctg cacccgtgaa aggcagattc accatctcaa aagatgattc aaaaaatacg      240

ctgtatctgc aaatgagcag cctgaatacc gaggacacag ccgtgtattg gtgtaccacc      300

cttacgtatt attatgatag tagtgcttat ctcaatgatg cttttgatat ctggggccaa      360

gggacaatgg tcaccgtctc ttcag                                            385


<210>  384
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  384
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaaaaaaa tatgcttatt ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcat ctctgaggac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacagtggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttactcaaca gacagcagtg gtaatcatag ggtgttcggc      300

ggagggacca agttgaccgt cctag                                            325


<210>  385
<211>  368
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  385
gaggtgcagc tggtgcagtc tggagcagag gtgaggaagc ccggggagtc tctcaggatc       60

tcctgtcagg gtttaggata cactttttcc acttattgga tcgcctgggt gcgccagaag      120

cccgggaaag gcctggagtg gatgggaatg atctatcctg gtgactcaga gaccagattc      180

ggcccgtcat tccaaggcca ggtcatcatg tcagtcgaca agtccctcgg tgccgcctac      240

ctgcagtgga cctggctgag ggcctcggac agcgccatgt attactgcgc gattaagggg      300

tcgcccacat caaccgccca tgatgcgctt gatatctggg gccaggggac aatgctcacc      360

gtctcttc                                                               368


<210>  386
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  386
tcctatgagc tgtcgcaacc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcagt gccgacacaa tttgcttatt ggtaccaaca gaagccaggc      120

caggcccctc ttttggtgat ttctaaagac actcagaggc ccccagggat ccctgagcga      180

ttctctggct ccagttccgg gacaacagcc acgttgacca tcactggagt ccagacagaa      240

gacgaggctg actatcactg tcagtcagca gacaccagtg atacttattg ggtgttcggc      300

ggagggacca agctgaccgt ccta                                             324


<210>  387
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  387
gaggtgcaac tattggagtc tgggggaggc ttggcacagc cgggggggtc cctgagactc       60

tcgtgtgtag cctctggatt cagctttagt tcttatggca tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagta atggatggta gtgctggaaa catatactac      180

gcagacgccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacactgtat      240

ctgcaaatga acagcctgag acccgaagac acggccgcat atttctgtgc gaaagattcg      300

ggagcgcttt gcagtggtgg tgattgcttg agggggtact tcgatctctg gggccgaggc      360

accctggtca ctgtctcctc ag                                               382


<210>  388
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  388
gacatcgtaa tgacccagtc tccagaatcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta ttcagcacca acaataagaa ctacgtagct      120

tggtaccagc agaaaccagg acagcctcct gcgctgctca tttactgggc ttctacccgg      180

gcatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaaat gtatagtcct      300

ccgcgaacat tcggccaagg gaccagggtg gaaatcaaac                            340


<210>  389
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  389
cgggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgctctg tctccggtgc ctccattagt actgctgatt actactggag ttggatccgc      120

cagcccccag gaaagggcct gcatttggtt ggatacatcc attacaccgg gggcacctac      180

tacaacccgt ccctccagag tcgagtttcc atgtcagtag acacgtccca gaaccagttc      240

tccctgaaga tgacctctat gactcccgca gacacggccg tctattattg tgccagactc      300

caccgttcgg ggaatgtatt tgaattctgg ggccagggaa cgctggtcat cgtctcctca      360

g                                                                      361


<210>  390
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  390
tcttctgagc tgactcagga ccctgctgtg tctgtggccg tgggacagac agccaggatc       60

acatgccagg gagacagcct cagagacttt tatgcaagtt ggtaccagca gaagccagga      120

caggccccta tacttgtcat ctatggtaaa aatgagcggc cctcagggat cccagaccgg      180

ttctctggct ctgactcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgagggtg actattattg tatctgccgg gacaacagtg gtgaccatcc cgtgttcggc      300

ggagggacca aactgaccgt ccta                                             324


<210>  391
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  391
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtgataa tataggttat      180

gcggactctg tgaagggccg attcaccatc tccagagaca tcgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagggata      300

tattacgata ttttcatgcc tctgcttgac tggggccggg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  392
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  392
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaccttct tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatcttt ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcat cagtatggta cctcccccta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  393
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  393
caggtccagc tggttcaatc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaaga cttctggaga cacctccagc agttatactg tcggctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat agcatactcc      180

gcacagaagt tccagggcag actcacgatt accgcggaca aatccacgag cacatcctac      240

atggagctga gcagcctgag atctgaggac acggccgttt attactgtgc gagaggggtg      300

gtagctgcta ctccgggttg gttcgacccc tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  394
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  394
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcggtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact tcctcacttt cggcggaggg      300

accaaggtag agatcaaac                                                   319


<210>  395
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  395
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac attagtagta gaagtagtac cataaagtac      180

gcagactctg tgaagggccg attcaccatc tccagagaca atgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agacgaggac acggctgtgt attactgtgc gagagtggat      300

tactatggtt cggggagcgt ttactggtac ttcgatctct ggggccgtgg caccctggtc      360

actgtctctt cag                                                         373


<210>  396
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  396
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcagcta cactttggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  397
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  397
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcggc agttatgtta tcagctgggt gcgacaggcc      120

cctggacaag ggcttcagtg gatgggaggg atcatcccta tctttggtaa accaaactac      180

gcacagaagt tccagggcag agtcacaatt accgcggacg aatccacgag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gaggggatgg      300

ttcggggagt tattgaaagg aacatactgg ttcgacccct ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  398
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  398
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctactca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtacc      300

ccaggttttg gccaggggac caagctggag atcaaac                               337


<210>  399
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  399
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtga atccttcagt ggttactact ggagctggat ccgccagccc      120

ccagggaggg gcctggagtg gattggggaa atcaatcaaa gtggaaacaa caactacaac      180

ccgtccctca agagtcgagt caccatatcc attgacacgt ccaacaaccg gttctccctg      240

agggtgagct ctgtgaccgc cgcggacacg gctgtctatt actgtgcgag agacaccagc      300

aagtactact ttgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  400
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  400
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgcg gggccagtca gagtgttacc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag ctgtatggta gctcacctct gtacactttt      300

ggccagggga ccaagctgga aatcaaac                                         328


<210>  401
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  401
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt cgctattgga tgacgtgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaaggaag atggaagtga gagatcctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcagatga acagcctgag agccgaggac acggctgttt atcactgcgc gagtcgccac      300

tgtagtgtta gcggctgcta tacggcgtcc tacctctaca tggacgtctg gggcaagggg      360

accacggtca ccgtctcctc a                                                381


<210>  402
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  402
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagtag tgatgttggt ggttataact atgtctcctg gtaccaacaa      120

tacccaggca aagcccccaa actcatgatt tatgatgtcg ataagtggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctttgggctc      240

cggactgaag atgaggctga ttattactgc tgctcatatg caggcagcta cactttggta      300

ttcggcggag ggaccaagct gaccgtcct                                        329


<210>  403
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  403
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcgactgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atttatcctg gtgactctga taccagatat      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccaccag caccgcctac      240

ctgcagtgga gcagcttgaa ggcctcggac accgccatgt attactgtgc gagacgtgga      300

gaagcagctg gtatttggta cttcgatctc tggggccgtg gcaccctggt cactgtctcc      360

tcag                                                                   364


<210>  404
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  404
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag actggagcct      240

gaagattttg cagtgtatta ctgtcagctg tatggtagct cacctctgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  405
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  405
caggtccagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatagta tcacctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatccctg tccttggtat agcaaactac      180

gcacagaagt tccaggacag agtcacgatt acggcggaca aatccacgag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagtgggc      300

gtgagtggtt ttaaaagtgg ctcgaactgg tacttcgatc tctggggccg tggcaccctg      360

gtcactgtct cctcag                                                      376


<210>  406
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  406
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccctc       60

tcctgcactg ggagcaactc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tatggtaata gcaatcggcc ctccggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gagtgattcg      300

gtgttcggcg gagggaccaa ggtgaccgtc ctag                                  334


<210>  407
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  407
cagctgcagc tgcaggagtc cggctcagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agtggtggtt actcctggag ctggatccgg      120

cagccaccag ggaagggcct ggagtggatt gggtacatct atcatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatcagtag acaggtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgcg gactcggccg tgtattactg tgccagaagt      300

ggagggctac gatttgactc ctggggccag ggaaccctgg tcaccgtctc ctca            354


<210>  408
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  408
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtaagctg gtaccaccag      120

cttccaggaa cagcccccaa actcctcatc tatggtgaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gagtgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  409
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  409
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggagggtc cctgagactc       60

tcctgtgcag cctccggatt caccttcagt gcttatgaaa tgacctgggt ccgccaggct      120

ccagggaagg ggctggagag gattgcatat attactacta gtggtaataa catctactac      180

gcagactctg tgaagggccg attcaccatc ttcagagaca accccaagaa gtcactgtat      240

ctgcagatga atagtctgag agccgacgac acggctgtct attactgtgc gaaaaccgga      300

caggtcgagt ggctggtgga caactacaac tactatatgg acgtgtgggg caaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  410
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  410
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttaga aaaagctact tagcctggta ccagcagaga      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcgtccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatc ttgcagtgta ttactgtcag cagtatggta gctcaccgct cactttcggc      300

ggagggacca aggtggagat caaac                                            325


<210>  411
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  411
gaggtgcagc tggtggagtc cgggggaggc ttagttcagc ctggggggtc cctgagactc       60

tcctgtgcag tctctggatt caccttcagt agctactgga tgcactgggt ccgccaagct      120

ccagggaagg ggctggtgtg ggtctcacgt attaatagtg atgggagtag cacaagctac      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa cacgctgtat      240

ctgcaaatga acagtctgag agccgaggac acggctgtgt attactgtgc aagagaagtg      300

gagcagctgg ctcatatggt tgactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  412
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  412
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaccaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg gtacatcttg ggtgttcggc      300

ggagggacca agctgaccgt ccta                                             324


<210>  413
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  413
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtactactt attactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gcgagtatct attacagtgg gagcacctac      180

tacaatccgt ccctcaagag tcgactcacc gtttccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tctattactg tgcgagacaa      300

tggaaatggt tcggggaagc ctggtacttc gatctctggg gccgtggcac cctggtcact      360

gtctcctcag                                                             370


<210>  414
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  414
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccagc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcaccttt cactttcggc      300

ggagggacca aggtggagat caaac                                            325


<210>  415
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  415
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt agctattgga tgaattgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaaccaag atggaggtga gaagtactat      180

gtggactccg tgaggggccg attcaccatc tccagagaca acgccaaaaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagaccct      300

tacgacctat acggtgacta cggggggacc tttgactact ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  416
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  416
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattagt agctggttgg cctggtatca gcagaaacca      120

aggaaagccc ctaagctcct gatctataag gcgtctactt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatagtt actcgctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  417
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  417
gaggtgcacc tggtggagtc tgggggagat ttggtccagc cgggggggtc cctgagactt       60

tcctgtggag gctcaggatt ctcctttaac agtgcttgga tgacctgggt ccgccaggcc      120

ccagggaagg ggctagagtg ggtggccaac ataaaggctg acggaggtga ctcctactat      180

ccggactctg tgaagggtcg atttaccatt tccaaagaca acaccaagaa cctcctgcat      240

ttgcagatgc atagcctaag agtcgacgac gcagccatgt attactgtgc cgtctggggc      300

gacacatggg gccttgacta ctggggcctg gggactcggg tcgccgtctc ctcag           355


<210>  418
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  418
caggctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaagcagcag agattttggt gctcatgact atgtctcctg gtaccaacaa      120

cgcccaggcc aagcccccag actcatactt tataaggtct atcagcggcc ctcaggggtc      180

cctggtcgct tctctggctc caagtctgac aacacggcct ccctgaccat ctctggactc      240

cagcctgaag atgaggctga ttattactgt tccacagctc cgggcgcctt gattttgctt      300

tttggcggag ggaccaagtt gaccgtc                                          327


<210>  419
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  419
caggtgcaat tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctaagactc       60

tcctgtgcag cctctggatt ttccttcaat aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atctcatatg aaggaagtaa gacgtactat      180

gcagattttg tgcagggtcg attcaccgtc tccagagact tttccaagaa cacgctgtat      240

ctccaaatga acagcctcag aattgaggac acggctgtat attactgtgc gaagtcccac      300

aaattattct ggttcgggca gtttaaaatg gatgctctgg atatctgggg ccaaggggca      360

ttggtcaccg tctcttcag                                                   379


<210>  420
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  420
cagtctgtac tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagccc caacatcgga agtaatagtg taaactggta ccaacaagtc      120

ccagggacgg cccccagact cctcattaac actgataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgttca gcatgggatg acagcctgag tggctgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  421
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  421
gaggcgcagc tggcggagtc tgggggaggc ctggtcaagc cgggggggtc ccaaacactc       60

tcctgtgcac cctctggatt cattttcagc cactatgcta tgagttgggt ccgtcaggct      120

ccagggaagg ggctggagtg ggtctcatcc attaatccta ttggggatta caaacccttc      180

gcagactcta tgaagggccg attcgccata tccagagaca acgtcaagaa tctgttgtat      240

ctgcaaatgg ttggcctgag agccgatgac acggctgttt attactgtgc gagagataac      300

tgggacgtcg ctggtatgga cgtctggggc caaggaacca cggtcaccgt ctcctca         357


<210>  422
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  422
cagcttgtgc tgactcaatc gccctctgcc tctgcctccc tgggagccgc ggtcaagctc       60

acctgcactc tgagcagtgg ccacatcacc aacgccatcg catggcatca gctgcagcca      120

gagaagggcc ctcgtttctt gatgaagatt aatagtgatg gcacccacaa caagggggac      180

gggatccctg atcgcttttc aggctccagt tctggggctg accgctacct caccatctcc      240

agcctccagt ctgacgatga ggctgactat ttttgtctga cctggggctc tggctcttgg      300

gtgttcggcg gagggaccaa gttgaccgtc ctag                                  334


<210>  423
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  423
gaagtgcagc tggtggaggc cgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggaat cacctctgat gattatgcca tgcactgggt ccggcaacct      120

ccagggaagg gcctggagtg ggtctcaggt attaattgga atagtggtaa cataggctat      180

gcggactctg tgaagggtcg cttcaccatc tccatagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagcccct      300

cggagttact gcagtaggac cagctgctgg ggtgaatact tccaggtctg gggccagggc      360

accctggtca ccgtctcctc ag                                               382


<210>  424
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  424
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtcttttt tacagctcca acagtaagaa ctacttagcc      120

tggtaccagc agaaaccacg acaacctcct aggctgctca tttactgggc atctacccga      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcggcc tgcaggctga agatgtggcg gtttattatt gtcagcagta ttatggtact      300

ccgtacactt ttggccaggg gaccaagctg gagatcaaac                            340


<210>  425
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  425
caggtgcagc tggtgcagtc tggggctgcg gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcgtcccta tctttggcac agcaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgac cacagcctac      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagagaggac      300

tactatggtt cggggagctt agtcgacccg tactactact accgtatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  426
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  426
gaaatagtgc tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cactttatta ctgtcagcag tataataact ggtggcgcac gttcggccaa      300

gggaccaagg tggaaatcaa                                                  320


<210>  427
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  427
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgt gagagatttg      300

gcgctttttg aagtggttat ccagcagggg gtctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  428
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  428
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaaaaaaa tatgcttatt ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcat ctatgaggac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttactcaaca gacagcagtg gtaatcattg ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  429
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  429
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgaaactc       60

tcctgtgcag cctctgggtt caccttcagt ggctctgcta tgcactgggt ccgccaggct      120

tccgggaaag ggctggagtg ggttggccat attagaagca aaactaacaa ttacgcgaca      180

gcatatgctg cgtcggtgaa aggcaggttc accatctcca gagatgattc aaagaacacg      240

gcgtatctgc aaatgaacag cctgaaaacc gaggacacgg ccgtgtatta ctgtactaga      300

cacccgtatt actctgcttc ggggatcaaa ttcgacccct ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  430
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  430
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcaccgtg gacgttcggc      300

aaagggacca aggtggaaat caaac                                            325


<210>  431
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  431
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtag catagcctat      180

acggactctg tgaagggccg attcaccatc tccagagata acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagcacac      300

tcgactggac accaatacta ctacggtatg gacgtctggg gccaagggac cacggtcact      360

gtctcctca                                                              369


<210>  432
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  432
gacatccaga tgacccagtc tccatcctcc ttgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctttttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcattcaatt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaatct      240

gaagattttg caacttacta ctgtcaacag agttacaata ccccttacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  433
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  433
cagctgcagc tgcaggagtc gggcccagga ctagtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccgtcagc agtagaagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct attatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgcgtcacc atatccgtag acacgtccaa gaatcagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagacac      300

acggtcgatt gtggtggtga ttgctttccc aatgatgctt ttgatatctg gggccaaggg      360

acaatggtca ccgtctcttc ag                                               382


<210>  434
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  434
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagttat tatgcaagct ggtaccagca gaagccagga      120

caggcccctt tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacacct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taacttccgg gacagcagtg gtcaccatcc cgtattcggc      300

gaagggacca agctgaccgt cctag                                            325


<210>  435
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  435
caggcgcaat tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcactg tctatggtgc gtccttcagt gattacttct ggacctggat ccgccagccc      120

cccgggaagg ggctggagtg gcttggggaa atcaggcaga ttggaaccac caactacaat      180

ccgtccctca agggtcgagc caccatttca atggacacgt ccaagagtca attctccctg      240

agcctgaggt ccgtgaccgc cgcggacacg gctgtctatt tttgtgcggg aggcgattct      300

cgcgtgtggg aggccctagt tgcctcgggc ccgggaatcc aggtcaccgt ctcctcag        358


<210>  436
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  436
gacatcgtga tgacccagtc tccagattcc ctggctgtgt ctctgggcgg gagggccacc       60

atcaactgca agtccagtca gagtgtttta aacagccaga acaataggga ctacttagct      120

tggtaccagc agaaaccagg acagcctccg aagttgctct tttattgggc atctacgcgg      180

gaatccgggg tccctgaccg cttcagtggc ggcgggtctg ggacagattt cactctcacc      240

atcgccagcc tgcaggctga agatgtggca gtctattact gtcagcaatt gtacagtcct      300

ccgcgaacct tcggccaagg gaccaaagtg gaaatcaaac                            340


<210>  437
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  437
aacgtgcaat tagtggagtc tgggggaggc ttggttcagc ctggcgggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc agctatgcct tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcacac attagtagta gtggtagtat catatactac      180

gcagactctg tgaagggccg attcaccatc tccagagact acgccaagaa ctccctgtgg      240

ctgcaaatga acagtctgac atctgaggac acggccttct attactgtgc aaagggcgtt      300

gactatggcg gcaaacttgc ctactttgac tcctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  438
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  438
ggcatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cacagtcacc       60

atcacttgcc gggcaaatca gaccattaag acctttttaa attggtatca acagacaccg      120

ggcaaagccc ctaaactcct gatctactct gcgtccattt tgcaaagtgg agtcccatca      180

aggttcagtg ccagtggatc tgggacagat tttactttga ccatcaacag cctgcagcct      240

gaagatactg cgacatattt ttgtcagcag tatgataatc tcctattcac tttcggctct      300

gggaccaaag tggaaatcaa ac                                               322


<210>  439
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  439
gaagtgcagc tggtggagtc tgggggaggc ttggtccagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cagctttggt gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagtggga gtagtgatta caaaccctat      180

gcgggctctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctggg acctgaggac acggccttgt attactgtgc aagaattgtc      300

gaccacggtg ctcagggggc ctactttgac cactggggcc agggaaccct ggtcatcgcc      360

tcctcag                                                                367


<210>  440
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  440
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttcacttgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

ttcactttcg gccctgggac cagagtggat atcaaac                               337


<210>  441
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  441
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtggtt actactggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggtacatct attacagtgg gagcacctac      180

tacaatccgt ccctcaagag tcgagttacc atatcagtag acacgtctaa gagccagttc      240

tccctgaagc tgaactctgt gactgccgcg gacacggccg tgtattactg tgcgagagtt      300

tcttacgatt tttggagtgg ttattgggcg ttcgacccct ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  442
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  442
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtgcactg gtaccagcag      120

cttccaggaa cagcccccaa actgctcatc tatggtaaca acaatcggcc ctcagggatc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattgctgc cagtcatatg acagaagcct gagtggtgtg      300

gttttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  443
<211>  391
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  443
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc gactactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtcgtgg cacaaactat      180

gcacagaagt ttcagggcag ggtcactatg accagggaca cgtccatcag cacagtctac      240

atggagctga gcaggctgac atctgacgac acggccgtct attactgtgc gagagtggtg      300

gtcctcggct atggccgccc aaacaattac tatgatggta ggaatgtgtg ggactactgg      360

ggccagggaa ccctggtcac cgtctcctca g                                     391


<210>  444
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  444
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcatcatc       60

tcttgttctg gaagcagctc caacatcgga agtaatactg taaagtggta tcatcagctc      120

ccaggaacgg cccccaaact cctcatctgt agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctgacacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tgctttggta      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  445
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  445
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcaat aactatgtta tgtactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgttgtat      240

ctgcaagcga acagcctgag agctgaggac acggctgtgt attactgtgc gagaggccag      300

aggtcgagca gtggctggta caaatcctac tactacggta tggacgtctg gggccaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  446
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  446
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaatactg taaactggta ccaacagctc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tggcctttat      300

gtcttcggaa ctgggaccaa ggtcaccgtc ctag                                  334


<210>  447
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  447
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtctctc       60

acctgcactg tctctgatgg ctccatcagc agtggaagtt actgctggag ctggatccgg      120

cagcccgccg ggaaggggct ggagtggatt gggcgtttct ataccagtgg gagcaccaac      180

tacaacccct ccctcaagag tcgagtcacc atatcagtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggccg tgtattactg tgcgagagat      300

ggggaaacaa ctgcaacgtc tgcgaggggc tcctcctgct actacatgga cgtctggggc      360

aaagggacca cggtcaccgt ctcctca                                          387


<210>  448
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  448
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtatcagcag      120

tttccaggaa cagcccccaa actcctcatc tatggtaaca gcaatcggcc ctcaggggtc      180

tctgaccgat tctctggctc caagtctggc acctcagcct ccctggccgt cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagaactct gagtgtggta      300

ttcggcggag ggaccaaact gaccgtccta g                                     331


<210>  449
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  449
caggtgcagc tggtggagtc tgggggaggc gtagtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agctttggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcactt atttggtatg atggaagaaa agaagactat      180

gcggagtccg tgaagggccg attcaccatc tccagagaca gttccaagaa cacgctgtat      240

ctgcaaatga acagtctgag agccgaggac acggctgtgt attactgtgc gaaagaaagg      300

ggttctcggt ggctggtacg attgaagtat tactacgatt tggacgtctg gggccaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  450
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  450
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaacctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcaccag cctgcagcct      240

gaagattttg caacttatta ctgtcaacac cttaatagtt accctttttt cggccctggg      300

accaaagtgg atatcaaac                                                   319


<210>  451
<211>  345
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  451
gaggtgcggc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt gactacgcca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtgcta ctggtggtag cacgttctac      180

gcagactccg tgaagggccg gttcagcatc tccagagaca attccaagaa cagcctggtc      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attattgtgc gaaaccctac      300

ggtatggacg tctggggcca agggaccacg gtcaccgtct cctca                      345


<210>  452
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  452
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gcaccaacag      120

cacccaggca aagcccccaa aaacatgatt tatgatgtca gtaagcggcc ctcgggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

cacactgagg acgaggccga ttattactgc agctcatata caagcaccag cacgccttgg      300

gtgttcggcg gagggaccaa gttgaccgtc ctag                                  334


<210>  453
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  453
caggtgcagc tggtggagtc tgggggaggc ttggtcaagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt cactttcagt ggctccttca tgagttggat ccgccaggct      120

ccaggaaagg ggctggagtg ggtttcattc attagtagtg gtggtgatgc cgtaaagtat      180

gcagactcag tgaagggccg attcaccatc tccagggaca acaccaagaa ctcactgtat      240

ttgcagatga acagcctgag agacgacgac acggccgtat attactgtac gagagatcgg      300

ataattgcag cacgtggtac cctttggtac tttgagaact ggggccaggg caccctggtc      360

accgtctcct cag                                                         373


<210>  454
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  454
gacatccaga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca agatattgtc atctggttag cctggtatca acagaagcca      120

gggaaagccc ctgatctcct gatctatggt gcatccagtt tacagagtgg ggtcccatca      180

agattcagcg gcagtggatc tgagacagat ttcactctca ccatcagcaa cctgcagcct      240

gaagattttg gaacttacta ctgtcaacag gctaacagtg tccctttcac tttcggccct      300

gggaccaaag tagatgtcaa ac                                               322


<210>  455
<211>  394
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  455
caggggcagc tggtgcaatc tgggggagac gtggtccagc ctgggaagtc cctgcgactc       60

tcctgtgcag cctctggatt caccttcacg aactatgcca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtg atatcaaatg acggaagtaa tgaaaaatat      180

gtagactccg tgaagggccg attctccctc tccagagaca attccaagaa caccgtgtat      240

ctggatatgc acagcctgag acctgaggac acggctatat actattgtgc gagggatcgt      300

tccaacctag agcgccttgt gatgacgttt gggggaatta tcgctggtgc ttttgatatc      360

tggggccaag gggcaagggt caccgtctct tcag                                  394


<210>  456
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  456
gaaattgtga tgacgcagtc tccaggcacc ctgtctgtgt ctccagggga aagagccacg       60

ctatcctgca gggccagtca gagtcttagc agccacttag cctggtacca gcagaaacct      120

ggccaggcgc ccaggctcct catttatggt gtctccacca gggccacagg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctcg ccatcagcag cctgcagtct      240

gaagattctg cagtttacta ctgtcagcag tatcatgtct ggcctcccat caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  457
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  457
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcagcgctt acaatggtaa cacaaactat      180

gcacagaagc tccagggcag agtcaccatg accacagaca catccacgag cacagcctac      240

atggagctga ggagcctgag atctgacgac acggccgtgt attactgtgc gagagaaggg      300

gtcggagtgg gagctactgg ggacttttac tactactcct acggtatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  458
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  458
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagtctcctg catagtaatg gatacaacta cttggattgg      120

tatctgcaga agccaggaca gtctccacaa ctcctgttct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt gggtctggga cagacttcac tctcaccatc      240

agcagcctgc agtctgaaga ttttgcactt tattactgtc agcagtataa taactggtgg      300

cgcacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  459
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  459
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgtactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaattaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagtgaac      300

agtgggagct actattccta ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  460
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  460
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

cctttaacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  461
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  461
gaggtgcagc tggtggagtc ggggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatgcta tgcactgggt ccgccaggct      120

ccagggaagg gactggagtt tgtttcaggt attagtagtc atgggggtaa cacatattat      180

gcaaactctg tgaagggcag attcaccatc tccagagaca attccaagaa cacgctgtat      240

cttcaaatgg gcagcctgag aactgaggac atggctgttt attactgtgc gaggcccgat      300

agtcgtggtt attattgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  462
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  462
gacatcgtga tgacccagtc tccagagtcc cgggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aaactgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

ccgtacactt ttggccaggg gtccaagctg gagatcaaac                            340


<210>  463
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  463
caggtgcaac tggtgcagtc tggggctgag gtgaagaagc ctggggcctc aatgaaggtc       60

tcctgcaagg cttctggata caccttcacc aattatgata tcatctgggt gcgacaggcc      120

actggacacg ggcttgagtg gatggggtgg ataaacccta gtaacaccaa cacaggctat      180

gcacagaagt tccagggcag ggtcaccatg accaggaaca cctccatagg cacagcctac      240

atggagctga gcggcctgac atctgaggac acggccatgt attactgtgc gcgaggacgt      300

cagtggaaca cctggtcgga gcactggttc gacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  464
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  464
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact taacctggta ccagcacaaa      120

cccggccagg ctcccaggct cctcatctat agtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgcgaca gacttcactc tcaccatcaa cagactggag      240

cctgaagatt ttgcagtgta ttactgtcta cactatggtg actccccgtt cacttttggc      300

caggggacca ggctggagat caaac                                            325


<210>  465
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  465
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccagacaagg ggctggagtg ggtggccaac ataaagcaag atggaagtca gaaatactat      180

gtggactccg caaagggccg attcaccatc tccagagaca acgccaagaa ctccctatat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagatata      300

atacgtcagg gcgaagacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  466
<211>  308
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  466
gacatccaga tgacccagtc tccatcgtcc ctgtctgcat ctgtaggaga cagagtcaca       60

atcacttgcc gggcacgtca gagcattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcacagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag acttacactg acacgtggac cttcggccaa      300

ggaaccaa                                                               308


<210>  467
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  467
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt acctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gcaacgtcga      300

ggtgaggccg tgtatagcaa tggctggtac aaatactact actgcatgga cgtctggggc      360

gaagggacca cggtcaccgt ctcctca                                          387


<210>  468
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  468
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattagt aggtggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagcgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatagtt attcggagac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  469
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  469
caggtgcagc tgcaggagtc gggcccagga ctggtgaaac cttcggggac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agtagtaact ggtggagttg ggtccgccag      120

cccccaggga aggggctgga gtggattggg gaaatctatc atagtgggag caccaactac      180

aacccgtccc tcaagagtcg agtcaccata tcagtggaca agtccaagaa ccagttctcc      240

ctgaagctga actctgtgac cgccgcggac acggccgtct attactgtgc gagtcggtgg      300

ggggattact ttgatagtag tggtgcctat gactcctggg gccagggaac cctgctcacc      360

gtctcctcag                                                             370


<210>  470
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  470
gacatccaga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggtattagc agctggctag cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcacgag cctgcagcct      240

gaagattttg caacttacta ttgtcaacag ggtaacagtt tccctctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  471
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  471
caggtgcaac tggtggagtc tgggggaggc gtggtccagc ctgggaagtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaaataa taaattctat      180

gtagactccg tgaagggccg attcaccatc tccagagaca attccaaaaa cacgctgtat      240

atggaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagaaagggt      300

ccgctatggc gttttgacta ctggggccag ggaaccttgg tcaccgtctc gtcag           355


<210>  472
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  472
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

attccaggaa cagcccccaa actcctcttc tatggtaaca acaatcggcc ctcaggggtc      180

cctgaccgat tctctgactc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gagtgcctgg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  473
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  473
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggtt catcgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtatatt actgtgcgag agagagcacg      300

caatggggcc agggaaccct ggtcaccgtc tcctcag                               337


<210>  474
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  474
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca cagtattagt agctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatactt attctcaaac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  475
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  475
cagctgcagc tgcaggagtc gggcccagga ttggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtgtct attatattgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atgtccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagggcc      300

ccgttccagc tgctagacaa atactacttc ttctactaca tggacgtctg gggcaaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  476
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  476
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcag cgtagcaact ggcctccggg cgtcaccttc      300

ggccaaggga cacgactgga gattaaac                                         328


<210>  477
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  477
caggtgcagc tggtacaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tttctgggta cacattcact agatatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgaatg gatgggatgg atcaacacca aaactgggag cccaagatat      180

ggccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatac      240

ctgcagatca actacctgaa ggctgaggac actgccgttt attactgcgc gagtcggcca      300

gggggagata tagaggtggc tgcccttgac tggtggggcc agggaaccct ggtccacgtc      360

tcctcag                                                                367


<210>  478
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  478
cagtctgccc tgactcagcc tccctccgtg tccgggtctc ctggacagtc agtcgccatc       60

tcctgcacag gaagcagtag tgacattggt agttataacc gtgtctcctg gtaccagcag      120

ccccccggca cagcccccaa actcctgatt tatgaagtca ctaatcggcc cccaggggtc      180

cctgatcgct tctctgggtc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

cgggctgaag acgagggtga ttatcactgc agctcctata caagcggcag cactgtgata      300

ttcggcggag ggaccaggct gaccgtcct                                        329


<210>  479
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  479
caggtgcagt tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaagtc       60

tcgtgcaagg cctctggata caccttcacc agaaatgata tcaactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atgaagccct acaatggtaa cacaggctat      180

gcagagaagt tccagggcag actcaccatg accacgaaca cctccataag cacagcctac      240

atggaactga gaagcctgag atctgacgac acggccgttt attactgtgc gagagaggat      300

tctgtaggag ccgatgcttt tgatatgtgg ggccaaggga caatggtcac cgtctcctca      360

g                                                                      361


<210>  480
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  480
gacatccaga tgacccagtc tccttcctcc ctgtctgcat ctgttggaga cagcgtcacc       60

atcgcttgcc gggcaagtca cagcattggt acctatttaa attggtatca acacaaacca      120

gggaaagccc ctaaactcct aatctatgct gcgtccagtt tgcaaagtgg ggtcccaccg      180

aggttcagtg gccgtggatc tgggacagat ttcactctca ccatcagcag tcttcaacct      240

gaagattttg gagtttattt ctgtcatcag agttacacta cccctcggac tttcggccaa      300

gggaccaggg tggaaatcaa ac                                               322


<210>  481
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  481
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

cttcagatga atagcctgag agctgaggac acggctgtgt attactgtgc gagagaagga      300

caagggacct accttgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  482
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  482
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagtctcctg catagtaatg gatacaacta cttggattgg      120

tatctgcaga agccaggaca gtctccacaa ctcctgttct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgacga tgttggggtt tattactgca tgcaaagtat acagcctcct      300

ctcactttcg gcggagggac caaggtggag atcaaac                               337


<210>  483
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  483
gaggtgcagc tggtggagtc tggaggagac ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggact caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcaatt atttatagcg gtggtagcac atactacgca      180

gactccgtga agggccgatt cagtatctcc agagacaatt ccaacaacac gctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtgtatt tctgtgcgag acacattcca      300

gcgtggggat acaaatgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  484
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  484
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaga aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctgagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

cggttcagtg gaagtggatc tgggacagat tttattttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaccag tatgattatc tcccgtacac ttttggccag      300

gggaccaagc tggacatcaa ac                                               322


<210>  485
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  485
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc ggaagtgatt ccttctgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct ctgatagtgg gaccacctac      180

tacaatccgt ccctcaacag tcgagtcacc atatccgttg acacgtccag gaaccagttc      240

tccctgaagt tgaggtctgt gaccgccgca gacacggctg tgtattattg tgtgagaggt      300

cggaacttga gtggtcatgg gttgctcgac acctggtgca aggtaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  486
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  486
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccagggtcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagacttcg caatttatta ctgtcagcag cgtcgcagct ggcctctcac attcggcgga      300

gggaccaggg tggagatcaa ac                                               322


<210>  487
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  487
caggtccagc ttgtgcagtc tggggctgaa gggaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata catcttcagt gactatacta tgcattgggt gcgccaggcc      120

cccggacaaa ggcttgagtg gatgggatgg atcaacgctg gctatggtaa cacaaaatat      180

tcacagaagt tccagggcag agtcaccatt accagggaca catccgcgag tacagtctac      240

atggagctga gcagcctgag atttgaagac acggctgtgt attactgtgc gagtatgacc      300

cggaggtcac accaaaccta ctacggtatg gacgtctggg gccaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  488
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  488
gaagttgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccaggagaaa      120

cctggccagg ctcccaggct cctcatctat agtgcatcca gcagggccac tggcatccca      180

gacaggttca gcggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag caatatacta acttcctcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  489
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  489
caactgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcaatg tctctggtgg ctccatcagc ggttccacct actactgggg ctggatccgc      120

cagtccccag ggaaggggct ggagtggatt ggaagtatct attatagtag gaacgccttc      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgacctctgt gaccgccgca gacacggctg tgtattactg tgcgacccgt      300

gactacagtt catatggttt tgatatctgg ggccaaggga caaaggtcac cgtctcttca      360

g                                                                      361


<210>  490
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  490
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagtag tgatgttggg agtcgtgacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcataatt tatgaggtca ctaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctggtctc      240

caggctgagg acgaggctga ttatttctgt tgttcatatt caggtagtag cattttcggt      300

gtgttcggag gaggcaccca gctgaccgtc ctcg                                  334


<210>  491
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  491
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttacc agctatggca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtatta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gaaactcctt      300

ggttcgggga ttacattaga taatgatgct tttgatatct ggggccaagg gactatggtc      360

accgtctctt cag                                                         373


<210>  492
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  492
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcaaccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag acttacagta cccctctgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  493
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  493
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg atgaacccta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accaggaaca cctccataag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagcctat      300

agtggctacg accccgcgtt gtattactac tactactact acatggacgt ctggggcaaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  494
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  494
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcag caatgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  495
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  495
gaagtgcaac tggtggagtc cgggggaggc ttagttcagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcaac aactacgtaa tgcactgggt ccgccaacct      120

ccagggaagg ggctggagtg ggtttcacgg attagtcatg atgggactgt aacaacttac      180

ggggactccg tgaggggccg attcaccatc tccagagaca acaccaagaa cacggtgtgg      240

ctacaaatga acagcctgag agtcgaggac acggctgtct atttttgtgc aagagatttt      300

gactgggtct tatatgatta ttggggccag ggaaccctgg tcgccgtctc ctcag           355


<210>  496
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  496
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccggacagag ggtcaccatc       60

tcttgttctg gaagcagctc caacgtcgaa aatcattatg tttattggtt ccagcagcag      120

ctcccaggag cggcccccaa actcctcatc tatatgaatg atcagcggcc ctcgggggtc      180

cctgaccgat tctctggttc caagtctggc acctccgcct ccctggccat cagtgggctc      240

cggtccgagg atgagactca ttattactgt gcagcgtggg atgtcagtct gactggtccg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  497
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  497
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcatctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac aacaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac      240

gtggaactga gcagcctgag atctgaggac acggccgtgt attattgtgc gagaataggc      300

cattttgata gtagtggtta ttacttagac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  498
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  498
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca ggcccactgg catcccagcc      180

aggttcactg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcac cgtaccaact ggcctccctt attcactttc      300

ggccctggga ccaaagtgga tatcaaac                                         328


<210>  499
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  499
cgggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcgttt tctatggtgg gtccttcagt ggttactact ggaactggat ccgccagccc      120

ccagggaagg ggctggaatg gattggggag atcaatcaca gtggagccac caactataac      180

ccgtccctca agagtcgatt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtctatt actgtgcgag aggccgaaca      300

attaccactt tctactccta ttacggtatg gacgtctggg gccaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  500
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  500
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga tagcgtcacc       60

atctcttgtc gggcgagtga ggacattaga aattatgtga cgtggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagaag tctgcaacct      240

gaagattttg caagttacta ctgtcaacag agttacagta cccccacttt cggcggaggg      300

accaaggtgg acatcaaac                                                   319


<210>  501
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  501
cagatgcagt tgcaggagtc gggcccagga ctggtgaagt cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatgacc agtagtagtt accactgggg ctgggtccgc      120

cagcccccag ggaaggggct ggagtggatc ggaaatttct attatagtgg gaggacctac      180

tacaatccgt ccctcaggag tcgagtcacc atatttgcag acacgtccaa gaaccagttc      240

tccctgagtc tgacctctgt gaccgccgca gacacggctg tgtattactg tgcaatcatt      300

acgatttttg ggttcggcgc ttttgatatc tggggccaag ggacagtggt caccgtctct      360

tcag                                                                   364


<210>  502
<211>  338
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  502
gatattgtgc tgacccagac tcctctctct ctgtccgtca cccctggaca gccggcctcc       60

atctcctgca agtctagtca gagcctccta catactgatg gaaagaccta tttgtattgg      120

tacctgcaga ggccaggcca gtctccacag ctcctaatgt atgaagtttc cagccggttc      180

tctggagtgc cagataggtt cagtggcagc gggtcaggga cagatttcac actgaaaatc      240

agccgggtgg aggctgagga tgttggggtt tattactgca tggaaggtag acattttccc      300

ttattcagtt tcggccctgg gaccaaagtg gatatcaa                              338


<210>  503
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  503
gaggtgcaac tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttacc agctatgcca tgaactgggt ccgccaggct      120

cctgggaagg ggctggagtg ggtctcagcc attagtgtta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgttgtat      240

ttgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gaaagatttt      300

ggatccggta ttgtgggagc cacggggttt gacttctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  504
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  504
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaccaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat gtgtaaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg gtacttatgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  505
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  505
gaggtgcagc tggtggagtc tgggggaggt gtggtacggc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatggca tgagctgggt ccgccaagct      120

ccagggaagg ggctggagtg ggtctctgct attaattgga atggtggtag cacaggttat      180

gcagactctg taaagggccg attcaccatc tccagagata atgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agccgaggac acggccttgt atcactgtgc gagacggcgt      300

agctcgtccc ggtatagcag tggctggtat atgtactact actacatgga cgtctggggc      360

aaagggacca cggtcaccgt ctcctca                                          387


<210>  506
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  506
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtgttagt acctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaacctcct gatctatgag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatactt attcggggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  507
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  507
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc aactcctgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatct attactgtgc gacacatcgt      300

tgtagtggtg gtttctgcta cttagcctac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  508
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  508
cagcctgtgc tgactcagcc accttctgca tcagcctccc tgggagcctc ggtcacactc       60

acctgcaccc tgagcagcgg ctacagtaat tataaagtgg actggtacca gcagagacca      120

gggaagggcc cccggtttgt gatgcgagtg ggcactggtg ggattgtggg atccaagggg      180

gatggcatcc ctgatcgctt ctcagtcttg ggctcaggcc tgaatcggta cctgaccatc      240

aagaacatcc aggaagagga tgagagtgac taccactgtg gggcagacca tggcagtggg      300

agcaacttcg tttttgtggt tttcggcgga gggaccaagc tgaccgtcct ag              352


<210>  509
<211>  371
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  509
gaggtgcaat tgctggagtc tgggggaggc ttgaaacggc cgggggggtc gctcagactg       60

tcttgtactg cctccggatt cgatctgggc gactatggcg tgagctgggt ccggcaggat      120

ccagggaaga cgctggagtg ggtcgcaggc atcactggtg gaagtggcga gaaatattac      180

gcagactccg tgaggggccg gttcaccatc tcaagagacg actccaagag tgcggtctac      240

ttacagatga acagcctgag aagcgacgac acggccttat atttttgtgc gagagaacgt      300

ggttattatg gactggggag tcagatcaat tggttcgaac attggggcca gggaaccctg      360

gtctccgtct c                                                           371


<210>  510
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  510
ggcatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cacagtcacc       60

atcacttgcc gggcaaatca gaccattaag acctttttaa attggtatca acagaagcca      120

gggaaagccc ctcatttttt gatctatgct gcatccgcct tacacagtgg ggtcccatca      180

aggttcagtg gcagtggagc tgggacagtc ttcgttctca ccatcaacag tctgcaacct      240

gaggattttg caacttacta ctgtcaacag agttacagca tccctccaac cttcggcggt      300

gggaccaggg tggagatcaa                                                  320


<210>  511
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  511
caggtgcacc tacagcagtg gggcgcgggg ctattgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggttactact ggagctggat ccgccagccc      120

ccaggaaagg ggctggagtg gattggggaa atcactcgta gtggaagcac cgactacaac      180

ccgtccctca agaatcgagt caccatgtca gtagactcgt ccaggacgca gttctccctg      240

agcctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag aggcttcgat      300

tccgcgtggg aactacaatt cctctggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  512
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  512
gacatcgtga tgacccagtc tccacactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta cacagaccca acaatatgaa ctacttagct      120

tggtaccagc agaaaccagg acagccccct aagttgctca tttactgggc atctacccgg      180

gcatccgggg tccctgaccg aatcagtggc agcgggtctg agacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata tgaagttact      300

cctcgcacat tcggccacgg gaccaaggtg gaaatcaaac                            340


<210>  513
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  513
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcaa cctctggatt cacgttcagt agttttgctt tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtgacagtt atatcagatg atggaaataa taaatactac      180

gtcgactccg tgaagggccg attcaccatc tccagggaca attccaagaa cacgctgttt      240

ctgcaaatga acagcctgag agttgaggac acggctatct attactgtgc gagagcctcg      300

tataatagca attggtctat tggtgaatac ttccgagact ggggccaggg caccctggtc      360

accgtctcct cag                                                         373


<210>  514
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  514
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtctttta tacacctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtcct      300

ccgtggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  515
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  515
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atcttatatg atggaagtaa tagatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaacagggg      300

ggactttatt gtagtggtac caactgctgg ggggggtacc ttgactactg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  516
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  516
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttac attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatcataatc tccctccgat caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  517
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  517
cagatcacgt tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcaccg tctctgggtt ctcactcagc actagtggag tgggtgtggg ctgcatccgc      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaggg acacttccaa aaaccaggtg      240

gtcctcacaa tgaccaacat ggaccctgtg gacacaggca catatttctg tgtacacaga      300

cacgttagcg gtgcctttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  518
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  518
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggagaca tatgtttctt ggtatcaaca gaagccaggc      120

cagtcccctg tgctggtcat ctatgaagat agcaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctgggggagt cttcggaact      300

gggaccaagg tcaccgtcct ag                                               322


<210>  519
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  519
gaggtgaaac tgttggagtc tgggggaggc ttgatacagc ctggggggtc ccttagactc       60

tcctgtacag cctctggaat catctttggt agtcatgtca tgagttgggt ccgccaggct      120

ccagggaagg gactgcaatg ggtctcaagt gttagtggta gtggaagtaa tatgtattat      180

gcagactccg tgaggggccg gttcaccatc tccagagaca attccaagaa cacactgttt      240

ctacaagtga acagcctgag agtcgaggac acggccatct attattgtgc gaaactcgcg      300

gcgcatagca gtggctggta cggggctgaa cttgactact ggggccaggg atccctggtc      360

accgtctcct cag                                                         373


<210>  520
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  520
tcctatgaac tgacacagcc gccctcagtg tcggtggccc caggacagac ggccaggatc       60

acctgctctg gagatggctt gtcaaaacaa tatacttttt ggtatcaaca gaggccaggc      120

caggcccctg tcctactcat atacaaggac actgagagac cctcagaaac ttctgagcga      180

ttctctggct ccgcctcagg gacaactgcc acgttgacca tcactggagt ccaggcagag      240

gacgaggctg actactattg tcaatccaca gacggtggcg gcggttttca ggggatcttc      300

ggcggaggga ccaggctgac cgtcctag                                         328


<210>  521
<211>  394
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  521
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact agctatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcaa cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt actactgtgc gagagctcgg      300

cttctaggat attgtagtag taccagctgc tacactatag ggtggggtgc ttttgatatc      360

tggggccaag ggacaatggt caccgtctct tcag                                  394


<210>  522
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  522
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtct ggacattagc aagtatttaa attggtatca gcacaaacca      120

gggaaagccc ctaacctcct gatctacgat gcattcaatt tggaaagagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc ttcctccggg ggtttcgacc      300

accttcggcc aagggacacg actggagatt aaac                                  334


<210>  523
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  523
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagaagga      300

caagggacct accttgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  524
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  524
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaaaaaaa tatgctcatt ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcat ctatgaggac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttgctcaaca gacagcagtg gtaatcagag ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  525
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  525
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgaaa tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac attagtagta gtggtagtgc catatactac      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agtcgaggac acggctgttt attactgtgc gagagaagcg      300

cggtcacgat attttgactg gttaccctca tactactttg actactgggg ccagggaacc      360

ctggtcaccg tctcctcag                                                   379


<210>  526
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  526
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacattggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcctgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctactcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cacccatgtg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  527
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  527
caggtgctcc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc agctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agtcgaggac acggctgttt attactgtgc gagagaagcg      300

cggtcacgat attttgactg gttaccctcg tactactttg actactgggg ccagggaacc      360

ctggtcaccg tctcctcag                                                   379


<210>  528
<211>  332
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  528
aattttattc tgactcagcc ccactctgtc tcggcgtctc cgggggagac ggtgaacatc       60

tcctgcaccc gcagcagtgg cgacattgcc cgcaactctg tgcagtggta ccaacagcgc      120

ccggactgtg cccccaccgt tctcatcttt gaggatgacc agagaccctc agcggtccct      180

gatcggttct ctggctccat cgacaggtcc tccaacactg cctccctcac catctctggg      240

ctgacgcctg aggacgaggc tgactactac tgtcactctt atgatgacaa ttatcaagcc      300

ttcttcggcg gagggaccag actgaccgtc ct                                    332


<210>  529
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  529
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttacc agctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctgcagtg ggtctcaact attagtgtta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gaaagatcct      300

gcgtcgtgga tagtgggacc tactcacttt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  530
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  530
cagcttgtac tgactcaatc gccctctgcc tctgcctccc tgggagcctc ggtcaagctc       60

acctgcactc tgagcagtgg gcacaccacc tacgccatcg catggcatca gcagcagcca      120

gagaagggcc ctcggtactt gatgaagctt aacagtgatg gcagccacac caggggggac      180

gggatccctg atcgcttctc aggctccagc tctggggctg agcgctacct caccatctcc      240

agcctccagt ctgaggatga ggctgactat tactgtcagt cctgggacac tggcataggg      300

gtgttcggcg gagggaccaa gttgaccgtc ctag                                  334


<210>  531
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  531
caggtgcagc tggtggagtc cgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aggcatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactat      180

gcagactccg tgaagggccg attcgccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag acctgaggac acggctgtat attactgtgc gagagatccg      300

agcccgttag tgcttattac ttcaattgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  532
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  532
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaggcaa tatacttatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacaccattg gtacttattg ggtattcggc      300

ggagggacca agctgaccgt cct                                              323


<210>  533
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  533
cagctacagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggaactt actactgcgg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtacat attatggtgg gagcaccctc      180

tacaacccgt ccctcagggg tcgagtcacc atatccgtag acacgtccaa gaaccagttt      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagacgg      300

ggtaattact atgatagtaa gaactggttc gacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  534
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  534
gaaatagtga tgacgcagtc tccagccacc gtgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg ccagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggccacctat gtacactttt      300

ggccagggga ccaaggtgga gatcaaac                                         328


<210>  535
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  535
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagaatt       60

tcctgtggag cctctggatt caccttcagt agttatagca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac attagtagta gtagtagtag gaaagactac      180

acagactctg tgaagggccg attcgccatc tccagagaca atgccaagaa ctcagtgtat      240

ctgcaaatga acagcctgag agacgaggac acggctgtgt attactgtgc gaaaaccgga      300

ggggcgtatt atgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  536
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  536
tcctatgtac tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacagcat tggaaataaa aatgtacact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgacgat agcggccggc cctcggggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcagctgtgg gatgatgata gtgatcgcgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  537
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  537
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtggtt acttctggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggtccatct attacagtgg gagcacctac      180

tacaacccgt ccctcaggag tcgaattacc atatcagtag acacgtctaa gaaccagttc      240

tccctgaagc tgagctctgt gactgccgcg gacacggccg tgtattactg tgcgaggggg      300

ggttcgggga gttattctct ttttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  538
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  538
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattacc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagattttg caacatatta ctgtcaacag tatgataatc tctactctgt acactttggc      300

caggggacca agctggagat caaac                                            325


<210>  539
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  539
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cactttcagt agctccgacc tgcactgggt ccgccaagct      120

acaggaaaag gtctggagtg ggtctcagct attggtactg ctggtgacac atactatcta      180

ggctccgtga agggccgatt caccatctcc agagaaaatg gcaagaactc cttgtatctt      240

caaatgaaca gcctgagagc cggggacacg gctgtgtatt actgtgcaag agtcctctat      300

gatagtagtg gtttttacaa ctggttcgac ccctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  540
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  540
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgaaaagtgg ggtcccatca      180

aggttcggtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacgaaa tgcctccgtg gacgttcggc      300

caagggacca aggtggaaat c                                                321


<210>  541
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  541
gaggagcaac tggtggagtc tgggggaggc ttggtgcaac ctggggagtc cctgagactc       60

tcctgtacag cctctggatc tacattcagt agcgctggca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg gatctcatat attagtgtca gtagtactac gatctactac      180

gcagagtctg tgaagggccg attcaccatc tccagagaaa atggcaagaa ctccttgtat      240

cttcaaatga acagcctgag agccggggac acggctgtgt attactgtgc aagagtcctc      300

tatgatagta gtggttttta caactggttc gacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  542
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  542
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccaggagaaa      120

cctggccagg ctcccaggct cctcatcttt ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag ctgtatggta gctcacctct gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  543
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  543
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttaat aactatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attggtggta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccgtc tccagagaca attccgagaa cacgctgtat      240

ctgcaaatga gcagcctgag agccgaggac acggccgtat attactgtgc gagggtagag      300

ggggactggt tattgggtgg gccatactac cactattacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  544
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  544
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaattatg tatactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctct aggaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccgg      240

tccgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgag tagttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  545
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  545
gaggtgcaac tggtggagtc tgggggaggc ttggtccagc cgggggggtc cctgagactc       60

cactgtgcag tctctgggct caccttaagt agatattgga tgagctgggt ccgccaggcc      120

ccagggaagg ggctggagtg gattggaagt atctattata gtaggaacgc cttctacaac      180

ccgtccctca agagtcgagt caccatatcc gtagacacgt ccaagaacca gttctccctg      240

aagctgacct ctgtgaccgc cgcagacacg gctgtgtatt actgtgcgca aggccgaggt      300

ggttattact ccccctttga cgactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  546
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  546
tcctatgagc tgacacagcc atcctcagtg tcagtgtctc cgggacagac agccaggatc       60

acctgctcag gagatgtact ggcaaaaaaa tatgctcggt ggttccagca gaagccaggc      120

caggcccctg tgttggtgat ttataaagac agtgagcggc cctcagggat ccctgagcga      180

ttctccggct ccagctcagg gaccacagtc accttgacca tcagcggggc ccaggttgag      240

gatgaggctg actattactg ttactctgcg gctgacaaca atctggtatt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  547
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  547
cagctgcagc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctatccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaacgggct ggagtggatt gggagtatct attatagtgg gagcacctac      180

tacaacccgt ccctcaaggg tcgagtctcc atatccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tctattactg tgcgagaatc      300

ttagtaattt ttactttaaa ctggttcgac ccctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  548
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  548
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcgg caatcccata      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  549
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  549
caggcgcaat tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcactg tctatggtgc gtccttcagt gattacttct ggacctggat ccgccagccc      120

cccgggaagg ggctggagtg gcttggggaa atcaggcaga ttggaaccac caactacaat      180

ccgtccctca agggtcgagc caccatttca atggacacgt ccaagagtca attctccctg      240

agcctgaggt ccgtgaccgc cgcggacacg gctgtctatt tttgtgcggg aggcgattct      300

cgcgtgtggg aggccctagt tgcctcgggc ccgggaatcc aggtcaccgt ctcctcag        358


<210>  550
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  550
gacatcgtga tgacccagtc tccagattcc ctggctgtgt ctctgggcgg gagggccacc       60

atcaactgca agtccagtca gagtgtttta aacagccaga acaataggga ctacttagct      120

tggtaccagc agaaaccagg acagcctccg aagttgctct tttattgggc atctacgcgg      180

gaatccgggg tccctgaccg cttcagtggc ggcgggtctg ggacagattt cactctcacc      240

atcgccagcc tgcaggctga agatgtggca gtctattact gtcaacaatt atatagtgct      300

ccgcgaacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  551
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  551
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc atctattgga tgagctgggt ccgccaggct      120

ccagggaagg ggctgcagtg ggtggccaac ataaagcaag atgcaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagactgggg      300

ggcagcagct ggcattttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  552
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  552
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggagataaa tattcttcct ggtatcagca gaagccaggc      120

cagtcccctg tgctggtcat ctatgaagat accaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg agcagcagca ctgcggtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  553
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  553
gaggtgcagc tggtggagtc tgggggaggc ctggtacagc cgggggggtc cctgagactc       60

tcctgtgcag ccactggatt caccttcagt agcaacgaca tgcactgggt ccgccaaccg      120

actggaaaag gtctggagtg ggtcgcagct attggtaatg ctggtgacac atactatcca      180

ggctccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgcatctt      240

caaatgcaca gcctgagagc cggggacacg gctgtctatt actgtgcaag aaacacggct      300

ggtagccaaa actggcactt cgatctctgg ggccgtggca cccaggtcac tgtctcctca      360

g                                                                      361


<210>  554
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  554
tcctatgaac tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagaa gaagccaggc      120

cagtcccctg tgctggtcat ctatgaagat aacaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcgtca ctgtggtctt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  555
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  555
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ccccatcagc agtagtcgtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atctccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgaactctgt gaccgccgca gacacggctg tgtattattg tgcgagacat      300

gatgggtcgg gggagatgga tacaattaca tgggggccca tttactacta catggacgtc      360

tggggcaaag ggaccacggt caccgtctcc tca                                   393


<210>  556
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  556
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aggcccccaa actcatgatt tattatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcac tctcaatgtg      300

ttatttggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  557
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  557
gaggtgtatt tgttggaggc tgggggagac ttggcacagc ctggggggtc cctgagactc       60

tcctgtgcag gctctggatt cacctttgac aactacgcca taagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcaggt attagtggta gtggagataa cacctattac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa gatgctctat      240

ctccaaatga acagcctaag agccgcggac acggccgtat attactgtgc gaaagttgca      300

tatagtggga gcaactcagt ggtctactac tactacatgg acgtctgggg caaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  558
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  558
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacaatc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt gcttttgact atgtctcctg gtatcaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtcg ttaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgttcatatg caggcaccca tgtggctttc      300

ggcggaggga ccaaggtgac cgtccta                                          327


<210>  559
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  559
cagatcacct tcaaggagtc tggtcctacg ctggtgaaac ccacagagac cctcacgctg       60

acctgcacct tctctgggtt ctcagtcagc actagtggag agggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcagtcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaggg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagg      300

ctttggttca gggatgcttt tgatatttgg ggccaaggga caacggtcac cgtctcctca      360

g                                                                      361


<210>  560
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  560
gacatccaga tgacccagtc tccatcgtcc ctgtctgcat ctgtaggaga cagagtcaca       60

atcacttgcc gggcacgtca gagcattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcacagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccctggcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  561
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  561
gaggtgcaac tagtggagtc tgggggaggc ttggtaaggc cagggcggtc cctgagactc       60

tcctgtgcaa cttctggatt caactttcgt gattacgcta tacactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtaggcttg attagaagcg aaccttatcg tgcgacaaca      180

gaatacgccg cgtctgtgag aggcagattc accctctcga gagatgattc caaaagcctc      240

gcctatttgc aaatgaacag cctgagaacc gaagacacag ccgtgtattt ctgcgctaga      300

actgagcgtt gtggtgctga ttgcacctcg cacatcaatt actatctgga cgtctggggc      360

agcgggacct cggtaactgt ctcctca                                          387


<210>  562
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  562
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca aagtgttgac agcaacttct tagcctggta ccagcacaaa      120

cctggccagg ctcccaggct cctcatatat gatgcatcca gcagggccac tggcatccca      180

gacagattca gtggcagtgg gtctgggaca gacttctatc tcatcatcag cagagtggag      240

cctgaagata ttgcagtgta ttactgtcag cagtatagta gttggccctt ctctttcggc      300

ggagggacca aggttcacat caaac                                            325


<210>  563
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  563
gaggtgtatt tgttggaggc tgggggagac ttggcacagc ctggggggtc cctgagactc       60

tcctgtgcag gctctggatt cacctttgac aactacgcca taagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcaggt attagtggta gtggagataa cacctattac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa gatgctctat      240

ctccaaatga acagcctaag agccgcggac acggccgtat attactgtgc gaaagttgca      300

tatagtggga gcaactcagt ggtctactac tactacatgg acgtctgggg caaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  564
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  564
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacaatc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt gcttttgact atgtctcctg gtatcaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtcg ttaagcggcc ctcaggggtc      180

cctgttcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tcctcatatc catgcaccta cacttgccag      300

gtgatattcg gcggagggac caagctgacc gtcctag                               337


<210>  565
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  565
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact agctatggta tgcattgggt gcgccaggcc      120

cccggacaaa ggcttgagtg gatgggatgg atcaacgttg gcaatggtaa cacaaaatat      180

tcacagaggt tccagggcag agtcaccatt accagggaca catccgcgag cacagcctac      240

atggaactga gcagcctgag atctgaagac acggctgtgt attactgtgc gatgggtccc      300

tcggccttca gctggctcga cccctggggc cagggaaccc tggtcaccgt ttcctcag        358


<210>  566
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  566
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcac      120

cttccaggaa cagcccccaa actcctcatc tatggtaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gagtggttgg      300

agtgtcttcg gaactgggac caaggtcacc gtcctag                               337


<210>  567
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  567
caggtgcagc tggcggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggaatg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagaagcacg      300

agtgggagct actactacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  568
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  568
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt gattataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga atattactgc agctcatata caagcagcag cactctactt      300

tatgtcttcg gaactgggac caaggtcacc gtcctag                               337


<210>  569
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  569
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcaac actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacaacccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacaga      300

cccccgagct accacggatg gtgttacttt gactactggg gccagggaaa cctggtcacc      360

gtctcctcag                                                             370


<210>  570
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  570
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc atctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccatatgtc cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  571
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  571
caggttcagg tggtgcagtc tggagctgag gtaaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacctttaag aactatggga tcagttgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcagcgctt acacaggaaa cacaaactat      180

gcacagaagt tccagggcag aatgaccatg accacagaca catccacggg aacaggttat      240

atggaactga ggagcctgag atctgacgac acggccgtgt attactgtgc gagagtacaa      300

cgacgtcgac ttgactactg gggccaggga accctggtca tcgtctcgtc ag              352


<210>  572
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  572
gatattgtgg tgacccagac tccactctct ctgtccgtca cccctggaca gccggcctcc       60

atctcctgca agtctagtga gaccctcctg catagtgatg gaaagaccta tttgtcttgg      120

tatctgcaga agccaggcca gcctccacag ctcctgatct atgaagtttc caaccggttc      180

tctggagtgc cagacaggtt cagtggcagc gggtcaggaa cagatttcac acttaaaatc      240

ggccgggtgg aggctgagga tgttgggctt tattactgca tgcaaagtat acagctcgcc      300

ttcggccaag ggacacgact ggaaattgaa c                                     331


<210>  573
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  573
gaggtgcagc tggtggaatc tgggggaacc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacgtttagt acctattggg tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaacagtat      180

gtgggctcgg tgaagggccg attcaccgtc tctagagaca acaccaagaa ctcactatat      240

ctacaaatga acagcctcag agccgaggac acggctgtat actactgtgc gagagaccct      300

tatgatagta ctggttatgg tgcttttgat atctggggcc aagggacaat ggtcaccgtc      360

t                                                                      361


<210>  574
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  574
gatgttgtga tgactcagtc tcctctctcc ctgcccgtca cccttggaca gccggcctcc       60

atctcctgca ggtctagtca aagcctcgta tacgaggatg gaaaaaccta cttgaattgg      120

tttcaccaga ggccaggcca ttctccaagg cgcctaattt ataaggtttc tacccgggac      180

tctggggtcc ctgacagaat cagcggcagt ggctcaggca ctgatttcac actgaaaatc      240

agcagggtgg aggctgagga tgttggggta tattactgca tgcaagggac acgctggccg      300

tacacttttg gccaggggac caggctggag atcaaac                               337


<210>  575
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  575
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc acttttggag tgggtgtggg ctgggtccgt      120

cagcccccag gaaaggccct ggagtgcctt gcactcattt attgggatga tgatgagcgc      180

tatagcccgt ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggta      240

gtccttacaa tgaccaacat ggaccctgca gacacaggca catattactg tgcacacagg      300

aaaaaagcga gcagtggctg gcagacattt gactactggg gccagggaac cctggtcatc      360

gtctcctcag                                                             370


<210>  576
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  576
gacatcgtga tgacccaatc tccagagtcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtctttta tacagctccg acaataagaa ctacttagct      120

tggtatcaac agaaaccagg acagcctcct aagctactca tttactgggc gtctatccgg      180

gaatccgggg tccctgaccg attcaggggg agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgcggca gtttattact gtcagcaata ttatggtgtt      300

cttctcactt tcggcggagg gaccaaggtg gagatcaaac                            340


<210>  577
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  577
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggtcactact ggagctggat ccgccagccc      120

ccagggaagg gactggagtg gattggggaa atcaatcaca gtggaagcac caactacaac      180

ccgtccctca agagtcgagt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag acccccccaa      300

gcagctcgta ttcattacta ctactacatg gacgtctggg gcaaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  578
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  578
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataattact ggcctcccct cactttcggc      300

ggagggacca aggtggagat caaac                                            325


<210>  579
<211>  347
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  579
gaggtgcggc tggtggagtc tgggggagtc ttggcccagc ctgggtcgtc cctgacgctc       60

tcctgtgcag cctctggatt caccgtcagt agtaattata tgagctggtt ccgccaggct      120

ccagggaagg ggctggagtg ggtcgcagtg gtttctggcg gtggcaatac atattacgca      180

gactccgtga ggggcagatt caccatcttc agagacaact ccaagaacat tctctttctt      240

caaatgaata acctgagagc cgaggacacg gctgcgtatt actgtgcgag atctccgtgg      300

ggttcagggg gccactgggg ccagggaacc ctggtcaccg tctcctc                    347


<210>  580
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  580
gatgttgtaa tgacccagac tccactctcc ttagttgtca cccttggaca gccggcctcc       60

atctcctgca gatctagtga aagtctcgta tatcgtgatg gaaacaccta cttgagttgg      120

ctactggtga ggccaggcca gcctccaaga ctcctacttt atatggtttc taaccgtttc      180

tctggggtcc cagaccgatt cagtggcagt ggggcaggga cagatttcac actgaaaatc      240

agcagggtgg aagctgagga tgtcggcctt tattactgca tgcaagctac acagtatccg      300

tacacttttg gccaggggac caagctggag atcaaac                               337


<210>  581
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  581
cagatcacct tgaaggagtc tggtcctatg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctggatt ctcactcgac acttatggaa tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagtccat ttctgaagag cagactcacc atcaccaagg acacctccaa aaacctggtg      240

gtccttacaa tgaccaactt ggacgctgtg gacacagcca catattactg tgtacgcagg      300

tattacgatt cttcgagtga tgaaggccat ggttttgaca tctggggcca agggacaata      360

ttcaccgtct cctcag                                                      376


<210>  582
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  582
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccaggag tgatgttggt ggttatacct atgtctcctg gtaccaacaa      120

caccctggca aagcccccaa actcctgatt tatcatgtca gtcagcggcc ctcaggggtc      180

cctgatcgct tctctggctc cctgtctggc aacacggcct ccctgatcat ctctgggctc      240

caggctgacg atgaggctga ttattactgc tgctcatatg caggcagcta cgctttcgcg      300

ctcttcggcg gagggaccaa ggtgaccgtc ctag                                  334


<210>  583
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  583
gaagagcatc tggtggagtc tgggggaggc tcggtacagc ctggcaggtc cctgaggctc       60

tcctgtgcag ccgctggatt caactttgat gctcatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagtggaa gtagtgatta caaagtctat      180

gcggactctg tgaggggccg attcaccatc tccagagaca acggcaagac ctccctgtat      240

ctgcaaatgg acagtctgag acctgaagac acggcctttt attattgtgc aaaaggtgta      300

gatcaaggag gggtgatcgc ctacttccag cactggggcc cgggcaccct agtcaccgtc      360

tcctcag                                                                367


<210>  584
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  584
gaaattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg cgtagtagtg gatacaacta tttgagttgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttgggctt tattactgca tgcaagctct acgaaccccc      300

ctcactttcg gcggagggac caaggtggag atcaaac                               337


<210>  585
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  585
gaggtgcagc tcttggagtc tgggggaggc ttgggacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttacc agttatgcca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcatct attgctggtg gtgatggttc cacatactat      180

gcagaatccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctatat      240

ctgcaaatga acagcctgag agccgaggac acggccctat attactgtgc gaaaggcata      300

acccatgatg atggtggccc tgatcactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  586
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  586
cactctgtgc tgactcagcc accctcaacg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga aataattatg tattctggta ccagcaactc      120

ccaggaacgg cccccaaact cctcatctat aagaatattc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccgg      240

tccgaggatg aggctgatta ttactgtgca acatgggatg acagcctgag tggtcgggtg      300

ttcggcggag ggaccaagct gaccgtc                                          327


<210>  587
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  587
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggaatc tctgaagatc       60

tcctgtaagg gttctggata cagtttcacc agctactgga tcggttgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggata atctatcctg gtgactctga taccacatac      180

aacccgtcct tccaaggcca agtcaccatc tctgccgaca agtccctcac taccgccttc      240

ctacattgga gcagtctgaa ggcctcggac accgccattt attactgtgc gagacggttc      300

tatgggccct cctcctttga ctactggggc cagggaaccc tggtcatcgt ctcctcag        358


<210>  588
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  588
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcacgatc       60

acatgccaag gagacagcct cagaagccat tatgcaagtt ggtataaggt gaagccagga      120

caggcccctt tacttgtcat ctatggtaga aacaaccggc cctcagggat cccagaccga      180

ttctctggct cccgatcagg aaacacagct tccttgacca tcactggggc ccaggtggat      240

gatgaggctg actattactg tagctctggg gacagcagta ctgaccatca cgtggtattc      300

gccggaggga ccaagctggc cgtcgtag                                         328


<210>  589
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  589
caggtgcaac tggtgcagtc tggggctgag gtgaagaggc ctggggcctc aatgaacatc       60

tcctgcaagg catcaggata caacttcaac aataattata tatattgggt gcgacaggcc      120

cctggtcaag gacttgagtg gatgggagta gtcaacccta ctggaggggg aacagcgtac      180

gcacaggggt ttcaggacag agtcaccatt accagtgaca ccccccgaaa cactgtctac      240

ctgggcgtga cgggactcca ctccgaagac acggccgtct atttctgtgc gagaggcggg      300

gagtggcgaa ttgttcctgg tggtagggac tacttcgact actggggcca gggaaccctg      360

gtcaccgtct ccgcag                                                      376


<210>  590
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  590
gacatggagg tgacccagtt tccatcttcc ctgtctgcct ctataggaga cagagtcacc       60

atcacttgcc gggcaactca gagtataagt acctatttaa attggtatca acagaaacca      120

gggaaagccc ctaatctcct gatttatagt gcttcccatt tacagagagg ggtcccagcc      180

aggttcagtg gcagtggatc tgggacagag ttcactctca ccatcacgac tctacaaccg      240

gaagatgttg gaacttacta ctgtcaccag agttacggtg ttccgatcac cttcggcgga      300

gggaccaagg tggacatcaa ac                                               322


<210>  591
<211>  394
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  591
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatt       60

tcctgtaagg gttttggata caactttacg aactactgga tcgggtgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga gaccagaaat      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatgag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagacttggg      300

gtgtcgaaat attgtagtgg tggtaggtgc ctctccggcg ggtccaactg gttcgacccc      360

tggggccagg gaaccctggt caccgtctcc tcag                                  394


<210>  592
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  592
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcctccgat gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  593
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  593
gaggtgcacc tggtggggtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggtt caccgtcagt agcaacttca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcaatt attcataacg gtggcgactc atactacaca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctt      240

caaatgaaca acctgagagc cgaggacacg gccgtgtatt actgtgcgag cagcagctgg      300

ttacgaggtg cttttgatat ctggggtcaa gggacaatgg tcaccgtctc ttcag           355


<210>  594
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  594
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagttcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcag caaatatgtg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  595

<400>  595
000

<210>  596

<400>  596
000

<210>  597
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  597
aacgtgcagt tagtggactc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttcgt gcttatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtcgcaggt attagtggga gtagtgatta cagagcctat      180

gcggactccc tgcagggccg attcaccatc tccagagaca acgccgagaa ctccctgtgg      240

ctgcatatga acagtctgac agatgaggac acggccttct attactgtgc aaggggcatt      300

gactatggcg gcatacttgc ctactttgac tcctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  598
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  598
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg caaagtcacg gatacaactt tttgagttgg      120

tacgtgcaga agccagggca gtctccacag ctcctgatct atttgggctc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagactttac actgaaaatc      240

agcagattag aggctgagga tgttggggtt tattactgca tgcaagctca acaaactccc      300

cacaccttcg gccaagggac acgactggag attaaac                               337


<210>  599
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  599
gaggtgcagc tggtggagtc tgggggagac ttggtaaagc cagggcggtc cctgagactc       60

tcctgttcag cttctggatt cacgtttggt gattatacta tgagctggtt ccgccaggct      120

ccagggaagg ggctagagtg ggttgctttc attagaagca aagcttatgg tgggacaaca      180

gaatacgccg cgtctgtgat aggcagattc accatctcaa gagatgattc caaaagcatc      240

gcctatctgc aaatgaacag cctgaaaagc gaggacacag ccgtatatta ctgttctaga      300

gttcgaggta gtttctatgg ttcggtagga aagaactacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  600
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  600
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacctgcaga agccagggca gtctccacag ctcctcatct atttgggttc tactcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactccc      300

ctgtacactt ttggccaggg gaccaagttg gagatcaaac                            340


<210>  601
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  601
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cagcttcagt agctatgtta tgaactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcag taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa tacactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagacatt      300

gatagtggct acgatcctac ccccgttttt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  602
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  602
gacatccaga tgacccagtc tccatcctcc ctgtctgcat gtgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaaggcc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagac ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagtt ccctttcgat caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  603
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  603
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcaccg tctctgggtt ctcactcagc actagtggag tgggtgtggg ctgcatccgc      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggta      240

gtccttacaa tgaccaacat ggaccctgca gacacaggca catattactg tgcacacagg      300

aaaaaagcga gcagtggctg gcagacattt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  604
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  604
gaagttgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccaggagaaa      120

cctggccagg ctcccaggct cctcatctat agtgcatcca gcagggccac tggcatccca      180

gacaggttca gcggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag caatatacta acttcctcac cttcggccaa      300

gggacacgac tggacattaa ac                                               322


<210>  605
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  605
gaggagcagt tggtggagtc cgggggaggc ttagttcagc cggggggatc cctgactctc       60

acttgtgaag cctctggatt cagcctcagc acctactgga tgatgggctg ggtccgccag      120

gtcccagggc aggggctggt gtgggtctca cgcattagca tgcatgggaa tcacataagt      180

tacgcggatt ccgtgaaggg ccgattcacc atctccagag acatctccaa gaacactctg      240

tatctccaac tgagcagtct gagagccgag gacacggctg tgtatttttg tgtgagagat      300

ggcggttctg acacgcatga ctggttcttc gatctctggg gccgtggcac cccggtcact      360

gtctcctcag                                                             370


<210>  606
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  606
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcactatc       60

tcctgcactg gaaccagcag tgatgttggg gagtacaacc ttgtctcctg gtaccagcaa      120

caccctggca aagtccccaa actcctgatt tatgtggtca gtcagcggcc ctcaggggtt      180

tctcatcgct tcgctggctc caagtctggc aacacggcct ttctaacagt ctctggactc      240

caggctgagg acgaggctga ttattattgt ttgtcatatg caggcggtgg aagggggttc      300

ttcggcggag ggaccaggct gaccgtcct                                        329


<210>  607
<211>  371
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  607
gaggtgcagc tgttgcagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagg aactatgcca tgagttgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtac cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgcgc gaaaaacgag      300

cggattacta tgctagtagt agttaccctc tttgactact ggggccaggg aaccctggtc      360

accgtctcct c                                                           371


<210>  608
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  608
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gtgatgcatt gccaaggcaa tttacttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaatcagca gacaccattg gtacttattg ggtattcggc      300

ggagggacca agctgtccgt cctag                                            325


<210>  609
<211>  343
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  609
caggttcagc tggtgcagtt tggagctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacctttacc agttatggta ttagttgggt gcgacaggcc      120

cctggacacg ggcttgagtg gatgggatgg atcagcgctt acaatggtaa aacaatctat      180

gcacagaagc tccagggcag agtcaccatg accacagaca catccacgag cacagcctac      240

atggtactga ggagcctgac atctgacgac acggccgtgt attactgtac gacacgggac      300

ggccgttact ggggccaggg aaccctggtc accgtctcct cag                        343


<210>  610
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  610
gatgttgtga tgactcagtc tccactctcc ctgcccgtca cccttggaca gccggcctcc       60

atctcctgca ggtctagtca aagcctcgta tacagtgatg gaaacaccta cttgaattgg      120

tttctgcaga ggccaggcca atctccaagg cgcctaattt ataaggtttc taaccgtgac      180

tctggggtcc cagacagatt cagcggcagt gggtcaggca ctgattttac actgaaaatc      240

agcagggtgg aggctgagga tgttggggtt tattactgca tgcaaggtac acactggccc      300

aacacttttg gccaggggac caagctggag atcaaac                               337


<210>  611
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  611
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc acctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggactg ggtctcgtcg attactggta gtggtgatac cacagactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccatgaa cacactgtat      240

ctgcaagtga gcagcctgag agtcgaggac acggccatat attactgtgc gaaaaccccg      300

gggggcagca gctttttcct aacatactgc tttgactcct ggggccaggg aaccctggtc      360

agcgtctcct cag                                                         373


<210>  612
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  612
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttaac accgcctcct tagcctggta ccagcagaaa      120

cctggccagt ctcccaggct cctcatctat ggtacatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgcgaca gacttcactc tcaccatcag cagactgcag      240

cctgaagatt ttgcagtgta ttactgtcag cagtacgata tctcaccggg aacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  613
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  613
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaaga cttctggata caccttcact agctatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagagatgtt      300

gatattagca gcagctggta cccgggctac tactacggta tggacgtctg gggccaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  614
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  614
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaattatg tatactggta tcagcaactc      120

ccaggaacgg cccccaaact cctcatctat aggaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccgg      240

tccgaggatg aggctgatta ttactgtgta gcatgggatg acagcctgag tggtgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  615
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  615
gaggtgcaac tggtggagtc tgggggaggc ttggtccagc cgggggggtc cctgagactc       60

cactgtgcag tctctgggct caccttaagt agatattgga tgagctgggt ccgccaggcc      120

ccagggaagg ggctggagtg ggtggccgcc ataaaggaag atggaagtga gatatactat      180

gtggactctg ttgagggccg attcaccatc tccagagaca acgccaagaa ctcagtgtat      240

ctccaaatga acagcctgag agccgaggac acggctgtct atcactgtgc gagaggtccg      300

tactggggcc aggggaccct ggtcgccgtc tccgcag                               337


<210>  616
<211>  313
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  616
ggcgtccagc tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagcca gtatttcgga aggtggttgg cctggtttca gcagaaacca      120

gggagagccc ctaatctcct gatctatgag gcgtctaaat tacaaagtgg ggtcccatcg      180

aggttcagcg gctttggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacgtacta ctgccaacgg tatgatggcc cgtttggcca agggaccaag      300

gtggagatca aac                                                         313


<210>  617
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  617
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agatactcct ggaattggat tcggcagccc      120

gccgggaagg gactggagtg gattgggcgc atctacacca gtgggaggac caactacaac      180

ccctccctca agagtcgaat caccatgtca gtagacacgt ccaagaacga gttctccctg      240

aaggtgagct ctgtgaccgc cgcggacacg gccgtgtatt actgtgcgag aggacgagat      300

tactatgata gtagtggcgc ctactacttt gactactggg gccagggaac cctggccacc      360

gtctcctcag                                                             370


<210>  618
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  618
cagactgtgg tgacccagga gccatcgttc tcagtgtccc ctggagggac agtcacactc       60

acttgtggct tgagctctgc ctcagtctct actagttact accccacctg gtaccagcag      120

accccaggcc aggctccacg cacgctcatc tacagcacaa acactcgctc ttctggggtc      180

cctgatcgct tctctggctc catccttggg aacaaagctg ccctcaccat cacgggggcc      240

caggcagatg atgaatctga ttattactgt gtgctgtata tgggtagtgg catttcgata      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  619
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  619
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtgc agcaaactac      180

gcacagaact tccagggcag agtcacgatt accgcggacg aatccacgag cacaggctac      240

atgcaactga gcagcctgag atttgaggac acggccgtgt attactgtgc gagaacgtct      300

cactatgata gtagtggttc ctattttgaa tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  620
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  620
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagaccct      240

gaagattttg cagtttatta ctgtcacaag cgtagcaact ggcctccttc gctcactttc      300

ggcggaggga ccaaggtgga gatcaa                                           326


<210>  621
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  621
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc acctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctat      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagacgaagg      300

ggtggtatcg gaatagagta cggtatggac gtctggggcc aagggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  622
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  622
tccaatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaacaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tactggtgat atataaagac actgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcaaca gccagcagtg gtacttatgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  623
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  623
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcttgtgcag cctctggatt caccttcagt agctatgcca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagat atttcatatg atggaagtga aaaatactat      180

gcagactccg tgaagggccg attcaccatc tacagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatttc      300

gggggggata atacagctat ggttgagtac ttctttgact tctggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  624
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  624
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattagt agctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatagtt attctccgac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  625
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  625
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccgtcagc agtggtagtt actactggag ctggatccgg      120

cagcccccag ggaagggact ggagtgcatt gggtatatct attacagtgg gagctccaac      180

tacaacccct ccctcaagag tcgagtcacc atatcagtag acacgtccaa gaaccagttc      240

tccctgaaga tgagctctgt gaccgctgcg gacacggccg tatattactg tgcggggagc      300

cctgtccctc ccacgattgt gggagcttcg tactggggcc agggaaccct ggtcaccgac      360

tcatcag                                                                367


<210>  626
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  626
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccttc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcgattct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatggcat caatcggtgg      300

ctggtattcg gcggagggac caagctgacc gtcctag                               337


<210>  627
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  627
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcctatg atggaactaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ttgcaaatga acagcctgag ggctgacgac acggctgtgt attactgtgc gaaaggacgt      300

gggaactacc ttactttctt tgactcctgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  628
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  628
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcccggaac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  629
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  629
gaggtgcaac tattggagtc tgggggaggc ttggcacagc cgggggggtc cctgagactc       60

tcgtgtgtag cctctggatt cagctttagt tcttatggca tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagta atggatggta gtgctggaaa catatactac      180

gcagacgccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacactgtat      240

ctgcaaatga acagcctgag acccgaagac acggccgcat atttctgtgc gaaagattcg      300

ggagcgcttt gcagtggtgg tgattgcttg agggggtact tcgatctctg gggccgaggc      360

accctggtca ctgtctcctc ag                                               382


<210>  630
<211>  343
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  630
gacatcgtaa tgacccagtc tccagaatcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta ttcagcacca acaataagaa ctacgtagct      120

tggtaccagc agaaaccagg acagcctcct gcgctgctca tttactgggc ttctacccgg      180

gcatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtaat      300

ccgctgtgga cgttcggcca agggaccaag gtggaaatca aac                        343


<210>  631
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  631
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt catcttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagatcaccc      300

ccggcgagtt attataaccc ctctaccggt tattttgact actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  632
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  632
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caactttcta ctgtcaacag agttacagta cccccatgca cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  633
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  633
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcacc agccactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtggtggtag cacaagctac      180

gcacagaagt tccagggcag agtcaccatg accagcgaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccatgt attactgtgc gagagatgta      300

ttttgggtac cagctgctag ctcctttgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  634
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  634
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct      240

gaagattttg cgacttatta ctgtcaacag cttaatagtt accttgggac cttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  635
<211>  345
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  635
gaggtgcggc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt gactacgcca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtgcta ctggtggtag cacgttctac      180

gcagactccg tgaagggccg gttcagcatc tccagagaca attccaagaa cagcctggtc      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attattgtgc gaaaccctac      300

ggtatggacg tctggggcca agggaccacg gtcaccgtct cctca                      345


<210>  636
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  636
gacatccaga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggtattagc agctggttag cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc ggggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagca tccctccaac cttcggcggt      300

gggaccaggg tggagatcaa                                                  320


<210>  637
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  637
caggtgcagc tggtggagtc tgggggaggc ttggtcaagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt ccccttcagt gccttctaca tgacttggat ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac atcactggtg atggtgtcgt ctcgtacgta      180

gactctgtga ggggccgatt cagcatctcc agggacaact ccaggagctc actgcatttg      240

caaatgaaca gactaagaga cgaagacacg gccatatatt actgtgcgag aggcaactac      300

ggaattgact tctggggcca gggaatcctg gtcaccgtct cctcag                     346


<210>  638
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  638
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccaggaga aagagccacc       60

ctctcttgca gggccagtca gagtctgagc aggacctact tggcctggta ccagcagaaa      120

cctggccagg ctcccaggtt cctcatctct aatgcatcca gcaggcccac tggcatccca      180

gacaggttca gtggcagtgg ctctgggaca gacttcactc tcaccatcgc cagactggag      240

actgacgatt ctgctgtgta ttactgtcag cagtatgata cctcaccgtg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  639
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  639
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcgagct      120

ccagggaagg gcctggagtg ggtctcaagt attagttgga atagtggtat aatagagtat      180

ggggactctg tgaagggccg attcaccatc tccagagaca acgccaagag caccctgtat      240

ttgcaaatga acagtctgag atctgaggac acggccatgt attactgtac aaaagatatt      300

ccagcaactg gtcgctttac tgcttttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttca                                                                 366


<210>  640
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  640
tcctatgacc tgacacagcc accctcggtg tcagtatccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt ggcaaaacaa tatgcttatt ggtatcagca gaagtcaggc      120

caggcccctc tactggtcat ctctgaggac aggaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc gccttgacta tcagtggggc ccaggtggag      240

gatgaaggtg actacttttg tttctcagca gacagccttg gtggtcatag gatgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  641
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  641
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cactctttat      240

ctgcaaatga acagcctgag agttgaggac acggctgtgt attactgtgc gagagatcaa      300

gaatggttca gggagttatt cctttttgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  642
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  642
gacatccaga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggtattagc agctggttag cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgat gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct      240

gaagattttg caacttacta ttgtcaacag gctaacagtt tccctccgac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  643
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  643
caggttcagt tactgcagtc tggaggtgag gtgaagaagc ctgggtcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacttttgac aactatggtc tcagctgggt gcgacaggcc      120

cctggacaag ggctccagtg gatggggtgg atcagcgctt acaatggtga cacaaactct      180

gcacagaagt tccaggacag agtcaccatg accatagaca catccatgag gacagcctac      240

atggaactga ggagcctgag atctgacgac acagccatgt attactgtgc cagatcagct      300

cattgtactg gcggtgtatg ctatcacctc cccgttgaca actggggcca gggaaccctg      360

gtcaccgtct cctc                                                        374


<210>  644
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  644
gactttcaga tgacccagtc tccatcgtat gtgtctgcat ctgtaggaga cagagtctcc       60

atcacttgcc ggacgagtca ggacattagt aattatttag cctggtatca gcagaaaccg      120

gggacagttc ctaaactgct catctatgtt gcatccactt tactgtcagg ggtcccatct      180

cgcttcagtg gcagtggatc tgggacacat ttcactctca ccatcaccag cctgcagcct      240

gaagatgttg cgacttatta ctgtcaaaaa tatgacagtg tccctctgac gttcgggcaa      300

gggaccaagg tggaaatcaa                                                  320


<210>  645
<211>  394
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  645
caagtgcaac tgcaggagtc gggccctaga ctggtgaagc cttcggagac cctctccctc       60

acttgcacag tctctggtgg ctccatgagt ggtttcttct ggagctgggt tcggcagtcc      120

cccgagaggg gatttgaata cattggctac ttttattcta gtgcaaaaac cgattacaac      180

ccctccctca gcagtcgcgt caccatgtca ttggacgcgt ccaaaaacct attctccttg      240

aagctgacct ctgtgaccac ttcggacacg gccgtctatt actgtgcgag agcccagaat      300

tactatcgtg gaaatactta ttattcgaca agatacccca gaccggatat ttttgacatg      360

tggggccgag ggacaagggt caccgtctct tcag                                  394


<210>  646
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  646
ggcgtccagc tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtgttagt acctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaacctcct gatctatgag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctggacact      240

gaagactttg gagtctatta ctgtcaccaa tatggcatct caccgttcac ctttggccag      300

gggaccacgg ttgacatcaa ac                                               322


<210>  647
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  647
caggttcagt tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cctctggtta cacctttccc agctatagta tcgcctgggt acgacaggcc      120

cctggacaag gacttgagtg gatgggacgg gtcagcgctt acaatggtta cacaaatttt      180

gcacagaagc tccagggccg agtcaccatg accacggaca caccctcgac cacagcctac      240

atggagttga agaacctcac atctgacgac acggccgtct attactgtgc gaggcggtac      300

tgtagtggtg gtatcgcaaa gtgtgggttc cacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  648
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  648
gatatagtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca actctagtca gagtctcctg catagtaatg gaaacaacta tctggattgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttagtttc taaccgggcc      180

gccggggtcc ctgacaggtt cagtggcagt ggatcaggaa taggctttac actgaaaatc      240

agtagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

ccaacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  649
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  649
caggtgcagc tggcgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg ctgctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatggggtgg atgaactcta acagtggtaa cgcaggctat      180

gcacagaagt tccagggcag agtcactatg accagggaca cctccacaag tacagcctac      240

atggagttga gcagcctgac atctgatgac acggccgtgt attattgtgc gagaatgcgc      300

accggctggc ccacacatgg ccgcccggat gacttctggg ggcggggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  650
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  650
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcaactc caacatcgga agttatactg taaactggta ccagcagttc      120

ccaggaacgg cccccaaact cctcatttat gataataatc agcggacctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctaatta ttactgttta gtatgggatg acagcctgaa tggcctggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  651
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  651
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcag caactacaac      180

ccgtccctca agagtcgagt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag aggctggggg      300

tggggagcag tggctggtag ggcggaatac tactttgact actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  652
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  652
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggtagtag cacctggggc      300

ttcggaactg ggaccaaggt caccgtccta g                                     331


<210>  653
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  653
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttacgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggatacaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagcccag      300

ggggggaact actactacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  654
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  654
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaactaaa ggtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgggcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actatttctg tcaggtgtgg gatagtagta gtgatcatca tgtggtattc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  655
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  655
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtagtt actactggag ctggatccgg      120

cagcccgccg ggaagggact ggagtggatt gggcgtgtct atatatatag cagtgggagt      180

accaactaca acccctccct caagagtcga gtcaccatat cagtagacac gtccaagaac      240

cagttctccc tgaagctgag ctctgtgacc gccgcagaca cggccgtgta ttactgtgcg      300

agaggtgcag cgtcctttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  656
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  656
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtgatg gatacaccta tttggattgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taagcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactcct      300

ctcactttcg gcggagggac caaggtggag atcaaac                               337


<210>  657
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  657
caggtgcagc tggtgcagtc tggggctgcg gtgaagaagc ctgggtcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacttttgac aactatggtc tcagctgggt gcgacaggcc      120

cctggacaag ggctccagtg gatggggtgg atcagcgctt acaatggtga cacaaactct      180

gcacagaagt tccaggacag agtcaccatg accatagaca catccatgag gacagcctac      240

atggaactga ggagcctgag atctgacgac acagccatgt attactgtgc cagatcagct      300

cattgtactg gcggtgtatg ctatcacctc cccgttgaca actggggcca gggaaccctg      360

gtcaccgtct cctc                                                        374


<210>  658
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  658
gaaattgtgt tgacacagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgc tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggtggcgcac gttcggccaa      300

gggaccaagg tggaaatcaa                                                  320


<210>  659
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  659
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc acctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggactg ggtctcgtcg attactggta gtggtgatac cacagactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

cttcaaatga acagcctgag agccgaggac atggccgtat attactgtgc gagagagagc      300

acgcaatggg gccagggaac cctggtcacc gtctcctcag                            340


<210>  660
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  660
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaag aaatatttaa gttggtatca gcaaaagcca      120

gggcaagtcc ctaggctcct catctacgac acatccaatt tggaaacagt gggagcagga      180

gtcccatcaa gattcagtgg aggtggatct gggacccatt ttagtttgac catcagcagc      240

ctgcagcctg aagatggtgc aacatattac tgtcaacagt atgataatct cccattcacc      300

ttcggccctg ggaccaaagt gcatatcaaa c                                     331


<210>  661
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  661
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaagctt       60

tcctgcaagg catttggata caccttcacc acccactgga tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatggcaata atcaacccta atagtggtga cagaagctac      180

gcacagaagt tccaaggcag agtcaccgtg accagcgaca cgtccacgaa cacagtgtct      240

atggagttga gcagcctgag atctgaggac acggccctgt attactgtgc gagagatgtg      300

agcagccaaa accgggcgtg gtggctcgac ccctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  662
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  662
tcttctgagc tgactcagga cccttctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgtcaag gagacagcct cagaaaatat tatgcaagct ggtatcagca gaagccagga      120

caggcccctg tacctgtcat ctatggtaaa aacgaccggc cctcagggat cccagaccga      180

atctctggct ccagttcagg aaacacagct tccttggcca tcactggggc tcaggcggaa      240

gatgaggctg actattactg ttactcccgg gacagaagtg gtaaccgttg ggtgttcggc      300

ggagggacca ggctgaccgt cctag                                            325


<210>  663
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  663
caggttcagc tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacctttacc agctatggta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcagcgctt acaatggtaa cacaaattat      180

gcacagaagg tccagggcag agtcaccatg accacagaca catccacgag cacagcctac      240

atggagctga ggagcctgag atctgacgac acggccgtgt attactgtgc gagagatggg      300

gaggagcggg cgaatgtcaa tgtccccatg atttacggta tggacgtctg gggccaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  664
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  664
gtcatctgga tgacccagtc tccatcctta ctctctgcat ctacaggaga cagagtcacc       60

atcagttgtc ggatgagtca gggcattagc aattatttag cctggtatca gcaaaaacca      120

gggaaagccc ctgagctcct gatctatgct gcatccactt tgcaaagtgc ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagttg cctgcagtct      240

gaagattttg caacttatta ctgtcaacag tattatagtt tcccgtacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  665
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  665
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagta actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct attatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagggac      300

ccgagggtgg tggtgactgc taggatgtac aactggttcg acccctgggg ccagggaacc      360

ctggtcaccg tctcctcag                                                   379


<210>  666
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  666
gaaatagtga tgacgcagtc tccaggcacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tgtcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcctccgat gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  667
<211>  385
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  667
caggtgcagc tgcaggagtc gggcccaggg ctggtgaagc cctcggagac actgtccctc       60

acctgcactg tctctggtgg ctccctcagt agttactact ggagctggat ccggcagccc      120

ccagggaagg gactggagtg gattggatat atctatgaca gtgggggtgc cagtcggagc      180

accaactaca acccctccct caagagtcga gtcaccatat cagtggacac gtccaggaac      240

cagctctccc tgaagctgag ttctgtgacc gctgcggaca cggccgttta ttactgtgcg      300

agagatcagc ggcagttcca gctgctagga cgattcgggt ggttcgaccc ctggggccag      360

ggaaccctgg tcaccgtctc ctcag                                            385


<210>  668
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  668
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcctcggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  669
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  669
gaggtgcagc tggtggagtc cgggggaggc ttggtccagc ctggagggtc cctgagactc       60

tcctgtgcaa cctctggatt catcttcagc gaccactaca tggactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggttggccgc actaagaaca aaggtcagag ttacaccgca      180

gaatacgccg cgtctgtgaa aggcagattc atcatctcaa gagatgattt aacgaagtca      240

atgtttctgc aaatgagcag cctgaaaacc gaggacacgg ccgtctacta ctgtgttctc      300

ggacactcgg tggagacaac tgtggcccgt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  670
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  670
caggctgtgg tgactcagga gccctcactg actgtgtccc caggagggac agtcactctc       60

acctgtgact ccagcactgg atctgtcacc agtggtcatt atgcccactg gttgcagcag      120

aagcctggcc aagtccccag gactctgatt tatgatacaa gcaacaaaca ctcctggaca      180

cctgcccggt tctcaggctc cctccttggg ggcaaagctg ccctgaccct ctcgggtgcg      240

cggcctgaag atgaggctga ttattattgc ttgctcactt atattgtcac ccatactgct      300

actcgagtgt tcggcggagg gaccaagctg accgtcctag                            340


<210>  671
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  671
caggtcacct tgagggagtc tggtccagcg ctggtgaaag ccacacagac cctcacactg       60

acctgcgcct tctctgggtt ctcactcacc actaatggaa tgtgtgtaac ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcactcattg attgggatga tgaaaaatac      180

tacaacacat ctctgaagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtc gacacaggca cttatttttg tgcacggatg      300

accgccgcag caactgccga tgcttttgat gtctggggcc aagggacagt ggtcaccgtc      360

tcttcag                                                                367


<210>  672
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  672
ccctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acttgctctg cagatgtctt gccaaagcaa tatgcttatt ggtaccaaca gaagccaggc      120

caggcccctg tgttggtgat atataaagac accgagaggc cctcagggat ccctgagcga      180

ttctctggcg ccagttcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actatttctg tcaatcagcg gacagcagtg gtgtttatct taattgggtg      300

ttcggcggag ggacaaggct gaccgtcct                                        329


<210>  673
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  673
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtactactt attactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gcgagtatct attacagtgg gagcacctac      180

tacaatccgt ccctcaagag tcgactcacc gtttccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tctattactg tgcgagacaa      300

tggaaatggt tcggggaagc ctggtacttc gatctctggg gccgtggcac cctggtcact      360

gtctcctcag                                                             370


<210>  674
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  674
cagcctgtgg tgactcaatc gccctctgcc tctgcctccc tgggagcctc ggtcaagctc       60

acctgcactc tggatagtgg gcacagaagc tacgccatcg catggcatca gcagcggcca      120

gagaagggcc ctcgcttctt gatgaggatt accactgatg gcaggcacac caagggggac      180

gggatccccg atcgcttctc aggctccggg tctgggactg agcgctacct caccatctcc      240

agcctccagt ctgaggatga ggctgactat tactgtcaga cttggggcac tttcggcgga      300

gggaccaggc tgaccgtcct ag                                               322


<210>  675
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  675
caggtacagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcagc aactaccata tgcactgggt gcgacaggcc      120

cctggacagg ggcttgagtg ggtgggaaca attgacccta gtggtcatag cccaaactac      180

gcacagagat tccagggcag agtcgccatg accagggaca cgtccacgag cacagtgtac      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagtgacaat      300

atagctgtga ttacaggagt aggatactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  676
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  676
caggctgtgg tgactcagga gccctcactg actgtgtccc caggagggac agtcactctc       60

acctgtggca tcaccactgg aactgtcacc cgtgatcatt atccctactg gttccagcag      120

aagcctggcc aagcccccag gacactgatt tatgatacaa gcaacaaaca ctcctggaca      180

cctgcccggt tctcaggctc cctccttggg gacaaagctg ccctgaccct ttcgggtgcg      240

cagcctgcag atgaggctga ctattactgc ttgctcacct atggtggtgg tcgagtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  677
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  677
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt gactacgcca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtgcta ctggtggtag cacgttctac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagtgggg      300

tatacgatca gtcgtcagtg gctggtagga gagtttgact actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  678
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  678
gactttcaga tgacccagtc tccatcgtat gtgtctgcat ctgtaggaga cagagtctcc       60

atcacttgcc ggacgagtca ggacattagt aattatttag cctggtatca gcagaaaccg      120

gggacagttc ctaaactgct catctatgtt gcatccactt tactgtcagg ggtcccatct      180

cgcttcagtg gcagtggatc tgggacacat ttcactctca ccatcaccag actggagcct      240

gaagactttg cagtctatta ctgtcaggag tatggtagct cggcgatcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  679
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  679
gaggtgcaac tggtggaatc tgggggaggc ttggtccagc ctggggggtc cctaagactc       60

tcctgtgcag tctcaggatt ctcctttaac agctattgga tggcctgggt ccgccaggct      120

ccagggaggg ggctggagtg ggtggccaac atagaacaaa acgggaatgc gatagtgtat      180

ttggactctg tgatgggccg attcaccgtc tccagagaca acgccaagaa ctctctgttt      240

ctgcacatga acagcctgag acccgaggac acggctatat attactgtac taacggcata      300

tatagcagca gttggtgggg ccggggaacc caggtcaccg tctcctcag                  349


<210>  680
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  680
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga gggggccacc       60

ctctcctgca gggccagtca gaatgtgaac aacatggtgg cctggtatca gcagaaacct      120

ggccaggctc ccagactcct catctttagt acttcaatga gggccacggg tgtcccagcc      180

cggttcagtg gcagagggtc tgggacagaa ttcactctca ctatcagcag cctgcagtct      240

gaagattttg caatttatta ctgtcagcac catgatacct ggccgtacgc ttttggccag      300

gggaccaagg tggatatcaa ac                                               322


<210>  681
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  681
caggtgcacc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgcag ctaatggtgg gtccttcagt agttatcaca ggagttggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcgatcata gtggaagacc caactacaac      180

ccgtccctca agagtcgagt caccatatca gtagacacct ccaagaacta cttctccctg      240

aggctgaact ctgtgaccgc cgcggacacg gctgtatatt actgtgcgac aggcgtttct      300

cgcgtgtggg aggcacttgt tgagtggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  682
<211>  338
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  682
gacatcgtgt tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atccactgca agtccaacca gagcatttta cacagcccca acagtcagaa ctacttagga      120

tggtatcagc agaaaccagg acagcctcct aggctactca tttactgggc atctgcccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cgctctcacc      240

atcagcaacc tgcagcctga agatgtggca gtttattact gtcagcaata ttatactcct      300

cctcgaacgt tcggccaggg gaccaaggtg gaaatcaa                              338


<210>  683
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  683
caggtgcaga tacagcagtg gggcgcagga gtgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggtcactact ggagctggat ccgtcagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagtac caagtacaac      180

ccgtccctca agagtcgagt caccatttca gtagacacgt ccaagaacca gttctccctg      240

aagctgagct ctgtgaccgc cgcagacacg gctgtgtatt attgtgcggg ggaggaggtt      300

cggggagtta aactgtacta ctactatgct atggacgtct ggggccaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  684
<211>  333
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  684
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtatcagcag      120

tttccaggaa cagcccccaa actcctcatc tatggtaaca gcaatcggcc ctcaggggtc      180

tctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cagtggactc      240

cagtctgagg atgaggctga ttattgctgc cagtcatatg acagaagcct gagtggtgtg      300

gttttcggcg gagggaccaa gctgaccgtc cta                                   333


<210>  685
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  685
gaagtgcact tggtggagtc tgggggaggc gcggtacagc cgggggggtc cctgagactc       60

tcctgtgcag cctctggact cagccctgtt gatcatgcca tgcactggat ccggcatcct      120

ccagggaagg gcctggagtg ggtcgcaggt atctatggga atcttgcccg catagattat      180

gcgaactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctccctgtat      240

ttgcaaatga acagtctcag acctgaagac acggccctct attattgtat aaaagatacg      300

tctccgggcg gacttgatta ctggggccag ggaacccagg tcaccgtttc ctcag           355


<210>  686
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  686
gatgcagttt tgactcagtc tccactctcc ctgcccgtca cccttggaca gccggcctcc       60

atctcctgca ggtctactca aagcctcgtg catggtagtg gaaacaccta cttgaattgg      120

tttcaccaga ggccaggcca atctcccagg cgcctgattt ataaggtttc taaccgggac      180

tatggggccc cagacagatt cagcggcagt gggtcgggca ctgagttcac actgaaaatc      240

agcagggtgg agcctgagga tgttggggtt tactactgca tgcaggctac atactggcct      300

tacactttcg gcggagggac caaggtggag atcaaac                               337


<210>  687
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  687
caggtgcagc tgcgggagtc gggccctgga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tttctggtgg ctccatcagc agtgatagtc actactggag ttggatccgc      120

cagcccccag ggaagcgact ggagtggatt ggattcacac atgacagtgg gaacaccaac      180

tacaacccgt ccctcaagag tcgagttacc atgtcattag actggtccaa gaacgaggtc      240

tccctcaatc tgagatctgt gactgtcgca gacacggcca tctattactg tgccagagtg      300

aaaaaggtga acagagacat ggtcagagaa ggatttgaca actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  688
<211>  317
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  688
gacatccaga tgacccagtc tccttccagc ctgtctgcat ttgtaggaga cacagtcacc       60

atcacttgcc gggccagtca gactactggt gagtggttgg cctggtatca gcagaaacca      120

gggaaagccc ctgacctcct gatctggaag acgtctaatt tagaaattgg agtcccatca      180

agattcagcg gccgtggatc tgggacacga ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttattt ctgccaacag tatggtgctt atccgtggac gttcggccag      300

gggaccaagg tggaaat                                                     317


<210>  689
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  689
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact acctatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcaa cacggcattt      240

ctgcatatcg gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagagatcag      300

gacagtggct acccaactta ctactactac tacatggacg tctggggcaa agggaccacg      360

gtcaccgtct cctc                                                        374


<210>  690
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  690
gatattgtga tgacccagac tccactctct ctgtccgtca cccctggaca gccggcctcc       60

atctcctgca agtctagtca gagcctcctg catagtgatg gaaagaccta tttgtattgg      120

tacctgcaga agccaggcca gtctccacag ctcctgatct atgaagtttc caaccggttc      180

tctggagtgc cagataggtt cagtggcagc gggtcaggga cagatttcac actgaaaatc      240

agccgggtgg aggctgagga tgttggggtt tattactgca tgcaaagtat acagcctcct      300

ctcactttcg gcggagggac caaggtggag atcaaac                               337


<210>  691
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  691
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc agttatgata tgaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg atgaacccta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accaggaaca cctccataag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagggggc      300

atttattatc tggttcgggg atttattata ggttactacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  692
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  692
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctactca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

cctctcactt tcggcggagg gaccaaggtg gagatcaaac                            340


<210>  693
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  693
gaggtggcgc tggtggagtc tgggggaggc ttggtaaagc ctggggggtc cctcagactc       60

tcctgtgcag cctcaggatt catcttcagt aatgcctgga tgacttgggt ccgtcaggct      120

cctggaaagg ggctggagtg ggtaggccgc atcaagagta aaagtgaagg tggaacacca      180

gagtacgctg cacccgtgaa agggagattc atcatctcta gagatgactc aacaaattcg      240

ctccatctgc aaatgaatta cctgagaatc gaggacacag ccgtctacta ctgtaccaca      300

gggggataca gttcttacgc ggctagtgac tattggggcc agggaaccct ggtcaccgtc      360

tcttca                                                                 366


<210>  694
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  694
cagtctgccc tgactcaacc tgcctccgtg tctggctctc ctggacagtt gatcaccatc       60

ttttgcaatg gaagcatcag tgacgttggt ggttggaatt atgtctcctg gtaccaacag      120

cacccagaca aagcccccaa aatgatgatt tatgatgtca gacatcggcc ctcaggggtt      180

tccagtcgct tctctggctc caagtccggc aacacggcct ccctgaccat ctctggactc      240

caggctgagg acgaaggtga ttattactgc agctcattta caagtcgagg cgccctcgtc      300

ctcttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  695
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  695
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac attagtagta gaagtagtac cataaagtac      180

gcagactctg tgaagggccg attcaccatc tccagagaca atgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agacgaggac acggctgtgt attactgtgc gagagtggat      300

tactatggtt cggggagcgt ttactggtac ttcgatctct ggggccgtgg caccctggtc      360

actgtctctt cag                                                         373


<210>  696
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  696
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg ctggcatctg ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  697
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  697
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtag catagcctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt atttctgtgc aaaagtaggg      300

tgggagcttt cgattgatgc ttttgatctc tggggccaag ggactatggt caccgtctct      360

tcag                                                                   364


<210>  698
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  698
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact taggctggta ccaccagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cactatggta gctcacggtc cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  699
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  699
cagatcacct tcaaggagtc tggtcctacg ctggtgaaac ccacagagac cctcacgctg       60

acctgcacct tctctgggtt ctcagtcagc actagtggag agggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcagtcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaggg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagg      300

ctttggttca gggatgcttt tgatatttgg ggccaaggga caacggtcac cgtctcctca      360

g                                                                      361


<210>  700
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  700
gacatccaga tgacccagtc tccatcgtcc ctgtctgcat ctgtaggaga cagagtcaca       60

atcacttgcc gggcacgtca gagcattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcacagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccccacttt cggcggaggg      300

accaaggtgg agatcaaac                                                   319


<210>  701
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  701
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc acctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagatattgg      300

ttcggggacc catactacta ctacggtatg gacgtctggg gccaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  702
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  702
gagatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttctctctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcccctgac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  703
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  703
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcagc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ctctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacggata      300

cagtaccagc tgaatggtat ggacgtctgg ggccaaggga ccacggtcac cgtctcctca      360


<210>  704
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  704
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agttatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcacagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta ccccatacac ttttggccag      300

gggaccaagc tggaaatcaa ac                                               322


<210>  705
<211>  390
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  705
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcagc agttatgaca tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg gtgaacccta atagtggtca cacaggctat      180

gcacaaaagt tccagggcag agtcaccatg accaggaaca cctccgtaag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt tttactgtgc gagaggtaga      300

gttggatatg taggttcggg gagccgggga tactactact actacgatat ggacgtctgg      360

ggccaaggga ccacggtcac cgtctcctca                                       390


<210>  706
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  706
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagatcctat tatgcaagct ggtaccagca gaagccacga      120

caggcccctg ttcttatcat ctctggtaat aacaaccggc cctcagggat tccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gtaaccatct aagggtattc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  707
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  707
gaggagcaac tggtggagtc tgggggcggc ttggtacagc cagggcggtc cctgagactc       60

tcctgtacag cctctggatt cacctttggc gattataaaa tggcgtgggt ccgccaggct      120

ccagggaggg ggccggagtg ggttggtctc attcgaagca gagctaacgg tgagtcaaca      180

gaatactccg cgtctgtaaa aggcagattc accgtctcca gagatgattc caaaggcatc      240

gcctatctgc aaatgtacaa cctacaaact gaggacacag ccatatatta ctgtactagg      300

gatcctacct tgtggccctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  708
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  708
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattggt ccctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgag acctctcgtt tacataatgg agtcccatca      180

aggttcagcg gcagtggttc tgggacagac ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caaattatta ttgtcatcaa tatatggctt tctggacgtt cggccaaggg      300

accagggtgg aaatcaaac                                                   319


<210>  709
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  709
gaggtgcagc tggtggagtc tggaggcggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggtt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg tgtctcagtt atttatagcg gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac ggtgtatctt      240

caaatgaaca ggctgagagc cgaggacacg gccgtgtatt actgtgcgag agatttattt      300

tccggggggg cctactgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  710
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  710
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gttccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cactctcgtg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  711
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  711
caggtgcaac tggtggagtc tgggggaggc gtggtccagc ctgggaagtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgaaa tgaactgggt ccgccaggct      120

ccaggctcgg ggctggagtg ggtggcagtt atatcatatg atggaattaa taaatactac      180

gcagactccg tgaagggccg attcaccttc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagaagga      300

caagggacct accttgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  712
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  712
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca ccagggccac tggtatccca      180

gccaggttca gtggcagtgg gtctgcgaca gacttcactc tcaccatcaa cagactggag      240

cctgaatatt ttgcagtgta ttactgtcta cactatggtg actccccgtt cacttttggc      300

caggggacca ggctggagat caaac                                            325


<210>  713
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  713
gaggtgcacc tggtggagtc tgggggagat ttggtccagc cgggggggtc cctgagactt       60

tcctgtggag gctcaggatt ctcctttaac agtgcttgga tgacctgggt ccgccaggcc      120

ccagggaagg ggctagagtg ggtggccaac ataaaggctg acggaggtga ctcctactat      180

ccggactctg tgaagggtcg atttaccatt tccaaagaca acaccaagaa cctcctgcat      240

ttgcagatgc atagcctaag agtcgacgac gcagccatgt attactgtgc cgtctggggc      300

gacacatggg gccttgacta cgggggcctg gggactcggg tcgccgtctc ctcag           355


<210>  714
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  714
caggctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaagcagcag agattttggt gctcatgact atgtctcctg gtaccaacaa      120

cgcccaggcc aagcccccag actcatactt tataaggtct atcagcggcc ctcaggggtc      180

cctggtcgct tctctggctc caagtctgac aacacggcct ccctgaccat ctctggactc      240

cagcctgaag atgaggctga ttattactgt tccacagctc cgggcgcctt gattttgctt      300

tttggcggag ggaccaagtt gaccgtc                                          327


<210>  715
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  715
caggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttggc gattataaaa tggcgtgggt ccgccaggct      120

ccagggaggg ggccggagtg ggttggtctc attcgaagca gagctaacgg tgagtcaaca      180

gaatactccg cgtctgtaaa aggcagattc accgtctcca gagatgattc caaaggcatc      240

gcctatctgc aaatgtacaa cctacaaact gaggacacag ccatatatta ctgtactagg      300

gatcctacct tgtggccctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  716
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  716
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg cagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg gacagcagca ctggagtctt cggaactggg      300

accaaggtca ccgtcctag                                                   319


<210>  717
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  717
caggtgcagc tgcaggagtc gggcccagga ctggtgaagg cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtc actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtattt cttatagagg gaccacccac      180

cagaacccgt ccctcaagag tcgagccatc atatctattg acacgtccaa gaaccacttc      240

tccctgatcc tgagctctct gaccgccgct gatacggctg tttattattg tgcgagatac      300

actacgatgg taggggagtt tgactcttgg ggccagggaa ccctggtcgc cgtctcctca      360

g                                                                      361


<210>  718
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  718
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgaa agtaatagtg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tgtccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tggttatgtc      300

ttcggaactg ggaccaaggt caccgtccta g                                     331


<210>  719
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  719
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagaatt       60

tcctgtggag cctctggatt caccttcagt agttatagca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac attagtagta gtagtagtag gaaagactac      180

acagactctg tgaagggccg attcgccatc tccagagaca atgccaagaa ctcagtgtat      240

ctgcaaatga acagcctgag agacgaggac acggctgtgt attactgtgc gaaaaccgga      300

ggggcgtatt atgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  720
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  720
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg cagatgcatt gccaaagcat tatgcttatt ggtaccagca gaggccaggc      120

caggcccctg tactggtgat atataaagac attgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcactggagc ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg gacagcagca ctccctatgt cttcggaact      300

gggaccaagg tcaccgtcct ag                                               322


<210>  721
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  721
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtct attactgtgc gagagggtca      300

gctggaaact actactacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  722
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  722
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattatg caacttacta ctgtcaacag agttacagta cccctggcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  723
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  723
caaatgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtaaaagtc       60

tcctgcaaga cttctggatt cacctttact agctctgcta tacagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gattggatgg atcgtcgttg gcagtggtaa cacaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgac cacagcctac      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagagaggac      300

tactatggtt cggggagctt agtcgacccg tactactact accgtatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  724
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  724
gactttcaga tgacccagtc tccatcgtat gtgtctgcat ctgtaggaga cagagtctcc       60

atcacttgcc ggacgagtca ggacattagt aattatttag cctggtatca gcagaaaccg      120

gggacagttc ctaaactgct catctatgtt gcatccactt tactgtcagg ggtcccatct      180

cgcttcagtg gcagtggatc tgggacacat ttcactctca ccatcaccag cctgcagcct      240

gaagatgttg cgacttatta ctgtcaaaaa tatgacagtg tccctctgac gttcgggcaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  725
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  725
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc acttttggag tgggtgtggg ctgggtccgt      120

cagcccccag gaaaggccct ggagtgcctt gcactcattt attgggatga tgatgagcgc      180

tatagcccgt ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggta      240

gtccttacaa tgaccaacat ggaccctgca gacacaggca catattactg tgcacacagg      300

aaaaaagcga gcagtggctg gcagacattt gactactggg gccagggaac cctggtcatc      360

gtctcctcag                                                             370


<210>  726
<211>  317
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  726
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg cagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttactcaaca gacagcagtg gtaatgtctt cggaactggg      300

accaaggtca ccgtcct                                                     317


<210>  727
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  727
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcaatt atatcatatg atggaagtaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cactctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctatat attactgtgc gagatcatat      300

gggggtgcct acggtggtaa ctccgactac tggggccagg gaaccctggt caccatctcc      360

tcag                                                                   364


<210>  728
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  728
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggtacctc attcggcgga      300

gggaccaagc tgaccgtcct ag                                               322


<210>  729
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  729
caggtgcacc tggtggagtc tggaggaggc gtggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agatttggcg tgcactgggt ccgccaggct      120

ccaggcaagg gcctggagtg ggtgactctc atatcgtttg atggaaggaa taaaaattat      180

gcaggctccg tgaggggccg cttcaccatc tccagagaca gttccaagag tacggtgtat      240

ctgcaaatga acagcctgag agccgaggac acggcactat attactgcgc gcgagagtac      300

catgatggtg ccaattggtc gggtgccttt gatgtctggg gccaagggac atgggtcacc      360

gtctcttcag                                                             370


<210>  730
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  730
gacatccaga tgacccagtc tccttccacc ctgtctacat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattggt ccctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatggt acaaccagtt tgcaaagtgg ggtcccagta      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcctccgat gtacactttt      300

ggccagggga ccaagctgga gattaaac                                         328


<210>  731
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  731
gaggtgtatt tgttggaggc tgggggagac ttggcacagc ctggggggtc cctgagactc       60

tcctgtgcag gctctggatt cacctttgac aactacgcca taagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcaggt attagtggta gtggagataa cacctattac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa gatgctctat      240

ctccaaatga acagcctaag agccgcggac acggccgtat attactgtgc gaaagttgca      300

tatagtggga gcaactcagt ggtctactac tactacatgg acgtctgggg caaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  732
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  732
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gtaacgccgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  733
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  733
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ccccatcagc agtagtcgtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atctccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgaactctgt gaccgccgca gacacggctg tgtattattg tgcgagacat      300

gatgggtcgg gggagatgga tacaattaca tgggggccca tttactacta catggacgtc      360

tggggcaaag ggaccacggt caccgtctcc tca                                   393


<210>  734
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  734
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aggcccccaa actcatgatt tattatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cactctctat      300

gtcttcggaa ctgggaccaa ggtcaccgtc ctag                                  334


<210>  735
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  735
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgttgtat      240

ttgcaaatga accgcctgag agcagaggac acgactgtgt attactgtgc gaaaggagtc      300

actgagggca gctggagttt tgactcctgg ggccagggaa cccaggtcag cgtctcctca      360

g                                                                      361


<210>  736
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  736
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaaaaaaa tatgctcatt ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcat ctatgaggac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttgctcaaca gacagcagtg gtaatcagag ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  737
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  737
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtgc agcaaactac      180

gcacagaact tccagggcag agtcacgatt accgcggaca aatccacgag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccatgt attactgtgc gagaatgcgc      300

agtggctggc ccacacatgg ccgcccggat gacttctggg gccggggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  738
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  738
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccagca gggccactgg catcccagac      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatagtt attctccgga cacttttggt      300

caggggacca agctggagat caaac                                            325


<210>  739
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  739
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggggac cctgtccctc       60

acctgcgctg tctctggtgg cgccatcagc agtaataact gctggagttg ggtccgccag      120

cccccaggga aggggcttga gtggattggg gaaatctatc ctagtgggac caccaactac      180

aacccgtccc tcaggagtcg agtctccatt tcagtagaca ggaccaagaa ttccttctcc      240

ctggaattgc gctctgtgac cgccgcggac acggccgtgt attactgtgc gagattagtg      300

ggagctactg cggaagactt ctggggccag ggaaccctag tcaccgtctc ctcag           355


<210>  740
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  740
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtttccatc       60

tcttgctcta caagcagctc caacatcgga cataatacta ttaactggta cctccagctc      120

ccaggaacgg cccccaaact cctcatctat cgtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctattta ttactgtgca gcgtgggatg acagcctgaa tggtcctgtc      300

ttcggaactg ggaccaaggt caccgtccta g                                     331


<210>  741
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  741
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcgtgtgtag cctctggatt cagctttagt tcttatggca tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attggtggta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccgtc tccagagaca attccgagaa cacgctgtat      240

ctgcaaatga gcagcctgag agccgaggac acggccgtat attactgtgc gagggtagag      300

ggggactggt tattgggtgg gccatactac cactattacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  742
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  742
gaaatagtga tgacgcagtc tccagtcacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatca ctgtcagcag tataataact ggccagggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  743
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  743
caggtccagc tggtacagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg tttccggata caccctcact gaactatcca tacactgggt gcgacaggct      120

cctggaaaag ggcttgagtg gatgggaggt tttgatcctg aagatgctga aacaatctac      180

gcacagcagt tccagggcag agtcaccatg accgaggaca catctacaga cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgttt attactgtgc gagaggggtg      300

gtagctgcta ctccgggttg gttcgacccc tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  744
<211>  317
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  744
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctttg gagataaatt gggggataaa tatgcttgct ggtttcagca gaagccaggc      120

cagtcccctg tgctgatcat ctatcaaggt gccaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctgtggtttt cggcggaggg      300

accaagctga ccgtcct                                                     317


<210>  745
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  745
gaagtgcagc tggtggagtc tgggggaggc ttggtccagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cagctttggt gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagtggga gtagtgatta caaaccctat      180

gcgggctctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctggg acctgaggac acggccttgt attactgtgc aagaattgtc      300

gaccacggtg ctcagggggc ctactttgac cactggggcc agggaaccct ggtcatcgcc      360

tcctcag                                                                367


<210>  746
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  746
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttcacttgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgacga tgttggggtt tattactgca tgcaagctct acaaactcct      300

ttcactttcg gccctgggac cagagtggat atcaaac                               337


<210>  747
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  747
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaaag ggtctggata cagctttagc gactactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagactgact      300

tttggtggtt cggggagtta ttatttctac tacaacggta tggacgtctg gggccaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  748
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  748
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcaaaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac cggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gatcatcagg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  749
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  749
gaggtgcagc tggtggagtc tgggggaggt gtggtacggc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt catctttgat gattatgaca tgacctgggt ccgccaagct      120

ccagggaagg ggctggagtg ggtctctggt attaattgga atggtggtag cacaggttat      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agccgaggac acggccttgt atcactgtgc agtgattatg      300

tctccaatcc cccgttatag tggctacgat tgggcgggtg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  750
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  750
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtgttagt acctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcattcaatt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagctg cctgcagtct      240

gaagattttg caacttatta ctgtcaacag tattatagtt accctccaaa cacttttggc      300

caggggacca agctggagat caa                                              323


<210>  751
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  751
caggtcacct tgaaagaatc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcaccc tctctggctt cgcagtcctc aaagccagaa tgggtgtgag ctggatccgt      120

cagtccccag ggaaggccct ggaatggctt gcacacactt tttcgggtga cgaagaatcc      180

tacaacccat ctctgaggac cagactcacc atctccacgg acacctccag aaggcaggtg      240

gtccttacca tgagcaacgt ggaccctgtg gacacagcca cttatttctg tgctcgagtc      300

aagacttatt acacctcgac gagacggatc ctctggttcg acccctgggg ccagggaatc      360

ctggtcaccg tctcctcag                                                   379


<210>  752
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  752
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtaagctg gtaccaccag      120

cttccaggaa cagcccccaa actcctcatc tatggtgaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cagtgggctc      240

cggtccgagg atgaggctga ttattactgt gcagcatggg atgacagcct gagtagttgg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  753
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  753
caggtgcaat tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cgccttcagt aactatgcta tacactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaatcaa taaatactac      180

gcagacgccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcaa      300

gaatggttca gggagttatt cctttttgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  754
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  754
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtcggaga cagaattacc       60

atcacttgcc gggcaaacca gaccattgcc aactctttaa attggtatca acaaaaacca      120

gggaaagccc ctgcactctt gatctatctt tcaagcaact tacacagcgg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tctactctgt acactttggc      300

caggggacca agctggagat caaac                                            325


<210>  755
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  755
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctacgaca tgcactgggt ccgccaagct      120

acaggaaaag gtctggagtg ggtctcagct attggtactg ctggtgacac atactatcca      180

ggctccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgtatctt      240

caaatgaaca gcctgagagc cggggacacg gctgtgtatt actgtgcaag agcggatcct      300

taccagctgc tcggccaaca ctactactac ggtatggacg tctggggcca agggaccacg      360

gtcaccgtct cctca                                                       375


<210>  756
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  756
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctct tatcaccttc      300

ggccaaggga cacgactgga gattaaac                                         328


<210>  757
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  757
gaagtgcagc tggtggagtc cgggggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgtag cctccgaatt cacctttagt agctattgga tgagctggtt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtca gaaatactat      180

gtggactctg caaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agtcgaggat acggctgtgt attactgtgc gagtcgcctt      300

tgtagttctt ccggctgcta tgcggcgtcc taccactaca tggacgtctg gggcaaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  758
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  758
gacatggagg tgacccagtt tccatcttcc ctgtctgcct ctataggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgaaaagtgg ggtcccatca      180

aggttcggtg gcagtggatc tgggacagag ttcactctca ccatcacgac tctacaaccg      240

gaagatgttg gaacttacta ctgtcaccag agttacggtg ttccgatcac cttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  759
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  759
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcgactgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atttatcctg gtgactctga taccagatat      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccaccag caccgcctac      240

ctgcagtgga gcagcttgaa ggcctcggac accgccatgt attactgtgc gagacgtgga      300

gaagcagctg gtatttggta cttcgatctc tggggccgtg gcaccctggt cactgtctcc      360

tcag                                                                   364


<210>  760
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  760
cagcctgtgc tgactcagcc accttctgca tcagcctccc tgggagcctc ggtcacactc       60

acctgcaccc tgagcagcgg ctacagtaat tataaagtgg actggtacca gcagagacca      120

gggaagggcc cccggtttgt gatgcgagtg ggcactggtg ggattgtggg atccaagggg      180

gatggcatcc ctgatcgctt ctcagtcttg ggctcaggcc tgaatcggta tctgacaatc      240

aagaacatcc aagaagagga tgagagtgac taccactgtg gggcagacca tggcagtggg      300

agcaacttcg tctatgtggt attcggcgga gggaccaagc tgaccgtcct ag              352


<210>  761
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  761
tcccagcccc tggaacaatc tgggtctgag ttgaagaaac caggggcctc agtgacaatc       60

tcctgcaaga cctctggaga cagtctcact aggcttgctg tgaattgggt gcgacaggcc      120

cctggacaag gtcttgagtg gatggggtgg atcaaaccca acaccgggga ggcgacatat      180

gcccaggcct tcacagggcg atttgtcttc tacgtcgaca cccctgtcag cacggcgtat      240

ttgcagatct atggcctaaa gcctgaggac agtgccgtct attactgtgc gagaggtcat      300

tatgatggtc tttggggcca gggaacccgg gtcaccgtct cctcag                     346


<210>  762
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  762
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaag aaatatttaa gttggtatca gcaaaagcca      120

gggcaagtcc ctaggctcct catctacgac acatccaatt tggaaacagt gggagcagga      180

gtcccatcaa gattcagtgg aggtggatct gggacccatt ttagtttgac catcagcagc      240

ctgcagcctg aagatggtgc aacatattac tgtcaacagt atgataatct cccattcacc      300

ttcggccctg ggaccaaagt gcatatcaaa c                                     331


<210>  763
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  763
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc acttttggag tgggtgtggg ctgggtccgt      120

cagcccccag gaaaggccct ggagtgcctt gcactcattt attgggatga tgatgagcgc      180

tatagcccgt ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggta      240

gtccttacaa tgaccaacat ggaccctgca gacacaggca catattactg tgcacacagg      300

aaaaaagcga gcagtggctg gcagacattt gactactggg gccagggaac cctggtcatc      360

gtctcctcag                                                             370


<210>  764
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  764
tcctatgtgc tgactcagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg gacagcagca cccatgtggt attcggcgga      300

gggaccaagc tgaccgtcct ag                                               322


<210>  765
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  765
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgaag cctctggatt caccttcagt agctacgaca tgcactgggt ccgccaaagt      120

acaggaaaag gtctggagtg ggtctcagct attggtactg ctggtgacac atactatcca      180

ggctccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgtatctt      240

caaatgaaca gcctgagagc cggggacacg gctgtgtatt actgtgcaag gaggttctgg      300

agtgggtact acggtatgga cgtctggggc caagggacca cggtcaccgt ctcctca         357


<210>  766
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  766
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gaaatacatt gccaaagcaa tatgtttttt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

atctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagga gactacagtg gtacttgggt gttcggcgga      300

gggaccaagc tgaccgtcct ag                                               322


<210>  767
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  767
caggtgcaat tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctaagactc       60

tcctgtgtag cctctggatt ttccttcaat aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atctcatatg aaggaagtaa gacgtactat      180

gcagattttg tgcagggtcg attcaccgtc tccagagact tttccaagaa cacgctgtat      240

ctccaaatga acagcctcag aattgaggac acggctgtat attactgtgc gaagtcccac      300

aaattattct ggttcgggca gtttaaaatg gatgctctgg atatctgggg ccaaggggca      360

ttggtcaccg tctcttcag                                                   379


<210>  768
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  768
cagtctgtac tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagccc caacatcgga agtaatagtg taaactggta ccaacaagtc      120

ccagggacgg cccccagact cctcattaac actgataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgttca gcatgggatg acagcctgag tggctgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  769
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  769
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggagggtc cctgagactc       60

tcctgtgcag cctccggatt caccttcagt gcttatgaaa tgacctgggt ccgccaggct      120

ccagggaagg ggctggagag gattgcatat attactacta gtggtaataa catctactac      180

gcagactctg tgaagggccg attcaccatc ttcagagaca accccaagaa gtcactgtat      240

ctgcagatga atagtctgag agccgacgac acggctgtct attactgtgc gaaaaccgga      300

caggtcgagt ggctggtgga caactacaac tactatatgg acgtgtgggg caaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  770
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  770
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttaga aaaagctact tagcctggta ccagcagaga      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcgtccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcaccgac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  771
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  771
gaggtgcaac tagtggagtc tgggggaggc ttggtaaggc cagggcggtc cctgagactc       60

tcctgtgcaa cttctggatt caactttcgt gattacgcta tacactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtaggcttg attagaagcg aaccttatcg tgcgacaaca      180

gaatacgccg cgtctgtgag aggcagattc accctctcga gagatgattc caaaagcctc      240

gcctatttgc aaatgaacag cctgagaacc gaagacacag ccgtgtattt ctgcgctaga      300

actgagcgtt gtggtgctga ttgcacctcg cacatcaatt actatctgga cgtctggggc      360

agcgggacct cggtaactgt ctcctca                                          387


<210>  772
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  772
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca aagtgttgac agcaacttct tagcctggta ccagcacaaa      120

cctggccagg ctcccaggct cctcatatat gatgcatcca gcagggccac tggcatccca      180

gacagattca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagcctagac      240

cctgaagatt ttgcagttta ttactgtcac aagcgtagca actggcctcc ttcgctcact      300

ttcggcggag ggaccaaggt tcacatcaaa c                                     331


<210>  773
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  773
caggtgcatc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atctcaaatg atgaatttaa taaattctat      180

gcaaactccg tgaagggccg attcaccatc tccagagaca attcgaagaa cacggtgtat      240

ttgcaattga acagtctgag aactgaggac acggctcgat attactgtgc gaaagggggg      300

gatggcagtg gctgggcctg ggacggtgat aaccccccaa cggactactg gggccaggga      360

accctggtca tcgtctcttc ag                                               382


<210>  774
<211>  338
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  774
gacatcgtga tgacccagtc tccggacttc ctggctgtgt ctctgggcga gagggccacc       60

atcagctgca agtccagtca gagtgtttta tacaccccca agaataagaa ctacttagct      120

tggtacaagc agaaaccagg acagcctcct aaggtgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcatc      240

atcagcagcc tgcaggctga ggatgcggca gtttattact gtcagcaata ttatactgct      300

cctctcactt tcggcggtgg gaccagggtg gagatcaa                              338


<210>  775
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  775
caggtgcagc tgcgggagtc gggcccagga ctggtgaggc cttcggagac cctgtccctc       60

aagtgcactg tctctggaga ctccgtcagc ggtaattctc acttctggac gtggatccgg      120

cagcccccag ggaagggact ggagtggatt gggtacatct ataatagtgt gtccaccgcc      180

tacaacgcct ccctcaagag tcgagtgacc atatcagtag actcgtccaa gaacctattc      240

tccctggaac tgacctctgt caccgctgcg gacacggccg tctatttttg tgcgggaggt      300

ttcgacgacg cgtgggagcc ccaggtctac tggggcctgg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  776
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  776
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaaaaaaa tatgcttatt ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcat ctctgaggac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttgctcaaca gacagcagtg gtaatcagag ggtgttcggc      300

ggagggacca agctgaccgt ccta                                             324


<210>  777
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  777
caggtgcagc tgcaggagtc gggccctgga ctggtgaggc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcggt aattactact ggagctggat ccgggagccc      120

ccagggaagg gactggagtg gattggatat atttactaca gtgggagcac caactacaac      180

ccctccctca agagtcgagc caccatatca gtagtcacgt ccaagaacca gttctctctg      240

aggctgagct ctgtgacccc tgcggacacg gccgtatatt attgtgcgag aggtccgtat      300

ttcagcagcc tggttttcgg cccctggggc cagggcaccc tggtcaccgt ctcctcag        358


<210>  778
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  778
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtccggatc       60

acatgccaag gagacagcct cagaaggtat tatgcaagtt ggtaccagcg gaagccagga      120

caggcccctg tacttgtcat ctatgataag aacacccggc cctcagggat cccagaccga      180

ttctctggct ccaactcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg tagctcccgg gacagcagtg gtaaccacct ctttgtcttc      300

ggtactggga ccaaggtcac cgtcctag                                         328


<210>  779
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  779
ctggtgcagc tgcaggagtc gggccccgga ctggtgaagc cttcccagac cctgtccctc       60

acctgcactg tctctggtgc cgccatcagc gatggtagtt accactggaa ctggatccgg      120

cagtccgccg ggaagggact ggaatggctt gggcgtgtgt ataataatgg ggtcaccaat      180

tataacccct ccctcgggag tcgagccacc atatcaccag acccgtccaa gggacagttc      240

atcctgacac tgtctgctgt gaccgccgca gacacggccg tgtattattg tgcgagagag      300

aggctcgcaa tattcgggga agtattgaag gattcgtact acatggacgt ctggggcaag      360

gggaccacgg tcatcgtctc ctca                                             384


<210>  780
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  780
gacatccaga tgacccagtc tccatcctcc ctgtctgcat tcgttggaga cagagtcacc       60

atcaattgcc gggcaagtca gagcattagg agacatttaa attggtatca actgaaacca      120

ggcaaagccc ctaagctcct gatctatgct gcctccactt tacaaactgg cgtcccatca      180

agatttagtg gcagtggatc tgggacagat ttcactctca ccatcaccaa tttgcagcct      240

gaagattttg caatttactg ctgtcaacag agttatagtg tttctccgta cacttttggg      300

caggggacca aggttgagat caaac                                            325


<210>  781
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  781
caggtcacct tgaaggagtc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcgccg tctctgggtt ctcactcagc aatgctaaaa tgggtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgaatga cgaaaaagct      180

tacagtacat ctctgaagac caggctcacc atctccaagg acacctccaa aagccaggtg      240

gtccttaccg tgaccaacat ggaccctgtg gacacagcca catattactg tgcacggata      300

gtcttaggag cttcggggac ttatccctct ccggggttcg acccctgggg ccagggaacc      360

ctggtcaccg tctcctcag                                                   379


<210>  782
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  782
cagactgtgg tgactcagga gccctcactg actgtgtccc caggagggac agtcactctc       60

acctgtgctt ccagtgctgg agcagtcacc agtggttact atccaaactg gttccagcag      120

aaacctggac aagcacccag ggcactgatt tatagtacag ccaacaaaca ctcctggacc      180

cctgcccggt tctcaggctc cctccttggg ggcaaagctg ccctgacact gtcaggtgtg      240

cagcctgagg acgaggctga gtattactgc ctgctctact atggtggtgc ttgggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  783
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  783
caactgcagc tggcggagtc tgggggaggc gtggtccagc ctgggaagtc cctgagactc       60

tcctgtgcag ggtctggatt caccttcagt gcccatgcca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggaatg ggtggcagtc atttcatatg atggacgtca taaatactat      180

ggagactccg tgaggggccg attcaccgtc tccagggaca actccaagag cacatttttt      240

ctgcaaatga acagcctgag acctgatgac acggctgtgt atttttgtgc gagagacttg      300

accctctata gcagcgacta ctattggggc tactttgact cctggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  784
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  784
gaaattgtat tgacacagtc tccagccacc ctgtctttgt ctccagggga acgagccacc       60

ctctcctgta gggccagtca gagtgttaat aagtacttag cctggtacca acagaaacct      120

ggccagactc ccagactcct catctatgat gcatccacca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtt cgggacagat ttctttctca ccatcggcag cctggaggct      240

gaggattttg cagtttatta ctgtcagcag cgtttccagt ggcctccggg gactttcggg      300

ggagggacca aggtggagat caaac                                            325


<210>  785
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  785
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt atctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatttg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatggg      300

agtgggagct actacggctg gttcgacccc tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  786
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  786
gaaattgtgc tgactcagtc tccagacttt cagtctgtga ctccaaagga gaaagtcacc       60

atcacctgcc gggccagtca gaacattggt agtagcttac actggtacca gcagaaacca      120

gatcagtctc caaaggtcat catcaagtat gcttcccagt ccttctcagg ggtcccctcg      180

aggttcagtg gcagtggatc tgggacagat ttcaccctca ccatcaatag cctggaagct      240

gaagatgctg caacttatta ctgtcatcag agtagtagtt tacctcccac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  787
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  787
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcaactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac agcaaactac      180

gcacagaagt tccagggcag agtcacgttt accgcggacg aatccacgag cacagcctac      240

atggaggtga gcagcctgag atctgaggac acggccgtgt attactgtgc gagatcgtgc      300

ggtgactgct attccgccga ccttgacttc tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  788
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  788
gaaattgtgt tgacacagtc tccagccacc ctgtccttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtattagc agcttcttag cctggtacca acaaaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

agattcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcgg cgtagcaact ggcctccttt cactttcggc      300

cctgggacca aagtggatat caaac                                            325


<210>  789
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  789
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatgt attatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagactt      300

ctgtggctac gcggccactt tgactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  790
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  790
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcag caattattgg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  791
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  791
gaggtgcagc tggtggagtc tgggggaggt gtggtacggc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt catctttgat gattatgaca tgacctgggt ccgccaagct      120

ccagggaagg ggctggagtg ggtctctggt attagttgga atggtggtaa cacaggttat      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agccgaggac acggccttgt atcactgtgc agtgattatg      300

tctccaatcc cccgttatag tggctacgat tgggcgggtg gtgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  792
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  792
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagct ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gtaacgccgt ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  793
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  793
gaggtgcagc tggtggagtc tgggggaggc ctggtacagc cgggggggtc cctgagactc       60

tcctgtgcag ccactggatt caccttcagt agcaacgaca tgcactgggt ccgccaaccg      120

actggaaaag gtctggagtg ggtcgcagct attggtaatg ctggtgacac atactatcca      180

ggctccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgcatctt      240

caaatgcaca gcctgagagc cggggacacg gctgtctatt actgtgcaag aaacacggct      300

ggtagccaaa actggcactt cgatctctgg ggccgtggca cccaggtcac tgtctcctca      360

g                                                                      361


<210>  794
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  794
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagaccct      240

gaagattttg cagtttatta ctgtcacaag cgtagcaact ggcctccttc gctcactttc      300

ggcggaggga ccaaggtgga gatcaaac                                         328


<210>  795
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  795
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtag catagcctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt atttctgtgc aaaagtaggg      300

tgggagcttt cgattgatgc ttttgatctc tggggccaag ggactatggt caccgtctct      360

tcag                                                                   364


<210>  796
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  796
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact taggctggta ccaccagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcaccgct cactttcggc      300

ggagggacca aggtggagat caaac                                            325


<210>  797
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  797
caggtacaac tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt ttctatgcta tccactgggt ccgccaggct      120

ccaggccagg ggctggagtg ggcggcagct atatcatctg atggaactta taaatactac      180

gccgactccg tgaagggccg attcaccatc tccagagaca attcgaagaa cacgtcgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagccctt      300

aataaggggt tcgacccctg gggccaggga accctgctca ccgtctcttc ag              352


<210>  798
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  798
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aaactactca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtagt      300

ccttacactt ttggccaggg gaccaagctg gagatcaaac                            340


<210>  799
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  799
cagggtcagc tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacctttatc agttatggtg tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcagccctt acagtagtaa cacaaactat      180

ccacagaagt tccagggcag agtcaccatg accacagtca catccacgag cacagtctac      240

atggagctga ggagcctgag atttgacgac acggccgtgt attactgtgc gagagatctg      300

gcgcggtatt gtagaagtgc cagctgctcc aacaaagggg ttgactactg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  800
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  800
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagtattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc agagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcag caatcatgtg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  801
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  801
gaggtgcagc tggtggagtc cgggggaggc ttagttcagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caacttcagt agctactgga tgcactgggt ccgccaagct      120

ccagggaagg ggctggtgtg ggtctcacgt attaatgggg atgggagtag cacgacctac      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa taagaataag      240

ttgtatctgc aaatgaatgg tctgagagcc gaggacacgg ctgtgtatta ctgtgcaagg      300

gcgagggcag tgactggtac cgggggcatt gggtactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  802
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  802
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acagtaaaca ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca ttaactgggc atctgcccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatactact      300

cctaacactt ttggccaggg gaccaagctg gagatcaaac                            340


<210>  803
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  803
caaatgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtaaaagtc       60

tcctgcaaga cttctggatt cacctttact agctctgcta tacagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gattggatgg atcgtcgttg gcagtggtaa cacaaactac      180

gcacagaagt tccaggaaag agtcaccatt accagggaca tgtccacaag cacagcctac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggctccccat      300

tgtaatagga ccagctgcta tgatgctttt gatctctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  804
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  804
gaaattgtgt tgacacagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact taggctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

tctgaagatt ttgcacttta ttactgtcag cagtataata actggtggcg cacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  805
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  805
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgcaggtt       60

tcctgcgagg catctggata caccttcacc acgtactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtggtggtag cacaacctac      180

gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac      240

atggacttga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagatcgg      300

ttaggggatg ggagctactt gggggggggc tactacggta tggacgtctg gggccaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  806
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  806
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctacc tagcctggta ccagcagaaa      120

cgtggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctag gctcactttc      300

ggcggaggga ccaaggtgga gatcaaac                                         328


<210>  807
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  807
caggtacagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact acctatgcta tgaattgggt gcgacaggcc      120

cctggacagg ggcttgagtg ggtgggaaca attgacccta gtggtcatag cccaaactac      180

gcacagagat tccagggcag agtcgccatg accagggaca cgtccacgag cacagtgtac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggctccccat      300

tgtaatagga ccagctgcta tgatgctttt gatctctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  808
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  808
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcaca       60

atcacttgcc gggcacgtca gagcattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcacagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagtt ccctttcgat caccttcggc      300

caggggacac gactggagat taaac                                            325


<210>  809
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  809
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cacattcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atgggaggaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa tacgctgtat      240

ctgcaaatga gcagcctgag agctgaggac acggctgtat attactgtgc gaaagaagga      300

gagtgggaac tacgggggaa tgctcttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttcag                                                                367


<210>  810
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  810
gatattgtgg tgacccagac tccactctct ctgtccgtca cccctggaca gccggcctcc       60

atctcctgca agtctagtca gagcctcctg catagtgatg gaaagaccta tttgtcttgg      120

tatctgcaga agccaggcca gcctccacag ctcctgatct atgaagtttc caaccggttc      180

tctggagtgc cagataggtt cagtggcagc gggtcaggga cagatttcac actgaaaatc      240

agccgggtgg aggctgagga tgttggggtt tattactgca tgcaaagtat acagcctcct      300

ctcactttcg gcggagggac caaagtggat atcaaac                               337


<210>  811
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  811
caggtcacct tgaaggagtc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcaccg tctctgggtt ctcactcagc aatgctagaa tgagtgtgaa ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgaatga cgaaaaatcc      180

tacagcacat ctctgaagag caggctcacc atctccaagg acacctccaa aagccaggtg      240

ctccttacca tgaccaacat ggaccctgtg gacacaggca catattattg tgtacggatg      300

ctgtgggaaa actggagcta cgatgattac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  812
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  812
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caagtagtag catcgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  813
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  813
caaatgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgaaggtc       60

tcctgcaagg cttctggatt cacctttatg agctctgctg tgcagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gataggatgg atcgtcattg gcagtggtaa cacaaactac      180

gcacagaagt tccaggaaag agtcaccatt accagggaca tgtccacaag cacagcctac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggccccatat      300

tgtagtagta tcagctgcaa tgatggtttt gatatctggg gccaagggac aatggtcacc      360

gtctcctcag                                                             370


<210>  814
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  814
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccagga      120

caggcccctg tagttgtcat ttatggtaaa aataaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagta gacagcagtg gtacttatcc tcatgtaata      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  815
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  815
caggtgcaac tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtcccgc       60

acctgcgctg tctatggtgc gtccttcagt aattactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtgaaaacac caactacaac      180

ccgtccctca agagccgagt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aggttgagct ctgtgaccgc cgcggacacg gctgtctatt actgtgcgag acttaggtat      300

agcagcagcg ggggccatat ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  816
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  816
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgttggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcaaaaatca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcaacag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tcccgtacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  817
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  817
caggtgcagc tgttggagtc gggcccagga ctggtgaagt cttcacagac cctgtacctc       60

acctgctctg tctctggtgg ctccgtcagc agtggcgctt attactggac gtgggtccgt      120

cagcccgccg ggtccccact ggagtggatc gggcgcattt atactagtgg gaccaccaac      180

tacaacccct ccctcaaccg gcgactcacc ctctcacttg acacgtccag gaaccagatc      240

tccctgaaac tgacgtctgt gaccgccgca gacacggccg cgtatttttg tgcgagagcc      300

cgaagctcta tggacaactt ctactacttc tatatggacg tctggggcaa agggaccacg      360

gtcaccgtct cctca                                                       375


<210>  818
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  818
gacatccaga tgacccagtc tccttcctcc ctgtctgcgt ctataggaga cagagtcacc       60

atcacttgcc gggcaagtca gaatattaga agctatttaa actggtatca gcacaaacca      120

gggaaagccc ctaaactcct gatctatgct gcatccactt tgcaaagtgg ggtcccgtca      180

aggttcagtg gcagtgaatc tgggacagac ttcactctca ccatcagcag tctgcagcct      240

gaagattttg caacttacta ctgtcaacag agttccagtt ccccgatcac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  819
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  819
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  820
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  820
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cgaagtcggg      240

gatgaggccg acttttattg tcaggtgtgg gatagtagta gtgatcatcc gggggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  821
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  821
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac agcaaattac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtat attactgtgc gcgaggactg      300

accggtagta gtgcttataa ggatgagatt tactttgact actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  822
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  822
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac actgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg gttctcgatt cggcggaggg      300

accaaactga ccgtcctag                                                   319


<210>  823
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  823
caggtgcagt tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat ccggcagccc      120

ccagggaagg gactggagtg gattgggtat atctattaca gtgggagcac caagtacaac      180

ccctccctca agagtcgagt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aagctgagct ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag agatggaggg      300

aatgcatata gcagtggctg gtaccggtac tactaccaca tggacgtctg gggcaaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  824
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  824
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcttgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgt tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggccttacac ttttggccag      300

gggaccaagc tggaaatcaa ac                                               322


<210>  825
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  825
cagatcacct tgaaggagtc tggtcctacg ctggtaaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggc ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gctctcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacaga      300

cttccaacgc cccaactgct accatctttt gaaaactggt tcgacccctg gggccaggga      360

accctggtca tcgtctcctc ag                                               382


<210>  826
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  826
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgagg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tactggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccatctctgg gaacacggcc accctgatca tcagcagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtggta gtgaccatgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  827
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  827
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctacgacc tgcactgggt ccgccaaggt      120

acaggaaaac gtctggagtg ggtctcagct attggtactg ctggtgacac atactatcta      180

ggctccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgtatctt      240

caaatgaaca gcctgagagc cggggacacg gctgtgtatt actgtgcaag agtcctctat      300

gatagtagtg gtttttacaa ctggttcgac ccctggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  828
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  828
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgttggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tggaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacgaaa tccctccgtg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  829
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  829
caaatgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgaaggtc       60

tcctgcaagg cttctggatt cacctttatg agctctgctg tgcagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gataggatgg atcgtcattg gcagtggtaa cacaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggccccatat      300

tgtagtagta tcagctgcaa tgatggtttt gatatctggg gccaagggac cacggtcacc      360

gtctcctcag                                                             370


<210>  830
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  830
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cgaagtcggg      240

gatgaggccg acttttactg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  831
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  831
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt agctattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtct      240

ctgcaaatga acagcctgag agtcgaggac acggctgtgt attattgtgt gagactgggg      300

gtcagcagct ggtactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  832
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  832
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccacact gaccgtccta g                                     331


<210>  833
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  833
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgagggtt       60

tcctgcaagg cacctggata caccttcacc acctactata tacactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtgctggtag tacaacctac      180

gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaggattc      300

catgtaccag ctgctcttcg gaactggttc gacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  834
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  834
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaatactg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctat aataataatc agcggccctc aggggtccct      180

gaccgactct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca acatgggatg acagcctgaa tggtccggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  835
<211>  365
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  835
gaagtgcagc tggtggagtc tggaggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgcag cctctgggtt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatcccg gtggtagcgc attctacgca      180

gactccgtga agggccgatt caccatctcc agacacaatt ccaacaacac actgtgtctt      240

caaatgaaca gcctgcgaac tgaggacacg gccgtgtatt attgtgcgag atcttacgat      300

attttgactg gttatagaga tgcttttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttc                                                                  365


<210>  836
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  836
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg tcaggttctg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tatggcaaca ccaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcaggct gagtggtttt      300

gtggtattcg gcggagggac caagctgacc gtcctag                               337


<210>  837
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  837
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctttgcta tgcactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaaggaag atggaagaga gaaatactat      180

gtggactctg tgaagggccg actcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagatctc      300

gtgacttacg gtttggacgt ctggggccaa gggaccacgg tcaccgtctc ctca            354


<210>  838
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  838
cagtctgtgc tgacgcagcc gccctcagtg tctgcggccc caggacagac ggccaggatc       60

acctgctcta cagatgcatt gccaaatgaa tatatttatt ggtaccagca gaagccaggc      120

caggcccctg tattggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagaa gacagcagtg gtacttatcc tcatgtaata      300

ttcggcggag ggaccaagtt gaccgtccta g                                     331


<210>  839
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  839
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcacacagg actcctccaa aaaccaggtg      240

gtcattacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacaga      300

cttccaacgc cccaactgct accatctttt gaaaactggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  840
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  840
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cgaagtcggg      240

gatgaggccg acttttactg tcaggtgtgg gatagtagta gtgatccctt ttatgtcttc      300

ggaactggga ccaaggtcac cgtcctag                                         328


<210>  841
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  841
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  842
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  842
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta tgcctccgat caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  843
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  843
gaggcgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgaag cctctggatt catctttagt agctattgga tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca atgccaagaa ttcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagtgaat      300

gatggccgtc caaatcccct cgaatactac tttgactact ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  844
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  844
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaacaa tatgcttatt ggtaccacca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg gtacttccgt attattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  845
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  845
gaggtgcacc tggcggagtc tgggggaggc ctggtcaagc cgggggagtc cctaagactc       60

tcctgtggag gctctggatt caccttcagt aactatgcta tgagttgggt ccgccaggct      120

caagggaagg ggctggagtg ggtctcttcc attaatgctg gtgccgatta cagaccctat      180

gcagactcag tgaagggccg attcattatc tccagagaca acgtcgacag ttttctgtat      240

ttgcaaatgc acagcctaag agtcgacgac acggctatat actactgtgc gagagataac      300

tgggacgtcg gtggaatgga cgtctggggc caagggacca cggtcaccgt ctcctca         357


<210>  846
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  846
caccttgtgc tgactcaatc gccctctgcc tctgcctccc tgggaggcgc ggtcaagctc       60

acctgcactc tgaacagtgg ccacaccagc aacgccatcg catggcatca gcagcagcca      120

gagaggggcc ctcgtttcct gatgagaatt aacagtgatg gcagccacaa caagggggac      180

gggatccctg atcgcttctc aggctccagc tctggggctg agcgctacct caccatctcc      240

agcctccagt ctgaggatga ggctgactat tattgtctga cctgggtcac tggctcttgg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  847
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  847
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtga ctccatcagt agtggtcgtt actattggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggttcgtct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagttacc atatcagtag acacgtctaa gaaccagttc      240

tccctgaggc tgagttctgt gactgccgcg gacacggccg tgtattactg tgcgagagaa      300

acatatagtg cctacgaaat gcccccgtac tttgactact ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  848
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  848
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg cacgtagtag cactcgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  849
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  849
gaggtgcagc tggtgcagtc aggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atccagcctg gtgactctga taccagatac      180

agcccatcct tccaaggcca ggtcaccatg tcagccgaca agtccaccag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagagatttg      300

attatagaat cgactatagc agctcgtccc ggctactacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  850
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  850
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt cccaaagcaa tatggttatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagca gacagcaggg gtgcggtctt cggaagtggg      300

accaaggtca ccgtcctag                                                   319


<210>  851
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  851
caggtccagc tggtgcaatc aggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggaga caccttcagc agctatacta tcaactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat accaaactac      180

gcacagaaat tccagggcag agtcaccatt accgcggaca aatccacgag cacagccttc      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagggagg      300

ggctacagta actacggggc ctcctactac atggacgcct ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  852
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  852
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggagg cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac cactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcaggct      240

gaagatgtgg cagtttatta ctgtcaacag tatgataatc tccctccagt tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  853
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  853
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgccagg cttctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg atgaagtcta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcactatg accaggaaca cctccataag tacagcctac      240

atggagttga ccagcctgag atctgaggac acggccgtgt attactgtgc gagaatgcgc      300

agtggctggc ccacacatgg ccgcccggat gacctctggg gccggggaac cctggtcacc      360

ttctcctcag                                                             370


<210>  854
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  854
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagcctgcag      240

cctgaagata ttgcaacata ttactgtcaa cagtatgata atctccctcg gacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  855
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  855
caggtcacct tgaaggagtc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcaccg tctctgggtt ctcactcagc aatgctagaa tgagtgtgaa ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgaatga cgaaaaatcc      180

tacagcacat ctctgaagag caggctcacc atctccaagg acacctccaa aagccaggtg      240

ctccttacca tgaccaacat ggaccctgtg gacacaggca catattattg tgtacggatg      300

ctgtgggaaa actggagcta cgatgattac tggggccagg gaaccctggt catcgtctcc      360

tcag                                                                   364


<210>  856
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  856
cagtctgtgc tgactcagcc accctcgccg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaattatg tatactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctat aggaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccgg      240

tccgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgag tgcttgggtg      300

ttcggcggag ggaccaagct gaccctccta g                                     331


<210>  857
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  857
caggtgcacc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaactt       60

tcctgcaagg catctgggta caccttcacc aactaccttt tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaaat gtcaacccta gtcgtggaac cgcaacctac      180

ccacaaaaat tggatgacag agtcaccatg accagcgaca agtccgcgag cacaatctac      240

atggagctga gcggcctgag gtctgaggac acggccattt attattgtgc gagagaaagg      300

agtgggacct acttctttga ctactggggc cagggaaccc tgctcaccgt ctcctcag        358


<210>  858
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  858
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag cgtcaccatc       60

tcttgttcgg gaagcagctc caatatcggt aataataaag taaactggta ccagcagctc      120

ccaggaacgg cccccaaagt cctcatctat aatagtaatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tggactccag      240

tctgaggatg aggctgatta ttactgtgca gtctgggatg acagcctgca tagttatgtc      300

ttcggaactg agaccaaggt caccgtccta g                                     331


<210>  859
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  859
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgc ctccatcagc agtagtaatt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggactatct attatagtgg gagcacctat      180

tataacccgt ccctcaagag tcgagtcacc atattcgtag acacgtccaa gagccagttc      240

tccctgaagc tgacctctgt gaccgccgca gacacggctg tgtattactg tgcgagacgc      300

catcactata acactgcctg gggatccact tactttgcct actggggcca gggaaccctg      360

gtcaccgtct cctc                                                        374


<210>  860
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  860
gacattgtgt tgacgcagtc tccaggcacc ctgtctctgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gcgtcttgcc cccaccctct tggcctggtt cctccagaaa      120

cgtggccagg ctcccaggct cctcatgtat gccgcatcca ccagggccac tgacatccca      180

gacaggttca atggcggtgg ttctggaaca gacttcactc tcaccatcag cagtctgcaa      240

cctgaagatt ttgcagctta ttactgtcaa cagagtttca gtacccctcg gacttttggc      300

caggggacca agctggcgat caaac                                            325


<210>  861
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  861
caagtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccctcagt ctttactact ggagctggat ccggcaggcc      120

ccagggaagg gactggagtg gattggctat atctattaca ctgggagcac caactacaat      180

ccctccctca agagtcgggt caccatatca gtagacacgc ccaggaacca gatctccctg      240

agtctgacct ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag aataccaact      300

ggtttccccc gttgttacat ggacgtctgg ggcaaaggga ccacggtcac cgtctcctca      360


<210>  862
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  862
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata gaagcgtcag tactgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  863
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  863
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggctat atctattaca ctgggagcac caactacaat      180

ccctccctca agagtcgggt caccatatca gtagacacgc ccaggaacca gatctccctg      240

agtctgacct ctgtgaccgc tgcggacacg gccgtgtatt actgtgcggc cccatattgt      300

agtcgtatca gctgcaatga tggttttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttcag                                                                367


<210>  864
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  864
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctttg gagatgcatt gccaaaacaa tatgcttatt ggtaccagca gaagccaggc      120

cagggccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccacctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg ggcagtagca ggggagtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  865
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  865
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtga ctccatcagt agtggtcgtt actattggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggttcgtct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagttacc atatcagtag acacgtccaa gaaccaattc      240

tccctgaagc tgagctctgt gaccgccgcg gacacggctg tgtattactg tgcgagagac      300

tttctacggt ggcacgacct ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  866
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  866
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtctta cacagctcca acaacaagga ctccttagtt      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctagccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcagcctga tgattttgca acttattgct gccaacagta taatagttac      300

ccgatcacct tcggccaagg gacacgactg gagatcaaac                            340


<210>  867
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  867
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatttggg gccaggggac aatggtcacc      360

gtctcttcag                                                             370


<210>  868
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  868
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatgctaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gaatggtgac      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  869
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  869
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcacc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataagtac      180

tacagcacat ctctgcagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggaa      300

actccggtga ctgctattga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  870
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  870
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aggtatctaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatact gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccctcgaac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  871
<211>  368
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  871
caggtccagc tggtgcaatc aggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggatt cacctttatg agctctgctg tgcagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gataggatgg atcgtcattg gcagtggtaa cacaaactac      180

gcacagaagt tccaggaaag agtcaccatt accagggaca tgtccacaag cacagcctac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggccccatat      300

tgtagtagta tcagctgcaa tgatggtttt gatatctggg gccaagggac aatggtcacc      360

gtctcttc                                                               368


<210>  872
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  872
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aactatttaa attggtatca gcagaaaccg      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gatgatattg caacatatta ctgtcaacag tatgataatc tccctctggc tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  873
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  873
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  874
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  874
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aactatttaa attggtatca gcagaaaccg      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccctca      180

aggttcagtg gcagtggatc tgggacagat ttctctctca ccatcagcag tctgcaacct      240

gaagattttg caacttactc ctgtcaacag agttacacta ccctcctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  875
<211>  394
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  875
caagtgcaac tgcaggagtc gggccctaga ctggtgaagc cttcggagac cctctccctc       60

acttgcacag tctctggtgg ctccatgagt ggtttcttct ggagctgggt tcggcagtcc      120

cccgagaggg gatttgaata cattggctac ttttattcta gtgcaaaaac cgattacaac      180

ccctccctca gcagtcgcgt caccatgtca ttggacgcgt ccaaaaacct attctccttg      240

aagctgacct ctgtgaccac ttcggacacg gccgtctatt actgtgcgag agcccagaat      300

tactatcgtg gaaatactta ttattcgaca agatacccca gaccggatat ttttgacatg      360

tggggccgag ggacaagggt caccgtctct tcag                                  394


<210>  876
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  876
gacattgtgt tgacgcagtc tccaggcacc ctgtctctgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gcgtcttgcc cccaccctct tggcctggtt cctccagaaa      120

cgtggccagg ctcccaggct cctcatgtat gccgcatcca ccagggccac tgacatccca      180

gacaggttca atggcggtgg ttctggaaca gacttcactc tcaccatcag cagcctggac      240

actgaagact ttggagtcta ttactgtcac caatatggca tctcaccgtt cacctttggc      300

caggggacca ggctggagat ca                                               322


<210>  877
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  877
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctttgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaaaaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgcgt attactgtgc gagagagtta      300

atgtcagtcg gctggggcca gggaaccctg gtcaccgtct cctcag                     346


<210>  878
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  878
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcacgttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatg tatggcaaca acaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagtct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gagtggttgg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  879
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  879
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggat caccgtaagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatgcag gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcg agagacaatt ccaagaacac gctgtatctt      240

caaatgaata gcctgagagc cgaggacacg gccgtatatt actgtgcgag agatgcgcta      300

tattacaatg gtccagggcg ggacgggatg gacgtctggg gccaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  880
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  880
gtcatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtgggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aagtatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgctaatc tcccattcac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  881
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  881
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggat caccgtaagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatgcag gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcg agagacaatt ccaagaacac gctgtatctt      240

caaatgaata gcctgagagc cgaggacacg gccgtatatt actgtgcgag agatgcgcta      300

tattacaatg gtccagggcg ggacgggatg gacgtctggg gccaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  882
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  882
gtcatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtgggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aagtatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tccctcggac ttttggccag      300

gggaccaagc tggagatcaa a                                                321


<210>  883
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  883
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atctcatctg atggaagtaa taaatactat      180

gcaggctccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatatg      300

gtggaaccac ttttcagtca ctactactac tacggtatgg acgtctgggg ccaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  884
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  884
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tatggtaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cagtgggctc      240

caggctgagg atgaggctga ttattcctgc cagtcctatg acagcagcct gagtggttat      300

gtcttcggaa ctgggaccaa ggtcaccgtc ctag                                  334


<210>  885
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  885
caggtcacct tgaaggagtc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcaccg tctctgggtt ctcactcagc aatgctagaa tgagtgtgaa ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgaatga cgaaaaatcc      180

tacagcacat ctctgaagag caggctcacc atctccaagg acacctccaa aagccaggtg      240

ctccttacca tgaccaacat ggaccctgtg gacacaggca catattattg tgtacggatg      300

ctgtgggaaa actggagcta cgatgattac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  886
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  886
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagttat tatgcaagct ggtaccagca gaagccagga      120

caggcccctt tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacacct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taacgtccgg gacagcagtg gtcaccatcc cgtattcggc      300

gaagggacca agctgaccgt cctag                                            325


<210>  887
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  887
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat ccggcagccc      120

ccagggaagg gactggagtg gattggttat atctattaca gtgggagcac caactacaac      180

ccctccctca agagtcgagt caccatatca gtagacatgt ccaagaacca gttctccctg      240

aagctgaggt ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag agccccgagg      300

gaaaggctcc aatgggggga gtactacttc gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  888
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  888
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

catgcaggca aagcccccaa actcatgatt tatgaggtca ttaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg cagttagtac cacttatgtt      300

atattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  889
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  889
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagg agctacgaca tgcactgggt ccgccaagtt      120

acaggaaaag gtctggagtg ggtctcaact attggtactg ctggtgacac atactatcca      180

ggctccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgtatctt      240

cagatgaaca gcctgagagc cggggacacg gctgtgtatt actgtgcaag agtgttcgag      300

actaaggtta tccgaggggg gcgttactac tactattact acatggacgt ctggggcaaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  890
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  890
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta acccgtcgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  891
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  891
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaat      180

ccgtccctca agagtcgagt caccatatca gtggacacgt ccaagaacca cttctccctg      240

aaaatgaact ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag atgtcgccag      300

atggggaact tctactacta ctacatggac gtctggggca aggggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  892
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  892
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttgcc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatccg gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctcc gaggtacact      300

tttggccagg ggaccaagct ggagatcaaa c                                     331


<210>  893
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  893
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtga ctccatcagc agtgctggtt actactggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggtacatct attacagtgg gagaacctac      180

tacaacccgt ccctcaagag tcgagttacc atgtcagtag acacgtctaa gaaccagttc      240

tccctgaggc tgcgctctgt gactgccgcg gacacggccg tgtattactg tgcgagggtg      300

gtccctaccc ggggccccgt cgcgtggttc gacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  894
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  894
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagagacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcac tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccttctgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  895
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  895
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaagtaa aaaagactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagatcaa      300

tctcagggcg cttatatttt gactggttat aggggctacg gtatggacgt ctggggccag      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  896
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  896
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacttgcaga agccagggca gtctccacag ttcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttat actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct tcaaactcca      300

ttcactttcg gccctgggac caaagtggat atcaaac                               337


<210>  897
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  897
caggtccagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaaaa ctgctggagg cacctccagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtgt agcaatctac      180

gcacagaagt tccagggcag agtcacgatt accgcggaca aatccacgag cacagcctac      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtac gacgacccag      300

gggggggact acggtgacaa cctctactac ttagactact ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  898
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  898
tcctatgtgc tgactcagcc accctcagtg tcagtggccc caggaaagac ggccagcatt       60

acctgtgagg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcat ctattatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcgcct ttatgtcttc      300

ggaactggga ccaaggtcac cgtcctag                                         328


<210>  899
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  899
gaggtgcagc tggtggagtc cggaggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggggt cactgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcactt atttatagcg ggggtagcac attctacgca      180

gactccgtga agggccgatt caccatctcc agacacaatt ccaagaacac gctgtatctt      240

caaatgaaca gcctgagacc tgaggacacg gccgtgtatt actgtgcgag aggcccggaa      300

ccggatgctt ttgatatctg gggccaaggg acaatggtca ccgtctcttc ag              352


<210>  900
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  900
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta acccgtcgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  901
<211>  362
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  901
gaggttcacc tggtggagtc cgggggaggc ttagttcagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caggttcagt aggtcctgga tgcactgggt ccgccaagct      120

ccagggaagg ggctggtttg ggtctcacac atcaatagtg atgggagtat aataaattat      180

gggaactccg tgaagggccg atttaccatc tccagagaca acgccaagaa cacactatat      240

ctgcaaatga acagtctgag agtcgaggac acggctatgt atttctgtgc aagtccgacg      300

agtgtaacag tggttggtca gccagatgtc tggggccaag ggacaatggt caccgtctct      360

tc                                                                     362


<210>  902
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  902
gaaattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg tatagtgatg gatacaacta tttggattgg      120

tacctgcaga agccagggca gtctccacaa ctcctgatct atttgggttc ttatcgggcc      180

tccggggtcc ctgacaggtt cagtggccgt ggatcaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct ggaagttcct      300

cacacttttg gccaggggac caagctggag atcaaac                               337


<210>  903
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  903
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat ccggcagccc      120

ccagggaagg gactggagtg gattgggcat atttattaca ctgggagcag ctattacaac      180

ccctccctca agagtcgagt caccatatca ctagacacct ccaagaacca gttctccctg      240

aagctgaact ctgtgaccgc cgcggacacg gccgtgtatt actgtgccag actacggtgg      300

ttacggggag ggattgactt ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  904
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  904
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat aacgaccggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg ggcagtagca ggggagtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  905
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  905
caggtgcagc tggtgcagtc tggggctgag gtgaaggcgc ctggggcctc agtgatgatc       60

tcctgcaggg cctctggata cacgttcgcc agtcttgata tcaactgggt gcgacagacc      120

gctggacgag ggtttgagtg gatgggatgg atgaccccca ggaatgggaa cacaggctat      180

gcacagaagt ttcagggccg agtcattatg accagggaca cctccataaa tactgcctac      240

ttggaactca ctcgcctgac atctgaagac acgggcacat attattgtgc gagaggtgtt      300

gcagctggcg ttgactactg gggccaggga tccctggtca ccgtctcctc ag              352


<210>  906
<211>  344
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  906
caggctgtgc tgactcagcc gtctgccctg tctgcatctc ctggagcatc agccaggctc       60

acctgcacct caggcagtgg catcgatgtt gggacgtaca ggatatattg gtatcagcag      120

aagtcaggga gtcctccccg ctatctcctg agttacaagt cagactcaga taaacatcag      180

ggctctggag tccccagccg cttctctgga tcgaaagatg cttcggccaa tgcaggggtt      240

ctattcatct ctgggctcca gtctgaggat gaggctgact attattgttt gatctggcac      300

atcaatgctt atgtcttcgg aactgggacc aaggtcaccg tcct                       344


<210>  907

<400>  907
000

<210>  908

<400>  908
000

<210>  909
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  909
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ccctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  910
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  910
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaacatt       60

acctgtgggg gaaacaacat tggaagaaaa agtgtgcact ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggccg acctttactg tcaggtgtgg gatagtagta gtgatcatcc gggggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  911
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  911
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgccagg cttctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg atgaagtcta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcactatg accaggaaca cctccataag tacagcctac      240

atggagttga ccagcctgag atctgaggac acggccgtgt attactgtgc gagaatgcgc      300

agtggctggc ccacacatgg ccgcccggat gacctctggg gccggggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  912
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  912
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcaactc caacatcgga agttatactg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatttat gataataatc agcggacctc aggggtccct      180

gaccgactct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctaatta ttactgtgca gtatgggatg acagcctgaa tggcctggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  913
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  913
caggtccagc tggtgcaatc tggggctgag gtgaagaggc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatacta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttgctgt agcaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggaca agtccacgag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagatcat      300

tctggttact atgatagtac ctcccttatg tctccgttct ttgactactg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  914
<211>  332
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  914
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccaacag      120

cttcctggaa cagcccccaa actcctcatc tttggtaaca ccaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcaacct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gaatggtgac      300

gtgttcggcg gagggaccaa gctgaccgtc ct                                    332


<210>  915
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  915
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcaga acttgtggtg tgggtgtggg ctgtatccga      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattattg tgcacaccta      300

ctccgaattg gcagtggcta ctactcgccg aggttaatcg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  916
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  916
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tgtactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg gggcagagtt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttctagtact      300

ccttggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  917
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  917
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcagc actagtggat tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacaacacat ctctgaggac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggcg      300

acgacaattt tctacggtat ggacgtctgg ggccaaggga ccacggtcac cgtctcctca      360


<210>  918
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  918
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacttgcaga agccagggca gtctccacag ttcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatctggga cagatttctc tctcaccatc      240

agcagtctgc aacctgaaga ttttgcaact tactcctgtc aacagagtta cactaccctc      300

ctcactttcg gcggagggac caaagtggag atcaaac                               337


<210>  919
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  919
caggtgcagc tggtgcagtc aggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcacc agccactata tgcactgggt gcggcaggcc      120

cctggacaag gccttgagtg gatgggaata atcaacccta gtggtggtag cacaagctac      180

gcacagaagt tccagggcag agtcaccatg accggggaca cgtccacgag cacagtctac      240

atggagttga gcagcctgag atctgaggac acggccgtgt actactgtgc gagagatttg      300

gcgggagtac cagctgcttt gggatgctgg ttcgacccct ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  920
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  920
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatacaaga gggacactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcag cgtagcaact ggcccttgat attcactttc      300

ggccctggga ccaaagtgga tatcaaac                                         328


<210>  921
<211>  403
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  921
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccgtcagc agtgatgatt tcagcagtgg tgataactac      120

tggagttggc tccggcagcc cccagggaag ggcctggagt ggattgggta catctattac      180

agtggactca ccaactacaa cccatccctc aagagccgcg ttatcatatc agtagacacg      240

tccaagaacc agttctccct gaaattgaac tctgtgactg ccgctgacac ggccgtgtat      300

tactgtgcct cggagcacaa gacccattat tatgatagca gtggttatta ctccaactgg      360

ttcgacccct ggggcccggg aaccctggtc accgtctcct cag                        403


<210>  922
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  922
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaaggtat tatgcaagtt ggtaccagca gaagccagga      120

caggcccctg tacttgtcat ctatggtaaa aacaaccggc cctcagggat cgcagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg tctattattg taactcccgg gacagcagtg gtagttatgt cttcggaatt      300

gggaccgagg tcaccgtcct a                                                321


<210>  923
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  923
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctatgt attactgtgc gaaagatggg      300

agtatagcag cagctgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  924
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  924
gtcatctgga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcagttgtc gggtgagtca gggcattagc agttatttag cctgctatca gcaagaacca      120

gggaaagccc ctgaactcct gatctatact gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagac tttactctca ccatcagcag actggagcct      240

gaagattttg cagtgtatta ctgtcagcag tatggtagct tatcgttcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  925
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  925
caggtgcagc tggtggagtc cgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcgtatg atggaggcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtat attactgtgc gaaaaattta      300

ggaccctatt gtagtggtgg tacctgctat tccttagttg gcgactactg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  926
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  926
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccgtc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctatg acagcagcct gagtggttat      300

gtcttcggaa ctgggaccaa ggtcaccgtc ctag                                  334


<210>  927
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  927
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagccccccg ggaaggggct ggagtggatt gggagtatct attatagtgg gatcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgcg gacacggctg tgtattactg tgcgagagat      300

tgggcaccta cgtactacga tatgccgtgt gcttttgata tctggggcca agggacaatg      360

gtctccgtct cttcag                                                      376


<210>  928
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  928
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatccg gcagggccac tggcatccca      180

gacaggttct gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagtctgcaa      240

cctgaagatt ttgcaactta ctactgtcaa cagagttaca gtacccctcg aacgttcggc      300

caagggacca aggtggagat caaac                                            325


<210>  929
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  929
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt tactatccta tgcactggct ctgggtccgc      120

caggctccag gcaaggggct ggagtgggtg gcagttacat catatgatgg aaccaataaa      180

tactacgcag actccgtgaa gggccgattc accatctcca gagacaattc caagaacact      240

ctgtatctgc aaatgaacag cctgagagct gaggacacgg ctgtgtatta ctgtgcgaga      300

gggggagcta ctaactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  930
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  930
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaacatt       60

acctgtgggg gaaacaacat tggaagaaaa agtgtgcact ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatcc gggggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  931
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  931
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctacgaca tgcactgggt ccgccaagct      120

acaggaaaag gtctggagtg ggtctcagct attggtactg ctggtgacac atactatcca      180

ggctccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgtatctt      240

caaatgaaca gcctgagagc cggggacacg gctgtgtatt actgtgcaag agcgaggggg      300

gggtataact ggaactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  932
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  932
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgat gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccccccgat caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  933
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  933
caggtgctgc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gcctggggac ctcggtcacc      360

gtctcc                                                                 366


<210>  934
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  934
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  935
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  935
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtta taaatacttc      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcag      300

ggtacggtgg taactcattt tgactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  936
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  936
gacatccaga tgacccagtc tccatcctcc ctgtctacat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattcgc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgtt gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcagcct      240

gaagattttg caacttacta ctgtcaacag agttacagta ccccaccgtg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  937
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  937
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ccctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  938
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  938
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tgtactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg gggcagagtt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca atttattact gtcagcaata ttatagtact      300

ccttggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  939
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  939
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcagt gactatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagagatctc      300

gacttctacg gttttgacgt ctggggccac gggaccaagg tcaccgtctc ctca            354


<210>  940
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  940
tcctatgtgc tgactcagcc tccctcggtg tcagtggccc caggcaggac ggccaggatt       60

acctgtgggg gaaataacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatcc ggagtgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  941
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  941
caggtgcagt tacagcagtg gggcgcaggg ctgttgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagccccccg ggaaggggct ggagtggatt gggagtatct attatagtgg gatcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atattcgtag acacgtccaa gagccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagacgc      300

catcactata acactgcctg gggatccact tactttgcct actggggcca gggaaccctg      360

gtcaccgtct cctc                                                        374


<210>  942
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  942
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cactatggta gctcacgggg ttggacgttc      300

ggccaaggga ccaaggtgga gatcaaac                                         328


<210>  943
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  943
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atgtcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtat attactgtgc gaaaaattta      300

ggaccctatt gtagtggtgg tacctgctat tccttagttg gtgactactg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  944
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  944
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgctaatc tcccattcac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  945
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  945
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cctctggata taccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag gccttgagtg gatgggatgg atgagtccta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accagggaca cctccataag cacagcctat      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagaatgcgc      300

agtggctggc ccacacatgg ccgcccggat gaccactggg gccaaggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  946
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  946
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcaactc caatatcgga agttatactg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatcttt ggtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tggcctccag      240

tctgaggatg aggctgatta ttactgtgtg gcatgggatg acagccggaa tggcctggta      300

ttcggcggag gggccaagct gaccgtcct                                        329


<210>  947
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  947
caggtccagc tggtgcaatc aggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggaga caccttcagc agctatacta tcaactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat accaaactac      180

gcacagaaat tccagggcag agtcaccatt accgcggaca aatccacgag cacagccttc      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagggagg      300

ggctacagta actacggggc ctcctactac atggacgtct ggggcaaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  948
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  948
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac cactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaaccgg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcaccag cctgcagcct      240

gaagatgttg caacatatta ctgtcaacag tctgataatc tccccatgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  949
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  949
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaggg ggctggagtg ggtggcaatt atatcatatg atggaactaa taaatactac      180

gcagactccg tggagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga gcagcctgag aggtgaggac acgtctgtgt atttctgtgc gagagaccca      300

agtatgtata gcagcagctg gtactacttt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  950
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  950
gacatccaga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggtattaac agctggttag cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct      240

gaagattttg caacttacta ttgtcaacag gctaacagtt tccctcccac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  951
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  951
gaagtgcagc tggtggagtc tgggggaggc gtggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccgtcaagct      120

ccagggaagg gtctggagtg ggtctctctt attagtgggg atggtggtaa cacatactat      180

gcagactctg tgaagggccg attcaccatc tccagagaca acagcaaaaa ctccctgtat      240

ctgcaaatga acagtctgag aactgaggac accgccttgt attactgtgc aaaagatgag      300

atggcttacc ctcctagtca tcactactac tactactaca tggacgtctg gggcaaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  952
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  952
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctcta cagatgcatt gccaaatgaa tatatttatt ggtaccagca gaagccaggc      120

caggcccctg tattggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagta gacagcagtg gtacttatcc tcatgtaata      300

ttcggcggag ggaccaagtt gaccgtccta g                                     331


<210>  953
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  953
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ccctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  954
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  954
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagcctggac      240

actgaagact ttggagtcta ttactgtcac caatatggca tctcaccgtt cacctttggc      300

caggggacca ggctggagat caaac                                            325


<210>  955
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  955
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ccctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  956
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  956
tcctatgtgc tgactcagcc accctcagtg tcagtggccc caggaaagac ggccaacatt       60

acctgtgggg gaaacaacat tggaagaaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcggccggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagta gacagcagtg gtacttatcc tcatgtaata      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  957
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  957
caggtgcacc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggggaa atccattaca gtgggagcac cagctacagc      180

ccctccctca agagtcgact cagcatatca gtagacaggt ccaagaacca gttctccctg      240

aagctggcct ctgtgaccgc tgcagacacg gccgtgtatt actgtgtgag ggataattac      300

tttgataata gtggtcatcc tgtgtatccg gttccctggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  958
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  958
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccgtc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctttg acatcggccg gggtggttgg      300

attttcggcg gagggaccaa gctcaccgtc c                                     331


<210>  959
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  959
caggtgcagc tggtgcagtc tggggctgag gtgaagacgc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcctgagtg gatgggatgg atgaacccta acagtggtaa cacaggctat      180

gcacacaaat tccagggcag agtcaccatg accaggaaca cctccataag cacagcctac      240

atggagctga gtagcctgag atctgaggac acggccgtgt attactgtgc gagaggcccg      300

agtattttga ctggttttta taaccctctt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  960
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  960
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattatc agctatttaa attggtatca ccagaaaccg      120

gggaaagccc ctaaactcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

agattcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta ccccgtacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  961
<211>  390
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  961
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtaatt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggactatcc attatagtgg gatcagctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa caacaagttc      240

tccctagagc tgagctctgt gaccgccgca gacacggctg tgtatttttg tgcgagacgg      300

acctattacg atttatggag tgcttattct agcaccgcct actactgcat ggacgtctgg      360

ggcaaaggga ccacggtcac cgtctcctca                                       390


<210>  962
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  962
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct      240

gaagattttg caacttatta ctgtcaacag cttaatagtt accctctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  963
<211>  394
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  963
caagtgcaac tgcaggagtc gggccctaga ctggtgaagc cttcggagac cctctccctc       60

acttgcacag tctctggtgg ctccatgagt ggtttcttct ggagctgggt tcggcagtcc      120

cccgagaggg gatttgaata cattggctac ttttattcta gtgcaaaaac cgattacaac      180

ccctccctca gcagtcgcgt caccatgtca ttggacgcgt ccaaaaacct attctccttg      240

aagctgacct ctgtgaccac ttcggacacg gccgtctatt actgtgcgag agcccagaat      300

tactatcgtg gaaatactta ttattcgaca agatacccca gaccggatat ttttgacatg      360

tggggccgag ggacaaggat caccgtctct tcag                                  394


<210>  964
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  964
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc aattatttag cctggtatca gcaaaaacca      120

gggacagccc ctaacctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtgaatc tgggacagac ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttccagtt ccccgatcac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  965
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  965
caggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtct      240

ctgcaaatga acagcctgag agtcgaggac acggctgtgt attattgtgt gagactgggg      300

gtcagcagct ggtactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  966
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  966
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatta      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tctgataatc tccccatgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  967
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  967
caggtgcacc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggggaa atccattaca gtgggagcac cagctacagc      180

ccctccctca agagtcgact cagcatatca gtagacaggt ccaagaacca gttctccctg      240

aagctggcct ctgtgaccgc tgcagacacg gccgtgtatt actgtgtgag ggataattac      300

tttgataata gtggtcatcc tgtgtatccg gttccctggt tcgacccctg gggccaggga      360

accctggtca ccgtgtcctc ag                                               382


<210>  968
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  968
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgagg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcggccggc cctcagggat ccctgaacga      180

ttctctggtt ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatcc ggagtgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  969
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  969
caggtgcgac tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc gactatgcca tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac agcaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aattcacgat cacagcctac      240

atggagctga gcagcctgcg atctgaggac acggccgtgt attactgtgc gagactaagt      300

ggcagtggct ggctcggcta cgctatggac gtctggggcc aagggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  970
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  970
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcattatt tatgatgtca gtaatcggcc ctcgggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc acctcatata caagcagcag cactctcaat      300

gtggtattcg gcggagggac caagctgacc gtcctag                               337


<210>  971
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  971
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagccccccg ggaaggggct ggagtggatt ggggaaatca atcatagtgg aagcaccaac      180

tacaatccgt ccctcaagag tcgagtcacc atatcagtgg acacgtccaa gaaccacttc      240

tccctgaaaa tgaactctgt gaccgccgcg gacacggctg tgtattactg tgcgaaagat      300

atggtggaac cacttttcag tcactactac tacggtatgg acgtctgggg ccaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  972
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  972
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac cactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaaccgg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcaccag cctgcagcct      240

gaagatgttg caacatatta ctgtcaacag tatgataatc tccctccagt tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  973
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  973
caggtgcacc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggggaa atccattaca gtgggagcac cagctacagc      180

ccctccctca agagtcgact cagcatatca gtagacaggt ccaagaacca gttctccctg      240

aagctggcct ctgtgaccgc tgcagacacg gccgtgtatt actgtgtgag ggataattac      300

tttgataata gtggtcatcc tgtgtatccg gttccctggt tcgacccctg gggccaggga      360

accctggtca ccgcctcctc ag                                               382


<210>  974
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  974
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtagggga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatta      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagattttg caacttatta ctgtcaacta cttaatagtc accccctcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  975
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  975
caggtgcaac tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc ggctactata ttcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gttgggatgg atcaacccta acagtggtgg cacaaactat      180

gcacagaagt ttcagggcag ggtcaccatg accagggaca cgtccatcag cacagcctat      240

atggagctga gcaggctgac atctgacgac acggccgtgt attactgtgc gagagcactg      300

tggttcgggg agttatcctc tgactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  976
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  976
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataatt atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagaag cactttggta      300

ttaggcggag ggaccaagct gaccgtccta g                                     331


<210>  977
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  977
caggtgcagt tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcaaatg atgggagaaa taaatactac      180

gcagactccg tgaagggccg actcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagaccatcc      300

aactggtact tcgatctctg gggccgtggc accctggtca ctgtctcctc ag              352


<210>  978
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  978
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctggactc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caagtagtag catcgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  979
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  979
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  980
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  980
caggctgtgc tgactcagcc gtctgccctg tctgcatctc ctggagcatc agccaggctc       60

acctgcacct caggcagtgg catcgatgtt gggacgtaca ggatatattg gtatcagcag      120

aagtcaggga gtcctccccg ctatctcctg agttacaagt cagactcaga taaacatcag      180

ggctctggag tccccagccg cttctctgga tcgaaagatg cttcggccaa tgcaggggtt      240

ctattcatct ctgggctcca gtctgaggat gaggctgact attattgttt gatctggcac      300

atcaatgctt atgtcttcgg aactgggacc aaggtcaccg tcctag                     346


<210>  981
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  981
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaggggac aatggtcacc      360

gtctcctcag                                                             370


<210>  982
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  982
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagtctgcaa      240

cctgaagatt ttgcaactta ctactgtcaa cagactcaca gtccgctcga cagttttggc      300

caggggacca agctggagat caaac                                            325


<210>  983
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  983
ggggtgcagc tggtacagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg cttctggata tactttcacc aattattgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg atgactctga taccagatac      180

gacccgtcct tcgaaggcca ggtcagcatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagaacccct      300

acgctgtaca actggttcca cccctggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  984
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  984
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccagga      120

caggcccctt tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacacct tccttgacca tcactggggc tcaggcggga      240

gatgaggctg actattactg taactcccgg gacaacagtg gtaacctcaa ttgggtgttc      300

ggcggaggga ccacactgac cgtcctag                                         328


<210>  985
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  985
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgacactc       60

tcctgtgcag cctctggatt cacctttgat gattatacca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attgattgga atggtggtac cataggctat      180

gcggactctg taaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgcg agctgaggac acggccttgt attactgtgc aaaagcgggg      300

tattatgctt acgtttgggg gagttatcgt ttcgagtatt ttgacaactg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  986
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  986
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gctctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccctccgtg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  987
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  987
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcggag acatcacgtg ctgcagatgg tatattctac      180

tcagactccg tgaggggccg gttcaccgtc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagattgg      300

gcacctacgt actacgatat gccgagtgct tttgatatct ggggccaggg gacaatggtc      360

accgtctctt cag                                                         373


<210>  988
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  988
gacatccaga tgacccagtc tccttcctcc ctgtctgcgt ctataggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcaa tattatagta ctccttggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  989
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  989
caggtggagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt catcttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcgtatg atggaggcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcag      300

ggtacggtgg taactcattt tgactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  990
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  990
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa aatgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgaaggtcgt ctatcatgat ggcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcaacagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  991
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  991
gaggtgcagc tggtggagtc cggaggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggggt cactgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcactt atttatagcg ggggtagcac attctacgca      180

gactccgtga agggccgatt caccatctcc agacacaatt ccaagaacac gctgtatctt      240

caaatgaaca gcctgagacc tgaggacacg gccgtgtatt actgtgcgag aggcccggaa      300

ccggatgctt ttgatatctg gggccaaggg acaatggtca ccgtctcttc ag              352


<210>  992
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  992
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct      240

gaagattttg caacttatta ctgtcaacag cttaatagtt actccttcga aactttcggc      300

cctgggacca aagtggctat caaac                                            325


<210>  993
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  993
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccgtcagc agtggtagtt actactggag ctggatccgg      120

cagcccccag ggaagggact ggagtgcatt gggtatatct attacagtgg gagctccaac      180

tacaacccct ccctcaagag tcgagtcacc atatcagtag acacgtccaa gaaccagttc      240

tccctgaaga tgagctctgt gaccgctgcg gacacggccg tatattactg tgcggggagc      300

cctgtccctc ccacgattgt gggagcttcg tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  994
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  994
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccttc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcgattct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatggcat caatcggtgg      300

ctggtattcg gcggagggac caagctgacc gtcctag                               337


<210>  995
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  995
caggtcacct tgaaggagtc tggtcctgtg ctggtgaaac ccacagagac cctcacgctg       60

acctgcaccg tctctgggtt ctcactcagc aatgctagaa tgagtgtgaa ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgaatga cgaaaaatcc      180

tacagcacat ctctgaagag caggctcacc atctccaagg acacctccaa aagccaggtg      240

ctccttacca tgaccaacat ggaccctgtg gacacaggca catattattg tgtacggatg      300

ctgtgggaaa actggagcta cgatgattac tggggccagg gaaccctggt catcgtcgcc      360

tcag                                                                   364


<210>  996
<211>  317
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  996
tcctatgaac tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tggtggtcat ctatcaagat agcaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctgcggtatt cggcggaggg      300

accaagctga ccgtcct                                                     317


<210>  997
<211>  380
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  997
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt gactatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagat atatcatttg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagact cttccgagaa caccctgtat      240

ctgcaaatgg acagcctgag agctgacgac acggctgtgt attactgtgc gcgagatttg      300

tccaccacct ggtaccttga gatgtgggga ccggatgctt ttgatatctg gggccaaggg      360

acagtggtca ccgtctcttc                                                  380


<210>  998
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  998
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctataggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattagt agctggttgg cctggtacca gcagatacca      120

gggaaagccc ctaagctcct gatctacaag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatagtt acccttacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  999
<211>  362
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  999
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggtcgtc cccgagactc       60

tcctgtgcag tctctggatt caccctcagt cgctattcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcggag acatcacgtg ctgcagatgg taaattctac      180

tcagactccg tgaggggccg gttcaccgtc tccagagaca attccaagaa ccttctgttt      240

ctgcaaatga acagcctgat acgtgacgac acggctgtct attactgtgc gagagattcg      300

gggctggctc gtgccttcag ttatgactac tggggccagg gagccctggt catcgtctcc      360

tc                                                                     362


<210>  1000
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1000
gacatccaga tgacccaatc tccatcctcc ctgtctgcat ctgtagggga cagagtcacc       60

atcacttgcc gggcaagtca gagtgttagc acctttgtga attggtatca gcataaacac      120

ggggaggtcc ctaatctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatcc      180

aggttcagtg gcagtggatc tgggacagac tttactctca ccatcaacag tctgcaactt      240

gaagattctg cgacttacta ctgtcaacag actcacagtc cgctcgacag ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1001
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1001
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcagt gactatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagaggccta      300

attagtttgt ttcggggagc tattttccac tactactacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1002
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1002
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatgtat gccgcatcca ccagggccac tgacatccca      180

gacaggttca atggcggtgg ttctggaaca gacttcactc tcaccatcag cagcctgcag      240

gctgaagatg tggcaattta ttactgtcag caatattata gtactccttg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  1003
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1003
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcatt gatcactact ggagttggat ccggcagtcc      120

ccagggaagg gactggagtg gattgcatat atctattcca ctgggagaac caactacaac      180

ccctccctca agagtcgcgt caccatatct atagacacgt ccaaggacca gttctccctg      240

aggctgagct ctgtgaccgc tgcggacacg gccgtgtatt tctgtgcgag aacaccccct      300

cggggaggtt tcgacgtctg gggccaaggg accacggtca ccgtctcctc a               351


<210>  1004
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1004
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagttat tatgcaagct ggtaccagca gaagccagga      120

caggcccctt tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattattg tctgacctgg gtcactggct cttgggtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  1005
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1005
caggtgcaac tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttccgt agatatggca tgtactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaactga taaatactat      180

acagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaaaagggg      300

gggccatact gtggtggtgg taactgctac gcggggtact ttgactactg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  1006
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1006
gacatccaga tgacccagtc tccttcctcc ctgtctgcgt ctataggaga cagagtcacc       60

atcacttgcc gggcaagtca gaatattaga agctatttaa actggtatca gcacaaacca      120

gggaaagccc ctaaactcct gatctatgct gcatccactt tgcaaagtgg ggtcccgtca      180

aggttcagtg gcagtgaatc tgggacagac ttcactctca ccatcagcag tctgcagcct      240

gaagattttg caacttacta ctgtcaacag agttccagtt ccccgatcac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1007
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1007
ggggtgcagc tggtacagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg cttctggata tactttcacc aattattgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg atgactctga taccagatac      180

gacccgtcct tcgaaggcca ggtcagcatc tcagccgaca agtccatcac caccgtctac      240

ctgcagtgga gtagcgtgaa ggccccggac accgccatgt attactgtgc gaggcgggac      300

aaagtgggag cgcttgactc ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  1008
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1008
gaaattgtgt tgacgcagtc tccaggcacc ctgtctatgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtattggc agcagctatt tagcctggta ccagcataaa      120

cctggccagg ctcccaggct cctcatctat ggtgcgtcca acagggccac agccatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag aagactggag      240

cctgaagatt ctgcggttta ttactgtcag caacatgctg gctctccaag gacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  1009
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1009
caggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga tcggcctgag agctgaggac acggctgtgt attactgtgc gagagatctc      300

gactactacg gtttggacgt ctggggccaa gggaccacgg tcaccgtctc ctca            354


<210>  1010
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1010
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctcta cagatgcatt gccaaatgaa tatatttatt ggtaccagca gaagccaggc      120

caggcccctg tattggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagta gacagcagtg gtacttatcc tcatgtaata      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1011
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1011
caggtgcgac tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc gactatgcca tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac agcaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aattcacgat cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagggagg      300

ggctacagta actacggggc ctcctactac atggacgtct ggggcaaggg gaccacggtc      360

accgtctcct ca                                                          372


<210>  1012
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1012
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcacgttatg atgtacactg gtaccagcag      120

cttccagaaa cagcccccaa actcctcatc tatgctaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc aacacggcct ccctgacaat ctctggactc      240

caggctgagg acgaggctga ttattactgc tgctcatatg cacgtagtag cactcgggtg      300

ttcggcggag ggaccacact gaccgtccta g                                     331


<210>  1013
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1013
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaggggac cacggtcacc      360

gtctcctcag                                                             370


<210>  1014
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1014
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggcaggac ggccaggatt       60

acctgtgggg gaaataacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cggagtcggg      240

gatgaggcag acttttactg tcaggtgtgg gatagtagta gtgatcatcc gggggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1015
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1015
caggtgcacc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggggaa atccattaca gtgggagcac cagctacagc      180

ccctccctca agagtcgact cagcatatca gtagacaggt ccaagaacca gttctccctg      240

aagctggcct ctgtgaccgc tgcagacacg gccgtgtatt actgtgtgag ggataattac      300

tttgataata gtggtcatcc tgtgtatccg ggtccctggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  1016
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1016
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tgtactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

ccttggacgt tcggccaagg gacacgactg gagattaaac                            340


<210>  1017
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1017
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggtcgtc cccgagactc       60

tcctgtgcag tctctggatt caccctcagt cgctattcta tgcactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcactt atttatagcg gtggtactac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaacg ccaagaactc actgtatctg      240

caaatgaaca gcctgagagc cgaggacacg gctgtgtatt actgtgcgcg tgggggaagc      300

atattgtggt ggctcattga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  1018
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1018
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgctaatc tcccattcac tttcggccct      300

ggtaccaaag tggatatcaa ac                                               322


<210>  1019
<211>  394
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1019
caagtgcaac tgcaggagtc gggccctaga ctggtgaagc cttcggagac cctctccctc       60

acttgcacag tctctggtgg ctccatgagt ggtttcttct ggagctgggt tcggcagtcc      120

cccgagaggg gatttgaata cattggctac ttttattcta gtgcaaaaac cgattacaac      180

ccctccctca gcagtcgcgt caccatgtca ttggacgcgt ccaaaaacct attctccttg      240

aagctgacct ctgtgaccac ttcggacacg gccgtctatt actgtgcgag agcccagaat      300

tactatcgtg gaaatactta ttattcgaca agatacccca gaccgaatat ttttgacatg      360

tggggccgag ggacaagggt caccgtctct tcag                                  394


<210>  1020
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1020
gaaattgtgt tgacgcagtc tccaggcacc ctgtctatgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gagttcattc tcaccatcag cggcctgcag      240

cccgaagatt ttgcagttta ttactgtcag cagtgttctg actggccgac gttcggccag      300

gggaccaggg tggagattaa ac                                               322


<210>  1021
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1021
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaggggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1022
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1022
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccacaatt       60

acctgtgggg gaaacaactt tgcgactaag agtgtccact ggtaccagca gaggccaggc      120

caggcccctg tgctggtcgt ctatgatgat aacgaccggc cctcagggat ccctgagcga      180

ttctctggct ccatctctgg gaacacggcc accctgacca tcagcagcgt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtcgta gtggtcactt tgtggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1023
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1023
caggtgcagt tacagcagtg gggcgcaggg ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctctggtgg gtccttcagt gcttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaac      180

ccgtccctca ggagtcgagt caccatatca gtagacacgt ccaagaacca attctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag agtgggttat      300

tcccaagggt actactacta ctacatggac gtctggggca aagggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  1024
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1024
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aactatttaa attggtatca gcagaaaccg      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccctca      180

aggttcagtg gcagtggatc tgggacagat ttctctctca ccatcagcag tctgcaacct      240

gaagattttg caacttactc ctgtcaacag agttacacta ccctcctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  1025
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1025
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt cgctactact ggagctggat ccggcagccc      120

ccagggaagg gactggagtg gattgggtat atctattaca gtgggagcac caactacaac      180

ccctccttca agagtcgagt caccatatca gttgacacct ccaagaacca gttctctctg      240

aagttgagct ctgtgaccgc tgcggacacg gccgtatatt actgtgcgag atatgggata      300

ggggagtggg agctacaata ctactttgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  1026
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1026
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcataatt tctgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg taggttatag gacggtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1027
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1027
gaagtgcagg tggtggagtc ggggggaggc ttggttcagc ctggcaggtc cctgagactc       60

tcctgcgtca gctctggatt catatttgat gattatgtca tgcactgggt ccgccaacgt      120

ccagggaagg gcctggagtg ggtcgcaggt atcacctaca atggcggcat cttaggctat      180

ggagactctg tgaagggccg ctttatcatc gccagagaca acgtcagagg cttcctgtcc      240

ctgcaaatgg gcgatctgag aactgaggac acggccttat attattgtgc gagagattac      300

tgtagtagta ccacttgccc cgcggagacg tactactaca tggacgtctg gggcaaaggg      360

accgcggtca ccgtctcctc a                                                381


<210>  1028
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1028
tcctatgagt tggctcaacc accctcggtg tcagtggccc caggggagac ggccaccatt       60

ttctgtaggg caacctacat tgggagaaaa aatgtacagt ggtaccagca gaagccaggc      120

caggcccctg ttctggtcgt ctatgatgat agcgaccggc cctcagggat ccccgggcga      180

ttctctggct ccaactctgg ggacacggcc accctgacca tcagcagaat cgaggccggg      240

gatgaggccg cctattactg tcaggtgtgg gatggtatta atgatcgtgt ggtcttcggc      300

ggcgggacca agctcaccgt cct                                              323


<210>  1029
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1029
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgaggt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcactt atttatagcg gtggtactac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac cctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agactttcta      300

cggtggcacg acctctgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  1030
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1030
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatta      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tccctccagt tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  1031
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1031
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctacgaca tgcactgggt ccgccaagct      120

acaggaaaag gtctggagtg ggtctcaact attggtactg ctggtgacac atactatcca      180

gactccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc tttgtttctt      240

caaatgaaca gcctgagagc cggggacacg gctgtatatt actgtgcaag agtggatttc      300

gatattttga ctggttatta ttcaaactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  1032
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1032
gacttccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga ccgagtcacc       60

atcacttgcc gggcaagtca gagcattagc acctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaatctcct aatctttgct gcatccagtt tgcacagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca gcatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagtt ccgagtggac gttcggccaa      300

gggaccaagg tggagatcaa ac                                               322


<210>  1033
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1033
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggcg      300

acgacatttt tctacggtat ggacgtctgg ggccaaggga ccacggtcac cgtctcc         357


<210>  1034
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1034
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg cacgtagtag cactcgggtg      300

ttcggcggag ggaccaagct gaccgtcct                                        329


<210>  1035
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1035
caggtgcagc tggtgcagtc tggggctgag gtgaaggcgc ctggggcctc agtgatgatc       60

tcctgcaggg cctctggata cacgttcgcc agtcttgata tcaactgggt gcgacaggcc      120

actggacaag gccttgagtg gatgggatgg atgaccccca ggaatgggaa cacaggctat      180

gcacagaagt ttcagggccg agtcattatg accagggaca cctccataaa tactgcctac      240

ttggaactca ctcgcctgac atctgaagac acgggcacat attattgtgc gagaggtgtt      300

gcagctggcg ttgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  1036
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1036
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctcta cagatgcatt gccaaaacaa tatgcttatt ggtaccacca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatcc ggagtgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1037
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1037
gaggcgcagt tgttggagtc tgggggagcc ctggtacagc cgggggggtc tctgagactc       60

tcctgtgcag cctctggatt cacttttagt tgctgtgcca tgggctgggt ccgccaggct      120

ccagggaggg ggctggagtg ggtctcaagt attcatgatg atggtgttgg cacattctac      180

gcagtctccg tgaaggggcg cttcagcatc tccagagaca attccaagaa cacggtgtat      240

ctgcaaatga atggcctgag agccgaggac acgggcgttt attactgtgc gaaatgggcg      300

ggaccaattg tgatgaaata ttaccttcag tactggggcc agggagccct ggtcaccgtc      360

tcctcag                                                                367


<210>  1038
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1038
cagtctctgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccctc       60

tcctgcgctg gggccacctc caacatcggg gcaggctctg atgtccactg gtaccagcaa      120

cttccaggaa cagcccccaa actcctcatc tattataaca ccaatcggcc ctccggggtc      180

cctgaccgat tctctggctc caagtctgcc acctcagcct ccctggtcat cactggcctc      240

cagactgagg atgaggctga ttattactgc cagtcgtatg acatcagcct gggtggttgg      300

gtgttcggcg gcgggaccaa gctgaccgtc ctag                                  334


<210>  1039
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1039
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cctctggata taccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag gccttgagtg gatgggatgg atgagtccta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accagggaca cctccataag cacagcctat      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagagaaaca      300

tatagtgcct acgacatgcc cccgtacttt gactactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  1040
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1040
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc aacaactact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag aagactgggg      240

cctgaagatt ctgcggttta ttactgtcag caacatgctg gctctccaag gacttttggc      300

ctggggacca agctggagat caaac                                            325


<210>  1041
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1041
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctacgaca tgcactgggt ccgccaagct      120

acaggaaaag gtctggagtg ggtctcagct attggtactg ctggtgacac atactatcca      180

gactccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgtatctt      240

caaatgaaca gcctgagagc cggggacacg gctgtgtatt actgtgcaag aggaggcgat      300

agtggctacg atttgggggc ctggtacttc gatctctggg gccgtggcac cctggtcact      360

gtctcctcag                                                             370


<210>  1042
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1042
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtgggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcgttagc atctatttga attggtatca acagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccgtcagcag tctgcagcct      240

gaggatttcg caacttacta ctgtcaacag agttacagta tgcctccgat caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  1043
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1043
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc aactactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagaacccct      300

acgctgtaca actggttcca cccctggggc cagggaaccc cggtcaccgt ctcctcag        358


<210>  1044
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1044
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccggacagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaattctc taaactggta ccagcaactc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tggttcttgg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1045
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1045
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcagc actagtggat tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacaacacat ctctgaggac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggcg      300

acgacatttt tctacggtat ggacgtctgg ggccaaggga ccacggtcac cgtctcctca      360


<210>  1046
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1046
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcaggta caacatcgga agtaattatg tatactggta ccagcagctc      120

ccaggaacgg cccccagact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccgg      240

tccgaggatg aggctgatta ttactgtgca gcatgggacg acagcctgag tggtttgata      300

ttcggcggag ggaccaagct gaccgtcc                                         328


<210>  1047
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1047
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacat tgaccaacat ggacactgtg gactcagcca cgtattactg tgcacacgcc      300

caatctggaa ctcctttata tgatgctttt gatatctggg gccaggggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1048
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1048
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccc gcagcagtgg cagcattgcc agcagctatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatggcat caatcgggca      300

tgggtgttcg gcggagggac caagctgacc gtcctag                               337


<210>  1049
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1049
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagccccccg ggaaggggct ggagtggatt gggagtatct attatagtgg gatcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagacac      300

caacgatatt gtagtagtag cagttgccac gtttgggact actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  1050
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1050
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggtagtag cacttggctg      300

ttcggcggag ggaccaagct gaccgtcct                                        329


<210>  1051
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1051
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcc                                                                 366


<210>  1052
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1052
gaagttatgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gactattttc agcacctact tagcctggta cctgcagaaa      120

cctggccagg ctcccaggct cctcatctat ggaacatcca acagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtata ttactgtcag cagtattata actacgtcac cttcggccaa      300

gggacacgac tggagatcaa ac                                               322


<210>  1053
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1053
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt agctattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac attctacgca      180

gactccgtga agggcagatt caccatctcc agagacaatt ccaagaacac gttgtatctt      240

caattgaaca gcctgagagc cgaggacacg gctgtgtatt actgtgcgag agaagttgtc      300

ggttactttg actgctgggg ccagggaacc ctggtcaccg tgtcctcag                  349


<210>  1054
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1054
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctcta cagatgcatt gccaaatgaa tatatttatt ggtaccagca gaagccaggc      120

caggcccctg tattggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagta gacagcagtg gtacttatcc tcatgtaata      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1055
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1055
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgaactgggt ccggcaacct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtgatag cataggctat      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccatgt attactgtgc aaaaggaagg      300

ggtgctggtt atacttccta catggacgtc tggggcaaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  1056
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1056
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgagg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcggccggc cctcagggat ccctgaacga      180

ttctctggtt ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actatttctg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcct                                           326


<210>  1057
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1057
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt cgctactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac cctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agatctcgtg      300

acttacggtt tggacgtctg gggccaaggg accacggtca ccgtctcctc a               351


<210>  1058
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1058
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaggcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg cacgtagtag cactcgggtg      300

ttcggcggag ggaccaagct gacc                                             324


<210>  1059
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1059
gaagtgcagc tggtggagtc tggaggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgcag cctctgggtt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatcccg gtggtagcgc attctacgca      180

gactccgtga agggccgatt caccatctcc agacacaatt ccaacaacac actgtgtctt      240

caaatgaaca gcctgcgaac tgaggacacg gccgtgtatt attgtgcgag atcttacgat      300

attttgactg gttatagaga tgcttttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttcag                                                                367


<210>  1060
<211>  332
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1060
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccagaaa cagcccccaa actcctcatc tatgctaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cagtggcctc      240

cagtctgagg ctgaggctga ttattactgt gtggcatggg atgacagccg gaatggcctg      300

gtattcggcg gcggggccaa gctgaccgtc ct                                    332


<210>  1061
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1061
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtct attactgtgc gagagacgac      300

aattctcccc agggcagtgg ctggtatttc tactactact acgctatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  1062
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1062
cagtctgtgt tgacgcagcc gccctcagtg tctgcggccc caggacagaa ggtcaccatc       60

tcctgctctg gaagcagctc caacattggg aataattatg tatcctggta ccagcagctc      120

ccaggaacag cccccaaact cctcatttat gacaataatg agcgaccctc agggattcct      180

gaccgattct ctggctccaa gtctggcacg tcagccaccc tgggcatcac cggactccag      240

actggggacg aggccgatta ttactgcgga acatgggata gcagcctgag tgcttatgtc      300

ttcggaactg ggaccaaggt caccgtccta g                                     331


<210>  1063
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1063
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga tcggcctgag agctgaggac acggctgtgt attactgtgc gagagattgg      300

gcacctacgt actacgatat gccgagtgct tttgatatct ggggccaagg gacaatggtc      360

accgtctctt cag                                                         373


<210>  1064
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1064
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cgaagtcggg      240

gatgaggccg acttttactg tcaggtgtgg gatagtagta gtgatcatcc gggggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1065
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1065
caggtggagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt catcttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcgtatg atggaggcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagattgg      300

gcacctacgt actacgatat gccgagtgct tttgatatct ggggccaagg gacaatggtc      360

accgtctctt cag                                                         373


<210>  1066
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1066
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa aatgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgaaggtcgt ctatcatgat ggcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcaacagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1067
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1067
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcagt gactatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atgaagtcta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcactatg accaggaaca cctccataag tacagcctac      240

atggagttga ccagcctgag atctgaggac acggccgtgt attactgtgc gagaatgcgc      300

agtggctggc ccacacatgg ccgcccggat gaccactggg gccggggagc cctggtcacc      360

gtctcctcag                                                             370


<210>  1068
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1068
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtgggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattatc agctatttaa attggtatca ccagaaaccg      120

gggaaagccc ctaaactcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tctgataatc tccccatgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  1069
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1069
caggtgcacc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggggaa atccattaca gtgggagcac cagctacagc      180

ccctccctca agagtcgact cagcatatca gtagacaggt ccaagaacca gttctccctg      240

aagctggcct ctgtgaccgc tgcagacacg gccgtgtatt actgtgtgag ggataattac      300

tttgataata gtggtaatcc tgtgtatccg gttccctggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  1070
<211>  343
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1070
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tgtactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg gggcagagtt cactctcacc      240

atcagcagcc tgcaggctga agatttttca gtttattact gtctgctctt tggttgctca      300

cggggttgga agttcggcca tgggacattg ttggaaatca aac                        343


<210>  1071
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1071
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1072
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1072
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

cagggccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagta gacagcagtg gtacttatcc tcatgtaata      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1073
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1073
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt agctattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtct      240

ctgcaaatga acagcctgag agtcgaggac acggctgtgt attattgtgt gagactgggg      300

gtcagcagct ggtactttga ctactggggc cagggaaccc tggtcaccgt gtcctcag        358


<210>  1074
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1074
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tgctggtcat ctatcaagat accaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg ggcagtagca ggggagtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  1075
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1075
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcaccg tctctgggtt ctcactcagc aatgctagaa tgagtgtgaa ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgaatga cgaaaaatcc      180

tacagcacat ctctgaagag caggctcacc atctccaagg acacctccaa aagccaggtg      240

ctccttacca tgaccaacat ggaccctgtg gacacaggca catattattg tgtacggatg      300

ctgtgggaaa actggagcta cgatgattac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1076
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1076
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccacaatt       60

acctgtgggg gaaacaactt tgcgactaag agtgtccact ggtaccagca gaggccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaagtttgg gaacacggcc atcctgatca tcagcagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtggta gtgaccatgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1077
<211>  399
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1077
gaggtgcagc tggtggagtc tgggggagac ttggtccagc ctggggggtc cctgagactc       60

acctgtgcag cctctggatt cacctttagt agccattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaaggaag atggaagaga gaaatactat      180

gtggactctg tgaagggccg actcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggcggtgt attactgtgc gagagtcgta      300

gttgaagtgg ctacgaataa aggtattcat ggggttgatt actactacta ctactacatg      360

gacgtctggg gcaaagggac cacggtcacc gtctcctca                             399


<210>  1078
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1078
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccagga      120

caggcccctg tagttgtcat ttatggtaaa aataaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacaaagcc tccttgacca tcactggggc tcaggcggga      240

gatgaggctg actattactg taactcccgg gacaacagtg gtaacctcaa ttgggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1079
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1079
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ccctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  1080
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1080
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaacaa tatgcttatt ggtaccacca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatcc ggagtgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1081
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1081
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgagggtt       60

tcctgcaagg cacctggata caccttcacc acctactata tacactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtgctggtag tacaacctac      180

gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagatctc      300

gtgacttacg gtttggacgt ctggggccaa gggaccacgg tcaccgtctc ctca            354


<210>  1082
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1082
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggcaggac ggccaggatt       60

acctgtgggg gaaataacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaagtttgg gaacacggcc accctgatca tcagcagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtggta gtgaccatgt ggtattcggc      300

ggagggacca tggtgaccgt cctag                                            325


<210>  1083
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1083
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctgaggt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcactt atttatagcg gtggtactac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctg      240

caaatgaaca gcctgagagc cgaggacacg gctgtgtatt actgtgcgag acaccaacga      300

tattgtagta gtagcagttg ccacgtttgg gactactggg gccagggaac cctgctcacc      360

gtctcctcag                                                             370


<210>  1084
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1084
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttatacct atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca ataagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc atcacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1085
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1085
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggact caccgtccgt agcaactaca tgacctgggt ccgccagact      120

ccagggaagg ggctggaatg ggtgtcagtt atttatagcg gtggtagcac attctacgca      180

gactccgtga agggcagatt caacatctcc agagacaatt ccaagaatac gctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agactttcta      300

cggtggcacg acctctgggg ccagggaacc ctggtcatcg tctcctcag                  349


<210>  1086
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1086
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tgtactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg gggcagagtt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca atttattact gtcagcaata ttatagtact      300

ccttggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  1087
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1087
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catccggaga caccttcacc acctactata tacactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtggtggtag cagaagctac      180

gcacagaagt tccagggcag aatctccatg accagtgaca cgtccacgag tacagtctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaggatac      300

ggttttgtcc ccaacgtctt gtactacttt gactactggg gccagggaac cctggtcacc      360

gtctccacag                                                             370


<210>  1088
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1088
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc atcacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggtagtag cacttggctg      300

ttcggcggag ggaccaagct gaccgtcct                                        329


<210>  1089
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1089
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcagc actagtggat tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacaacacat ctctgaggac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggcg      300

acgacttttt tctacgttat ggacgtctgg ggccaaggga ccacggtcac cgtctcctca      360


<210>  1090
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1090
cagtctctgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcacgttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatg tatggcaaca acaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc aacacggcct ccctgacaat ctctggactc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caagtagtag catcgtggta      300

ttcggcggag ggaccaaggt gaccgtccta g                                     331


<210>  1091
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1091
gaggtgcagc tggtggagtc tgggggaggc ctggtcaagc ctgggggatc cctgagactc       60

tcctgtgcag cctctggatt caccttccgt gactatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcatcc attagtagtg gtgggagtta catatactac      180

gcagactcag tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gcgtggggga      300

agcatattgt ggtggctcat tgactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  1092
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1092
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcac cagtcgtgtg      300

gttttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1093
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1093
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtga ctccatcagt agtggtcgtt actattggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggttcgtct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagttacc atatcagtag acacgtctaa gaaccagttc      240

tccctgaggc tgagttctgt gactgccgcg gacacggccg tgtattactg tgcgagagaa      300

acatatagtg cctacgaaat gcccccgtac tttgactact ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  1094
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1094
gatgttgtga tgactcagtc tccactctcc ctgcccgtca cccttggaca gccggcctcc       60

atctcctgca ggtctagtca aagcctcgta cacagtgatg gaaacaccta cttgaattgg      120

tttcagcaga ggccaggcca atctccaagg cgcctaattt ataaggtttc taaccgggac      180

tctggggtcc cagacagatt cagcggcagt gggtcaggca cggatttcac actgaaaatc      240

agcagggtgg aggctgagga tgttggggtt tattactgca tgcaaggcac acactggccc      300

ttcggccaag ggacacgact ggagattaaa c                                     331


<210>  1095
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1095
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttacc agctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcaggc attagcatta gtggtggtag tacatattac      180

gcagcctccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gaaagatagt      300

aggtcgggta tagcaggggt cgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1096
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1096
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggcaggac ggccaggatt       60

acctgtgggg gaaataacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaagtttgg gaacacggcc accctgatca tcagcagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtggta gtgaccatgt ggtattcggc      300

ggagggacca aggtgaccgt cctag                                            325


<210>  1097
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1097
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgc ctccatcagc agtagtaatg actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtgggtg gcagttatat catatgatgg aagtaataaa      180

tactacgcag actccgtgaa gggccgattc accatctcca gagacaattc caagaacacg      240

ctgtatctgc aaatgaacag cctgagagct gaggacacgg ctgtgtatta ctgtgcgaaa      300

gattacgtgg gggccgttat ggttcgggga gttaattacc attactacgg tatggacgtc      360

tggggccaag ggaccacggt caccgtctct tca                                   393


<210>  1098
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1098
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aagtatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gatgatattg caacatatta ctgtcaacag tatgataatc tccctccagt tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  1099
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1099
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggact caccgtcagt agcaactaca tgagttgggt ccgccaggct      120

ccagggaagg ggctggagtg cgtctcagtt atttatgccg gtggtaatac atactacgca      180

gactccgtga agggcagatt caccatctcc agagacaatt ccaagaacac gctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gctgtgtatt actgtgcgag aggcgatggt      300

ggttattact caccctttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  1100
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1100
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaaggtcct gatctatgct gcatccacta tgcaaagtgg ggtcccatca      180

aggttcaggg gcagtggctc tgggacagat ttcactctca ccatcagcag tctgcaactt      240

gaggattttg caacttacta ctgtcaacag agttacagta cccctcagac gtttggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  1101
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1101
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atctcatctg atggaagtaa taaatactat      180

gcaggctccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatatg      300

gtggaaccat ttttcagtca ctactactac tacggtatgg acgtctgggg ccaagggacc      360

acggtcaccg tctcctca                                                    378


<210>  1102
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1102
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttatacct atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca ataagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc atcacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1103
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1103
cagatcacct tgaaggagtc tggtcctacg ctggtaaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggc ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gctctcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacaga      300

cttccaacgc cccaactgct accatctttt gaaaactggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  1104
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1104
cagtctgtgc tgactcagcc accctcggtg tctgaagccc ccaggcagag ggtcaccatc       60

tcctgttctg gaggcagctc caacatcgga aataatgctg taaactggta ccagcagctc      120

ccaggaaagg ctcccaaact cctcatctat tatgatgatc tgctgccctc aggggtctct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca tcatgggatg acagcctgat tggtccggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1105
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1105
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt gaccgtcggt agcaactaca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac attctacgca      180

gactccgtga agggcagatt caccatctcc agagacaatt ccaagaacac gttgtatctt      240

caattgaaca gcctgagagc cgaggacacg gctgtgtatt actgtgcgag agaagttgtc      300

ggttactttg actgctgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  1106
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1106
gacatccagt tgacccagtc tccatccttc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc acttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct      240

gaagattttg caacttatta ctgtcaacaa cttaatagtt accctgggta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  1107
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1107
caggtgcagt tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcaaatg atgggagaaa taaatactac      180

gcagactccg tgaagggccg actcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagattgg      300

gcacctacgt actacgatat gccgagtgct tttgatatct ggggccaagg gacaatggtc      360

accgtctctt cag                                                         373


<210>  1108
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1108
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctggactc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caagtagtag catcgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1109
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1109
caaatgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgaaggtc       60

tcctgcaagg cttctggatt cacctttatg agctctgctg tgcagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gataggatgg atcgtcattg gcagtggtaa cacaaactac      180

gcacagaagt tccaggaaag agtcaccatt accagggaca tgtccacaag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagaaaca      300

tatagtgcct acgaaatgcc cccgtacttt gactactggg gccagggaac cctggtcatc      360

gtctcctcag                                                             370


<210>  1110
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1110
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagttat tatgcaagct ggtaccagca gaagccagga      120

caggcccctt tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacacct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattattg taactcccgg gacaacagtg gtaacctcaa ttgggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1111

<400>  1111
000

<210>  1112

<400>  1112
000

<210>  1113
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1113
caagtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccctcagt ctttactact ggagctggat ccggcaggcc      120

ccagggaagg gactggagtg gattggctat atctattaca ctgggagcac caactacaat      180

ccctccctca agagtcgggt caccatatca gtagacacgc ccaggaacca gatctccctg      240

agtctgacct ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag aataccaact      300

ggtttccccc gttgttacat ggacgtctgg ggcaaaggga ccacggtcac cgtctcctca      360


<210>  1114
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1114
gacatccaga tgacccagtc tccttcctcc ctgtctgcgt ctataggaga cagagtcacc       60

atcacttgcc gggcaagtca gaatattaga agctatttaa actggtatca gcacaaacca      120

gggaaagccc ctaaactcct gatctatgct gcatccactt tgcaaagtgg ggtcccgtca      180

aggttcagtg gcagtgaatc tgggacagac ttcactctca ccatcagcag tctgcagcct      240

gaagattttg caacttacta ctgtcaacag agttccagtt ccccgatcac ttttggccag      300

gggaccaagc tggcgatcaa ac                                               322


<210>  1115
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1115
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1116
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1116
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1117
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1117
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat ccggcagccc      120

ccagggaagg gactggagtg gattgggcat atttattaca ctgggagcag ctattacaac      180

ccctccctca agagtcgagt caccatatca ctagacacct ccaagaacca gttctccctg      240

aagctgaact ctgtgaccgc cgcggacacg gccgtgtatt actgtgccag actacggtgg      300

ttacggggag ggattgactt ctggggccag ggaaccctgg tcatcgtctc ctcag           355


<210>  1118
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1118
aatttaatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcaa caatcaggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1119
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1119
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catccggaga caccttcacc acctactata tacactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtggtggtag cagaagctac      180

gcacagaagt tccagggcag aatctccatg accagtgaca cgtccacgag tacagtctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaggatac      300

ggttttgtcc ccaacgtctt gtactacttt gactactggg gccagggaat cctggtcacc      360

gtctcctcag                                                             370


<210>  1120
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1120
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccc gcagcagtgg cagcattgcc agcagctatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcag cgatgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1121
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1121
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaggggac aatggtcacc      360

gtctcctcag                                                             370


<210>  1122
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1122
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctct gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatggcat caatcgggca      300

tgggtgttcg gcggagggac caagctgacc gtcctag                               337


<210>  1123
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1123
caggtggagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt catcttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcgtatg atggaggcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagcccag      300

ggggggaact actactacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  1124
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1124
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa aatgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgaaggtcgt ctatcatgat ggcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcaacagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1125
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1125
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ccctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  1126
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1126
gacattgtgt tgacgcagtc tccaggcacc ctgtctctgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gcgtcttgcc cccaccctct tggcctggtt cctccagaaa      120

cgtggccagg ctcccaggct cctcatgtat gccgcatcca ccagggccac tgacatccca      180

gacaggttca atggcggtgg ttctggaaca gacttcactc tcaccatcag cagtctgcaa      240

cctgaagatt ttgcaactta ctactgtcaa cagagttaca gtacccttct gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  1127
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1127
cagctgcagc tgcaggagtc cggctcagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agtggtggtt actcctggag ctggatccgg      120

cagccaccag ggaagggcct ggagtggatt ggctacatct atcatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatcagtag acaagtccaa gaaccagttc      240

tccctgaagg tgagctctgt gaccgccgcg gacacggccg tgtattactg tgccagaagt      300

gggggagtga agttcgaccc ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  1128
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1128
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg cagacaacta cacttataat      300

tatgtcttcg gaactgagac caaggtcacc gtcctag                               337


<210>  1129
<211>  362
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1129
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggtcgtc cccgagactc       60

tcctgtgcag tctctggatt caccctcagt cgctattcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcggag acatcacgtg ctgcagatgg taaattctac      180

tcagactccg tgaggggccg gttcaccgtc tccagagaca attccaagaa ccttctgttt      240

ctgcaaatga acagcctgat acgtgacgac acggctgtct attactgtgc gagagattcg      300

gggctggctc gtgccttcag ttatgactac tggggccagg gagcccgggt catcgtctcc      360

tc                                                                     362


<210>  1130
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1130
gacatccaga tgacccagtc tccttcctcc ctgtctgcgt ctataggaga cagagtcacc       60

atcacttgcc gggcaagtca gaatattaga agctatttaa actggtatca gcacaaacca      120

gggaaagccc ctaaactcct gatctatgct gcatccactt tgcaaagtgg ggtcccgtca      180

aggttcagtg gcagtgaatc tgggacagac ttcactctca ccatcagcag tctgcagcct      240

gaagattttg caacttacta ctgtcaacag agttccagtt ccccgatcac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1131
<211>  396
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1131
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt cgctatgcta tgtactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcactt atatcatatg atggacgtaa tgaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctggtgac tcggctgtgt attattgtgc gagagatctc      300

gcctaccacc cttaccgcga ctacggtgac gatgattact actactacta cggtatggac      360

gtctggggcc aagggaccac ggtcaccgtc tcctca                                396


<210>  1132
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1132
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctttg gagatgcatt gccaaaacaa tatgcttatt ggtaccagca gaagccaggc      120

cagggccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccacctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg gtacttatcg ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1133
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1133
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  1134
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1134
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacttgcaga agccagggca gtctccacag ttcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgagaggtt cagtggcagt ggaacaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgct tgcaagctct acaatttccg      300

tacacttttg gccaggggac caagctggag atcaaac                               337


<210>  1135
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1135
ggggtgcagc tggtacagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg cttctggata tactttcacc aattattgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg atgactctga taccagatac      180

gacccgtcct tcgaaggcca ggtcagcatc tcagccgaca agtccatcac caccgtctac      240

ctgcagtgga gtagcgtgaa ggccccggac accgccatgt atcactgtgc gaggcgggac      300

aaagtgggag cgcttgactc ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  1136
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1136
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcaggct      240

gaagatgtgg caatttatta ctgtcagcaa tattatagta ctccttggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  1137
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1137
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgc ctccatcagc agtagtaatt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggactatct attatagtgg gagcacctat      180

tataacccgt ccctcaagag tcgagtcacc atattcgtag acacgtccaa gagccagttc      240

tccctgaagc tgacctctgt gaccgccgca gacacggctg tgtattactg tgcgagacgc      300

catcactata acactgcctg gggatccact tactttgcct actggggcca gggaaccctg      360

gtcaccgtct cctcag                                                      376


<210>  1138
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1138
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattagt agctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgagacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttattg ctgccaacag tataatagtt acccgatcac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  1139
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1139
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcaaatg atgggagaaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga tcggcctgag agctgaggac acggctgtgt attactgtgc gagagatcaa      300

tctcagggcg cttatatttt gactggttat aggggctacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1140
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1140
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc ggccaagtca gagcattacc acctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaggctcct gatctatgct gtatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gatgatattg caacatatta ctgtcaacag tatgctaatc tcccattcac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  1141
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1141
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcacc agctactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaaccctg gtggtggtag tacaacctac      180

gcacagaagt tccagggcag agtcaccatg accagtgaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccatgt attactgtgc gagaggggca      300

attcccccaa atagcagagc cgaaattgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  1142
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1142
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtgcca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcaa tattataact ggccgctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  1143
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1143
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cctctggata taccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag gccttgagtg gatgggatgg atgagtccta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accagggaca cctccataag cacagcctat      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagactaagt      300

ggcagtggct ggctcggcta cgctatggac gtctggggcc aagggaccac ggtcaccgtc      360

tcc                                                                    363


<210>  1144
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1144
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctcta cagatgcatt gccaaatgaa tatatttatt ggtaccagca gaagccaggc      120

caggcccctg tattggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagta gacagcagtg gtacttatcc tcatgtaata      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1145
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1145
caggtgcagc tggtgcagtc tggggctgag gtgaaggcgc ctagggcctc agtgatgatc       60

tcctgcaggg cctctggata cacgttcgcc agtcttgata tcaactgggt gcgacaggcc      120

actggacaag ggcctgagtg gatgggatgg atgaacccta acagtggtaa cacaggctat      180

gcacacaaat tccagggcag agtcaccatg accagggaca cctccacgag cacagtctac      240

atggagttga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaggattc      300

catgtaccag ctgctcttcg gaactggttc gacccctggg gccagggacc cctggtcacc      360

gtctcctcag                                                             370


<210>  1146
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1146
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccacaatt       60

acctgtgggg gaaacaactt tgcgactaag agtgtccact ggtaccagca gaggccaggc      120

caggcccctg tgctggtcgt ctatgatgat aacgaccggc cctcagggat ccctgagcga      180

ttctctggct ccatctctgg gaacacggcc accctgatca tcagcagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtcgta gtggtcactt tgtggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1147
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1147
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ccctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  1148
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1148
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtgggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgctaatc tcacattaac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  1149
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1149
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agttatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaagtaa taaatactat      180

gcagagtccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgttgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagatctt      300

caccaggatt gggtagtggt ggtagctgct aatgtctacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1150
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1150
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccaacag      120

cttcctggaa cagcccccaa actcctcatc tttggtaaca ccaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc aacacggcct ccctgacaat ctctggactc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1151
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1151
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaggggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1152
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1152
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccacaatt       60

acctgtgggg gaaacaactt tgcgactaag agtgtccact ggtaccagca gaggccaggc      120

caggcccctg tgctggtcgt ctatgatgat aacgaccggc cctcagggat ccctgagcga      180

ttctctggct ccatctctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1153
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1153
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cctctggata taccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag gccttgagtg gatgggatgg atgagtccta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accagggaca cctccataag cacagcctat      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagagacttt      300

ctacggtggc acgacctctg gggccagggg accctggtca ccgtctcctc ag              352


<210>  1154
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1154
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttgcc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatccg gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctcc gaggtacact      300

tttggccagg ggaccaagct ggaaatcaaa c                                     331


<210>  1155
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1155
gaggcgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgaag cctctggatt catctttagt agctattgga tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca attccaagaa caccctgtat      240

cttcaaatga acagcctgag agccgaggac acggccgtgt attactgtgc gagagacttt      300

ctacggtggc acgacctctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  1156
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1156
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaacaa tatgcttatt ggtaccacca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg gtacttccgt attattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1157
<211>  380
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1157
cagctgcagc tgcaggagtc gggcccagga ctagtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccgtcagc agtagaagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct attatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgcgtcacc atatccgtag acacgtccaa gaatcagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagacac      300

acggtcgatt gtggtggtga ttgctttccc aatgatgctt ttgatatctg gggccaaggg      360

acaatggtca ccgtctcttc                                                  380


<210>  1158
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1158
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tgctggtcat ctatcaagat accaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcaacagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtagta gtgatcatcc ggagtgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1159
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1159
cagctgcagc tgcaggagtc gggcccagga ctagtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccgtcagc agtagaagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt ggggaaatca atcatagtgg aagcaccaac      180

tacaacccgt ccctcaggag tcgagtcacc atatcagtag acacgtccaa gaaccaattc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagacac      300

acggtcgatt gtggtggtga ttgctttccc aatgatgctt ttgatatctg gggccagggg      360

acaatggtca ccgtctcttc ag                                               382


<210>  1160
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1160
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttgcc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatccg gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcac caatatggca tctcaccgtt cacctttggc      300

caggggacca ggctggagat ca                                               322


<210>  1161
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1161
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcacc agctactatt tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaatc atcaacccta gtggtggtag cacaacctac      180

gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag tgcggtctac      240

atggagctga ggagcctgag atctgaggac acggccgtgt attactgtgc gagagagaat      300

gactacggtg actacgttga gccccgtgac tactactacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1162
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1162
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg ctgcttatgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1163
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1163
cagctgcagc tgcaggagtc cggctcagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agtggtggtt actcctggag ctggatccgg      120

cagccaccag ggaagggcct ggagtggatt ggctacatct atcatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atattcgtag acacgtccaa gagccagttc      240

tccctgaagc tgacctctgt gaccgccgca gacacggctg tgtattactg tgcgagacgc      300

catcactata acactgcctg gggatccact tactttgcct actggggcca gggaaccctg      360

gtcaccgtct cctc                                                        374


<210>  1164
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1164
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcacgatc       60

acatgccaag gagacagcct cagaagccat tatgcaagtt ggtataaggt gaagccagga      120

caggcccctt tacttgtcat ctatggtaga aacaaccggc cctcagggat cccagaccga      180

ttctctggct cccgatcagg aaacacagct tccttgacca tcactggggc ccaggtggat      240

gatgaggctg attattactg ccagtcctat gacagcagcc tgaatggtga cgtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1165
<211>  368
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1165
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcttc                                                               368


<210>  1166
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1166
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcggccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcct                                           326


<210>  1167
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1167
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctgaata caccttcact agctatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagaccgggc      300

aaagcagcag cttttgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  1168
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1168
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatccg gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctcc gaggtacact      300

tttggccagg ggaccaagct ggcgatcaaa c                                     331


<210>  1169
<211>  362
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1169
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggtcgtc cccgagactc       60

tcctgtgcag tctctggatt caccctcagt cgctattcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcggag acatcacgtg ctgcagatgg taaattctac      180

tcagactccg tgaggggccg gttcaccgtc tccagagaca attccaagaa ccttctgttt      240

ctgcaaatga acagcctgat acgtgacgac acggctgtct attactgtgc gagagattcg      300

gggctggctc gtgccttcag tcatgactac tggggccagg gagccctggt catcgtctcc      360

tc                                                                     362


<210>  1170
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1170
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccacact gaccgtccta g                                     331


<210>  1171
<211>  379
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1171
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt catcttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg tgtggcagtt acatcatatg atggaaccaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cactctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagacacacg      300

gtcgattgtg gtggtgattg ctttcccaat gatgcttttg atatctgggg ccaggggaca      360

atggtcaccg tctcttcag                                                   379


<210>  1172
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1172
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctcc gaggtacact      300

tttggccagg ggaccaaact ggagatcaaa c                                     331


<210>  1173
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1173
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaac      180

ccgtccctca ggagtcgagt caccatatca gtagacacgt ccaagaacca attctccctg      240

aagctgagct ctgtgaccgc tgcggactcg gccgtgtatt actgtgcgaa agatggaggg      300

aatgcatata gcagtggctg gtaccggtac ttctaccaca tggacgtctg gggcaaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  1174
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1174
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cgaagtcggg      240

gatgaggccg acttttactg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1175
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1175
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catccggaga caccttcacc acctactata tacactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtggtggtag cacaagctac      180

gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagaggattc      300

catgtaccag ctgctcttcg gaactggttc gacccctggg gccagggaac cccggtcacc      360

gtctcctcag                                                             370


<210>  1176
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1176
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacttgcaga agccagggca gtctccacag ttcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttat actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaaggcac acactggccc      300

ttcggccaag ggacacgact ggagatcaaa c                                     331


<210>  1177
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1177
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcacc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataagtac      180

tacagcacat ctctgcagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggaa      300

actccggtga ctgctattga ctactggggc cagggaaccc tggtcaccgt gtcctcag        358


<210>  1178
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1178
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa aatgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgaaggtcgt ctatcatgat ggcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccatctctgg gaacacggcc accctgacca tcagcagcgt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1179
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1179
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt acctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaaataa gaaatactgt      180

gcagactccg tgaagggccg atgcaccatc tccagagaca attccaagaa cacgctgtat      240

ctacaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagagggg      300

ccatttgggg accgtgaagc ctctggtgct tttgatgtct ggggccaagg gacaatggtc      360

accgtctctt cag                                                         373


<210>  1180
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1180
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaaaaaaa tatacttatt ggtaccagca gaagtcaggc      120

caggcccctg tggtggtcat ctatgaggac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaggctg actactactg ttactcaaca gacagcagtg gtaagggggt gttcggcgga      300

gggaccaagc tgaccgtcct ag                                               322


<210>  1181
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1181
caggtgcagc tggtggagtc tgggggaggc ttggtcaagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt gactactaca tgagctggat ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac attagtagta gtggtattac catatactac      180

gcagactctg tgaagggccg attcaccatc tccagggaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtgt attactgtac aggggtggta      300

gctgctcccg ctgaatactt ccagcactgg ggccagggca ccctggtcac cgtctcctca      360

g                                                                      361


<210>  1182
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1182
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatccctt ttatgtcttc      300

ggaactggga ccaaggtcac cgtcctag                                         328


<210>  1183
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1183
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattattg tgcacaccta      300

ctccgaattg gcagtggcta ctactcgccg aggttaatcg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  1184
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1184
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gactattttc agcacctact tagcctggta cctgcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca ccagggccac tggtatccca      180

gtcaggttca gtggcagtgg gtctgggaca gagttcactc tcaccatcag cagcctgcag      240

tctgaagatt ttgcagttta ttcctgtcag cagtatgatg actggccccc ggaggtcact      300

ttcggcggag ggaccaaggt ggagatcaaa c                                     331


<210>  1185
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1185
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcagc actagtggat tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacaacacat ctctgaggac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcatgggcg      300

acgacatttt tctacggtat ggacgtctgg ggccaaggga ccacggtcac cgtctcctca      360


<210>  1186
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1186
tcctatgagt tggctcaacc accctcggtg tcagtggccc caggggagac ggccaccatt       60

ttctgtaggg caacctacat tgggagaaaa aatgtacagt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cgaagtcggg      240

gatgaggccg acttttactg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcct                                           326


<210>  1187
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1187
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattattg tgcacaccta      300

ctccgaattg gcagtggcta ctactcgccg aggttaatcg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  1188
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1188
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagca gacagcaggg gtgcggtctt cggaagtggg      300

accaaggtca ccgtcctag                                                   319


<210>  1189
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1189
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcacc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataagtac      180

tacagcacat ctctgcagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggaa      300

actccggtga ctgctattga ctactggggc cagggaatcc tggtcaccgt ctcctcag        358


<210>  1190
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1190
gacattgtgt tgacgcagtc tccaggcacc ctgtctctgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gcgtcttgcc cccaccctct tggcctggtt cctccagaaa      120

cgtggccagg ctcccaggct cctcatgtat gccgcatcca ccagggccac tgacatccca      180

gacaggttca atggcggtgg ttctggaaca gacttcactc tcaccatcag cagcctggac      240

actgaagact ttggagtcta ttactgtcac caatatggca tctcaccgtt cacctttggc      300

caggggacca ggctggagat caaac                                            325


<210>  1191
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1191
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt aggcattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg actcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagactgggg      300

ttctattacg gtggagccga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  1192
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1192
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctct gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatggcat caatcgggca      300

tgggtgttcg gcggagggac caagctgacc gtcctag                               337


<210>  1193
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1193
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaac      180

ccgtccctca ggagtcgagt caccatatca gtggacacgt ccaagaacca cttctccctg      240

aaaatgaact ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag atgtcgccag      300

atggggaact tctactacta ctacctggac gtctggggcc aagggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  1194
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1194
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccagaaa cagcccccaa actcctcatc tatgctaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cagtgggctc      240

cagtctgagg atgaggctga ttattactgt gcagcatggg atgacagcct gaatggttct      300

tgggtgttcg gcggagggac caagctgacc gtcctag                               337


<210>  1195
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1195
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattattg tgcacaccta      300

ctccgaattg gcagtggcta ctactcgccg aggttaatcg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  1196
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1196
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagct ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc ccccagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gtaacgccgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1197
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1197
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggat caccgtaagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatgcag gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcg agagacaatt ccaagaacac gctgtatctt      240

caaatgaata gcctgagagc cgaggacacg gccgtatatt actgtgcgag agatgcgcta      300

tattacaatg gtccagggcg ggacgggatg gacgtctggg gccaagggtc cacggtcacc      360

gtctcctca                                                              369


<210>  1198
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1198
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt cccaaagcaa tatggttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcggccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcgcct ttatgtcttc      300

ggaactggga ccaatgtcac cgtcctag                                         328


<210>  1199
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1199
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cctctggata taccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag gccttgagtg gatgggatgg atgagtccta acagtggtaa cacaggctat      180

gcacagaagt ttcagggccg agtcattatg accagggaca cctccataaa tactgcctac      240

ttggaactca ctcgcctgac atctgaagac acgggcacat attattgtgc gagaggtgtt      300

gcagctggcg ttgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  1200
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1200
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagcct      240

gaagattttg caacttacta ctgtcaacag agttccagtt ccccgatcac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1201
<211>  353
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1201
caggtgcagc tggtggagtc cgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctatgt attactgtgc gaaagatggg      300

agtatagcag cagctgacta ctggggccag ggaaccctgg tcaccgtctc ctc             353


<210>  1202
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1202
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtctta cacagctcca acaacaagga ctccttagtt      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctagccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

ccttggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  1203
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1203
caggtgcacc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggggaa atccattaca gtgggagcac cagctacagc      180

ccctccctca agagtcgact cagcatatca gtagacaggt ccaagaacca gttctccctg      240

aagctggcct ctgtgaccgc tgcagacacg gccgtgtatt actgtgtgag ggataattac      300

tttgataata gtggtcatcc tgtgtatccg gttccctggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  1204
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1204
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccgtc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctatg acagcagcct gagtggttcg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1205
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1205
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgaac      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcc                                                                 366


<210>  1206
<211>  316
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1206
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataagc tcactctcgg cggagggacc      300

aaggtggaga tcaaac                                                      316


<210>  1207
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1207
caggtgcagc tgttggagtc gggcccagga ctggtgaagt cttcacagac cctgtacctc       60

acctgctctg tctctggtgg ctccgtcagc agtggcgctt attactggac gtgggtccgt      120

cagcccgccg ggtccccact ggagtggatc gggcgcattt atactagtgg gaccaccaac      180

tacaacccct ccctcaaccg gcgactcacc ctctcacttg acacgtccag gaaccagatc      240

tccctgaaac tgacgtctgt gaccgccgca gacacggccg cgtatttttg tgcgagagcc      300

cgaagctcta tggacaactt ctactacttc tatatggacg tctggggcaa agggaccgcg      360

gtcaccgtct cctca                                                       375


<210>  1208
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1208
gaaattgtat tgacacagtc tccaggcacc ctgtccttgt ctccagggga gagagccata       60

ctctcctgca gggccagtca gaacattaag aacacgtatc tatcctggta ccagcagacg      120

cctgggcagg ctcccaggct cctcatccac ggtgcatcca acagggccac tgacatccca      180

gccaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagcctgcag      240

cctgaggatt tcgcagttta ttactgtctg caggattata acttaccatg gacgttcggc      300

caggggacca aggtggaaat caa                                              323


<210>  1209
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1209
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgagggtt       60

tcctgcaagg cacctggata caccttcacc acctactata tacactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagaccgggc      300

aaagcagcag cttttgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  1210
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1210
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcaa tattataact ggccgctcac tttcggcgga      300

gggaccaaag tggagatcaa ac                                               322


<210>  1211
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1211
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg atacaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga tcggcctgag agctgaggac acggctgtgt attactgtgc gagagattgg      300

gcacctacgt actacgatat gccgagtgct tttgatatct ggggccaggg gacaatggtc      360

accgtctctt cag                                                         373


<210>  1212
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1212
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac actgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg ggcagtagca ggggagtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  1213
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1213
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcgctg tctctggtgg gtccttcagt gcttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaac      180

ccgtccctca ggagtcgagt caccatatca gtagacacgt ccaagaacca attctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag agtgggttat      300

tcccaagggt actactacta ctacatggac gtctggggaa aagggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  1214
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1214
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctttg acatcggccg gggtggttgg      300

attttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1215
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1215
caggtccagc tggtgcaatc aggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc gactatgcca tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac agcaaactac      180

gcacagaagt tccaggaaag agtcaccatt accagggaca tgtccacaag cacagcctac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggccccatat      300

tgtagtagta tcatctgcaa tgatggtttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1216
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1216
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc atcacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1217
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1217
caggtgcagc tggtgcaggc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcacc agctactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaacccta gtggtggtag cacaagctac      180

gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtttat      240

atggagctga gcagcctgag atctgaggac acggccgtgt actactgtgc gagaggggcc      300

gcagtaccag ccgcggggga atttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1218
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1218
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattagt agctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaaactcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatagtt attcgtacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1219
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1219
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctctggtgg gtccttcagt gcttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaat      180

ccgtccctca agagtcgagt caccatatca gtggacacgt ccaagaacca cttctccctg      240

aaaatgaact ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag agtgggttat      300

tcccaagggt actactacta ctacatggac gtctggggca aggggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  1220
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1220
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg cacgtagtag cactcgggtg      300

ttcggcggag ggaccaagct gaccgtcct                                        329


<210>  1221
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1221
caggtgcagc tggtgcagtc tggggctgag gtgaaggcgc ctggggcctc agtgatgatc       60

tcctgcaggg cctctggata cacgttcgcc agtcttgata tcaactgggt gcgacagacc      120

gctggacgag ggtttgagtg gatgggatgg atgagtccta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accagggaca cctccataaa tactgcctac      240

ttggaactca ctcgcctgac atctgaagac acgggcacat attattgtgc gagaggtgtt      300

gcagctggcg ttgactactg gggccaggga accctggtca ccgtctcctc ag              352


<210>  1222
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1222
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtctta cacagctcca acaacaagga ctccttagtt      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctagccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

ccttggacgt tcagccaagg gaccaaggtg gaaatcaaac                            340


<210>  1223
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1223
caggtgcagc tggtggagtc tgggggaggc gtggtccagt ctggggggtc cctgagactt       60

tcctgtgcag cctctggatt caccttcagt acctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcaatt atatcatatg atggaattaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacggtgtat      240

ctgcaaatga acagcctgag aactgaggac acggctatgt actactgtgc gaagggggat      300

gggagctacc tgatggacta ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1224
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1224
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc aacaacctag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagtc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tatgatgact ggcccccgga ggtcactttc      300

ggcggaggga ccaaggtgga gatcaaac                                         328


<210>  1225
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1225
gaggtgcagc tggtggagtc tgggggagac ttggtccagc ctggggggtc cctgagactc       60

acctgtgcag cctctggatt cacctttagt agccattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaaggaag atggaagaga gaaatactat      180

gtggactctg tgaagggccg actcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagactgggg      300

ttctattacg gtggagccga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  1226
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1226
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagtt ggtaccagca gaagccagga      120

caggcccctg tagttgtcat ttatggtaaa aataaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacaaagcc tccttgacca tcactggggc tcaggcggga      240

gatgaggctg actattactg taactcccgg gacaacagtg gtaacctcaa ttgggtgttc      300

ggcggaggga ccaagctgac cgtcctag                                         328


<210>  1227
<211>  344
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1227
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctttgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaaaaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgcgt attactgtgc gagagagtta      300

atgtcagtcg gctggggcca gggaaccctg gtcaccgtct cctc                       344


<210>  1228
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1228
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tgtactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg gggcagagtt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca atttattact gtcagcaata ttatagtacc      300

ctcgctttcg gcggagggac caaggtggag atcaaac                               337


<210>  1229
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1229
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  1230
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1230
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccgtc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctttg acatcggccg gggtggttgg      300

attttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1231
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1231
caggtccaac tgatacagtc tggaggtgaa atgaagaggt ctggggcctc agtgagggtc       60

tcctgcagga cctctggcta cagttttacg agttttggta tcacgtgggt gcgcctgacc      120

cctggacaac cgccggagtg gctgggatgg atcagcggct acgacggcaa cacaaagtat      180

gcaccgaagt tccagggcag agtcgtcatg acaatagaca catcgacgac cacagcctac      240

atggaactga ggagcctgag atctgacgac acggccctct attattgtgc gagaagaata      300

agatataatg actcgggcta ttatcactat tacatggatg cctggggcag agggaccgcg      360

gtcaccgtct cctca                                                       375


<210>  1232
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1232
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaacaa tatgcttatt ggtaccacca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccatctctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatggtatta atgatcgtgt ggtcttcggc      300

ggcgggacca agctcaccgt cct                                              323


<210>  1233
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1233
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattattg tgcacaccta      300

ctccgaattg gcagtggcta ctactcgccg aggttaatcg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  1234
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1234
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacttgcaga agccagggca gtctccacag ttcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt gggtctggga cagacttcac tctcaccatc      240

agcagactgg agcctgaaga ttttgcagtg tattactgtc agcagtatgg tagctcacta      300

tttactttcg gccctgggac caaagtggat gtgaaac                               337


<210>  1235
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1235
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcagc actagtggat tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacaacacat ctctgaggac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattattg tgcacgggcg      300

acgacatttt tctacggtat ggacgtctgg ggccaaggga ccacggtcac cgtctcctca      360


<210>  1236
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1236
gatgttgtga tgactcagtc tccactctcc ctgcccgtca cccttggaca gccggcctcc       60

atctcctgca ggtctagtca aagcctcgta cacagtgatg gaaacaccta cttgaattgg      120

tttcagcaga ggccaggcca atctccaagg cgcctaattt ataaggtttc taaccgggac      180

tctggggtcc cagacagatt cagcggcagt gggtcaggca cggatttcac actgaaaatc      240

agcagggtgg aggctgagga tgttggggtt tattactgca tgcaaggcac accctggccc      300

ttcggccaag ggacacgact ggagattaaa c                                     331


<210>  1237
<211>  365
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1237
gaagtgcagc tggtggagtc tggaggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgcag cctctgggtt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatcccg gtggtagcgc attctacgca      180

gactccgtga agggccgatt caccatctcc agacacaatt ccaacaacac actgtgtctt      240

caaatgaaca gcctgcgaac tgaggacacg gccgtgtatt attgtgcgag atcttacgat      300

attttgactg gttatagaga tgcttttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttc                                                                  365


<210>  1238
<211>  332
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1238
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg tcaggttctg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tatggcaaca ccaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgt gtggcatggg atgacagccg gaatggcctg      300

gtattcggcg gaggggccaa gctgaccgtc ct                                    332


<210>  1239
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1239
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggtcgtc cccgagactc       60

tcctgtgcag tctctggatt caccctcagt cgctattcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcggag acatcacgtg ctgcagatgg taaattctac      180

tcagactccg tgaggggccg gttcaccgtc tccagagaca attccaagaa ccttctgttt      240

ctgcaaatga acagcctgat acgtgacgac acggctgtct attactgtgc gagagattcg      300

gggctggctc gtgccttcag ttatgactac tggggccagg gagccctggt catcgtctcc      360

tcag                                                                   364


<210>  1240
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1240
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcag ctctgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1241
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1241
caggtccaac tgatacagtc tggaggtgaa atgaagaggt ctggggcctc agtgagggtc       60

tcctgcagga cctctggcta cagttttacg agttttggta tcacgtgggt gcgcctgacc      120

cctggacaac cgccggagtg gctgggatgg atcagcggct acgacggcaa cacaaagtat      180

gcaccgaagt tccagggcag agtcgtcatg acaatagaca catcgacgac cacagcctac      240

atggaactga ggagcctgag atctgacgac acggccctct attattgtgc gagaagaata      300

agatataatg actcgggcta ttatcactat tacatggatg cctggggcag agggaccgcg      360

gtcaccgtct cctca                                                       375


<210>  1242
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1242
caagtagtga tgacgcagtc tcccgccact ctgtctgtgt ctccaggggg gagagccacc       60

ctctcctgca gggccagtga gagtgttaga cgcaacttag cctggttcca gctgaaacct      120

ggccaggctc ccaggctcct catccatggt gcatccacca gggcctctgg tgtcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcattctca ccatcagcgg cctgcagccc      240

gaagattttg cagtttatta ctgtcagcag tgttctgact ggccgacgtt cggccagggg      300

accagggtgg agattaaac                                                   319


<210>  1243
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1243
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaat      180

ccgtccctca agagtcgagt caccatatca gtggacacgt ccaagaacca cttctccctg      240

aaaatgaact ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag atgtcgccag      300

atggggaact tctactacta ctacatggac gtctggggca aggggaccac ggtcaccgtc      360

tcc                                                                    363


<210>  1244
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1244
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccgtc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctttg acatcggccg gggtggttgg      300

attttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1245
<211>  371
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1245
caggtgcagt tacagcagtg gggcgcaggg ctgttgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtga ctccatcagt agtggtcgtt actattggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggttcgtct attacagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagttacc atatcagtag acacgtctaa gaaccagttc      240

tccctgaggc tgagttctgt gactgccgcg gacacggccg tgtattactg tgcgagagaa      300

acatatagtg cctacgaaat gcccccgtac tttgactact ggggccaggg aaccctggtc      360

accgtctcct c                                                           371


<210>  1246
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1246
gacatccaga tgacccagtc tccttcctcc ctgtctgcgt ctataggaga cagagtcacc       60

atcacttgcc gggcaagtca gaatattaga agctatttaa actggtatca gcacaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcaccag cctgcagcct      240

gaagatgttg caacatatta ctgtcaacag tatgataatc tccctctggc tttcggccct      300

gggaccaaag tggatgtgaa ac                                               322


<210>  1247
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1247
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactggg tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagagac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagactcggg      300

tcggagtcaa aaattgacta ctactactac ggtatggacg tctggggcca agggaccacg      360

gtcaccgtct cctca                                                       375


<210>  1248
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1248
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc ggccaagtca gagcattacc acctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaggctcct gatctatgct gtatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta ccccccctac cttcggccaa      300

gggacacgac tggagattaa ac                                               322


<210>  1249
<211>  394
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1249
caagtgcaac tgcaggagtc gggccctaga ctggtgaagc cttcggagac cctctccctc       60

acttgcacag tctctggtgg ctccatgagt ggtttcttct ggagctgggt tcggcagtcc      120

cccgagaggg gatttgaata cattggctac ttttattcta gtgcaaaaac cgattacaac      180

ccctccctca gcagtcgcgt caccatgtca ttggacgcgt ccaaaaacct attctccttg      240

aagctgacct ctgtgaccac ttcggacacg gccgtctatt actgtgcgag agcccagaat      300

tactatcgtg gaaatactta ttattcgaca agatacccca gaccggatat ttttgacatg      360

tggggccgcg ggacaagggt caccgtctct tcag                                  394


<210>  1250
<211>  332
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1250
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaggcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc acctcagcct ccctggccat cagtggcctc      240

cagtctgagg atgaggctga ttattactgt gtggcatggg atgacagccg gaacggcctg      300

gtattcggcg gaggggccaa gctgaccgtc ct                                    332


<210>  1251
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1251
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattgggact atctattata gtgggagcac ctattataac      180

ccgtccctca agagtcgagt caccatatca gtggacacgt ccaagaacca cttctccctg      240

aaaatgaact ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag acgcgatcac      300

tataacactg cctggggatc cacttacttt ggctactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  1252
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1252
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccctc       60

tcctgcgctg gggccacctc caacatcggg gcaggctctg atgtccactg gtaccagcaa      120

cttccaggaa cagcccccaa actcctcatg tatggcaaca acaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctttg acatcggccg gggtggttgg      300

attttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1253
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1253
caggtccagc tggtgcaatc aggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggaga caccttcagc agctatacta tcaactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat accaaactac      180

gcacagaaat tccagggcag agtcaccatt accgcggaca aatccacgag cacagccttc      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagggagg      300

ggctacagta actacggggc ctcctactac atggacgtct ggggcaaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  1254
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1254
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccagaaa cagcccccaa actcctcatc tatgctaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gagtggttcg      300

gtattcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1255
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1255
cagctgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcgctg tctctggtgg gtccttcagt gcttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaac      180

ccgtccctca ggagtcgagt caccatatca gtagacaagt ccaagaacca gttctccctg      240

aaggtgagct ctgtgaccgc cgcggacacg gccgtgtatt actgtgcaag aagtggggga      300

gtgaagttcg acccctgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  1256
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1256
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttgcc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatccg gcagggccac tggcatccca      180

gacaggttca gtggcagtgg atcaggcaca gattttacac tgaaaatcag cagagtgcag      240

gctgaggatg ttggggttta ttactgcatg caagctctac aaactccgtg gacgttcggc      300

caagggacca aggtggaaat caaac                                            325


<210>  1257
<211>  368
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1257
cagctgcagc tgcgggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtatct attatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgttg acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgttttactg tgcgagaatg      300

tcgaggggat acaactatgc gtatactttt gatatctggg gccaggggac aatggtcacc      360

gtctcttc                                                               368


<210>  1258
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1258
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

catccaggca aagcccccaa actcaagatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caggtagtgt gctattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1259
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1259
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc aactactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagaacccct      300

acgctgtaca actggttcca cccctggggc cagggaaccc cggtcaccgt ctcctcag        358


<210>  1260
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1260
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccgtc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctttg acatcggccg gggtggttgg      300

attttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1261
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1261
caaatgcaat tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgaaggtc       60

tcctgttcgg cctctggatt cccctttagt tcgtctgcta tccagtgggt gcgacaggct      120

cgtggacaag gccttgagtg gataggatgg gtcgtcgttg gcagtggtaa cacaaactac      180

gcacagaagt tccaagaaag agtcaccatc accagagaca tgtccacaag tacagcctcc      240

atggagctgc gcagcctgag gtccgaggac acggccgtat attactgtgc gcaacgtcga      300

ggtgaggccg tgtatagcaa tggctggtac aaatactact actgcatgga cgtctggggc      360

gaagggacca cggtcaccgt ctcctca                                          387


<210>  1262
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1262
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccccacttt cggcggaggg      300

accaaggtgg agatcaaac                                                   319


<210>  1263
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1263
caggtgcaac tggtacagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcact agttatgata tcaactgggt acgacaggcc      120

accggacaag ggcttgagtg gatgggatgg atgagcccta acagtggtaa cacagcctat      180

gcacagaatt tccagggcag acttaccttg accagggaca cttccacaag cacagcctac      240

atggagctga gtagcctgag atctgacgac acggccgtgt atttctgtac gagaggagag      300

ggggtattgg gaccgttctg gggccaggga accctggtca ccgtctcctc ag              352


<210>  1264
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1264
gaagttgtgt tgacgcagtc tccaggcacc ctgtccttgt ctccaggaga aagagccacc       60

ctgtcctgca gggccagtca gagtgttaac cacggctact cagcctggtt ccagctgaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccgc tggcgtccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatg ttgcagtgta ttactgtcac cagtatgata gctcacaggg gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  1265
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1265
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact agccacacta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggacgg atgaactcta acagtgggaa cacagcctat      180

gcacagaagt tccagggcag agtcaccatg accagggaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagcagcagc      300

tggttacgag gtgcttttga tatctggggt caagggacaa tggtcaccgt ctcttcag        358


<210>  1266
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1266
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtgacc       60

atcacttgcc gggcaagtca gagcattgcc ggctatttaa actggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatggt acaaccagtt tgcaaagtgg ggtcccagta      180

aggttcagtg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgtcaacag tatgataatc tcctcttatt cactttcggc      300

cctgggacca aagtggatat caaac                                            325


<210>  1267
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1267
gaggtgcagc tggtggagtc cgggggaggg ttggtacagc cagggcggtc cctgagactc       60

tcctgtacag cttctggatt cagctttggt gattatgcta tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtgggtttt attagaaaca aagattatgg cgggacaaca      180

gaattcgccg cgtcagtgaa aggcagattc accatctcaa gagatgactc caaaaccatc      240

gcctatttgc aaatgaacag cctgacaatc gaggacacag ccgtgtacta ttgtaccaga      300

agcctatatc ttagggcttt tgatttctgg ggccaaggga cgatggtcac cgtctcttca      360

g                                                                      361


<210>  1268
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1268
cagtctgtcc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaggcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata gaagcgtcag tactgtggta      300

ttcggcggag ggaccaaggt gaccgtccta g                                     331


<210>  1269
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1269
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagacccgac      300

tatagcagtg gctggtttag ctactggtac ttcgatctct ggggccgtgg caccctggtc      360

actgtctcct cag                                                         373


<210>  1270
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1270
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttct tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgccag cagtatggtc gctcaccgat caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  1271
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1271
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt acctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtggta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attactgtgc gcaacgtcga      300

ggtgaggccg tgtatagcaa tggctggtac aaatactact actgcatgga cgtctggggc      360

gaagggacca cggtcaccgt ctcctca                                          387


<210>  1272
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1272
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cacagtcacc       60

atcacttgcc gggcaagtca gagcattgcc ggctatttaa actggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatggt acaaccagtt tgcaaagtgg ggtcccagta      180

aggttcagtg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacgg tataatagtt actcgctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  1273
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1273
gaagtgcagc tggtggagtc tgggggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt gactattgga tggcctgggt ccgccagact      120

ccagggaagg ggctggagtg ggtggccaac ataaaacaag atgggagtga gacactcttt      180

gtggactctg tgaggggccg attcgccgtc tccagggaca acgccaagag gtcactgtat      240

ctgcaaatga acagcctgag agacgaggat acgggtatat attactgtgc gagagattgg      300

aacgagcgtg atactgatac ttacggggcc gactggggcc agggaaccct ggtgaccgtc      360

tcctcag                                                                367


<210>  1274
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1274
cgttttgtaa tgactcagtc tccactctcc ctgcccgtca cccttggaca gacggcctcc       60

atctcctgcc ggtctagtga agacctcctt tacactgatg gaaacaccta tttgatttgg      120

tttcaccaga ggccaggcca atctccaagg cgcctcattc ataaggtttc taaccgggac      180

tctggggtcc cagacagatt cagtggcagt gggtcaggca ctgatttcac actgacaatc      240

agcagggtgg aggctgagga tgttggggtt tattactgca tgcaaggtac acgctggccc      300

tggacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  1275
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1275
caggtccagc ttgtgcagtc tggggctgaa gggaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcacc aattatgata tcatctgggt gcgacaggcc      120

actggacaag ggattgagtg gatggggtgg atgaattcta acagcggtaa cgcaggctac      180

gcacagaagt tccagggcag agtcactatg accagggaca cctccataag tacagcctac      240

atggagttga gcagcctgag atctgaggac acggccgtgt attattgtgc gagaatgcgc      300

actggctggc ccacacatgg ccgcccggat gacttctggg ggcggggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  1276
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1276
gacatccaga tgacccagtc tccttcctcc ctgtctgcat ctgttggaga cagcgtcacc       60

atcgcttgcc gggcaagtca cagcattggt acctatttaa attggtatca acccaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgaaaagtgg ggtcccatca      180

aggttcggtg gcagtggatc tgggacagat ttcactctca ccatcagctg cctgcagtct      240

gaagattttg caacttatta ctgtcaacag tattatagtt actcttggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  1277
<211>  385
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1277
cagctgcagc tgcgggcgtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtactt actactgggg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt ggcaatatca attatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatccgtag acacgtccaa gaaccaattc      240

tccctgaagc tgagctctgt gaccgccgcg gacacggctg tgtatcactg tgcgagactt      300

gccccggggt acgatttttg gagggccggg gaatcatact actttgacta ctggggccag      360

ggaaccctgg tcaccgtctc ctcag                                            385


<210>  1278
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1278
gatgttgtga tgactcagtc tccactctcc ctgcccgtca cccttggaca gccggcctcc       60

atctcctgca ggtctagtca aagcctcgta tacagtgatg gaaacaccta cttgaattgg      120

tttcagcaga ggccaggcca atctccaagg cgcctaattt ataaggtttc taactgggac      180

tctggggtcc cagacagatt cagcggcagt gggtcaggca ctgatttcac actgaaaatc      240

agcagggtgg aggctgagga tgttggggtt tattactgca tgcaaggtac acactggccg      300

atcaccttcg gccaagggac acgactggag attaaac                               337


<210>  1279
<211>  373
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1279
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtggtt actactggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggtacatct attacagtgg gagcacctac      180

tacaatccgt ccctcaagag tcgagttacc atatcagtag acacgtctaa gagccagttc      240

tccctgaagc tgaactctgt gactgccgcg gacacggccg tgtattactg tgcgagagtt      300

tcttacgatt tttggagtgg ttattgggcg ttcgacccct ggggccaggg aaccctggtc      360

accgtctcct cag                                                         373


<210>  1280
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1280
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtgcactg gtaccagcag      120

cttccaggaa cagcccccaa actgctcatc tatggtaaca acaatcggcc ctcagggatc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagaactct gagtgtggta      300

ttcggcggag ggaccaaact gaccgtccta g                                     331


<210>  1281
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1281
caggtgcacc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggggaa atccattaca gtgggagcac cagctacagc      180

ccctccctca agagtcgact cagcatatca gtagacaggt ccaagaacca gttctccctg      240

aagctggcct ctgtgaccgc tgcagacacg gccgtgtatt actgtgcggc tccccattgt      300

aataggacca gctgctatga tgcttttgat ctctggggcc aagggaccac ggtcaccgtc      360

tcctcag                                                                367


<210>  1282
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1282
gacatcgtga tgacccagtc tccagacttc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgttttt aattgggaca accataggga ctacttagct      120

tggtaccagc agaaaccagg acagcctcct aagctactca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcagta taataactgg      300

cccctgacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  1283
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1283
caggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt agctattgga tgagctgggt ccgccaggct      120

ccagggaagg tgctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtat attattgtgc gagagagggg      300

cagtggccga accaagcttt tgacatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  1284
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1284
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg cagatgcatt gccaaagcat tatgcttatt ggtaccagca gaggccaggc      120

caggcccctg tactggtgat atataaagac attgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaggcgtgg gacagcagca ctgcggtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  1285
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1285
caggtgcagc tggtgcaatc tgggtctgcg ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact agctatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagaggccgc      300

agctatgggc tctcgcttgg ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  1286
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1286
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aattatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgct gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tcctccaatt cactttcggc      300

cctgggacca aagtggatat caaac                                            325


<210>  1287
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1287
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagagtc       60

tcctgtgcag cgtctggatt caccttcagt agccatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtgtcagtt atatggtatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtct      240

ctgcaaatga acagcctgag agccgaagac acggctgtgt attactgtgc gagagagagc      300

gcggacatat catctcgtct tgactactgg ggccggggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  1288
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1288
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaacaaaa tatgcttatt ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcat ctatgacgac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttactcaaca gacagcagtg gtaatgtctt cggaactggg      300

accaaggtca ccgtcctag                                                   319


<210>  1289
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1289
gagggcccac ttttggagtc tggggggggc ttacttcagc ctggggagtc cctgagactc       60

tcctgtgtag cctctggatt caccttcagg acctgtgcca tgagttggtt ccgccaggct      120

ccaggaaagg ggctggagtg ggtctcaact attactgaaa gtggtgatga cacacacctt      180

tcggactccg tgaagggccg cttcaccatc tccagggaca attcggagaa cacactgtat      240

ctgcaaatga acagcctgag agtcgaagac accggcgttt attattgtgc ggtcgctacc      300

cattacttca atagtggtcg tgcctactgg ggccagggaa ccctggtcac cgtttcctca      360

g                                                                      361


<210>  1290
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1290
gatattgtgc tgacccagac tcctctctcg tcacctgtca cccttggaca gccggcctcc       60

atctcctgca agtctagtca gagcctccta cacagtaatg gggacaccta cttgagttgg      120

tttctgcaga ggccaggcca gcctccaaga cccctgattt ataagatttc taaccgcatc      180

tctggggtcc cagatagatt cagtggcagt ggggcaggga cagatttcac actgagaatc      240

accggggtgg aggctgaaga tgtcggcgtt tatttctgca tgcaagctac acaatttcct      300

cggacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  1291
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1291
caggtccagc tggttcaatc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaaga cttctggaga cacctccagc agttatactg tcggctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat agcatactcc      180

gcacagaagt tccagggcag actcacgatt accgcggaca aatccacgag cacatcctac      240

atggagctga gcagcctgag atctgaggac acggccgttt attactgtgc gagaggggtg      300

gtagctgcta ctccgggttg gttcgacccc tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1292
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1292
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggcctccgat gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  1293
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1293
cagatcacct tcaaggagtc tggtcctacg ctggtgaaac ccacagagac cctcacgctg       60

acctgcacct tctctgggtt ctcagtcagc actagtggag agggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcagtcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaggg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagg      300

ctttggttca gggatgcttt tgatatttgg ggccaaggga caacggtcac cgtctcctca      360

g                                                                      361


<210>  1294
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1294
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctgcagggga aagagccacc       60

ctctcctgca gggccagtca gagtattagc agcaacttag cctggtacca ccagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgccaacag tataatagtt actcgctcac tttcggcgga      300

gggaccaagg tggagatcaa ac                                               322


<210>  1295
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1295
caggtgcagc tgctggagtc gggcccagga ctggtgaagt cttcacagac cctgtatctc       60

acctgctctg tctctggtgg ctccgtcagt agtggcgcct actactggac ctgggtccgc      120

cagcccgccg ggtccggact ggaatggatc gggcgcattt atactagcgg gaccaccaac      180

tacaacccct ccctcaatcg ccgcctcacc ctttcactag acacgtccag gaaccagatc      240

tccctgaagc tggcgtctgt gaccgccgca gacacggccg cctatttttg tgcgagagcc      300

cgaagctcca tggacaactt ctactacttc tatatggacg tttggggcaa agggaccgcg      360

gtcaccgtct cctca                                                       375


<210>  1296
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1296
gaaattgtat tgacacagtc tccaggcacc ctggccttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gaacattaag aacacctatc tatcctggta ccaacagacg      120

cctgggcagg ctcccaggct cctcatccat ggtgcatcca ccagggccac tgacattcca      180

gccaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagcctgcag      240

cctgaagatt tcgcagttta ttactgtctg caggattata acttaccatg gacgttcggc      300

ccggggacca aggtggaaat caa                                              323


<210>  1297
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1297
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt catcctcagt gaccactaca tggactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggttggccgt actagaaaca aagctaacag ttataccaca      180

gaatacgccg cgtctgtgaa aggcagattc accatctcaa gagatgattc aaagaactca      240

ctgtatctgc aaatgaacag cctgaaaacc gaggacacgg ccgtgtatta ctgtgctagc      300

gtgattacgt ttgggggagt tatcgttaga agctactggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  1298
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1298
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgta gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag tattatggta gctcaccgtt cggtttcggc      300

cctgggacca aagtggatat caaac                                            325


<210>  1299
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1299
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcca tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatccctg tctttggtac aacaaactac      180

gcacagaagc tccagggcag agtcacgatt agtgcggacg aatccacgag cacagcctac      240

atggaggtga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagtaagt      300

gggtacggtg actacggggc atactctgac tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  1300
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1300
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc aggttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcag cgtagcaact ggcctccgcg gctcactttc      300

ggcggaggga ccaaggtgga gatcaaac                                         328


<210>  1301
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1301
gaagtgcagc tggtggagtc cgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgtag cctccgaatt cacctttagt agctattgga tgagctggtt ccgccaggct      120

ccagggaagg ggctggagtg ggtctctggt attaattgga atggtggtag cacaggttat      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagcctgaa aaccgaggac acggccgtgt attactgtgc tagcgtgatt      300

acgtttgggg gagttatcgt tagaagctac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1302
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1302
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaatactg taaactggta ccaacagctc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aaaataatta ttactgtgca gtatgggatg acagcctgaa tggtgtggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1303
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1303
gaggtgcagc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttaat aactatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attggtggta gtggtggtag cacatactac      180

gcagactccg tgaagggccg gttcaccgtc tccagagaca attccgagaa cacgctgtat      240

ctgcaaatga gcagcctgag agccgaggac acggccgtat attactgtgc gagggtagag      300

ggggactggt tattgggtgg gccatactac cactattacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1304
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1304
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga agtaattatg tatactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctct aggaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctaatta ttactgttta gtatgggatg acagcctgaa tggcctggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1305
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1305
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcaggt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagcggac      300

actatggttc ggggaactta ttttgagtac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1306
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1306
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcttg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattgctgc agctcatata caagcagcag agctgtgcta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1307
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1307
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt cacctttagt agctatctca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatgggcta atggaaatag atattatgca      180

gactccgtga agggccgatt caccatctcc agagacattt ccaagaacac gctgtatctg      240

cagatgaata gcctgagagc cgaggacacg gccatgtatt actgtgcgag agactattgt      300

aatggtgtta cctgcaactc gaactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  1308
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1308
gacttcgtga tgacccagtc tccaggctcc ctggctgtgt ctctgggcga gagggccacc       60

atcaattgca ggtccagtca gagtgtttta gacaactcca gcaataagaa ccacttagct      120

tggcaccagc agaaaccagg acagcctcct aaactgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtagt      300

cattggacgt tcggccaagg gaccaaggtg gaaatcaaac                            340


<210>  1309
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1309
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggggac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agtagtaact ggtggagttg ggtccgccag      120

cccccaggga aggggctgga gtggattggg gaaatctatc atagtgggag caccaactac      180

aacccgtccc tcaagagtcg agtcaccata tcagtagaca agtccaagaa ccagttctcc      240

ctgaagctga gctctgtgac cgccgcggac acggccgtgt attactgtgc gagagggtgg      300

tactttgact actggggcca gggaaccctg gtcaccgtct ccgcag                     346


<210>  1310
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1310
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

catccaggca aagcccccaa actcatgatt tatgaggtca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tactcatatg caggtagtag cacttgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1311
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1311
caggttcagc tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacctttacc agctatggta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcagcgctt acaatggtaa cacaaactat      180

gcacagaagc tccagggcag agtcaccatg accacagaca catccacgag cacagcctac      240

atggagctga ggagcctgag atctgacgac acggccgtgt attactgtgc gagagaaggg      300

gaggagcggg cgaatgtcaa tgtccccatg atttacggta tggacgtctg gggccaaggg      360

accacggtca ctgtctcctc a                                                381


<210>  1312
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1312
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatca ctgtcagcag tataataact ggcctccgat gtacactttt      300

ggccagggga ccaagctgga gatcaaac                                         328


<210>  1313
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1313
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttccac aactatgcta tcagctgggt gcgacaggcc      120

cctggccaag ggcttgagtg gatgggaggg ttcatcccta tccttggtac aacaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag tacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gagagtggag      300

ggggaggggg ttgactccta ctactacggt atggacgtct ggggccaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  1314
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1314
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg cagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcaaca gacagcagtg gtagttatgt ggtattcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1315
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1315
cagctgcagc tgcaggagtc cggctcagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcgctg tctctggtgg ctccatcagc agtggtggtt actcctggag ctggatccgg      120

cagccaccag ggaagggcct ggagtggatt gggtacatct atcatagtgg gagcacctac      180

tacaacccgt ccctcaagag tcgagtcacc atatcagtag acaggtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgcg gactcggccg tgtattactg tgccagaagt      300

ggagggctac gatttgactc ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  1316
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1316
gacatccaga tgacccagtc tccatcgtat gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctgcactctt gatctatctt tcaagcaact tacacagcgg ggtcccatca      180

aggttcagtg gcagtggagc tgggacagtc ttcgttctca ccatcaacag tctgcaacct      240

gaggattttg caacttacta ctgtcaacag agttacagca tccctccaac cttcggcggt      300

gggaccaggg tggagatcaa ac                                               322


<210>  1317
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1317
caggttcagc tggagcagtc tggagctgaa cttaagaagc ctgggacctc actgaaggtc       60

tcctgcaagg cttctggtta ctccttcagc ggatctggca tcagttgggt gcgacaggcc      120

cctggacagg gactggagtg gatgggatgg atcggcagaa acaatgtcgg cgatcgcgat      180

gttaacacaa actatgcaca gaggttcaag ggcagagtca ccatgacgac agacacttcc      240

acgagcactg cctacatgga gctgaggagc ctgacatctg acgacacggc cgtgtattac      300

tgtgcgagag attgggattg tagtggtggc agttgcacgg actgcttcga cccctggggc      360

cagggaacgc tggtcaccgt ctcctcag                                         388


<210>  1318
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1318
tcccaacttg tgactcaatc gccctctgcc tctgcctccc tgggagcctc ggtcaagctc       60

acctgcactc tgagtagtgg gcacaccaat tacgccatcg catggcatca gcaggagcca      120

gagaagggcc ctcggttctt gatgaaggtt aacagtgatg gcagccacaa caagggggac      180

gggatccctg atcgcttctc aggctccagc tccggggctg agcgctacct caccatctcc      240

agcctccagt ctgaggatga ggctgattat tactgtcaga cctggggccc tggcattcgg      300

gtgttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  1319
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1319
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaaag ggtctggata cagctttagc gactactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagactgact      300

tttggtggtt cggggagtta ttatttctac tacaacggta tggacgtctg gggccaaggg      360

accacggtca ccgtctcctc a                                                381


<210>  1320
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1320
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcaaaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac cggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcaccgct cactttcggc      300

ggagggacca aggtggagat caaac                                            325


<210>  1321
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1321
gaagtgcaac tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcattgggt ccggcaagct      120

ccagggaagg gcctagagtg ggtctcaggt atcagttgga acagtggtac cataggctat      180

gcggactctg tgaagggccg attcatcatc tccagagaca acgccaagaa ctccttgtat      240

ctgcaaatga acagtctgag acctgaggac acggccttgt attactgtgc aaaagatata      300

atacgtcagg gcgaagacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  1322
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1322
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gaacattgcc agctatttga attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc ggggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagagtttg caacttacta ctgtcaccag agttacttta cccctcaaac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1323
<211>  385
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1323
gcggtgccgg tggtggagac ggggggaggc ttggtccagc ctggggagtc cctgcgactc       60

tcctgtggaa tgtctggatt caccgtctac tccaaccaca tgagctgggt ccgccaggct      120

ccaggtaagg ggctggagtg ggtctcagtt atttatggcg atggttatgt cgatggcggt      180

ggcacattct acgcagactc cgtgaagggc agattcacca tttcccgaga caactccagg      240

aacactctgt atcttcaaat gagccgcctg agagccgagg acacggctgt ttactactgt      300

gcgagacgag agatacttgg atacatcaac ggggtcggga cttctaatat ctggggccga      360

gggacagtgg tcaccgtctc ctcag                                            385


<210>  1324
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1324
gaaatagtga tgacgcagtc tccagtcacc ctgtctgtgt ctccagggga aggagccacc       60

ctctcctgca gggccagtcg gagtgttagg aacaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctgct catctatgat gcatctacta gggccattga tttcccaggc      180

aggttcagtg gcagtgggtc tgggacagag ttcattctca ccatcaacag cctgcagtct      240

gaagattctg cagtttatta ttgtcagcag tatgatgatt ggccgtggac gtgcggccag      300

ggtaccaaga tagaaatcaa                                                  320


<210>  1325
<211>  396
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1325
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgaaa tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac attagtagta gtggtagtac catatactac      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgttt attactgtgc gagatgggac      300

tactatggtt cggggagtta ttataacgtc ccttcatact actactacta cggtatggac      360

gtctggggcc aagggaccac ggtcaccgtc tcctca                                396


<210>  1326
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1326
gccatccgga tgacccagtc tccatcctca ttctctgcat ctacaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggtattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagctg cctgcagtct      240

gaagattttg caacttatta ctgtcaacag tattatagtt accctccaaa cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  1327
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1327
cagttgcagg tggtgcagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtga ccccgtcatt aatactaatt actactgggg ctggattcgc      120

cagccccccg ggaagggcct ggagtggatc gggactctct cttacagtgg cggcacccac      180

tacaatccgt ccctcagttc tcgagtcacc atagccgtag actcgtccaa gaagcgattc      240

tccctgacct tgcgatctgt gaccgccgca gacacggcca tatactactg tgcgagacat      300

ccggttgacg gatacaacta tggttacagc gacctctggg gccaaggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  1328
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1328
gagattgtgt tgacgcagtc tccagccacc ctggctctgt cagtggggga aagagccacc       60

ctctcctgcg tggccagtca gagagttagc agcgactaca tcgcctggta ccagaagaaa      120

ccaggcctgg cgcccaggct cctcgtctat catggatctg cctgggccac tggcagctca      180

gccaggttca gtggcagtgg gtctgggaca gccttcaccc tcaccattag cagtctggag      240

cctgaagatt ttgcagtcta ttattgtcaa cagtatggta attcaccatt cactttcggc      300

cctgggacca aggtggagtt caaac                                            325


<210>  1329
<211>  391
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1329
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc gactactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtcgtgg cacaaactat      180

gcacagaagt ttcagggcag ggtcactatg accagggaca cgtccatcag cacagtctac      240

atggagctga gcaggctgac atctgacgac acggccgtct attactgtgc gagagtggtg      300

gtcctcggct atggccgccc aaacaattac tatgatggta ggaatgtgtg ggactactgg      360

ggccagggaa ccctggtcac cgtctcctca g                                     391


<210>  1330
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1330
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccaggagaaa      120

cctggccagg ctcccaggct cctcatgtac agtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgcgaca gacttcactc tcaccatcaa cagactggag      240

cctgaagatt ttgcagtata ttactgtcaa caatatgttg agcccccgtt cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  1331
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1331
caggttcagt tggtgcagtc tggagctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cctctggtta cacctttccc agctatagta tcgcctgggt acgacaggcc      120

cctggacaag gacttgagtg gatgggacgg gtcagcgctt acaatggtta cacaaatttt      180

gcacagaagc tccagggccg agtcaccatg accacggaca caccctcgac cacagcctac      240

atggagttga agtacctcac atctgacgac acggccgtct attactgtgc gaggcggtac      300

tgtagtggtg gtatcgcaaa gtgtgggttc cacccctggg gccagggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  1332
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1332
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgaaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcaggct      240

gaagatgtgg cagtatatta ctgtcagcaa tattatagta tttcttggac gttcggccaa      300

gggaccaggg tggaaatcaa ac                                               322


<210>  1333
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1333
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctctcactg       60

acctgcacct tctctgggtt ctcactcggc actagtggaa tgtgtgtgag ctggatccgt      120

cagccccccg gaaaggccct ggagtggctc gctctcattt attgggatga tgataagcac      180

tacagcccgt ctctgaggaa cagactcacc atcaccaggg acacctccaa aaaccaggtg      240

gtcctcgcaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagg      300

ctttggttca gggatgcttt tgatatttgg ggccaaggga caacggtcac cgtctcctca      360

g                                                                      361


<210>  1334
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1334
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagct ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg tcagtcctgg gacactggca taggggtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  1335
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1335
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggaatg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctctat      240

ctgcaaatcc acagcctgag agccgaggac acggctgtgt attactgtgc gagagatcag      300

gacagtggct acccaactta ctactactac tccatggacg tctggggcaa agggaccacg      360

gtcaccgtct cctc                                                        374


<210>  1336
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1336
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgcg gggccagtca gagtgttacc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcgtccca      180

gacaggttca gtggcagtgg gtctgggaca gagttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtata ttactgtcaa caatatgttg agcccccgtt cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  1337
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1337
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cgccttcagt aactatgcta tacactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaaacaa taaagactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagtccct      300

gttatggttc ggggagttta ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1338
<211>  332
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1338
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttgtt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtcc gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cacccccttt      300

gtcttcggaa ctgggaccaa ggtcaccgtc ct                                    332


<210>  1339
<211>  367
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1339
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtgc agcaaactac      180

gcacagaact tccagggcag agtcacgatt accgcggacg aatccacgag cacaggctac      240

atgcaactga gcagcctgag atttgaggac acggccgtgt attactgtgc gagaacgtct      300

cactatgata gtagtggttc ctattttgaa tactggggcc agggaaccct ggtcaccgtc      360

tcctcag                                                                367


<210>  1340
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1340
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cactttatta ctgtcagcag tataataact ggtggcgcac gttcggccaa      300

gggaccaagg tggaaatcaa                                                  320


<210>  1341
<211>  345
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1341
gaggtgcggc tgttggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttacc agctatgcca tgagctgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactat      180

gcagactccg tgaagggccg attcgccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccgtat attattgtgc gaaaccctac      300

ggtatggacg tctggggcca agggaccacg gtcaccgtct cctca                      345


<210>  1342
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1342
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgttttc aacaccgtca accataggga ctacttaggg      120

tggtaccagc agaaaccagg acagcctcct aagctactca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtatattact gtcagcaata ttatagtact      300

cctttaacgt tcggccaagg gaccaaggtg gaaaacaaac                            340


<210>  1343
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1343
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atgaaattaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagac cactctggat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagctggg      300

ggtgggagct accgggggcc ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1344
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1344
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccgt ctctgggctc      240

caggctgagg atgaggctga atattactgc agcgcatatg caggcagcaa caatttggta      300

ttcggcggag ggaccaaatt gaccgtccta g                                     331


<210>  1345
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1345
caggtgcagc tggtgcagtc tggggctgcg gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcgtcccta tctttggcac agcaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgac cacagcctac      240

atggagctga acagcctgag atctgaggac acggccgtgt attactgtgc gagagaggac      300

tactatggtt cggggagctt agtcgacccg tactactact accgtatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  1346
<211>  320
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1346
gaaattgtgt tgacacagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgcgacagac ttcactctca ccatcaacag actggagcct      240

gaagattttg cagtatatta ctgtcaacaa tatgttgagc ccccgttcac ttttggccag      300

gggaccaagc tggagatcaa                                                  320


<210>  1347
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1347
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatgcca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtgacagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaatcgtat      300

aatgggaact actacgatgc ttttgatatc tggggccaag ggacaatggt caccgtctct      360

tcag                                                                   364


<210>  1348
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1348
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccggtca gactgttagc agcagctact tagcctggta ccagcacaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcgtacac tttcggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1349
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1349
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgtactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atttattatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatt tccagagaca attccaagaa cacgctctat      240

ctgcaaatcc acagcctgag agccgaggac acggctgtgt attactgtgc gagagagggg      300

cagatggctg caactaccgg aattgactac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1350
<211>  340
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1350
cagcttgtac tgactcaatc gccctctgcc tctgcctccc tgggagcctc ggtcaagctc       60

acctgcactc tgagcagtgg gcacaccacc tacgccatcg catggcatca gcagcagcca      120

gagaagggcc ctcggtactt gatgaagctt aacagtgatg gcagccacac caggggggac      180

gggatccctg atcgcttctc aggctccagc tctggggctg agcgctacct caccatctcc      240

aacctccagt ctgaggatga ggctgactat tactgttact cccgggacag aagtggtaac      300

cgttgggtgt tcggcggagg gaccaggctg accgtcctag                            340


<210>  1351
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1351
cagatcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1352
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1352
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttataact atgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc acctcatata caagcagcag cactctcaat      300

gtggtattcg gcggagggac caagttgacc gtcctag                               337


<210>  1353
<211>  393
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1353
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggtt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggttggccgt attaaaagca aaattgatgg tgggacaaca      180

gactacgctg cacccgtgaa aggcagattc accatctcaa gagatgattc aaaaaacacg      240

ctgtatctgc aaatgaacag cctgaaaacc gaggacacag ccgtgtatta ctgtaccaca      300

gcgggaagct attactatga tactgttggt ccaggcctcc cagagggaaa atttgactac      360

tggggccagg gaaccctggt caccgtctcc tca                                   393


<210>  1354
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1354
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtgcca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcaa tattataact ggccgctcac tttcggcgga      300

gggaccaaag tggagatcaa ac                                               322


<210>  1355
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1355
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgaactgggt ccggcaacct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtgatag cataggctat      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggctgtgt attattgtgt gagactgggg      300

gtcagcagct ggtactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  1356
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1356
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aggtatctaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gcagtgaatc tgggacagac ttcactctca ccatcagcag tctgcagcct      240

gaagattttg caacttacta ctgtcaacag agttccagtt ccccgatcac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1357
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1357
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcacc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacacattt tttcgaatga cgaaaaatcc      180

tacagcacat ctctgaagag caggctcacc atctccaagg acacctccaa aagccaggtg      240

ctccttacca tgaccaacat ggaccctgtg gacacaggca catattattg tgtacggatg      300

ctgtgggaaa actggagcta cgatgattac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  1358
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1358
caggctgtgc tgactcagcc gtctgccctg tctgcatctc ctggagcatc agccaggctc       60

acctgcacct caggcagtgg catcgatgtt gggacgtaca ggatatattg gtatcagcag      120

aagtcaggga gtcctccccg ctatctcctg agttacaagt cagactcaga taaacatcag      180

ggctctggag tccccagccg cttctctgga tcgaaagatg cttcggccaa tgcaggggtt      240

ctattcatct ctgggctcca gtctgaggat gaggctgact attattgttt gatctggcac      300

atcaatgctt atgtcttcgg aactgggacc aaggtcaccg tcctag                     346


<210>  1359
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1359
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattattg tgcacaccta      300

ctccgaattg gcagtggcta ctactcgccg aggttaatcg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  1360
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1360
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcattctca ccatcagcgg cctgcagccc      240

gaaggttttg cagtttatta ctgtcagcaa tattatagta ctccttggac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  1361
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1361
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  1362
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1362
gatattgtga tgacccagac tccactctct ctgtccatca cccctggaca gccggcctcc       60

atctcctgca agtctagtca gagcctcctg cgtagtgatt caaagaccta tttgttttgg      120

tacctgcaga agccaggcca gtctccacag ctcctaatct atgaagtttc cagccggttc      180

tctggagtgc cagataggtt cagtggcagc gggtcaggga cagatttcac actgaaaatc      240

agccgggtgg aggctgagga tgttggggtt tattactgca tgcaagctct acaaactccg      300

tggacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  1363
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1363
caggtcacct tgagggagtc tggtcctgcg ctggtaaaac ccacacagac cctcacactg       60

acctgcacct tctctggatt ctcactcagc actagcggaa tgtgtttgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ccctggagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggga caatggtcac cgtctcttca      360

g                                                                      361


<210>  1364
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1364
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgcaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagg tactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg cagcttatta ctgtcaacag agtttcagta cccctcggac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1365
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1365
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggtt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtttctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agatctcgac      300

tactacggtt tggacgtctg gggccaaggg accacggtca ccgtctcctc a               351


<210>  1366
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1366
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcaacag tataataact ggcctcacac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1367
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1367
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgccagg cttctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg atgaagtcta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcactatg accaggaaca cctccataag tacagcctac      240

atggagttga ccagcctgag atctgaggac acggccgtgt attactgtgc gagaatacgc      300

agtggctggc ccacacatgg ccgcccggat gacctctggg gccggggaac cctggtcacc      360

gtctcctcag                                                             370


<210>  1368
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1368
cagtctgtgt tgacgcagcc gccctcagtg tctgcggccc caggacagaa ggtcaccatc       60

tcctgctctg gaagcagctc caacattggg aataattatg tatcctggta ccagcagctc      120

ccaggaacag cccccaaact cctcatttat gacaataatg agcgaccctc agggattcct      180

gaccgattct ctggctccaa gtctggcacg tcagccaccc tgggcatcac cggactccag      240

actggggacg aggccgatta ttactgcgga acatgggata gcagcctgag tgcttatgtc      300

ttcggaactg ggaccagggt caccgtccta g                                     331


<210>  1369
<211>  353
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1369
ggggtgcagc tggtacagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg cttctggata tactttcacc aattattgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg atgactctga taccagatac      180

gacccgtcct tcgaaggcca ggtcagcatc tcagccgaca agtccatcac caccgtctat      240

ctgcagtgga gtagcgtgaa ggccccggac accgccatgt attactgtgc gaggcgggac      300

aaagtgggag cgcttgactc ctggggccag ggaaccctgg tcaccgtctc ctc             353


<210>  1370
<211>  346
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1370
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtctta cacagctcca acaacaagga ctccttagtt      120

tggtaccagc agaaaccagg acagcctcct aagctgctca ttttctgggc atcttgccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcagta tggtagctca      300

cctccgaggt acacttttgg ccaggggacc aagctggaga tcaaac                     346


<210>  1371
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1371
caggtcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcacgcattg attgggatga tgataagtac      180

tacagcacat ctctgcagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggaa      300

attccggtga ctgctattga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  1372
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1372
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag cgtcaccatc       60

tcttgttcgg gaagcagctc caatatcggt aataataaag taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctat aataataatc agcggccctc aggggtccct      180

gaccgactct ctggctccaa gtctggcaac acggcctccc tgacaatctc tggactccag      240

gctgaggacg aggctgatta ttactgctgc tcatatgcag gcaggtatac ttgggtgttc      300

ggcggaggga ccacactgac cgtcctag                                         328


<210>  1373
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1373
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcatt gatcactact ggagttggat ccggcagtcc      120

ccagggaagg gactggagtg gattgcatat atctattcca ctgggagaac caactacaac      180

ccctccctca agagtcgcgt caccatatct atagacacgt ccaaggacca gttctccctg      240

aggctgagct ctgtgaccgc tgcggacacg gccgtgtatt tctgtgcgag aacaccccat      300

cggggaggtt tcgacgtctg gggccaaggg accacggtca ccgtctcctc a               351


<210>  1374
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1374
gatgttgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca gatctagtga gagcctcctg cacagtgatg gacacaacta tctcgattgg      120

tatctgcaga agccagggca gtctccacag gtcctgatct acttcggttc aaatcgggcc      180

tccggggtcc ctgagaggtt cagtggcagt ggaacaggca cagattttac actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgct tgcaagctct acaatttccg      300

tacacttttg gccaggggac caggctggag atcaaac                               337


<210>  1375
<211>  376
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1375
caggtgcagc tgttggagtc gggcccagga ctggtgaagt cttcacagac cctgtacctc       60

acctgctctg tctctggtgg ctccgtcagc agtggcgctt attactggac gtgggtccgt      120

cagcccgccg ggtccccact ggagtggatc gggcgcattt atactagtgg gaccaccaac      180

tacaacccct ccctcaaccg gcgactcacc ctctcacttg acacgtccag gaaccagatc      240

tccctgaaac tgacgtctgt gaccgccgca gacacggccg cgtatttttg tgcgagagcc      300

cgaagctcta tggacaactt ctactacttc tctatggacg tctggggcaa agggaccgcg      360

gtcaccgtct cctcag                                                      376


<210>  1376
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1376
gaaattgtgt tgacgcagtc tccaggcacc ctgtctctgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gcgtcttgcc cccaccctct tggcctggtt cctccagaaa      120

cgtggccagg ctcccaggct cctcatgtat gccgcatcca ccagggccac tgacatccca      180

gacaggttca atggcggtgg ttctggaaca gacttcactc tcaccatcag cagcctggac      240

actgaagact ttggagtcta ttactgtcac caatatggca tctcaccgtt cacctttggc      300

caggggacca ggctggagat caaac                                            325


<210>  1377
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1377
gaggtgcagc tggtgcagtc aggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atccagcctg gtgactctga taccagatac      180

agcccatcct tccaaggcca ggtcaccatg tcagccgaca agtccaccag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagagatttg      300

attatagaat cgactatagc agctcgtccc ggctactacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1378
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1378
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aggtatctaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tccctcggac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1379
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1379
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccccgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1380
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1380
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgat gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccccccgac caccttcggc      300

caagggacac gactggagat taaac                                            325


<210>  1381
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1381
caagtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccctcagt ctttactact ggagctggat ccggcaggcc      120

ccagggaagg gactggagtg gattggctat atctattaca ctgggagcac caactacaat      180

ccctccctca agagtcgggt caccatatca gtagacacgc ccaggaacca gatctccctg      240

agtctgacct ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag aataccaact      300

ggtttccccc gttgttacat ggacgtctgg ggcaaaggga ccacggtcac cgtctcctca      360


<210>  1382
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1382
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gaatattaga agctatttaa actggtatca gcacaaacca      120

gggaaagccc ctaaactcct gatctatgct gcatccactt tgcaaagtgg ggtcccgtca      180

aggttcagtg gcagtgaatc tgggacagac ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccctcgaac gttcggccaa      300

gggaccaagg tggaaatcaa ac                                               322


<210>  1383
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1383
caggtgcagt tacagcagtg gggcgcaggg ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctctggtgg gtccttcagt gcttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaac      180

ccgtccctca ggagtcgagt caccatatca gtagacacgt ccaagaacca attctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag agactttcta      300

cggtggcacg acctctgggg ccagggaacc ctggtcaccg tctcctcag                  349


<210>  1384
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1384
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtagggga cagagtcacc       60

atcacttgcc gggcaagtca gagtgttagc acctttgtga attggtatca gcataaacac      120

ggggaggtcc ctaatctcct gatctatgct gcatccactt tgcaaagtgg ggtcccgtca      180

aggttcagtg gcagtgaatc tgggacagac ttcactctca ccatcagcag tctgcagcct      240

gaagattttg caacttacta ctgtcaacag agttccagtt ccccgatcac ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1385
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1385
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgacc      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcctca                                                              369


<210>  1386
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1386
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatcc      180

aggttcagtg gcagtggatc tgggacagac tttactctca ccatcaacag tctgcaactt      240

gaagattcta cgacttacta ctgtcaacag actcacagtc cgctcgacag ttttggccag      300

gggaccaagc tggagatcaa ac                                               322


<210>  1387
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1387
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaggggac tagggtcacc      360

gtctcttcag                                                             370


<210>  1388
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1388
gtcatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtgggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aagtatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tccctcggac ttttggccag      300

gggaccaagc tggagatcaa a                                                321


<210>  1389
<211>  349
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1389
caggtgcagt tacagcagtg gggcgcaggg ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctctggtgg gtccttcagt gcttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattgggact atctattata gtgggagcac ctattataac      180

ccgtccctca agagtcgagt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aagctgacct ctgtgaccgc cgcagacacg gctgtgtatt actgtgcgag accatccaac      300

tggtacttcg atctctgggg ccgtggcacc ctgatcactg tctcctcag                  349


<210>  1390
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1390
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcaa tattataact ggccgctcac tttcggcgga      300

gggaccaaag tggagatcaa ac                                               322


<210>  1391
<211>  358
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1391
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt tactatccta tgcactggct ctgggtccgc      120

caggctccag gcaaggggct ggagtgggtg gcagttacat catatgatgg aaccaataaa      180

tactacgcag actccgtgaa gggccgattc accatctcca gagacaattc caagaacact      240

ctgtatctgc aaatgaacag cctgagagct gaggacacgg ctgtgtatta ctgtgcgaga      300

gggggagcta ctaactttga ctactggggc cagggaaccc tggtcaccgt ctcctcag        358


<210>  1392
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1392
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaacatt       60

acctgtgggg gaaacaacat tggaagaaaa agtgtgcact ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatcc ggagtgggtg      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1393
<211>  355
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1393
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctgaata caccttcact agctatgcta tgaattgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagaccgggc      300

aaagcagcag cttttgacta ctggggccag ggaaccctgg tcaccgtctc ctcag           355


<210>  1394
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1394
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtaatg gatacaactt tttggattgg      120

tacctgcaga agccagggca gtctccacag ctcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttac actgaaaatc      240

agcagagtgc aggctgagga tgttggggtt tattactgca tgcaagctct acaaactccg      300

tggacgttcg gccaagggac caaggtggaa atcaaac                               337


<210>  1395
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1395
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattattg tgcacaccta      300

ctccgaattg gcagtggcta ctactcgccg aggttaatcg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  1396
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1396
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgagg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcggccggc cctcagggat ccctgaacga      180

ttctctggtt ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actatttctg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaagga ccaagctgac cgtcct                                           326


<210>  1397
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1397
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aactatgcta tgagttgggt ccgccaggct      120

caagggaagg ggctggagtg gattgggagt atctattata gtgggagcac ctactacaac      180

ccgtccctca agagtcgcgt caccatatcc gtagacacgt ccaagaatca gttctccctg      240

aagctgagct ctgtgaccgc cgcagacacg gctgtgtatt actgtgcgag atgtcgccag      300

atggggaact tctactacta ctacatggac gtctggggca aagggacgac ggtcaccgtc      360

tcctca                                                                 366


<210>  1398
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1398
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcaactc caatatcgga agttatactg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatcttt ggtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tggtccggta      300

ttcggcggag ggaccaagct gaccgtccta g                                     331


<210>  1399
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1399
gaggtgcagc tggtgcagtc aggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atccagcctg gtgactctga taccagatac      180

agcccatcct tccaaggcca ggtcaccatg tcagccgaca agtccaccag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagagatttg      300

attatagaat cgactatagc agctcgtccc ggctactacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1400
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1400
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tctgataatc tccccatgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  1401
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1401
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagggggtat      300

agcagtggct ggtactactt tgactactgg ggccagggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  1402
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1402
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcaacag tataataact ggcctcacac ttttggccag      300

gggaccaagc tggcgatcaa ac                                               322


<210>  1403
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1403
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agttatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaagtaa taaatactat      180

gcagagtccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgttgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagatctt      300

caccaggatt gggtagtggt ggtagctgct aatgtctacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1404
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1404
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagatat tatgcaagct ggtaccagca gaagccagga      120

caggcccctg tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattattg taattcccgg gacagtagtg gtaacccccg gtggttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1405
<211>  388
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1405
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattattg tgcacaccta      300

ctccgaattg gcagtggcta ctactcgccg aggttaatcg atgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttcag                                         388


<210>  1406
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1406
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtggta gtgaccatgt ggtattcggc      300

ggagggacca agttgaccgt cctag                                            325


<210>  1407
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1407
caaatgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgaaggtc       60

tcctgcaagg cttctggatt cacctttatg agctctgctg tgcagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gataggatgg atcgtcattg gcagtggtaa cacaaactac      180

gcacagaagt tccaggaaag agtcaccatt accagggaca tgtccacaag cacagcctac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggccccatat      300

tgtagtagta tcagctgcaa tgatggtttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1408
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1408
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cagtatggta gctcacctcc gaggtacact      300

tttggccagg ggaccaagct ggagatcaaa c                                     331


<210>  1409
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1409
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcagc actagtggat tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacaacacat ctctgaggac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacgggcg      300

acgacatttt tctacggtat ggacgtctgg ggccaaggga ccacggccac cgtctcctca      360


<210>  1410
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1410
tcctatgagc tgacacagcc accctcggtg tcagtgtccc cgggacagac ggccaggatc       60

acctgctcta cagatgcatt gccaaatgaa tatatttatt ggtaccagca gaagccaggc      120

caggcccctg tattggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattattg tcaatcagta gacagcagtg gtacttatcg ggtgttcggc      300

ggagggacca agctgaccgt cctag                                            325


<210>  1411
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1411
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggaa ctcctttata tgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1412
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1412
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtattagt agctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaaccgg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcaccag cctgcagcct      240

gaagatgttg caacatatta ctgtcaacag tatgctaatc tcccattcac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  1413
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1413
caggtgcaac tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttccgt agatatggca tgtactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaactga taaatactat      180

acagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaaaagggg      300

gggccatact gtggtggtgg taactgctac gcggggtact ttgactactg gggccaggga      360

atcctggtca ccgtctcctc ag                                               382


<210>  1414
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1414
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaagca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gatgatattg caacatatta ctgtcaacag tatgataatc tccctctggc tttcggccct      300

gggaccaaag tggatgtgaa ac                                               322


<210>  1415
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1415
gaagtgcagg tggtggagtc ggggggaggc ttggtacaac ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgaa gattatgcca tgcactgggt ccgtcaagct      120

ccagggaagg gcctggagtg ggtctcagga gttagttgga atagtggtat cataggctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ttgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaactcgac      300

gtgggtggct acgatttcgt ctctggccac tattatgctt ttgatatctg gggccaaggg      360

acaatggtca ccgtctcttc ag                                               382


<210>  1416
<211>  337
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1416
gatgttgtga tgactcagtc tccactctcc ctgcccgtca cccttggaca gccggcctcc       60

atctcctgca ggtctagtca gagcctcgta tacagtgatg gaaacaccta cttgaattgg      120

tttcagcaga ggccaggcca gtctccaagg cgcctaattt ataaggtttc tagccgggac      180

tctggggtcc cagacagatt cagcggcagt gggtcaggca ctgctttcac tctgaaaatc      240

agcagggtgg aggctgagga tgttggggtt tattactgca tgcaaggtac acactggccg      300

tacacttttg gccaggggac caagctggag atcaaac                               337


<210>  1417
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1417
cagatcacct tgagggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actactagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attggggtga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacacgcc      300

caaactggat ctcctttata tgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1418
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1418
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggcaggac ggccaggatt       60

acctgtgggg gaaataacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaagtttgg gaacacggcc accctgatca tcagcagggt cgaagccggg      240

gatgaggccg actattcctg tcaggtgtgg gatagtggta gtgaccatgt ggtattcggc      300

ggagggacca agttgaccgt cctag                                            325


<210>  1419
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1419
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcagt gactatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcag cacggcatat      240

ctgcagatca gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagaggccta      300

attagtttgt ttcggggagc tattttccac tactactacg gtatggacgt ctggggccaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  1420
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1420
cagtctgccc tgactcagcc tcgctcagtg tccgggtctc ctggacagtc agtcaccatc       60

tcctgcactg gaaccagcag tgatgttggt ggttatacct atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca ataagcggcc ctcaggggtc      180

cctgatcgct tctctggctc caagtctggc atcacggcct ccctgaccat ctctgggctc      240

caggctgagg atgaggctga ttattactgc tgctcatatg caggcaggta tacttgggtg      300

ttcggcggag ggaccacact gaccgtccta g                                     331


<210>  1421
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1421
caggtgcgac tggtgcagtc tggggctgag gtgaagaagc ctgggacctc agtgaaggtc       60

tcctgcaagg cttctggatt cacctttatg agctctgctg tgcagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gataggatgg atcgtcattg gcagtggtaa cacaaactac      180

gcacagaagt tccagggcag agtcaccatg accagtgaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggaccaatat      300

tgtagtatta tcagctgcaa tgatggtttt gatatctggg gccaagggac aatggtcacc      360

gtctcttcag                                                             370


<210>  1422
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1422
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag caacctgcag      240

cctgaagatt ttgcaactta ctactgtcaa cagagttaca gtacccctca gacgtttggc      300

caagggacca aggtggaaat caaac                                            325


<210>  1423
<211>  403
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1423
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccgtcagc agtgatgatt tcagcagtgg tgataactac      120

tggagttggc tccggcagcc cccagggaag ggcctggagt ggattgggta catctattac      180

agtggactca ccaactacaa cccatccctc aagagccgcg ttatcatatc agtagacacg      240

tccaagaacc agttctccct gaaattgaac tctgtgactg ccgctgacac ggccgtgtat      300

tactgtgcct cggagcacaa gacccattat tatgatagca gtggttatta ctccaactgg      360

ttcgacccct ggggccaggg aaccctggtc accgtctcct cag                        403


<210>  1424
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1424
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gaatattaga agctatttaa actggtatca gcacaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tccctcggac ttttggccag      300

gggaccaagc tggagatcaa a                                                321


<210>  1425
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1425
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atgtcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtct attactgtgc gagagacgac      300

aattctcccc agggcagtgg ctggtatttc tactacgact acgctatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  1426
<211>  322
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1426
gacatccaga tgacccagtc tccatcctcc ctgtctacat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattcgc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcaccag cctgcagcct      240

gaagatgttg caacatatta ctgtcaacag tatgctaatc tcccattcac tttcggccct      300

gggaccaaag tggatatcaa ac                                               322


<210>  1427
<211>  361
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1427
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctcacactg       60

acctgcacct tctctgggtt ctcactcacc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataagtac      180

tacagcacat ctctgcagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacaggca cgtattattg tgcacggaca      300

atggctacga taaatgcttt tgatatctgg ggccaaggaa ccctggtcac cgtctcctca      360

g                                                                      361


<210>  1428
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1428
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

cacccaggca aagcccccaa actcatgatt tatgagggca gtaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctggactc      240

caggctgagg acgaggctga ttattactgc tgctcatatg caagtagtag catcgtggtc      300

ttcggcggag ggtccaagct gaccgtccta g                                     331


<210>  1429

<400>  1429
000

<210>  1430

<400>  1430
000

<210>  1431
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1431
cagatcacct tgaaggagtc tggtcctacg ctggtgaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actaaaagag tgggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcactcattt attgggatga tgatcagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagc      300

ggaccccccg acctctcgcc ggtattgtcc caggggtggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  1432
<211>  319
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1432
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaagcaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atatagagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccacctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagtactg gctgggtgtt cggcggaggg      300

accaagctga ccgtcctag                                                   319


<210>  1433
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1433

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Pro Ile Ser Ser Ser 
            20                  25                  30          


Arg Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Asp Gly Ser Gly Glu Met Asp Thr Ile Thr Trp Gly 
            100                 105                 110         


Pro Ile Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  1434
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1434

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Thr Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1435
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1435

Gln Val Leu Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Thr 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser His 
            20                  25                  30          


Ala Leu His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ala Ile Asp Val Asn Arg Lys Phe Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Gly Ile Ala Phe Thr Asp Ile Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  1436
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1436

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Ala Val Ser Cys Thr Gly Thr Thr Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Glu Val Thr Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Glu Tyr Tyr Cys Cys Ser Tyr Ala Gly Asn 
                85                  90                  95      


Tyr Ile Arg Val Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105                 110 


<210>  1437
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1437

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Leu Ile Ser Ser Asp Gly Gly Asn Lys Phe Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val Pro Thr Thr Val Thr Ala Phe Thr Val Phe Thr Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1438
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1438

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro 
                85                  90                  95      


Pro Ser Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  1439
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1439

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Ser Gly Ser Ile Arg Ser Asp 
            20                  25                  30          


Asn Ile Tyr Trp Asp Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Thr Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Asn Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Met Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gln Lys Gly Trp Val Ser Met Val Gln Gly Val Pro Gln 
            100                 105                 110         


Tyr Asn Phe Asp Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  1440
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1440

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Pro Ser Thr 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Ala Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Tyr Gly Gly Ser Pro 
                85                  90                  95      


Arg Ile Ser Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 


<210>  1441
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1441

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Gly His Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Tyr Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Tyr Gly Leu Thr Tyr Tyr Met Asp Val Trp Gly Lys Gly 
            100                 105                 110         


Thr Thr Val Thr Val Ser Ser 
        115                 


<210>  1442
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1442

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Asn Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Tyr Tyr His 
                85                  90                  95      


Pro Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  1443
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1443

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Pro Ile Ser Ser Ser 
            20                  25                  30          


Arg Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Asp Gly Ser Gly Glu Met Asp Thr Ile Thr Trp Gly 
            100                 105                 110         


Pro Ile Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  1444
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1444

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Tyr Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110         


<210>  1445
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1445

Glu Glu Gln Leu Val Glu Ser Gly Gly Gly Ser Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Val Thr Gly Phe Asn Phe Asn Glu His 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Ser Asp Tyr Ile Val Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Val Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Asn Leu Arg Pro Glu Asp Thr Ala Phe Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Val Asp Glu Gly Gly Leu Ile Ala Tyr Phe Gln Arg Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1446
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1446

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Arg Ser Leu Leu Arg Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Ala Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Ala Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Arg Ile 
65                  70                  75                  80  


Ser Lys Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  1447
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1447

Gln Val Gln Leu Ala Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ala Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Gly Asn Ala Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1448
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1448

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Asn Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Phe Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Gln Arg Thr Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asn Tyr Tyr Cys Leu Val Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1449
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1449

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Asn Thr Ala Phe 
65                  70                  75                  80  


Leu His Ile Gly Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Asp Ser Gly Tyr Pro Thr Tyr Tyr Tyr Tyr Tyr Leu 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1450
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1450

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Ile Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Asp Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Leu Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Gly Ala Leu Phe Gly Gly Gly Thr Met Leu Thr 
            100                 105             


<210>  1451
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1451

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gln 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Ser Asn Tyr 
            20                  25                  30          


Ala Met Thr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Thr Gly Ser Gly Tyr Ser Gly Gly Ser Thr Tyr 
    50                  55                  60                  


Tyr Ala Gly Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser 
65                  70                  75                  80  


Lys Lys Thr Val Val Leu His Met Asn Ser Leu Arg Val Glu Asp Thr 
                85                  90                  95      


Ala Val Tyr Tyr Cys Ala Lys Val Arg Val Ser Asp Gly Gly Ser Tyr 
            100                 105                 110         


Gly Gly Leu Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125         


<210>  1452
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1452

Tyr Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Thr Val Thr Ile Thr Cys Arg Ala Gly Gln Pro Ile Ser Asn Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Ile Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Tyr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys His Gln Ser Tyr Phe Thr Pro Gln 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Asn Leu Glu Ile 
            100                 105     


<210>  1453
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1453

Glu Val Gln Leu Leu Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Glu Arg Ile Thr Met Leu Val Val Val Thr Leu Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1454
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1454

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Lys Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Tyr Ile Ser Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Lys Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Gly Thr Trp Asp Ser Ser Leu 
                85                  90                  95      


Ser Ala Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1455
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1455

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Ser Ala Ser Gly Phe Pro Phe Ser Ser Ser 
            20                  25                  30          


Ala Ile Gln Trp Val Arg Gln Ala Arg Gly Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Val Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Ser 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Ser Arg Tyr Cys Thr Ser Tyr Ala Cys His Gly Ser Tyr Gly 
            100                 105                 110         


Ala Asp Val Trp Gly Gln Gly Thr Lys Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1456
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1456

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Ser Val Thr Ile Ser Cys Arg Ala Ser Glu Asp Ile Arg Asn Tyr 
            20                  25                  30          


Val Thr Trp Tyr Gln Gln Lys Pro Gly Lys Leu Pro Lys Val Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Tyr Ser Gly Val Pro Ser Arg Phe Arg Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Gly Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Asn Tyr Ile Ser Ala Pro Gln 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Val Lys 
            100                 105         


<210>  1457
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1457

Gln Gly Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ile Ser Tyr 
            20                  25                  30          


Gly Val Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Pro Tyr Ser Ser Asn Thr Asn Tyr Pro Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Val Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Phe Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Ala Arg Tyr Cys Arg Ser Ala Ser Cys Ser Asn Lys 
            100                 105                 110         


Gly Val Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Phe Ser 
        115                 120                 125         


<210>  1458
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1458

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Ser Asn His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1459
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1459

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Gly Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Pro Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Pro Ser Ala Tyr Tyr Asp Ile Leu Thr Gly Tyr Ser Gly Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  1460
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1460

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Asn Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Ser Ile Tyr Ser Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1461
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1461

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ser Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Arg Arg Cys Ser Val Ser Gly Cys Tyr Met Ala Ser Tyr Tyr 
            100                 105                 110         


Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1462
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1462

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln Tyr Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Trp Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Tyr Thr Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1463
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1463

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Thr Ile Ser Lys Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Ser Ser Leu Asn Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Trp Cys Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn 
            100                 105                 110         


Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1464
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1464

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Glu Ala 
65                  70                  75                  80  


Glu Asp Ala Ala Thr Tyr Tyr Cys His Gln Ser Ser Ser Leu Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1465
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1465

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Ser Ser Tyr 
            20                  25                  30          


Val Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Ser Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ile Asp Ser Gly Tyr Asp Pro Thr Pro Val Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1466
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1466

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Cys Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Gly Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1467
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1467

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gly 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Thr Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Ile Ser Val Asp Lys Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Arg Trp Gly Asp Tyr Phe Asp Ser Ser Gly Ala Tyr Asp Ser 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1468
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1468

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Arg Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Leu Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Val Lys 
            100                 105         


<210>  1469
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1469

Arg Val Gln Leu Val Gln Ser Gly Ala Glu Val Arg Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Lys Val Ser Gly Tyr Ser Leu Ser Glu Leu 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Gly Glu Thr Val Tyr Ala Gln Arg Phe 
    50                  55                  60                  


Gln Gly Arg Val Ser Met Thr Glu Asp Ile Ser Thr Asp Thr Ala His 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Gly Gly Leu Asn Gly Asp Tyr Val Thr Gly Gly Ala Tyr Tyr 
            100                 105                 110         


Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1470
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1470

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Phe Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Arg Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110         


<210>  1471
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1471

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Pro Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Lys Gly Trp Gly His Ser Tyr Gly Tyr Val Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1472
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1472

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  1473
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1473

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Ser Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Met Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Leu Val Gly Arg Ile Asp Pro Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1474
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1474

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Arg Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Phe Thr Ser Arg 
                85                  90                  95      


Gly Ala Leu Val Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1475
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1475

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Cys Ile Ser Ser Ser Ser Ser Phe Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Val Trp Val Asp Gly Glu Leu Leu Ser Gly Gly Ile 
            100                 105                 110         


Pro Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1476
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1476

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Glu Ser Asn 
            20                  25                  30          


Ser Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1477
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1477

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Arg Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Ala Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Ser Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Val Asn Ser Met Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Ile Leu Trp Arg Gly Ser Ser Trp Ala Asp Arg His Tyr Tyr 
            100                 105                 110         


Tyr Tyr Ser Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1478
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1478

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Thr Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Pro Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Val Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1479
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1479

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Ala Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Tyr His Asp Gly Ala Asn Trp Ser Gly Ala Phe Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Trp Val Thr Val Ser Ser 
        115                 120             


<210>  1480
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1480

Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  1481
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1481

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Leu Ile Ser Tyr Asp Gly Asn Asn Lys Tyr Tyr Ala Asp Ser Ala 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Gly Arg Gly Leu Asp Pro Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1482
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1482

Ser Tyr Glu Leu Thr Gln Ser Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Arg Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Ser Gln Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Ala Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1483
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1483

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ile Ser Ser Ser Gly Gly Ala Thr Tyr Asn Ala Asp Ser 
    50                  55                  60                  


Val Arg Gly Arg Phe Thr Thr Ser Arg Asp Asn Ser Lys Asn Ile Leu 
65                  70                  75                  80  


Tyr Leu Gln Met Asn Ser Leu Arg Gly Glu Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Val Lys Gly Leu Phe Asp Trp Phe Pro Leu Trp Gly Gln Gly Thr 
            100                 105                 110         


Met Val Thr Val Ser Ser 
        115             


<210>  1484
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1484

Asp Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ile Leu Ser Cys Arg Ala Ser Gln Ser Val Arg Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Ser Gly Ala Ser Thr Arg Ala Thr Ala Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Thr Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Cys Ala Val Tyr Tyr Cys His Gln Tyr Asn Asn Trp Pro Gln 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1485
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1485

Gln Gly Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Glu Ala Ser Gly Tyr Thr Phe Leu Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Thr Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Met Thr Met Thr Thr Asp Thr Ser Thr Gly Thr Gly Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gln Arg Arg Arg Leu Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1486
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1486

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Asn Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Gln Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Leu Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1487
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1487

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Ala Ser Ile Ser Ser Gly 
            20                  25                  30          


Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Ile Tyr Thr Ser Gly Asn Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Thr Gly Tyr Ile Gly Thr Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  1488
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1488

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr His Cys Gln Gln Ser Tyr Ser Thr Leu Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  1489
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1489

Glu Gly Gln Leu Leu Glu Ser Gly Gly Gly Leu Leu Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Ser Lys Phe Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly His Phe Thr Ile Ser Arg Asp Asn Phe Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Ser Ala Asp Asp Thr Ala Val Tyr His Cys Ala 
                85                  90                  95      


Lys Glu Pro Gln Gln Trp Gly Leu Asn Ala Phe Glu Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  1490
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1490

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Asn Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln Tyr Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ile Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Thr 
                85                  90                  95      


His Val Ala Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 


<210>  1491
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1491

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Glu Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Arg Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn Gln Ser Gly Asn Asn Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Ile Asp Thr Ser Asn Asn Arg Phe Ser Leu 
65                  70                  75                  80  


Arg Val Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Thr Ser Lys Tyr Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1492
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1492

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Gly Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  1493
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1493

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Val Ser Ser Ile Thr Ser Leu Leu Gly Tyr Tyr Phe Asp Ser 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1494
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1494

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Arg Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  1495
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1495

Asn Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe His His Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Ser Asp Tyr Arg Ala Tyr Ala Asp Ser Leu 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Tyr Ala Lys Asn Ser Leu Trp 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Thr Ser Glu Asp Thr Ala Phe Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Val Asp Tyr Gly Gly Lys Leu Ala Tyr Phe Asp Ser Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1496
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1496

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Leu Gly Tyr Asn Ser Leu Ser Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro His Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Leu Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Leu Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110         


<210>  1497
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1497

Gln Val Gln Leu Val Gln Ser Gly Pro Glu Leu Lys Glu Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Leu Thr Thr Thr 
            20                  25                  30          


Ser Met Asp Trp Val Arg Gln Val Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Arg Pro Gly Thr Gly Ser Pro Thr Tyr Val Glu Gly Phe 
    50                  55                  60                  


Arg Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Leu Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Gly Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gly Asp Lys Ser Glu Glu Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Ser Val Ser Ser 
        115                 


<210>  1498
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1498

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Asp Arg Ala Thr Leu Tyr Cys Lys Ala Ser Gln Asn Val Gly Asn Tyr 
            20                  25                  30          


Leu Ala Trp Phe Gln Gln Lys Pro Gly Gln Pro Pro Arg Leu Val Ile 
        35                  40                  45              


Phe Gly Val Ser Asn Arg Ala Ser Gly Ile Pro Leu Arg Phe Ser Gly 
    50                  55                  60                  


Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Gly Ile Tyr Tyr Cys Gln Gln Arg Arg His Trp Arg Thr 
                85                  90                  95      


Phe Gly Gln Gly Thr Arg Val Glu Ile Lys 
            100                 105     


<210>  1499
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1499

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ser Gly Asp Thr Ser Ser Ser Tyr 
            20                  25                  30          


Thr Val Gly Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Ala Tyr Ser Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Leu Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ser Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1500
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1500

Gln Pro Val Leu Thr Gln Pro Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Thr Cys Thr Leu Ser Ser Gly Tyr Ser Asn Tyr Lys 
            20                  25                  30          


Val Asp Trp Tyr Gln Gln Arg Pro Gly Lys Gly Pro Arg Phe Val Met 
        35                  40                  45              


Arg Val Gly Thr Gly Gly Ile Val Gly Ser Lys Gly Asp Gly Ile Pro 
    50                  55                  60                  


Asp Arg Phe Ser Val Leu Gly Ser Gly Leu Asn Arg Tyr Leu Thr Ile 
65                  70                  75                  80  


Lys Asn Ile Gln Glu Glu Asp Glu Ser Asp Tyr His Cys Gly Ala Asp 
                85                  90                  95      


His Gly Ser Gly Ser Asn Phe Val Phe Val Val Phe Gly Gly Gly Thr 
            100                 105                 110         


Arg Leu Thr Val Leu 
        115         


<210>  1501
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1501

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Ala Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Val Val Val Arg Cys Pro Gly Thr Gly Asp Val Cys Ser 
            100                 105                 110         


Thr Tyr Tyr Tyr Gln Ser Met Asp Val Trp Gly Gln Gly Thr Thr Val 
        115                 120                 125             


Thr Val Ser Ser 
    130         


<210>  1502
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1502

Gln Ser Ala Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Lys Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Phe Ala Gly Ser 
                85                  90                  95      


Asn Ile Pro Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  1503
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1503

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Gly Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gly Val Val Thr Tyr Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1504
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1504

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ala Gly Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Thr Thr Ser Leu Gln Ser Gly Val Pro Val Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  1505
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1505

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Gln Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Thr Pro Val Thr Ala Ile Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1506
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1506

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Ile Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Arg Thr 
                85                  90                  95      


Leu Ser Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1507
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1507

Gln Val Gln Leu Arg Glu Ser Gly Pro Gly Leu Val Arg Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Lys Cys Thr Val Ser Gly Asp Ser Val Ser Gly Asn 
            20                  25                  30          


Ser His Phe Trp Thr Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr Asn Ser Val Ser Thr Ala Tyr Asn Ala Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Ser Ser Lys Asn Leu Phe 
65                  70                  75                  80  


Ser Leu Glu Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Phe 
                85                  90                  95      


Cys Ala Gly Gly Phe Asp Asp Ala Trp Glu Pro Gln Val Tyr Trp Gly 
            100                 105                 110         


Leu Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1508
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1508

Asp Ile Val Met Thr Gln Ser Pro Asp Phe Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Phe Asn Thr 
            20                  25                  30          


Val Asn His Arg Asp Tyr Leu Gly Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Phe Tyr Trp Ala Ser Ser Arg Arg Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr His Asn Met Val Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  1509
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1509

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Leu Ser Gly Phe Ala Val Leu Lys Ala 
            20                  25                  30          


Arg Met Gly Val Ser Trp Ile Arg Gln Ser Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Thr Phe Ser Gly Asp Glu Glu Ser Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Arg Thr Arg Leu Thr Ile Ser Thr Asp Thr Ser Arg Arg Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Ser Asn Val Asp Pro Val Asp Thr Ala Thr Tyr Phe 
                85                  90                  95      


Cys Ala Arg Val Lys Thr Tyr Tyr Thr Ser Thr Arg Arg Ile Leu Trp 
            100                 105                 110         


Phe Asp Pro Trp Gly Gln Gly Ile Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1510
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1510

Asn Phe Ile Leu Thr Gln Pro His Ser Val Ser Ala Ser Pro Gly Glu 
1               5                   10                  15      


Thr Val Asn Ile Ser Cys Thr Arg Ser Ser Gly Asp Ile Ala Arg Asn 
            20                  25                  30          


Ser Val Gln Trp Tyr Gln Gln Arg Pro Asp Cys Ala Pro Thr Val Leu 
        35                  40                  45              


Ile Phe Glu Asp Asp Gln Arg Pro Ser Ala Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Arg Ser Ser Asn Thr Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Thr Pro Glu Asp Glu Ala Asp Tyr Tyr Cys His Ser Tyr Asp Asp 
                85                  90                  95      


Asn Tyr Gln Ala Phe Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105                 110     


<210>  1511
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1511

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Asp Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Arg Tyr Tyr Ala Ala Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Gly Asp Gly Tyr Arg Ser Gln Phe Asp Pro Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1512
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1512

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  1513
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1513

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Thr Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Tyr Trp Phe Gly Asp Pro Tyr Tyr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  1514
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1514

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Thr Asn Phe Leu Thr 
                85                  90                  95      


Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105     


<210>  1515
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1515

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Asn Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Leu Arg Gln Pro Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Val Gly Arg Ile Tyr Ser Ser Gly Asn Thr His Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Arg Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Asn Leu Asn Phe Val Ile Ala Ala Asp Thr Ala Val Tyr Phe 
                85                  90                  95      


Cys Ala Arg Asp Arg Asn Gly Ile Ala Ala Thr Asp Phe Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  1516
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1516

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asp Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Asp Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  1517
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1517

Gln Ile Thr Phe Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Ser Thr Ser 
            20                  25                  30          


Gly Glu Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Val Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Arg Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  1518
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1518

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Arg Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Thr Tyr Ser Thr Phe Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Asn Val Glu Ile Lys 
            100                 105         


<210>  1519
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1519

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Val Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Asn Arg Leu Thr Ile Thr Lys Asp Thr Ser Gln Ile Gln Val 
65                  70                  75                  80  


Ile Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Arg Glu Trp Glu Pro Tyr Arg Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1520
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1520

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Phe Tyr Ser 
            20                  25                  30          


Ser Asn Lys Lys Asn Tyr Leu Ala Trp Phe Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Ala Pro Lys Leu Leu Val Tyr Trp Ala Ser Ala Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Gln Thr Phe Gly Pro Gly Thr Lys Val Asp Ile 
            100                 105                 110         


Lys 
    


<210>  1521
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1521

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Thr Ile Ser Lys Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Ser Ser Leu Asn Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Trp Cys Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn 
            100                 105                 110         


Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1522
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1522

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Phe Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Phe Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Gly Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  1523
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1523

Gln Ile Thr Leu Lys Glu Ser Gly Pro Pro Leu Val Glu Pro Lys Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Glu Ala Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys His Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Arg Asn Arg Leu Thr Ile Thr Arg Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Leu Thr Asn Val Asp Pro Ala Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Ala Val Ile Leu Asn Phe Asp His Trp Gly Gln Gly 
            100                 105                 110         


Phe Leu Val Thr Val Ser Ser 
        115                 


<210>  1524
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1524

Phe Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Gly Ile Thr Cys Ser Gly Asp Lys Leu Gly His Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Ile Leu Leu Ile Tyr 
        35                  40                  45              


Gln Asp Asp Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Thr Ile Ala Thr Leu Thr Ile Ser Gly Thr Gln Pro Val 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Asn Asp Ala Gly Val 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105         


<210>  1525
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1525

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ile Asn Lys Tyr Tyr Ala Asp Ala Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Arg Ser Gly Ser Tyr Tyr Ala Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1526
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1526

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Phe Gln Gln Lys Pro Gly Lys Ala Pro Lys Ser Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Lys Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser His Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1527
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1527

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Val Gly Tyr Thr Ile Ser Arg Gln Trp Leu Val Gly Glu Phe 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1528
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1528

Gln Ser Ala Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Thr Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Glu Tyr Tyr Cys Ser Ala Tyr Ala Gly Ser 
                85                  90                  95      


Asn Asn Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1529
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1529

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Asp Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Gly Glu Ala Ala Gly Ile Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1530
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1530

Gln Pro Val Leu Thr Gln Pro Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Thr Cys Thr Leu Ser Ser Gly Tyr Ser Asn Tyr Lys 
            20                  25                  30          


Val Asp Trp Tyr Gln Gln Arg Pro Gly Lys Gly Pro Arg Phe Val Met 
        35                  40                  45              


Arg Val Gly Thr Gly Gly Ile Val Gly Ser Lys Gly Asp Gly Ile Pro 
    50                  55                  60                  


Asp Arg Phe Ser Val Leu Gly Ser Gly Leu Asn Arg Tyr Leu Thr Ile 
65                  70                  75                  80  


Lys Asn Ile Gln Glu Glu Asp Glu Ser Asp Tyr His Cys Gly Ala Asp 
                85                  90                  95      


His Gly Ser Gly Ser Asn Phe Glu Tyr Val Val Phe Gly Gly Gly Thr 
            100                 105                 110         


Lys Leu Thr Val Leu 
        115         


<210>  1531
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1531

Gln Val His Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Asp Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Thr Arg Ser Gly Ser Thr Asp Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Asn Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Phe Asp Ser Ala Trp Glu Leu Gln Phe Leu Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1532
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1532

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Thr Cys Lys Ser Ser Gln Ser Val Leu His Arg 
            20                  25                  30          


Pro Asn Asn Met Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Ala Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Glu Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Phe Cys Gln Gln 
                85                  90                  95      


Tyr Glu Ile Thr Pro Arg Thr Phe Gly His Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1533
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1533

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Pro Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Gln 
        35                  40                  45              


Trp Ile Gly Asn Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Ser Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gln Ser Arg Gly Tyr Ser Tyr Ala Trp Ser Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1534
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1534

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser His Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Thr Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ile 
                85                  90                  95      


Val Leu Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105             


<210>  1535
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1535

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Gln Gly Thr Tyr Leu Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1536
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1536

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Leu Pro Lys Val Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Tyr Ser Gly Val Pro Ser Arg Phe Arg Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Ser Pro 
                85                  90                  95      


Asp Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  1537
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1537

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Gly Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Gly Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gly Ser Ser Gly Glu Gly Gly Leu Tyr Tyr Tyr Tyr Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  1538
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1538

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Thr Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Gly 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ala Gly Gln Ala Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala His Tyr Tyr Cys Gln Ser Gly Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1539
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1539

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Gly Ser 
            20                  25                  30          


Asp Ser Phe Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Ser Asp Ser Gly Thr Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Asn Ser Arg Val Thr Ile Ser Val Asp Thr Ser Arg Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Val Arg Gly Arg Asn Leu Ser Gly His Gly Trp Leu Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1540
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1540

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Val Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Ile Tyr Tyr Cys Gln Gln Arg Arg Ser Trp Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Arg Val Glu Ile Lys 
            100                 105         


<210>  1541
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1541

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Thr Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Ala Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Leu Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Pro Lys Asn Gln Val 
65                  70                  75                  80  


Ile Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Gly Arg Trp Phe Gly Glu Leu Ser Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Ala Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1542
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1542

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Arg Leu Leu Phe Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1543
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1543

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Ser Tyr 
            20                  25                  30          


Gly Val His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys His Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Val Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ser Gly Gly Asn Tyr Gly Asp Ser Tyr Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1544
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1544

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Ser Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Arg Ser Gly Thr Tyr 
                85                  90                  95      


Phe Asn Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1545
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1545

Glu Glu His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ala Gly Phe Lys Phe Gly Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Ser Asp Tyr Ile Val Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Cys Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Phe Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Val Asp Gln Gly Gly Val Ile Ala Tyr Phe His His Trp 
            100                 105                 110         


Gly Pro Gly Thr Leu Val Thr Val Ser Ala 
        115                 120         


<210>  1546
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1546

Tyr Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Arg Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Ser Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Ile Gly Leu Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Arg Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  1547
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1547

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Ala Trp Val 
        35                  40                  45              


Ala Leu Ile Ser Tyr Asp Gly Tyr Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Ile Asn Ser Lys Asn Thr Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ser Ala Gly Asn Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  1548
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1548

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Thr Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Leu Lys Ser Gly Arg Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  1549
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1549

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Ala Val Ser Gly Phe Ser Leu Ser Asn Ala 
            20                  25                  30          


Lys Met Gly Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Asn Asp Glu Lys Ala Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Val Leu Thr Val Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ile Val Leu Gly Ala Ser Gly Thr Tyr Pro Ser Pro Gly 
            100                 105                 110         


Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1550
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1550

Gln Thr Val Val Thr Gln Glu Pro Ser Leu Thr Val Ser Pro Gly Gly 
1               5                   10                  15      


Thr Val Thr Leu Thr Cys Ala Ser Ser Ala Gly Ala Val Thr Ser Gly 
            20                  25                  30          


Tyr Tyr Pro Asn Trp Phe Gln Gln Lys Pro Gly Gln Ala Pro Arg Ala 
        35                  40                  45              


Leu Ile Tyr Ser Thr Ala Asn Lys His Ser Trp Thr Leu Ala Arg Phe 
    50                  55                  60                  


Ser Gly Ser Leu Leu Gly Gly Lys Ala Ala Leu Thr Leu Ser Gly Val 
65                  70                  75                  80  


Gln Pro Glu Asp Glu Ala Glu Tyr Tyr Cys Leu Leu Tyr Tyr Gly Gly 
                85                  90                  95      


Ala Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  1551
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1551

Glu Glu Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Thr Phe Gly Asp Tyr 
            20                  25                  30          


Lys Met Ala Trp Val Arg Gln Ala Pro Gly Arg Gly Pro Glu Trp Val 
        35                  40                  45              


Gly Leu Ile Arg Ser Arg Ala Asn Gly Glu Ser Thr Glu Tyr Ser Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Val Ser Arg Asp Asp Ser Lys Gly Ile 
65                  70                  75                  80  


Ala Tyr Leu Gln Met Tyr Asn Leu Gln Thr Glu Asp Thr Ala Ile Tyr 
                85                  90                  95      


Tyr Cys Thr Arg Asp Pro Thr Leu Trp Pro Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1552
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1552

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Thr Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Pro Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Glu Thr Ser Arg Leu His Asn Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Asn Tyr Tyr Cys His Gln Tyr Met Ala Phe Trp Thr 
                85                  90                  95      


Phe Gly Gln Gly Thr Arg Val Glu Ile Lys 
            100                 105     


<210>  1553
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1553

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Val Pro Gly Lys Gly Leu Val Trp Val 
        35                  40                  45              


Ser Arg Ile Asn Ser Asp Gly Ser Ser Thr Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Glu Met Asn Ser Leu Arg Ala Gln Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gly Ser Pro Trp Leu Arg Gly Asp Ile Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1554
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1554

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Met Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ser Asn His Ala Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  1555
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1555

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Thr Ile Ser Lys Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Ser Ser Leu Asn Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Trp Cys Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn 
            100                 105                 110         


Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1556
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1556

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Gly Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  1557
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1557

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Arg Asp Thr Ser Ala Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Arg Ser His Gln Thr Tyr Phe Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  1558
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1558

Asp Ile Val Met Thr Gln Ser Pro Glu Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Leu Leu Tyr Ser 
            20                  25                  30          


Ser Asp Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ile Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Gly Arg Ser Pro Ile Thr Phe Gly His Gly Thr Arg Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1559
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1559

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Thr Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asp Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Ser Tyr Cys Ser Ser Thr Arg Cys Tyr Thr Val Gly 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1560
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1560

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Asn Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Val Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp Pro 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1561
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1561

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Asn Ser Gly 
            20                  25                  30          


Asn Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Met Phe Thr Ser Gly Ser Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Thr Ser Arg Val Thr Met Ser Ile Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Asn Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Met Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gly His Val Ala Ala Trp Glu Ser Cys Tyr Tyr Trp Gly 
            100                 105                 110         


Gln Gly Ile Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1562
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1562

Asn Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Asn Ser 
            20                  25                  30          


Asn Gly Leu Thr Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Phe Val Ser Asn Arg Ala Ser Gly Val Ser 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Ala Asp Phe Thr Leu Thr Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Gln Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  1563
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1563

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Leu Asp Asp Tyr 
            20                  25                  30          


Gly Leu Ser Trp Val Arg His Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Asn Trp Asn Gly Gly Arg Thr Ala Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr His Cys 
                85                  90                  95      


Ala Arg Ala Arg Gly Pro Ser Glu Gln Tyr Tyr Asp Leu Leu Thr Gly 
            100                 105                 110         


Tyr Tyr Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val 
        115                 120                 125             


Ser Ser 
    130 


<210>  1564
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1564

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Gly Ala Ser Gln Ser Ile Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Ala Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Phe Cys Gln Gln Tyr Gly Gly Ser Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1565
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1565

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ile Ser Thr Ser Gly Gly Ala Thr Tyr Asn Ala Asp Ser 
    50                  55                  60                  


Val Arg Gly Arg Phe Thr Thr Ser Arg Asp Asn Ser Lys Asn Ile Leu 
65                  70                  75                  80  


Tyr Leu Gln Met Asn Ser Leu Arg Gly Glu Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Val Lys Gly Leu Phe Asp Trp Phe Pro Leu Trp Gly Gln Gly Thr 
            100                 105                 110         


Met Val Thr Val Ser Ser 
        115             


<210>  1566
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1566

Ser Tyr Glu Leu Thr Gln Ser Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Arg Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr His Val 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105         


<210>  1567
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1567

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val His Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Leu Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Arg Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gln Met Gly Pro Leu Gly Ser Thr Ser Ser Ala Ala Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1568
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1568

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Met Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Val Val Ile Tyr 
        35                  40                  45              


Glu Asp Asn Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Leu Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1569
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1569

Glu Val Lys Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Thr Ser Gly Phe Ser Phe Ser Ser Tyr 
            20                  25                  30          


Asp Met Asn Trp Val Arg Gln Ala Pro Glu Lys Gly Pro Glu Trp Val 
        35                  40                  45              


Ala Val Ile Thr Val Ser Gly Asp Thr Glu Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Gln Asn Lys Val Phe Leu 
65                  70                  75                  80  


Gln Met Asp Ser Leu Thr Ala Glu Asp Thr Ala Thr Tyr Phe Cys Ala 
                85                  90                  95      


Lys Asp Phe Thr Ala Trp Tyr Ala Val Gly Phe Trp Gly Gln Gly Thr 
            100                 105                 110         


Thr Val Ile Val Ser Ser 
        115             


<210>  1570
<211>  104
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1570

Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Gly His Phe 
            20                  25                  30          


Leu Ala Trp Phe Gln Gln Thr Pro Gly Lys Ala Pro Lys Pro Leu Ile 
        35                  40                  45              


Tyr Ala Thr Ser Lys Met Gln Arg Gly Val Pro Ser Gln Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu His Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Tyr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Val 
            100                 


<210>  1571
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1571

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Ala Arg Tyr Phe Asp Trp Ile Phe Glu Gly Ser Asp Tyr 
            100                 105                 110         


Tyr Tyr Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val 
        115                 120                 125             


Ser Ser 
    130 


<210>  1572
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1572

Gln Ser Ala Leu Thr Gln Pro Pro Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Arg Val Ser Trp Tyr Gln Gln Pro Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Leu Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1573
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1573

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Ala Ser Gly Phe Thr Phe Ser Ser Ser 
            20                  25                  30          


Glu Ile Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser His Ile Ser Ser Ser Gly Ser Ile Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Ser Tyr Arg Ser Ser Trp Tyr Tyr Tyr Tyr Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  1574
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1574

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Val 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1575
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1575

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Met Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Arg Ala Ser Arg Gly Thr Phe Asn Thr His 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Thr Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Ala Thr Thr Asn Tyr Ala His Asn Phe 
    50                  55                  60                  


Gln Gly Arg Ile Thr Ile Thr Ala Asp Asp Ser Thr Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Thr Ser Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gly Gly Gly Asn Ser Tyr Ser Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Pro Gly Thr Thr Val Ile Val Ser Ser 
        115                 120             


<210>  1576
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1576

Glu Ile Met Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Thr 
            20                  25                  30          


Ser Gly His Asn Leu Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Lys Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ala Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  1577
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1577

Asp Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Thr Leu Gly Asn Phe 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Ala Pro Gly Arg Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Val Asn Thr Ala Gly Thr Thr Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Phe 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Val Arg Val Asp Asp Ser Gly Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gly Ser Gly Gly Ser Trp Gly Trp Leu Asp Pro Trp Gly 
            100                 105                 110         


Gln Gly Val Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1578
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1578

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Leu Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asn Asn Leu Gly Asp Arg Tyr Ala 
            20                  25                  30          


Phe Trp Tyr Arg Gln Arg Pro Gly Gln Ser Pro Leu Leu Ile Ile Tyr 
        35                  40                  45              


Gln Asp Asn Asn Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Thr Gly Thr Gln Ala Leu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Phe Cys Gln Ala Trp Asp Gly Gly Thr Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105     


<210>  1579
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1579

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Ile Phe Gly Asp Tyr 
            20                  25                  30          


Ala Met Gly Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Phe Ile Arg Gly Lys Ala Tyr Asp Gly Thr Thr Glu Tyr Ala Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Tyr Ile 
65                  70                  75                  80  


Ala His Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ile Arg Asp Tyr Asp Phe Trp Gly Gly Tyr Tyr Tyr His Pro 
            100                 105                 110         


Leu Arg Ala Phe Asp Ile Trp Gly Arg Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1580
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1580

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Thr Lys Arg Pro Ser Gly Val Pro Glu Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Ser Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Tyr Thr Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  1581
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1581

Gln Val His Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Phe Ile Thr His Asp Gly Ser Lys Gln Glu Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Arg Leu Arg Ala Glu Asp Thr Thr Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Val Thr Glu Gly Ser Trp Ser Phe Asp Ser Trp Gly Gln 
            100                 105                 110         


Gly Thr Gln Val Ser Val Ser Ser 
        115                 120 


<210>  1582
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1582

Asn Ile Val Leu Thr Gln Ser Pro Leu Phe Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Arg Leu Ile Asn Asp 
            20                  25                  30          


Tyr Gly Arg Thr Phe Leu Tyr Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Ser Glu Val Ser Lys Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Gln Ile 
65                  70                  75                  80  


Arg Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ser 
                85                  90                  95      


Ala Ser Leu Pro Thr Phe Gly Pro Gly Thr Lys Val Asn Val Lys 
            100                 105                 110     


<210>  1583
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1583

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Ser Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Gln Ile Val Val Leu Phe Asp Met Trp Gly Gln Gly 
            100                 105                 110         


Thr Arg Val Thr Val Ser Ser 
        115                 


<210>  1584
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1584

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Gly Ser Asp Val Gly Gly Ser 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Val Leu Phe Gly Gly Gly Thr Lys Leu Ser Val Leu 
            100                 105                 110     


<210>  1585
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1585

Gln Val Gln Phe Ala Gln Ser Gly Ala Glu Val Lys Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Asn Tyr 
            20                  25                  30          


Ala Val His Trp Val Arg Gln Ala Pro Gly Gln Ser Pro Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Ala Gly Asn Gly Asn Thr Lys Tyr Ser Glu Lys Phe 
    50                  55                  60                  


Lys Gly Arg Val Thr Ile Thr Arg Asp Thr Ser Ala Asn Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Phe Tyr Cys 
                85                  90                  95      


Ala Arg Leu Leu Tyr Thr Ala Val Gly Tyr Tyr Tyr Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1586
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1586

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Ile Thr Ile Thr Cys Arg Ala Asn Gln Thr Ile Ala Asn Ser 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Ala Leu Leu Ile 
        35                  40                  45              


Tyr Leu Ser Ser Asn Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Phe Cys Gln Gln Gly Ala Thr Thr Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Thr Val Asp Ile Lys 
            100                 105         


<210>  1587
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1587

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ile Thr Tyr Tyr Tyr Asp Ser Ser Gly Tyr Trp Trp Asp Asp Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1588
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1588

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Ser Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  1589
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1589

Glu Val Glu Val Val Glu Ser Gly Gly Gly Leu Val His Pro Gly Gly 
1               5                   10                  15      


Ser Arg Arg Leu Ser Cys Val Ala Ser Gly Phe Ser Phe Ser Thr Ser 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Arg Gly Pro Glu Trp Val 
        35                  40                  45              


Ala Ser Ile Lys Asp Asp Gly Asn Glu Lys Gln Tyr Leu Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Ser Ile Ser Arg Asp Asn Gly Asn Asn Leu Val Phe 
65                  70                  75                  80  


Leu Gln Met Asp Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Leu Ser Phe His Pro Tyr Ala Phe Phe Tyr Tyr Met Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  1590
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1590

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Gly Thr Ser Asn Ile Gly Ser Gly 
            20                  25                  30          


Tyr His Val His Trp Tyr Lys Gln Leu Pro Glu Glu Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Gly Asn Ser His Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Val Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ser Asp Asp Glu Ala Asp Tyr Phe Cys Gln Ser Tyr Asp Gly Tyr 
                85                  90                  95      


Leu Thr Ala Tyr Val Phe Gly Ser Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1591
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1591

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Met Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Ala Asn Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly His Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Ser Ser Thr Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Leu Thr Thr Asn Thr Ser Met Gly Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Gly Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gln Trp Ser Thr Trp Ser Glu His Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1592
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1592

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Thr Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Ser Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Asn Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Glu Pro Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  1593
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1593

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Thr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Lys Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Gly Glu Glu Val Arg Gly Val Lys Leu Tyr Tyr Tyr Tyr Ala 
            100                 105                 110         


Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1594
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1594

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Ile Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ile 
                85                  90                  95      


Ser Thr Trp Val Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  1595
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1595

Glu Val Gln Leu Val Glu Ser Gly Gly Arg Leu Val Leu Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Val Tyr 
            20                  25                  30          


Glu Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Leu 
        35                  40                  45              


Ser Tyr Ile Gly Thr Ser Gly Ser Pro Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Arg Gly Trp Asn Tyr Gly Leu Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1596
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1596

Ser Tyr Glu Leu Thr Gln Pro Ser Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Arg Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Arg Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile His 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Thr Ser Gly Thr Met Ala Thr Leu Thr Ile Thr Gly Ala Gln Leu Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Phe Ser Met Asp Ser Ser Gly Asp Leu 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1597
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1597

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Arg Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Phe Ser Asp Phe 
            20                  25                  30          


Phe Trp Thr Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Arg Arg Ser Gly Leu Thr Thr Tyr Asn Ser Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Ile Asp Thr Ser Arg Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Arg Leu Asp Ser Val Thr Ala Ala Asp Thr Ala Met Tyr Tyr Cys Ala 
                85                  90                  95      


Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Ile Asp Trp Gly Gln Gly 
            100                 105                 110         


Thr Gln Val Ala Val Ser Ser 
        115                 


<210>  1598
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1598

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val Ser Trp Tyr His Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly Ser 
                85                  90                  95      


Asn His Ala Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1599
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1599

Gln Val Gln Leu Leu Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Asn Pro Ser Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Asn Ser Ser Asp Thr Met Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Asp Arg Val Thr Met Thr Arg Asp Thr Ser Thr Arg Thr Val Tyr 
65                  70                  75                  80  


Met Asp Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ser Gly Gly Gly Arg Gly Asp Phe Ser Asn Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  1600
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1600

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Val Gly Gln Ala Pro Val Leu Met Ile Tyr 
        35                  40                  45              


Lys Asp Thr Glu Arg Ala Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Arg Asp Thr Lys Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Thr Asp Ser Ser Gly Val Tyr 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105             


<210>  1601
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1601

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Leu Ile Ser Ser Asp Gly Gly Asn Lys Phe Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val Pro Thr Thr Val Thr Ala Phe Thr Val Phe Thr Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1602
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1602

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Tyr Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Gly 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1603
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1603

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Gly Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Ser Tyr 
                85                  90                  95      


Cys Ala Arg Gly Val Asp Thr Tyr Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1604
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1604

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ala Gly Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Glu Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Leu Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Ser Cys Gln Gln Ser Tyr Ser Thr Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  1605
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1605

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Thr Ile Ser Lys Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Ser Ser Leu Asn Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Trp Cys Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn 
            100                 105                 110         


Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1606
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1606

Ser Gln Leu Val Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Thr Cys Thr Leu Ser Ser Gly His Thr Asn Tyr Ala 
            20                  25                  30          


Ile Ala Trp His Gln Gln Glu Pro Glu Lys Gly Pro Arg Phe Leu Met 
        35                  40                  45              


Lys Val Asn Ser Asp Gly Ser His Asn Lys Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Ser Ser Gly Ala Glu Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Thr Trp Gly 
                85                  90                  95      


Pro Gly Ile Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1607
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1607

Glu Val Arg Leu Val Gln Ser Gly Pro Glu Val Lys Glu Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Asn Phe Ala Asp Tyr 
            20                  25                  30          


Trp Val Gly Trp Val Arg Gln Met Ser Gly Gly Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile His Pro Pro Asp Ser Gln Thr Arg Leu Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Met Ser Val Asp Lys Ser Ile Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Thr Ala Ser Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Leu Ser Pro Leu Gln Leu Leu Ser Gly Gly Phe Tyr Ser 
            100                 105                 110         


Phe Asp Tyr Trp Gly Gln Gly Thr Arg Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1608
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1608

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Gly Ala Ser Leu Ser Cys Arg Ala Ser Gln Ser Val Gly Thr Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Glu Gly Ser Asn Arg Ala Thr Gly Ile Pro Gly Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Thr Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Tyr Gly Trp Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1609
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1609

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ala Phe Ser Asn Tyr 
            20                  25                  30          


Ala Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Asn Asn Lys Asp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Pro Val Met Val Arg Gly Val Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1610
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1610

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Val Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Arg Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Phe Cys Ile Ser Tyr Thr Ser Ser 
                85                  90                  95      


Arg Thr Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1611
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1611

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Arg Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Phe Ser Asp Phe 
            20                  25                  30          


Phe Trp Thr Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Arg Arg Ser Gly Leu Thr Thr Tyr Asn Ser Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Ile Asp Thr Ser Arg Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Arg Leu Asp Ser Val Thr Ala Ala Asp Thr Ala Met Tyr Tyr Cys Ala 
                85                  90                  95      


Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Ile Asp Trp Gly Gln Gly 
            100                 105                 110         


Thr Gln Val Ala Val Ser Ser 
        115                 


<210>  1612
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1612

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Phe Asn Ile 
            20                  25                  30          


His Asn Asn Arg Asp Tyr Leu Gly Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Val Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ala Gly Leu Gln Val Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Met Tyr Ser Pro Pro Arg Thr Phe Gly Gln Gly Thr Arg Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1613
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1613

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Gly Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Pro Gly Ser Arg Tyr Ser Gly Gly Trp Tyr Asp Tyr Tyr Tyr 
            100                 105                 110         


Ala Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1614
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1614

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  1615
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1615

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Glu Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Gln Lys Tyr Tyr Val Asp Ser Ala 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Arg Leu Cys Ser Ser Ser Gly Cys Tyr Ala Ala Ser Tyr His 
            100                 105                 110         


Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1616
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1616

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln His His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Gln Arg Pro Ser Gly Val Pro Asp Ser Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Tyr Thr Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1617
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1617

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Thr Leu Ser Cys Ala Ala Ser Gly Phe Pro Phe Ser Thr Tyr 
            20                  25                  30          


Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Val Trp Val 
        35                  40                  45              


Ser Ser Ile Lys Asp Asp Ala Thr Asn Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Gln Asn Thr Val His 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Gly Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Glu Gly Arg Leu Asn Met Val Arg Gly Tyr Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1618
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1618

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Arg Ser Leu Leu Ser Lys 
            20                  25                  30          


Asn Lys Asn Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Lys Leu Leu Thr Tyr Trp Ala Ser Thr Arg Ala Ser Gly Val Pro Asp 
    50                  55                  60                  


Arg Phe Ala Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr 
                85                  90                  95      


Ser Ser Pro Phe Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  1619
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1619

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Ala Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Lys Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Ser Asp Ser Glu Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Ser Ile Ser Ala Asp Lys Ser Ile Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Thr Tyr Tyr Cys 
                85                  90                  95      


Ala Arg His Trp Cys Ser Gly Gly Ser Cys Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  1620
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1620

Glu Ile Val Leu Thr Gln Ser Pro Thr Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Gly 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Asn Ala Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Glu Tyr Gly Ser Ser Ala 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105             


<210>  1621
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1621

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Leu Ser Asp Phe 
            20                  25                  30          


Tyr Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Ser Tyr Phe Ser Ser Gly Arg Ser Ser Thr Tyr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Thr Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Asp Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Thr Arg Lys Ala Tyr Tyr Tyr Asp Ser Arg Gly Tyr Asn 
            100                 105                 110         


Pro Phe Tyr His Tyr Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr 
        115                 120                 125             


Val Thr Val Ser Ser 
    130             


<210>  1622
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1622

Glu Ile Val Met Thr Gln Ser Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asp Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Ile Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Asp Thr Leu Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 110         


<210>  1623
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1623

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Pro Thr Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Gly Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Asp Thr Asp Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  1624
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1624

Gln Pro Val Leu Thr Gln Pro Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Thr Cys Thr Leu Ser Ser Gly Tyr Ser Asn Tyr Lys 
            20                  25                  30          


Val Asp Trp Phe Gln Gln Arg Pro Gly Lys Gly Pro Arg Phe Val Met 
        35                  40                  45              


Arg Val Gly Thr Gly Gly Ile Val Gly Ser Lys Gly Asp Gly Ile Pro 
    50                  55                  60                  


Asp Arg Phe Ser Val Leu Gly Ser Gly Leu Asn Arg Tyr Leu Thr Ile 
65                  70                  75                  80  


Lys Asn Ile Gln Glu Glu Asp Glu Ser Asp Tyr His Cys Gly Ala Asp 
                85                  90                  95      


His Gly Ser Gly Ser Asn Phe Val Tyr Val Val Phe Gly Gly Gly Thr 
            100                 105                 110         


Lys Leu Thr Val Leu 
        115         


<210>  1625
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1625

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Ala Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Ser Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Met Asp Gly Ser Ala Gly Asn Ile Tyr Tyr Ala Asp Ala Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Ala Tyr Phe Cys 
                85                  90                  95      


Ala Lys Asp Ser Gly Ala Leu Cys Ser Gly Gly Asp Cys Leu Arg Gly 
            100                 105                 110         


Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1626
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1626

Asp Ile Val Met Thr Gln Ser Pro Glu Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Leu Leu Tyr Ser 
            20                  25                  30          


Ser Asp Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ile Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Arg Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Gly Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Gly Thr Pro Tyr Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1627
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1627

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Met Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Ala Asn Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly His Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Ser Ser Thr Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Gly Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Gly Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gln Trp Ser Thr Trp Ser Glu His Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ala 
        115                 120             


<210>  1628
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1628

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Glu Thr Gln Ser Ile Ser Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Pro Arg Phe Ser Gly 
    50                  55                  60                  


Arg Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Ser Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  1629

<400>  1629
000

<210>  1630

<400>  1630
000

<210>  1631
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1631

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Phe Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Phe Tyr Cys 
                85                  90                  95      


Ala Lys Asp Leu Pro Pro Tyr Ala Ser Gly Trp Tyr Glu Gly Gly Phe 
            100                 105                 110         


Asp Tyr Trp Gly Arg Gly Thr Gln Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1632
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1632

Gln Thr Val Val Thr Gln Glu Pro Ser Leu Thr Val Ser Pro Gly Gly 
1               5                   10                  15      


Thr Val Thr Leu Thr Cys Ala Ser Ser Thr Gly Ala Val Thr Ser Gly 
            20                  25                  30          


Tyr Phe Pro Asn Trp Phe Gln Gln Lys Pro Gly Gln Ala Pro Arg Ala 
        35                  40                  45              


Leu Ile Phe Ser Thr Asn Asn Arg His Ser Trp Thr Pro Ala Arg Phe 
    50                  55                  60                  


Ser Gly Ser Leu Leu Gly Asp Lys Ala Ala Leu Thr Leu Ser Gly Val 
65                  70                  75                  80  


Gln Pro Glu Asp Glu Ala Glu Tyr Tyr Cys Leu Leu Tyr Tyr Gly Gly 
                85                  90                  95      


Pro Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  1633
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1633

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Val Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Phe 
65                  70                  75                  80  


Leu Gln Met Ile Gly Leu Arg Glu Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gln Gly Arg Gly Gly Tyr Tyr Ser Pro Phe Asp Asp Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  1634
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1634

Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Thr Leu Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr His Cys Gln Gln Tyr Asn Asn Trp Pro Leu 
                85                  90                  95      


Ala Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1635
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1635

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Asn Ala 
            20                  25                  30          


Arg Met Gly Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Gly Asp Glu Lys Ser Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Leu Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Thr Trp Gly Thr Trp Ile Gln Ala Trp Tyr Phe Asp 
            100                 105                 110         


Ile Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1636
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1636

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Ile Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln Tyr Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Gly 
                85                  90                  95      


Asn Thr Phe Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1637
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1637

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Thr Arg Ser 
            20                  25                  30          


Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Glu Leu Gly Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Val Cys Glu Trp Leu Cys Asp Phe Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1638
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1638

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Asp 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Ala Ala Asp Asn Lys Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1639
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1639

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Phe Asp Gly Ser Asn Lys His Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Asp Phe Trp Ser Gly Tyr Tyr Thr Gly Trp Phe Asp 
            100                 105                 110         


Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1640
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1640

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Asn Arg Val Glu Ile 
            100                 105     


<210>  1641
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1641

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Leu Thr Ile Val Val Ile Pro Ala Ala Pro Asn Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1642
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1642

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Arg Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Pro Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1643
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1643

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Phe Ile Ser Gly Thr Gly Asp Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Gln Ala Arg Val Gln Asp Tyr Ile Trp Gly Ser Tyr Arg 
            100                 105                 110         


Ser Tyr Gly Met Asp Val Trp Gly Leu Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1644
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1644

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro His Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  1645
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1645

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Thr Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  1646
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1646

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Ala Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Glu Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1647
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1647

Gln Val Gln Leu Arg Glu Ser Gly Pro Gly Leu Val Arg Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Lys Cys Thr Val Ser Gly Asp Ser Val Ser Gly Asn 
            20                  25                  30          


Ser His Phe Trp Thr Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Phe Asn Ser Val Ser Thr Ala Tyr Asn Ala Ser 
    50                  55                  60                  


Leu Arg Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Glu Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Gly Gly Phe Gly Asp Ala Trp Glu Pro Gln Gly Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1648
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1648

Asp Ile Val Met Thr Gln Ser Pro Asp Phe Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Ser Cys Lys Ser Ser Gln Thr Val Phe Asn Ser 
            20                  25                  30          


Ala Asn His Arg Asn Tyr Leu Gly Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Arg Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr His Asn Met Val Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile 
            100                 105                 110     


<210>  1649

<400>  1649
000

<210>  1650

<400>  1650
000

<210>  1651
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1651

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Leu Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Met Asp Gly Ser Ala Gly Asn Ile Tyr Tyr Ala Asp Ala Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gln Met Gly Pro Leu Gly Ser Thr Ser Ser Ala Ala Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1652
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1652

Glu Ile Val Leu Thr Gln Ser Pro Ala Ile Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Asn Tyr Ile Ser Ala Pro Gln 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Val Lys 
            100                 105         


<210>  1653
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1653

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Ala Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser His Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Ser Tyr Arg Gly Thr Thr His Gln Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Ala Ile Ile Ser Ile Asp Thr Ser Lys Asn His Phe 
65                  70                  75                  80  


Ser Leu Ile Leu Ser Ser Leu Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Tyr Thr Thr Met Val Gly Glu Phe Asp Ser Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Ala Val Ser Ser 
        115                 120 


<210>  1654
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1654

Ser Tyr Glu Leu Thr Gln Thr Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Asp Gln Tyr Ala 
            20                  25                  30          


Phe Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Thr Glu Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Thr Asn 
                85                  90                  95      


Pro Val Val Phe Gly Gly Gly Thr Thr Leu Thr Val Leu 
            100                 105                 


<210>  1655
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1655

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Gly Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Ser Ser Ser Tyr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Trp Leu Gln Leu Arg Ser Asp Tyr Tyr Tyr Phe Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  1656
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1656

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Asn Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Phe Cys Gln Gln Cys Tyr Asn Trp Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1657
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1657

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Ser Ser Arg Tyr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Arg Gly Tyr Ser Tyr Gly Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1658
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1658

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser Gly 
    50                  55                  60                  


Thr Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Leu Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1659
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1659

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Phe 
            20                  25                  30          


Gly Val Gly Val Gly Trp Val Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Cys Leu Ala Leu Ile Tyr Trp Asp Asp Asp Glu Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Ala Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1660
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1660

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Arg Ser Ser 
                85                  90                  95      


Gly Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105             


<210>  1661
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1661

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Thr Phe Ser Phe Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Gly Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Ser Gly Ser Ser Trp Asp Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1662
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1662

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Arg Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Gly Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  1663
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1663

Glu Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Pro Phe Ser Asn Ile 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Arg Ile Lys Ser Lys Thr Ala Gly Glu Ile Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Asp Arg Phe Asn Ile Ser Arg Asp Asp Ser Gln Lys Met 
65                  70                  75                  80  


Leu Phe Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Gly Met Tyr 
                85                  90                  95      


Tyr Cys Ile Thr Asp Trp Arg Val Asp Tyr Trp Gly Gln Gly Ala Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1664
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1664

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Val Pro Val Leu Val Ile Phe 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Ala 
65                  70                  75                  80  


Asp Glu Gly Asp Tyr Tyr Cys Tyr Ser Thr Asp Ser Ser Gly Asp Gln 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1665
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1665

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Val Ser Thr Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Tyr Arg Asp Trp Ile Trp Gly Gln Gly Thr Leu Val Thr Val 
            100                 105                 110         


Ser Ser 
        


<210>  1666
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1666

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Lys Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Arg Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Ala 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr His Asn Leu Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1667
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1667

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Asn Arg Phe Gln Tyr Cys Ser Ser Thr Thr Cys Tyr Thr 
            100                 105                 110         


Leu Leu Pro Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1668
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1668

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Arg 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  1669
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1669

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Leu Phe Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Asn Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Tyr Thr Gly Ser Tyr Lys Ser Tyr Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  1670
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1670

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Ser Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Ile Ser Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1671
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1671

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Met Ser Trp Ile Arg Gln Thr Pro Gly Lys Gly Leu Glu His Ile 
        35                  40                  45              


Ser Tyr Ile Ser Gly Asp Gly Ser Asp Lys Ile Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ser Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Ala Ala Arg Thr Ala Pro Asn Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Ser Val Ser Ser 
        115     


<210>  1672
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1672

Asp Val Val Val Thr Gln Ser Pro Leu Ser Leu Pro Val Ile Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Gln Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Glu Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Gly Asp Val Gly Ile Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Thr His Trp Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  1673
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1673

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Phe Tyr Cys 
                85                  90                  95      


Ala Arg Gly Asp Gly Asp Val Tyr Asn Phe Leu Leu Val Arg Asn Trp 
            100                 105                 110         


Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1674
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1674

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Gly Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  1675
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1675

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Thr Lys Asn Thr Val Trp 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Val Phe Asp Trp Val Leu Tyr Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1676
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1676

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Ile Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ala Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Cys 
                85                  90                  95      


Tyr Thr Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1677
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1677

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Phe Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Asn Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Ser 
                85                  90                  95      


Cys Ala Ser Leu Trp Phe Gly Asp Leu Tyr Ser Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1678
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1678

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Phe Thr Cys Arg Ala Ser Gln Gly Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ile Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Lys Tyr Asn Ser Ala Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1679
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1679

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Asp Ser Ala Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Phe Tyr Leu Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Arg Ser Ser Trp Asn Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1680
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1680

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Phe Val 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Asn Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Leu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1681
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1681

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ser Gly Asp Thr Ser Ser Ser Tyr 
            20                  25                  30          


Thr Val Gly Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Ala Tyr Ser Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
            100                 105                 110         


Tyr Tyr Arg Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1682
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1682

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Thr Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro Arg 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1683
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1683

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Ser Ser Gly 
            20                  25                  30          


Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Ile Tyr Thr Ser Gly Ser Thr Thr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asn Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Asn Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Val Gly Gly Ile Ser Pro Tyr Tyr Tyr Tyr Tyr Tyr Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1684
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1684

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Met 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Asn Thr Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  1685
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1685

Gln Val His Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Phe 
            20                  25                  30          


Gly Val His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Thr Leu Ile Ser Phe Asp Gly Arg Asn Lys Asn Tyr Ala Gly Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Ser Ser Lys Ser Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Tyr His Asp Gly Ala Asn Trp Ser Gly Ala Phe Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Trp Val Thr Val Ser Ser 
        115                 120             


<210>  1686
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1686

Gln Ser Val Leu Ser Gln Pro Pro Ser Thr Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Thr Ser Asn Ile Gly Arg Asn 
            20                  25                  30          


Thr Leu Asn Trp Tyr Gln Gln Arg Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ile Asn Asn Arg Arg Pro Ser Gly Val Pro Asp Arg Val Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Gly Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Asp Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Val Leu 
                85                  90                  95      


Gln Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1687
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1687

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Arg Ile Tyr Thr Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Val Pro Ala Ala Asp Gly Met Asp Val Trp Gly Gln Gly Thr 
            100                 105                 110         


Thr Val Thr Val Ser Ser 
        115             


<210>  1688
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1688

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Phe Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Phe Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Asn Trp Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1689
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1689

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Lys Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Ser Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Gly Ser Val Thr Ala Ala Asp Thr Ala Met Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Gly Ser Ile Gly Trp Tyr His Tyr Phe Glu Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  1690
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1690

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  1691
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1691

Gln Gly Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Glu Ala Ser Gly Tyr Thr Phe Leu Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met 
        35                  40                  45              


Gly Trp Met Ser Pro Thr Ser Gly Tyr Thr Asp Ser Ala Pro Lys Phe 
    50                  55                  60                  


Gln Gly Arg Leu Thr Met Thr Arg Ser Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Gly Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Lys Pro Leu Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  1692
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1692

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Thr Leu Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Ala Cys Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Phe Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Arg Leu Gln Ala Glu Asp Val Ala His Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Cys Ser Ser Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1693
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1693

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Gly Asn Ala Gly Tyr Gly Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Tyr 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1694
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1694

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Phe Ser Cys Ser Gly Ser Asn Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Val Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1695
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1695

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Phe 
            20                  25                  30          


Gly Val Gly Val Gly Trp Val Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Cys Leu Ala Leu Ile Tyr Trp Asp Asp Asp Glu Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Ala Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1696
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1696

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Asn Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Gly Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  1697
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1697

Glu Val Gln Leu Leu Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Gly Ser Gly Gly Asn Thr His Tyr Ala Glu Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Phe 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Lys Pro Asp Thr Ser Ser Thr Thr Leu Asn Met Asp Ala 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  1698
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1698

Ser His Glu Leu Thr Gln Pro Ser Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asn Ile Leu Thr Lys Lys Tyr Ala 
            20                  25                  30          


Arg Trp Phe Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Leu Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Thr Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Val Ala Asp Asn Asn Arg Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  1699
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1699

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Ser Ala Lys Leu Val Ala Thr Ile Ser Tyr Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1700
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1700

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Glu Ala Pro Arg Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Ala Val Asn Trp Tyr Gln Gln Leu Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Tyr Asp Asp Leu Leu Pro Ser Gly Val Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1701
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1701

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Asn Trp Leu Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Gly Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly 
            100                 105                 110         


Thr Thr Val Thr Val Ser Ser 
        115                 


<210>  1702
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1702

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Thr Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Arg Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Thr Thr Leu Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1703
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1703

Glu Val Gln Leu Val Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Thr Ser Gly Phe Thr Phe Asn Arg His 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Ser Asp Tyr Ile Val Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Tyr Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Asp Leu Asn Ser Leu Arg Val Glu Asp Thr Ala Phe Tyr Phe Cys 
                85                  90                  95      


Ala Lys Gly Val Asp Met Thr Gly Arg Leu Ala Tyr Phe Asp His Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Ala Thr Val Ser Ser 
        115                 120         


<210>  1704
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1704

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Tyr His Leu Ala Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Ala Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Leu Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 110         


<210>  1705
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1705

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Asp Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Glu Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Arg Gly Gly Ser Tyr Gln Thr Cys Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1706
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1706

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1707
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1707

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser His 
            20                  25                  30          


Thr Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Met Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Gly Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Trp Gly Pro Asp Tyr Gly Asp Tyr Ala Ser Asn Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1708
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1708

Ser Tyr Glu Leu Thr Gln Pro Ser Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Val Leu Ala Lys Asn Tyr Ala 
            20                  25                  30          


Arg Trp Phe Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Lys Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Ala Ala Asp Asn Asn Arg Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1709
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1709

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Ser Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Ser Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asn Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Thr Lys Gly Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Phe Thr Met Thr Asn Met Glu Ser Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Asn Thr Tyr Ser Asn Gly Val Asp Val Trp Gly Arg Gly 
            100                 105                 110         


Thr Thr Val Thr Val Ser Ser 
        115                 


<210>  1710
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1710

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asn Gly Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Val Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Gly Gly Ser Arg Thr Asp Phe Thr Leu Thr Ile Ser Gly Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Gly Ile Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Leu Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  1711
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1711

Glu Glu Gln Leu Val Glu Ser Gly Gly Gly Leu Val Glu Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Gly Ala Ser Gly Phe Ile Phe Ser Asn Tyr 
            20                  25                  30          


Asp Leu Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Leu 
        35                  40                  45              


Ser Tyr Ile Ser His Ser Gly Arg Thr Thr Trp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Lys Ser Leu His 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Asp Ser Asp Tyr Tyr Asp Asn Ser Gly Tyr Pro Asp Ala Phe 
            100                 105                 110         


Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Thr Ser 
        115                 120                 125 


<210>  1712
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1712

Ser Ser Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Ser Gln Tyr Val 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Thr Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ala 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Arg Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr His Cys Gln Ser Ala Asp Ser Thr Gly Thr Phe 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr His Leu Thr Val Leu 
            100                 105             


<210>  1713
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1713

Glu Ala Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Ser 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Asn Val Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Thr Lys Ala Ser Arg Tyr Cys Ser Ser Thr Ile Cys Tyr Trp Asn Trp 
            100                 105                 110         


Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1714
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1714

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Ser Leu Gln Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Arg Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Ser Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  1715

<400>  1715
000

<210>  1716

<400>  1716
000

<210>  1717
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1717

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Asp Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Leu Val Gly Arg Ile Asp Pro Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1718
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1718

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Ser 
            20                  25                  30          


Leu Ser Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Lys Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Leu Leu 
                85                  90                  95      


Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105             


<210>  1719
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1719

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Leu Asn Pro Gly Ala Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Ser Asp Thr Ser Thr Asn Thr Val Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Lys Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Gln Ile Val Pro His Ala Asp Gly Phe Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  1720
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1720

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Arg Thr Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  1721
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1721

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Arg Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Val Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Gly Ser Tyr Pro Glu Tyr Phe Gln His Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1722
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1722

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Tyr Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Val Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Glu 
            100                 105                 


<210>  1723
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1723

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Thr Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  1724
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1724

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn Ala 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val 
            100                 105         


<210>  1725
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1725

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Val Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Asn Arg Leu Thr Ile Thr Lys Asp Thr Ser Gln Ile Gln Val 
65                  70                  75                  80  


Ile Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Arg Glu Trp Glu Pro Tyr Arg Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1726
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1726

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Leu Leu Tyr Thr 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Phe Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Pro Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1727
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1727

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Glu Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val Gly Gly Tyr Ser Gly Tyr Asp Leu Gly Phe Asp Tyr 
            100                 105                 110         


Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1728
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1728

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Asn Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Val Val Ile Phe 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Tyr Ile 
                85                  90                  95      


Trp Gly Trp Met Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1729
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1729

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ala Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Asn Asn Lys Tyr Tyr Ala Asp Ser Leu 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Arg Thr Ala Val Phe Leu Phe Phe Gly Leu Gly Asp Ala 
            100                 105                 110         


Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1730
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1730

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Val Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Leu Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1731
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1731

Gln Val Gln Leu Val Gln Ser Gly Ala Ala Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Val Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
            100                 105                 110         


Tyr Tyr Arg Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1732
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1732

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Arg Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  1733
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1733

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ser Val Ser Gly Gly Ser Ile Arg Ser Tyr 
            20                  25                  30          


Phe Trp Asn Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Asn Tyr Lys Pro Ser Phe Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Leu Asp Thr Ser Lys Asn Gln Ile Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Thr Trp Leu Arg Asp Ala Phe Gly Ile Trp Gly Gln Gly Thr 
            100                 105                 110         


Met Val Thr Val Ser Ser 
        115             


<210>  1734
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1734

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Ser Cys Lys Ser Ser Gln Ser Val Leu Asn Ser 
            20                  25                  30          


Gln Asn Asn Arg Asp Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ser Glu Asp Phe Ala Leu Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Asn Asn Trp Trp Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1735
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1735

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser His 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Ala Leu Arg Glu Arg Gly Val Gln Leu Trp Ser Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1736
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1736

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Ile Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Gly Ala Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1737
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1737

Glu Val Arg Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Gln Trp Val 
        35                  40                  45              


Ser Thr Ile Ser Val Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Pro Ala Ser Gly Ile Val Gly Pro Thr His Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1738
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1738

Gln Leu Val Leu Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Thr Cys Thr Leu Ser Ser Gly His Thr Thr Tyr Ala 
            20                  25                  30          


Ile Ala Trp His Gln Gln Gln Pro Glu Lys Gly Pro Arg Tyr Leu Met 
        35                  40                  45              


Lys Leu Asn Ser Asp Gly Ser His Thr Arg Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Ser Ser Gly Ala Glu Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Trp Asp 
                85                  90                  95      


Thr Gly Ile Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1739
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1739

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Ala Glu Thr Ile Tyr Ala Gln Gln Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Lys Ser Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Gly Phe Ala Val Phe Gly Arg Ala Ala Val Pro Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1740
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1740

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Phe Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Phe Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Ile Ile Tyr 
        35                  40                  45              


Gln Gly Ala Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1741
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1741

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Asp Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Phe Arg Arg Ser Tyr Gly Ser Gly Ser Tyr Tyr Asn Ile 
            100                 105                 110         


Ser Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1742
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1742

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Val Gly Ser 
                85                  90                  95      


Ser Thr Tyr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1743
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1743

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Ala Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Val Val Val Arg Cys Pro Gly Thr Gly Asp Val Cys Ser 
            100                 105                 110         


Thr Tyr Tyr Tyr Gln Ser Met Asp Val Trp Gly Gln Gly Thr Thr Val 
        115                 120                 125             


Thr Val Ser Ser 
    130         


<210>  1744
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1744

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Arg Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Phe Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Met Tyr Ser Pro Pro 
                85                  90                  95      


Arg Thr Phe Gly Gln Gly Thr Arg Val Glu Ile Lys 
            100                 105             


<210>  1745
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1745

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg His 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Val Arg Glu Tyr Gly Ser Gly His Pro Leu Pro Ile Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1746
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1746

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Ala Asp Ala Leu Ser Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Val Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Ser His Trp 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105         


<210>  1747
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1747

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Ser Tyr Trp Trp Ser Trp Ile Arg Gln Ser Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly His Thr Tyr Ile Ser Gly Ser Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Tyr Ile Ser Glu Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Met Asn Ser Val Thr Ala Arg Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ile Val Arg Pro Cys Ser Tyr Pro Ser Cys Ser Gly Tyr 
            100                 105                 110         


Asn Phe Phe Tyr Tyr Leu Asp Val Trp Gly Lys Gly Thr Thr Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  1748
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1748

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ile Asn 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Val Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Gly Ile Ser Gly Val His 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Pro Val Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  1749
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1749

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ser Val Ser Gly Gly Ser Ile Arg Ser Tyr 
            20                  25                  30          


Phe Trp Asn Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Asn Tyr Lys Pro Ser Phe Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Leu Asp Thr Ser Lys Asn Gln Ile Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Thr Trp Leu Arg Asp Ala Phe Gly Ile Trp Gly Gln Gly Thr 
            100                 105                 110         


Met Val Thr Val Ser Ser 
        115             


<210>  1750
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1750

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Asn Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Ser Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ser 
                85                  90                  95      


Gly Asn Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1751
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1751

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Lys Ala Pro Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Ala Gly Ser Thr Thr Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Phe His Val Pro Ala Ala Leu Arg Asn Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1752
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1752

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asn Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Leu Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Val Ala Trp Asp Asp Ser Arg 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1753
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1753

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Ala Asn Asp Ser Gly Ser Phe Tyr Asn Gly Pro Phe 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1754
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1754

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Arg Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  1755
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1755

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Tyr Gly Gly Ser Phe Ser Asp Tyr 
            20                  25                  30          


Phe Leu Thr Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Val Thr His Ile Gly Ser Ile Tyr Tyr Asn Thr Ser Leu Gln 
    50                  55                  60                  


Ser Arg Leu Thr Ile Ser Met Asp Ala Ser Lys Asn Gln Phe Leu Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Ser Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Lys Gly Thr Ala Tyr Ala Trp Glu Val Leu His Ala Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1756
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1756

Asp Ile Val Met Thr Gln Ser Pro Asp Phe Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Phe Asn Ser 
            20                  25                  30          


Glu Asn His Tyr Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Val Pro Lys Leu Leu Val Tyr Trp Ala Ser Thr Arg Glu Ala Gly Val 
    50                  55                  60                  


Pro Glu Arg Phe Ser Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Thr Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Gly Ala Pro Arg Thr Phe Gly Arg Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1757
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1757

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Gly Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Val Arg Leu Pro Pro Gly Arg Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly His Ile Ser Tyr Ser Gly Asn Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Thr Ser Lys Asn Leu Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Gly Ile Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Phe Pro Arg Lys Gln Trp Leu Val Arg Gly Tyr Trp Tyr Phe 
            100                 105                 110         


Asp Val Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1758
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1758

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Lys Asn Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Lys Lys Pro Gly Glu Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Lys Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Thr Ala Thr Tyr Phe Cys Gln Gln Tyr Asp Asn Leu Leu Phe 
                85                  90                  95      


Thr Phe Gly Ser Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  1759
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1759

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Ile Phe Thr Ser Gly Ser Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gly Gly Leu Leu Trp Phe Gly Gly Ala Gly Asn Tyr Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1760
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1760

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Pro Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu 
            100                 105                 110         


Ile Lys 
        


<210>  1761
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1761

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Ser Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Glu Gly Glu Trp Glu Leu Arg Gly Asn Ala Leu Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  1762
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1762

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Phe Asn Trp 
            20                  25                  30          


Asp Asn His Arg Asp Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Gly Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln His 
                85                  90                  95      


Arg Ser Asn Trp Pro Pro Arg Leu Thr Phe Gly Gly Gly Thr Lys Val 
            100                 105                 110         


Glu Ile Lys 
        115 


<210>  1763
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1763

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Thr Pro Gly Ala 
1               5                   10                  15      


Ser Val Met Val Ser Cys Arg Val Ser Gly Tyr Thr Phe Thr Ser Leu 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Thr Thr Ala Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Thr Pro Arg Asn Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Ile Met Thr Arg Asp Thr Ala Ile Asn Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Thr Gly Leu Asn Ser Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Ala Ala Gly Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1764
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1764

Gln Ala Val Leu Thr Gln Pro Ser Ala Leu Ser Ala Ser Pro Gly Ala 
1               5                   10                  15      


Ser Ala Arg Ile Thr Cys Ser Ser Gly Ser Gly Ile Asp Ile Lys Met 
            20                  25                  30          


Tyr Arg Ile Tyr Trp Tyr Gln Gln Lys Pro Gly Ser Pro Pro Arg Tyr 
        35                  40                  45              


Leu Leu Ser Tyr Lys Ser Asp Ser Asp Lys Gln Gln Gly Ser Gly Val 
    50                  55                  60                  


Pro Ser Arg Phe Ser Gly Ser Lys Asp Ala Ser Ala Asn Ala Gly Val 
65                  70                  75                  80  


Leu Phe Ile Ser Gly Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys 
                85                  90                  95      


Leu Ile Trp His Ile Asn Ala Tyr Val Phe Gly Thr Gly Thr Lys Val 
            100                 105                 110         


Thr Val Leu 
        115 


<210>  1765
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1765

Gln Val Gln Leu Ala Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Gly Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Ser Asn Ser Gly Asn Ala Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Thr Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1766
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1766

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Asn Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Phe Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Gln Arg Thr Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Ser Tyr Tyr Cys Leu Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1767
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1767

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Glu Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Arg Leu Cys Ser Ser Ser Gly Cys Tyr Ala Ala Ser Tyr His 
            100                 105                 110         


Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1768
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1768

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn Ala 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1769
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1769

Gln Glu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Ile Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Asn Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Arg Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Pro Pro Pro Pro Ser Lys Trp Leu Leu Asn Tyr Tyr Tyr Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Pro Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1770
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1770

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Pro Asn Ile Gly Ser Ser 
            20                  25                  30          


Thr Ile Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ser Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1771
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1771

Gln Val Leu Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gly 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Ser Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Glu Ile Tyr His Arg Gly Gln Thr Gly Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Arg Arg Val Thr Ile Ser Leu Asp Lys Ser Gln Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Arg Arg Glu Ser Ser Pro Tyr His Phe Tyr Tyr Gly Val 
            100                 105                 110         


Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1772
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1772

Gln Pro Val Val Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Thr Cys Thr Leu Asp Ser Gly His Arg Ser Tyr Ala 
            20                  25                  30          


Ile Ala Trp His Gln Gln Arg Pro Glu Lys Gly Pro Arg Phe Leu Met 
        35                  40                  45              


Arg Ile Thr Thr Asp Gly Arg His Thr Lys Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Glu Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Thr Trp Gly 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105         


<210>  1773
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1773

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Thr Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Arg Ser Gly Ser Tyr Tyr Ala Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1774
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1774

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Thr Asp Ser Ser Gly Asn Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  1775
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1775

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Ala Phe Gly Phe Thr Phe Gly Thr Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Pro Asp Gly Ser Asp Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Arg Asp Ser Val Asp 
65                  70                  75                  80  


Leu Gln Met Asn Asn Val Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Tyr Asp Ser Gly Trp Tyr Met Asp Asn Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Ile Leu Val Thr Ala Ala Ser 
        115                 120             


<210>  1776
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1776

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Arg Asp Asp Val Gly Arg Tyr 
            20                  25                  30          


Asn His Val Ser Trp Tyr Gln Gln Gln Pro Gly Lys Ala Pro Arg Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Tyr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Ser Cys Cys Ser Tyr Ala Glu Gly 
                85                  90                  95      


Tyr Ile Leu Val Phe Gly Gly Gly Thr Arg Val Thr Val Leu 
            100                 105                 110 


<210>  1777
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1777

Gln Val Gln Ile Gln Gln Trp Gly Ala Gly Val Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly His 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Lys Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Pro Pro Val Thr Thr Phe Phe Val Phe Ser Leu Leu Phe Asp 
            100                 105                 110         


Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1778
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1778

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Tyr Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Ser Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Ala Ser Leu 
                85                  90                  95      


Ser Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1779
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1779

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Arg Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Glu Gly Glu Trp Glu Leu Arg Gly Asn Ala Leu Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  1780
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1780

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Ala Asp Ala Leu Pro Lys His Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ile Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Gly Ser Gly Ser Ser 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Ala Val Leu 
            100                 105             


<210>  1781
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1781

Glu Val Gln Leu Val Glu Ser Gly Gly Val Leu Ala Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Glu Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ile Ser Ser Gly Tyr Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  1782
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1782

Glu Ile Val Met Thr Gln Ser Pro Val Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1783
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1783

Glu Val Arg Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Thr Phe Gly Ser Tyr 
            20                  25                  30          


Val Met His Trp Val Arg Gln Val Pro Gly Lys Gly Leu Val Trp Val 
        35                  40                  45              


Ser Arg Ile Ser His Asp Ala Thr Ser Thr Thr Tyr Thr Asp Ser Val 
    50                  55                  60                  


Gln Gly Arg Phe Thr Val Ser Arg Asp Asn Ala Arg Asn Thr Leu Phe 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val Asn Tyr Val Phe Tyr Asp Phe Trp Gly Gln Gly Ser 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1784
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1784

Gln Ala Val Leu Thr Gln Pro Pro Ser Leu Ser Ala Ser Pro Gly Ala 
1               5                   10                  15      


Ser Thr Ser Leu Thr Cys Thr Leu His Ser Gly Ile Asn Val Glu Thr 
            20                  25                  30          


Tyr Pro Ile Tyr Trp Tyr Gln Gln Lys Pro Gly Ser Pro Pro Arg Tyr 
        35                  40                  45              


Leu Leu Gln Tyr Asn Ser Asp Ser His Lys Gln Gln Gly Ser Gly Val 
    50                  55                  60                  


Pro Ser Arg Phe Ser Gly Ser Lys Asp Ala Ser Ala Asn Ala Gly Ile 
65                  70                  75                  80  


Leu Leu Ile Ser Gly Leu Gln Ser Glu Asp Glu Ala Asp Tyr His Cys 
                85                  90                  95      


Met Ile Trp His Asn Asp Ala Ala Val Phe Gly Gly Gly Thr Lys Leu 
            100                 105                 110         


Thr Val Leu 
        115 


<210>  1785
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1785

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Asp Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Gln Trp Pro Asn Gln Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  1786
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1786

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile His 
        35                  40                  45              


Gln Asp Ser Gln Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr His Val 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105         


<210>  1787
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1787

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Thr Thr Leu Asp 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Gly Gly Gly Ser Tyr Arg Gly Pro Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1788
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1788

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ala Gly Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ala Ser Leu Gln Ala 
65                  70                  75                  80  


Glu Asp Val Ala Val Phe Tyr Cys Gln Leu Tyr Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1789
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1789

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Ser Tyr Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Ala Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Asn Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Ser Gly Pro Pro Tyr Met Ala Thr Phe Ser Tyr Tyr Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1790
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1790

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Phe Gln His His Pro Asp Lys Ala Pro Arg Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Pro Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  1791
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1791

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr 
            20                  25                  30          


Tyr Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Cys Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Gly Ser Thr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Ile Arg Asp Gly Val Trp Gly Leu Asn Glu Asn Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1792
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1792

Gln Pro Val Leu Thr Gln Ser Ser Ser Ala Ser Ala Ser Leu Gly Ser 
1               5                   10                  15      


Ser Val Lys Leu Thr Cys Thr Leu Ser Ser Gly His Ser Ser Tyr Ile 
            20                  25                  30          


Ile Ala Trp His Gln Gln Gln Pro Gly Lys Ala Pro Arg Tyr Leu Met 
        35                  40                  45              


Lys Leu Glu Gly Ser Gly Ser Tyr Asn Lys Gly Ser Gly Val Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Ser Ser Gly Ala Asp Cys Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Asn Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Glu Thr Trp Asp 
                85                  90                  95      


Ser Asn Thr Arg Val Phe Ala Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1793
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1793

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Asp Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Ser Tyr Cys Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Val Tyr Ile Tyr Ser Ser Gly Ser Thr Asn Tyr Asn 
    50                  55                  60                  


Pro Ser Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn 
65                  70                  75                  80  


Gln Phe Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val 
                85                  90                  95      


Tyr Tyr Cys Ala Arg Asp Gly Glu Thr Thr Ala Thr Ser Ala Arg Gly 
            100                 105                 110         


Ser Ser Cys Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  1794
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1794

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Asn Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro Arg 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1795
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1795

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Ser Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Leu Gly Asp Gly Tyr Asn Leu Arg Val Pro Ala Tyr 
            100                 105                 110         


Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1796
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1796

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Asn Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Val Val Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Gln Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Tyr Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  1797
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1797

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gly 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Ser Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Glu Ile Tyr His Gly Gly Ser Thr Asp Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Ile Ser Val Asp Lys Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Asp His Val Asn Val Arg Asp Tyr Trp Gly Pro Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1798
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1798

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Ile Pro Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  1799
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1799

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Asn Ser Asn Ser Phe Ile Tyr Tyr Ala Asp Ser Met 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Asn Gly Asn Ser Asn Trp Asn Phe Gly Ser Tyr Tyr Tyr 
            100                 105                 110         


Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1800
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1800

Glu Ile Val Leu Thr Gln Ser Pro Ala Ile Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Thr Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Phe Tyr Tyr Cys Gln Gln Arg Gly Asn Trp Trp Thr 
                85                  90                  95      


Phe Ala Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  1801
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1801

Arg Val Gln Leu Val Gln Ser Gly Ala Glu Val Arg Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Lys Val Ser Gly Tyr Ser Leu Ser Glu Leu 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Gly Glu Thr Val Tyr Ala Gln Arg Phe 
    50                  55                  60                  


Gln Gly Arg Val Ser Met Thr Glu Asp Ile Ser Thr Asp Thr Ala His 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Gly Gly Leu Asn Gly Asp Tyr Val Thr Gly Gly Ala Tyr Tyr 
            100                 105                 110         


Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1802
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1802

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Thr Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Ile Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys His Gln Tyr Asp Tyr Leu Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  1803
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1803

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asn Tyr 
            20                  25                  30          


His Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Ala Ala Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Gly Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ala Ala Ser Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  1804
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1804

Gln Ser Ala Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Lys Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Pro Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val 
            100                 105                 110 


<210>  1805
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1805

Gln Val His Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Thr Ser Phe Ser Asp Tyr 
            20                  25                  30          


Phe Trp Thr Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Arg Glu Met Gly Thr Ile Asn Tyr Asn Ser Ser Leu Glu 
    50                  55                  60                  


Ser Arg Ala Val Ile Ser Met Asp Thr Ser Arg Ser Gln Phe Ser Leu 
65                  70                  75                  80  


Ser Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Val Val Ser Gly Pro Gly 
            100                 105                 110         


Thr Gln Val Thr Val Ser Ser 
        115                 


<210>  1806
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1806

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Gly Val Pro Leu Gly 
1               5                   10                  15      


Gly Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Asn Val Phe Asn Ser 
            20                  25                  30          


His Asn Asn Arg Asp Tyr Leu Ala Trp Tyr Gln Gln Arg Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Asp Phe Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ala Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr His Ala Ala Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1807
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1807

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Leu His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Phe Ile Thr His Asp Gly Ser Lys Gln Glu Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Glu Arg Ile Thr Met Leu Val Val Val Thr Leu Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Ser Val Ser 
        115                 120             


<210>  1808
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1808

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Phe Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Asp Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Phe Thr Phe Gly Pro Gly Thr Arg Val Asp Ile Lys 
            100                 105                 110         


<210>  1809
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1809

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Ser Gly Ile Ser Gly Asn Gly Tyr Phe Thr Phe Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ser Ile Ser Arg Asp Asn Ser Arg Asp Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Thr Gly Leu Leu Thr Leu Lys Pro Phe Trp Gly Lys Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1810
<211>  102
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1810

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Ser Asn Phe 
            20                  25                  30          


Leu Ser Trp Tyr Gln Tyr Ile Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Val Phe Thr Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Thr Tyr Thr Asp Thr Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr 
            100         


<210>  1811
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1811

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Ala Tyr Phe Cys 
                85                  90                  95      


Ala Gln Val Leu Cys Ser Ser Thr Ser Cys His Tyr Tyr Tyr Gly Met 
            100                 105                 110         


Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1812
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1812

Ser Tyr Glu Leu Thr Gln Pro Leu Ser Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Ser Cys Gly Gly Asn Lys Ile Gly Arg Ile His Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Arg Asp Ser Asn Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Ala Gln Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Thr Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1813
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1813

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Tyr Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Ile His Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Gln Met Ala Ala Thr Thr Gly Ile Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1814
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1814

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Arg Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Thr Asp Thr Ser Gly Asn His 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1815
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1815

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Ala 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Thr Ile Ser Lys Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Ser Ser Leu Asn Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Trp Cys Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn 
            100                 105                 110         


Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1816
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1816

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Ser 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Val Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Thr Asp Ser Ser Gly Asn His 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1817
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1817

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Arg Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Arg Ile Ser Cys Gln Gly Leu Gly Tyr Thr Phe Ser Thr Tyr 
            20                  25                  30          


Trp Ile Ala Trp Val Arg Gln Lys Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Met Ile Tyr Pro Gly Asp Ser Glu Thr Arg Phe Gly Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Ile Met Ser Val Asp Lys Ser Leu Gly Ala Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Thr Trp Leu Arg Ala Ser Asp Ser Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Ile Lys Gly Ser Pro Thr Ser Thr Ala His Asp Ala Leu Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Leu Thr Val Ser Ser 
        115                 120             


<210>  1818
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1818

Ser Tyr Glu Leu Ser Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Val Pro Thr Gln Phe Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Leu Leu Val Ile Ser 
        35                  40                  45              


Lys Asp Thr Gln Arg Pro Pro Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Ala Thr Leu Thr Ile Thr Gly Val Gln Thr Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr His Cys Gln Ser Ala Asp Thr Ser Asp Thr Tyr 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1819
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1819

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Ala Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Ser Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Met Asp Gly Ser Ala Gly Asn Ile Tyr Tyr Ala Asp Ala Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Ala Tyr Phe Cys 
                85                  90                  95      


Ala Lys Asp Ser Gly Ala Leu Cys Ser Gly Gly Asp Cys Leu Arg Gly 
            100                 105                 110         


Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1820
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1820

Asp Ile Val Met Thr Gln Ser Pro Glu Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Phe Ser 
            20                  25                  30          


Thr Asn Asn Lys Asn Tyr Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Ala Leu Leu Ile Tyr Trp Ala Ser Thr Arg Ala Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Met Tyr Ser Pro Pro Arg Thr Phe Gly Gln Gly Thr Arg Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1821
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1821

Arg Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ser Val Ser Gly Ala Ser Ile Ser Thr Ala 
            20                  25                  30          


Asp Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu His 
        35                  40                  45              


Leu Val Gly Tyr Ile His Tyr Thr Gly Gly Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Gln Ser Arg Val Ser Met Ser Val Asp Thr Ser Gln Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Met Thr Ser Met Thr Pro Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Leu His Arg Ser Gly Asn Val Phe Glu Phe Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Ile Val Ser Ser 
        115                 120 


<210>  1822
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1822

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Val Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Asp Phe Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Glu Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asp Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Gly Asp Tyr Tyr Cys Ile Cys Arg Asp Asn Ser Gly Asp His 
                85                  90                  95      


Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1823
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1823

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Asp Asn Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Ile Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Ile Tyr Tyr Asp Ile Phe Met Pro Leu Leu Asp Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1824
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1824

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Thr 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Phe Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys His Gln Tyr Gly Thr Ser Pro 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  1825
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1825

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ser Gly Asp Thr Ser Ser Ser Tyr 
            20                  25                  30          


Thr Val Gly Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Ala Tyr Ser Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Leu Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ser Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1826
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1826

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Gly Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Phe Leu Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  1827
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1827

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Arg Ser Ser Thr Ile Lys Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Asp Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Asp Tyr Tyr Gly Ser Gly Ser Val Tyr Trp Tyr Phe Asp 
            100                 105                 110         


Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1828
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1828

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Tyr Thr Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1829
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1829

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Gly Ser Tyr 
            20                  25                  30          


Val Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Gln Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Lys Pro Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Trp Phe Gly Glu Leu Leu Lys Gly Thr Tyr Trp Phe Asp 
            100                 105                 110         


Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1830
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1830

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Gly Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  1831
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1831

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Glu Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Arg Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn Gln Ser Gly Asn Asn Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Ile Asp Thr Ser Asn Asn Arg Phe Ser Leu 
65                  70                  75                  80  


Arg Val Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Thr Ser Lys Tyr Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1832
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1832

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Gly Ala Ser Gln Ser Val Thr Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Leu Tyr Gly Ser Ser Pro 
                85                  90                  95      


Leu Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  1833
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1833

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Glu Asp Gly Ser Glu Arg Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr His Cys 
                85                  90                  95      


Ala Ser Arg His Cys Ser Val Ser Gly Cys Tyr Thr Ala Ser Tyr Leu 
            100                 105                 110         


Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1834
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1834

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln Tyr Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asp Lys Trp Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Phe Gly Leu 
65                  70                  75                  80  


Arg Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Tyr Thr Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1835
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1835

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Asp Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Gly Glu Ala Ala Gly Ile Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1836
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1836

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Leu Tyr Gly Ser Ser Pro Leu 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  1837
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1837

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Ile Thr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Val Leu Gly Ile Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Asp Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gly Val Ser Gly Phe Lys Ser Gly Ser Asn Trp Tyr Phe 
            100                 105                 110         


Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  1838
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1838

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Leu Ser Cys Thr Gly Ser Asn Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Asp Ser Val Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  1839
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1839

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Ser Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ser Gly Gly Leu Arg Phe Asp Ser Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1840
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1840

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val Ser Trp Tyr His Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asp Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1841
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1841

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ala Tyr 
            20                  25                  30          


Glu Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Arg Ile 
        35                  40                  45              


Ala Tyr Ile Thr Thr Ser Gly Asn Asn Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Phe Arg Asp Asn Pro Lys Lys Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Thr Gly Gln Val Glu Trp Leu Val Asp Asn Tyr Asn Tyr Tyr 
            100                 105                 110         


Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1842
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1842

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Arg Lys Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Leu Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1843
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1843

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Val Trp Val 
        35                  40                  45              


Ser Arg Ile Asn Ser Asp Gly Ser Ser Thr Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Val Glu Gln Leu Ala His Met Val Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  1844
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1844

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Asn Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Thr Ser 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1845
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1845

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Thr 
            20                  25                  30          


Thr Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Ala Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Val Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gln Trp Lys Trp Phe Gly Glu Ala Trp Tyr Phe Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1846
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1846

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ser Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1847
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1847

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Asn Gln Asp Gly Gly Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Tyr Asp Leu Tyr Gly Asp Tyr Gly Gly Thr Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1848
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1848

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Arg Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Thr Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Ser Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1849
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1849

Glu Val His Leu Val Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Gly Gly Ser Gly Phe Ser Phe Asn Ser Ala 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Ala Asp Gly Gly Asp Ser Tyr Tyr Pro Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Lys Asp Asn Thr Lys Asn Leu Leu His 
65                  70                  75                  80  


Leu Gln Met His Ser Leu Arg Val Asp Asp Ala Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Val Trp Gly Asp Thr Trp Gly Leu Asp Tyr Trp Gly Leu Gly Thr 
            100                 105                 110         


Arg Val Ala Val Ser Ser 
        115             


<210>  1850
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1850

Gln Ala Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Ser Ser Arg Asp Phe Gly Ala His 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu 
        35                  40                  45              


Ile Leu Tyr Lys Val Tyr Gln Arg Pro Ser Gly Val Pro Gly Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Asp Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Pro Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Thr Ala Pro Gly Ala 
                85                  90                  95      


Leu Ile Leu Leu Phe Gly Gly Gly Thr Lys Leu Thr Val 
            100                 105                 


<210>  1851
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1851

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Asn Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Glu Gly Ser Lys Thr Tyr Tyr Ala Asp Phe Val 
    50                  55                  60                  


Gln Gly Arg Phe Thr Val Ser Arg Asp Phe Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ile Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Ser His Lys Leu Phe Trp Phe Gly Gln Phe Lys Met Asp Ala 
            100                 105                 110         


Leu Asp Ile Trp Gly Gln Gly Ala Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1852
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1852

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Pro Asn Ile Gly Ser Asn 
            20                  25                  30          


Ser Val Asn Trp Tyr Gln Gln Val Pro Gly Thr Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Asn Thr Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1853
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1853

Glu Ala Gln Leu Ala Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Gln Thr Leu Ser Cys Ala Pro Ser Gly Phe Ile Phe Ser His Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Asn Pro Ile Gly Asp Tyr Lys Pro Phe Ala Asp Ser Met 
    50                  55                  60                  


Lys Gly Arg Phe Ala Ile Ser Arg Asp Asn Val Lys Asn Leu Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Val Gly Leu Arg Ala Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Asn Trp Asp Val Ala Gly Met Asp Val Trp Gly Gln Gly 
            100                 105                 110         


Thr Thr Val Thr Val Ser Ser 
        115                 


<210>  1854
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1854

Gln Leu Val Leu Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ala Val Lys Leu Thr Cys Thr Leu Ser Ser Gly His Ile Thr Asn Ala 
            20                  25                  30          


Ile Ala Trp His Gln Leu Gln Pro Glu Lys Gly Pro Arg Phe Leu Met 
        35                  40                  45              


Lys Ile Asn Ser Asp Gly Thr His Asn Lys Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Ser Ser Gly Ala Asp Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ser Asp Asp Glu Ala Asp Tyr Phe Cys Leu Thr Trp Gly 
                85                  90                  95      


Ser Gly Ser Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1855
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1855

Glu Val Gln Leu Val Glu Ala Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ile Thr Ser Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Asn Trp Asn Ser Gly Asn Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Ile Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Ala Pro Arg Ser Tyr Cys Ser Arg Thr Ser Cys Trp Gly Glu 
            100                 105                 110         


Tyr Phe Gln Val Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1856
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1856

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Leu Phe Tyr Ser 
            20                  25                  30          


Ser Asn Ser Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Arg Gln 
        35                  40                  45              


Pro Pro Arg Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Gly Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Gly Thr Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1857
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1857

Gln Val Gln Leu Val Gln Ser Gly Ala Ala Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Val Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
            100                 105                 110         


Tyr Tyr Arg Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1858
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1858

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Leu Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Trp Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105     


<210>  1859
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1859

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Val Arg Asp Leu Ala Leu Phe Glu Val Val Ile Gln Gln Gly Val Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1860
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1860

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Thr Asp Ser Ser Gly Asn His 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1861
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1861

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Gly Ser 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Ser Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly His Ile Arg Ser Lys Thr Asn Asn Tyr Ala Thr Ala Tyr Ala Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Ala Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Thr Arg His Pro Tyr Tyr Ser Ala Ser Gly Ile Lys Phe Asp 
            100                 105                 110         


Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1862
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1862

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Trp Thr Phe Gly Lys Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1863
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1863

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Ala Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Ala His Ser Thr Gly His Gln Tyr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  1864
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1864

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Phe Asn Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Asn Thr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  1865
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1865

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Arg 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Thr Val Asp Cys Gly Gly Asp Cys Phe Pro Asn Asp 
            100                 105                 110         


Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1866
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1866

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Leu Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Pro Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Phe Arg Asp Ser Ser Gly His His 
                85                  90                  95      


Pro Val Phe Gly Glu Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1867
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1867

Gln Ala Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Tyr Gly Ala Ser Phe Ser Asp Tyr 
            20                  25                  30          


Phe Trp Thr Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Leu 
        35                  40                  45              


Gly Glu Ile Arg Gln Ile Gly Thr Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Gly Arg Ala Thr Ile Ser Met Asp Thr Ser Lys Ser Gln Phe Ser Leu 
65                  70                  75                  80  


Ser Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Phe Cys Ala 
                85                  90                  95      


Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Val Ala Ser Gly Pro Gly 
            100                 105                 110         


Ile Gln Val Thr Val Ser Ser 
        115                 


<210>  1868
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1868

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Gly Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Asn Ser 
            20                  25                  30          


Gln Asn Asn Arg Asp Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Phe Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ala Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Leu Tyr Ser Pro Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1869
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1869

Asn Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Leu Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser His Ile Ser Ser Ser Gly Ser Ile Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Tyr Ala Lys Asn Ser Leu Trp 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Thr Ser Glu Asp Thr Ala Phe Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Val Asp Tyr Gly Gly Lys Leu Ala Tyr Phe Asp Ser Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1870
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1870

Gly Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Thr Val Thr Ile Thr Cys Arg Ala Asn Gln Thr Ile Lys Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Ile Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Thr Ala Thr Tyr Phe Cys Gln Gln Tyr Asp Asn Leu Leu Phe 
                85                  90                  95      


Thr Phe Gly Ser Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1871
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1871

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Gly Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Ser Asp Tyr Lys Pro Tyr Ala Gly Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Gly Pro Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Val Asp His Gly Ala Gln Gly Ala Tyr Phe Asp His Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Ile Ala Ser Ser 
        115                 120         


<210>  1872
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1872

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Phe Thr Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Phe Thr Phe Gly Pro Gly Thr Arg Val Asp Ile Lys 
            100                 105                 110         


<210>  1873
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1873

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Ser Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Val Ser Tyr Asp Phe Trp Ser Gly Tyr Trp Ala Phe Asp 
            100                 105                 110         


Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1874
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1874

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Cys Cys Gln Ser Tyr Asp Arg Ser 
                85                  90                  95      


Leu Ser Gly Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1875
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1875

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Pro Asn Ser Arg Gly Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Arg Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Val Val Leu Gly Tyr Gly Arg Pro Asn Asn Tyr Tyr Asp 
            100                 105                 110         


Gly Arg Asn Val Trp Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val 
        115                 120                 125             


Ser Ser 
    130 


<210>  1876
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1876

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Ile Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Thr Val Lys Trp Tyr His Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Cys Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Asp Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Ala Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1877
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1877

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asn Tyr 
            20                  25                  30          


Val Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Ala Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gln Arg Ser Ser Ser Gly Trp Tyr Lys Ser Tyr Tyr Tyr 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1878
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1878

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  1879
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1879

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Asp Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Ser Tyr Cys Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Phe Tyr Thr Ser Gly Ser Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Gly Glu Thr Thr Ala Thr Ser Ala Arg Gly Ser Ser 
            100                 105                 110         


Cys Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1880
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1880

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Phe Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Ser Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Val Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Arg Thr 
                85                  90                  95      


Leu Ser Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1881
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1881

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Leu Ile Trp Tyr Asp Gly Arg Lys Glu Asp Tyr Ala Glu Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Ser Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Glu Arg Gly Ser Arg Trp Leu Val Arg Leu Lys Tyr Tyr Tyr 
            100                 105                 110         


Asp Leu Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1882
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1882

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln His Leu Asn Ser Tyr Pro Phe 
                85                  90                  95      


Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105     


<210>  1883
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1883

Glu Val Arg Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Ala Thr Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ser Ile Ser Arg Asp Asn Ser Lys Asn Ser Leu Val 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Pro Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  1884
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1884

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Phe Val Ser Trp His Gln Gln His Pro Gly Lys Ala Pro Lys Asn 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


His Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Thr 
                85                  90                  95      


Ser Thr Pro Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1885
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1885

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Gly Ser 
            20                  25                  30          


Phe Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Phe Ile Ser Ser Gly Gly Asp Ala Val Lys Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Thr Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Asp Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Thr Arg Asp Arg Ile Ile Ala Ala Arg Gly Thr Leu Trp Tyr Phe Glu 
            100                 105                 110         


Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1886
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1886

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Val Ile Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asp Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Glu Thr Asp Phe Thr Leu Thr Ile Ser Asn Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Gly Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Val Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Val Lys 
            100                 105         


<210>  1887
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1887

Gln Gly Gln Leu Val Gln Ser Gly Gly Asp Val Val Gln Pro Gly Lys 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Asn Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Asn Asp Gly Ser Asn Glu Lys Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ser Leu Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr 
65                  70                  75                  80  


Leu Asp Met His Ser Leu Arg Pro Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Arg Ser Asn Leu Glu Arg Leu Val Met Thr Phe Gly Gly 
            100                 105                 110         


Ile Ile Ala Gly Ala Phe Asp Ile Trp Gly Gln Gly Ala Arg Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  1888
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1888

Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Leu Ser Ser His 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Val Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Ala Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Ser Ala Val Tyr Tyr Cys Gln Gln Tyr His Val Trp Pro Pro 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  1889
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1889

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Leu 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Val Gly Val Gly Ala Thr Gly Asp Phe Tyr Tyr Tyr 
            100                 105                 110         


Ser Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1890
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1890

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Phe Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile 
65                  70                  75                  80  


Ser Ser Leu Gln Ser Glu Asp Phe Ala Leu Tyr Tyr Cys Gln Gln Tyr 
                85                  90                  95      


Asn Asn Trp Trp Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  1891
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1891

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ile Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Asn Ser Gly Ser Tyr Tyr Ser Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1892
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1892

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Leu Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1893
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1893

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Phe Val 
        35                  40                  45              


Ser Gly Ile Ser Ser His Gly Gly Asn Thr Tyr Tyr Ala Asn Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Gly Ser Leu Arg Thr Glu Asp Met Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Asp Ser Arg Gly Tyr Tyr Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  1894
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1894

Asp Ile Val Met Thr Gln Ser Pro Glu Ser Arg Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Tyr Thr Phe Gly Gln Gly Ser Lys Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1895
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1895

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Met Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Asp Ile Ile Trp Val Arg Gln Ala Thr Gly His Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Pro Ser Asn Thr Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Gly Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Gly Leu Thr Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gln Trp Asn Thr Trp Ser Glu His Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1896
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1896

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Thr Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Ser Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Asn Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Leu His Tyr Gly Asp Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  1897
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1897

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Asp Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Gln Lys Tyr Tyr Val Asp Ser Ala 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  1898
<211>  102
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1898

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Arg Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Thr Tyr Thr Asp Thr Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr 
            100         


<210>  1899
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1899

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gln Arg Arg Gly Glu Ala Val Tyr Ser Asn Gly Trp Tyr Lys Tyr 
            100                 105                 110         


Tyr Tyr Cys Met Asp Val Trp Gly Glu Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1900
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1900

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Arg Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Ser Glu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1901
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1901

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gly 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Ser Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Ile Ser Val Asp Lys Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Arg Trp Gly Asp Tyr Phe Asp Ser Ser Gly Ala Tyr Asp Ser 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Leu Thr Val Ser Ser 
        115                 120             


<210>  1902
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1902

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Asn Ser Phe Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1903
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1903

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Lys 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Asn Asn Lys Phe Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Met Glu Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Lys Gly Pro Leu Trp Arg Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1904
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1904

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Ile Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Phe Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Asp Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Ala Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1905
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1905

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Glu Ser Thr Gln Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
            100                 105                 110         


<210>  1906
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1906

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser His Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Thr Tyr Ser Gln 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1907
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1907

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Val Tyr Tyr Ile Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ala Pro Phe Gln Leu Leu Asp Lys Tyr Tyr Phe Phe Tyr 
            100                 105                 110         


Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1908
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1908

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Gly Val Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 


<210>  1909
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1909

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Arg Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Lys Thr Gly Ser Pro Arg Tyr Gly Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Asn Tyr Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Arg Pro Gly Gly Asp Ile Glu Val Ala Ala Leu Asp Trp Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val His Val Ser Ser 
        115                 120         


<210>  1910
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1910

Gln Ser Ala Leu Thr Gln Pro Pro Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Ala Ile Ser Cys Thr Gly Ser Ser Ser Asp Ile Gly Ser Tyr 
            20                  25                  30          


Asn Arg Val Ser Trp Tyr Gln Gln Pro Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Glu Val Thr Asn Arg Pro Pro Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Arg Ala Glu Asp Glu Gly Asp Tyr His Cys Ser Ser Tyr Thr Ser Gly 
                85                  90                  95      


Ser Thr Val Ile Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105                 110 


<210>  1911
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1911

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Lys Pro Tyr Asn Gly Asn Thr Gly Tyr Ala Glu Lys Phe 
    50                  55                  60                  


Gln Gly Arg Leu Thr Met Thr Thr Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Asp Ser Val Gly Ala Asp Ala Phe Asp Met Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  1912
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1912

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Ser Val Thr Ile Ala Cys Arg Ala Ser His Ser Ile Gly Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Pro Arg Phe Ser Gly 
    50                  55                  60                  


Arg Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Gly Val Tyr Phe Cys His Gln Ser Tyr Thr Thr Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Val Glu Ile Lys 
            100                 105         


<210>  1913
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1913

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Gln Gly Thr Tyr Leu Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1914
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1914

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Phe Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Asp Asp Val Gly Val Tyr Tyr Cys Met Gln Ser 
                85                  90                  95      


Ile Gln Pro Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  1915
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1915

Glu Val Gln Leu Val Glu Ser Gly Gly Asp Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ile Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Ser Ile Ser Arg Asp Asn Ser Asn Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Phe Cys Ala 
                85                  90                  95      


Arg His Ile Pro Ala Trp Gly Tyr Lys Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  1916
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1916

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Arg Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Glu Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Ile Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys His Gln Tyr Asp Tyr Leu Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Asp Ile Lys 
            100                 105         


<210>  1917
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1917

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Gly Ser 
            20                  25                  30          


Asp Ser Phe Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Ser Asp Ser Gly Thr Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Asn Ser Arg Val Thr Ile Ser Val Asp Thr Ser Arg Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Val Arg Gly Arg Asn Leu Ser Gly His Gly Leu Leu Asp Thr Trp 
            100                 105                 110         


Cys Lys Val Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1918
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1918

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Val Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Ile Tyr Tyr Cys Gln Gln Arg Arg Ser Trp Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Arg Val Glu Ile Lys 
            100                 105         


<210>  1919
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1919

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Gly Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Ser Asp Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Gln Arg Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Ala Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Arg Asp Thr Ser Ala Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Arg Ser His Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  1920
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1920

Glu Val Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Glu Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Ser Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Thr Asn Phe Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  1921
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1921

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Asn Val Ser Gly Gly Ser Ile Ser Gly Ser 
            20                  25                  30          


Thr Tyr Tyr Trp Gly Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Arg Asn Ala Phe Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Thr Arg Asp Tyr Ser Ser Tyr Gly Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Lys Val Thr Val Ser Ser 
        115                 120 


<210>  1922
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1922

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Arg 
            20                  25                  30          


Asp Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Ile Ile Tyr Glu Val Thr Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Phe Cys Cys Ser Tyr Ser Gly Ser 
                85                  90                  95      


Ser Ile Phe Gly Val Phe Gly Gly Gly Thr Gln Leu Thr Val Leu 
            100                 105                 110     


<210>  1923
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1923

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Ser Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Ile Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Leu Leu Gly Ser Gly Ile Thr Leu Asp Asn Asp Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  1924
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1924

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Thr Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Thr Tyr Ser Thr Pro Leu 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  1925
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1925

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Tyr Ser Gly Tyr Asp Pro Ala Leu Tyr Tyr Tyr Tyr Tyr 
            100                 105                 110         


Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1926
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1926

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Ser Asn Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1927
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1927

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asn Tyr 
            20                  25                  30          


Val Met His Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Ile Ser His Asp Gly Thr Val Thr Thr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Thr Lys Asn Thr Val Trp 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Asp Phe Asp Trp Val Leu Tyr Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Ala Val Ser Ser 
        115             


<210>  1928
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1928

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Val Glu Asn His 
            20                  25                  30          


Tyr Val Tyr Trp Phe Gln Gln Gln Leu Pro Gly Ala Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Met Asn Asp Gln Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  


Arg Ser Glu Asp Glu Thr His Tyr Tyr Cys Ala Ala Trp Asp Val Ser 
                85                  90                  95      


Leu Thr Gly Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1929
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1929

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ile Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Val Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Gly His Phe Asp Ser Ser Gly Tyr Tyr Leu Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1930
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1930

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Pro Thr Gly Ile Pro Ala Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Thr Asn Trp Pro Pro 
                85                  90                  95      


Leu Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 


<210>  1931
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1931

Arg Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Val Phe Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Asn Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ala Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Phe Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Arg Thr Ile Thr Thr Phe Tyr Ser Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  1932
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1932

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Ser Val Thr Ile Ser Cys Arg Ala Ser Glu Asp Ile Arg Asn Tyr 
            20                  25                  30          


Val Thr Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Arg Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Ser Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Asp Ile Lys 
            100                 105     


<210>  1933
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1933

Gln Met Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Ser Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Met Thr Ser Ser 
            20                  25                  30          


Ser Tyr His Trp Gly Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Asn Phe Tyr Tyr Ser Gly Arg Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Arg Ser Arg Val Thr Ile Phe Ala Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Ser Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Ile Ile Thr Ile Phe Gly Phe Gly Ala Phe Asp Ile Trp Gly 
            100                 105                 110         


Gln Gly Thr Val Val Thr Val Ser Ser 
        115                 120     


<210>  1934
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1934

Asp Ile Val Leu Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu His Thr 
            20                  25                  30          


Asp Gly Lys Thr Tyr Leu Tyr Trp Tyr Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Met Tyr Glu Val Ser Ser Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Glu Gly 
                85                  90                  95      


Arg His Phe Pro Leu Phe Ser Phe Gly Pro Gly Thr Lys Val Asp Ile 
            100                 105                 110         


<210>  1935
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1935

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Val Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Phe Gly Ser Gly Ile Val Gly Ala Thr Gly Phe Asp Phe 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1936
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1936

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Asn Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Met Cys 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1937
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1937

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Asn Trp Asn Gly Gly Ser Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr His Cys 
                85                  90                  95      


Ala Arg Arg Arg Ser Ser Ser Arg Tyr Ser Ser Gly Trp Tyr Met Tyr 
            100                 105                 110         


Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1938
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1938

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Glu Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Thr Tyr Ser Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  1939
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1939

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Asn Ser 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Thr His Arg Cys Ser Gly Gly Phe Cys Tyr Leu Ala Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1940
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1940

Gln Pro Val Leu Thr Gln Pro Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Thr Cys Thr Leu Ser Ser Gly Tyr Ser Asn Tyr Lys 
            20                  25                  30          


Val Asp Trp Tyr Gln Gln Arg Pro Gly Lys Gly Pro Arg Phe Val Met 
        35                  40                  45              


Arg Val Gly Thr Gly Gly Ile Val Gly Ser Lys Gly Asp Gly Ile Pro 
    50                  55                  60                  


Asp Arg Phe Ser Val Leu Gly Ser Gly Leu Asn Arg Tyr Leu Thr Ile 
65                  70                  75                  80  


Lys Asn Ile Gln Glu Glu Asp Glu Ser Asp Tyr His Cys Gly Ala Asp 
                85                  90                  95      


His Gly Ser Gly Ser Asn Phe Val Phe Val Val Phe Gly Gly Gly Thr 
            100                 105                 110         


Lys Leu Thr Val Leu 
        115         


<210>  1941
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1941

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Lys Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Asp Leu Gly Asp Tyr 
            20                  25                  30          


Gly Val Ser Trp Val Arg Gln Asp Pro Gly Lys Thr Leu Glu Trp Val 
        35                  40                  45              


Ala Gly Ile Thr Gly Gly Ser Gly Glu Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Ser Ala Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ser Asp Asp Thr Ala Leu Tyr Phe Cys 
                85                  90                  95      


Ala Arg Glu Arg Gly Tyr Tyr Gly Leu Gly Ser Gln Ile Asn Trp Phe 
            100                 105                 110         


Glu His Trp Gly Gln Gly Thr Leu Val Ser Val Ser 
        115                 120                 


<210>  1942
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1942

Gly Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Thr Val Thr Ile Thr Cys Arg Ala Asn Gln Thr Ile Lys Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro His Phe Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ala Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ala Gly Thr Val Phe Val Leu Thr Ile Asn Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ile Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Arg Val Glu Ile 
            100                 105     


<210>  1943
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1943

Gln Val His Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Thr Arg Ser Gly Ser Thr Asp Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Asn Arg Val Thr Met Ser Val Asp Ser Ser Arg Thr Gln Phe Ser Leu 
65                  70                  75                  80  


Ser Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Phe Asp Ser Ala Trp Glu Leu Gln Phe Leu Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1944
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1944

Asp Ile Val Met Thr Gln Ser Pro His Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu His Arg 
            20                  25                  30          


Pro Asn Asn Met Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Ala Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Ile Ser Gly Ser Gly Ser Glu Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Glu Val Thr Pro Arg Thr Phe Gly His Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1945
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1945

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Thr Ser Gly Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Ala Leu His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Thr Val Ile Ser Asp Asp Gly Asn Asn Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Phe 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Ser Tyr Asn Ser Asn Trp Ser Ile Gly Glu Tyr Phe Arg 
            100                 105                 110         


Asp Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1946
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1946

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Leu Leu Tyr Thr 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Pro Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1947
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1947

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Leu Tyr Asp Gly Ser Asn Arg Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gln Gly Gly Leu Tyr Cys Ser Gly Thr Asn Cys Trp Gly Gly 
            100                 105                 110         


Tyr Leu Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  1948
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1948

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu His Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr His Asn Leu Pro Pro 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  1949
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1949

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Cys Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Arg Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Phe 
                85                  90                  95      


Cys Val His Arg His Val Ser Gly Ala Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1950
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1950

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Glu Thr Tyr Val 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Gly Gly 
                85                  90                  95      


Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105         


<210>  1951
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1951

Glu Val Lys Leu Leu Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Ile Ile Phe Gly Ser His 
            20                  25                  30          


Val Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Gln Trp Val 
        35                  40                  45              


Ser Ser Val Ser Gly Ser Gly Ser Asn Met Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Phe 
65                  70                  75                  80  


Leu Gln Val Asn Ser Leu Arg Val Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Leu Ala Ala His Ser Ser Gly Trp Tyr Gly Ala Glu Leu Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Ser Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  1952
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1952

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Gly Leu Ser Lys Gln Tyr Thr 
            20                  25                  30          


Phe Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Leu Ile Tyr 
        35                  40                  45              


Lys Asp Thr Glu Arg Pro Ser Glu Thr Ser Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ala Ser Gly Thr Thr Ala Thr Leu Thr Ile Thr Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Thr Asp Gly Gly Gly Gly Phe 
                85                  90                  95      


Gln Gly Ile Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105                 


<210>  1953
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1953

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Arg Leu Leu Gly Tyr Cys Ser Ser Thr Ser Cys Tyr Thr 
            100                 105                 110         


Ile Gly Trp Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  1954
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1954

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Leu Asp Ile Ser Lys Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Phe Asn Leu Glu Arg Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Pro 
                85                  90                  95      


Gly Val Ser Thr Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110     


<210>  1955
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1955

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Gln Gly Thr Tyr Leu Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  1956
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1956

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Thr Asp Ser Ser Gly Asn Gln 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1957
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1957

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Glu Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Gly Ser Ala Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Ala Arg Ser Arg Tyr Phe Asp Trp Leu Pro Ser Tyr Tyr 
            100                 105                 110         


Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1958
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1958

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Ile Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Thr Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1959
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1959

Gln Val Leu Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Ala Arg Ser Arg Tyr Phe Asp Trp Leu Pro Ser Tyr Tyr 
            100                 105                 110         


Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1960
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1960

Asn Phe Ile Leu Thr Gln Pro His Ser Val Ser Ala Ser Pro Gly Glu 
1               5                   10                  15      


Thr Val Asn Ile Ser Cys Thr Arg Ser Ser Gly Asp Ile Ala Arg Asn 
            20                  25                  30          


Ser Val Gln Trp Tyr Gln Gln Arg Pro Asp Cys Ala Pro Thr Val Leu 
        35                  40                  45              


Ile Phe Glu Asp Asp Gln Arg Pro Ser Ala Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Arg Ser Ser Asn Thr Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Thr Pro Glu Asp Glu Ala Asp Tyr Tyr Cys His Ser Tyr Asp Asp 
                85                  90                  95      


Asn Tyr Gln Ala Phe Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105                 110     


<210>  1961
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1961

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Gln Trp Val 
        35                  40                  45              


Ser Thr Ile Ser Val Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Pro Ala Ser Trp Ile Val Gly Pro Thr His Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1962
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1962

Gln Leu Val Leu Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Thr Cys Thr Leu Ser Ser Gly His Thr Thr Tyr Ala 
            20                  25                  30          


Ile Ala Trp His Gln Gln Gln Pro Glu Lys Gly Pro Arg Tyr Leu Met 
        35                  40                  45              


Lys Leu Asn Ser Asp Gly Ser His Thr Arg Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Ser Ser Gly Ala Glu Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Trp Asp 
                85                  90                  95      


Thr Gly Ile Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1963
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1963

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg His 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ala Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Ser Pro Leu Val Leu Ile Thr Ser Ile Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1964
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1964

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Arg Gln Tyr Thr 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Thr Ile Gly Thr Tyr 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1965
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1965

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Thr Tyr Tyr Cys Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Thr Tyr Tyr Gly Gly Ser Thr Leu Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Arg Gly Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg Gly Asn Tyr Tyr Asp Ser Lys Asn Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1966
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1966

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Val Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Met Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  1967
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1967

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Ile Ser Cys Gly Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Ser Ser Arg Lys Asp Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ala Ile Ser Arg Asp Asn Ala Lys Asn Ser Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Asp Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Thr Gly Gly Ala Tyr Tyr Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  1968
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1968

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Ser Ile Gly Asn Lys Asn Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Leu Trp Asp Asp Asp Ser Asp Arg 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  1969
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1969

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Phe Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Arg Ser Arg Ile Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gly Gly Ser Gly Ser Tyr Ser Leu Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  1970
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1970

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Thr Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Tyr Ser 
                85                  90                  95      


Val His Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  1971
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1971

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Ser 
            20                  25                  30          


Asp Leu His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Leu Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Gly Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Leu Tyr Asp Ser Ser Gly Phe Tyr Asn Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1972
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1972

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Lys Ser Gly Val Pro Ser Arg Phe Gly Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Glu Met Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105         


<210>  1973
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1973

Glu Glu Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Glu 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Ser Thr Phe Ser Ser Ala 
            20                  25                  30          


Gly Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Ser Tyr Ile Ser Val Ser Ser Thr Thr Ile Tyr Tyr Ala Glu Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Glu Asn Gly Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Leu Tyr Asp Ser Ser Gly Phe Tyr Asn Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  1974
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1974

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Glu Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Phe Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Leu Tyr Gly Ser Ser Pro 
                85                  90                  95      


Leu Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  1975
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1975

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Glu Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Glu Gly Asp Trp Leu Leu Gly Gly Pro Tyr Tyr His Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  1976
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1976

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Tyr Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Ser Arg Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Ser Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1977
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1977

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu His Cys Ala Val Ser Gly Leu Thr Leu Ser Arg Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Ser Ile Tyr Tyr Ser Arg Asn Ala Phe Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Gln Gly Arg Gly Gly Tyr Tyr Ser Pro Phe Asp Asp Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1978
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1978

Ser Tyr Glu Leu Thr Gln Pro Ser Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Val Leu Ala Lys Lys Tyr Ala 
            20                  25                  30          


Arg Trp Phe Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Ala Ala Asp Asn Asn Leu Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1979
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1979

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Asn Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Gly Arg Val Ser Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ile Leu Val Ile Phe Thr Leu Asn Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  1980
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1980

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Gly Asn Pro Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  1981
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1981

Gln Ala Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Tyr Gly Ala Ser Phe Ser Asp Tyr 
            20                  25                  30          


Phe Trp Thr Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Leu 
        35                  40                  45              


Gly Glu Ile Arg Gln Ile Gly Thr Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Gly Arg Ala Thr Ile Ser Met Asp Thr Ser Lys Ser Gln Phe Ser Leu 
65                  70                  75                  80  


Ser Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Phe Cys Ala 
                85                  90                  95      


Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Val Ala Ser Gly Pro Gly 
            100                 105                 110         


Ile Gln Val Thr Val Ser Ser 
        115                 


<210>  1982
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1982

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Gly Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Asn Ser 
            20                  25                  30          


Gln Asn Asn Arg Asp Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Phe Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ala Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Leu Tyr Ser Ala Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  1983
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1983

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ile Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Gln Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Ala Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Gly Ser Ser Trp His Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1984
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1984

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ser 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Thr Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Ser Ser Ser Thr Ala Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1985
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1985

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Thr Gly Phe Thr Phe Ser Ser Asn 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Pro Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ala Ile Gly Asn Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu His Leu 
65                  70                  75                  80  


Gln Met His Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asn Thr Ala Gly Ser Gln Asn Trp His Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Gln Val Thr Val Ser Ser 
        115                 120 


<210>  1986
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1986

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Lys Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Asn Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Val Thr Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  1987
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1987

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Pro Ile Ser Ser Ser 
            20                  25                  30          


Arg Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Asp Gly Ser Gly Glu Met Asp Thr Ile Thr Trp Gly 
            100                 105                 110         


Pro Ile Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  1988
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1988

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Tyr Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Thr Leu Asn Val Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  1989
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1989

Glu Val Tyr Leu Leu Glu Ala Gly Gly Asp Leu Ala Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ser Gly Phe Thr Phe Asp Asn Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Gly Asp Asn Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Lys Met Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Val Ala Tyr Ser Gly Ser Asn Ser Val Val Tyr Tyr Tyr Tyr 
            100                 105                 110         


Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1990
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1990

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ala Phe 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Val Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Thr 
                85                  90                  95      


His Val Ala Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 


<210>  1991
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1991

Gln Ile Thr Phe Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Ser Thr Ser 
            20                  25                  30          


Gly Glu Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Val Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Arg Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  1992
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1992

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Arg Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  1993
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1993

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Arg Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Thr Ser Gly Phe Asn Phe Arg Asp Tyr 
            20                  25                  30          


Ala Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Leu Ile Arg Ser Glu Pro Tyr Arg Ala Thr Thr Glu Tyr Ala Ala 
    50                  55                  60                  


Ser Val Arg Gly Arg Phe Thr Leu Ser Arg Asp Asp Ser Lys Ser Leu 
65                  70                  75                  80  


Ala Tyr Leu Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Phe Cys Ala Arg Thr Glu Arg Cys Gly Ala Asp Cys Thr Ser His Ile 
            100                 105                 110         


Asn Tyr Tyr Leu Asp Val Trp Gly Ser Gly Thr Ser Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  1994
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1994

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asp Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Asp Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Tyr Leu Ile Ile Ser Arg Val Glu 
65                  70                  75                  80  


Pro Glu Asp Ile Ala Val Tyr Tyr Cys Gln Gln Tyr Ser Ser Trp Pro 
                85                  90                  95      


Phe Ser Phe Gly Gly Gly Thr Lys Val His Ile Lys 
            100                 105             


<210>  1995
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1995

Glu Val Tyr Leu Leu Glu Ala Gly Gly Asp Leu Ala Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ser Gly Phe Thr Phe Asp Asn Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Gly Asp Asn Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Lys Met Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Val Ala Tyr Ser Gly Ser Asn Ser Val Val Tyr Tyr Tyr Tyr 
            100                 105                 110         


Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  1996
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1996

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ala Phe 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Val Lys Arg Pro Ser Gly Val Pro Val Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Pro Cys Thr 
                85                  90                  95      


Tyr Thr Cys Gln Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  1997
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1997

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Gln Arg Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Val Gly Asn Gly Asn Thr Lys Tyr Ser Gln Arg Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Arg Asp Thr Ser Ala Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Met Gly Pro Ser Ala Phe Ser Trp Leu Asp Pro Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  1998
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1998

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln His Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Gly Trp Ser Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110         


<210>  1999
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1999

Gln Val Gln Leu Ala Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Thr Ser Gly Ser Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  2000
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2000

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Asp Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Glu Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110         


<210>  2001
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2001

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Asn Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Pro Pro Ser Tyr His Gly Trp Cys Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Asn Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2002
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2002

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ile Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr His Met 
                85                  90                  95      


Ser Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2003
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2003

Gln Val Gln Val Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Lys Asn Tyr 
            20                  25                  30          


Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Thr Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Met Thr Met Thr Thr Asp Thr Ser Thr Gly Thr Gly Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gln Arg Arg Arg Leu Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Ile Val Ser Ser 
        115         


<210>  2004
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2004

Asp Ile Val Val Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Glu Thr Leu Leu His Ser 
            20                  25                  30          


Asp Gly Lys Thr Tyr Leu Ser Trp Tyr Leu Gln Lys Pro Gly Gln Pro 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Glu Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Gly Arg Val Glu Ala Glu Asp Val Gly Leu Tyr Tyr Cys Met Gln Ser 
                85                  90                  95      


Ile Gln Leu Ala Phe Gly Gln Gly Thr Arg Leu Glu Ile Glu 
            100                 105                 110 


<210>  2005
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2005

Glu Val Gln Leu Val Glu Ser Gly Gly Thr Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Trp Val Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Gln Tyr Val Gly Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Thr Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Tyr Asp Ser Thr Gly Tyr Gly Ala Phe Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val 
        115                 120 


<210>  2006
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2006

Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Glu 
            20                  25                  30          


Asp Gly Lys Thr Tyr Leu Asn Trp Phe His Gln Arg Pro Gly His Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Thr Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Ile Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr Arg Trp Pro Tyr Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110         


<210>  2007
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2007

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Phe 
            20                  25                  30          


Gly Val Gly Val Gly Trp Val Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Cys Leu Ala Leu Ile Tyr Trp Asp Asp Asp Glu Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Ala Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120             


<210>  2008
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2008

Asp Ile Val Met Thr Gln Ser Pro Glu Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Leu Leu Tyr Ser 
            20                  25                  30          


Ser Asp Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ile Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Arg Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Ala Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Gly Val Leu Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2009
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2009

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly His 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Pro Pro Gln Ala Ala Arg Ile His Tyr Tyr Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2010
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2010

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Tyr Trp Pro Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2011
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2011

Glu Val Arg Leu Val Glu Ser Gly Gly Val Leu Ala Gln Pro Gly Ser 
1               5                   10                  15      


Ser Leu Thr Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Val Ser Gly Gly Gly Asn Thr Tyr Tyr Ala Asp Ser Val Arg 
    50                  55                  60                  


Gly Arg Phe Thr Ile Phe Arg Asp Asn Ser Lys Asn Ile Leu Phe Leu 
65                  70                  75                  80  


Gln Met Asn Asn Leu Arg Ala Glu Asp Thr Ala Ala Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ser Pro Trp Gly Ser Gly Gly His Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2012
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2012

Asp Val Val Met Thr Gln Thr Pro Leu Ser Leu Val Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Glu Ser Leu Val Tyr Arg 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Ser Trp Leu Leu Val Arg Pro Gly Gln Pro 
        35                  40                  45              


Pro Arg Leu Leu Leu Tyr Met Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ala Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Leu Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Thr Gln Tyr Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  2013
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2013

Gln Ile Thr Leu Lys Glu Ser Gly Pro Met Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Asp Thr Tyr 
            20                  25                  30          


Gly Met Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Phe 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Leu Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Leu Asp Ala Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Val Arg Arg Tyr Tyr Asp Ser Ser Ser Asp Glu Gly His Gly Phe 
            100                 105                 110         


Asp Ile Trp Gly Gln Gly Thr Ile Phe Thr Val Ser Ser 
        115                 120                 125 


<210>  2014
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2014

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Arg Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Thr Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr His Val Ser Gln Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Leu Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Tyr Ala Phe Ala Leu Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  2015
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2015

Glu Glu His Leu Val Glu Ser Gly Gly Gly Ser Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ala Gly Phe Asn Phe Asp Ala His 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Ser Asp Tyr Lys Val Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Gly Lys Thr Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Ala Phe Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Val Asp Gln Gly Gly Val Ile Ala Tyr Phe Gln His Trp 
            100                 105                 110         


Gly Pro Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2016
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2016

Glu Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Arg Ser 
            20                  25                  30          


Ser Gly Tyr Asn Tyr Leu Ser Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Leu Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Arg Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2017
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2017

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Gly Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ala Gly Gly Asp Gly Ser Thr Tyr Tyr Ala Glu Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Ile Thr His Asp Asp Gly Gly Pro Asp His Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2018
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2018

His Ser Val Leu Thr Gln Pro Pro Ser Thr Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Tyr Val Phe Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Lys Asn Ile Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Gly Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val 
            100                 105                 


<210>  2019
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2019

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Thr Tyr Asn Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Leu Thr Thr Ala Phe 
65                  70                  75                  80  


Leu His Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Phe Tyr Gly Pro Ser Ser Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Ile Val Ser Ser 
        115                 


<210>  2020
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2020

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Thr Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser His Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Lys Val Lys Pro Gly Gln Ala Pro Leu Leu Val Ile Tyr 
        35                  40                  45              


Gly Arg Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Arg Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Val Asp 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Gly Asp Ser Ser Thr Asp His 
                85                  90                  95      


His Val Val Phe Ala Gly Gly Thr Lys Leu Ala Val Val 
            100                 105                 


<210>  2021
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2021

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Arg Pro Gly Ala 
1               5                   10                  15      


Ser Met Asn Ile Ser Cys Lys Ala Ser Gly Tyr Asn Phe Asn Asn Asn 
            20                  25                  30          


Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Val Val Asn Pro Thr Gly Gly Gly Thr Ala Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Gln Asp Arg Val Thr Ile Thr Ser Asp Thr Pro Arg Asn Thr Val Tyr 
65                  70                  75                  80  


Leu Gly Val Thr Gly Leu His Ser Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Gly Gly Glu Trp Arg Ile Val Pro Gly Gly Arg Asp Tyr Phe 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ala 
        115                 120                 125 


<210>  2022
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2022

Asp Met Glu Val Thr Gln Phe Pro Ser Ser Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Thr Gln Ser Ile Ser Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser His Leu Gln Arg Gly Val Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Thr Thr Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Gly Thr Tyr Tyr Cys His Gln Ser Tyr Gly Val Pro Ile 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2023
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2023

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Phe Gly Tyr Asn Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Glu Thr Arg Asn Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Met Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Val Ser Lys Tyr Cys Ser Gly Gly Arg Cys Leu Ser 
            100                 105                 110         


Gly Gly Ser Asn Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2024
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2024

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Met Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  2025
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2025

Glu Val His Leu Val Gly Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Phe Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ile Ile His Asn Gly Gly Asp Ser Tyr Tyr Thr Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Asn Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Ser Ser Ser Trp Leu Arg Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr 
            100                 105                 110         


Met Val Thr Val Ser Ser 
        115             


<210>  2026
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2026

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Ser Lys Tyr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2027

<400>  2027
000

<210>  2028

<400>  2028
000

<210>  2029
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2029

Asn Val Gln Leu Val Asp Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Ala Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Gly Ile Ser Gly Ser Ser Asp Tyr Arg Ala Tyr Ala Asp Ser Leu 
    50                  55                  60                  


Gln Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Glu Asn Ser Leu Trp 
65                  70                  75                  80  


Leu His Met Asn Ser Leu Thr Asp Glu Asp Thr Ala Phe Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ile Asp Tyr Gly Gly Ile Leu Ala Tyr Phe Asp Ser Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2030
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2030

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Gln Ser 
            20                  25                  30          


His Gly Tyr Asn Phe Leu Ser Trp Tyr Val Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Leu Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Gln Gln Thr Pro His Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110         


<210>  2031
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2031

Glu Val Gln Leu Val Glu Ser Gly Gly Asp Leu Val Lys Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ser Ala Ser Gly Phe Thr Phe Gly Asp Tyr 
            20                  25                  30          


Thr Met Ser Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Phe Ile Arg Ser Lys Ala Tyr Gly Gly Thr Thr Glu Tyr Ala Ala 
    50                  55                  60                  


Ser Val Ile Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Ser Ile 
65                  70                  75                  80  


Ala Tyr Leu Gln Met Asn Ser Leu Lys Ser Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ser Arg Val Arg Gly Ser Phe Tyr Gly Ser Val Gly Lys Asn 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2032
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2032

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Thr Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Leu Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2033
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2033

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Ser Ser Tyr 
            20                  25                  30          


Val Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Ser Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ile Asp Ser Gly Tyr Asp Pro Thr Pro Val Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2034
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2034

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Cys Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Gly Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ser Leu Ser 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2035
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2035

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Cys Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Ala Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2036
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2036

Glu Val Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Glu Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Ser Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Thr Asn Phe Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210>  2037
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2037

Glu Glu Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Thr Leu Thr Cys Glu Ala Ser Gly Phe Ser Leu Ser Thr Tyr 
            20                  25                  30          


Trp Met Met Gly Trp Val Arg Gln Val Pro Gly Gln Gly Leu Val Trp 
        35                  40                  45              


Val Ser Arg Ile Ser Met His Gly Asn His Ile Ser Tyr Ala Asp Ser 
    50                  55                  60                  


Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Ile Ser Lys Asn Thr Leu 
65                  70                  75                  80  


Tyr Leu Gln Leu Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Phe 
                85                  90                  95      


Cys Val Arg Asp Gly Gly Ser Asp Thr His Asp Trp Phe Phe Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr Pro Val Thr Val Ser Ser 
        115                 120             


<210>  2038
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2038

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Glu Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Val Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Val Val Ser Gln Arg Pro Ser Gly Val Ser His Arg Phe 
    50                  55                  60                  


Ala Gly Ser Lys Ser Gly Asn Thr Ala Phe Leu Thr Val Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Leu Ser Tyr Ala Gly Gly 
                85                  90                  95      


Gly Arg Gly Phe Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105                 110 


<210>  2039
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2039

Glu Val Gln Leu Leu Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Glu Arg Ile Thr Met Leu Val Val Val Thr Leu Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2040
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2040

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Arg Gln Phe Thr 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Thr Ile Gly Thr Tyr 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Ser Val Leu 
            100                 105             


<210>  2041
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2041

Gln Val Gln Leu Val Gln Phe Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Gly Ile Ser Trp Val Arg Gln Ala Pro Gly His Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Asn Gly Lys Thr Ile Tyr Ala Gln Lys Leu 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Val Leu Arg Ser Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Thr Thr Arg Asp Gly Arg Tyr Trp Gly Gln Gly Thr Leu Val Thr Val 
            100                 105                 110         


Ser Ser 
        


<210>  2042
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2042

Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr His Trp Pro Asn Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  2043
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2043

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Asp Trp Val 
        35                  40                  45              


Ser Ser Ile Thr Gly Ser Gly Asp Thr Thr Asp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Met Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Val Ser Ser Leu Arg Val Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Thr Pro Gly Gly Ser Ser Phe Phe Leu Thr Tyr Cys Phe Asp 
            100                 105                 110         


Ser Trp Gly Gln Gly Thr Leu Val Ser Val Ser Ser 
        115                 120                 


<210>  2044
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2044

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asn Thr Ala 
            20                  25                  30          


Ser Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Thr Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Ile Ser Pro 
                85                  90                  95      


Gly Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2045
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2045

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val Asp Ile Ser Ser Ser Trp Tyr Pro Gly Tyr Tyr Tyr 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2046
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2046

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Tyr Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Arg Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Val Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Gly Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2047
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2047

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu His Cys Ala Val Ser Gly Leu Thr Leu Ser Arg Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ala Ile Lys Glu Asp Gly Ser Glu Ile Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Glu Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr His Cys 
                85                  90                  95      


Ala Arg Gly Pro Tyr Trp Gly Gln Gly Thr Leu Val Ala Val Ser Ala 
            100                 105                 110         


<210>  2048
<211>  104
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2048

Gly Val Gln Leu Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Tyr Phe Gly Arg Trp 
            20                  25                  30          


Leu Ala Trp Phe Gln Gln Lys Pro Gly Arg Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Glu Ala Ser Lys Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Phe Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Arg Tyr Asp Gly Pro Phe Gly 
                85                  90                  95      


Gln Gly Thr Lys Val Glu Ile Lys 
            100                 


<210>  2049
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2049

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Arg Tyr 
            20                  25                  30          


Ser Trp Asn Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Arg Ile Tyr Thr Ser Gly Arg Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Ile Thr Met Ser Val Asp Thr Ser Lys Asn Glu Phe Ser Leu 
65                  70                  75                  80  


Lys Val Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Arg Asp Tyr Tyr Asp Ser Ser Gly Ala Tyr Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Ala Thr Val Ser Ser 
        115                 120             


<210>  2050
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2050

Gln Thr Val Val Thr Gln Glu Pro Ser Phe Ser Val Ser Pro Gly Gly 
1               5                   10                  15      


Thr Val Thr Leu Thr Cys Gly Leu Ser Ser Ala Ser Val Ser Thr Ser 
            20                  25                  30          


Tyr Tyr Pro Thr Trp Tyr Gln Gln Thr Pro Gly Gln Ala Pro Arg Thr 
        35                  40                  45              


Leu Ile Tyr Ser Thr Asn Thr Arg Ser Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Ile Leu Gly Asn Lys Ala Ala Leu Thr Ile Thr Gly Ala 
65                  70                  75                  80  


Gln Ala Asp Asp Glu Ser Asp Tyr Tyr Cys Val Leu Tyr Met Gly Ser 
                85                  90                  95      


Gly Ile Ser Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2051
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2051

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Ala Ala Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Gly Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2052
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2052

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Ser Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile 
            100                 105             


<210>  2053
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2053

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Thr Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Arg Gly Gly Ile Gly Ile Glu Tyr Gly Met Asp Val Trp 
            100                 105                 110         


Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2054
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2054

Ser Asn Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Thr Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Thr Ala Ser Ser Gly Thr Tyr 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2055
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2055

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asp Ile Ser Tyr Asp Gly Ser Glu Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Tyr Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Phe Gly Gly Asp Asn Thr Ala Met Val Glu Tyr Phe Phe 
            100                 105                 110         


Asp Phe Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2056
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2056

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Ser Pro 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2057
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2057

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Gly 
            20                  25                  30          


Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Cys Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Ser Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Met Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Gly Ser Pro Val Pro Pro Thr Ile Val Gly Ala Ser Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Asp Ser Ser 
        115                 120         


<210>  2058
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2058

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Phe Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ile Asn Arg Trp Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2059
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2059

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Thr Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Arg Gly Asn Tyr Leu Thr Phe Phe Asp Ser Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2060
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2060

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2061
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2061

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Ala Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Ser Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Met Asp Gly Ser Ala Gly Asn Ile Tyr Tyr Ala Asp Ala Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Ala Tyr Phe Cys 
                85                  90                  95      


Ala Lys Asp Ser Gly Ala Leu Cys Ser Gly Gly Asp Cys Leu Arg Gly 
            100                 105                 110         


Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2062
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2062

Asp Ile Val Met Thr Gln Ser Pro Glu Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Phe Ser 
            20                  25                  30          


Thr Asn Asn Lys Asn Tyr Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Ala Leu Leu Ile Tyr Trp Ala Ser Thr Arg Ala Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Asn Pro Leu Trp Thr Phe Gly Gln Gly Thr Lys Val Glu 
            100                 105                 110         


Ile Lys 
        


<210>  2063
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2063

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Pro Pro Ala Ser Tyr Tyr Asn Pro Ser Thr Gly Tyr Phe 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2064
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2064

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Phe Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Met 
                85                  90                  95      


His Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2065
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2065

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser His 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Ser Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val Phe Trp Val Pro Ala Ala Ser Ser Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2066
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2066

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Leu Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2067
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2067

Glu Val Arg Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Ala Thr Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ser Ile Ser Arg Asp Asn Ser Lys Asn Ser Leu Val 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Pro Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  2068
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2068

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ile Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Arg Val Glu Ile 
            100                 105     


<210>  2069
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2069

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Pro Phe Ser Ala Phe 
            20                  25                  30          


Tyr Met Thr Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Thr Gly Asp Gly Val Val Ser Tyr Val Asp Ser Val Arg 
    50                  55                  60                  


Gly Arg Phe Ser Ile Ser Arg Asp Asn Ser Arg Ser Ser Leu His Leu 
65                  70                  75                  80  


Gln Met Asn Arg Leu Arg Asp Glu Asp Thr Ala Ile Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Asn Tyr Gly Ile Asp Phe Trp Gly Gln Gly Ile Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  2070
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2070

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Leu Ser Arg Thr 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Phe Leu 
        35                  40                  45              


Ile Ser Asn Ala Ser Ser Arg Pro Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ala Arg Leu Glu 
65                  70                  75                  80  


Thr Asp Asp Ser Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Thr Ser Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2071
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2071

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Arg Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Trp Asn Ser Gly Ile Ile Glu Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Ser Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Thr Lys Asp Ile Pro Ala Thr Gly Arg Phe Thr Ala Phe Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  2072
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2072

Ser Tyr Asp Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Ala Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Leu Leu Val Ile Ser 
        35                  40                  45              


Glu Asp Arg Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Ala Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Gly Asp Tyr Phe Cys Phe Ser Ala Asp Ser Leu Gly Gly His 
                85                  90                  95      


Arg Met Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2073
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2073

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Glu Trp Phe Arg Glu Leu Phe Leu Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2074
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2074

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Phe Pro Pro 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2075
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2075

Gln Val Gln Leu Leu Gln Ser Gly Gly Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Asp Asn Tyr 
            20                  25                  30          


Gly Leu Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Gln Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Asn Gly Asp Thr Asn Ser Ala Gln Lys Phe 
    50                  55                  60                  


Gln Asp Arg Val Thr Met Thr Ile Asp Thr Ser Met Arg Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Ala His Cys Thr Gly Gly Val Cys Tyr His Leu Pro Val 
            100                 105                 110         


Asp Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2076
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2076

Asp Phe Gln Met Thr Gln Ser Pro Ser Tyr Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Ser Ile Thr Cys Arg Thr Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Thr Val Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Val Ala Ser Thr Leu Leu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr His Phe Thr Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Lys Tyr Asp Ser Val Pro Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105     


<210>  2077
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2077

Gln Val Gln Leu Gln Glu Ser Gly Pro Arg Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Met Ser Gly Phe 
            20                  25                  30          


Phe Trp Ser Trp Val Arg Gln Ser Pro Glu Arg Gly Phe Glu Tyr Ile 
        35                  40                  45              


Gly Tyr Phe Tyr Ser Ser Ala Lys Thr Asp Tyr Asn Pro Ser Leu Ser 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Leu Asp Ala Ser Lys Asn Leu Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Thr Ser Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg Tyr 
            100                 105                 110         


Pro Arg Pro Asp Ile Phe Asp Met Trp Gly Arg Gly Thr Arg Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2078
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2078

Gly Val Gln Leu Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Glu Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Asp Thr 
65                  70                  75                  80  


Glu Asp Phe Gly Val Tyr Tyr Cys His Gln Tyr Gly Ile Ser Pro Phe 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Thr Val Asp Ile Lys 
            100                 105         


<210>  2079
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2079

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Pro Ser Tyr 
            20                  25                  30          


Ser Ile Ala Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Val Ser Ala Tyr Asn Gly Tyr Thr Asn Phe Ala Gln Lys Leu 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Asp Thr Pro Ser Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Lys Asn Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Tyr Cys Ser Gly Gly Ile Ala Lys Cys Gly Phe His Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2080
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2080

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Asn Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Asn Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Val Ser Asn Arg Ala Ala Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Ile Gly Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2081
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2081

Gln Val Gln Leu Ala Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ala Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Ser Asn Ser Gly Asn Ala Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Thr Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2082
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2082

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Asn Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Phe Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Gln Arg Thr Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asn Tyr Tyr Cys Leu Val Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2083
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2083

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Ser Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Trp Gly Trp Gly Ala Val Ala Gly Arg Ala Glu Tyr Tyr Phe 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2084
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2084

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Ser Thr Trp Gly Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  2085
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2085

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Tyr Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Gln Gly Gly Asn Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  2086
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2086

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Thr Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Gly Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Phe Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2087
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2087

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Val Tyr Ile Tyr Ser Ser Gly Ser Thr Asn Tyr Asn 
    50                  55                  60                  


Pro Ser Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn 
65                  70                  75                  80  


Gln Phe Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val 
                85                  90                  95      


Tyr Tyr Cys Ala Arg Gly Ala Ala Ser Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2088
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2088

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asp Gly Tyr Thr Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Lys Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2089
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2089

Gln Val Gln Leu Val Gln Ser Gly Ala Ala Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Asp Asn Tyr 
            20                  25                  30          


Gly Leu Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Gln Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Asn Gly Asp Thr Asn Ser Ala Gln Lys Phe 
    50                  55                  60                  


Gln Asp Arg Val Thr Met Thr Ile Asp Thr Ser Met Arg Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Ala His Cys Thr Gly Gly Val Cys Tyr His Leu Pro Val 
            100                 105                 110         


Asp Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2090
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2090

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Ala Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Trp Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105     


<210>  2091
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2091

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Asp Trp Val 
        35                  40                  45              


Ser Ser Ile Thr Gly Ser Gly Asp Thr Thr Asp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Met Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Ser Thr Gln Trp Gly Gln Gly Thr Leu Val Thr Val Ser 
            100                 105                 110         


Ser 
    


<210>  2092
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2092

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Lys Lys Tyr 
            20                  25                  30          


Leu Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Thr Ser Asn Leu Glu Thr Val Gly Ala Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Gly Gly Ser Gly Thr His Phe Ser Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Gly Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn 
                85                  90                  95      


Leu Pro Phe Thr Phe Gly Pro Gly Thr Lys Val His Ile Lys 
            100                 105                 110 


<210>  2093
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2093

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Ser Cys Lys Ala Phe Gly Tyr Thr Phe Thr Thr His 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Ala Ile Ile Asn Pro Asn Ser Gly Asp Arg Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Val Thr Ser Asp Thr Ser Thr Asn Thr Val Ser 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val Ser Ser Gln Asn Arg Ala Trp Trp Leu Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2094
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2094

Ser Ser Glu Leu Thr Gln Asp Pro Ser Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Lys Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Pro Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asp Arg Pro Ser Gly Ile Pro Asp Arg Ile Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Ala Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Arg Asp Arg Ser Gly Asn Arg 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105             


<210>  2095
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2095

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Val 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gly Glu Glu Arg Ala Asn Val Asn Val Pro Met Ile Tyr 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2096
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2096

Val Ile Trp Met Thr Gln Ser Pro Ser Leu Leu Ser Ala Ser Thr Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Met Ser Gln Gly Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Glu Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Ala Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Cys Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2097
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2097

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Asn Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Pro Arg Val Val Val Thr Ala Arg Met Tyr Asn Trp 
            100                 105                 110         


Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2098
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2098

Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Val Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Met Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  2099
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2099

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Leu Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Asp Ser Gly Gly Ala Ser Arg Ser Thr Asn Tyr Asn 
    50                  55                  60                  


Pro Ser Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Arg Asn 
65                  70                  75                  80  


Gln Leu Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val 
                85                  90                  95      


Tyr Tyr Cys Ala Arg Asp Gln Arg Gln Phe Gln Leu Leu Gly Arg Phe 
            100                 105                 110         


Gly Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2100
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2100

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2101
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2101

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Thr Ser Gly Phe Ile Phe Ser Asp His 
            20                  25                  30          


Tyr Met Asp Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Thr Lys Asn Lys Gly Gln Ser Tyr Thr Ala Glu Tyr Ala Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Ile Ile Ser Arg Asp Asp Leu Thr Lys Ser 
65                  70                  75                  80  


Met Phe Leu Gln Met Ser Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Val Leu Gly His Ser Val Glu Thr Thr Val Ala Arg Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2102
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2102

Gln Ala Val Val Thr Gln Glu Pro Ser Leu Thr Val Ser Pro Gly Gly 
1               5                   10                  15      


Thr Val Thr Leu Thr Cys Asp Ser Ser Thr Gly Ser Val Thr Ser Gly 
            20                  25                  30          


His Tyr Ala His Trp Leu Gln Gln Lys Pro Gly Gln Val Pro Arg Thr 
        35                  40                  45              


Leu Ile Tyr Asp Thr Ser Asn Lys His Ser Trp Thr Pro Ala Arg Phe 
    50                  55                  60                  


Ser Gly Ser Leu Leu Gly Gly Lys Ala Ala Leu Thr Leu Ser Gly Ala 
65                  70                  75                  80  


Arg Pro Glu Asp Glu Ala Asp Tyr Tyr Cys Leu Leu Thr Tyr Ile Val 
                85                  90                  95      


Thr His Thr Ala Thr Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val 
            100                 105                 110         


Leu 
    


<210>  2103
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2103

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Ala Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Ala Phe Ser Gly Phe Ser Leu Thr Thr Asn 
            20                  25                  30          


Gly Met Cys Val Thr Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Asp Trp Asp Asp Glu Lys Tyr Tyr Asn Thr Ser 
    50                  55                  60                  


Leu Lys Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Phe 
                85                  90                  95      


Cys Ala Arg Met Thr Ala Ala Ala Thr Ala Asp Ala Phe Asp Val Trp 
            100                 105                 110         


Gly Gln Gly Thr Val Val Thr Val Ser Ser 
        115                 120         


<210>  2104
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2104

Pro Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Ala Asp Val Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Thr Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ala 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Phe Cys Gln Ser Ala Asp Ser Ser Gly Val Tyr 
                85                  90                  95      


Leu Asn Trp Val Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105                 110 


<210>  2105
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2105

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Thr 
            20                  25                  30          


Thr Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Ala Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Val Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gln Trp Lys Trp Phe Gly Glu Ala Trp Tyr Phe Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2106
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2106

Gln Pro Val Val Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Thr Cys Thr Leu Asp Ser Gly His Arg Ser Tyr Ala 
            20                  25                  30          


Ile Ala Trp His Gln Gln Arg Pro Glu Lys Gly Pro Arg Phe Leu Met 
        35                  40                  45              


Arg Ile Thr Thr Asp Gly Arg His Thr Lys Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Glu Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Thr Trp Gly 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Arg Leu Thr Val Leu 
            100                 105         


<210>  2107
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2107

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asn Tyr 
            20                  25                  30          


His Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Thr Ile Asp Pro Ser Gly His Ser Pro Asn Tyr Ala Gln Arg Phe 
    50                  55                  60                  


Gln Gly Arg Val Ala Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Asp Asn Ile Ala Val Ile Thr Gly Val Gly Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2108
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2108

Gln Ala Val Val Thr Gln Glu Pro Ser Leu Thr Val Ser Pro Gly Gly 
1               5                   10                  15      


Thr Val Thr Leu Thr Cys Gly Ile Thr Thr Gly Thr Val Thr Arg Asp 
            20                  25                  30          


His Tyr Pro Tyr Trp Phe Gln Gln Lys Pro Gly Gln Ala Pro Arg Thr 
        35                  40                  45              


Leu Ile Tyr Asp Thr Ser Asn Lys His Ser Trp Thr Pro Ala Arg Phe 
    50                  55                  60                  


Ser Gly Ser Leu Leu Gly Asp Lys Ala Ala Leu Thr Leu Ser Gly Ala 
65                  70                  75                  80  


Gln Pro Ala Asp Glu Ala Asp Tyr Tyr Cys Leu Leu Thr Tyr Gly Gly 
                85                  90                  95      


Gly Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2109
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2109

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Ala Thr Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Val Gly Tyr Thr Ile Ser Arg Gln Trp Leu Val Gly Glu Phe 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2110
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2110

Asp Phe Gln Met Thr Gln Ser Pro Ser Tyr Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Ser Ile Thr Cys Arg Thr Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Thr Val Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Val Ala Ser Thr Leu Leu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr His Phe Thr Leu Thr Ile Thr Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Glu Tyr Gly Ser Ser Ala Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  2111
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2111

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Phe Ser Phe Asn Ser Tyr 
            20                  25                  30          


Trp Met Ala Trp Val Arg Gln Ala Pro Gly Arg Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Glu Gln Asn Gly Asn Ala Ile Val Tyr Leu Asp Ser Val 
    50                  55                  60                  


Met Gly Arg Phe Thr Val Ser Arg Asp Asn Ala Lys Asn Ser Leu Phe 
65                  70                  75                  80  


Leu His Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Thr Asn Gly Ile Tyr Ser Ser Ser Trp Trp Gly Arg Gly Thr Gln Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2112
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2112

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Gly Ala Thr Leu Ser Cys Arg Ala Ser Gln Asn Val Asn Asn Met 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Phe Ser Thr Ser Met Arg Ala Thr Gly Val Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Arg Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Ile Tyr Tyr Cys Gln His His Asp Thr Trp Pro Tyr 
                85                  90                  95      


Ala Phe Gly Gln Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2113
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2113

Gln Val His Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Ala Asn Gly Gly Ser Phe Ser Ser Tyr 
            20                  25                  30          


His Arg Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asp His Ser Gly Arg Pro Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Tyr Phe Ser Leu 
65                  70                  75                  80  


Arg Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Thr Gly Val Ser Arg Val Trp Glu Ala Leu Val Glu Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2114
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2114

Asp Ile Val Leu Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile His Cys Lys Ser Asn Gln Ser Ile Leu His Ser 
            20                  25                  30          


Pro Asn Ser Gln Asn Tyr Leu Gly Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Arg Leu Leu Ile Tyr Trp Ala Ser Ala Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ala Leu Thr 
65                  70                  75                  80  


Ile Ser Asn Leu Gln Pro Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Thr Pro Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


<210>  2115
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2115

Gln Val Gln Ile Gln Gln Trp Gly Ala Gly Val Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly His 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Lys Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Gly Glu Glu Val Arg Gly Val Lys Leu Tyr Tyr Tyr Tyr Ala Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  2116
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2116

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Phe Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Ser Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ser Glu Asp Glu Ala Asp Tyr Cys Cys Gln Ser Tyr Asp Arg Ser 
                85                  90                  95      


Leu Ser Gly Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2117
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2117

Glu Val His Leu Val Glu Ser Gly Gly Gly Ala Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Ser Pro Val Asp His 
            20                  25                  30          


Ala Met His Trp Ile Arg His Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Gly Ile Tyr Gly Asn Leu Ala Arg Ile Asp Tyr Ala Asn Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ile Lys Asp Thr Ser Pro Gly Gly Leu Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Gln Val Thr Val Ser Ser 
        115             


<210>  2118
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2118

Asp Ala Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Thr Gln Ser Leu Val His Gly 
            20                  25                  30          


Ser Gly Asn Thr Tyr Leu Asn Trp Phe His Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Arg Asp Tyr Gly Ala Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Glu Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Pro Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Thr Tyr Trp Pro Tyr Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2119
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2119

Gln Val Gln Leu Arg Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Asp 
            20                  25                  30          


Ser His Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Arg Leu Glu 
        35                  40                  45              


Trp Ile Gly Phe Thr His Asp Ser Gly Asn Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Met Ser Leu Asp Trp Ser Lys Asn Glu Val 
65                  70                  75                  80  


Ser Leu Asn Leu Arg Ser Val Thr Val Ala Asp Thr Ala Ile Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Val Lys Lys Val Asn Arg Asp Met Val Arg Glu Gly Phe 
            100                 105                 110         


Asp Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2120
<211>  105
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2120

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Phe Val Gly 
1               5                   10                  15      


Asp Thr Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Thr Gly Glu Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asp Leu Leu Ile 
        35                  40                  45              


Trp Lys Thr Ser Asn Leu Glu Ile Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Arg Gly Ser Gly Thr Arg Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Phe Cys Gln Gln Tyr Gly Ala Tyr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu 
            100                 105 


<210>  2121
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2121

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Asn Thr Ala Phe 
65                  70                  75                  80  


Leu His Ile Gly Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Asp Ser Gly Tyr Pro Thr Tyr Tyr Tyr Tyr Tyr Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2122
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2122

Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asp Gly Lys Thr Tyr Leu Tyr Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Glu Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ser 
                85                  90                  95      


Ile Gln Pro Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2123
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2123

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Met Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gly Ile Tyr Tyr Leu Val Arg Gly Phe Ile Ile Gly Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2124
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2124

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2125
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2125

Glu Val Ala Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Ser Asn Ala 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Ser Lys Ser Glu Gly Gly Thr Pro Glu Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Ile Ile Ser Arg Asp Asp Ser Thr Asn Ser 
65                  70                  75                  80  


Leu His Leu Gln Met Asn Tyr Leu Arg Ile Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Thr Thr Gly Gly Tyr Ser Ser Tyr Ala Ala Ser Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2126
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2126

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Leu Ile Thr Ile Phe Cys Asn Gly Ser Ile Ser Asp Val Gly Gly Trp 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Asp Lys Ala Pro Lys Met 
        35                  40                  45              


Met Ile Tyr Asp Val Arg His Arg Pro Ser Gly Val Ser Ser Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Gly Asp Tyr Tyr Cys Ser Ser Phe Thr Ser Arg 
                85                  90                  95      


Gly Ala Leu Val Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2127
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2127

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Arg Ser Ser Thr Ile Lys Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Asp Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Asp Tyr Tyr Gly Ser Gly Ser Val Tyr Trp Tyr Phe Asp 
            100                 105                 110         


Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2128
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2128

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ile 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2129
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2129

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Ala Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Phe Cys 
                85                  90                  95      


Ala Lys Val Gly Trp Glu Leu Ser Ile Asp Ala Phe Asp Leu Trp Gly 
            100                 105                 110         


Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120     


<210>  2130
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2130

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Gly Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Tyr Gly Ser Ser Arg 
                85                  90                  95      


Ser Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2131
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2131

Gln Ile Thr Phe Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Ser Thr Ser 
            20                  25                  30          


Gly Glu Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Val Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Arg Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2132
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2132

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Arg Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  2133
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2133

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Thr Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Tyr Trp Phe Gly Asp Pro Tyr Tyr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2134
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2134

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Ser Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2135
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2135

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ile Gln Tyr Gln Leu Asn Gly Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2136
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2136

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2137
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2137

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Val Asn Pro Asn Ser Gly His Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Phe Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Val Gly Tyr Val Gly Ser Gly Ser Arg Gly Tyr Tyr 
            100                 105                 110         


Tyr Tyr Tyr Asp Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val 
        115                 120                 125             


Ser Ser 
    130 


<210>  2138
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2138

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Arg Gln Ala Pro Val Leu Ile Ile Ser 
        35                  40                  45              


Gly Asn Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn His 
                85                  90                  95      


Leu Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2139
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2139

Glu Glu Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Thr Phe Gly Asp Tyr 
            20                  25                  30          


Lys Met Ala Trp Val Arg Gln Ala Pro Gly Arg Gly Pro Glu Trp Val 
        35                  40                  45              


Gly Leu Ile Arg Ser Arg Ala Asn Gly Glu Ser Thr Glu Tyr Ser Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Val Ser Arg Asp Asp Ser Lys Gly Ile 
65                  70                  75                  80  


Ala Tyr Leu Gln Met Tyr Asn Leu Gln Thr Glu Asp Thr Ala Ile Tyr 
                85                  90                  95      


Tyr Cys Thr Arg Asp Pro Thr Leu Trp Pro Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2140
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2140

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Pro Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Glu Thr Ser Arg Leu His Asn Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Asn Tyr Tyr Cys His Gln Tyr Met Ala Phe Trp Thr 
                85                  90                  95      


Phe Gly Gln Gly Thr Arg Val Glu Ile Lys 
            100                 105     


<210>  2141
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2141

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Cys Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Arg Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Leu Phe Ser Gly Gly Ala Tyr Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2142
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2142

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Phe Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2143
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2143

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Lys 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Glu Met Asn Trp Val Arg Gln Ala Pro Gly Ser Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ile Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Phe Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Gln Gly Thr Tyr Leu Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2144
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2144

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Asn Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Tyr Phe Ala Val Tyr Tyr Cys Leu His Tyr Gly Asp Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2145
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2145

Glu Val His Leu Val Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Gly Gly Ser Gly Phe Ser Phe Asn Ser Ala 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Ala Asp Gly Gly Asp Ser Tyr Tyr Pro Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Lys Asp Asn Thr Lys Asn Leu Leu His 
65                  70                  75                  80  


Leu Gln Met His Ser Leu Arg Val Asp Asp Ala Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Val Trp Gly Asp Thr Trp Gly Leu Asp Tyr Gly Gly Leu Gly Thr 
            100                 105                 110         


Arg Val Ala Val Ser Ser 
        115             


<210>  2146
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2146

Gln Ala Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Ser Ser Arg Asp Phe Gly Ala His 
            20                  25                  30          


Asp Tyr Val Ser Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu 
        35                  40                  45              


Ile Leu Tyr Lys Val Tyr Gln Arg Pro Ser Gly Val Pro Gly Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Asp Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Pro Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Thr Ala Pro Gly Ala 
                85                  90                  95      


Leu Ile Leu Leu Phe Gly Gly Gly Thr Lys Leu Thr Val 
            100                 105                 


<210>  2147
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2147

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Gly Asp Tyr 
            20                  25                  30          


Lys Met Ala Trp Val Arg Gln Ala Pro Gly Arg Gly Pro Glu Trp Val 
        35                  40                  45              


Gly Leu Ile Arg Ser Arg Ala Asn Gly Glu Ser Thr Glu Tyr Ser Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Val Ser Arg Asp Asp Ser Lys Gly Ile 
65                  70                  75                  80  


Ala Tyr Leu Gln Met Tyr Asn Leu Gln Thr Glu Asp Thr Ala Ile Tyr 
                85                  90                  95      


Tyr Cys Thr Arg Asp Pro Thr Leu Trp Pro Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2148
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2148

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Ala Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Gly Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  2149
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2149

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Ala Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser His Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Ser Tyr Arg Gly Thr Thr His Gln Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Ala Ile Ile Ser Ile Asp Thr Ser Lys Asn His Phe 
65                  70                  75                  80  


Ser Leu Ile Leu Ser Ser Leu Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Tyr Thr Thr Met Val Gly Glu Phe Asp Ser Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Ala Val Ser Ser 
        115                 120 


<210>  2150
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2150

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Glu Ser Asn 
            20                  25                  30          


Ser Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ser Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  2151
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2151

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Ile Ser Cys Gly Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Ser Ser Arg Lys Asp Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ala Ile Ser Arg Asp Asn Ala Lys Asn Ser Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Asp Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Thr Gly Gly Ala Tyr Tyr Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2152
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2152

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Ala Asp Ala Leu Pro Lys His Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ile Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Pro Tyr 
                85                  90                  95      


Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105         


<210>  2153
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2153

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ser Ala Gly Asn Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  2154
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2154

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Tyr Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  2155
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2155

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ser Gly Phe Thr Phe Thr Ser Ser 
            20                  25                  30          


Ala Ile Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
            100                 105                 110         


Tyr Tyr Arg Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2156
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2156

Asp Phe Gln Met Thr Gln Ser Pro Ser Tyr Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Ser Ile Thr Cys Arg Thr Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Thr Val Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Val Ala Ser Thr Leu Leu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr His Phe Thr Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Lys Tyr Asp Ser Val Pro Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2157
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2157

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Phe 
            20                  25                  30          


Gly Val Gly Val Gly Trp Val Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Cys Leu Ala Leu Ile Tyr Trp Asp Asp Asp Glu Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Ala Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120             


<210>  2158
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2158

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Ala Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Thr Asp Ser Ser Gly Asn Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  2159
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2159

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ile Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Tyr Gly Gly Ala Tyr Gly Gly Asn Ser Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Ile Ser Ser 
        115                 120     


<210>  2160
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2160

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Thr 
                85                  90                  95      


Ser Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105         


<210>  2161
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2161

Gln Val His Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Phe 
            20                  25                  30          


Gly Val His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Thr Leu Ile Ser Phe Asp Gly Arg Asn Lys Asn Tyr Ala Gly Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Ser Ser Lys Ser Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Tyr His Asp Gly Ala Asn Trp Ser Gly Ala Phe Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Trp Val Thr Val Ser Ser 
        115                 120             


<210>  2162
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2162

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Thr Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Pro Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Thr Thr Ser Leu Gln Ser Gly Val Pro Val Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Met Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  2163
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2163

Glu Val Tyr Leu Leu Glu Ala Gly Gly Asp Leu Ala Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ser Gly Phe Thr Phe Asp Asn Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Gly Asp Asn Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Lys Met Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Val Ala Tyr Ser Gly Ser Asn Ser Val Val Tyr Tyr Tyr Tyr 
            100                 105                 110         


Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2164
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2164

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn Ala 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2165
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2165

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Pro Ile Ser Ser Ser 
            20                  25                  30          


Arg Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Asp Gly Ser Gly Glu Met Asp Thr Ile Thr Trp Gly 
            100                 105                 110         


Pro Ile Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2166
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2166

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Tyr Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  2167
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2167

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Arg Leu Arg Ala Glu Asp Thr Thr Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Val Thr Glu Gly Ser Trp Ser Phe Asp Ser Trp Gly Gln 
            100                 105                 110         


Gly Thr Gln Val Ser Val Ser Ser 
        115                 120 


<210>  2168
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2168

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Thr Asp Ser Ser Gly Asn Gln 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2169
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2169

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Ala Ala Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2170
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2170

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Ser Pro 
                85                  90                  95      


Asp Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2171
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2171

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gly 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ala Ile Ser Ser Asn 
            20                  25                  30          


Asn Cys Trp Ser Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Glu Ile Tyr Pro Ser Gly Thr Thr Asn Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Arg Ser Arg Val Ser Ile Ser Val Asp Arg Thr Lys Asn Ser Phe Ser 
65                  70                  75                  80  


Leu Glu Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Val Gly Ala Thr Ala Glu Asp Phe Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2172
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2172

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Ser Ile Ser Cys Ser Thr Ser Ser Ser Asn Ile Gly His Asn 
            20                  25                  30          


Thr Ile Asn Trp Tyr Leu Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Arg Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Ile Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Pro Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  2173
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2173

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Ser Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Glu Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Glu Gly Asp Trp Leu Leu Gly Gly Pro Tyr Tyr His Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2174
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2174

Glu Ile Val Met Thr Gln Ser Pro Val Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr His Cys Gln Gln Tyr Asn Asn Trp Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2175
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2175

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Ala Glu Thr Ile Tyr Ala Gln Gln Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2176
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2176

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Phe Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Phe Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Ile Ile Tyr 
        35                  40                  45              


Gln Gly Ala Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2177
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2177

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Gly Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Ser Asp Tyr Lys Pro Tyr Ala Gly Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Gly Pro Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Val Asp His Gly Ala Gln Gly Ala Tyr Phe Asp His Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Ile Ala Ser Ser 
        115                 120         


<210>  2178
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2178

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Phe Thr Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Asp Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Phe Thr Phe Gly Pro Gly Thr Arg Val Asp Ile Lys 
            100                 105                 110         


<210>  2179
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2179

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Ser Asp Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Thr Phe Gly Gly Ser Gly Ser Tyr Tyr Phe Tyr Tyr Asn 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2180
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2180

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Arg Ser Ser 
                85                  90                  95      


Gly Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2181
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2181

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Asp Asp Tyr 
            20                  25                  30          


Asp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Asn Trp Asn Gly Gly Ser Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr His Cys 
                85                  90                  95      


Ala Val Ile Met Ser Pro Ile Pro Arg Tyr Ser Gly Tyr Asp Trp Ala 
            100                 105                 110         


Gly Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2182
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2182

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Phe Asn Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Cys Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Tyr Pro Pro 
                85                  90                  95      


Asn Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile 
            100                 105         


<210>  2183
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2183

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Leu Ser Gly Phe Ala Val Leu Lys Ala 
            20                  25                  30          


Arg Met Gly Val Ser Trp Ile Arg Gln Ser Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Thr Phe Ser Gly Asp Glu Glu Ser Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Arg Thr Arg Leu Thr Ile Ser Thr Asp Thr Ser Arg Arg Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Ser Asn Val Asp Pro Val Asp Thr Ala Thr Tyr Phe 
                85                  90                  95      


Cys Ala Arg Val Lys Thr Tyr Tyr Thr Ser Thr Arg Arg Ile Leu Trp 
            100                 105                 110         


Phe Asp Pro Trp Gly Gln Gly Ile Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2184
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2184

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val Ser Trp Tyr His Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asp Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  


Arg Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser 
                85                  90                  95      


Leu Ser Ser Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2185
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2185

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ala Phe Ser Asn Tyr 
            20                  25                  30          


Ala Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ile Asn Lys Tyr Tyr Ala Asp Ala Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Glu Trp Phe Arg Glu Leu Phe Leu Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2186
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2186

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Ile Thr Ile Thr Cys Arg Ala Asn Gln Thr Ile Ala Asn Ser 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Ala Leu Leu Ile 
        35                  40                  45              


Tyr Leu Ser Ser Asn Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Tyr Ser 
                85                  90                  95      


Val His Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2187
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2187

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Asp Pro Tyr Gln Leu Leu Gly Gln His Tyr Tyr Tyr Gly Met 
            100                 105                 110         


Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2188
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2188

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Leu Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 


<210>  2189
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2189

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Glu Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Gln Lys Tyr Tyr Val Asp Ser Ala 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Arg Leu Cys Ser Ser Ser Gly Cys Tyr Ala Ala Ser Tyr His 
            100                 105                 110         


Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2190
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2190

Asp Met Glu Val Thr Gln Phe Pro Ser Ser Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Lys Ser Gly Val Pro Ser Arg Phe Gly Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Thr Thr Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Gly Thr Tyr Tyr Cys His Gln Ser Tyr Gly Val Pro Ile 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2191
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2191

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Asp Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Gly Glu Ala Ala Gly Ile Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2192
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2192

Gln Pro Val Leu Thr Gln Pro Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Thr Cys Thr Leu Ser Ser Gly Tyr Ser Asn Tyr Lys 
            20                  25                  30          


Val Asp Trp Tyr Gln Gln Arg Pro Gly Lys Gly Pro Arg Phe Val Met 
        35                  40                  45              


Arg Val Gly Thr Gly Gly Ile Val Gly Ser Lys Gly Asp Gly Ile Pro 
    50                  55                  60                  


Asp Arg Phe Ser Val Leu Gly Ser Gly Leu Asn Arg Tyr Leu Thr Ile 
65                  70                  75                  80  


Lys Asn Ile Gln Glu Glu Asp Glu Ser Asp Tyr His Cys Gly Ala Asp 
                85                  90                  95      


His Gly Ser Gly Ser Asn Phe Val Tyr Val Val Phe Gly Gly Gly Thr 
            100                 105                 110         


Lys Leu Thr Val Leu 
        115         


<210>  2193
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2193

Ser Gln Pro Leu Glu Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Lys Thr Ser Gly Asp Ser Leu Thr Arg Leu 
            20                  25                  30          


Ala Val Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Lys Pro Asn Thr Gly Glu Ala Thr Tyr Ala Gln Ala Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Tyr Val Asp Thr Pro Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Tyr Gly Leu Lys Pro Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly His Tyr Asp Gly Leu Trp Gly Gln Gly Thr Arg Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  2194
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2194

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Lys Lys Tyr 
            20                  25                  30          


Leu Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Thr Ser Asn Leu Glu Thr Val Gly Ala Gly Val Pro Ser Arg 
    50                  55                  60                  


Phe Ser Gly Gly Gly Ser Gly Thr His Phe Ser Leu Thr Ile Ser Ser 
65                  70                  75                  80  


Leu Gln Pro Glu Asp Gly Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn 
                85                  90                  95      


Leu Pro Phe Thr Phe Gly Pro Gly Thr Lys Val His Ile Lys 
            100                 105                 110 


<210>  2195
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2195

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Phe 
            20                  25                  30          


Gly Val Gly Val Gly Trp Val Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Cys Leu Ala Leu Ile Tyr Trp Asp Asp Asp Glu Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Ala Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120             


<210>  2196
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2196

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr His Val 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105         


<210>  2197
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2197

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Ser Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Arg Phe Trp Ser Gly Tyr Tyr Gly Met Asp Val Trp Gly Gln Gly 
            100                 105                 110         


Thr Thr Val Thr Val Ser Ser 
        115                 


<210>  2198
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2198

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asn Thr Leu Pro Lys Gln Tyr Val 
            20                  25                  30          


Phe Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Ile Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Gly Asp Tyr Ser Gly Thr Trp 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105         


<210>  2199
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2199

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Ser Phe Asn Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Glu Gly Ser Lys Thr Tyr Tyr Ala Asp Phe Val 
    50                  55                  60                  


Gln Gly Arg Phe Thr Val Ser Arg Asp Phe Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ile Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Ser His Lys Leu Phe Trp Phe Gly Gln Phe Lys Met Asp Ala 
            100                 105                 110         


Leu Asp Ile Trp Gly Gln Gly Ala Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2200
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2200

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Pro Asn Ile Gly Ser Asn 
            20                  25                  30          


Ser Val Asn Trp Tyr Gln Gln Val Pro Gly Thr Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Asn Thr Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2201
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2201

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ala Tyr 
            20                  25                  30          


Glu Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Arg Ile 
        35                  40                  45              


Ala Tyr Ile Thr Thr Ser Gly Asn Asn Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Phe Arg Asp Asn Pro Lys Lys Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Thr Gly Gln Val Glu Trp Leu Val Asp Asn Tyr Asn Tyr Tyr 
            100                 105                 110         


Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2202
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2202

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Arg Lys Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2203
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2203

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Arg Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Thr Ser Gly Phe Asn Phe Arg Asp Tyr 
            20                  25                  30          


Ala Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Leu Ile Arg Ser Glu Pro Tyr Arg Ala Thr Thr Glu Tyr Ala Ala 
    50                  55                  60                  


Ser Val Arg Gly Arg Phe Thr Leu Ser Arg Asp Asp Ser Lys Ser Leu 
65                  70                  75                  80  


Ala Tyr Leu Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Phe Cys Ala Arg Thr Glu Arg Cys Gly Ala Asp Cys Thr Ser His Ile 
            100                 105                 110         


Asn Tyr Tyr Leu Asp Val Trp Gly Ser Gly Thr Ser Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2204
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2204

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asp Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Asp Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro 
                85                  90                  95      


Pro Ser Leu Thr Phe Gly Gly Gly Thr Lys Val His Ile Lys 
            100                 105                 110 


<210>  2205
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2205

Gln Val His Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Asn Asp Glu Phe Asn Lys Phe Tyr Ala Asn Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Leu Asn Ser Leu Arg Thr Glu Asp Thr Ala Arg Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Gly Asp Gly Ser Gly Trp Ala Trp Asp Gly Asp Asn Pro 
            100                 105                 110         


Pro Thr Asp Tyr Trp Gly Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120                 125         


<210>  2206
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2206

Asp Ile Val Met Thr Gln Ser Pro Asp Phe Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Ser Cys Lys Ser Ser Gln Ser Val Leu Tyr Thr 
            20                  25                  30          


Pro Lys Asn Lys Asn Tyr Leu Ala Trp Tyr Lys Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Val Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Ile 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Ala Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Thr Ala Pro Leu Thr Phe Gly Gly Gly Thr Arg Val Glu Ile 
            100                 105                 110         


<210>  2207
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2207

Gln Val Gln Leu Arg Glu Ser Gly Pro Gly Leu Val Arg Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Lys Cys Thr Val Ser Gly Asp Ser Val Ser Gly Asn 
            20                  25                  30          


Ser His Phe Trp Thr Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr Asn Ser Val Ser Thr Ala Tyr Asn Ala Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Ser Ser Lys Asn Leu Phe 
65                  70                  75                  80  


Ser Leu Glu Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Phe 
                85                  90                  95      


Cys Ala Gly Gly Phe Asp Asp Ala Trp Glu Pro Gln Val Tyr Trp Gly 
            100                 105                 110         


Leu Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2208
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2208

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Ser 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Thr Asp Ser Ser Gly Asn Gln 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2209
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2209

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Arg Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Gly Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Glu Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Ala Thr Ile Ser Val Val Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Arg Leu Ser Ser Val Thr Pro Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Pro Tyr Phe Ser Ser Leu Val Phe Gly Pro Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2210
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2210

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Arg Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Arg Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Thr Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Arg Asp Ser Ser Gly Asn His 
                85                  90                  95      


Leu Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 


<210>  2211
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2211

Leu Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Ala Ala Ile Ser Asp Gly 
            20                  25                  30          


Ser Tyr His Trp Asn Trp Ile Arg Gln Ser Ala Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Leu Gly Arg Val Tyr Asn Asn Gly Val Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Gly Ser Arg Ala Thr Ile Ser Pro Asp Pro Ser Lys Gly Gln Phe 
65                  70                  75                  80  


Ile Leu Thr Leu Ser Ala Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Arg Leu Ala Ile Phe Gly Glu Val Leu Lys Asp Ser 
            100                 105                 110         


Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Ile Val Ser Ser 
        115                 120                 125             


<210>  2212
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2212

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Phe Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Asn Cys Arg Ala Ser Gln Ser Ile Arg Arg His 
            20                  25                  30          


Leu Asn Trp Tyr Gln Leu Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Thr Asn Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Ile Tyr Cys Cys Gln Gln Ser Tyr Ser Val Ser Pro 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2213
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2213

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Ala Val Ser Gly Phe Ser Leu Ser Asn Ala 
            20                  25                  30          


Lys Met Gly Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Asn Asp Glu Lys Ala Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Val Leu Thr Val Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ile Val Leu Gly Ala Ser Gly Thr Tyr Pro Ser Pro Gly 
            100                 105                 110         


Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2214
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2214

Gln Thr Val Val Thr Gln Glu Pro Ser Leu Thr Val Ser Pro Gly Gly 
1               5                   10                  15      


Thr Val Thr Leu Thr Cys Ala Ser Ser Ala Gly Ala Val Thr Ser Gly 
            20                  25                  30          


Tyr Tyr Pro Asn Trp Phe Gln Gln Lys Pro Gly Gln Ala Pro Arg Ala 
        35                  40                  45              


Leu Ile Tyr Ser Thr Ala Asn Lys His Ser Trp Thr Pro Ala Arg Phe 
    50                  55                  60                  


Ser Gly Ser Leu Leu Gly Gly Lys Ala Ala Leu Thr Leu Ser Gly Val 
65                  70                  75                  80  


Gln Pro Glu Asp Glu Ala Glu Tyr Tyr Cys Leu Leu Tyr Tyr Gly Gly 
                85                  90                  95      


Ala Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2215
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2215

Gln Leu Gln Leu Ala Glu Ser Gly Gly Gly Val Val Gln Pro Gly Lys 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ser Gly Phe Thr Phe Ser Ala His 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Arg His Lys Tyr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Lys Ser Thr Phe Phe 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Asp Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Asp Leu Thr Leu Tyr Ser Ser Asp Tyr Tyr Trp Gly Tyr Phe 
            100                 105                 110         


Asp Ser Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2216
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2216

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asn Lys Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Thr Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Phe Gly Thr Asp Phe Phe Leu Thr Ile Gly Ser Leu Glu Ala 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Phe Gln Trp Pro Pro 
                85                  90                  95      


Gly Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2217
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2217

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ile Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Phe Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Gly Ser Gly Ser Tyr Tyr Gly Trp Phe Asp Pro Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2218
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2218

Glu Ile Val Leu Thr Gln Ser Pro Asp Phe Gln Ser Val Thr Pro Lys 
1               5                   10                  15      


Glu Lys Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Gly Ser Ser 
            20                  25                  30          


Leu His Trp Tyr Gln Gln Lys Pro Asp Gln Ser Pro Lys Val Ile Ile 
        35                  40                  45              


Lys Tyr Ala Ser Gln Ser Phe Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Glu Ala 
65                  70                  75                  80  


Glu Asp Ala Ala Thr Tyr Tyr Cys His Gln Ser Ser Ser Leu Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2219
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2219

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Phe Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Val Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Cys Gly Asp Cys Tyr Ser Ala Asp Leu Asp Phe Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2220
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2220

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Ser Ser Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Arg Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105             


<210>  2221
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2221

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Met Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Leu Leu Trp Leu Arg Gly His Phe Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2222
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2222

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Ser Asn Tyr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2223
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2223

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Asp Asp Tyr 
            20                  25                  30          


Asp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Gly Gly Asn Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr His Cys 
                85                  90                  95      


Ala Val Ile Met Ser Pro Ile Pro Arg Tyr Ser Gly Tyr Asp Trp Ala 
            100                 105                 110         


Gly Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2224
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2224

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn Ala 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2225
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2225

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Thr Gly Phe Thr Phe Ser Ser Asn 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Pro Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ala Ile Gly Asn Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu His Leu 
65                  70                  75                  80  


Gln Met His Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asn Thr Ala Gly Ser Gln Asn Trp His Phe Asp Leu Trp Gly Arg 
            100                 105                 110         


Gly Thr Gln Val Thr Val Ser Ser 
        115                 120 


<210>  2226
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2226

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Ser Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  2227
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2227

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Ala Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Phe Cys 
                85                  90                  95      


Ala Lys Val Gly Trp Glu Leu Ser Ile Asp Ala Phe Asp Leu Trp Gly 
            100                 105                 110         


Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120     


<210>  2228
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2228

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Gly Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2229
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2229

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Phe Tyr 
            20                  25                  30          


Ala Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ala 
        35                  40                  45              


Ala Ala Ile Ser Ser Asp Gly Thr Tyr Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ser Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Leu Asn Lys Gly Phe Asp Pro Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Leu Thr Val Ser Ser 
        115         


<210>  2230
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2230

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Ser Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2231
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2231

Gln Gly Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ile Ser Tyr 
            20                  25                  30          


Gly Val Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Pro Tyr Ser Ser Asn Thr Asn Tyr Pro Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Val Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Phe Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Ala Arg Tyr Cys Arg Ser Ala Ser Cys Ser Asn Lys 
            100                 105                 110         


Gly Val Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2232
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2232

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Ser Asn His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2233
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2233

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Val Trp Val 
        35                  40                  45              


Ser Arg Ile Asn Gly Asp Gly Ser Ser Thr Thr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Lys Asn Lys 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ala Arg Ala Arg Ala Val Thr Gly Thr Gly Gly Ile Gly Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2234
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2234

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Ser Lys His Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Asn Trp Ala Ser Ala Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Thr Thr Pro Asn Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2235
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2235

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ser Gly Phe Thr Phe Thr Ser Ser 
            20                  25                  30          


Ala Ile Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Pro His Cys Asn Arg Thr Ser Cys Tyr Asp Ala Phe Asp Leu 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2236
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2236

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Gly Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Ser Glu Asp Phe Ala Leu Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Trp 
                85                  90                  95      


Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2237
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2237

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Gln Val Ser Cys Glu Ala Ser Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Thr Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Asp Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Arg Leu Gly Asp Gly Ser Tyr Leu Gly Gly Gly Tyr Tyr 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2238
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2238

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Arg Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Arg Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  2239
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2239

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Thr Ile Asp Pro Ser Gly His Ser Pro Asn Tyr Ala Gln Arg Phe 
    50                  55                  60                  


Gln Gly Arg Val Ala Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Pro His Cys Asn Arg Thr Ser Cys Tyr Asp Ala Phe Asp Leu 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2240
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2240

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Arg Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ser Leu Ser 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2241
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2241

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Arg Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Glu Gly Glu Trp Glu Leu Arg Gly Asn Ala Leu Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  2242
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2242

Asp Ile Val Val Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asp Gly Lys Thr Tyr Leu Ser Trp Tyr Leu Gln Lys Pro Gly Gln Pro 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Glu Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ser 
                85                  90                  95      


Ile Gln Pro Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Asp Ile Lys 
            100                 105                 110         


<210>  2243
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2243

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Asn Ala 
            20                  25                  30          


Arg Met Ser Val Asn Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Asn Asp Glu Lys Ser Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Leu Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2244
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2244

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Ser Ser 
                85                  90                  95      


Ser Ile Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2245
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2245

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Met Ser Ser 
            20                  25                  30          


Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Ile Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2246
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2246

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Val Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Pro His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2247
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2247

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Arg Thr Cys Ala Val Tyr Gly Ala Ser Phe Ser Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Glu Asn Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Arg Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Leu Arg Tyr Ser Ser Ser Gly Gly His Ile Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2248
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2248

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Ser Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Asn Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2249
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2249

Gln Val Gln Leu Leu Glu Ser Gly Pro Gly Leu Val Lys Ser Ser Gln 
1               5                   10                  15      


Thr Leu Tyr Leu Thr Cys Ser Val Ser Gly Gly Ser Val Ser Ser Gly 
            20                  25                  30          


Ala Tyr Tyr Trp Thr Trp Val Arg Gln Pro Ala Gly Ser Pro Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Ile Tyr Thr Ser Gly Thr Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Asn Arg Arg Leu Thr Leu Ser Leu Asp Thr Ser Arg Asn Gln Ile 
65                  70                  75                  80  


Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Ala Tyr Phe 
                85                  90                  95      


Cys Ala Arg Ala Arg Ser Ser Met Asp Asn Phe Tyr Tyr Phe Tyr Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2250
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2250

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Ser Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2251
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2251

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2252
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2252

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Glu Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2253
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2253

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Leu Thr Gly Ser Ser Ala Tyr Lys Asp Glu Ile Tyr Phe 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2254
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2254

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Thr Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Ser Arg 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2255
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2255

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Lys Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Gly Gly Asn Ala Tyr Ser Ser Gly Trp Tyr Arg Tyr Tyr Tyr 
            100                 105                 110         


His Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2256
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2256

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Val Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2257
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2257

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Ala Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Pro Thr Pro Gln Leu Leu Pro Ser Phe Glu Asn 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120                 125         


<210>  2258
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2258

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Glu Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ile Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Gly Ser Asp His 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2259
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2259

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Leu His Trp Val Arg Gln Gly Thr Gly Lys Arg Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Leu Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Leu Tyr Asp Ser Ser Gly Phe Tyr Asn Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2260
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2260

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Glu Ile Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2261
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2261

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Met Ser Ser 
            20                  25                  30          


Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Ile Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2262
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2262

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Glu Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2263
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2263

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2264
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2264

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Thr Leu Thr Val Leu 
            100                 105                 110 


<210>  2265
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2265

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Lys Ala Pro Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Ala Gly Ser Thr Thr Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Phe His Val Pro Ala Ala Leu Arg Asn Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2266
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2266

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asn Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Leu Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2267
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2267

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Pro Gly Gly Ser Ala Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg His Asn Ser Asn Asn Thr Leu Cys Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ser Tyr Asp Ile Leu Thr Gly Tyr Arg Asp Ala Phe Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  2268
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2268

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ser Gly 
            20                  25                  30          


Ser Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Thr Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Arg 
                85                  90                  95      


Leu Ser Gly Phe Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2269
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2269

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Glu Asp Gly Arg Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Leu Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Val Thr Tyr Gly Leu Asp Val Trp Gly Gln Gly Thr 
            100                 105                 110         


Thr Val Thr Val Ser Ser 
        115             


<210>  2270
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2270

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Thr Asp Ala Leu Pro Asn Glu Tyr Ile 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Glu Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Pro His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2271
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2271

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Gln Asp Ser Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Ile Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Pro Thr Pro Gln Leu Leu Pro Ser Phe Glu Asn 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2272
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2272

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Glu Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp Pro 
                85                  90                  95      


Phe Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 


<210>  2273
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2273

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2274
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2274

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Met Pro Pro 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2275
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2275

Glu Ala Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Ala Ser Gly Phe Ile Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Asn Asp Gly Arg Pro Asn Pro Leu Glu Tyr Tyr Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2276
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2276

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Thr Ser 
                85                  90                  95      


Val Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2277
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2277

Glu Val His Leu Ala Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Gly Gly Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Gln Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Asn Ala Gly Ala Asp Tyr Arg Pro Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Ile Ser Arg Asp Asn Val Asp Ser Phe Leu Tyr 
65                  70                  75                  80  


Leu Gln Met His Ser Leu Arg Val Asp Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Asn Trp Asp Val Gly Gly Met Asp Val Trp Gly Gln Gly 
            100                 105                 110         


Thr Thr Val Thr Val Ser Ser 
        115                 


<210>  2278
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2278

His Leu Val Leu Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Gly 
1               5                   10                  15      


Ala Val Lys Leu Thr Cys Thr Leu Asn Ser Gly His Thr Ser Asn Ala 
            20                  25                  30          


Ile Ala Trp His Gln Gln Gln Pro Glu Arg Gly Pro Arg Phe Leu Met 
        35                  40                  45              


Arg Ile Asn Ser Asp Gly Ser His Asn Lys Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Ser Ser Gly Ala Glu Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Leu Thr Trp Val 
                85                  90                  95      


Thr Gly Ser Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2279
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2279

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Ser Ser Gly 
            20                  25                  30          


Arg Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Phe Val Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Arg Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Thr Tyr Ser Ala Tyr Glu Met Pro Pro Tyr Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2280
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2280

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Arg Ser 
                85                  90                  95      


Ser Thr Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2281
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2281

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Gln Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Met Ser Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Ile Ile Glu Ser Thr Ile Ala Ala Arg Pro Gly Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2282
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2282

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Phe Pro Lys Gln Tyr Gly 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Arg Gly Ala Val 
                85                  90                  95      


Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  2283
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2283

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Asp Thr Phe Ser Ser Tyr 
            20                  25                  30          


Thr Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Pro Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
            100                 105                 110         


Ala Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2284
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2284

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Gly Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn His Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala 
65                  70                  75                  80  


Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Pro 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2285
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2285

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Gln Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Lys Ser Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Thr Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Phe Ser Ser 
        115                 120             


<210>  2286
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2286

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro 
                85                  90                  95      


Arg Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2287
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2287

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Asn Ala 
            20                  25                  30          


Arg Met Ser Val Asn Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Asn Asp Glu Lys Ser Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Leu Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120     


<210>  2288
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2288

Gln Ser Val Leu Thr Gln Pro Pro Ser Pro Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Tyr Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Arg Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Ala Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Leu Leu 
            100                 105                 110 


<210>  2289
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2289

Gln Val His Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Leu Leu His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Asn Val Asn Pro Ser Arg Gly Thr Ala Thr Tyr Pro Gln Lys Leu 
    50                  55                  60                  


Asp Asp Arg Val Thr Met Thr Ser Asp Lys Ser Ala Ser Thr Ile Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Gly Leu Arg Ser Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Arg Ser Gly Thr Tyr Phe Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Leu Thr Val Ser Ser 
        115                 


<210>  2290
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2290

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Lys Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Val Leu 
        35                  40                  45              


Ile Tyr Asn Ser Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Val Trp Asp Asp Ser Leu 
                85                  90                  95      


His Ser Tyr Val Phe Gly Thr Glu Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  2291
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2291

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Ala Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Thr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Phe Val Asp Thr Ser Lys Ser Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg His His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe 
            100                 105                 110         


Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2292
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2292

Asp Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Arg Leu Ala Pro Thr 
            20                  25                  30          


Leu Leu Ala Trp Phe Leu Gln Lys Arg Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Ala Ala Ser Thr Arg Ala Thr Asp Ile Pro Asp Arg Phe Asn 
    50                  55                  60                  


Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Ala Tyr Tyr Cys Gln Gln Ser Phe Ser Thr Pro 
                85                  90                  95      


Arg Thr Phe Gly Gln Gly Thr Lys Leu Ala Ile Lys 
            100                 105             


<210>  2293
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2293

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Leu Ser Leu Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Thr Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Pro Arg Asn Gln Ile Ser Leu 
65                  70                  75                  80  


Ser Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ile Pro Thr Gly Phe Pro Arg Cys Tyr Met Asp Val Trp Gly Lys 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2294
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2294

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Arg Ser Val 
                85                  90                  95      


Ser Thr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2295
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2295

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Thr Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Pro Arg Asn Gln Ile Ser Leu 
65                  70                  75                  80  


Ser Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Ala Pro Tyr Cys Ser Arg Ile Ser Cys Asn Asp Gly Phe Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  2296
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2296

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Phe Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Gly Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Thr Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Gly Ser Ser Arg Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2297
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2297

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Ser Ser Gly 
            20                  25                  30          


Arg Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Phe Val Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Phe Leu Arg Trp His Asp Leu Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2298
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2298

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu His Ser 
            20                  25                  30          


Ser Asn Asn Lys Asp Ser Leu Val Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ser Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Pro Asp Asp Phe Ala Thr Tyr Cys Cys Gln Gln 
                85                  90                  95      


Tyr Asn Ser Tyr Pro Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2299
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2299

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2300
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2300

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Ala Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Asn Gly Asp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2301
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2301

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Gln Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Thr Pro Val Thr Ala Ile Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2302
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2302

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Arg Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Thr Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2303
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2303

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Met Ser Ser 
            20                  25                  30          


Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Ile Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2304
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2304

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Leu 
                85                  90                  95      


Ala Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2305
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2305

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2306
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2306

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Ser Cys Gln Gln Ser Tyr Thr Thr Leu Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2307
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2307

Gln Val Gln Leu Gln Glu Ser Gly Pro Arg Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Met Ser Gly Phe 
            20                  25                  30          


Phe Trp Ser Trp Val Arg Gln Ser Pro Glu Arg Gly Phe Glu Tyr Ile 
        35                  40                  45              


Gly Tyr Phe Tyr Ser Ser Ala Lys Thr Asp Tyr Asn Pro Ser Leu Ser 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Leu Asp Ala Ser Lys Asn Leu Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Thr Ser Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg Tyr 
            100                 105                 110         


Pro Arg Pro Asp Ile Phe Asp Met Trp Gly Arg Gly Thr Arg Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2308
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2308

Asp Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Arg Leu Ala Pro Thr 
            20                  25                  30          


Leu Leu Ala Trp Phe Leu Gln Lys Arg Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Ala Ala Ser Thr Arg Ala Thr Asp Ile Pro Asp Arg Phe Asn 
    50                  55                  60                  


Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp 
65                  70                  75                  80  


Thr Glu Asp Phe Gly Val Tyr Tyr Cys His Gln Tyr Gly Ile Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile 
            100                 105         


<210>  2309
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2309

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ala Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Leu Met Ser Val Gly Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  2310
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2310

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Arg 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Met Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Val Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2311
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2311

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ile Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ala Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Ala Leu Tyr Tyr Asn Gly Pro Gly Arg Asp Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2312
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2312

Val Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Lys Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Ala Asn Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2313
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2313

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ile Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ala Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Ala Leu Tyr Tyr Asn Gly Pro Gly Arg Asp Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2314
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2314

Val Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Lys Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2315
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2315

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Ser Asp Gly Ser Asn Lys Tyr Tyr Ala Gly Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Met Val Glu Pro Leu Phe Ser His Tyr Tyr Tyr Tyr Gly 
            100                 105                 110         


Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2316
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2316

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Ser Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Gly Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  2317
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2317

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Asn Ala 
            20                  25                  30          


Arg Met Ser Val Asn Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Asn Asp Glu Lys Ser Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Leu Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2318
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2318

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Leu Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Pro Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Val Arg Asp Ser Ser Gly His His 
                85                  90                  95      


Pro Val Phe Gly Glu Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2319
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2319

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Met Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Pro Arg Glu Arg Leu Gln Trp Gly Glu Tyr Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2320
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2320

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Ala Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ile Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Val Ser 
                85                  90                  95      


Thr Thr Tyr Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2321
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2321

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Ser Tyr 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Val Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Phe Glu Thr Lys Val Ile Arg Gly Gly Arg Tyr Tyr Tyr Tyr 
            100                 105                 110         


Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2322
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2322

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Asn Pro Ser 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2323
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2323

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn His Phe Ser Leu 
65                  70                  75                  80  


Lys Met Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2324
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2324

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ala Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Gly Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Pro Arg Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110 


<210>  2325
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2325

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Ser Ser Ala 
            20                  25                  30          


Gly Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr Tyr Ser Gly Arg Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Met Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Arg Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Val Val Pro Thr Arg Gly Pro Val Ala Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2326
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2326

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Arg Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Thr Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Leu Leu 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2327
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2327

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Ser Lys Lys Asp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Ser Gln Gly Ala Tyr Ile Leu Thr Gly Tyr Arg Gly 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2328
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2328

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Phe Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ile Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 110         


<210>  2329
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2329

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ala Gly Gly Thr Ser Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Val Ala Ile Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Thr Thr Thr Gln Gly Gly Asp Tyr Gly Asp Asn Leu Tyr Tyr Leu Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2330
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2330

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Glu Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Tyr Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp Arg 
                85                  90                  95      


Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 


<210>  2331
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2331

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Val Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Leu Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg His Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Pro Glu Pro Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2332
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2332

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Asn Pro Ser 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2333
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2333

Glu Val His Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Arg Phe Ser Arg Ser 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Val Trp Val 
        35                  40                  45              


Ser His Ile Asn Ser Asp Gly Ser Ile Ile Asn Tyr Gly Asn Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Met Tyr Phe Cys 
                85                  90                  95      


Ala Ser Pro Thr Ser Val Thr Val Val Gly Gln Pro Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120     


<210>  2334
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2334

Glu Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Tyr Ser 
            20                  25                  30          


Asp Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Tyr Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Arg Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Glu Val Pro His Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  2335
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2335

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly His Ile Tyr Tyr Thr Gly Ser Ser Tyr Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Leu Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Leu Arg Trp Leu Arg Gly Gly Ile Asp Phe Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2336
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2336

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Asn Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Gly Ser Ser Arg Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2337
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2337

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Ala Pro Gly Ala 
1               5                   10                  15      


Ser Val Met Ile Ser Cys Arg Ala Ser Gly Tyr Thr Phe Ala Ser Leu 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Thr Ala Gly Arg Gly Phe Glu Trp Met 
        35                  40                  45              


Gly Trp Met Thr Pro Arg Asn Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Ile Met Thr Arg Asp Thr Ser Ile Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Glu Leu Thr Arg Leu Thr Ser Glu Asp Thr Gly Thr Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Ala Ala Gly Val Asp Tyr Trp Gly Gln Gly Ser Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2338
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2338

Gln Ala Val Leu Thr Gln Pro Ser Ala Leu Ser Ala Ser Pro Gly Ala 
1               5                   10                  15      


Ser Ala Arg Leu Thr Cys Thr Ser Gly Ser Gly Ile Asp Val Gly Thr 
            20                  25                  30          


Tyr Arg Ile Tyr Trp Tyr Gln Gln Lys Ser Gly Ser Pro Pro Arg Tyr 
        35                  40                  45              


Leu Leu Ser Tyr Lys Ser Asp Ser Asp Lys His Gln Gly Ser Gly Val 
    50                  55                  60                  


Pro Ser Arg Phe Ser Gly Ser Lys Asp Ala Ser Ala Asn Ala Gly Val 
65                  70                  75                  80  


Leu Phe Ile Ser Gly Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys 
                85                  90                  95      


Leu Ile Trp His Ile Asn Ala Tyr Val Phe Gly Thr Gly Thr Lys Val 
            100                 105                 110         


Thr Val Leu 
        115 


<210>  2339

<400>  2339
000

<210>  2340

<400>  2340
000

<210>  2341
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2341

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2342
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2342

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Asn Ile Thr Cys Gly Gly Asn Asn Ile Gly Arg Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Leu Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2343
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2343

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Gln Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Lys Ser Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Thr Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2344
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2344

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Asn Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Gln Arg Thr Ser Gly Val Pro Asp Arg Leu Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asn Tyr Tyr Cys Ala Val Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2345
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2345

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Arg Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Thr Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Ala Val Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp His Ser Gly Tyr Tyr Asp Ser Thr Ser Leu Met Ser Pro 
            100                 105                 110         


Phe Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2346
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2346

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Gly Asn Thr Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Thr Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Asn Gly Asp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2347
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2347

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Arg Thr Cys 
            20                  25                  30          


Gly Val Gly Val Gly Cys Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu 
            100                 105                 110         


Ile Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2348
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2348

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Met Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Ala Glu Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Ser Ser Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2349
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2349

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Leu Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Asn Thr Ser 
    50                  55                  60                  


Leu Arg Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ala Thr Thr Ile Phe Tyr Gly Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2350
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2350

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Phe Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile 
65                  70                  75                  80  


Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Ser Cys Gln Gln Ser 
                85                  90                  95      


Tyr Thr Thr Leu Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2351
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2351

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser His 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Gly Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Ala Gly Val Pro Ala Ala Leu Gly Cys Trp Phe Asp 
            100                 105                 110         


Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2352
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2352

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Tyr Lys Arg Asp Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Leu 
                85                  90                  95      


Ile Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 


<210>  2353
<211>  134
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2353

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Asp 
            20                  25                  30          


Asp Phe Ser Ser Gly Asp Asn Tyr Trp Ser Trp Leu Arg Gln Pro Pro 
        35                  40                  45              


Gly Lys Gly Leu Glu Trp Ile Gly Tyr Ile Tyr Tyr Ser Gly Leu Thr 
    50                  55                  60                  


Asn Tyr Asn Pro Ser Leu Lys Ser Arg Val Ile Ile Ser Val Asp Thr 
65                  70                  75                  80  


Ser Lys Asn Gln Phe Ser Leu Lys Leu Asn Ser Val Thr Ala Ala Asp 
                85                  90                  95      


Thr Ala Val Tyr Tyr Cys Ala Ser Glu His Lys Thr His Tyr Tyr Asp 
            100                 105                 110         


Ser Ser Gly Tyr Tyr Ser Asn Trp Phe Asp Pro Trp Gly Pro Gly Thr 
        115                 120                 125             


Leu Val Thr Val Ser Ser 
    130                 


<210>  2354
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2354

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Arg Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Ala Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Val Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Ser Tyr 
                85                  90                  95      


Val Phe Gly Ile Gly Thr Glu Val Thr Val Leu 
            100                 105         


<210>  2355
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2355

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Gly Ser Ile Ala Ala Ala Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2356
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2356

Val Ile Trp Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Val Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Cys Tyr Gln Gln Glu Pro Gly Lys Ala Pro Glu Leu Leu Ile 
        35                  40                  45              


Tyr Thr Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Leu Ser Phe 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2357
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2357

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Gly Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Leu Gly Pro Tyr Cys Ser Gly Gly Thr Cys Tyr Ser Leu 
            100                 105                 110         


Val Gly Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2358
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2358

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Val Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Gly Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  2359
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2359

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ile Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Cys Ala Phe 
            100                 105                 110         


Asp Ile Trp Gly Gln Gly Thr Met Val Ser Val Ser Ser 
        115                 120                 125 


<210>  2360
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2360

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Gly Arg Ala Thr Gly Ile Pro Asp Arg Phe Cys 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2361
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2361

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Tyr Tyr 
            20                  25                  30          


Pro Met His Trp Leu Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Val Ala Val Thr Ser Tyr Asp Gly Thr Asn Lys Tyr Tyr Ala Asp 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ala Arg Gly Gly Ala Thr Asn Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2362
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2362

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Asn Ile Thr Cys Gly Gly Asn Asn Ile Gly Arg Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2363
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2363

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Arg Gly Gly Tyr Asn Trp Asn Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2364
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2364

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Pro 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2365
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2365

Gln Val Leu Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Leu Gly Thr Ser Val Thr Val Ser 
        115                 120         


<210>  2366
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2366

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2367
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2367

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Tyr Lys Tyr Phe Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Gly Thr Val Val Thr His Phe Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2368
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2368

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Thr Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Val Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2369
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2369

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2370
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2370

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Met Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Ala Glu Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Ile Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2371
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2371

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Asp Phe Tyr Gly Phe Asp Val Trp Gly His Gly Thr 
            100                 105                 110         


Lys Val Thr Val Ser Ser 
        115             


<210>  2372
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2372

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Arg 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Glu Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2373
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2373

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ile Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Phe Val Asp Thr Ser Lys Ser Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg His His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe 
            100                 105                 110         


Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2374
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2374

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Tyr Gly Ser Ser Arg 
                85                  90                  95      


Gly Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  2375
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2375

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Met Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Leu Gly Pro Tyr Cys Ser Gly Gly Thr Cys Tyr Ser Leu 
            100                 105                 110         


Val Gly Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2376
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2376

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Ala Asn Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2377
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2377

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Ser Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp His 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2378
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2378

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Asn Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Phe Gly Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Val Ala Trp Asp Asp Ser Arg 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Ala Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2379
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2379

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Asp Thr Phe Ser Ser Tyr 
            20                  25                  30          


Thr Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Pro Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  2380
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2380

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn His Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Ser Asp Asn Leu Pro Met 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2381
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2381

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Arg Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ile Ile Ser Tyr Asp Gly Thr Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Glu Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Gly Glu Asp Thr Ser Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Asp Pro Ser Met Tyr Ser Ser Ser Trp Tyr Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2382
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2382

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Asn Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Phe Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2383
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2383

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Leu Ile Ser Gly Asp Gly Gly Asn Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Glu Met Ala Tyr Pro Pro Ser His His Tyr Tyr Tyr Tyr 
            100                 105                 110         


Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2384
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2384

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Thr Asp Ala Leu Pro Asn Glu Tyr Ile 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Pro His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2385
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2385

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2386
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2386

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp 
65                  70                  75                  80  


Thr Glu Asp Phe Gly Val Tyr Tyr Cys His Gln Tyr Gly Ile Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2387
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2387

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2388
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2388

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Asn Ile Thr Cys Gly Gly Asn Asn Ile Gly Arg Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Pro His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2389
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2389

Gln Val His Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile His Tyr Ser Gly Ser Thr Ser Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Arg Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val Pro 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2390
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2390

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Val Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ile Gly 
                85                  90                  95      


Arg Gly Gly Trp Ile Phe Gly Gly Gly Thr Lys Leu Thr Val 
            100                 105                 110 


<210>  2391
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2391

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Thr Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Pro Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Gly Asn Thr Gly Tyr Ala His Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Ser Ile Leu Thr Gly Phe Tyr Asn Pro Leu Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2392
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2392

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ile Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr His Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2393
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2393

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Thr Ile His Tyr Ser Gly Ile Ser Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Asn Asn Lys Phe 
65                  70                  75                  80  


Ser Leu Glu Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Phe 
                85                  90                  95      


Cys Ala Arg Arg Thr Tyr Tyr Asp Leu Trp Ser Ala Tyr Ser Ser Thr 
            100                 105                 110         


Ala Tyr Tyr Cys Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val 
        115                 120                 125             


Ser Ser 
    130 


<210>  2394
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2394

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2395
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2395

Gln Val Gln Leu Gln Glu Ser Gly Pro Arg Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Met Ser Gly Phe 
            20                  25                  30          


Phe Trp Ser Trp Val Arg Gln Ser Pro Glu Arg Gly Phe Glu Tyr Ile 
        35                  40                  45              


Gly Tyr Phe Tyr Ser Ser Ala Lys Thr Asp Tyr Asn Pro Ser Leu Ser 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Leu Asp Ala Ser Lys Asn Leu Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Thr Ser Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg Tyr 
            100                 105                 110         


Pro Arg Pro Asp Ile Phe Asp Met Trp Gly Arg Gly Thr Arg Ile Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2396
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2396

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Thr Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Ser Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2397
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2397

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2398
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2398

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Leu Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Ser Asp Asn Leu Pro Met 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2399
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2399

Gln Val His Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile His Tyr Ser Gly Ser Thr Ser Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Arg Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val Pro 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2400
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2400

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Glu Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Glu Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2401
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2401

Gln Val Arg Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ile Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Ser Gly Ser Gly Trp Leu Gly Tyr Ala Met Asp Val Trp 
            100                 105                 110         


Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2402
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2402

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Ile Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Thr Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Asn Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2403
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2403

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn His Phe 
65                  70                  75                  80  


Ser Leu Lys Met Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Lys Asp Met Val Glu Pro Leu Phe Ser His Tyr Tyr Tyr Gly 
            100                 105                 110         


Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2404
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2404

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn His Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Pro 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2405
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2405

Gln Val His Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile His Tyr Ser Gly Ser Thr Ser Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Arg Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val Pro 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Ala Ser Ser 
        115                 120                 125         


<210>  2406
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2406

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Leu Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Leu Leu Asn Ser His Pro Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  2407
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2407

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Leu 
        35                  40                  45              


Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Arg Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Leu Trp Phe Gly Glu Leu Ser Ser Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2408
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2408

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Arg 
                85                  90                  95      


Ser Thr Leu Val Leu Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2409
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2409

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Asn Asp Gly Arg Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Ser Asn Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2410
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2410

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Ser Ser 
                85                  90                  95      


Ser Ile Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2411
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2411

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2412
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2412

Gln Ala Val Leu Thr Gln Pro Ser Ala Leu Ser Ala Ser Pro Gly Ala 
1               5                   10                  15      


Ser Ala Arg Leu Thr Cys Thr Ser Gly Ser Gly Ile Asp Val Gly Thr 
            20                  25                  30          


Tyr Arg Ile Tyr Trp Tyr Gln Gln Lys Ser Gly Ser Pro Pro Arg Tyr 
        35                  40                  45              


Leu Leu Ser Tyr Lys Ser Asp Ser Asp Lys His Gln Gly Ser Gly Val 
    50                  55                  60                  


Pro Ser Arg Phe Ser Gly Ser Lys Asp Ala Ser Ala Asn Ala Gly Val 
65                  70                  75                  80  


Leu Phe Ile Ser Gly Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys 
                85                  90                  95      


Leu Ile Trp His Ile Asn Ala Tyr Val Phe Gly Thr Gly Thr Lys Val 
            100                 105                 110         


Thr Val Leu 
        115 


<210>  2413
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2413

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2414
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2414

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Thr His Ser Pro Leu 
                85                  90                  95      


Asp Ser Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2415
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2415

Gly Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Asp Asp Ser Asp Thr Arg Tyr Asp Pro Ser Phe 
    50                  55                  60                  


Glu Gly Gln Val Ser Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Pro Thr Leu Tyr Asn Trp Phe His Pro Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2416
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2416

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Leu Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Pro Ser Leu Thr Ile Thr Gly Ala Gln Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Asn Ser Gly Asn Leu 
                85                  90                  95      


Asn Trp Val Phe Gly Gly Gly Thr Thr Leu Thr Val Leu 
            100                 105                 


<210>  2417
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2417

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Thr Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Asp Trp Asn Gly Gly Thr Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Ala Gly Tyr Tyr Ala Tyr Val Trp Gly Ser Tyr Arg Phe Glu 
            100                 105                 110         


Tyr Phe Asp Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2418
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2418

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Leu 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2419
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2419

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Glu Thr Ser Arg Ala Ala Asp Gly Ile Phe Tyr Ser Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  2420
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2420

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2421
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2421

Gln Val Glu Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Gly Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Gly Thr Val Val Thr His Phe Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2422
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2422

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Asn Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Lys Val Val Tyr 
        35                  40                  45              


His Asp Gly Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Asn Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2423
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2423

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Val Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Leu Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg His Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Pro Glu Pro Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2424
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2424

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Ser Phe 
                85                  90                  95      


Glu Thr Phe Gly Pro Gly Thr Lys Val Ala Ile Lys 
            100                 105             


<210>  2425
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2425

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Gly 
            20                  25                  30          


Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Cys Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Ser Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Met Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Gly Ser Pro Val Pro Pro Thr Ile Val Gly Ala Ser Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2426
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2426

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Phe Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ile Asn Arg Trp Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2427
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2427

Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Asn Ala 
            20                  25                  30          


Arg Met Ser Val Asn Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Asn Asp Glu Lys Ser Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Leu Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Ile Val Ala Ser 
        115                 120     


<210>  2428
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2428

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Val Val Ile Tyr 
        35                  40                  45              


Gln Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Ala Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2429
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2429

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asp Ile Ser Phe Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Ser Ser Glu Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asp Ser Leu Arg Ala Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Ser Thr Thr Trp Tyr Leu Glu Met Trp Gly Pro Asp 
            100                 105                 110         


Ala Phe Asp Ile Trp Gly Gln Gly Thr Val Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2430
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2430

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Ile Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2431
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2431

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Ser 
1               5                   10                  15      


Ser Pro Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Leu Ser Arg Tyr 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Glu Thr Ser Arg Ala Ala Asp Gly Lys Phe Tyr Ser Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Lys Asn Leu Leu Phe 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Ile Arg Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ser Gly Leu Ala Arg Ala Phe Ser Tyr Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Ala Leu Val Ile Val Ser Ser 
        115                 120     


<210>  2432
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2432

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Phe 
            20                  25                  30          


Val Asn Trp Tyr Gln His Lys His Gly Glu Val Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Gln Leu 
65                  70                  75                  80  


Glu Asp Ser Ala Thr Tyr Tyr Cys Gln Gln Thr His Ser Pro Leu Asp 
                85                  90                  95      


Ser Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2433
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2433

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Leu Ile Ser Leu Phe Arg Gly Ala Ile Phe His Tyr Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2434
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2434

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Ala Ala Ser Thr Arg Ala Thr Asp Ile Pro Asp Arg Phe Asn 
    50                  55                  60                  


Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Ala Glu Asp Val Ala Ile Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2435
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2435

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ile Asp His 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Ala Tyr Ile Tyr Ser Thr Gly Arg Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Ile Asp Thr Ser Lys Asp Gln Phe Ser Leu 
65                  70                  75                  80  


Arg Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Phe Cys Ala 
                85                  90                  95      


Arg Thr Pro Pro Arg Gly Gly Phe Asp Val Trp Gly Gln Gly Thr Thr 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2436
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2436

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Leu Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Leu Thr Trp Val Thr Gly Ser Trp Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2437
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2437

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Arg Tyr 
            20                  25                  30          


Gly Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Thr Asp Lys Tyr Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Lys Gly Gly Pro Tyr Cys Gly Gly Gly Asn Cys Tyr Ala Gly 
            100                 105                 110         


Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2438
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2438

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Ser Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2439
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2439

Gly Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Asp Asp Ser Asp Thr Arg Tyr Asp Pro Ser Phe 
    50                  55                  60                  


Glu Gly Gln Val Ser Ile Ser Ala Asp Lys Ser Ile Thr Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Val Lys Ala Pro Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Asp Lys Val Gly Ala Leu Asp Ser Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2440
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2440

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Met Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Gly Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Asn Arg Ala Thr Ala Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Arg Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Ser Ala Val Tyr Tyr Cys Gln Gln His Ala Gly Ser Pro 
                85                  90                  95      


Arg Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2441
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2441

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ile Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Asp Tyr Tyr Gly Leu Asp Val Trp Gly Gln Gly Thr 
            100                 105                 110         


Thr Val Thr Val Ser Ser 
        115             


<210>  2442
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2442

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Thr Asp Ala Leu Pro Asn Glu Tyr Ile 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Pro His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2443
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2443

Gln Val Arg Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ile Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  2444
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2444

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Arg 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Glu Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Ala Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Arg Ser 
                85                  90                  95      


Ser Thr Arg Val Phe Gly Gly Gly Thr Thr Leu Thr Val Leu 
            100                 105                 110 


<210>  2445
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2445

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2446
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2446

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Arg 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Gly Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2447
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2447

Gln Val His Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile His Tyr Ser Gly Ser Thr Ser Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Arg Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Gly Pro 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2448
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2448

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Met Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Trp Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2449
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2449

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Ser 
1               5                   10                  15      


Ser Pro Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Leu Ser Arg Tyr 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Leu Ile Tyr Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Gly Ser Ile Leu Trp Trp Leu Ile Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2450
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2450

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Ala Asn Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2451
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2451

Gln Val Gln Leu Gln Glu Ser Gly Pro Arg Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Met Ser Gly Phe 
            20                  25                  30          


Phe Trp Ser Trp Val Arg Gln Ser Pro Glu Arg Gly Phe Glu Tyr Ile 
        35                  40                  45              


Gly Tyr Phe Tyr Ser Ser Ala Lys Thr Asp Tyr Asn Pro Ser Leu Ser 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Leu Asp Ala Ser Lys Asn Leu Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Thr Ser Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg Tyr 
            100                 105                 110         


Pro Arg Pro Asn Ile Phe Asp Met Trp Gly Arg Gly Thr Arg Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2452
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2452

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Met Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Glu Phe Ile Leu Thr Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Cys Ser Asp Trp Pro 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Val Glu Ile Lys 
            100                 105         


<210>  2453
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2453

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2454
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2454

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Thr Ile Thr Cys Gly Gly Asn Asn Phe Ala Thr Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Asn Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ile Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Ser Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Arg Ser Gly His 
                85                  90                  95      


Phe Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2455
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2455

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Phe Ser Ala Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Gly Tyr Ser Gln Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2456
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2456

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Ser Cys Gln Gln Ser Tyr Thr Thr Leu Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2457
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2457

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Arg Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Asn Tyr Asn Pro Ser Phe Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Tyr Gly Ile Gly Glu Trp Glu Leu Gln Tyr Tyr Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2458
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2458

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Ile Ile Ser Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Val Gly Tyr 
                85                  90                  95      


Arg Thr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2459
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2459

Glu Val Gln Val Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ser Ser Gly Phe Ile Phe Asp Asp Tyr 
            20                  25                  30          


Val Met His Trp Val Arg Gln Arg Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Gly Ile Thr Tyr Asn Gly Gly Ile Leu Gly Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Ile Ala Arg Asp Asn Val Arg Gly Phe Leu Ser 
65                  70                  75                  80  


Leu Gln Met Gly Asp Leu Arg Thr Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Tyr Cys Ser Ser Thr Thr Cys Pro Ala Glu Thr Tyr Tyr 
            100                 105                 110         


Tyr Met Asp Val Trp Gly Lys Gly Thr Ala Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2460
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2460

Ser Tyr Glu Leu Ala Gln Pro Pro Ser Val Ser Val Ala Pro Gly Glu 
1               5                   10                  15      


Thr Ala Thr Ile Phe Cys Arg Ala Thr Tyr Ile Gly Arg Lys Asn Val 
            20                  25                  30          


Gln Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Gly Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asp Thr Ala Thr Leu Thr Ile Ser Arg Ile Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Ala Tyr Tyr Cys Gln Val Trp Asp Gly Ile Asn Asp Arg 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2461
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2461

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Val Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Leu Ile Tyr Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Phe Leu Arg Trp His Asp Leu Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2462
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2462

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Leu Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Pro 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2463
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2463

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Phe Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Asp Phe Asp Ile Leu Thr Gly Tyr Tyr Ser Asn Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2464
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2464

Asp Phe Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Phe Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ser Glu Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2465
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2465

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ala Thr Thr Phe Phe Tyr Gly Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser 
        115                 


<210>  2466
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2466

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Arg Ser 
                85                  90                  95      


Ser Thr Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2467
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2467

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Ala Pro Gly Ala 
1               5                   10                  15      


Ser Val Met Ile Ser Cys Arg Ala Ser Gly Tyr Thr Phe Ala Ser Leu 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Thr Pro Arg Asn Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Ile Met Thr Arg Asp Thr Ser Ile Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Glu Leu Thr Arg Leu Thr Ser Glu Asp Thr Gly Thr Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Ala Ala Gly Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2468
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2468

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Thr Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Glu Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2469
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2469

Glu Ala Gln Leu Leu Glu Ser Gly Gly Ala Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Cys Cys 
            20                  25                  30          


Ala Met Gly Trp Val Arg Gln Ala Pro Gly Arg Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile His Asp Asp Gly Val Gly Thr Phe Tyr Ala Val Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ser Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Gly Leu Arg Ala Glu Asp Thr Gly Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Trp Ala Gly Pro Ile Val Met Lys Tyr Tyr Leu Gln Tyr Trp 
            100                 105                 110         


Gly Gln Gly Ala Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2470
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2470

Gln Ser Leu Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Leu Ser Cys Ala Gly Ala Thr Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Ser Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Tyr Asn Thr Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Ala Thr Ser Ala Ser Leu Val Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ile Ser 
                85                  90                  95      


Leu Gly Gly Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2471
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2471

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Ser Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Thr Tyr Ser Ala Tyr Asp Met Pro Pro Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2472
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2472

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Asn Asn 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Arg Arg Leu Gly 
65                  70                  75                  80  


Pro Glu Asp Ser Ala Val Tyr Tyr Cys Gln Gln His Ala Gly Ser Pro 
                85                  90                  95      


Arg Thr Phe Gly Leu Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2473
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2473

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Met His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Pro Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Gly Asp Ser Gly Tyr Asp Leu Gly Ala Trp Tyr Phe Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2474
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2474

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ile Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Val Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Met Pro Pro 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2475
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2475

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Pro Thr Leu Tyr Asn Trp Phe His Pro Trp Gly Gln Gly 
            100                 105                 110         


Thr Pro Val Thr Val Ser Ser 
        115                 


<210>  2476
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2476

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Ser Leu Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Ser Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2477
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2477

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Leu Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Asn Thr Ser 
    50                  55                  60                  


Leu Arg Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ala Thr Thr Phe Phe Tyr Gly Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2478
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2478

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Arg Tyr Asn Ile Gly Ser Asn 
            20                  25                  30          


Tyr Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Gly Leu Ile Phe Gly Gly Gly Thr Lys Leu Thr Val 
            100                 105                 


<210>  2479
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2479

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Leu Thr Asn Met Asp Thr Val Asp Ser Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Ser Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2480
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2480

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Arg Ser Ser Gly Ser Ile Ala Ser Ser 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ile Asn Arg Ala Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2481
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2481

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ile Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Gln Arg Tyr Cys Ser Ser Ser Ser Cys His Val Trp 
            100                 105                 110         


Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2482
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2482

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Ser Thr Trp Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2483
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2483

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120         


<210>  2484
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2484

Glu Val Met Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Thr Ile Phe Ser Thr 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Leu Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Thr Ser Asn Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Asn Tyr Val 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  2485
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2485

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Glu Val Val Gly Tyr Phe Asp Cys Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2486
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2486

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Thr Asp Ala Leu Pro Asn Glu Tyr Ile 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Pro His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2487
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2487

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Asp Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Arg Gly Ala Gly Tyr Thr Ser Tyr Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  2488
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2488

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Glu Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Phe Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2489
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2489

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Arg Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Leu Val Thr Tyr Gly Leu Asp Val Trp Gly Gln Gly Thr Thr 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2490
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2490

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Arg Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Arg Ser 
                85                  90                  95      


Ser Thr Arg Val Phe Gly Gly Gly Thr Lys Leu Thr 
            100                 105             


<210>  2491
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2491

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Pro Gly Gly Ser Ala Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg His Asn Ser Asn Asn Thr Leu Cys Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ser Tyr Asp Ile Leu Thr Gly Tyr Arg Asp Ala Phe Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  2492
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2492

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Glu Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Ala Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ser Glu Ala Glu Ala Asp Tyr Tyr Cys Val Ala Trp Asp Asp Ser 
                85                  90                  95      


Arg Asn Gly Leu Val Phe Gly Gly Gly Ala Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2493
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2493

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Asp Asn Ser Pro Gln Gly Ser Gly Trp Tyr Phe Tyr Tyr 
            100                 105                 110         


Tyr Tyr Ala Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2494
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2494

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Lys Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Tyr Val Ser Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Glu Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Gly Thr Trp Asp Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  2495
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2495

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ile Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  2496
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2496

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Glu Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2497
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2497

Gln Val Glu Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Gly Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  2498
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2498

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Asn Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Lys Val Val Tyr 
        35                  40                  45              


His Asp Gly Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Asn Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2499
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2499

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Lys Ser Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Thr Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp His 
            100                 105                 110         


Trp Gly Arg Gly Ala Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2500
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2500

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ile Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr His Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Ser Asp Asn Leu Pro Met 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2501
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2501

Gln Val His Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile His Tyr Ser Gly Ser Thr Ser Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Arg Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Asn Tyr Phe Asp Asn Ser Gly Asn Pro Val Tyr Pro Val Pro 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2502
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2502

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Met Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Ala Glu Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Phe Ser Val Tyr Tyr Cys Leu Leu 
                85                  90                  95      


Phe Gly Cys Ser Arg Gly Trp Lys Phe Gly His Gly Thr Leu Leu Glu 
            100                 105                 110         


Ile Lys 
        


<210>  2503
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2503

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2504
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2504

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Gly Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Pro His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2505
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2505

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2506
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2506

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Thr Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Gly Ser Ser Arg Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2507
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2507

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Phe Ser Leu Ser Asn Ala 
            20                  25                  30          


Arg Met Ser Val Asn Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Asn Asp Glu Lys Ser Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Leu Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2508
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2508

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Thr Ile Thr Cys Gly Gly Asn Asn Phe Ala Thr Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Lys Phe Gly Asn Thr Ala Ile Leu Ile Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Gly Ser Asp His 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2509
<211>  133
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2509

Glu Val Gln Leu Val Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Thr Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser His 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Glu Asp Gly Arg Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Leu Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Val Val Glu Val Ala Thr Asn Lys Gly Ile His Gly Val 
            100                 105                 110         


Asp Tyr Tyr Tyr Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr 
        115                 120                 125             


Val Thr Val Ser Ser 
    130             


<210>  2510
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2510

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Val Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Lys Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Asn Ser Gly Asn Leu 
                85                  90                  95      


Asn Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2511
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2511

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2512
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2512

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Glu Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2513
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2513

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Lys Ala Pro Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Ala Gly Ser Thr Thr Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Val Thr Tyr Gly Leu Asp Val Trp Gly Gln Gly Thr 
            100                 105                 110         


Thr Val Thr Val Ser Ser 
        115             


<210>  2514
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2514

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Arg 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Lys Phe Gly Asn Thr Ala Thr Leu Ile Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Gly Ser Asp His 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Met Val Thr Val Leu 
            100                 105             


<210>  2515
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2515

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Val Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Leu Ile Tyr Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg His Gln Arg Tyr Cys Ser Ser Ser Ser Cys His Val Trp Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Leu Thr Val Ser Ser 
        115                 120             


<210>  2516
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2516

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Thr Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Ile Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2517
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2517

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Arg Ser Asn 
            20                  25                  30          


Tyr Met Thr Trp Val Arg Gln Thr Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Asn Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Phe Leu Arg Trp His Asp Leu Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Ile Val Ser Ser 
        115     


<210>  2518
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2518

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Met Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Ala Glu Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Ile Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2519
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2519

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Asp Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Arg Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Ile Ser Met Thr Ser Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Tyr Gly Phe Val Pro Asn Val Leu Tyr Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Thr 
        115                 120             


<210>  2520
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2520

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Ile Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Ser Thr Trp Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2521
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2521

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Leu Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Asn Thr Ser 
    50                  55                  60                  


Leu Arg Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ala Thr Thr Phe Phe Tyr Val Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2522
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2522

Gln Ser Leu Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Arg 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Met Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Ser Ser 
                85                  90                  95      


Ser Ile Val Val Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  2523
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2523

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Asp Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Gly Gly Ser Tyr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gly Ser Ile Leu Trp Trp Leu Ile Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2524
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2524

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Thr Ser Arg Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2525
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2525

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Ser Ser Gly 
            20                  25                  30          


Arg Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Phe Val Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Arg Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Thr Tyr Ser Ala Tyr Glu Met Pro Pro Tyr Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2526
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2526

Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val His Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Gln Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr His Trp Pro Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110 


<210>  2527
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2527

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Ile Ser Gly Gly Ser Thr Tyr Tyr Ala Ala Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ser Arg Ser Gly Ile Ala Gly Val Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2528
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2528

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Arg 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Lys Phe Gly Asn Thr Ala Thr Leu Ile Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Gly Ser Asp His 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105             


<210>  2529
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2529

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Ala Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Asp Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Val Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ala Lys Asp Tyr Val Gly Ala Val Met Val Arg Gly Val Asn 
            100                 105                 110         


Tyr His Tyr Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2530
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2530

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Lys Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Pro 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2531
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2531

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Cys Val 
        35                  40                  45              


Ser Val Ile Tyr Ala Gly Gly Asn Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Asp Gly Gly Tyr Tyr Ser Pro Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2532
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2532

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Val Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Met Gln Ser Gly Val Pro Ser Arg Phe Arg Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Leu 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Gln 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2533
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2533

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Ser Asp Gly Ser Asn Lys Tyr Tyr Ala Gly Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Met Val Glu Pro Phe Phe Ser His Tyr Tyr Tyr Tyr Gly 
            100                 105                 110         


Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2534
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2534

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Thr Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Ile Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2535
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2535

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Ala Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Pro Thr Pro Gln Leu Leu Pro Ser Phe Glu Asn 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2536
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2536

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Glu Ala Pro Arg Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Gly Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Ala Val Asn Trp Tyr Gln Gln Leu Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Tyr Asp Asp Leu Leu Pro Ser Gly Val Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ser Trp Asp Asp Ser Leu 
                85                  90                  95      


Ile Gly Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2537
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2537

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Gly Ser Asn 
            20                  25                  30          


Tyr Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Glu Val Val Gly Tyr Phe Asp Cys Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2538
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2538

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Gly 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2539
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2539

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Asn Asp Gly Arg Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  2540
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2540

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Ser Ser 
                85                  90                  95      


Ser Ile Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2541
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2541

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Met Ser Ser 
            20                  25                  30          


Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Ile Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Thr Tyr Ser Ala Tyr Glu Met Pro Pro Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120             


<210>  2542
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2542

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Leu Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Pro Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Asn Ser Gly Asn Leu 
                85                  90                  95      


Asn Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2543

<400>  2543
000

<210>  2544

<400>  2544
000

<210>  2545
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2545

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Leu Ser Leu Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Thr Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Pro Arg Asn Gln Ile Ser Leu 
65                  70                  75                  80  


Ser Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ile Pro Thr Gly Phe Pro Arg Cys Tyr Met Asp Val Trp Gly Lys 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2546
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2546

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Ser Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Ala Ile Lys 
            100                 105         


<210>  2547
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2547

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2548
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2548

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2549
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2549

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly His Ile Tyr Tyr Thr Gly Ser Ser Tyr Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Leu Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Leu Arg Trp Leu Arg Gly Gly Ile Asp Phe Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Ile Val Ser Ser 
        115             


<210>  2550
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2550

Asn Leu Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Asn Asn Gln Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2551
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2551

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Asp Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Arg Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Ile Ser Met Thr Ser Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Tyr Gly Phe Val Pro Asn Val Leu Tyr Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Ile Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2552
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2552

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Arg Ser Ser Gly Ser Ile Ala Ser Ser 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Ser Asp Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2553
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2553

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2554
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2554

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Ser Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ile Asn Arg Ala Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2555
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2555

Gln Val Glu Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Gly Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Gln Gly Gly Asn Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  2556
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2556

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Asn Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Lys Val Val Tyr 
        35                  40                  45              


His Asp Gly Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Asn Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2557
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2557

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2558
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2558

Asp Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Arg Leu Ala Pro Thr 
            20                  25                  30          


Leu Leu Ala Trp Phe Leu Gln Lys Arg Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Ala Ala Ser Thr Arg Ala Thr Asp Ile Pro Asp Arg Phe Asn 
    50                  55                  60                  


Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Leu 
                85                  90                  95      


Leu Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  2559
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2559

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Lys Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Val Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ser Gly Gly Val Lys Phe Asp Pro Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2560
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2560

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Asp Asn 
                85                  90                  95      


Tyr Thr Tyr Asn Tyr Val Phe Gly Thr Glu Thr Lys Val Thr Val Leu 
            100                 105                 110         


<210>  2561
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2561

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Ser 
1               5                   10                  15      


Ser Pro Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Leu Ser Arg Tyr 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Glu Thr Ser Arg Ala Ala Asp Gly Lys Phe Tyr Ser Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Lys Asn Leu Leu Phe 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Ile Arg Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ser Gly Leu Ala Arg Ala Phe Ser Tyr Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Ala Arg Val Ile Val Ser Ser 
        115                 120     


<210>  2562
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2562

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Ser Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2563
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2563

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Ala Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Leu Ile Ser Tyr Asp Gly Arg Asn Glu Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Gly Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Ala Tyr His Pro Tyr Arg Asp Tyr Gly Asp Asp Asp 
            100                 105                 110         


Tyr Tyr Tyr Tyr Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val 
        115                 120                 125             


Thr Val Ser Ser 
    130         


<210>  2564
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2564

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Phe Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Gly Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Thr Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2565
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2565

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2566
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2566

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Phe Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Glu Arg Phe Ser Gly Ser Gly Thr Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Leu Gln Ala 
                85                  90                  95      


Leu Gln Phe Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  2567
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2567

Gly Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Asp Asp Ser Asp Thr Arg Tyr Asp Pro Ser Phe 
    50                  55                  60                  


Glu Gly Gln Val Ser Ile Ser Ala Asp Lys Ser Ile Thr Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Val Lys Ala Pro Asp Thr Ala Met Tyr His Cys 
                85                  90                  95      


Ala Arg Arg Asp Lys Val Gly Ala Leu Asp Ser Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2568
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2568

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Ala 
65                  70                  75                  80  


Glu Asp Val Ala Ile Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2569
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2569

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Ala Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Thr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Phe Val Asp Thr Ser Lys Ser Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg His His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe 
            100                 105                 110         


Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2570
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2570

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Glu Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Cys Cys Gln Gln Tyr Asn Ser Tyr Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  2571
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2571

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Asn Asp Gly Arg Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ile Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Ser Gln Gly Ala Tyr Ile Leu Thr Gly Tyr Arg Gly 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2572
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2572

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Pro Ser Gln Ser Ile Thr Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Ala Val Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Ala Asn Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2573
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2573

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Gly Gly Gly Ser Thr Thr Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Ser Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ala Ile Pro Pro Asn Ser Arg Ala Glu Ile Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2574
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2574

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Cys Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Asn Trp Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2575
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2575

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Ser Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Ser Gly Ser Gly Trp Leu Gly Tyr Ala Met Asp Val Trp 
            100                 105                 110         


Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120     


<210>  2576
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2576

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Thr Asp Ala Leu Pro Asn Glu Tyr Ile 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Pro His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2577
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2577

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Ala Pro Arg Ala 
1               5                   10                  15      


Ser Val Met Ile Ser Cys Arg Ala Ser Gly Tyr Thr Phe Ala Ser Leu 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Pro Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Gly Asn Thr Gly Tyr Ala His Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Phe His Val Pro Ala Ala Leu Arg Asn Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Pro Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2578
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2578

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Thr Ile Thr Cys Gly Gly Asn Asn Phe Ala Thr Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Asn Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ile Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Arg Ser Gly His 
                85                  90                  95      


Phe Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2579
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2579

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2580
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2580

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Ala Asn Leu Thr Leu 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2581
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2581

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Glu Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu His Gln Asp Trp Val Val Val Val Ala Ala Asn Val 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2582
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2582

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Gly Asn Thr Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2583
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2583

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2584
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2584

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Thr Ile Thr Cys Gly Gly Asn Asn Phe Ala Thr Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Asn Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ile Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2585
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2585

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Ser Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Phe Leu Arg Trp His Asp Leu Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2586
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2586

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ala Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Gly Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Pro Arg Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110 


<210>  2587
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2587

Glu Ala Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Ala Ser Gly Phe Ile Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Phe Leu Arg Trp His Asp Leu Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2588
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2588

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Thr Ser 
                85                  90                  95      


Val Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2589
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2589

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Arg 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Thr Val Asp Cys Gly Gly Asp Cys Phe Pro Asn Asp 
            100                 105                 110         


Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2590
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2590

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Thr Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Asn Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Glu Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2591
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2591

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Arg 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Arg Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Thr Val Asp Cys Gly Gly Asp Cys Phe Pro Asn Asp 
            100                 105                 110         


Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2592
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2592

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ala Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Gly Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys His Gln Tyr Gly Ile Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile 
            100                 105         


<210>  2593
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2593

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Tyr Leu His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Thr Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Ala Val Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Asn Asp Tyr Gly Asp Tyr Val Glu Pro Arg Asp Tyr Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2594
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2594

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Ala Ala Tyr 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2595
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2595

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Phe Val Asp Thr Ser Lys Ser Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg His His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe 
            100                 105                 110         


Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2596
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2596

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Thr Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser His Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Lys Val Lys Pro Gly Gln Ala Pro Leu Leu Val Ile Tyr 
        35                  40                  45              


Gly Arg Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Arg Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Val Asp 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser Leu Asn Gly 
                85                  90                  95      


Asp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2597
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2597

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2598
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2598

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2599
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2599

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Glu Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Gly Lys Ala Ala Ala Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2600
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2600

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Gly Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Pro Arg Tyr Thr Phe Gly Gln Gly Thr Lys Leu Ala Ile Lys 
            100                 105                 110 


<210>  2601
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2601

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Ser 
1               5                   10                  15      


Ser Pro Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Leu Ser Arg Tyr 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Glu Thr Ser Arg Ala Ala Asp Gly Lys Phe Tyr Ser Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Lys Asn Leu Leu Phe 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Ile Arg Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ser Gly Leu Ala Arg Ala Phe Ser His Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Ala Leu Val Ile Val Ser Ser 
        115                 120     


<210>  2602
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2602

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Thr Leu Thr Val Leu 
            100                 105                 110 


<210>  2603
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2603

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Cys Val 
        35                  40                  45              


Ala Val Thr Ser Tyr Asp Gly Thr Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg His Thr Val Asp Cys Gly Gly Asp Cys Phe Pro Asn Asp Ala 
            100                 105                 110         


Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125     


<210>  2604
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2604

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Pro Arg Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110 


<210>  2605
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2605

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Ser Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Lys Asp Gly Gly Asn Ala Tyr Ser Ser Gly Trp Tyr Arg Tyr Phe Tyr 
            100                 105                 110         


His Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2606
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2606

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Glu Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2607
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2607

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Asp Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Phe His Val Pro Ala Ala Leu Arg Asn Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Pro Val Thr Val Ser Ser 
        115                 120             


<210>  2608
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2608

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Phe Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ile Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr His Trp Pro Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110 


<210>  2609
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2609

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Gln Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Thr Pro Val Thr Ala Ile Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2610
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2610

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Asn Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Lys Val Val Tyr 
        35                  40                  45              


His Asp Gly Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ile Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Ser Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2611
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2611

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Asn Lys Lys Tyr Cys Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Cys Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Pro Phe Gly Asp Arg Glu Ala Ser Gly Ala Phe Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  2612
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2612

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Lys Tyr Thr 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Val Val Ile Tyr 
        35                  40                  45              


Glu Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Thr Asp Ser Ser Gly Lys Gly 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105         


<210>  2613
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2613

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr 
            20                  25                  30          


Tyr Met Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Gly Ile Thr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Thr Gly Val Val Ala Ala Pro Ala Glu Tyr Phe Gln His Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2614
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2614

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp Pro 
                85                  90                  95      


Phe Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 


<210>  2615
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2615

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu 
            100                 105                 110         


Ile Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2616
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2616

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Thr Ile Phe Ser Thr 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Leu Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Val Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Phe Ala Val Tyr Ser Cys Gln Gln Tyr Asp Asp Trp Pro 
                85                  90                  95      


Pro Glu Val Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110 


<210>  2617
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2617

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Leu Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Asn Thr Ser 
    50                  55                  60                  


Leu Arg Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Trp Ala Thr Thr Phe Phe Tyr Gly Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2618
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2618

Ser Tyr Glu Leu Ala Gln Pro Pro Ser Val Ser Val Ala Pro Gly Glu 
1               5                   10                  15      


Thr Ala Thr Ile Phe Cys Arg Ala Thr Tyr Ile Gly Arg Lys Asn Val 
            20                  25                  30          


Gln Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Glu Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2619
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2619

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu 
            100                 105                 110         


Ile Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2620
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2620

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Arg Gly Ala Val 
                85                  90                  95      


Phe Gly Ser Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  2621
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2621

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Gln Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Thr Pro Val Thr Ala Ile Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Ile Leu Val Thr Val Ser Ser 
        115                 


<210>  2622
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2622

Asp Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Arg Leu Ala Pro Thr 
            20                  25                  30          


Leu Leu Ala Trp Phe Leu Gln Lys Arg Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Ala Ala Ser Thr Arg Ala Thr Asp Ile Pro Asp Arg Phe Asn 
    50                  55                  60                  


Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp 
65                  70                  75                  80  


Thr Glu Asp Phe Gly Val Tyr Tyr Cys His Gln Tyr Gly Ile Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2623
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2623

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg His 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Leu Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Phe Tyr Tyr Gly Gly Ala Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2624
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2624

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Ser Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ile Asn Arg Ala Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2625
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2625

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn His Phe Ser Leu 
65                  70                  75                  80  


Lys Met Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Leu Asp Val Trp 
            100                 105                 110         


Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2626
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2626

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Glu Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Ala Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser 
                85                  90                  95      


Leu Asn Gly Ser Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2627
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2627

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu 
            100                 105                 110         


Ile Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2628
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2628

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Pro Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn Ala 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2629
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2629

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ile Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ala Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Ala Leu Tyr Tyr Asn Gly Pro Gly Arg Asp Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Ser Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2630
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2630

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Phe Pro Lys Gln Tyr Gly 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp Arg 
                85                  90                  95      


Leu Tyr Val Phe Gly Thr Gly Thr Asn Val Thr Val Leu 
            100                 105                 


<210>  2631
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2631

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Ser Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Ile Met Thr Arg Asp Thr Ser Ile Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Glu Leu Thr Arg Leu Thr Ser Glu Asp Thr Gly Thr Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Ala Ala Gly Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2632
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2632

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Ser Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2633
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2633

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Gly Ser Ile Ala Ala Ala Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2634
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2634

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu His Ser 
            20                  25                  30          


Ser Asn Asn Lys Asp Ser Leu Val Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ser Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2635
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2635

Gln Val His Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile His Tyr Ser Gly Ser Thr Ser Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Arg Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val Pro 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2636
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2636

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Val Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Gly Ser Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2637
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2637

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Asn Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120         


<210>  2638
<211>  105
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2638

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Lys Leu Thr Leu 
                85                  90                  95      


Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105 


<210>  2639
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2639

Gln Val Gln Leu Leu Glu Ser Gly Pro Gly Leu Val Lys Ser Ser Gln 
1               5                   10                  15      


Thr Leu Tyr Leu Thr Cys Ser Val Ser Gly Gly Ser Val Ser Ser Gly 
            20                  25                  30          


Ala Tyr Tyr Trp Thr Trp Val Arg Gln Pro Ala Gly Ser Pro Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Ile Tyr Thr Ser Gly Thr Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Asn Arg Arg Leu Thr Leu Ser Leu Asp Thr Ser Arg Asn Gln Ile 
65                  70                  75                  80  


Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Ala Tyr Phe 
                85                  90                  95      


Cys Ala Arg Ala Arg Ser Ser Met Asp Asn Phe Tyr Tyr Phe Tyr Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Ala Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2640
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2640

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ile Leu Ser Cys Arg Ala Ser Gln Asn Ile Lys Asn Thr 
            20                  25                  30          


Tyr Leu Ser Trp Tyr Gln Gln Thr Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile His Gly Ala Ser Asn Arg Ala Thr Asp Ile Pro Ala Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Leu Gln Asp Tyr Asn Leu Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105         


<210>  2641
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2641

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Lys Ala Pro Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Gly Lys Ala Ala Ala Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2642
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2642

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Asn Trp Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2643
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2643

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Tyr Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ile Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  2644
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2644

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Thr Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Gly Ser Ser Arg Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2645
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2645

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Phe Ser Ala Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Gly Tyr Ser Gln Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2646
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2646

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ile Gly 
                85                  90                  95      


Arg Gly Gly Trp Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2647
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2647

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Pro Tyr Cys Ser Ser Ile Ile Cys Asn Asp Gly Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2648
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2648

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Ile Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2649
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2649

Gln Val Gln Leu Val Gln Ala Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ala Ala Val Pro Ala Ala Gly Glu Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2650
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2650

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Ser Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2651
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2651

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Phe Ser Ala Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn His Phe Ser Leu 
65                  70                  75                  80  


Lys Met Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Gly Tyr Ser Gln Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2652
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2652

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Arg Ser 
                85                  90                  95      


Ser Thr Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2653
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2653

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Ala Pro Gly Ala 
1               5                   10                  15      


Ser Val Met Ile Ser Cys Arg Ala Ser Gly Tyr Thr Phe Ala Ser Leu 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Thr Ala Gly Arg Gly Phe Glu Trp Met 
        35                  40                  45              


Gly Trp Met Ser Pro Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Glu Leu Thr Arg Leu Thr Ser Glu Asp Thr Gly Thr Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Ala Ala Gly Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2654
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2654

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu His Ser 
            20                  25                  30          


Ser Asn Asn Lys Asp Ser Leu Val Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ser Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Trp Thr Phe Ser Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2655
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2655

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Ser Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ile Ile Ser Tyr Asp Gly Ile Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Asp Gly Ser Tyr Leu Met Asp Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2656
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2656

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Asn Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Val Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Asp Trp Pro Pro 
                85                  90                  95      


Glu Val Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  2657
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2657

Glu Val Gln Leu Val Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Thr Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser His 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Glu Asp Gly Arg Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Leu Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Phe Tyr Tyr Gly Gly Ala Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2658
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2658

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Val Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Lys Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Asn Ser Gly Asn Leu 
                85                  90                  95      


Asn Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2659
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2659

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ala Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Leu Met Ser Val Gly Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  2660
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2660

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Met Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Ala Glu Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Ile Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Leu Ala Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2661
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2661

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2662
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2662

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Val Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ile Gly 
                85                  90                  95      


Arg Gly Gly Trp Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2663
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2663

Gln Val Gln Leu Ile Gln Ser Gly Gly Glu Met Lys Arg Ser Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Arg Thr Ser Gly Tyr Ser Phe Thr Ser Phe 
            20                  25                  30          


Gly Ile Thr Trp Val Arg Leu Thr Pro Gly Gln Pro Pro Glu Trp Leu 
        35                  40                  45              


Gly Trp Ile Ser Gly Tyr Asp Gly Asn Thr Lys Tyr Ala Pro Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Val Met Thr Ile Asp Thr Ser Thr Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Ile Arg Tyr Asn Asp Ser Gly Tyr Tyr His Tyr Tyr Met 
            100                 105                 110         


Asp Ala Trp Gly Arg Gly Thr Ala Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2664
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2664

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ile Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Gly Ile Asn Asp Arg 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2665
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2665

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu 
            100                 105                 110         


Ile Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2666
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2666

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Phe Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile 
65                  70                  75                  80  


Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr 
                85                  90                  95      


Gly Ser Ser Leu Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Val Lys 
            100                 105                 110         


<210>  2667
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2667

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Leu Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Asn Thr Ser 
    50                  55                  60                  


Leu Arg Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ala Thr Thr Phe Phe Tyr Gly Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2668
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2668

Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val His Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Gln Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr Pro Trp Pro Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110 


<210>  2669
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2669

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Pro Gly Gly Ser Ala Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg His Asn Ser Asn Asn Thr Leu Cys Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ser Tyr Asp Ile Leu Thr Gly Tyr Arg Asp Ala Phe Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  2670
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2670

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ser Gly 
            20                  25                  30          


Ser Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Thr Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Val Ala Trp Asp Asp Ser 
                85                  90                  95      


Arg Asn Gly Leu Val Phe Gly Gly Gly Ala Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2671
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2671

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Ser 
1               5                   10                  15      


Ser Pro Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Leu Ser Arg Tyr 
            20                  25                  30          


Ser Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Glu Thr Ser Arg Ala Ala Asp Gly Lys Phe Tyr Ser Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Lys Asn Leu Leu Phe 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Ile Arg Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ser Gly Leu Ala Arg Ala Phe Ser Tyr Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Ala Leu Val Ile Val Ser Ser 
        115                 120     


<210>  2672
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2672

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Ser Ser Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2673
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2673

Gln Val Gln Leu Ile Gln Ser Gly Gly Glu Met Lys Arg Ser Gly Ala 
1               5                   10                  15      


Ser Val Arg Val Ser Cys Arg Thr Ser Gly Tyr Ser Phe Thr Ser Phe 
            20                  25                  30          


Gly Ile Thr Trp Val Arg Leu Thr Pro Gly Gln Pro Pro Glu Trp Leu 
        35                  40                  45              


Gly Trp Ile Ser Gly Tyr Asp Gly Asn Thr Lys Tyr Ala Pro Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Val Met Thr Ile Asp Thr Ser Thr Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Ile Arg Tyr Asn Asp Ser Gly Tyr Tyr His Tyr Tyr Met 
            100                 105                 110         


Asp Ala Trp Gly Arg Gly Thr Ala Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2674
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2674

Gln Val Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Gly Arg Ala Thr Leu Ser Cys Arg Ala Ser Glu Ser Val Arg Arg Asn 
            20                  25                  30          


Leu Ala Trp Phe Gln Leu Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


His Gly Ala Ser Thr Arg Ala Ser Gly Val Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Ile Leu Thr Ile Ser Gly Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Cys Ser Asp Trp Pro Thr 
                85                  90                  95      


Phe Gly Gln Gly Thr Arg Val Glu Ile Lys 
            100                 105     


<210>  2675
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2675

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn His Phe Ser Leu 
65                  70                  75                  80  


Lys Met Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120     


<210>  2676
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2676

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Val Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ile Gly 
                85                  90                  95      


Arg Gly Gly Trp Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2677
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2677

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Ser Ile Ser Ser Gly 
            20                  25                  30          


Arg Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Phe Val Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Arg Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Thr Tyr Ser Ala Tyr Glu Met Pro Pro Tyr Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2678
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2678

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Ile Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Leu 
                85                  90                  95      


Ala Phe Gly Pro Gly Thr Lys Val Asp Val Lys 
            100                 105         


<210>  2679
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2679

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Val Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Asp Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Ser Glu Ser Lys Ile Asp Tyr Tyr Tyr Tyr Gly Met 
            100                 105                 110         


Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2680
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2680

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Pro Ser Gln Ser Ile Thr Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Ala Val Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Pro 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  2681
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2681

Gln Val Gln Leu Gln Glu Ser Gly Pro Arg Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Met Ser Gly Phe 
            20                  25                  30          


Phe Trp Ser Trp Val Arg Gln Ser Pro Glu Arg Gly Phe Glu Tyr Ile 
        35                  40                  45              


Gly Tyr Phe Tyr Ser Ser Ala Lys Thr Asp Tyr Asn Pro Ser Leu Ser 
    50                  55                  60                  


Ser Arg Val Thr Met Ser Leu Asp Ala Ser Lys Asn Leu Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Thr Ser Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg Tyr 
            100                 105                 110         


Pro Arg Pro Asp Ile Phe Asp Met Trp Gly Arg Gly Thr Arg Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2682
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2682

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Arg Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Val Ala Trp Asp Asp Ser 
                85                  90                  95      


Arg Asn Gly Leu Val Phe Gly Gly Gly Ala Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2683
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2683

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Thr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn His Phe Ser Leu 
65                  70                  75                  80  


Lys Met Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Arg Asp His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe Gly Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2684
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2684

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Leu Ser Cys Ala Gly Ala Thr Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Ser Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Met Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ile Gly 
                85                  90                  95      


Arg Gly Gly Trp Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2685
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2685

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Asp Thr Phe Ser Ser Tyr 
            20                  25                  30          


Thr Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Pro Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  2686
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2686

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Glu Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Ala Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Gly Ser Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2687
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2687

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Phe Ser Ala Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Lys Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Val Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ser Gly Gly Val Lys Phe Asp Pro Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2688
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2688

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ala Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Gly Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Gln 
65                  70                  75                  80  


Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala Leu Gln Thr Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2689
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2689

Gln Leu Gln Leu Arg Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Phe Tyr 
                85                  90                  95      


Cys Ala Arg Met Ser Arg Gly Tyr Asn Tyr Ala Tyr Thr Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2690
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2690

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Lys Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Val Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2691
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2691

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Pro Thr Leu Tyr Asn Trp Phe His Pro Trp Gly Gln Gly 
            100                 105                 110         


Thr Pro Val Thr Val Ser Ser 
        115                 


<210>  2692
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2692

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Val Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ile Gly 
                85                  90                  95      


Arg Gly Gly Trp Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2693
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2693

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Ser Ala Ser Gly Phe Pro Phe Ser Ser Ser 
            20                  25                  30          


Ala Ile Gln Trp Val Arg Gln Ala Arg Gly Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Val Val Val Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Ser 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gln Arg Arg Gly Glu Ala Val Tyr Ser Asn Gly Trp Tyr Lys Tyr 
            100                 105                 110         


Tyr Tyr Cys Met Asp Val Trp Gly Glu Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2694
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2694

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  2695
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2695

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Ser Pro Asn Ser Gly Asn Thr Ala Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Leu Thr Leu Thr Arg Asp Thr Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Thr Arg Gly Glu Gly Val Leu Gly Pro Phe Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2696
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2696

Glu Val Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asn His Gly 
            20                  25                  30          


Tyr Ser Ala Trp Phe Gln Leu Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Ala Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Val Ala Val Tyr Tyr Cys His Gln Tyr Asp Ser Ser Gln 
                85                  90                  95      


Gly Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  2697
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2697

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser His 
            20                  25                  30          


Thr Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Met Asn Ser Asn Ser Gly Asn Thr Ala Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Ser Ser Trp Leu Arg Gly Ala Phe Asp Ile Trp Gly Gln Gly 
            100                 105                 110         


Thr Met Val Thr Val Ser Ser 
        115                 


<210>  2698
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2698

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ala Gly Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Thr Thr Ser Leu Gln Ser Gly Val Pro Val Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Leu Leu 
                85                  90                  95      


Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105             


<210>  2699
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2699

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Ser Phe Gly Asp Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Phe Ile Arg Asn Lys Asp Tyr Gly Gly Thr Thr Glu Phe Ala Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Thr Ile 
65                  70                  75                  80  


Ala Tyr Leu Gln Met Asn Ser Leu Thr Ile Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Thr Arg Ser Leu Tyr Leu Arg Ala Phe Asp Phe Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2700
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2700

Gln Ser Val Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Arg Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Arg Ser Val 
                85                  90                  95      


Ser Thr Val Val Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  2701
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2701

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Asp Tyr Ser Ser Gly Trp Phe Ser Tyr Trp Tyr Phe Asp 
            100                 105                 110         


Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2702
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2702

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Arg Ser Pro 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2703
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2703

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gln Arg Arg Gly Glu Ala Val Tyr Ser Asn Gly Trp Tyr Lys Tyr 
            100                 105                 110         


Tyr Tyr Cys Met Asp Val Trp Gly Glu Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2704
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2704

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Thr Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ala Gly Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Thr Thr Ser Leu Gln Ser Gly Val Pro Val Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Arg Tyr Asn Ser Tyr Ser Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2705
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2705

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr 
            20                  25                  30          


Trp Met Ala Trp Val Arg Gln Thr Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Thr Leu Phe Val Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Ala Val Ser Arg Asp Asn Ala Lys Arg Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Asp Glu Asp Thr Gly Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Trp Asn Glu Arg Asp Thr Asp Thr Tyr Gly Ala Asp Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2706
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2706

Arg Phe Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Thr Ala Ser Ile Ser Cys Arg Ser Ser Glu Asp Leu Leu Tyr Thr 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Ile Trp Phe His Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile His Lys Val Ser Asn Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr Arg Trp Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2707
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2707

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Gly Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Asp Ile Ile Trp Val Arg Gln Ala Thr Gly Gln Gly Ile Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Ser Asn Ser Gly Asn Ala Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Thr Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2708
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2708

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Ser Val Thr Ile Ala Cys Arg Ala Ser His Ser Ile Gly Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Pro Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Lys Ser Gly Val Pro Ser Arg Phe Gly Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Cys Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Tyr Ser Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2709
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2709

Gln Leu Gln Leu Arg Ala Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Thr Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Asn Ile Asn Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr His 
                85                  90                  95      


Cys Ala Arg Leu Ala Pro Gly Tyr Asp Phe Trp Arg Ala Gly Glu Ser 
            100                 105                 110         


Tyr Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2710
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2710

Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Gln Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Trp Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr His Trp Pro Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110         


<210>  2711
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2711

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Tyr Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Ser Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Val Ser Tyr Asp Phe Trp Ser Gly Tyr Trp Ala Phe Asp 
            100                 105                 110         


Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  2712
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2712

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Arg Thr 
                85                  90                  95      


Leu Ser Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2713
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2713

Gln Val His Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile His Tyr Ser Gly Ser Thr Ser Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Arg Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Ala Pro His Cys Asn Arg Thr Ser Cys Tyr Asp Ala Phe Asp Leu Trp 
            100                 105                 110         


Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2714
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2714

Asp Ile Val Met Thr Gln Ser Pro Asp Phe Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Phe Asn Trp 
            20                  25                  30          


Asp Asn His Arg Asp Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Asn Asn Trp Pro Leu Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2715
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2715

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Val Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Gln Trp Pro Asn Gln Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2716
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2716

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Ala Asp Ala Leu Pro Lys His Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ile Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Ala Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2717
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2717

Gln Val Gln Leu Val Gln Ser Gly Ser Ala Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Ser Tyr Gly Leu Ser Leu Gly Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2718
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2718

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Leu Gln 
                85                  90                  95      


Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105             


<210>  2719
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2719

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Val Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser His 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Ser Ala Asp Ile Ser Ser Arg Leu Asp Tyr Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2720
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2720

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Thr Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Asp Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Thr Asp Ser Ser Gly Asn Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  2721
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2721

Glu Gly Pro Leu Leu Glu Ser Gly Gly Gly Leu Leu Gln Pro Gly Glu 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Thr Phe Arg Thr Cys 
            20                  25                  30          


Ala Met Ser Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Thr Glu Ser Gly Asp Asp Thr His Leu Ser Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Glu Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Gly Val Tyr Tyr Cys 
                85                  90                  95      


Ala Val Ala Thr His Tyr Phe Asn Ser Gly Arg Ala Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2722
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2722

Asp Ile Val Leu Thr Gln Thr Pro Leu Ser Ser Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Asp Thr Tyr Leu Ser Trp Phe Leu Gln Arg Pro Gly Gln Pro 
        35                  40                  45              


Pro Arg Pro Leu Ile Tyr Lys Ile Ser Asn Arg Ile Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ala Gly Thr Asp Phe Thr Leu Arg Ile 
65                  70                  75                  80  


Thr Gly Val Glu Ala Glu Asp Val Gly Val Tyr Phe Cys Met Gln Ala 
                85                  90                  95      


Thr Gln Phe Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2723
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2723

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ser Gly Asp Thr Ser Ser Ser Tyr 
            20                  25                  30          


Thr Val Gly Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Ala Tyr Ser Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Leu Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ser Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2724
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2724

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Met Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  2725
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2725

Gln Ile Thr Phe Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Ser Thr Ser 
            20                  25                  30          


Gly Glu Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Val Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Arg Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2726
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2726

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Ala Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr His Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Ser Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2727
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2727

Gln Val Gln Leu Leu Glu Ser Gly Pro Gly Leu Val Lys Ser Ser Gln 
1               5                   10                  15      


Thr Leu Tyr Leu Thr Cys Ser Val Ser Gly Gly Ser Val Ser Ser Gly 
            20                  25                  30          


Ala Tyr Tyr Trp Thr Trp Val Arg Gln Pro Ala Gly Ser Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Ile Tyr Thr Ser Gly Thr Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Asn Arg Arg Leu Thr Leu Ser Leu Asp Thr Ser Arg Asn Gln Ile 
65                  70                  75                  80  


Ser Leu Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Ala Tyr Phe 
                85                  90                  95      


Cys Ala Arg Ala Arg Ser Ser Met Asp Asn Phe Tyr Tyr Phe Tyr Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Ala Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2728
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2728

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ala Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Asn Ile Lys Asn Thr 
            20                  25                  30          


Tyr Leu Ser Trp Tyr Gln Gln Thr Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile His Gly Ala Ser Thr Arg Ala Thr Asp Ile Pro Ala Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Leu Gln Asp Tyr Asn Leu Pro 
                85                  90                  95      


Trp Thr Phe Gly Pro Gly Thr Lys Val Glu Ile 
            100                 105         


<210>  2729
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2729

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Leu Ser Asp His 
            20                  25                  30          


Tyr Met Asp Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Thr Arg Asn Lys Ala Asn Ser Tyr Thr Thr Glu Tyr Ala Ala 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Ser 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ala Ser Val Ile Thr Phe Gly Gly Val Ile Val Arg Ser Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2730
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2730

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Tyr Tyr Gly Ser Ser Pro 
                85                  90                  95      


Phe Gly Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105             


<210>  2731
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2731

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Val Phe Gly Thr Thr Asn Tyr Ala Gln Lys Leu 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Val Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Ser Gly Tyr Gly Asp Tyr Gly Ala Tyr Ser Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2732
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2732

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Arg Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Arg Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  2733
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2733

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Glu Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Ser Trp Phe Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Asn Trp Asn Gly Gly Ser Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Val Ile Thr Phe Gly Gly Val Ile Val Arg Ser Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2734
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2734

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Asn Asn Tyr Tyr Cys Ala Val Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2735
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2735

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Ser Glu Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Glu Gly Asp Trp Leu Leu Gly Gly Pro Tyr Tyr His Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2736
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2736

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Tyr Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Ser Arg Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asn Tyr Tyr Cys Leu Val Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2737
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2737

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Gly Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Asp Thr Met Val Arg Gly Thr Tyr Phe Glu Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2738
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2738

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Cys Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Arg Ala Val Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2739
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2739

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Leu Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Ala Asn Gly Asn Arg Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Ile Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Tyr Cys Asn Gly Val Thr Cys Asn Ser Asn Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2740
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2740

Asp Phe Val Met Thr Gln Ser Pro Gly Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Arg Ser Ser Gln Ser Val Leu Asp Asn 
            20                  25                  30          


Ser Ser Asn Lys Asn His Leu Ala Trp His Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Ser His Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  2741
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2741

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gly 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Asn Trp Trp Ser Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Val Thr Ile Ser Val Asp Lys Ser Lys Asn Gln Phe Ser 
65                  70                  75                  80  


Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Trp Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ala 
        115 


<210>  2742
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2742

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Tyr Ala Gly Ser 
                85                  90                  95      


Ser Thr Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2743
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2743

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Leu 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Glu Glu Arg Ala Asn Val Asn Val Pro Met Ile Tyr 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2744
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2744

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr His Cys Gln Gln Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Met Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 


<210>  2745
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2745

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe His Asn Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Ile Pro Ile Leu Gly Thr Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Glu Gly Glu Gly Val Asp Ser Tyr Tyr Tyr Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  2746
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2746

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Ala Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Thr Asp Ser Ser Gly Ser Tyr 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2747
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2747

Gln Leu Gln Leu Gln Glu Ser Gly Ser Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Ser Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Arg Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Ser Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ser Gly Gly Leu Arg Phe Asp Ser Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2748
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2748

Asp Ile Gln Met Thr Gln Ser Pro Ser Tyr Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Ala Leu Leu Ile 
        35                  40                  45              


Tyr Leu Ser Ser Asn Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ala Gly Thr Val Phe Val Leu Thr Ile Asn Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ile Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Arg Val Glu Ile Lys 
            100                 105         


<210>  2749
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2749

Gln Val Gln Leu Glu Gln Ser Gly Ala Glu Leu Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Leu Lys Val Ser Cys Lys Ala Ser Gly Tyr Ser Phe Ser Gly Ser 
            20                  25                  30          


Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Gly Arg Asn Asn Val Gly Asp Arg Asp Val Asn Thr Asn 
    50                  55                  60                  


Tyr Ala Gln Arg Phe Lys Gly Arg Val Thr Met Thr Thr Asp Thr Ser 
65                  70                  75                  80  


Thr Ser Thr Ala Tyr Met Glu Leu Arg Ser Leu Thr Ser Asp Asp Thr 
                85                  90                  95      


Ala Val Tyr Tyr Cys Ala Arg Asp Trp Asp Cys Ser Gly Gly Ser Cys 
            100                 105                 110         


Thr Asp Cys Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2750
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2750

Ser Gln Leu Val Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Thr Cys Thr Leu Ser Ser Gly His Thr Asn Tyr Ala 
            20                  25                  30          


Ile Ala Trp His Gln Gln Glu Pro Glu Lys Gly Pro Arg Phe Leu Met 
        35                  40                  45              


Lys Val Asn Ser Asp Gly Ser His Asn Lys Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Ser Ser Gly Ala Glu Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Thr Trp Gly 
                85                  90                  95      


Pro Gly Ile Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  2751
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2751

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Ser Asp Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Thr Phe Gly Gly Ser Gly Ser Tyr Tyr Phe Tyr Tyr Asn 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2752
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2752

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2753
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2753

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Thr Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  2754
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2754

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Ala Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Glu Phe Ala Thr Tyr Tyr Cys His Gln Ser Tyr Phe Thr Pro Gln 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2755
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2755

Ala Val Pro Val Val Glu Thr Gly Gly Gly Leu Val Gln Pro Gly Glu 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Gly Met Ser Gly Phe Thr Val Tyr Ser Asn 
            20                  25                  30          


His Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Gly Asp Gly Tyr Val Asp Gly Gly Gly Thr Phe Tyr 
    50                  55                  60                  


Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Arg 
65                  70                  75                  80  


Asn Thr Leu Tyr Leu Gln Met Ser Arg Leu Arg Ala Glu Asp Thr Ala 
                85                  90                  95      


Val Tyr Tyr Cys Ala Arg Arg Glu Ile Leu Gly Tyr Ile Asn Gly Val 
            100                 105                 110         


Gly Thr Ser Asn Ile Trp Gly Arg Gly Thr Val Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2756
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2756

Glu Ile Val Met Thr Gln Ser Pro Val Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Gly Ala Thr Leu Ser Cys Arg Ala Ser Arg Ser Val Arg Asn Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Thr Arg Ala Ile Asp Phe Pro Gly Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Ile Leu Thr Ile Asn Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Ser Ala Val Tyr Tyr Cys Gln Gln Tyr Asp Asp Trp Pro Trp 
                85                  90                  95      


Thr Cys Gly Gln Gly Thr Lys Ile Glu Ile 
            100                 105     


<210>  2757
<211>  132
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2757

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Glu Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Gly Ser Thr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Trp Asp Tyr Tyr Gly Ser Gly Ser Tyr Tyr Asn Val Pro Ser 
            100                 105                 110         


Tyr Tyr Tyr Tyr Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val 
        115                 120                 125             


Thr Val Ser Ser 
    130         


<210>  2758
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2758

Ala Ile Arg Met Thr Gln Ser Pro Ser Ser Phe Ser Ala Ser Thr Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Cys Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Tyr Pro Pro 
                85                  90                  95      


Asn Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2759
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2759

Gln Leu Gln Val Val Gln Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Asp Pro Val Ile Asn Thr 
            20                  25                  30          


Asn Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Thr Leu Ser Tyr Ser Gly Gly Thr His Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Ser Ser Arg Val Thr Ile Ala Val Asp Ser Ser Lys Lys Arg Phe 
65                  70                  75                  80  


Ser Leu Thr Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Ile Tyr Tyr 
                85                  90                  95      


Cys Ala Arg His Pro Val Asp Gly Tyr Asn Tyr Gly Tyr Ser Asp Leu 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2760
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2760

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ala Leu Ser Val Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Val Ala Ser Gln Arg Val Ser Ser Asp 
            20                  25                  30          


Tyr Ile Ala Trp Tyr Gln Lys Lys Pro Gly Leu Ala Pro Arg Leu Leu 
        35                  40                  45              


Val Tyr His Gly Ser Ala Trp Ala Thr Gly Ser Ser Ala Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Ala Phe Thr Leu Thr Ile Ser Ser Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Asn Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Pro Gly Thr Lys Val Glu Phe Lys 
            100                 105             


<210>  2761
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2761

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Pro Asn Ser Arg Gly Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Arg Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Val Val Leu Gly Tyr Gly Arg Pro Asn Asn Tyr Tyr Asp 
            100                 105                 110         


Gly Arg Asn Val Trp Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val 
        115                 120                 125             


Ser Ser 
    130 


<210>  2762
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2762

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Glu Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Ser Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Asn Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Glu Pro Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2763
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2763

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Pro Ser Tyr 
            20                  25                  30          


Ser Ile Ala Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Val Ser Ala Tyr Asn Gly Tyr Thr Asn Phe Ala Gln Lys Leu 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Thr Asp Thr Pro Ser Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Lys Tyr Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Tyr Cys Ser Gly Gly Ile Ala Lys Cys Gly Phe His Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2764
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2764

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Lys Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala 
65                  70                  75                  80  


Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Ser Ile Ser Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Val Glu Ile Lys 
            100                 105         


<210>  2765
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2765

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Gly Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys His Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Arg Asn Arg Leu Thr Ile Thr Arg Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Ala Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2766
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2766

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Trp Asp Thr Gly Ile Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2767
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2767

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Ile His Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Asp Ser Gly Tyr Pro Thr Tyr Tyr Tyr Tyr Ser Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2768
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2768

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Gly Ala Ser Gln Ser Val Thr Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Glu Pro Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2769
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2769

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ala Phe Ser Asn Tyr 
            20                  25                  30          


Ala Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Asn Asn Lys Asp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Pro Val Met Val Arg Gly Val Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2770
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2770

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Val Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Arg Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Pro Phe Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  2771
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2771

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Ala Ala Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Gly Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  2772
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2772

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Leu Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Trp Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105     


<210>  2773
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2773

Glu Val Arg Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ala Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Pro Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  2774
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2774

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Phe Asn Thr 
            20                  25                  30          


Val Asn His Arg Asp Tyr Leu Gly Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Leu Thr Phe Gly Gln Gly Thr Lys Val Glu Asn 
            100                 105                 110         


Lys 
    


<210>  2775
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2775

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Glu Ile Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Thr Thr Leu Asp 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Gly Gly Gly Ser Tyr Arg Gly Pro Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2776
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2776

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Glu Tyr Tyr Cys Ser Ala Tyr Ala Gly Ser 
                85                  90                  95      


Asn Asn Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2777
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2777

Gln Val Gln Leu Val Gln Ser Gly Ala Ala Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Val Pro Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
            100                 105                 110         


Tyr Tyr Arg Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2778
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2778

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Asn Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Val Glu Pro Pro Phe 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile 
            100                 105     


<210>  2779
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2779

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Thr Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Ser Tyr Asn Gly Asn Tyr Tyr Asp Ala Phe Asp Ile Trp Gly 
            100                 105                 110         


Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120     


<210>  2780
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2780

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Gly Gln Thr Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2781
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2781

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Tyr Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Ile His Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Gln Met Ala Ala Thr Thr Gly Ile Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2782
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2782

Gln Leu Val Leu Thr Gln Ser Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Thr Cys Thr Leu Ser Ser Gly His Thr Thr Tyr Ala 
            20                  25                  30          


Ile Ala Trp His Gln Gln Gln Pro Glu Lys Gly Pro Arg Tyr Leu Met 
        35                  40                  45              


Lys Leu Asn Ser Asp Gly Ser His Thr Arg Gly Asp Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Ser Ser Gly Ala Glu Arg Tyr Leu Thr Ile Ser 
65                  70                  75                  80  


Asn Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Arg Asp 
                85                  90                  95      


Arg Ser Gly Asn Arg Trp Val Phe Gly Gly Gly Thr Arg Leu Thr Val 
            100                 105                 110         


Leu 
    


<210>  2783
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2783

Gln Ile Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2784
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2784

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Thr Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Asn Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  2785
<211>  131
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2785

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Lys Ser Lys Ile Asp Gly Gly Thr Thr Asp Tyr Ala Ala 
    50                  55                  60                  


Pro Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Thr Thr Ala Gly Ser Tyr Tyr Tyr Asp Thr Val Gly Pro Gly 
            100                 105                 110         


Leu Pro Glu Gly Lys Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr 
        115                 120                 125             


Val Ser Ser 
    130     


<210>  2786
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2786

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Cys Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Asn Trp Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2787
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2787

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Asp Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2788
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2788

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Arg Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Ser Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2789
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2789

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Phe Ser Asn Asp Glu Lys Ser Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val 
65                  70                  75                  80  


Leu Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  2790
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2790

Gln Ala Val Leu Thr Gln Pro Ser Ala Leu Ser Ala Ser Pro Gly Ala 
1               5                   10                  15      


Ser Ala Arg Leu Thr Cys Thr Ser Gly Ser Gly Ile Asp Val Gly Thr 
            20                  25                  30          


Tyr Arg Ile Tyr Trp Tyr Gln Gln Lys Ser Gly Ser Pro Pro Arg Tyr 
        35                  40                  45              


Leu Leu Ser Tyr Lys Ser Asp Ser Asp Lys His Gln Gly Ser Gly Val 
    50                  55                  60                  


Pro Ser Arg Phe Ser Gly Ser Lys Asp Ala Ser Ala Asn Ala Gly Val 
65                  70                  75                  80  


Leu Phe Ile Ser Gly Leu Gln Ser Glu Asp Glu Ala Asp Tyr Tyr Cys 
                85                  90                  95      


Leu Ile Trp His Ile Asn Ala Tyr Val Phe Gly Thr Gly Thr Lys Val 
            100                 105                 110         


Thr Val Leu 
        115 


<210>  2791
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2791

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu 
            100                 105                 110         


Ile Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2792
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2792

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Ile Leu Thr Ile Ser Gly Leu Gln Pro 
65                  70                  75                  80  


Glu Gly Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2793
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2793

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2794
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2794

Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser Ile Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Arg Ser 
            20                  25                  30          


Asp Ser Lys Thr Tyr Leu Phe Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Glu Val Ser Ser Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2795
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2795

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Cys Leu Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Glu Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210>  2796
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2796

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Ala Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Arg Tyr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Ala Tyr Tyr Cys Gln Gln Ser Phe Ser Thr Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2797
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2797

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Phe Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Leu Asp Tyr Tyr Gly Leu Asp Val Trp Gly Gln Gly Thr Thr 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2798
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2798

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro His 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2799
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2799

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Gln Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Lys Ser Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Thr Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  2800
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2800

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln 
1               5                   10                  15      


Lys Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Tyr Val Ser Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Glu Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln 
65                  70                  75                  80  


Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Gly Thr Trp Asp Ser Ser Leu 
                85                  90                  95      


Ser Ala Tyr Val Phe Gly Thr Gly Thr Arg Val Thr Val Leu 
            100                 105                 110 


<210>  2801
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2801

Gly Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Asp Asp Ser Asp Thr Arg Tyr Asp Pro Ser Phe 
    50                  55                  60                  


Glu Gly Gln Val Ser Ile Ser Ala Asp Lys Ser Ile Thr Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Val Lys Ala Pro Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Asp Lys Val Gly Ala Leu Asp Ser Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2802
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2802

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu His Ser 
            20                  25                  30          


Ser Asn Asn Lys Asp Ser Leu Val Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Phe Trp Ala Ser Cys Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Gly Ser Ser Pro Pro Arg Tyr Thr Phe Gly Gln Gly Thr Lys Leu 
            100                 105                 110         


Glu Ile Lys 
        115 


<210>  2803
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2803

Gln Val Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Gln Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Ile Pro Val Thr Ala Ile Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2804
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2804

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Lys Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asn Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Leu Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg Tyr 
                85                  90                  95      


Thr Trp Val Phe Gly Gly Gly Thr Thr Leu Thr Val Leu 
            100                 105                 


<210>  2805
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2805

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ile Asp His 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Ala Tyr Ile Tyr Ser Thr Gly Arg Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Ile Asp Thr Ser Lys Asp Gln Phe Ser Leu 
65                  70                  75                  80  


Arg Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Phe Cys Ala 
                85                  90                  95      


Arg Thr Pro His Arg Gly Gly Phe Asp Val Trp Gly Gln Gly Thr Thr 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2806
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2806

Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Glu Ser Leu Leu His Ser 
            20                  25                  30          


Asp Gly His Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Val Leu Ile Tyr Phe Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Glu Arg Phe Ser Gly Ser Gly Thr Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Leu Gln Ala 
                85                  90                  95      


Leu Gln Phe Pro Tyr Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110         


<210>  2807
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2807

Gln Val Gln Leu Leu Glu Ser Gly Pro Gly Leu Val Lys Ser Ser Gln 
1               5                   10                  15      


Thr Leu Tyr Leu Thr Cys Ser Val Ser Gly Gly Ser Val Ser Ser Gly 
            20                  25                  30          


Ala Tyr Tyr Trp Thr Trp Val Arg Gln Pro Ala Gly Ser Pro Leu Glu 
        35                  40                  45              


Trp Ile Gly Arg Ile Tyr Thr Ser Gly Thr Thr Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Asn Arg Arg Leu Thr Leu Ser Leu Asp Thr Ser Arg Asn Gln Ile 
65                  70                  75                  80  


Ser Leu Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Ala Tyr Phe 
                85                  90                  95      


Cys Ala Arg Ala Arg Ser Ser Met Asp Asn Phe Tyr Tyr Phe Ser Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Ala Val Thr Val Ser Ser 
        115                 120                 125 


<210>  2808
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2808

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Arg Leu Ala Pro Thr 
            20                  25                  30          


Leu Leu Ala Trp Phe Leu Gln Lys Arg Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Ala Ala Ser Thr Arg Ala Thr Asp Ile Pro Asp Arg Phe Asn 
    50                  55                  60                  


Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp 
65                  70                  75                  80  


Thr Glu Asp Phe Gly Val Tyr Tyr Cys His Gln Tyr Gly Ile Ser Pro 
                85                  90                  95      


Phe Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2809
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2809

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Gln Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Met Ser Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Ile Ile Glu Ser Thr Ile Ala Ala Arg Pro Gly Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2810
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2810

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Arg Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2811
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2811

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2812
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2812

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Pro 
                85                  90                  95      


Thr Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  2813
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2813

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Leu Ser Leu Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Thr Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Pro Arg Asn Gln Ile Ser Leu 
65                  70                  75                  80  


Ser Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ile Pro Thr Gly Phe Pro Arg Cys Tyr Met Asp Val Trp Gly Lys 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  2814
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2814

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2815
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2815

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Phe Ser Ala Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Phe Leu Arg Trp His Asp Leu Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2816
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2816

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Phe 
            20                  25                  30          


Val Asn Trp Tyr Gln His Lys His Gly Glu Val Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Glu Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Ser Ser Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2817
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2817

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  2818
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2818

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Gln Leu 
65                  70                  75                  80  


Glu Asp Ser Thr Thr Tyr Tyr Cys Gln Gln Thr His Ser Pro Leu Asp 
                85                  90                  95      


Ser Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2819
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2819

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Arg Val Thr Val Ser Ser 
        115                 120             


<210>  2820
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2820

Val Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Lys Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2821
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2821

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Phe Ser Ala Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Thr Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Thr Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Pro Ser Asn Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Ile 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  2822
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2822

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Asn Trp Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  2823
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2823

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Tyr Tyr 
            20                  25                  30          


Pro Met His Trp Leu Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Val Ala Val Thr Ser Tyr Asp Gly Thr Asn Lys Tyr Tyr Ala Asp 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ala Arg Gly Gly Ala Thr Asn Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  2824
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2824

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Asn Ile Thr Cys Gly Gly Asn Asn Ile Gly Arg Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Glu Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2825
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2825

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Glu Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Gly Lys Ala Ala Ala Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2826
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2826

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Phe Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Gln Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  2827
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2827

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu 
            100                 105                 110         


Ile Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2828
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2828

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Glu Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Phe Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Arg Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  2829
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2829

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Gln Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  2830
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2830

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Asn Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Phe Gly Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2831
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2831

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Gln Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Met Ser Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Ile Ile Glu Ser Thr Ile Ala Ala Arg Pro Gly Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2832
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2832

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Ser Asp Asn Leu Pro Met 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  2833
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2833

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Tyr Ser Ser Gly Trp Tyr Tyr Phe Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2834
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2834

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro His 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Ala Ile Lys 
            100                 105         


<210>  2835
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2835

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Glu Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu His Gln Asp Trp Val Val Val Val Ala Ala Asn Val 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2836
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2836

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Arg Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn Pro 
                85                  90                  95      


Arg Trp Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2837
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2837

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu 
            100                 105                 110         


Ile Asp Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2838
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2838

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Gly Ser Asp His 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2839
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2839

Gln Met Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Met Ser Ser 
            20                  25                  30          


Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Ile Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2840
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2840

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Pro Arg Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110 


<210>  2841
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2841

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Leu Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Asn Thr Ser 
    50                  55                  60                  


Leu Arg Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ala Thr Thr Phe Phe Tyr Gly Met Asp Val Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Ala Thr Val Ser Ser 
        115                 120 


<210>  2842
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2842

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Thr Asp Ala Leu Pro Asn Glu Tyr Ile 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Val Asp Ser Ser Gly Thr Tyr 
                85                  90                  95      


Arg Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2843
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2843

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2844
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2844

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Tyr Ala Asn Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2845
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2845

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Arg Tyr 
            20                  25                  30          


Gly Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Thr Asp Lys Tyr Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Lys Gly Gly Pro Tyr Cys Gly Gly Gly Asn Cys Tyr Ala Gly 
            100                 105                 110         


Tyr Phe Asp Tyr Trp Gly Gln Gly Ile Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2846
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2846

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Ala Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Leu 
                85                  90                  95      


Ala Phe Gly Pro Gly Thr Lys Val Asp Val Lys 
            100                 105         


<210>  2847
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2847

Glu Val Gln Val Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Glu Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Val Ser Trp Asn Ser Gly Ile Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Leu Asp Val Gly Gly Tyr Asp Phe Val Ser Gly His Tyr Tyr 
            100                 105                 110         


Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2848
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2848

Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Gln Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Ser Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Ala Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr His Trp Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210>  2849
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2849

Gln Ile Thr Leu Arg Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Thr 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Gly Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ala Gln Thr Gly Ser Pro Leu Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2850
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2850

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Arg 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Lys Phe Gly Asn Thr Ala Thr Leu Ile Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Ser Cys Gln Val Trp Asp Ser Gly Ser Asp His 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  2851
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2851

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Ser Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Leu Ile Ser Leu Phe Arg Gly Ala Ile Phe His Tyr Tyr 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  2852
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2852

Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Thr Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Asn Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Ile Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Arg 
                85                  90                  95      


Tyr Thr Trp Val Phe Gly Gly Gly Thr Thr Leu Thr Val Leu 
            100                 105                 110 


<210>  2853
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2853

Gln Val Arg Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Met Ser Ser 
            20                  25                  30          


Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Ile Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Ser Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Asp Gln Tyr Cys Ser Ile Ile Ser Cys Asn Asp Gly Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  2854
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2854

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Asn Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro 
                85                  90                  95      


Gln Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  2855
<211>  134
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2855

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Asp 
            20                  25                  30          


Asp Phe Ser Ser Gly Asp Asn Tyr Trp Ser Trp Leu Arg Gln Pro Pro 
        35                  40                  45              


Gly Lys Gly Leu Glu Trp Ile Gly Tyr Ile Tyr Tyr Ser Gly Leu Thr 
    50                  55                  60                  


Asn Tyr Asn Pro Ser Leu Lys Ser Arg Val Ile Ile Ser Val Asp Thr 
65                  70                  75                  80  


Ser Lys Asn Gln Phe Ser Leu Lys Leu Asn Ser Val Thr Ala Ala Asp 
                85                  90                  95      


Thr Ala Val Tyr Tyr Cys Ala Ser Glu His Lys Thr His Tyr Tyr Asp 
            100                 105                 110         


Ser Ser Gly Tyr Tyr Ser Asn Trp Phe Asp Pro Trp Gly Gln Gly Thr 
        115                 120                 125             


Leu Val Thr Val Ser Ser 
    130                 


<210>  2856
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2856

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2857
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2857

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Met Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Asp Asn Ser Pro Gln Gly Ser Gly Trp Tyr Phe Tyr Tyr 
            100                 105                 110         


Asp Tyr Ala Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  2858
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2858

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Thr Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Arg Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Tyr Ala Asn Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  2859
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2859

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Thr Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Gln Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Gly Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  2860
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2860

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Ser Ser 
                85                  90                  95      


Ser Ile Val Val Phe Gly Gly Gly Ser Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  2861

<400>  2861
000

<210>  2862

<400>  2862
000

<210>  2863
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2863

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Lys 
            20                  25                  30          


Arg Val Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Gln Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Ser Gly Pro Pro Asp Leu Ser Pro Val Leu Ser Gln Gly 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  2864
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2864

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Lys Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Arg Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Thr Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Thr Gly Trp Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  2865
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2865

Gly Gly Pro Ile Ser Ser Ser Arg Tyr Tyr 
1               5                   10  


<210>  2866
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2866

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  2867
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2867

Ala Arg His Asp Gly Ser Gly Glu Met Asp Thr Ile Thr Trp Gly Pro 
1               5                   10                  15      


Ile Tyr Tyr Tyr Met Asp Val 
            20              


<210>  2868
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2868

Gly Phe Thr Phe Ser Ser His Ala 
1               5               


<210>  2869
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2869

Ile Ala Ile Asp Val Asn Arg Lys 
1               5               


<210>  2870
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2870

Ala Arg Asp Gln Gly Ile Ala Phe Thr Asp Ile Asp Tyr 
1               5                   10              


<210>  2871
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2871

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  2872
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2872

Ile Ser Ser Asp Gly Gly Asn Lys 
1               5               


<210>  2873
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2873

Ala Arg Asp Val Pro Thr Thr Val Thr Ala Phe Thr Val Phe Thr Tyr 
1               5                   10                  15      


<210>  2874
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2874

Ser Gly Ser Ile Arg Ser Asp Asn Ile Tyr 
1               5                   10  


<210>  2875
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2875

Ile Tyr Tyr Ser Gly Thr Thr 
1               5           


<210>  2876
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2876

Ala Arg Gln Lys Gly Trp Val Ser Met Val Gln Gly Val Pro Gln Tyr 
1               5                   10                  15      


Asn Phe Asp Gly Met Asp Val 
            20              


<210>  2877
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2877

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  2878
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2878

Met Asn Pro Asn Ser Gly His Thr 
1               5               


<210>  2879
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2879

Ala Arg Gly Tyr Gly Leu Thr Tyr Tyr Met Asp Val 
1               5                   10          


<210>  2880
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2880

Gly Gly Pro Ile Ser Ser Ser Arg Tyr Tyr 
1               5                   10  


<210>  2881
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2881

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  2882
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2882

Ala Arg His Asp Gly Ser Gly Glu Met Asp Thr Ile Thr Trp Gly Pro 
1               5                   10                  15      


Ile Tyr Tyr Tyr Met Asp Val 
            20              


<210>  2883
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2883

Gly Phe Asn Phe Asn Glu His Ala 
1               5               


<210>  2884
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2884

Ile Ser Gly Ser Ser Asp Tyr Ile 
1               5               


<210>  2885
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2885

Ala Lys Gly Val Asp Glu Gly Gly Leu Ile Ala Tyr Phe Gln Arg 
1               5                   10                  15  


<210>  2886
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2886

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  2887
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2887

Met Asn Pro Asn Ser Gly Asn Ala 
1               5               


<210>  2888
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2888

Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
1               5                   10                  15      


<210>  2889
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2889

Gly Tyr Thr Phe Thr Thr Tyr Ala 
1               5               


<210>  2890
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2890

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  2891
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2891

Ala Arg Asp Gln Asp Ser Gly Tyr Pro Thr Tyr Tyr Tyr Tyr Tyr Leu 
1               5                   10                  15      


Asp Val 
        


<210>  2892
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2892

Gly Phe Ser Phe Ser Asn Tyr Ala 
1               5               


<210>  2893
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2893

Ile Ser Gly Thr Gly Ser Gly Tyr Ser Gly Gly Ser Thr 
1               5                   10              


<210>  2894
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2894

Ala Lys Val Arg Val Ser Asp Gly Gly Ser Tyr Gly Gly Leu Asp Val 
1               5                   10                  15      


<210>  2895
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2895

Gly Phe Thr Phe Arg Asn Tyr Ala 
1               5               


<210>  2896
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2896

Ile Ser Gly Ser Gly Gly Thr Thr 
1               5               


<210>  2897
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2897

Ala Lys Asn Glu Arg Ile Thr Met Leu Val Val Val Thr Leu Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  2898
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2898

Gly Phe Pro Phe Ser Ser Ser Ala 
1               5               


<210>  2899
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2899

Val Val Val Gly Ser Gly Asn Thr 
1               5               


<210>  2900
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2900

Ala Ala Ser Arg Tyr Cys Thr Ser Tyr Ala Cys His Gly Ser Tyr Gly 
1               5                   10                  15      


Ala Asp Val 
            


<210>  2901
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2901

Gly Tyr Thr Phe Ile Ser Tyr Gly 
1               5               


<210>  2902
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2902

Ile Ser Pro Tyr Ser Ser Asn Thr 
1               5               


<210>  2903
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2903

Ala Arg Asp Leu Ala Arg Tyr Cys Arg Ser Ala Ser Cys Ser Asn Lys 
1               5                   10                  15      


Gly Val Asp Tyr 
            20  


<210>  2904
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2904

Gly Phe Thr Val Ser Gly Asn Tyr 
1               5               


<210>  2905
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2905

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  2906
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2906

Ala Arg Asp Pro Ser Ala Tyr Tyr Asp Ile Leu Thr Gly Tyr Ser Gly 
1               5                   10                  15      


Asp Val 
        


<210>  2907
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2907

Gly Ser Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  2908
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2908

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  2909
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2909

Ala Ser Arg Arg Cys Ser Val Ser Gly Cys Tyr Met Ala Ser Tyr Tyr 
1               5                   10                  15      


Tyr Met Asp Val 
            20  


<210>  2910
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2910

Gly Phe Thr Phe Ser Asn Ala Trp 
1               5               


<210>  2911
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2911

Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr 
1               5                   10  


<210>  2912
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2912

Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  2913
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2913

Gly Phe Ser Phe Ser Ser Tyr Val 
1               5               


<210>  2914
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2914

Ile Ser Tyr Asp Gly Ser Ser Lys 
1               5               


<210>  2915
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2915

Ala Arg Asp Ile Asp Ser Gly Tyr Asp Pro Thr Pro Val Phe Asp Tyr 
1               5                   10                  15      


<210>  2916
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2916

Gly Gly Ser Ile Ser Ser Ser Asn Trp 
1               5                   


<210>  2917
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2917

Ile Tyr His Ser Gly Ser Thr 
1               5           


<210>  2918
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2918

Ala Ser Arg Trp Gly Asp Tyr Phe Asp Ser Ser Gly Ala Tyr Asp Ser 
1               5                   10                  15      


<210>  2919
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2919

Gly Tyr Ser Leu Ser Glu Leu Ser 
1               5               


<210>  2920
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2920

Phe Asp Pro Glu Asp Gly Glu Thr 
1               5               


<210>  2921
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2921

Ala Ser Gly Gly Leu Asn Gly Asp Tyr Val Thr Gly Gly Ala Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Met Asp Val 
            20      


<210>  2922
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2922

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  2923
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2923

Ile Ile Pro Ile Phe Gly Thr Ala 
1               5               


<210>  2924
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2924

Ala Arg Lys Gly Trp Gly His Ser Tyr Gly Tyr Val Asp Tyr 
1               5                   10                  


<210>  2925
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2925

Gly Phe Thr Phe Ser Thr Tyr Ser 
1               5               


<210>  2926
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2926

Ile Ser Tyr Asp Gly Ser Ser Lys 
1               5               


<210>  2927
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2927

Ala Arg Gly Leu Val Gly Arg Ile Asp Pro 
1               5                   10  


<210>  2928
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2928

Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  2929
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2929

Ile Ser Ser Ser Ser Ser Phe Ile 
1               5               


<210>  2930
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2930

Ala Arg Asp Pro Val Trp Val Asp Gly Glu Leu Leu Ser Gly Gly Ile 
1               5                   10                  15      


Pro Phe Asp Tyr 
            20  


<210>  2931
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2931

Gly Gly Ser Ile Arg Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  2932
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2932

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  2933
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2933

Ala Ile Leu Trp Arg Gly Ser Ser Trp Ala Asp Arg His Tyr Tyr Tyr 
1               5                   10                  15      


Tyr Ser Met Asp Val 
            20      


<210>  2934
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2934

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  2935
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2935

Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210>  2936
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2936

Ala Arg Glu Tyr His Asp Gly Ala Asn Trp Ser Gly Ala Phe Asp Val 
1               5                   10                  15      


<210>  2937
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2937

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  2938
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2938

Ile Ser Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  2939
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2939

Ala Arg Asp Leu Gly Arg Gly Leu Asp Pro 
1               5                   10  


<210>  2940
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2940

Gly Phe Thr Phe Ser Asn Tyr Ala 
1               5               


<210>  2941
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2941

Ile Ser Ser Ser Gly Gly Ala Thr 
1               5               


<210>  2942
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2942

Val Lys Gly Leu Phe Asp Trp Phe Pro Leu 
1               5                   10  


<210>  2943
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2943

Gly Tyr Thr Phe Leu Ser Tyr Asp 
1               5               


<210>  2944
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2944

Ile Ser Ala Tyr Thr Gly Asn Thr 
1               5               


<210>  2945
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2945

Ala Arg Val Gln Arg Arg Arg Leu Asp Tyr 
1               5                   10  


<210>  2946
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2946

Gly Ala Ser Ile Ser Ser Gly Ser Tyr Tyr 
1               5                   10  


<210>  2947
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2947

Ile Tyr Thr Ser Gly Asn Thr 
1               5           


<210>  2948
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2948

Ala Thr Gly Tyr Ile Gly Thr Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  


<210>  2949
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2949

Gly Phe Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  2950
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2950

Ile Ser Lys Phe Gly Ser Thr 
1               5           


<210>  2951
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2951

Ala Lys Glu Pro Gln Gln Trp Gly Leu Asn Ala Phe Glu Ile 
1               5                   10                  


<210>  2952
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2952

Gly Glu Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  2953
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2953

Ile Asn Gln Ser Gly Asn Asn 
1               5           


<210>  2954
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2954

Ala Arg Asp Thr Ser Lys Tyr Tyr Phe Asp Tyr 
1               5                   10      


<210>  2955
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2955

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  2956
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2956

Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210>  2957
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2957

Ala Lys Val Ser Ser Ile Thr Ser Leu Leu Gly Tyr Tyr Phe Asp Ser 
1               5                   10                  15      


<210>  2958
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2958

Gly Phe Thr Phe His His Tyr Ala 
1               5               


<210>  2959
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2959

Ile Ser Gly Ser Ser Asp Tyr Arg 
1               5               


<210>  2960
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2960

Ala Lys Gly Val Asp Tyr Gly Gly Lys Leu Ala Tyr Phe Asp Ser 
1               5                   10                  15  


<210>  2961
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2961

Gly Tyr Thr Leu Thr Thr Thr Ser 
1               5               


<210>  2962
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2962

Met Arg Pro Gly Thr Gly Ser Pro 
1               5               


<210>  2963
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2963

Ala Arg Val Gly Asp Lys Ser Glu Glu Phe Asp Tyr 
1               5                   10          


<210>  2964
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2964

Gly Asp Thr Ser Ser Ser Tyr Thr 
1               5               


<210>  2965
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2965

Ile Ile Pro Ile Leu Gly Ile Ala 
1               5               


<210>  2966
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2966

Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro 
1               5                   10                  


<210>  2967
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2967

Gly Phe Ser Leu Thr Thr Ser Gly Met Cys 
1               5                   10  


<210>  2968
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2968

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  2969
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2969

Ala Arg Val Val Val Arg Cys Pro Gly Thr Gly Asp Val Cys Ser Thr 
1               5                   10                  15      


Tyr Tyr Tyr Gln Ser Met Asp Val 
            20                  


<210>  2970
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2970

Gly Phe Ser Leu Gly Thr Ser Gly Met Cys 
1               5                   10  


<210>  2971
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2971

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  2972
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2972

Ala Arg Gly Val Val Thr Tyr Asp Tyr 
1               5                   


<210>  2973
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2973

Gly Phe Ser Leu Thr Thr Ser Gly Met Cys 
1               5                   10  


<210>  2974
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2974

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  2975
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2975

Ala Arg Glu Thr Pro Val Thr Ala Ile Asp Tyr 
1               5                   10      


<210>  2976
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2976

Gly Asp Ser Val Ser Gly Asn Ser His Phe 
1               5                   10  


<210>  2977
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2977

Ile Tyr Asn Ser Val Ser Thr 
1               5           


<210>  2978
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2978

Ala Gly Gly Phe Asp Asp Ala Trp Glu Pro Gln Val Tyr 
1               5                   10              


<210>  2979
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2979

Gly Phe Ala Val Leu Lys Ala Arg Met Gly 
1               5                   10  


<210>  2980
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2980

Thr Phe Ser Gly Asp Glu Glu 
1               5           


<210>  2981
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2981

Ala Arg Val Lys Thr Tyr Tyr Thr Ser Thr Arg Arg Ile Leu Trp Phe 
1               5                   10                  15      


Asp Pro 
        


<210>  2982
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2982

Gly Phe Thr Phe Ser Asn Tyr Ala 
1               5               


<210>  2983
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2983

Ile Ser Tyr Asp Gly Ser Asn Arg 
1               5               


<210>  2984
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2984

Ala Arg Gly Asp Gly Tyr Arg Ser Gln Phe Asp Pro 
1               5                   10          


<210>  2985
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2985

Gly Tyr Ser Phe Thr Thr Tyr Trp 
1               5               


<210>  2986
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2986

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  2987
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2987

Ala Arg Tyr Trp Phe Gly Asp Pro Tyr Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  2988
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2988

Gly Asp Ser Ile Asn Ser Gly Gly Tyr Ser 
1               5                   10  


<210>  2989
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2989

Ile Tyr Ser Ser Gly Asn Thr 
1               5           


<210>  2990
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2990

Ala Arg Asp Arg Asn Gly Ile Ala Ala Thr Asp Phe 
1               5                   10          


<210>  2991
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2991

Gly Phe Ser Val Ser Thr Ser Gly Glu Gly 
1               5                   10  


<210>  2992
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2992

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  2993
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2993

Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile 
1               5                   10          


<210>  2994
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2994

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  2995
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2995

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  2996
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2996

Ala His Arg Arg Glu Trp Glu Pro Tyr Arg Tyr 
1               5                   10      


<210>  2997
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2997

Gly Phe Thr Phe Ser Asn Ala Trp 
1               5               


<210>  2998
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2998

Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr 
1               5                   10  


<210>  2999
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  2999

Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  3000
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3000

Gly Phe Ser Leu Thr Thr Ser Gly Glu Ala 
1               5                   10  


<210>  3001
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3001

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3002
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3002

Ala His Arg Ala Val Ile Leu Asn Phe Asp His 
1               5                   10      


<210>  3003
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3003

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3004
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3004

Ile Ser Tyr Asp Gly Ile Asn Lys 
1               5               


<210>  3005
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3005

Ala Arg Pro Arg Ser Gly Ser Tyr Tyr Ala Tyr Phe Asp Tyr 
1               5                   10                  


<210>  3006
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3006

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  3007
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3007

Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210>  3008
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3008

Ala Lys Val Gly Tyr Thr Ile Ser Arg Gln Trp Leu Val Gly Glu Phe 
1               5                   10                  15      


Asp Tyr 
        


<210>  3009
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3009

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  3010
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3010

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3011
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3011

Ala Arg Arg Gly Glu Ala Ala Gly Ile Trp Tyr Phe Asp Leu 
1               5                   10                  


<210>  3012
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3012

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  3013
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3013

Ile Thr Arg Ser Gly Ser Thr 
1               5           


<210>  3014
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3014

Ala Arg Gly Phe Asp Ser Ala Trp Glu Leu Gln Phe Leu 
1               5                   10              


<210>  3015
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3015

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  3016
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3016

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3017
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3017

Ala Arg Gln Ser Arg Gly Tyr Ser Tyr Ala Trp Ser Phe Asp Tyr 
1               5                   10                  15  


<210>  3018
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3018

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3019
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3019

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3020
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3020

Ala Arg Glu Gly Gln Gly Thr Tyr Leu Asp Tyr 
1               5                   10      


<210>  3021
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3021

Gly Phe Thr Phe Ser Asn Tyr Gly 
1               5               


<210>  3022
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3022

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3023
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3023

Ala Gly Ser Ser Gly Glu Gly Gly Leu Tyr Tyr Tyr Tyr Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  3024
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3024

Gly Gly Ser Ile Ser Gly Ser Asp Ser Phe 
1               5                   10  


<210>  3025
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3025

Ile Ser Asp Ser Gly Thr Thr 
1               5           


<210>  3026
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3026

Val Arg Gly Arg Asn Leu Ser Gly His Gly Trp Leu Asp Pro 
1               5                   10                  


<210>  3027
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3027

Gly Phe Thr Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  3028
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3028

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3029
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3029

Ala His Arg Gly Arg Trp Phe Gly Glu Leu Ser Phe Asp Tyr 
1               5                   10                  


<210>  3030
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3030

Gly Phe Thr Phe Asp Ser Tyr Gly 
1               5               


<210>  3031
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3031

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3032
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3032

Ala Arg Asp Ser Gly Gly Asn Tyr Gly Asp Ser Tyr Phe Asp Tyr 
1               5                   10                  15  


<210>  3033
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3033

Gly Phe Lys Phe Gly Asp Tyr Ala 
1               5               


<210>  3034
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3034

Ile Ser Gly Ser Ser Asp Tyr Ile 
1               5               


<210>  3035
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3035

Ala Lys Gly Val Asp Gln Gly Gly Val Ile Ala Tyr Phe His His 
1               5                   10                  15  


<210>  3036
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3036

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  3037
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3037

Ile Ser Tyr Asp Gly Tyr Asn Lys 
1               5               


<210>  3038
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3038

Ala Arg Gly Ser Ala Gly Asn Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  3039
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3039

Gly Phe Ser Leu Ser Asn Ala Lys Met Gly 
1               5                   10  


<210>  3040
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3040

Ile Phe Ser Asn Asp Glu Lys 
1               5           


<210>  3041
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3041

Ala Arg Ile Val Leu Gly Ala Ser Gly Thr Tyr Pro Ser Pro Gly Phe 
1               5                   10                  15      


Asp Pro 
        


<210>  3042
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3042

Gly Phe Thr Phe Gly Asp Tyr Lys 
1               5               


<210>  3043
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3043

Ile Arg Ser Arg Ala Asn Gly Glu Ser Thr 
1               5                   10  


<210>  3044
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3044

Thr Arg Asp Pro Thr Leu Trp Pro 
1               5               


<210>  3045
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3045

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  3046
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3046

Ile Asn Ser Asp Gly Ser Ser Thr 
1               5               


<210>  3047
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3047

Ala Gly Ser Pro Trp Leu Arg Gly Asp Ile Asp Tyr 
1               5                   10          


<210>  3048
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3048

Gly Phe Thr Phe Ser Asn Ala Trp 
1               5               


<210>  3049
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3049

Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr 
1               5                   10  


<210>  3050
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3050

Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  3051
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3051

Gly Tyr Thr Phe Thr Ser Tyr Tyr 
1               5               


<210>  3052
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3052

Ile Asn Pro Ser Gly Gly Ser Thr 
1               5               


<210>  3053
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3053

Ala Ser Met Thr Arg Arg Ser His Gln Thr Tyr Phe Gly Met Asp Val 
1               5                   10                  15      


<210>  3054
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3054

Gly Tyr Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  3055
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3055

Ile Asn Thr Asp Thr Gly Asn Pro 
1               5               


<210>  3056
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3056

Ala Arg Asp Pro Ser Tyr Cys Ser Ser Thr Arg Cys Tyr Thr Val Gly 
1               5                   10                  15      


Trp Phe Asp Pro 
            20  


<210>  3057
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3057

Gly Asp Ser Ile Asn Ser Gly Asn Tyr Tyr 
1               5                   10  


<210>  3058
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3058

Met Phe Thr Ser Gly Ser Thr 
1               5           


<210>  3059
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3059

Ala Arg Gly His Val Ala Ala Trp Glu Ser Cys Tyr Tyr 
1               5                   10              


<210>  3060
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3060

Gly Phe Thr Leu Asp Asp Tyr Gly 
1               5               


<210>  3061
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3061

Ile Asn Trp Asn Gly Gly Arg Thr 
1               5               


<210>  3062
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3062

Ala Arg Ala Arg Gly Pro Ser Glu Gln Tyr Tyr Asp Leu Leu Thr Gly 
1               5                   10                  15      


Tyr Tyr Asp Ala Phe Asp Ile 
            20              


<210>  3063
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3063

Gly Phe Thr Phe Ser Asn Tyr Ala 
1               5               


<210>  3064
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3064

Ile Ile Ser Thr Ser Gly Gly Ala Thr 
1               5                   


<210>  3065
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3065

Val Lys Gly Leu Phe Asp Trp Phe Pro Leu 
1               5                   10  


<210>  3066
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3066

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3067
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3067

Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               


<210>  3068
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3068

Ala Gln Met Gly Pro Leu Gly Ser Thr Ser Ser Ala Ala Asp Tyr 
1               5                   10                  15  


<210>  3069
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3069

Gly Phe Ser Phe Ser Ser Tyr Asp 
1               5               


<210>  3070
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3070

Ile Thr Val Ser Gly Asp Thr 
1               5           


<210>  3071
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3071

Ala Lys Asp Phe Thr Ala Trp Tyr Ala Val Gly Phe 
1               5                   10          


<210>  3072
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3072

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  3073
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3073

Met Asn Pro Asn Ser Gly Asn Thr 
1               5               


<210>  3074
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3074

Ala Arg Glu Ala Arg Tyr Phe Asp Trp Ile Phe Glu Gly Ser Asp Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Gly Met Asp Val 
            20              


<210>  3075
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3075

Gly Phe Thr Phe Ser Ser Ser Glu 
1               5               


<210>  3076
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3076

Ile Ser Ser Ser Gly Ser Ile Ile 
1               5               


<210>  3077
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3077

Ala Arg Arg Ser Tyr Arg Ser Ser Trp Tyr Tyr Tyr Tyr Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  3078
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3078

Arg Gly Thr Phe Asn Thr His Ala 
1               5               


<210>  3079
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3079

Ile Ile Pro Ile Phe Ala Thr Thr 
1               5               


<210>  3080
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3080

Ala Arg Val Gly Gly Gly Asn Ser Tyr Ser Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  3081
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3081

Gly Phe Thr Leu Gly Asn Phe Trp 
1               5               


<210>  3082
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3082

Val Asn Thr Ala Gly Thr Thr Thr 
1               5               


<210>  3083
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3083

Ala Arg Asp Gly Ser Gly Gly Ser Trp Gly Trp Leu Asp Pro 
1               5                   10                  


<210>  3084
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3084

Gly Phe Ile Phe Gly Asp Tyr Ala 
1               5               


<210>  3085
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3085

Ile Arg Gly Lys Ala Tyr Asp Gly Thr Thr 
1               5                   10  


<210>  3086
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3086

Ile Arg Asp Tyr Asp Phe Trp Gly Gly Tyr Tyr Tyr His Pro Leu Arg 
1               5                   10                  15      


Ala Phe Asp Ile 
            20  


<210>  3087
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3087

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3088
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3088

Ile Thr His Asp Gly Ser Lys Gln 
1               5               


<210>  3089
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3089

Ala Lys Gly Val Thr Glu Gly Ser Trp Ser Phe Asp Ser 
1               5                   10              


<210>  3090
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3090

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  3091
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3091

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3092
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3092

Ala Arg His Gln Ile Val Val Leu Phe Asp Met 
1               5                   10      


<210>  3093
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3093

Gly Phe Thr Phe Thr Asn Tyr Ala 
1               5               


<210>  3094
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3094

Ile Asn Ala Gly Asn Gly Asn Thr 
1               5               


<210>  3095
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3095

Ala Arg Leu Leu Tyr Thr Ala Val Gly Tyr Tyr Tyr Asp Tyr 
1               5                   10                  


<210>  3096
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3096

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3097
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3097

Ile Ile Pro Ile Phe Gly Thr Ala 
1               5               


<210>  3098
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3098

Ala Ile Thr Tyr Tyr Tyr Asp Ser Ser Gly Tyr Trp Trp Asp Asp 
1               5                   10                  15  


<210>  3099
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3099

Gly Phe Ser Phe Ser Thr Ser Trp 
1               5               


<210>  3100
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3100

Ile Lys Asp Asp Gly Asn Glu Lys 
1               5               


<210>  3101
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3101

Ala Arg Ser Leu Ser Phe His Pro Tyr Ala Phe Phe Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  3102
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3102

Gly Tyr Ile Phe Ala Asn Tyr Asp 
1               5               


<210>  3103
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3103

Met Asn Pro Ser Ser Thr Asn Thr 
1               5               


<210>  3104
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3104

Ala Arg Gly Arg Gln Trp Ser Thr Trp Ser Glu His Trp Phe Asp Pro 
1               5                   10                  15      


<210>  3105
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3105

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  3106
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3106

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3107
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3107

Ala Gly Glu Glu Val Arg Gly Val Lys Leu Tyr Tyr Tyr Tyr Ala Met 
1               5                   10                  15      


Asp Val 
        


<210>  3108
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3108

Gly Phe Thr Phe Ser Val Tyr Glu 
1               5               


<210>  3109
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3109

Ile Gly Thr Ser Gly Ser Pro Ile 
1               5               


<210>  3110
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3110

Ala Arg Asp Arg Gly Trp Asn Tyr Gly Leu Asp Tyr 
1               5                   10          


<210>  3111
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3111

Gly Gly Ser Phe Ser Asp Phe Phe 
1               5               


<210>  3112
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3112

Ile Arg Arg Ser Gly Leu Thr 
1               5           


<210>  3113
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3113

Ala Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Ile Asp 
1               5                   10              


<210>  3114
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3114

Gly Tyr Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  3115
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3115

Ile Asn Pro Asn Ser Ser Asp Thr 
1               5               


<210>  3116
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3116

Ala Arg Asp Ser Gly Gly Gly Arg Gly Asp Phe Ser Asn Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  3117
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3117

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3118
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3118

Ile Ser Ser Asp Gly Gly Asn Lys 
1               5               


<210>  3119
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3119

Ala Arg Asp Val Pro Thr Thr Val Thr Ala Phe Thr Val Phe Thr Tyr 
1               5                   10                  15      


<210>  3120
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3120

Gly Phe Ser Leu Gly Thr Ser Gly Met Cys 
1               5                   10  


<210>  3121
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3121

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  3122
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3122

Ala Arg Gly Val Asp Thr Tyr Asp Tyr 
1               5                   


<210>  3123
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3123

Gly Phe Thr Phe Ser Asn Ala Trp 
1               5               


<210>  3124
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3124

Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr 
1               5                   10  


<210>  3125
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3125

Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  3126
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3126

Gly Tyr Asn Phe Ala Asp Tyr Trp 
1               5               


<210>  3127
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3127

Ile His Pro Pro Asp Ser Gln Thr 
1               5               


<210>  3128
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3128

Ala Arg Arg Leu Ser Pro Leu Gln Leu Leu Ser Gly Gly Phe Tyr Ser 
1               5                   10                  15      


Phe Asp Tyr 
            


<210>  3129
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3129

Gly Phe Ala Phe Ser Asn Tyr Ala 
1               5               


<210>  3130
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3130

Ile Ser Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  3131
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3131

Ala Arg Val Pro Val Met Val Arg Gly Val Tyr Phe Asp Tyr 
1               5                   10                  


<210>  3132
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3132

Gly Gly Ser Phe Ser Asp Phe Phe 
1               5               


<210>  3133
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3133

Ile Arg Arg Ser Gly Leu Thr 
1               5           


<210>  3134
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3134

Ala Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Ile Asp 
1               5                   10              


<210>  3135
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3135

Gly Leu Thr Val Ser Ser Asn Tyr 
1               5               


<210>  3136
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3136

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  3137
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3137

Ala Arg Asp Pro Gly Ser Arg Tyr Ser Gly Gly Trp Tyr Asp Tyr Tyr 
1               5                   10                  15      


Tyr Ala Met Asp Val 
            20      


<210>  3138
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3138

Glu Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  3139
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3139

Ile Lys Gln Asp Gly Ser Gln Lys 
1               5               


<210>  3140
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3140

Ala Ser Arg Leu Cys Ser Ser Ser Gly Cys Tyr Ala Ala Ser Tyr His 
1               5                   10                  15      


Tyr Met Asp Val 
            20  


<210>  3141
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3141

Gly Phe Pro Phe Ser Thr Tyr Trp 
1               5               


<210>  3142
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3142

Ile Lys Asp Asp Ala Thr Asn Thr 
1               5               


<210>  3143
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3143

Ala Arg Asp Glu Gly Arg Leu Asn Met Val Arg Gly Tyr Asp Tyr 
1               5                   10                  15  


<210>  3144
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3144

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  3145
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3145

Ile Tyr Pro Ser Asp Ser Glu Thr 
1               5               


<210>  3146
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3146

Ala Arg His Trp Cys Ser Gly Gly Ser Cys Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  3147
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3147

Gly Phe Thr Leu Ser Asp Phe Tyr 
1               5               


<210>  3148
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3148

Phe Ser Ser Gly Arg Ser Ser Thr 
1               5               


<210>  3149
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3149

Ala Arg Asp Thr Arg Lys Ala Tyr Tyr Tyr Asp Ser Arg Gly Tyr Asn 
1               5                   10                  15      


Pro Phe Tyr His Tyr Tyr Gly Met Asp Val 
            20                  25      


<210>  3150
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3150

Gly Tyr Ser Phe Pro Thr Tyr Trp 
1               5               


<210>  3151
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3151

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3152
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3152

Ala Arg Arg Asp Thr Asp Phe Asp Tyr 
1               5                   


<210>  3153
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3153

Gly Phe Ser Phe Ser Ser Tyr Gly 
1               5               


<210>  3154
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3154

Met Asp Gly Ser Ala Gly Asn Ile 
1               5               


<210>  3155
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3155

Ala Lys Asp Ser Gly Ala Leu Cys Ser Gly Gly Asp Cys Leu Arg Gly 
1               5                   10                  15      


Tyr Phe Asp Leu 
            20  


<210>  3156
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3156

Gly Tyr Ile Phe Ala Asn Tyr Asp 
1               5               


<210>  3157
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3157

Met Asn Pro Ser Ser Thr Asn Thr 
1               5               


<210>  3158
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3158

Ala Arg Gly Arg Gln Trp Ser Thr Trp Ser Glu His Trp Phe Asp Pro 
1               5                   10                  15      


<210>  3159

<400>  3159
000

<210>  3160

<400>  3160
000

<210>  3161

<400>  3161
000

<210>  3162
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3162

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3163
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3163

Ile Ser Phe Asp Gly Ser Asn Lys 
1               5               


<210>  3164
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3164

Ala Lys Asp Leu Pro Pro Tyr Ala Ser Gly Trp Tyr Glu Gly Gly Phe 
1               5                   10                  15      


Asp Tyr 
        


<210>  3165
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3165

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3166
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3166

Val Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3167
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3167

Ala Gln Gly Arg Gly Gly Tyr Tyr Ser Pro Phe Asp Asp 
1               5                   10              


<210>  3168
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3168

Gly Phe Ser Leu Ser Asn Ala Arg Met Gly 
1               5                   10  


<210>  3169
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3169

Ile Phe Ser Gly Asp Glu Lys 
1               5           


<210>  3170
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3170

Ala Arg Thr Thr Trp Gly Thr Trp Ile Gln Ala Trp Tyr Phe Asp Ile 
1               5                   10                  15      


<210>  3171
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3171

Gly Phe Thr Phe Thr Arg Ser Ala 
1               5               


<210>  3172
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3172

Ile Val Val Gly Ser Gly Asn Thr 
1               5               


<210>  3173
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3173

Ala Ala Val Cys Glu Trp Leu Cys Asp Phe 
1               5                   10  


<210>  3174
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3174

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3175
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3175

Ile Trp Phe Asp Gly Ser Asn Lys 
1               5               


<210>  3176
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3176

Ala Arg Glu Gly Asp Phe Trp Ser Gly Tyr Tyr Thr Gly Trp Phe Asp 
1               5                   10                  15      


Pro 
    


<210>  3177
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3177

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3178
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3178

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3179
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3179

Ala Lys Asp Leu Thr Ile Val Val Ile Pro Ala Ala Pro Asn Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  3180
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3180

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3181
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3181

Ile Ser Gly Thr Gly Asp Ser Thr 
1               5               


<210>  3182
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3182

Ala Lys Asp Gln Ala Arg Val Gln Asp Tyr Ile Trp Gly Ser Tyr Arg 
1               5                   10                  15      


Ser Tyr Gly Met Asp Val 
            20          


<210>  3183
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3183

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  3184
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3184

Ile Ser Trp Asn Ser Gly Thr Ile 
1               5               


<210>  3185
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3185

Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val 
1               5                   10                  


<210>  3186
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3186

Gly Asp Ser Val Ser Gly Asn Ser His Phe 
1               5                   10  


<210>  3187
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3187

Ile Phe Asn Ser Val Ser Thr 
1               5           


<210>  3188
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3188

Ala Gly Gly Phe Gly Asp Ala Trp Glu Pro Gln Gly Tyr 
1               5                   10              


<210>  3189

<400>  3189
000

<210>  3190

<400>  3190
000

<210>  3191

<400>  3191
000

<210>  3192
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3192

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3193
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3193

Met Asp Gly Ser Ala Gly Asn Ile 
1               5               


<210>  3194
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3194

Ala Gln Met Gly Pro Leu Gly Ser Thr Ser Ser Ala Ala Asp Tyr 
1               5                   10                  15  


<210>  3195
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3195

Gly Gly Ser Ile Ser Ser Ser Ser His Tyr 
1               5                   10  


<210>  3196
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3196

Ile Ser Tyr Arg Gly Thr Thr 
1               5           


<210>  3197
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3197

Ala Arg Tyr Thr Thr Met Val Gly Glu Phe Asp Ser 
1               5                   10          


<210>  3198
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3198

Gly Phe Thr Phe Ser Gly Tyr Ser 
1               5               


<210>  3199
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3199

Ile Ser Ser Ser Ser Ser Tyr Ile 
1               5               


<210>  3200
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3200

Ala Arg Trp Leu Gln Leu Arg Ser Asp Tyr Tyr Tyr Phe Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  3201
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3201

Gly Phe Thr Phe Ser Thr Tyr Ser 
1               5               


<210>  3202
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3202

Ile Ser Ser Ser Ser Arg Tyr Ile 
1               5               


<210>  3203
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3203

Ala Arg Gly Pro Arg Gly Tyr Ser Tyr Gly Tyr Phe Asp Tyr 
1               5                   10                  


<210>  3204
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3204

Gly Phe Ser Leu Ser Thr Phe Gly Val Gly 
1               5                   10  


<210>  3205
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3205

Ile Tyr Trp Asp Asp Asp Glu 
1               5           


<210>  3206
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3206

Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
1               5                   10                  15  


<210>  3207
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3207

Gly Phe Thr Phe Ser Phe Tyr Trp 
1               5               


<210>  3208
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3208

Ile Lys Gln Asp Gly Gly Glu Lys 
1               5               


<210>  3209
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3209

Ala Arg Leu Ser Gly Ser Ser Trp Asp Phe Asp Tyr 
1               5                   10          


<210>  3210
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3210

Gly Phe Pro Phe Ser Asn Ile Trp 
1               5               


<210>  3211
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3211

Ile Lys Ser Lys Thr Ala Gly Glu Ile Thr 
1               5                   10  


<210>  3212
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3212

Ile Thr Asp Trp Arg Val Asp Tyr 
1               5               


<210>  3213
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3213

Gly Phe Ser Val Ser Thr Asn Tyr 
1               5               


<210>  3214
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3214

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  3215
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3215

Ala Arg Asp Tyr Arg Asp Trp Ile 
1               5               


<210>  3216
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3216

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  3217
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3217

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3218
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3218

Ala His Asn Arg Phe Gln Tyr Cys Ser Ser Thr Thr Cys Tyr Thr Leu 
1               5                   10                  15      


Leu Pro Phe Asp Tyr 
            20      


<210>  3219
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3219

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3220
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3220

Ile Ser Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  3221
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3221

Ala Arg Pro Tyr Thr Gly Ser Tyr Lys Ser Tyr Met Asp Val 
1               5                   10                  


<210>  3222
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3222

Gly Phe Thr Phe Ser Gly Tyr Tyr 
1               5               


<210>  3223
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3223

Ile Ser Gly Asp Gly Ser Asp Lys 
1               5               


<210>  3224
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3224

Ala Thr Ala Ala Arg Thr Ala Pro Asn 
1               5                   


<210>  3225
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3225

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3226
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3226

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3227
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3227

Ala Arg Gly Asp Gly Asp Val Tyr Asn Phe Leu Leu Val Arg Asn Trp 
1               5                   10                  15      


Phe Asp Pro 
            


<210>  3228
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3228

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3229
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3229

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3230
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3230

Ala Arg Val Phe Asp Trp Val Leu Tyr Asp Tyr 
1               5                   10      


<210>  3231
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3231

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  3232
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3232

Phe Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3233
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3233

Ala Ser Leu Trp Phe Gly Asp Leu Tyr Ser Phe Asp Tyr 
1               5                   10              


<210>  3234
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3234

Ala Phe Thr Phe Ser Ser Phe Trp 
1               5               


<210>  3235
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3235

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  3236
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3236

Ala Arg Leu Gly Arg Ser Ser Trp Asn Phe Asp Tyr 
1               5                   10          


<210>  3237
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3237

Gly Asp Thr Ser Ser Ser Tyr Thr 
1               5               


<210>  3238
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3238

Ile Ile Pro Ile Leu Gly Ile Ala 
1               5               


<210>  3239
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3239

Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Arg Met Asp Val 
            20          


<210>  3240
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3240

Gly Asp Ser Ile Ser Ser Gly Ser Tyr Tyr 
1               5                   10  


<210>  3241
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3241

Ile Tyr Thr Ser Gly Ser Thr 
1               5           


<210>  3242
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3242

Ala Arg Val Gly Gly Ile Ser Pro Tyr Tyr Tyr Tyr Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  3243
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3243

Gly Phe Thr Phe Ser Arg Phe Gly 
1               5               


<210>  3244
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3244

Ile Ser Phe Asp Gly Arg Asn Lys 
1               5               


<210>  3245
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3245

Ala Arg Glu Tyr His Asp Gly Ala Asn Trp Ser Gly Ala Phe Asp Val 
1               5                   10                  15      


<210>  3246
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3246

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  3247
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3247

Ile Tyr Thr Ser Gly Ser Thr 
1               5           


<210>  3248
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3248

Ala Arg Asp Val Pro Ala Ala Asp Gly Met Asp Val 
1               5                   10          


<210>  3249
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3249

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  3250
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3250

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3251
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3251

Ala Arg Val Gly Ser Ile Gly Trp Tyr His Tyr Phe Glu Tyr 
1               5                   10                  


<210>  3252
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3252

Gly Tyr Thr Phe Leu Ser Tyr Asp 
1               5               


<210>  3253
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3253

Met Ser Pro Thr Ser Gly Tyr Thr 
1               5               


<210>  3254
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3254

Ala Arg Gly Lys Pro Leu Asp Tyr 
1               5               


<210>  3255
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3255

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  3256
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3256

Met Asn Pro Asn Ser Gly Asn Ala 
1               5               


<210>  3257
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3257

Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Tyr 
1               5                   10                  15      


<210>  3258
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3258

Gly Phe Ser Leu Ser Thr Phe Gly Val Gly 
1               5                   10  


<210>  3259
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3259

Ile Tyr Trp Asp Asp Asp Glu 
1               5           


<210>  3260
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3260

Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
1               5                   10                  15  


<210>  3261
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3261

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3262
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3262

Ile Ser Gly Ser Gly Gly Asn Thr 
1               5               


<210>  3263
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3263

Ala Lys Asp Lys Pro Asp Thr Ser Ser Thr Thr Leu Asn Met Asp Ala 
1               5                   10                  15      


<210>  3264
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3264

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Tyr 
1               5                   10  


<210>  3265
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3265

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3266
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3266

Ala Ser Ala Lys Leu Val Ala Thr Ile Ser Tyr Phe Asp Tyr 
1               5                   10                  


<210>  3267
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3267

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  3268
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3268

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  3269
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3269

Ala Arg Val Gly Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10              


<210>  3270
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3270

Gly Phe Thr Phe Asn Arg His Ala 
1               5               


<210>  3271
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3271

Ile Ser Gly Ser Ser Asp Tyr Ile 
1               5               


<210>  3272
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3272

Ala Lys Gly Val Asp Met Thr Gly Arg Leu Ala Tyr Phe Asp His 
1               5                   10                  15  


<210>  3273
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3273

Gly Phe Ile Phe Ser Thr Tyr Ala 
1               5               


<210>  3274
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3274

Ile Ser Tyr Asp Gly Asp Asn Lys 
1               5               


<210>  3275
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3275

Ala Arg Pro Arg Gly Gly Ser Tyr Gln Thr Cys Phe Asp Tyr 
1               5                   10                  


<210>  3276
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3276

Gly Tyr Thr Phe Thr Ser His Thr 
1               5               


<210>  3277
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3277

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  3278
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3278

Ala Arg Trp Gly Pro Asp Tyr Gly Asp Tyr Ala Ser Asn Asp Tyr 
1               5                   10                  15  


<210>  3279
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3279

Gly Phe Ser Leu Thr Thr Ser Gly Val Gly 
1               5                   10  


<210>  3280
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3280

Ile Tyr Trp Asp Asn Asp Lys 
1               5           


<210>  3281
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3281

Ala His Asn Thr Tyr Ser Asn Gly Val Asp Val 
1               5                   10      


<210>  3282
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3282

Gly Phe Ile Phe Ser Asn Tyr Asp 
1               5               


<210>  3283
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3283

Ile Ser His Ser Gly Arg Thr Thr 
1               5               


<210>  3284
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3284

Ala Arg Asp Ser Asp Tyr Tyr Asp Asn Ser Gly Tyr Pro Asp Ala Phe 
1               5                   10                  15      


Asp Ile 
        


<210>  3285
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3285

Gly Phe Thr Phe Asp Asp Ser Ala 
1               5               


<210>  3286
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3286

Ile Ser Trp Asn Ser Gly Asn Val 
1               5               


<210>  3287
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3287

Thr Lys Ala Ser Arg Tyr Cys Ser Ser Thr Ile Cys Tyr Trp Asn Trp 
1               5                   10                  15      


Phe Asp Pro 
            


<210>  3288

<400>  3288
000

<210>  3289

<400>  3289
000

<210>  3290

<400>  3290
000

<210>  3291
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3291

Gly Tyr Thr Phe Thr Thr Tyr Ala 
1               5               


<210>  3292
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3292

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  3293
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3293

Ala Arg Gly Leu Val Gly Arg Ile Asp Pro 
1               5                   10  


<210>  3294
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3294

Gly Tyr Thr Phe Thr Asn Tyr Tyr 
1               5               


<210>  3295
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3295

Leu Asn Pro Gly Ala Gly Ser Thr 
1               5               


<210>  3296
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3296

Ala Arg Asp Gln Gln Ile Val Pro His Ala Asp Gly Phe Asp Ile 
1               5                   10                  15  


<210>  3297
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3297

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3298
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3298

Ile Ile Pro Val Phe Gly Thr Ala 
1               5               


<210>  3299
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3299

Ala Arg Ile Gly Ser Tyr Pro Glu Tyr Phe Gln His 
1               5                   10          


<210>  3300
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3300

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  3301
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3301

Ile Ser Trp Asn Ser Gly Thr Ile 
1               5               


<210>  3302
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3302

Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val 
1               5                   10                  


<210>  3303
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3303

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  3304
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3304

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3305
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3305

Ala His Arg Arg Glu Trp Glu Pro Tyr Arg Tyr 
1               5                   10      


<210>  3306
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3306

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  3307
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3307

Ile Lys Glu Asp Gly Ser Glu Lys 
1               5               


<210>  3308
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3308

Ala Arg Asp Val Gly Gly Tyr Ser Gly Tyr Asp Leu Gly Phe Asp Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Met Asp Val 
            20          


<210>  3309
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3309

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3310
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3310

Ile Ser Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  3311
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3311

Ala Lys Asp Arg Thr Ala Val Phe Leu Phe Phe Gly Leu Gly Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  3312
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3312

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3313
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3313

Ile Val Pro Ile Phe Gly Thr Ala 
1               5               


<210>  3314
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3314

Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Arg Met Asp Val 
            20          


<210>  3315
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3315

Gly Gly Ser Ile Arg Ser Tyr Phe 
1               5               


<210>  3316
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3316

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3317
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3317

Ala Arg Ala Thr Trp Leu Arg Asp Ala Phe Gly Ile 
1               5                   10          


<210>  3318
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3318

Gly Tyr Ser Phe Thr Ser His Trp 
1               5               


<210>  3319
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3319

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3320
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3320

Ala Ser Ala Leu Arg Glu Arg Gly Val Gln Leu Trp Ser Val 
1               5                   10                  


<210>  3321
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3321

Gly Phe Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  3322
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3322

Ile Ser Val Ser Gly Gly Ser Thr 
1               5               


<210>  3323
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3323

Ala Lys Asp Pro Ala Ser Gly Ile Val Gly Pro Thr His Phe Asp Tyr 
1               5                   10                  15      


<210>  3324
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3324

Gly Tyr Thr Leu Thr Glu Leu Ser 
1               5               


<210>  3325
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3325

Phe Asp Pro Glu Asp Ala Glu Thr 
1               5               


<210>  3326
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3326

Ala Thr Gly Phe Ala Val Phe Gly Arg Ala Ala Val Pro Tyr 
1               5                   10                  


<210>  3327
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3327

Gly Gly Ser Ile Ser Ser Gly Asp Tyr Tyr 
1               5                   10  


<210>  3328
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3328

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3329
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3329

Ala Arg Phe Arg Arg Ser Tyr Gly Ser Gly Ser Tyr Tyr Asn Ile Ser 
1               5                   10                  15      


Phe Asp Tyr 
            


<210>  3330
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3330

Gly Phe Ser Leu Thr Thr Ser Gly Met Cys 
1               5                   10  


<210>  3331
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3331

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  3332
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3332

Ala Arg Val Val Val Arg Cys Pro Gly Thr Gly Asp Val Cys Ser Thr 
1               5                   10                  15      


Tyr Tyr Tyr Gln Ser Met Asp Val 
            20                  


<210>  3333
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3333

Gly Tyr Thr Phe Thr Arg His Ala 
1               5               


<210>  3334
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3334

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  3335
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3335

Val Arg Glu Tyr Gly Ser Gly His Pro Leu Pro Ile 
1               5                   10          


<210>  3336
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3336

Gly Gly Ser Ile Ser Ser Gly Ser Tyr Trp 
1               5                   10  


<210>  3337
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3337

Thr Tyr Ile Ser Gly Ser Thr 
1               5           


<210>  3338
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3338

Ala Arg Ile Val Arg Pro Cys Ser Tyr Pro Ser Cys Ser Gly Tyr Asn 
1               5                   10                  15      


Phe Phe Tyr Tyr Leu Asp Val 
            20              


<210>  3339
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3339

Gly Gly Ser Ile Arg Ser Tyr Phe 
1               5               


<210>  3340
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3340

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3341
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3341

Ala Arg Ala Thr Trp Leu Arg Asp Ala Phe Gly Ile 
1               5                   10          


<210>  3342
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3342

Gly Tyr Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  3343
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3343

Ile Asn Pro Ser Ala Gly Ser Thr 
1               5               


<210>  3344
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3344

Ala Arg Gly Phe His Val Pro Ala Ala Leu Arg Asn Trp Phe Asp Pro 
1               5                   10                  15      


<210>  3345
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3345

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Tyr 
1               5                   10  


<210>  3346
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3346

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3347
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3347

Ala Arg Glu Ala Asn Asp Ser Gly Ser Phe Tyr Asn Gly Pro Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  3348
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3348

Gly Gly Ser Phe Ser Asp Tyr Phe 
1               5               


<210>  3349
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3349

Val Thr His Ile Gly Ser Ile 
1               5           


<210>  3350
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3350

Ala Lys Gly Thr Ala Tyr Ala Trp Glu Val Leu His Ala 
1               5                   10              


<210>  3351
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3351

Gly Gly Ser Ile Gly Ser Tyr Tyr 
1               5               


<210>  3352
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3352

Ile Ser Tyr Ser Gly Asn Thr 
1               5           


<210>  3353
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3353

Ala Arg Val Phe Pro Arg Lys Gln Trp Leu Val Arg Gly Tyr Trp Tyr 
1               5                   10                  15      


Phe Asp Val 
            


<210>  3354
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3354

Gly Gly Ser Ile Ser Ser Gly Ser Tyr Tyr 
1               5                   10  


<210>  3355
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3355

Ile Phe Thr Ser Gly Ser Thr 
1               5           


<210>  3356
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3356

Ala Arg Gly Gly Leu Leu Trp Phe Gly Gly Ala Gly Asn Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  3357
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3357

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3358
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3358

Ile Ser Tyr Asp Gly Ser Ser Lys 
1               5               


<210>  3359
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3359

Ala Lys Glu Gly Glu Trp Glu Leu Arg Gly Asn Ala Leu Asp Ile 
1               5                   10                  15  


<210>  3360
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3360

Gly Tyr Thr Phe Thr Ser Leu Asp 
1               5               


<210>  3361
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3361

Met Thr Pro Arg Asn Gly Asn Thr 
1               5               


<210>  3362
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3362

Ala Arg Gly Val Ala Ala Gly Val Asp Tyr 
1               5                   10  


<210>  3363
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3363

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  3364
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3364

Met Asn Ser Asn Ser Gly Asn Ala 
1               5               


<210>  3365
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3365

Ala Arg Met Arg Thr Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
1               5                   10                  15      


<210>  3366
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3366

Glu Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  3367
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3367

Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               


<210>  3368
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3368

Ala Ser Arg Leu Cys Ser Ser Ser Gly Cys Tyr Ala Ala Ser Tyr His 
1               5                   10                  15      


Tyr Met Asp Val 
            20  


<210>  3369
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3369

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  3370
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3370

Ile Tyr Tyr Ser Gly Arg Thr 
1               5           


<210>  3371
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3371

Ala Arg Ala Pro Pro Pro Pro Ser Lys Trp Leu Leu Asn Tyr Tyr Tyr 
1               5                   10                  15      


Met Asp Val 
            


<210>  3372
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3372

Gly Gly Ser Ile Ser Ser Ser Asn Trp 
1               5                   


<210>  3373
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3373

Ile Tyr His Arg Gly Gln Thr 
1               5           


<210>  3374
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3374

Ala Arg Asp Arg Arg Glu Ser Ser Pro Tyr His Phe Tyr Tyr Gly Val 
1               5                   10                  15      


Asp Val 
        


<210>  3375
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3375

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  3376
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3376

Ile Ser Trp Asn Ser Gly Thr Ile 
1               5               


<210>  3377
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3377

Ala Arg Pro Arg Ser Gly Ser Tyr Tyr Ala Tyr Phe Asp Tyr 
1               5                   10                  


<210>  3378
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3378

Gly Phe Thr Phe Gly Thr Tyr Trp 
1               5               


<210>  3379
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3379

Ile Lys Pro Asp Gly Ser Asp Lys 
1               5               


<210>  3380
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3380

Ala Arg Gly Val Tyr Asp Ser Gly Trp Tyr Met Asp Asn Phe Asp Tyr 
1               5                   10                  15      


<210>  3381
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3381

Gly Gly Ser Phe Ser Gly His Tyr 
1               5               


<210>  3382
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3382

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  3383
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3383

Ala Arg Gly Pro Pro Val Thr Thr Phe Phe Val Phe Ser Leu Leu Phe 
1               5                   10                  15      


Asp Pro 
        


<210>  3384
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3384

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3385
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3385

Ile Ser Tyr Asp Gly Arg Asn Lys 
1               5               


<210>  3386
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3386

Ala Lys Glu Gly Glu Trp Glu Leu Arg Gly Asn Ala Leu Asp Ile 
1               5                   10                  15  


<210>  3387
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3387

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  3388
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3388

Ile Lys Glu Asp Gly Ser Glu Lys 
1               5               


<210>  3389
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3389

Ala Arg Gly Ile Ser Ser Gly Tyr 
1               5               


<210>  3390
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3390

Gly Phe Thr Phe Gly Ser Tyr Val 
1               5               


<210>  3391
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3391

Ile Ser His Asp Ala Thr Ser Thr 
1               5               


<210>  3392
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3392

Ala Arg Asp Val Asn Tyr Val Phe Tyr Asp Phe 
1               5                   10      


<210>  3393
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3393

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3394
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3394

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3395
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3395

Ala Arg Glu Gly Gln Trp Pro Asn Gln Ala Phe Asp Ile 
1               5                   10              


<210>  3396
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3396

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3397
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3397

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3398
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3398

Ala Arg Ala Gly Gly Gly Ser Tyr Arg Gly Pro Phe Asp Tyr 
1               5                   10                  


<210>  3399
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3399

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  3400
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3400

Ile Tyr Tyr Ser Gly Ser Ser 
1               5           


<210>  3401
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3401

Ala Ser Gly Pro Pro Tyr Met Ala Thr Phe Ser Tyr Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  3402
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3402

Gly Phe Thr Phe Ser Asp Tyr Tyr 
1               5               


<210>  3403
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3403

Ile Ser Ser Ser Gly Ser Thr Ile 
1               5               


<210>  3404
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3404

Ala Arg Asp Pro Ile Arg Asp Gly Val Trp Gly Leu Asn Glu Asn Asp 
1               5                   10                  15      


Tyr 
    


<210>  3405
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3405

Asp Gly Ser Ile Ser Ser Gly Ser Tyr Cys 
1               5                   10  


<210>  3406
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3406

Ile Tyr Ser Ser Gly Ser Thr 
1               5           


<210>  3407
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3407

Ala Arg Asp Gly Glu Thr Thr Ala Thr Ser Ala Arg Gly Ser Ser Cys 
1               5                   10                  15      


Tyr Tyr Met Asp Val 
            20      


<210>  3408
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3408

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Tyr 
1               5                   10  


<210>  3409
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3409

Ile Ser Tyr Ser Gly Ser Thr 
1               5           


<210>  3410
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3410

Ala Arg Asp Leu Gly Asp Gly Tyr Asn Leu Arg Val Pro Ala Tyr Phe 
1               5                   10                  15      


Asp Leu 
        


<210>  3411
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3411

Gly Gly Ser Ile Ser Ser Ser Asn Trp 
1               5                   


<210>  3412
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3412

Ile Tyr His Gly Gly Ser Thr 
1               5           


<210>  3413
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3413

Ala Arg Val Asp His Val Asn Val Arg Asp Tyr 
1               5                   10      


<210>  3414
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3414

Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  3415
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3415

Ile Ser Asn Ser Asn Ser Phe Ile 
1               5               


<210>  3416
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3416

Ala Arg Val Asn Gly Asn Ser Asn Trp Asn Phe Gly Ser Tyr Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Met Asp Val 
            20      


<210>  3417
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3417

Gly Tyr Ser Leu Ser Glu Leu Ser 
1               5               


<210>  3418
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3418

Phe Asp Pro Glu Asp Gly Glu Thr 
1               5               


<210>  3419
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3419

Ala Ser Gly Gly Leu Asn Gly Asp Tyr Val Thr Gly Gly Ala Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Met Asp Val 
            20      


<210>  3420
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3420

Gly Tyr Thr Phe Ser Asn Tyr His 
1               5               


<210>  3421
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3421

Ile Ile Pro Ile Phe Gly Ala Ala 
1               5               


<210>  3422
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3422

Ala Arg Gly Ala Ala Ser Phe Asp Tyr 
1               5                   


<210>  3423
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3423

Gly Thr Ser Phe Ser Asp Tyr Phe 
1               5               


<210>  3424
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3424

Ile Arg Glu Met Gly Thr Ile 
1               5           


<210>  3425
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3425

Ala Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Val Val 
1               5                   10              


<210>  3426
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3426

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3427
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3427

Ile Thr His Asp Gly Ser Lys Gln 
1               5               


<210>  3428
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3428

Ala Lys Asn Glu Arg Ile Thr Met Leu Val Val Val Thr Leu Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  3429
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3429

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  3430
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3430

Ile Ser Gly Asn Gly Tyr Phe Thr 
1               5               


<210>  3431
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3431

Ala Lys Thr Gly Leu Leu Thr Leu Lys Pro Phe 
1               5                   10      


<210>  3432
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3432

Gly Tyr Thr Phe Thr Asn Tyr Ala 
1               5               


<210>  3433
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3433

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  3434
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3434

Ala Gln Val Leu Cys Ser Ser Thr Ser Cys His Tyr Tyr Tyr Gly Met 
1               5                   10                  15      


Asp Val 
        


<210>  3435
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3435

Gly Phe Thr Phe Ser Asn Tyr Gly 
1               5               


<210>  3436
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3436

Ile Tyr Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3437
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3437

Ala Arg Glu Gly Gln Met Ala Ala Thr Thr Gly Ile Asp Tyr 
1               5                   10                  


<210>  3438
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3438

Gly Phe Thr Phe Ser Asn Ala Trp 
1               5               


<210>  3439
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3439

Ile Lys Gly Lys Thr Asp Gly Gly Thr Thr 
1               5                   10  


<210>  3440
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3440

Thr Thr Leu Thr Tyr Tyr Tyr Asp Ser Ser Ala Tyr Leu Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  3441
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3441

Gly Tyr Thr Phe Ser Thr Tyr Trp 
1               5               


<210>  3442
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3442

Ile Tyr Pro Gly Asp Ser Glu Thr 
1               5               


<210>  3443
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3443

Ala Ile Lys Gly Ser Pro Thr Ser Thr Ala His Asp Ala Leu Asp Ile 
1               5                   10                  15      


<210>  3444
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3444

Gly Phe Ser Phe Ser Ser Tyr Gly 
1               5               


<210>  3445
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3445

Met Asp Gly Ser Ala Gly Asn Ile 
1               5               


<210>  3446
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3446

Ala Lys Asp Ser Gly Ala Leu Cys Ser Gly Gly Asp Cys Leu Arg Gly 
1               5                   10                  15      


Tyr Phe Asp Leu 
            20  


<210>  3447
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3447

Gly Ala Ser Ile Ser Thr Ala Asp Tyr Tyr 
1               5                   10  


<210>  3448
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3448

Ile His Tyr Thr Gly Gly Thr 
1               5           


<210>  3449
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3449

Ala Arg Leu His Arg Ser Gly Asn Val Phe Glu Phe 
1               5                   10          


<210>  3450
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3450

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  3451
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3451

Ile Ser Trp Asn Ser Asp Asn Ile 
1               5               


<210>  3452
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3452

Ala Lys Gly Ile Tyr Tyr Asp Ile Phe Met Pro Leu Leu Asp 
1               5                   10                  


<210>  3453
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3453

Gly Asp Thr Ser Ser Ser Tyr Thr 
1               5               


<210>  3454
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3454

Ile Ile Pro Ile Leu Gly Ile Ala 
1               5               


<210>  3455
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3455

Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro 
1               5                   10                  


<210>  3456
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3456

Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  3457
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3457

Ile Ser Ser Arg Ser Ser Thr Ile 
1               5               


<210>  3458
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3458

Ala Arg Val Asp Tyr Tyr Gly Ser Gly Ser Val Tyr Trp Tyr Phe Asp 
1               5                   10                  15      


Leu 
    


<210>  3459
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3459

Gly Gly Thr Phe Gly Ser Tyr Val 
1               5               


<210>  3460
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3460

Ile Ile Pro Ile Phe Gly Lys Pro 
1               5               


<210>  3461
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3461

Ala Arg Gly Trp Phe Gly Glu Leu Leu Lys Gly Thr Tyr Trp Phe Asp 
1               5                   10                  15      


Pro 
    


<210>  3462
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3462

Gly Glu Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  3463
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3463

Ile Asn Gln Ser Gly Asn Asn 
1               5           


<210>  3464
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3464

Ala Arg Asp Thr Ser Lys Tyr Tyr Phe Asp Tyr 
1               5                   10      


<210>  3465
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3465

Gly Phe Thr Phe Ser Arg Tyr Trp 
1               5               


<210>  3466
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3466

Ile Lys Glu Asp Gly Ser Glu Arg 
1               5               


<210>  3467
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3467

Ala Ser Arg His Cys Ser Val Ser Gly Cys Tyr Thr Ala Ser Tyr Leu 
1               5                   10                  15      


Tyr Met Asp Val 
            20  


<210>  3468
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3468

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  3469
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3469

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3470
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3470

Ala Arg Arg Gly Glu Ala Ala Gly Ile Trp Tyr Phe Asp Leu 
1               5                   10                  


<210>  3471
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3471

Gly Gly Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  3472
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3472

Ile Ile Pro Val Leu Gly Ile Ala 
1               5               


<210>  3473
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3473

Ala Arg Val Gly Val Ser Gly Phe Lys Ser Gly Ser Asn Trp Tyr Phe 
1               5                   10                  15      


Asp Leu 
        


<210>  3474
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3474

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Ser 
1               5                   10  


<210>  3475
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3475

Ile Tyr His Ser Gly Ser Thr 
1               5           


<210>  3476
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3476

Ala Arg Ser Gly Gly Leu Arg Phe Asp Ser 
1               5                   10  


<210>  3477
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3477

Gly Phe Thr Phe Ser Ala Tyr Glu 
1               5               


<210>  3478
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3478

Ile Thr Thr Ser Gly Asn Asn Ile 
1               5               


<210>  3479
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3479

Ala Lys Thr Gly Gln Val Glu Trp Leu Val Asp Asn Tyr Asn Tyr Tyr 
1               5                   10                  15      


Met Asp Val 
            


<210>  3480
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3480

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  3481
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3481

Ile Asn Ser Asp Gly Ser Ser Thr 
1               5               


<210>  3482
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3482

Ala Arg Glu Val Glu Gln Leu Ala His Met Val Asp Tyr 
1               5                   10              


<210>  3483
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3483

Gly Gly Ser Ile Ser Ser Thr Thr Tyr Tyr 
1               5                   10  


<210>  3484
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3484

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3485
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3485

Ala Arg Gln Trp Lys Trp Phe Gly Glu Ala Trp Tyr Phe Asp Leu 
1               5                   10                  15  


<210>  3486
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3486

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  3487
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3487

Ile Asn Gln Asp Gly Gly Glu Lys 
1               5               


<210>  3488
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3488

Ala Arg Asp Pro Tyr Asp Leu Tyr Gly Asp Tyr Gly Gly Thr Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  3489
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3489

Gly Phe Ser Phe Asn Ser Ala Trp 
1               5               


<210>  3490
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3490

Ile Lys Ala Asp Gly Gly Asp Ser 
1               5               


<210>  3491
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3491

Ala Val Trp Gly Asp Thr Trp Gly Leu Asp Tyr 
1               5                   10      


<210>  3492
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3492

Gly Phe Ser Phe Asn Asn Tyr Gly 
1               5               


<210>  3493
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3493

Ile Ser Tyr Glu Gly Ser Lys Thr 
1               5               


<210>  3494
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3494

Ala Lys Ser His Lys Leu Phe Trp Phe Gly Gln Phe Lys Met Asp Ala 
1               5                   10                  15      


Leu Asp Ile 
            


<210>  3495
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3495

Gly Phe Ile Phe Ser His Tyr Ala 
1               5               


<210>  3496
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3496

Ile Asn Pro Ile Gly Asp Tyr Lys 
1               5               


<210>  3497
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3497

Ala Arg Asp Asn Trp Asp Val Ala Gly Met Asp Val 
1               5                   10          


<210>  3498
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3498

Gly Ile Thr Ser Asp Asp Tyr Ala 
1               5               


<210>  3499
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3499

Ile Asn Trp Asn Ser Gly Asn Ile 
1               5               


<210>  3500
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3500

Ala Lys Ala Pro Arg Ser Tyr Cys Ser Arg Thr Ser Cys Trp Gly Glu 
1               5                   10                  15      


Tyr Phe Gln Val 
            20  


<210>  3501
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3501

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3502
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3502

Ile Val Pro Ile Phe Gly Thr Ala 
1               5               


<210>  3503
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3503

Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Arg Met Asp Val 
            20          


<210>  3504
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3504

Gly Phe Thr Phe Ser Asn Tyr Gly 
1               5               


<210>  3505
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3505

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3506
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3506

Val Arg Asp Leu Ala Leu Phe Glu Val Val Ile Gln Gln Gly Val 
1               5                   10                  15  


<210>  3507
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3507

Gly Phe Thr Phe Ser Gly Ser Ala 
1               5               


<210>  3508
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3508

Ile Arg Ser Lys Thr Asn Asn Tyr Ala Thr 
1               5                   10  


<210>  3509
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3509

Thr Arg His Pro Tyr Tyr Ser Ala Ser Gly Ile Lys Phe Asp Pro 
1               5                   10                  15  


<210>  3510
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3510

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  3511
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3511

Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210>  3512
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3512

Ala Lys Ala His Ser Thr Gly His Gln Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  3513
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3513

Gly Gly Ser Val Ser Ser Arg Ser Tyr Tyr 
1               5                   10  


<210>  3514
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3514

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3515
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3515

Ala Arg His Thr Val Asp Cys Gly Gly Asp Cys Phe Pro Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  3516
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3516

Gly Ala Ser Phe Ser Asp Tyr Phe 
1               5               


<210>  3517
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3517

Ile Arg Gln Ile Gly Thr Thr 
1               5           


<210>  3518
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3518

Ala Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Val Ala 
1               5                   10              


<210>  3519
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3519

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3520
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3520

Ile Ser Ser Ser Gly Ser Ile Ile 
1               5               


<210>  3521
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3521

Ala Lys Gly Val Asp Tyr Gly Gly Lys Leu Ala Tyr Phe Asp Ser 
1               5                   10                  15  


<210>  3522
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3522

Gly Phe Ser Phe Gly Asp Tyr Ala 
1               5               


<210>  3523
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3523

Ile Ser Gly Ser Ser Asp Tyr Lys 
1               5               


<210>  3524
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3524

Ala Arg Ile Val Asp His Gly Ala Gln Gly Ala Tyr Phe Asp His 
1               5                   10                  15  


<210>  3525
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3525

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Tyr 
1               5                   10  


<210>  3526
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3526

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3527
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3527

Ala Arg Val Ser Tyr Asp Phe Trp Ser Gly Tyr Trp Ala Phe Asp Pro 
1               5                   10                  15      


<210>  3528
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3528

Gly Tyr Thr Phe Thr Asp Tyr Tyr 
1               5               


<210>  3529
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3529

Ile Asn Pro Asn Ser Arg Gly Thr 
1               5               


<210>  3530
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3530

Ala Arg Val Val Val Leu Gly Tyr Gly Arg Pro Asn Asn Tyr Tyr Asp 
1               5                   10                  15      


Gly Arg Asn Val Trp Asp Tyr 
            20              


<210>  3531
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3531

Gly Phe Thr Phe Asn Asn Tyr Val 
1               5               


<210>  3532
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3532

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3533
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3533

Ala Arg Gly Gln Arg Ser Ser Ser Gly Trp Tyr Lys Ser Tyr Tyr Tyr 
1               5                   10                  15      


Gly Met Asp Val 
            20  


<210>  3534
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3534

Asp Gly Ser Ile Ser Ser Gly Ser Tyr Cys 
1               5                   10  


<210>  3535
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3535

Phe Tyr Thr Ser Gly Ser Thr 
1               5           


<210>  3536
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3536

Ala Arg Asp Gly Glu Thr Thr Ala Thr Ser Ala Arg Gly Ser Ser Cys 
1               5                   10                  15      


Tyr Tyr Met Asp Val 
            20      


<210>  3537
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3537

Gly Phe Thr Phe Ser Ser Phe Gly 
1               5               


<210>  3538
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3538

Ile Trp Tyr Asp Gly Arg Lys Glu 
1               5               


<210>  3539
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3539

Ala Lys Glu Arg Gly Ser Arg Trp Leu Val Arg Leu Lys Tyr Tyr Tyr 
1               5                   10                  15      


Asp Leu Asp Val 
            20  


<210>  3540
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3540

Gly Phe Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  3541
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3541

Ile Ser Ala Thr Gly Gly Ser Thr 
1               5               


<210>  3542
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3542

Ala Lys Pro Tyr Gly Met Asp Val 
1               5               


<210>  3543
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3543

Gly Phe Thr Phe Ser Gly Ser Phe 
1               5               


<210>  3544
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3544

Ile Ser Ser Gly Gly Asp Ala Val 
1               5               


<210>  3545
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3545

Thr Arg Asp Arg Ile Ile Ala Ala Arg Gly Thr Leu Trp Tyr Phe Glu 
1               5                   10                  15      


Asn 
    


<210>  3546
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3546

Gly Phe Thr Phe Thr Asn Tyr Ala 
1               5               


<210>  3547
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3547

Ile Ser Asn Asp Gly Ser Asn Glu 
1               5               


<210>  3548
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3548

Ala Arg Asp Arg Ser Asn Leu Glu Arg Leu Val Met Thr Phe Gly Gly 
1               5                   10                  15      


Ile Ile Ala Gly Ala Phe Asp Ile 
            20                  


<210>  3549
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3549

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3550
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3550

Ile Ser Ala Tyr Asn Gly Asn Thr 
1               5               


<210>  3551
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3551

Ala Arg Glu Gly Val Gly Val Gly Ala Thr Gly Asp Phe Tyr Tyr Tyr 
1               5                   10                  15      


Ser Tyr Gly Met Asp Val 
            20          


<210>  3552
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3552

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3553
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3553

Ile Ser Tyr Asp Gly Ile Asn Lys 
1               5               


<210>  3554
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3554

Ala Arg Val Asn Ser Gly Ser Tyr Tyr Ser Tyr Phe Asp Tyr 
1               5                   10                  


<210>  3555
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3555

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  3556
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3556

Ile Ser Ser His Gly Gly Asn Thr 
1               5               


<210>  3557
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3557

Ala Arg Pro Asp Ser Arg Gly Tyr Tyr 
1               5                   


<210>  3558
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3558

Gly Tyr Thr Phe Thr Asn Tyr Asp 
1               5               


<210>  3559
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3559

Ile Asn Pro Ser Asn Thr Asn Thr 
1               5               


<210>  3560
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3560

Ala Arg Gly Arg Gln Trp Asn Thr Trp Ser Glu His Trp Phe Asp Pro 
1               5                   10                  15      


<210>  3561
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3561

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3562
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3562

Ile Lys Gln Asp Gly Ser Gln Lys 
1               5               


<210>  3563
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3563

Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val 
1               5                   10                  


<210>  3564
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3564

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  3565
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3565

Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               


<210>  3566
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3566

Ala Gln Arg Arg Gly Glu Ala Val Tyr Ser Asn Gly Trp Tyr Lys Tyr 
1               5                   10                  15      


Tyr Tyr Cys Met Asp Val 
            20          


<210>  3567
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3567

Gly Gly Ser Ile Ser Ser Ser Asn Trp 
1               5                   


<210>  3568
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3568

Ile Tyr His Ser Gly Ser Thr 
1               5           


<210>  3569
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3569

Ala Ser Arg Trp Gly Asp Tyr Phe Asp Ser Ser Gly Ala Tyr Asp Ser 
1               5                   10                  15      


<210>  3570
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3570

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3571
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3571

Ile Trp Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  3572
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3572

Ala Arg Lys Gly Pro Leu Trp Arg Phe Asp Tyr 
1               5                   10      


<210>  3573
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3573

Gly Phe Ile Val Ser Ser Asn Tyr 
1               5               


<210>  3574
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3574

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  3575
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3575

Ala Arg Glu Ser Thr Gln 
1               5       


<210>  3576
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3576

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  3577
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3577

Val Tyr Tyr Ile Gly Ser Thr 
1               5           


<210>  3578
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3578

Ala Arg Ala Pro Phe Gln Leu Leu Asp Lys Tyr Tyr Phe Phe Tyr Tyr 
1               5                   10                  15      


Met Asp Val 
            


<210>  3579
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3579

Gly Tyr Thr Phe Thr Arg Tyr Ala 
1               5               


<210>  3580
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3580

Ile Asn Thr Lys Thr Gly Ser Pro 
1               5               


<210>  3581
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3581

Ala Ser Arg Pro Gly Gly Asp Ile Glu Val Ala Ala Leu Asp Trp 
1               5                   10                  15  


<210>  3582
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3582

Gly Tyr Thr Phe Thr Arg Asn Asp 
1               5               


<210>  3583
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3583

Met Lys Pro Tyr Asn Gly Asn Thr 
1               5               


<210>  3584
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3584

Ala Arg Glu Asp Ser Val Gly Ala Asp Ala Phe Asp Met 
1               5                   10              


<210>  3585
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3585

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3586
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3586

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3587
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3587

Ala Arg Glu Gly Gln Gly Thr Tyr Leu Asp Tyr 
1               5                   10      


<210>  3588
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3588

Gly Leu Thr Val Ser Ser Asn Tyr 
1               5               


<210>  3589
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3589

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  3590
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3590

Ala Arg His Ile Pro Ala Trp Gly Tyr Lys 
1               5                   10  


<210>  3591
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3591

Gly Gly Ser Ile Ser Gly Ser Asp Ser Phe 
1               5                   10  


<210>  3592
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3592

Ile Ser Asp Ser Gly Thr Thr 
1               5           


<210>  3593
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3593

Val Arg Gly Arg Asn Leu Ser Gly His Gly Leu Leu Asp Thr 
1               5                   10                  


<210>  3594
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3594

Gly Tyr Ile Phe Ser Asp Tyr Thr 
1               5               


<210>  3595
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3595

Ile Asn Ala Gly Tyr Gly Asn Thr 
1               5               


<210>  3596
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3596

Ala Ser Met Thr Arg Arg Ser His Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  3597
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3597

Gly Gly Ser Ile Ser Gly Ser Thr Tyr Tyr 
1               5                   10  


<210>  3598
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3598

Ile Tyr Tyr Ser Arg Asn Ala 
1               5           


<210>  3599
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3599

Ala Thr Arg Asp Tyr Ser Ser Tyr Gly Phe Asp Ile 
1               5                   10          


<210>  3600
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3600

Gly Phe Thr Phe Thr Ser Tyr Gly 
1               5               


<210>  3601
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3601

Ile Ser Ile Ser Gly Gly Ser Thr 
1               5               


<210>  3602
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3602

Ala Lys Leu Leu Gly Ser Gly Ile Thr Leu Asp Asn Asp Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  3603
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3603

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  3604
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3604

Met Asn Pro Asn Ser Gly Asn Thr 
1               5               


<210>  3605
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3605

Ala Arg Ala Tyr Ser Gly Tyr Asp Pro Ala Leu Tyr Tyr Tyr Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Met Asp Val 
            20      


<210>  3606
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3606

Gly Phe Thr Phe Asn Asn Tyr Val 
1               5               


<210>  3607
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3607

Ile Ser His Asp Gly Thr Val Thr 
1               5               


<210>  3608
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3608

Ala Arg Asp Phe Asp Trp Val Leu Tyr Asp Tyr 
1               5                   10      


<210>  3609
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3609

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3610
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3610

Ile Ile Pro Ile Phe Gly Thr Thr 
1               5               


<210>  3611
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3611

Ala Arg Ile Gly His Phe Asp Ser Ser Gly Tyr Tyr Leu Asp Tyr 
1               5                   10                  15  


<210>  3612
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3612

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  3613
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3613

Ile Asn His Ser Gly Ala Thr 
1               5           


<210>  3614
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3614

Ala Arg Gly Arg Thr Ile Thr Thr Phe Tyr Ser Tyr Tyr Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  3615
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3615

Gly Gly Ser Met Thr Ser Ser Ser Tyr His 
1               5                   10  


<210>  3616
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3616

Phe Tyr Tyr Ser Gly Arg Thr 
1               5           


<210>  3617
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3617

Ala Ile Ile Thr Ile Phe Gly Phe Gly Ala Phe Asp Ile 
1               5                   10              


<210>  3618
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3618

Gly Phe Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  3619
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3619

Ile Ser Val Ser Gly Gly Ser Thr 
1               5               


<210>  3620
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3620

Ala Lys Asp Phe Gly Ser Gly Ile Val Gly Ala Thr Gly Phe Asp Phe 
1               5                   10                  15      


<210>  3621
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3621

Gly Phe Thr Phe Asp Asp Tyr Gly 
1               5               


<210>  3622
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3622

Ile Asn Trp Asn Gly Gly Ser Thr 
1               5               


<210>  3623
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3623

Ala Arg Arg Arg Ser Ser Ser Arg Tyr Ser Ser Gly Trp Tyr Met Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Met Asp Val 
            20          


<210>  3624
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3624

Gly Tyr Ser Phe Thr Asn Ser Trp 
1               5               


<210>  3625
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3625

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3626
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3626

Ala Thr His Arg Cys Ser Gly Gly Phe Cys Tyr Leu Ala Tyr 
1               5                   10                  


<210>  3627
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3627

Gly Phe Asp Leu Gly Asp Tyr Gly 
1               5               


<210>  3628
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3628

Ile Thr Gly Gly Ser Gly Glu Lys 
1               5               


<210>  3629
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3629

Ala Arg Glu Arg Gly Tyr Tyr Gly Leu Gly Ser Gln Ile Asn Trp Phe 
1               5                   10                  15      


Glu His 
        


<210>  3630
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3630

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  3631
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3631

Ile Thr Arg Ser Gly Ser Thr 
1               5           


<210>  3632
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3632

Ala Arg Gly Phe Asp Ser Ala Trp Glu Leu Gln Phe Leu 
1               5                   10              


<210>  3633
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3633

Gly Phe Thr Phe Ser Ser Phe Ala 
1               5               


<210>  3634
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3634

Ile Ser Asp Asp Gly Asn Asn Lys 
1               5               


<210>  3635
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3635

Ala Arg Ala Ser Tyr Asn Ser Asn Trp Ser Ile Gly Glu Tyr Phe Arg 
1               5                   10                  15      


Asp 
    


<210>  3636
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3636

Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210>  3637
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3637

Ile Leu Tyr Asp Gly Ser Asn Arg 
1               5               


<210>  3638
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3638

Ala Lys Gln Gly Gly Leu Tyr Cys Ser Gly Thr Asn Cys Trp Gly Gly 
1               5                   10                  15      


Tyr Leu Asp Tyr 
            20  


<210>  3639
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3639

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  3640
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3640

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3641
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3641

Val His Arg His Val Ser Gly Ala Phe Asp Tyr 
1               5                   10      


<210>  3642
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3642

Gly Ile Ile Phe Gly Ser His Val 
1               5               


<210>  3643
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3643

Val Ser Gly Ser Gly Ser Asn Met 
1               5               


<210>  3644
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3644

Ala Lys Leu Ala Ala His Ser Ser Gly Trp Tyr Gly Ala Glu Leu Asp 
1               5                   10                  15      


Tyr 
    


<210>  3645
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3645

Gly Tyr Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  3646
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3646

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  3647
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3647

Ala Arg Ala Arg Leu Leu Gly Tyr Cys Ser Ser Thr Ser Cys Tyr Thr 
1               5                   10                  15      


Ile Gly Trp Gly Ala Phe Asp Ile 
            20                  


<210>  3648
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3648

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3649
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3649

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3650
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3650

Ala Arg Glu Gly Gln Gly Thr Tyr Leu Asp Tyr 
1               5                   10      


<210>  3651
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3651

Gly Phe Thr Phe Ser Ser Tyr Glu 
1               5               


<210>  3652
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3652

Ile Ser Ser Ser Gly Ser Ala Ile 
1               5               


<210>  3653
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3653

Ala Arg Glu Ala Arg Ser Arg Tyr Phe Asp Trp Leu Pro Ser Tyr Tyr 
1               5                   10                  15      


Phe Asp Tyr 
            


<210>  3654
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3654

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3655
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3655

Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               


<210>  3656
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3656

Ala Arg Glu Ala Arg Ser Arg Tyr Phe Asp Trp Leu Pro Ser Tyr Tyr 
1               5                   10                  15      


Phe Asp Tyr 
            


<210>  3657
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3657

Gly Phe Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  3658
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3658

Ile Ser Val Ser Gly Gly Ser Thr 
1               5               


<210>  3659
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3659

Ala Lys Asp Pro Ala Ser Trp Ile Val Gly Pro Thr His Phe Asp Tyr 
1               5                   10                  15      


<210>  3660
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3660

Gly Phe Thr Phe Ser Arg His Ala 
1               5               


<210>  3661
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3661

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3662
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3662

Ala Arg Asp Pro Ser Pro Leu Val Leu Ile Thr Ser Ile Asp Tyr 
1               5                   10                  15  


<210>  3663
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3663

Gly Gly Ser Ile Ser Ser Gly Thr Tyr Tyr 
1               5                   10  


<210>  3664
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3664

Thr Tyr Tyr Gly Gly Ser Thr 
1               5           


<210>  3665
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3665

Ala Arg Arg Gly Asn Tyr Tyr Asp Ser Lys Asn Trp Phe Asp Pro 
1               5                   10                  15  


<210>  3666
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3666

Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  3667
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3667

Ile Ser Ser Ser Ser Ser Arg Lys 
1               5               


<210>  3668
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3668

Ala Lys Thr Gly Gly Ala Tyr Tyr Asp Tyr 
1               5                   10  


<210>  3669
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3669

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Phe 
1               5                   10  


<210>  3670
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3670

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3671
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3671

Ala Arg Gly Gly Ser Gly Ser Tyr Ser Leu Phe Asp Tyr 
1               5                   10              


<210>  3672
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3672

Gly Phe Thr Phe Ser Ser Ser Asp 
1               5               


<210>  3673
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3673

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  3674
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3674

Ala Arg Val Leu Tyr Asp Ser Ser Gly Phe Tyr Asn Trp Phe Asp Pro 
1               5                   10                  15      


<210>  3675
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3675

Gly Ser Thr Phe Ser Ser Ala Gly 
1               5               


<210>  3676
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3676

Ile Ser Val Ser Ser Thr Thr Ile 
1               5               


<210>  3677
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3677

Ala Arg Val Leu Tyr Asp Ser Ser Gly Phe Tyr Asn Trp Phe Asp Pro 
1               5                   10                  15      


<210>  3678
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3678

Gly Phe Thr Phe Asn Asn Tyr Ala 
1               5               


<210>  3679
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3679

Ile Gly Gly Ser Gly Gly Ser Thr 
1               5               


<210>  3680
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3680

Ala Arg Val Glu Gly Asp Trp Leu Leu Gly Gly Pro Tyr Tyr His Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  3681
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3681

Gly Leu Thr Leu Ser Arg Tyr Trp 
1               5               


<210>  3682
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3682

Ile Tyr Tyr Ser Arg Asn Ala 
1               5           


<210>  3683
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3683

Ala Gln Gly Arg Gly Gly Tyr Tyr Ser Pro Phe Asp Asp 
1               5                   10              


<210>  3684
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3684

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  3685
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3685

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3686
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3686

Ala Arg Ile Leu Val Ile Phe Thr Leu Asn Trp Phe Asp Pro 
1               5                   10                  


<210>  3687
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3687

Gly Ala Ser Phe Ser Asp Tyr Phe 
1               5               


<210>  3688
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3688

Ile Arg Gln Ile Gly Thr Thr 
1               5           


<210>  3689
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3689

Ala Gly Gly Asp Ser Arg Val Trp Glu Ala Leu Val Ala 
1               5                   10              


<210>  3690
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3690

Gly Phe Thr Phe Ser Ile Tyr Trp 
1               5               


<210>  3691
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3691

Ile Lys Gln Asp Ala Ser Glu Lys 
1               5               


<210>  3692
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3692

Ala Arg Leu Gly Gly Ser Ser Trp His Phe Asp Tyr 
1               5                   10          


<210>  3693
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3693

Gly Phe Thr Phe Ser Ser Asn Asp 
1               5               


<210>  3694
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3694

Ile Gly Asn Ala Gly Asp Thr 
1               5           


<210>  3695
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3695

Ala Arg Asn Thr Ala Gly Ser Gln Asn Trp His Phe Asp Leu 
1               5                   10                  


<210>  3696
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3696

Gly Gly Pro Ile Ser Ser Ser Arg Tyr Tyr 
1               5                   10  


<210>  3697
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3697

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3698
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3698

Ala Arg His Asp Gly Ser Gly Glu Met Asp Thr Ile Thr Trp Gly Pro 
1               5                   10                  15      


Ile Tyr Tyr Tyr Met Asp Val 
            20              


<210>  3699
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3699

Gly Phe Thr Phe Asp Asn Tyr Ala 
1               5               


<210>  3700
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3700

Ile Ser Gly Ser Gly Asp Asn Thr 
1               5               


<210>  3701
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3701

Ala Lys Val Ala Tyr Ser Gly Ser Asn Ser Val Val Tyr Tyr Tyr Tyr 
1               5                   10                  15      


Met Asp Val 
            


<210>  3702
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3702

Gly Phe Ser Val Ser Thr Ser Gly Glu Gly 
1               5                   10  


<210>  3703
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3703

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3704
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3704

Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile 
1               5                   10          


<210>  3705
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3705

Gly Phe Asn Phe Arg Asp Tyr Ala 
1               5               


<210>  3706
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3706

Ile Arg Ser Glu Pro Tyr Arg Ala Thr Thr 
1               5                   10  


<210>  3707
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3707

Ala Arg Thr Glu Arg Cys Gly Ala Asp Cys Thr Ser His Ile Asn Tyr 
1               5                   10                  15      


Tyr Leu Asp Val 
            20  


<210>  3708
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3708

Gly Phe Thr Phe Asp Asn Tyr Ala 
1               5               


<210>  3709
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3709

Ile Ser Gly Ser Gly Asp Asn Thr 
1               5               


<210>  3710
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3710

Ala Lys Val Ala Tyr Ser Gly Ser Asn Ser Val Val Tyr Tyr Tyr Tyr 
1               5                   10                  15      


Met Asp Val 
            


<210>  3711
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3711

Gly Tyr Thr Phe Thr Ser Tyr Gly 
1               5               


<210>  3712
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3712

Ile Asn Val Gly Asn Gly Asn Thr 
1               5               


<210>  3713
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3713

Ala Met Gly Pro Ser Ala Phe Ser Trp Leu Asp Pro 
1               5                   10          


<210>  3714
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3714

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3715
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3715

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3716
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3716

Ala Arg Ser Thr Ser Gly Ser Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  3717
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3717

Gly Phe Ser Leu Asn Thr Ser Gly Val Gly 
1               5                   10  


<210>  3718
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3718

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3719
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3719

Ala His Arg Pro Pro Ser Tyr His Gly Trp Cys Tyr Phe Asp Tyr 
1               5                   10                  15  


<210>  3720
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3720

Gly Tyr Thr Phe Lys Asn Tyr Gly 
1               5               


<210>  3721
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3721

Ile Ser Ala Tyr Thr Gly Asn Thr 
1               5               


<210>  3722
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3722

Ala Arg Val Gln Arg Arg Arg Leu Asp Tyr 
1               5                   10  


<210>  3723
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3723

Gly Phe Thr Phe Ser Thr Tyr Trp 
1               5               


<210>  3724
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3724

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  3725
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3725

Ala Arg Asp Pro Tyr Asp Ser Thr Gly Tyr Gly Ala Phe Asp Ile 
1               5                   10                  15  


<210>  3726
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3726

Gly Phe Ser Leu Ser Thr Phe Gly Val Gly 
1               5                   10  


<210>  3727
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3727

Ile Tyr Trp Asp Asp Asp Glu 
1               5           


<210>  3728
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3728

Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
1               5                   10                  15  


<210>  3729
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3729

Gly Gly Ser Phe Ser Gly His Tyr 
1               5               


<210>  3730
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3730

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  3731
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3731

Ala Arg Pro Pro Gln Ala Ala Arg Ile His Tyr Tyr Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  3732
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3732

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  3733
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3733

Val Ser Gly Gly Gly Asn Thr 
1               5           


<210>  3734
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3734

Ala Arg Ser Pro Trp Gly Ser Gly Gly His 
1               5                   10  


<210>  3735
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3735

Gly Phe Ser Leu Asp Thr Tyr Gly Met Gly 
1               5                   10  


<210>  3736
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3736

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3737
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3737

Val Arg Arg Tyr Tyr Asp Ser Ser Ser Asp Glu Gly His Gly Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  3738
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3738

Gly Phe Asn Phe Asp Ala His Ala 
1               5               


<210>  3739
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3739

Ile Ser Gly Ser Ser Asp Tyr Lys 
1               5               


<210>  3740
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3740

Ala Lys Gly Val Asp Gln Gly Gly Val Ile Ala Tyr Phe Gln His 
1               5                   10                  15  


<210>  3741
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3741

Gly Phe Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  3742
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3742

Ile Ala Gly Gly Asp Gly Ser Thr 
1               5               


<210>  3743
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3743

Ala Lys Gly Ile Thr His Asp Asp Gly Gly Pro Asp His 
1               5                   10              


<210>  3744
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3744

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  3745
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3745

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3746
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3746

Ala Arg Arg Phe Tyr Gly Pro Ser Ser Phe Asp Tyr 
1               5                   10          


<210>  3747
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3747

Gly Tyr Asn Phe Asn Asn Asn Tyr 
1               5               


<210>  3748
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3748

Val Asn Pro Thr Gly Gly Gly Thr 
1               5               


<210>  3749
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3749

Ala Arg Gly Gly Glu Trp Arg Ile Val Pro Gly Gly Arg Asp Tyr Phe 
1               5                   10                  15      


Asp Tyr 
        


<210>  3750
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3750

Gly Tyr Asn Phe Thr Asn Tyr Trp 
1               5               


<210>  3751
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3751

Ile Tyr Pro Gly Asp Ser Glu Thr 
1               5               


<210>  3752
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3752

Ala Arg Leu Gly Val Ser Lys Tyr Cys Ser Gly Gly Arg Cys Leu Ser 
1               5                   10                  15      


Gly Gly Ser Asn Trp Phe Asp Pro 
            20                  


<210>  3753
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3753

Gly Phe Thr Val Ser Ser Asn Phe 
1               5               


<210>  3754
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3754

Ile His Asn Gly Gly Asp Ser 
1               5           


<210>  3755
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3755

Ala Ser Ser Ser Trp Leu Arg Gly Ala Phe Asp Ile 
1               5                   10          


<210>  3756

<400>  3756
000

<210>  3757

<400>  3757
000

<210>  3758

<400>  3758
000

<210>  3759
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3759

Gly Phe Thr Phe Arg Ala Tyr Ala 
1               5               


<210>  3760
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3760

Ile Ser Gly Ser Ser Asp Tyr Arg 
1               5               


<210>  3761
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3761

Ala Arg Gly Ile Asp Tyr Gly Gly Ile Leu Ala Tyr Phe Asp Ser 
1               5                   10                  15  


<210>  3762
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3762

Gly Phe Thr Phe Gly Asp Tyr Thr 
1               5               


<210>  3763
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3763

Ile Arg Ser Lys Ala Tyr Gly Gly Thr Thr 
1               5                   10  


<210>  3764
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3764

Ser Arg Val Arg Gly Ser Phe Tyr Gly Ser Val Gly Lys Asn Tyr Gly 
1               5                   10                  15      


Met Asp Val 
            


<210>  3765
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3765

Gly Phe Ser Phe Ser Ser Tyr Val 
1               5               


<210>  3766
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3766

Ile Ser Tyr Asp Gly Ser Ser Lys 
1               5               


<210>  3767
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3767

Ala Arg Asp Ile Asp Ser Gly Tyr Asp Pro Thr Pro Val Phe Asp Tyr 
1               5                   10                  15      


<210>  3768
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3768

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  3769
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3769

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3770
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3770

Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
1               5                   10                  15  


<210>  3771
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3771

Gly Phe Ser Leu Ser Thr Tyr Trp 
1               5               


<210>  3772
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3772

Ile Ser Met His Gly Asn His Ile 
1               5               


<210>  3773
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3773

Val Arg Asp Gly Gly Ser Asp Thr His Asp Trp Phe Phe Asp Leu 
1               5                   10                  15  


<210>  3774
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3774

Gly Phe Thr Phe Arg Asn Tyr Ala 
1               5               


<210>  3775
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3775

Ile Ser Gly Ser Gly Gly Thr Thr 
1               5               


<210>  3776
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3776

Ala Lys Asn Glu Arg Ile Thr Met Leu Val Val Val Thr Leu Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  3777
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3777

Gly Tyr Thr Phe Thr Ser Tyr Gly 
1               5               


<210>  3778
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3778

Ile Ser Ala Tyr Asn Gly Lys Thr 
1               5               


<210>  3779
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3779

Thr Thr Arg Asp Gly Arg Tyr 
1               5           


<210>  3780
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3780

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  3781
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3781

Ile Thr Gly Ser Gly Asp Thr Thr 
1               5               


<210>  3782
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3782

Ala Lys Thr Pro Gly Gly Ser Ser Phe Phe Leu Thr Tyr Cys Phe Asp 
1               5                   10                  15      


Ser 
    


<210>  3783
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3783

Gly Tyr Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  3784
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3784

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  3785
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3785

Ala Arg Asp Val Asp Ile Ser Ser Ser Trp Tyr Pro Gly Tyr Tyr Tyr 
1               5                   10                  15      


Gly Met Asp Val 
            20  


<210>  3786
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3786

Gly Leu Thr Leu Ser Arg Tyr Trp 
1               5               


<210>  3787
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3787

Ile Lys Glu Asp Gly Ser Glu Ile 
1               5               


<210>  3788
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3788

Ala Arg Gly Pro Tyr 
1               5   


<210>  3789
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3789

Gly Gly Ser Ile Ser Arg Tyr Ser 
1               5               


<210>  3790
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3790

Ile Tyr Thr Ser Gly Arg Thr 
1               5           


<210>  3791
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3791

Ala Arg Gly Arg Asp Tyr Tyr Asp Ser Ser Gly Ala Tyr Tyr Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  3792
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3792

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3793
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3793

Ile Ile Pro Ile Phe Gly Ala Ala 
1               5               


<210>  3794
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3794

Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr 
1               5                   10                  15  


<210>  3795
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3795

Gly Tyr Ser Phe Thr Thr Tyr Trp 
1               5               


<210>  3796
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3796

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3797
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3797

Ala Arg Arg Arg Gly Gly Ile Gly Ile Glu Tyr Gly Met Asp Val 
1               5                   10                  15  


<210>  3798
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3798

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3799
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3799

Ile Ser Tyr Asp Gly Ser Glu Lys 
1               5               


<210>  3800
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3800

Ala Lys Asp Phe Gly Gly Asp Asn Thr Ala Met Val Glu Tyr Phe Phe 
1               5                   10                  15      


Asp Phe 
        


<210>  3801
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3801

Gly Gly Ser Val Ser Ser Gly Ser Tyr Tyr 
1               5                   10  


<210>  3802
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3802

Ile Tyr Tyr Ser Gly Ser Ser 
1               5           


<210>  3803
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3803

Ala Gly Ser Pro Val Pro Pro Thr Ile Val Gly Ala Ser Tyr 
1               5                   10                  


<210>  3804
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3804

Gly Phe Thr Phe Ser Asn Tyr Gly 
1               5               


<210>  3805
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3805

Ile Ser Tyr Asp Gly Thr Asn Lys 
1               5               


<210>  3806
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3806

Ala Lys Gly Arg Gly Asn Tyr Leu Thr Phe Phe Asp Ser 
1               5                   10              


<210>  3807
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3807

Gly Phe Ser Phe Ser Ser Tyr Gly 
1               5               


<210>  3808
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3808

Met Asp Gly Ser Ala Gly Asn Ile 
1               5               


<210>  3809
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3809

Ala Lys Asp Ser Gly Ala Leu Cys Ser Gly Gly Asp Cys Leu Arg Gly 
1               5                   10                  15      


Tyr Phe Asp Leu 
            20  


<210>  3810
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3810

Gly Phe Ile Phe Ser Ser Tyr Ala 
1               5               


<210>  3811
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3811

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3812
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3812

Ala Arg Ser Pro Pro Ala Ser Tyr Tyr Asn Pro Ser Thr Gly Tyr Phe 
1               5                   10                  15      


Asp Tyr 
        


<210>  3813
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3813

Gly Tyr Thr Phe Thr Ser His Tyr 
1               5               


<210>  3814
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3814

Ile Asn Pro Ser Gly Gly Ser Thr 
1               5               


<210>  3815
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3815

Ala Arg Asp Val Phe Trp Val Pro Ala Ala Ser Ser Phe Asp Tyr 
1               5                   10                  15  


<210>  3816
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3816

Gly Phe Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  3817
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3817

Ile Ser Ala Thr Gly Gly Ser Thr 
1               5               


<210>  3818
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3818

Ala Lys Pro Tyr Gly Met Asp Val 
1               5               


<210>  3819
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3819

Gly Phe Pro Phe Ser Ala Phe Tyr 
1               5               


<210>  3820
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3820

Ile Thr Gly Asp Gly Val Val 
1               5           


<210>  3821
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3821

Ala Arg Gly Asn Tyr Gly Ile Asp Phe 
1               5                   


<210>  3822
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3822

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  3823
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3823

Ile Ser Trp Asn Ser Gly Ile Ile 
1               5               


<210>  3824
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3824

Thr Lys Asp Ile Pro Ala Thr Gly Arg Phe Thr Ala Phe Asp Ile 
1               5                   10                  15  


<210>  3825
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3825

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3826
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3826

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3827
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3827

Ala Arg Asp Gln Glu Trp Phe Arg Glu Leu Phe Leu Phe Asp Tyr 
1               5                   10                  15  


<210>  3828
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3828

Gly Tyr Thr Phe Asp Asn Tyr Gly 
1               5               


<210>  3829
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3829

Ile Ser Ala Tyr Asn Gly Asp Thr 
1               5               


<210>  3830
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3830

Ala Arg Ser Ala His Cys Thr Gly Gly Val Cys Tyr His Leu Pro Val 
1               5                   10                  15      


Asp Asn 
        


<210>  3831
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3831

Gly Gly Ser Met Ser Gly Phe Phe 
1               5               


<210>  3832
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3832

Phe Tyr Ser Ser Ala Lys Thr 
1               5           


<210>  3833
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3833

Ala Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg 
1               5                   10                  15      


Tyr Pro Arg Pro Asp Ile Phe Asp Met 
            20                  25  


<210>  3834
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3834

Gly Tyr Thr Phe Pro Ser Tyr Ser 
1               5               


<210>  3835
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3835

Val Ser Ala Tyr Asn Gly Tyr Thr 
1               5               


<210>  3836
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3836

Ala Arg Arg Tyr Cys Ser Gly Gly Ile Ala Lys Cys Gly Phe His Pro 
1               5                   10                  15      


<210>  3837
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3837

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  3838
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3838

Met Asn Ser Asn Ser Gly Asn Ala 
1               5               


<210>  3839
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3839

Ala Arg Met Arg Thr Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
1               5                   10                  15      


<210>  3840
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3840

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  3841
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3841

Ile Asn His Ser Gly Ser Ser 
1               5           


<210>  3842
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3842

Ala Arg Gly Trp Gly Trp Gly Ala Val Ala Gly Arg Ala Glu Tyr Tyr 
1               5                   10                  15      


Phe Asp Tyr 
            


<210>  3843
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3843

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3844
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3844

Ile Ser Tyr Asp Gly Tyr Asn Lys 
1               5               


<210>  3845
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3845

Ala Arg Ala Gln Gly Gly Asn Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  3846
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3846

Gly Gly Ser Ile Ser Ser Gly Ser Tyr Tyr 
1               5                   10  


<210>  3847
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3847

Ile Tyr Ser Ser Gly Ser Thr 
1               5           


<210>  3848
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3848

Ala Arg Gly Ala Ala Ser Phe Asp Tyr 
1               5                   


<210>  3849
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3849

Gly Tyr Thr Phe Asp Asn Tyr Gly 
1               5               


<210>  3850
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3850

Ile Ser Ala Tyr Asn Gly Asp Thr 
1               5               


<210>  3851
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3851

Ala Arg Ser Ala His Cys Thr Gly Gly Val Cys Tyr His Leu Pro Val 
1               5                   10                  15      


Asp Asn 
        


<210>  3852
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3852

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  3853
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3853

Ile Thr Gly Ser Gly Asp Thr Thr 
1               5               


<210>  3854
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3854

Ala Arg Glu Ser Thr Gln 
1               5       


<210>  3855
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3855

Gly Tyr Thr Phe Thr Thr His Trp 
1               5               


<210>  3856
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3856

Ile Asn Pro Asn Ser Gly Asp Arg 
1               5               


<210>  3857
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3857

Ala Arg Asp Val Ser Ser Gln Asn Arg Ala Trp Trp Leu Asp Pro 
1               5                   10                  15  


<210>  3858
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3858

Gly Tyr Thr Phe Thr Ser Tyr Gly 
1               5               


<210>  3859
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3859

Ile Ser Ala Tyr Asn Gly Asn Thr 
1               5               


<210>  3860
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3860

Ala Arg Asp Gly Glu Glu Arg Ala Asn Val Asn Val Pro Met Ile Tyr 
1               5                   10                  15      


Gly Met Asp Val 
            20  


<210>  3861
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3861

Gly Gly Ser Ile Ser Ser Ser Ser Asn Tyr 
1               5                   10  


<210>  3862
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3862

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3863
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3863

Ala Arg Asp Pro Arg Val Val Val Thr Ala Arg Met Tyr Asn Trp Phe 
1               5                   10                  15      


Asp Pro 
        


<210>  3864
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3864

Gly Gly Ser Leu Ser Ser Tyr Tyr 
1               5               


<210>  3865
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3865

Ile Tyr Asp Ser Gly Gly Ala Ser Arg Ser Thr 
1               5                   10      


<210>  3866
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3866

Ala Arg Asp Gln Arg Gln Phe Gln Leu Leu Gly Arg Phe Gly Trp Phe 
1               5                   10                  15      


Asp Pro 
        


<210>  3867
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3867

Gly Phe Ile Phe Ser Asp His Tyr 
1               5               


<210>  3868
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3868

Thr Lys Asn Lys Gly Gln Ser Tyr Thr Ala 
1               5                   10  


<210>  3869
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3869

Val Leu Gly His Ser Val Glu Thr Thr Val Ala Arg Asp Tyr 
1               5                   10                  


<210>  3870
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3870

Gly Phe Ser Leu Thr Thr Asn Gly Met Cys 
1               5                   10  


<210>  3871
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3871

Ile Asp Trp Asp Asp Glu Lys 
1               5           


<210>  3872
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3872

Ala Arg Met Thr Ala Ala Ala Thr Ala Asp Ala Phe Asp Val 
1               5                   10                  


<210>  3873
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3873

Gly Gly Ser Ile Ser Ser Thr Thr Tyr Tyr 
1               5                   10  


<210>  3874
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3874

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3875
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3875

Ala Arg Gln Trp Lys Trp Phe Gly Glu Ala Trp Tyr Phe Asp Leu 
1               5                   10                  15  


<210>  3876
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3876

Gly Tyr Thr Phe Ser Asn Tyr His 
1               5               


<210>  3877
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3877

Ile Asp Pro Ser Gly His Ser Pro 
1               5               


<210>  3878
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3878

Ala Ser Asp Asn Ile Ala Val Ile Thr Gly Val Gly Tyr 
1               5                   10              


<210>  3879
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3879

Gly Phe Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  3880
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3880

Ile Ser Ala Thr Gly Gly Ser Thr 
1               5               


<210>  3881
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3881

Ala Lys Val Gly Tyr Thr Ile Ser Arg Gln Trp Leu Val Gly Glu Phe 
1               5                   10                  15      


Asp Tyr 
        


<210>  3882
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3882

Gly Phe Ser Phe Asn Ser Tyr Trp 
1               5               


<210>  3883
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3883

Ile Glu Gln Asn Gly Asn Ala Ile 
1               5               


<210>  3884
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3884

Thr Asn Gly Ile Tyr Ser Ser Ser Trp 
1               5                   


<210>  3885
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3885

Gly Gly Ser Phe Ser Ser Tyr His 
1               5               


<210>  3886
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3886

Ile Asp His Ser Gly Arg Pro 
1               5           


<210>  3887
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3887

Ala Thr Gly Val Ser Arg Val Trp Glu Ala Leu Val Glu 
1               5                   10              


<210>  3888
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3888

Gly Gly Ser Phe Ser Gly His Tyr 
1               5               


<210>  3889
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3889

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  3890
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3890

Ala Gly Glu Glu Val Arg Gly Val Lys Leu Tyr Tyr Tyr Tyr Ala Met 
1               5                   10                  15      


Asp Val 
        


<210>  3891
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3891

Gly Leu Ser Pro Val Asp His Ala 
1               5               


<210>  3892
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3892

Ile Tyr Gly Asn Leu Ala Arg Ile 
1               5               


<210>  3893
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3893

Ile Lys Asp Thr Ser Pro Gly Gly Leu Asp Tyr 
1               5                   10      


<210>  3894
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3894

Gly Gly Ser Ile Ser Ser Asp Ser His Tyr 
1               5                   10  


<210>  3895
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3895

Thr His Asp Ser Gly Asn Thr 
1               5           


<210>  3896
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3896

Ala Arg Val Lys Lys Val Asn Arg Asp Met Val Arg Glu Gly Phe Asp 
1               5                   10                  15      


Asn 
    


<210>  3897
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3897

Gly Tyr Thr Phe Thr Thr Tyr Ala 
1               5               


<210>  3898
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3898

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  3899
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3899

Ala Arg Asp Gln Asp Ser Gly Tyr Pro Thr Tyr Tyr Tyr Tyr Tyr Met 
1               5                   10                  15      


Asp Val 
        


<210>  3900
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3900

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  3901
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3901

Met Asn Pro Asn Ser Gly Asn Thr 
1               5               


<210>  3902
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3902

Ala Arg Gly Gly Ile Tyr Tyr Leu Val Arg Gly Phe Ile Ile Gly Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  3903
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3903

Gly Phe Ile Phe Ser Asn Ala Trp 
1               5               


<210>  3904
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3904

Ile Lys Ser Lys Ser Glu Gly Gly Thr Pro 
1               5                   10  


<210>  3905
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3905

Thr Thr Gly Gly Tyr Ser Ser Tyr Ala Ala Ser Asp Tyr 
1               5                   10              


<210>  3906
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3906

Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  3907
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3907

Ile Ser Ser Arg Ser Ser Thr Ile 
1               5               


<210>  3908
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3908

Ala Arg Val Asp Tyr Tyr Gly Ser Gly Ser Val Tyr Trp Tyr Phe Asp 
1               5                   10                  15      


Leu 
    


<210>  3909
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3909

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  3910
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3910

Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210>  3911
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3911

Ala Lys Val Gly Trp Glu Leu Ser Ile Asp Ala Phe Asp Leu 
1               5                   10                  


<210>  3912
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3912

Gly Phe Ser Val Ser Thr Ser Gly Glu Gly 
1               5                   10  


<210>  3913
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3913

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  3914
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3914

Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile 
1               5                   10          


<210>  3915
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3915

Gly Tyr Ser Phe Thr Thr Tyr Trp 
1               5               


<210>  3916
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3916

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3917
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3917

Ala Arg Tyr Trp Phe Gly Asp Pro Tyr Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  3918
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3918

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  3919
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3919

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  3920
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3920

Ala Arg Ile Gln Tyr Gln Leu Asn Gly Met Asp Val 
1               5                   10          


<210>  3921
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3921

Gly Tyr Thr Phe Ser Ser Tyr Asp 
1               5               


<210>  3922
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3922

Val Asn Pro Asn Ser Gly His Thr 
1               5               


<210>  3923
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3923

Ala Arg Gly Arg Val Gly Tyr Val Gly Ser Gly Ser Arg Gly Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Asp Met Asp Val 
            20              


<210>  3924
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3924

Gly Phe Thr Phe Gly Asp Tyr Lys 
1               5               


<210>  3925
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3925

Ile Arg Ser Arg Ala Asn Gly Glu Ser Thr 
1               5                   10  


<210>  3926
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3926

Thr Arg Asp Pro Thr Leu Trp Pro 
1               5               


<210>  3927
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3927

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  3928
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3928

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  3929
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3929

Ala Arg Asp Leu Phe Ser Gly Gly Ala Tyr 
1               5                   10  


<210>  3930
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3930

Gly Phe Thr Phe Ser Ser Tyr Glu 
1               5               


<210>  3931
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3931

Ile Ser Tyr Asp Gly Ile Asn Lys 
1               5               


<210>  3932
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3932

Ala Arg Glu Gly Gln Gly Thr Tyr Leu Asp Tyr 
1               5                   10      


<210>  3933
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3933

Gly Phe Ser Phe Asn Ser Ala Trp 
1               5               


<210>  3934
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3934

Ile Lys Ala Asp Gly Gly Asp Ser 
1               5               


<210>  3935
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3935

Ala Val Trp Gly Asp Thr Trp Gly Leu Asp Tyr 
1               5                   10      


<210>  3936
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3936

Gly Phe Thr Phe Gly Asp Tyr Lys 
1               5               


<210>  3937
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3937

Ile Arg Ser Arg Ala Asn Gly Glu Ser Thr 
1               5                   10  


<210>  3938
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3938

Thr Arg Asp Pro Thr Leu Trp Pro 
1               5               


<210>  3939
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3939

Gly Gly Ser Ile Ser Ser Ser Ser His Tyr 
1               5                   10  


<210>  3940
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3940

Ile Ser Tyr Arg Gly Thr Thr 
1               5           


<210>  3941
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3941

Ala Arg Tyr Thr Thr Met Val Gly Glu Phe Asp Ser 
1               5                   10          


<210>  3942
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3942

Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  3943
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3943

Ile Ser Ser Ser Ser Ser Arg Lys 
1               5               


<210>  3944
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3944

Ala Lys Thr Gly Gly Ala Tyr Tyr Asp Tyr 
1               5                   10  


<210>  3945
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3945

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3946
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3946

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3947
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3947

Ala Arg Gly Ser Ala Gly Asn Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  3948
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3948

Gly Phe Thr Phe Thr Ser Ser Ala 
1               5               


<210>  3949
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3949

Ile Val Val Gly Ser Gly Asn Thr 
1               5               


<210>  3950
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3950

Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Arg Met Asp Val 
            20          


<210>  3951
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3951

Gly Phe Ser Leu Ser Thr Phe Gly Val Gly 
1               5                   10  


<210>  3952
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3952

Ile Tyr Trp Asp Asp Asp Glu 
1               5           


<210>  3953
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3953

Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
1               5                   10                  15  


<210>  3954
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3954

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3955
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3955

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3956
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3956

Ala Arg Ser Tyr Gly Gly Ala Tyr Gly Gly Asn Ser Asp Tyr 
1               5                   10                  


<210>  3957
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3957

Gly Phe Thr Phe Ser Arg Phe Gly 
1               5               


<210>  3958
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3958

Ile Ser Phe Asp Gly Arg Asn Lys 
1               5               


<210>  3959
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3959

Ala Arg Glu Tyr His Asp Gly Ala Asn Trp Ser Gly Ala Phe Asp Val 
1               5                   10                  15      


<210>  3960
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3960

Gly Phe Thr Phe Asp Asn Tyr Ala 
1               5               


<210>  3961
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3961

Ile Ser Gly Ser Gly Asp Asn Thr 
1               5               


<210>  3962
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3962

Ala Lys Val Ala Tyr Ser Gly Ser Asn Ser Val Val Tyr Tyr Tyr Tyr 
1               5                   10                  15      


Met Asp Val 
            


<210>  3963
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3963

Gly Gly Pro Ile Ser Ser Ser Arg Tyr Tyr 
1               5                   10  


<210>  3964
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3964

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  3965
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3965

Ala Arg His Asp Gly Ser Gly Glu Met Asp Thr Ile Thr Trp Gly Pro 
1               5                   10                  15      


Ile Tyr Tyr Tyr Met Asp Val 
            20              


<210>  3966
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3966

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  3967
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3967

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  3968
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3968

Ala Lys Gly Val Thr Glu Gly Ser Trp Ser Phe Asp Ser 
1               5                   10              


<210>  3969
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3969

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  3970
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3970

Ile Ile Pro Ile Phe Gly Ala Ala 
1               5               


<210>  3971
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3971

Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
1               5                   10                  15      


<210>  3972
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3972

Gly Gly Ala Ile Ser Ser Asn Asn Cys 
1               5                   


<210>  3973
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3973

Ile Tyr Pro Ser Gly Thr Thr 
1               5           


<210>  3974
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3974

Ala Arg Leu Val Gly Ala Thr Ala Glu Asp Phe 
1               5                   10      


<210>  3975
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3975

Gly Phe Ser Phe Ser Ser Tyr Gly 
1               5               


<210>  3976
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3976

Ile Gly Gly Ser Gly Gly Ser Thr 
1               5               


<210>  3977
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3977

Ala Arg Val Glu Gly Asp Trp Leu Leu Gly Gly Pro Tyr Tyr His Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  3978
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3978

Gly Tyr Thr Leu Thr Glu Leu Ser 
1               5               


<210>  3979
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3979

Phe Asp Pro Glu Asp Ala Glu Thr 
1               5               


<210>  3980
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3980

Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro 
1               5                   10                  


<210>  3981
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3981

Gly Phe Ser Phe Gly Asp Tyr Ala 
1               5               


<210>  3982
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3982

Ile Ser Gly Ser Ser Asp Tyr Lys 
1               5               


<210>  3983
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3983

Ala Arg Ile Val Asp His Gly Ala Gln Gly Ala Tyr Phe Asp His 
1               5                   10                  15  


<210>  3984
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3984

Gly Tyr Ser Phe Ser Asp Tyr Trp 
1               5               


<210>  3985
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3985

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  3986
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3986

Ala Arg Leu Thr Phe Gly Gly Ser Gly Ser Tyr Tyr Phe Tyr Tyr Asn 
1               5                   10                  15      


Gly Met Asp Val 
            20  


<210>  3987
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3987

Gly Phe Ile Phe Asp Asp Tyr Asp 
1               5               


<210>  3988
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3988

Ile Asn Trp Asn Gly Gly Ser Thr 
1               5               


<210>  3989
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3989

Ala Val Ile Met Ser Pro Ile Pro Arg Tyr Ser Gly Tyr Asp Trp Ala 
1               5                   10                  15      


Gly Asp Ala Phe Asp Ile 
            20          


<210>  3990
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3990

Gly Phe Ala Val Leu Lys Ala Arg Met Gly 
1               5                   10  


<210>  3991
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3991

Thr Phe Ser Gly Asp Glu Glu 
1               5           


<210>  3992
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3992

Ala Arg Val Lys Thr Tyr Tyr Thr Ser Thr Arg Arg Ile Leu Trp Phe 
1               5                   10                  15      


Asp Pro 
        


<210>  3993
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3993

Gly Phe Ala Phe Ser Asn Tyr Ala 
1               5               


<210>  3994
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3994

Ile Ser Tyr Asp Gly Ile Asn Lys 
1               5               


<210>  3995
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3995

Ala Arg Asp Gln Glu Trp Phe Arg Glu Leu Phe Leu Phe Asp Tyr 
1               5                   10                  15  


<210>  3996
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3996

Gly Phe Thr Phe Ser Ser Tyr Asp 
1               5               


<210>  3997
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3997

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  3998
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3998

Ala Arg Ala Asp Pro Tyr Gln Leu Leu Gly Gln His Tyr Tyr Tyr Gly 
1               5                   10                  15      


Met Asp Val 
            


<210>  3999
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3999

Glu Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  4000
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4000

Ile Lys Gln Asp Gly Ser Gln Lys 
1               5               


<210>  4001
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4001

Ala Ser Arg Leu Cys Ser Ser Ser Gly Cys Tyr Ala Ala Ser Tyr His 
1               5                   10                  15      


Tyr Met Asp Val 
            20  


<210>  4002
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4002

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  4003
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4003

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4004
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4004

Ala Arg Arg Gly Glu Ala Ala Gly Ile Trp Tyr Phe Asp Leu 
1               5                   10                  


<210>  4005
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4005

Gly Asp Ser Leu Thr Arg Leu Ala 
1               5               


<210>  4006
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4006

Ile Lys Pro Asn Thr Gly Glu Ala 
1               5               


<210>  4007
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4007

Ala Arg Gly His Tyr Asp Gly Leu 
1               5               


<210>  4008
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4008

Gly Phe Ser Leu Ser Thr Phe Gly Val Gly 
1               5                   10  


<210>  4009
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4009

Ile Tyr Trp Asp Asp Asp Glu 
1               5           


<210>  4010
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4010

Ala His Arg Lys Lys Ala Ser Ser Gly Trp Gln Thr Phe Asp Tyr 
1               5                   10                  15  


<210>  4011
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4011

Gly Phe Thr Phe Ser Ser Tyr Asp 
1               5               


<210>  4012
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4012

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  4013
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4013

Ala Arg Arg Phe Trp Ser Gly Tyr Tyr Gly Met Asp Val 
1               5                   10              


<210>  4014
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4014

Gly Phe Ser Phe Asn Asn Tyr Gly 
1               5               


<210>  4015
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4015

Ile Ser Tyr Glu Gly Ser Lys Thr 
1               5               


<210>  4016
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4016

Ala Lys Ser His Lys Leu Phe Trp Phe Gly Gln Phe Lys Met Asp Ala 
1               5                   10                  15      


Leu Asp Ile 
            


<210>  4017
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4017

Gly Phe Thr Phe Ser Ala Tyr Glu 
1               5               


<210>  4018
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4018

Ile Thr Thr Ser Gly Asn Asn Ile 
1               5               


<210>  4019
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4019

Ala Lys Thr Gly Gln Val Glu Trp Leu Val Asp Asn Tyr Asn Tyr Tyr 
1               5                   10                  15      


Met Asp Val 
            


<210>  4020
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4020

Gly Phe Asn Phe Arg Asp Tyr Ala 
1               5               


<210>  4021
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4021

Ile Arg Ser Glu Pro Tyr Arg Ala Thr Thr 
1               5                   10  


<210>  4022
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4022

Ala Arg Thr Glu Arg Cys Gly Ala Asp Cys Thr Ser His Ile Asn Tyr 
1               5                   10                  15      


Tyr Leu Asp Val 
            20  


<210>  4023
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4023

Gly Phe Thr Phe Ser Asn Tyr Gly 
1               5               


<210>  4024
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4024

Ile Ser Asn Asp Glu Phe Asn Lys 
1               5               


<210>  4025
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4025

Ala Lys Gly Gly Asp Gly Ser Gly Trp Ala Trp Asp Gly Asp Asn Pro 
1               5                   10                  15      


Pro Thr Asp Tyr 
            20  


<210>  4026
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4026

Gly Asp Ser Val Ser Gly Asn Ser His Phe 
1               5                   10  


<210>  4027
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4027

Ile Tyr Asn Ser Val Ser Thr 
1               5           


<210>  4028
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4028

Ala Gly Gly Phe Asp Asp Ala Trp Glu Pro Gln Val Tyr 
1               5                   10              


<210>  4029
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4029

Gly Gly Ser Ile Gly Asn Tyr Tyr 
1               5               


<210>  4030
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4030

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4031
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4031

Ala Arg Gly Pro Tyr Phe Ser Ser Leu Val Phe Gly Pro 
1               5                   10              


<210>  4032
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4032

Gly Ala Ala Ile Ser Asp Gly Ser Tyr His 
1               5                   10  


<210>  4033
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4033

Val Tyr Asn Asn Gly Val Thr 
1               5           


<210>  4034
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4034

Ala Arg Glu Arg Leu Ala Ile Phe Gly Glu Val Leu Lys Asp Ser Tyr 
1               5                   10                  15      


Tyr Met Asp Val 
            20  


<210>  4035
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4035

Gly Phe Ser Leu Ser Asn Ala Lys Met Gly 
1               5                   10  


<210>  4036
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4036

Ile Phe Ser Asn Asp Glu Lys 
1               5           


<210>  4037
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4037

Ala Arg Ile Val Leu Gly Ala Ser Gly Thr Tyr Pro Ser Pro Gly Phe 
1               5                   10                  15      


Asp Pro 
        


<210>  4038
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4038

Gly Phe Thr Phe Ser Ala His Ala 
1               5               


<210>  4039
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4039

Ile Ser Tyr Asp Gly Arg His Lys 
1               5               


<210>  4040
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4040

Ala Arg Asp Leu Thr Leu Tyr Ser Ser Asp Tyr Tyr Trp Gly Tyr Phe 
1               5                   10                  15      


Asp Ser 
        


<210>  4041
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4041

Gly Phe Thr Phe Ser Ile Tyr Gly 
1               5               


<210>  4042
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4042

Ile Ser Phe Asp Gly Ser Asn Lys 
1               5               


<210>  4043
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4043

Ala Lys Asp Gly Ser Gly Ser Tyr Tyr Gly Trp Phe Asp Pro 
1               5                   10                  


<210>  4044
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4044

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4045
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4045

Ile Ile Pro Ile Phe Gly Thr Ala 
1               5               


<210>  4046
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4046

Ala Arg Ser Cys Gly Asp Cys Tyr Ser Ala Asp Leu Asp Phe 
1               5                   10                  


<210>  4047
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4047

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  4048
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4048

Met Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4049
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4049

Ala Arg Leu Leu Trp Leu Arg Gly His Phe Asp Tyr 
1               5                   10          


<210>  4050
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4050

Gly Phe Ile Phe Asp Asp Tyr Asp 
1               5               


<210>  4051
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4051

Ile Ser Trp Asn Gly Gly Asn Thr 
1               5               


<210>  4052
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4052

Ala Val Ile Met Ser Pro Ile Pro Arg Tyr Ser Gly Tyr Asp Trp Ala 
1               5                   10                  15      


Gly Gly Ala Phe Asp Ile 
            20          


<210>  4053
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4053

Gly Phe Thr Phe Ser Ser Asn Asp 
1               5               


<210>  4054
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4054

Ile Gly Asn Ala Gly Asp Thr 
1               5           


<210>  4055
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4055

Ala Arg Asn Thr Ala Gly Ser Gln Asn Trp His Phe Asp Leu 
1               5                   10                  


<210>  4056
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4056

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  4057
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4057

Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210>  4058
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4058

Ala Lys Val Gly Trp Glu Leu Ser Ile Asp Ala Phe Asp Leu 
1               5                   10                  


<210>  4059
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4059

Gly Phe Thr Phe Ser Phe Tyr Ala 
1               5               


<210>  4060
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4060

Ile Ser Ser Asp Gly Thr Tyr Lys 
1               5               


<210>  4061
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4061

Ala Arg Ala Leu Asn Lys Gly Phe Asp Pro 
1               5                   10  


<210>  4062
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4062

Gly Tyr Thr Phe Ile Ser Tyr Gly 
1               5               


<210>  4063
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4063

Ile Ser Pro Tyr Ser Ser Asn Thr 
1               5               


<210>  4064
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4064

Ala Arg Asp Leu Ala Arg Tyr Cys Arg Ser Ala Ser Cys Ser Asn Lys 
1               5                   10                  15      


Gly Val Asp Tyr 
            20  


<210>  4065
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4065

Gly Phe Asn Phe Ser Ser Tyr Trp 
1               5               


<210>  4066
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4066

Ile Asn Gly Asp Gly Ser Ser Thr 
1               5               


<210>  4067
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4067

Ala Arg Ala Arg Ala Val Thr Gly Thr Gly Gly Ile Gly Tyr 
1               5                   10                  


<210>  4068
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4068

Gly Phe Thr Phe Thr Ser Ser Ala 
1               5               


<210>  4069
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4069

Ile Val Val Gly Ser Gly Asn Thr 
1               5               


<210>  4070
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4070

Ala Ala Pro His Cys Asn Arg Thr Ser Cys Tyr Asp Ala Phe Asp Leu 
1               5                   10                  15      


<210>  4071
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4071

Gly Tyr Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  4072
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4072

Ile Asn Pro Ser Gly Gly Ser Thr 
1               5               


<210>  4073
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4073

Ala Arg Asp Arg Leu Gly Asp Gly Ser Tyr Leu Gly Gly Gly Tyr Tyr 
1               5                   10                  15      


Gly Met Asp Val 
            20  


<210>  4074
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4074

Gly Tyr Thr Phe Thr Thr Tyr Ala 
1               5               


<210>  4075
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4075

Ile Asp Pro Ser Gly His Ser Pro 
1               5               


<210>  4076
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4076

Ala Ala Pro His Cys Asn Arg Thr Ser Cys Tyr Asp Ala Phe Asp Leu 
1               5                   10                  15      


<210>  4077
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4077

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  4078
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4078

Ile Ser Tyr Asp Gly Arg Asn Lys 
1               5               


<210>  4079
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4079

Ala Lys Glu Gly Glu Trp Glu Leu Arg Gly Asn Ala Leu Asp Ile 
1               5                   10                  15  


<210>  4080
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4080

Gly Phe Ser Leu Ser Asn Ala Arg Met Ser 
1               5                   10  


<210>  4081
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4081

Ile Phe Ser Asn Asp Glu Lys 
1               5           


<210>  4082
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4082

Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr 
1               5                   10              


<210>  4083
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4083

Gly Phe Thr Phe Met Ser Ser Ala 
1               5               


<210>  4084
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4084

Ile Val Ile Gly Ser Gly Asn Thr 
1               5               


<210>  4085
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4085

Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
1               5                   10                  15      


<210>  4086
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4086

Gly Ala Ser Phe Ser Asn Tyr Tyr 
1               5               


<210>  4087
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4087

Ile Asn His Ser Glu Asn Thr 
1               5           


<210>  4088
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4088

Ala Arg Leu Arg Tyr Ser Ser Ser Gly Gly His Ile Phe Asp Tyr 
1               5                   10                  15  


<210>  4089
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4089

Gly Gly Ser Val Ser Ser Gly Ala Tyr Tyr 
1               5                   10  


<210>  4090
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4090

Ile Tyr Thr Ser Gly Thr Thr 
1               5           


<210>  4091
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4091

Ala Arg Ala Arg Ser Ser Met Asp Asn Phe Tyr Tyr Phe Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  4092
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4092

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4093
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4093

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4094
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4094

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4095
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4095

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4096
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4096

Ile Ile Pro Ile Phe Gly Thr Ala 
1               5               


<210>  4097
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4097

Ala Arg Gly Leu Thr Gly Ser Ser Ala Tyr Lys Asp Glu Ile Tyr Phe 
1               5                   10                  15      


Asp Tyr 
        


<210>  4098
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4098

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  4099
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4099

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4100
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4100

Ala Arg Asp Gly Gly Asn Ala Tyr Ser Ser Gly Trp Tyr Arg Tyr Tyr 
1               5                   10                  15      


Tyr His Met Asp Val 
            20      


<210>  4101
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4101

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  4102
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4102

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4103
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4103

Ala His Arg Leu Pro Thr Pro Gln Leu Leu Pro Ser Phe Glu Asn Trp 
1               5                   10                  15      


Phe Asp Pro 
            


<210>  4104
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4104

Gly Phe Thr Phe Ser Ser Tyr Asp 
1               5               


<210>  4105
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4105

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  4106
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4106

Ala Arg Val Leu Tyr Asp Ser Ser Gly Phe Tyr Asn Trp Phe Asp Pro 
1               5                   10                  15      


<210>  4107
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4107

Gly Phe Thr Phe Met Ser Ser Ala 
1               5               


<210>  4108
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4108

Ile Val Ile Gly Ser Gly Asn Thr 
1               5               


<210>  4109
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4109

Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
1               5                   10                  15      


<210>  4110
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4110

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  4111
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4111

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  4112
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4112

Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr 
1               5                   10          


<210>  4113
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4113

Gly Tyr Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  4114
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4114

Ile Asn Pro Ser Ala Gly Ser Thr 
1               5               


<210>  4115
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4115

Ala Arg Gly Phe His Val Pro Ala Ala Leu Arg Asn Trp Phe Asp Pro 
1               5                   10                  15      


<210>  4116
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4116

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4117
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4117

Ile Tyr Pro Gly Gly Ser Ala 
1               5           


<210>  4118
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4118

Ala Arg Ser Tyr Asp Ile Leu Thr Gly Tyr Arg Asp Ala Phe Asp Ile 
1               5                   10                  15      


<210>  4119
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4119

Gly Phe Thr Phe Ser Ser Phe Ala 
1               5               


<210>  4120
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4120

Ile Lys Glu Asp Gly Arg Glu Lys 
1               5               


<210>  4121
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4121

Ala Arg Asp Leu Val Thr Tyr Gly Leu Asp Val 
1               5                   10      


<210>  4122
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4122

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4123
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4123

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4124
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4124

Ala His Arg Leu Pro Thr Pro Gln Leu Leu Pro Ser Phe Glu Asn Trp 
1               5                   10                  15      


Phe Asp Pro 
            


<210>  4125
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4125

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4126
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4126

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4127
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4127

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4128
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4128

Gly Phe Ile Phe Ser Ser Tyr Trp 
1               5               


<210>  4129
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4129

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  4130
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4130

Ala Arg Val Asn Asp Gly Arg Pro Asn Pro Leu Glu Tyr Tyr Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  4131
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4131

Gly Phe Thr Phe Ser Asn Tyr Ala 
1               5               


<210>  4132
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4132

Ile Asn Ala Gly Ala Asp Tyr Arg 
1               5               


<210>  4133
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4133

Ala Arg Asp Asn Trp Asp Val Gly Gly Met Asp Val 
1               5                   10          


<210>  4134
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4134

Gly Asp Ser Ile Ser Ser Gly Arg Tyr Tyr 
1               5                   10  


<210>  4135
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4135

Val Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4136
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4136

Ala Arg Glu Thr Tyr Ser Ala Tyr Glu Met Pro Pro Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4137
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4137

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  4138
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4138

Ile Gln Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4139
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4139

Ala Arg Asp Leu Ile Ile Glu Ser Thr Ile Ala Ala Arg Pro Gly Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4140
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4140

Gly Asp Thr Phe Ser Ser Tyr Thr 
1               5               


<210>  4141
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4141

Ile Ile Pro Ile Leu Gly Ile Pro 
1               5               


<210>  4142
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4142

Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
1               5                   10                  15      


Ala 
    


<210>  4143
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4143

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4144
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4144

Met Lys Ser Asn Ser Gly Asn Thr 
1               5               


<210>  4145
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4145

Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Leu 
1               5                   10                  15      


<210>  4146
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4146

Gly Phe Ser Leu Ser Asn Ala Arg Met Ser 
1               5                   10  


<210>  4147
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4147

Ile Phe Ser Asn Asp Glu Lys 
1               5           


<210>  4148
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4148

Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr 
1               5                   10              


<210>  4149
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4149

Gly Tyr Thr Phe Thr Asn Tyr Leu 
1               5               


<210>  4150
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4150

Val Asn Pro Ser Arg Gly Thr Ala 
1               5               


<210>  4151
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4151

Ala Arg Glu Arg Ser Gly Thr Tyr Phe Phe Asp Tyr 
1               5                   10          


<210>  4152
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4152

Gly Ala Ser Ile Ser Ser Ser Asn Tyr Tyr 
1               5                   10  


<210>  4153
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4153

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4154
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4154

Ala Arg Arg His His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe Ala 
1               5                   10                  15      


Tyr 
    


<210>  4155
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4155

Gly Gly Ser Leu Ser Leu Tyr Tyr 
1               5               


<210>  4156
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4156

Ile Tyr Tyr Thr Gly Ser Thr 
1               5           


<210>  4157
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4157

Ala Arg Ile Pro Thr Gly Phe Pro Arg Cys Tyr Met Asp Val 
1               5                   10                  


<210>  4158
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4158

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  4159
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4159

Ile Tyr Tyr Thr Gly Ser Thr 
1               5           


<210>  4160
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4160

Ala Ala Pro Tyr Cys Ser Arg Ile Ser Cys Asn Asp Gly Phe Asp Ile 
1               5                   10                  15      


<210>  4161
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4161

Gly Asp Ser Ile Ser Ser Gly Arg Tyr Tyr 
1               5                   10  


<210>  4162
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4162

Val Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4163
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4163

Ala Arg Asp Phe Leu Arg Trp His Asp Leu 
1               5                   10  


<210>  4164
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4164

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4165
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4165

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4166
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4166

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4167
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4167

Gly Phe Ser Leu Thr Thr Ser Gly Met Cys 
1               5                   10  


<210>  4168
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4168

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4169
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4169

Ala Arg Glu Thr Pro Val Thr Ala Ile Asp Tyr 
1               5                   10      


<210>  4170
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4170

Gly Phe Thr Phe Met Ser Ser Ala 
1               5               


<210>  4171
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4171

Ile Val Ile Gly Ser Gly Asn Thr 
1               5               


<210>  4172
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4172

Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
1               5                   10                  15      


<210>  4173
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4173

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4174
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4174

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4175
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4175

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4176
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4176

Gly Gly Ser Met Ser Gly Phe Phe 
1               5               


<210>  4177
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4177

Phe Tyr Ser Ser Ala Lys Thr 
1               5           


<210>  4178
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4178

Ala Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg 
1               5                   10                  15      


Tyr Pro Arg Pro Asp Ile Phe Asp Met 
            20                  25  


<210>  4179
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4179

Gly Phe Thr Phe Ser Ser Phe Ala 
1               5               


<210>  4180
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4180

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4181
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4181

Ala Arg Glu Leu Met Ser Val Gly 
1               5               


<210>  4182
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4182

Gly Ile Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4183
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4183

Ile Tyr Ala Gly Gly Ser Thr 
1               5           


<210>  4184
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4184

Ala Arg Asp Ala Leu Tyr Tyr Asn Gly Pro Gly Arg Asp Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  4185
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4185

Gly Ile Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4186
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4186

Ile Tyr Ala Gly Gly Ser Thr 
1               5           


<210>  4187
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4187

Ala Arg Asp Ala Leu Tyr Tyr Asn Gly Pro Gly Arg Asp Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  4188
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4188

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  4189
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4189

Ile Ser Ser Asp Gly Ser Asn Lys 
1               5               


<210>  4190
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4190

Ala Lys Asp Met Val Glu Pro Leu Phe Ser His Tyr Tyr Tyr Tyr Gly 
1               5                   10                  15      


Met Asp Val 
            


<210>  4191
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4191

Gly Phe Ser Leu Ser Asn Ala Arg Met Ser 
1               5                   10  


<210>  4192
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4192

Ile Phe Ser Asn Asp Glu Lys 
1               5           


<210>  4193
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4193

Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr 
1               5                   10              


<210>  4194
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4194

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  4195
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4195

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4196
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4196

Ala Arg Ala Pro Arg Glu Arg Leu Gln Trp Gly Glu Tyr Tyr Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  4197
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4197

Gly Phe Thr Phe Arg Ser Tyr Asp 
1               5               


<210>  4198
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4198

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  4199
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4199

Ala Arg Val Phe Glu Thr Lys Val Ile Arg Gly Gly Arg Tyr Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Met Asp Val 
            20          


<210>  4200
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4200

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  4201
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4201

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4202
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4202

Ala Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210>  4203
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4203

Gly Asp Ser Ile Ser Ser Ala Gly Tyr Tyr 
1               5                   10  


<210>  4204
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4204

Ile Tyr Tyr Ser Gly Arg Thr 
1               5           


<210>  4205
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4205

Ala Arg Val Val Pro Thr Arg Gly Pro Val Ala Trp Phe Asp Pro 
1               5                   10                  15  


<210>  4206
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4206

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  4207
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4207

Ile Trp Tyr Asp Gly Ser Lys Lys 
1               5               


<210>  4208
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4208

Ala Arg Asp Gln Ser Gln Gly Ala Tyr Ile Leu Thr Gly Tyr Arg Gly 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4209
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4209

Gly Gly Thr Ser Ser Ser Tyr Ala 
1               5               


<210>  4210
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4210

Ile Ile Pro Ile Leu Gly Val Ala 
1               5               


<210>  4211
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4211

Thr Thr Thr Gln Gly Gly Asp Tyr Gly Asp Asn Leu Tyr Tyr Leu Asp 
1               5                   10                  15      


Tyr 
    


<210>  4212
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4212

Gly Val Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4213
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4213

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  4214
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4214

Ala Arg Gly Pro Glu Pro Asp Ala Phe Asp Ile 
1               5                   10      


<210>  4215
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4215

Gly Phe Arg Phe Ser Arg Ser Trp 
1               5               


<210>  4216
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4216

Ile Asn Ser Asp Gly Ser Ile Ile 
1               5               


<210>  4217
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4217

Ala Ser Pro Thr Ser Val Thr Val Val Gly Gln Pro Asp Val 
1               5                   10                  


<210>  4218
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4218

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  4219
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4219

Ile Tyr Tyr Thr Gly Ser Ser 
1               5           


<210>  4220
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4220

Ala Arg Leu Arg Trp Leu Arg Gly Gly Ile Asp Phe 
1               5                   10          


<210>  4221
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4221

Gly Tyr Thr Phe Ala Ser Leu Asp 
1               5               


<210>  4222
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4222

Met Thr Pro Arg Asn Gly Asn Thr 
1               5               


<210>  4223
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4223

Ala Arg Gly Val Ala Ala Gly Val Asp Tyr 
1               5                   10  


<210>  4224

<400>  4224
000

<210>  4225

<400>  4225
000

<210>  4226

<400>  4226
000

<210>  4227
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4227

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4228
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4228

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4229
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4229

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  4230
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4230

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4231
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4231

Met Lys Ser Asn Ser Gly Asn Thr 
1               5               


<210>  4232
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4232

Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Leu 
1               5                   10                  15      


<210>  4233
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4233

Gly Gly Thr Phe Ser Ser Tyr Thr 
1               5               


<210>  4234
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4234

Ile Ile Pro Ile Leu Ala Val Ala 
1               5               


<210>  4235
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4235

Ala Arg Asp His Ser Gly Tyr Tyr Asp Ser Thr Ser Leu Met Ser Pro 
1               5                   10                  15      


Phe Phe Asp Tyr 
            20  


<210>  4236
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4236

Gly Phe Ser Leu Arg Thr Cys Gly Val Gly 
1               5                   10  


<210>  4237
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4237

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4238
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4238

Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu Ile 
1               5                   10                  15      


Asp Ala Phe Asp Ile 
            20      


<210>  4239
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4239

Gly Phe Ser Leu Ser Thr Ser Gly Leu Cys 
1               5                   10  


<210>  4240
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4240

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4241
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4241

Ala Arg Ala Thr Thr Ile Phe Tyr Gly Met Asp Val 
1               5                   10          


<210>  4242
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4242

Gly Tyr Thr Phe Thr Ser His Tyr 
1               5               


<210>  4243
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4243

Ile Asn Pro Ser Gly Gly Ser Thr 
1               5               


<210>  4244
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4244

Ala Arg Asp Leu Ala Gly Val Pro Ala Ala Leu Gly Cys Trp Phe Asp 
1               5                   10                  15      


Pro 
    


<210>  4245
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4245

Gly Gly Ser Val Ser Ser Asp Asp Phe Ser Ser Gly Asp Asn Tyr 
1               5                   10                  15  


<210>  4246
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4246

Ile Tyr Tyr Ser Gly Leu Thr 
1               5           


<210>  4247
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4247

Ala Ser Glu His Lys Thr His Tyr Tyr Asp Ser Ser Gly Tyr Tyr Ser 
1               5                   10                  15      


Asn Trp Phe Asp Pro 
            20      


<210>  4248
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4248

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4249
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4249

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4250
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4250

Ala Lys Asp Gly Ser Ile Ala Ala Ala Asp Tyr 
1               5                   10      


<210>  4251
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4251

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4252
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4252

Ile Ser Tyr Asp Gly Gly Asn Lys 
1               5               


<210>  4253
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4253

Ala Lys Asn Leu Gly Pro Tyr Cys Ser Gly Gly Thr Cys Tyr Ser Leu 
1               5                   10                  15      


Val Gly Asp Tyr 
            20  


<210>  4254
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4254

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  4255
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4255

Ile Tyr Tyr Ser Gly Ile Thr 
1               5           


<210>  4256
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4256

Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Cys Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  4257
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4257

Gly Phe Thr Phe Ser Tyr Tyr Pro 
1               5               


<210>  4258
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4258

Thr Ser Tyr Asp Gly Thr Asn Lys 
1               5               


<210>  4259
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4259

Ala Arg Gly Gly Ala Thr Asn Phe Asp Tyr 
1               5                   10  


<210>  4260
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4260

Gly Phe Thr Phe Ser Ser Tyr Asp 
1               5               


<210>  4261
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4261

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  4262
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4262

Ala Arg Ala Arg Gly Gly Tyr Asn Trp Asn Phe Asp Tyr 
1               5                   10              


<210>  4263
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4263

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4264
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4264

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4265
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4265

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4266
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4266

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4267
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4267

Ile Ser Tyr Asp Gly Ser Tyr Lys 
1               5               


<210>  4268
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4268

Ala Arg Asp Gln Gly Thr Val Val Thr His Phe Asp Tyr 
1               5                   10              


<210>  4269
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4269

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4270
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4270

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4271
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4271

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  4272
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4272

Gly Tyr Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  4273
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4273

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  4274
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4274

Ala Arg Asp Leu Asp Phe Tyr Gly Phe Asp Val 
1               5                   10      


<210>  4275
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4275

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  4276
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4276

Ile Tyr Tyr Ser Gly Ile Thr 
1               5           


<210>  4277
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4277

Ala Arg Arg His His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe Ala 
1               5                   10                  15      


Tyr 
    


<210>  4278
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4278

Gly Phe Thr Phe Ser Asn Tyr Gly 
1               5               


<210>  4279
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4279

Met Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4280
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4280

Ala Lys Asn Leu Gly Pro Tyr Cys Ser Gly Gly Thr Cys Tyr Ser Leu 
1               5                   10                  15      


Val Gly Asp Tyr 
            20  


<210>  4281
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4281

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4282
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4282

Met Ser Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4283
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4283

Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp His 
1               5                   10                  15      


<210>  4284
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4284

Gly Asp Thr Phe Ser Ser Tyr Thr 
1               5               


<210>  4285
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4285

Ile Ile Pro Ile Leu Gly Ile Pro 
1               5               


<210>  4286
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4286

Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  4287
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4287

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4288
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4288

Ile Ser Tyr Asp Gly Thr Asn Lys 
1               5               


<210>  4289
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4289

Ala Arg Asp Pro Ser Met Tyr Ser Ser Ser Trp Tyr Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4290
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4290

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  4291
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4291

Ile Ser Gly Asp Gly Gly Asn Thr 
1               5               


<210>  4292
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4292

Ala Lys Asp Glu Met Ala Tyr Pro Pro Ser His His Tyr Tyr Tyr Tyr 
1               5                   10                  15      


Tyr Met Asp Val 
            20  


<210>  4293
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4293

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4294
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4294

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4295
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4295

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  4296
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4296

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4297
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4297

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4298
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4298

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  4299
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4299

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  4300
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4300

Ile His Tyr Ser Gly Ser Thr 
1               5           


<210>  4301
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4301

Val Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val 
1               5                   10                  15      


Pro Trp Phe Asp Pro 
            20      


<210>  4302
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4302

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4303
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4303

Met Asn Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4304
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4304

Ala Arg Gly Pro Ser Ile Leu Thr Gly Phe Tyr Asn Pro Leu Asp Tyr 
1               5                   10                  15      


<210>  4305
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4305

Gly Gly Ser Ile Ser Ser Ser Asn Tyr Tyr 
1               5                   10  


<210>  4306
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4306

Ile His Tyr Ser Gly Ile Ser 
1               5           


<210>  4307
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4307

Ala Arg Arg Thr Tyr Tyr Asp Leu Trp Ser Ala Tyr Ser Ser Thr Ala 
1               5                   10                  15      


Tyr Tyr Cys Met Asp Val 
            20          


<210>  4308
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4308

Gly Gly Ser Met Ser Gly Phe Phe 
1               5               


<210>  4309
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4309

Phe Tyr Ser Ser Ala Lys Thr 
1               5           


<210>  4310
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4310

Ala Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg 
1               5                   10                  15      


Tyr Pro Arg Pro Asp Ile Phe Asp Met 
            20                  25  


<210>  4311
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4311

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4312
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4312

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4313
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4313

Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr 
1               5                   10          


<210>  4314
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4314

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  4315
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4315

Ile His Tyr Ser Gly Ser Thr 
1               5           


<210>  4316
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4316

Val Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val 
1               5                   10                  15      


Pro Trp Phe Asp Pro 
            20      


<210>  4317
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4317

Gly Gly Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  4318
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4318

Ile Ile Pro Ile Phe Gly Thr Ala 
1               5               


<210>  4319
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4319

Ala Arg Leu Ser Gly Ser Gly Trp Leu Gly Tyr Ala Met Asp Val 
1               5                   10                  15  


<210>  4320
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4320

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  4321
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4321

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4322
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4322

Ala Lys Asp Met Val Glu Pro Leu Phe Ser His Tyr Tyr Tyr Gly Met 
1               5                   10                  15      


Asp Val 
        


<210>  4323
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4323

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  4324
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4324

Ile His Tyr Ser Gly Ser Thr 
1               5           


<210>  4325
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4325

Val Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val 
1               5                   10                  15      


Pro Trp Phe Asp Pro 
            20      


<210>  4326
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4326

Gly Tyr Thr Phe Thr Gly Tyr Tyr 
1               5               


<210>  4327
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4327

Ile Asn Pro Asn Ser Gly Gly Thr 
1               5               


<210>  4328
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4328

Ala Arg Ala Leu Trp Phe Gly Glu Leu Ser Ser Asp Tyr 
1               5                   10              


<210>  4329
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4329

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4330
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4330

Ile Ser Asn Asp Gly Arg Asn Lys 
1               5               


<210>  4331
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4331

Ala Arg Pro Ser Asn Trp Tyr Phe Asp Leu 
1               5                   10  


<210>  4332
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4332

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4333
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4333

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4334
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4334

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4335
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4335

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4336
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4336

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4337
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4337

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4338
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4338

Gly Tyr Thr Phe Thr Asn Tyr Trp 
1               5               


<210>  4339
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4339

Ile Tyr Pro Asp Asp Ser Asp Thr 
1               5               


<210>  4340
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4340

Ala Arg Thr Pro Thr Leu Tyr Asn Trp Phe His Pro 
1               5                   10          


<210>  4341
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4341

Gly Phe Thr Phe Asp Asp Tyr Thr 
1               5               


<210>  4342
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4342

Ile Asp Trp Asn Gly Gly Thr Ile 
1               5               


<210>  4343
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4343

Ala Lys Ala Gly Tyr Tyr Ala Tyr Val Trp Gly Ser Tyr Arg Phe Glu 
1               5                   10                  15      


Tyr Phe Asp Asn 
            20  


<210>  4344
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4344

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4345
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4345

Thr Ser Arg Ala Ala Asp Gly Ile 
1               5               


<210>  4346
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4346

Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  4347
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4347

Gly Phe Ile Phe Ser Ser Tyr Ala 
1               5               


<210>  4348
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4348

Ile Ser Tyr Asp Gly Gly Asn Lys 
1               5               


<210>  4349
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4349

Ala Arg Asp Gln Gly Thr Val Val Thr His Phe Asp Tyr 
1               5                   10              


<210>  4350
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4350

Gly Val Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4351
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4351

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  4352
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4352

Ala Arg Gly Pro Glu Pro Asp Ala Phe Asp Ile 
1               5                   10      


<210>  4353
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4353

Gly Gly Ser Val Ser Ser Gly Ser Tyr Tyr 
1               5                   10  


<210>  4354
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4354

Ile Tyr Tyr Ser Gly Ser Ser 
1               5           


<210>  4355
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4355

Ala Gly Ser Pro Val Pro Pro Thr Ile Val Gly Ala Ser Tyr 
1               5                   10                  


<210>  4356
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4356

Gly Phe Ser Leu Ser Asn Ala Arg Met Ser 
1               5                   10  


<210>  4357
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4357

Ile Phe Ser Asn Asp Glu Lys 
1               5           


<210>  4358
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4358

Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr 
1               5                   10              


<210>  4359
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4359

Gly Phe Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  4360
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4360

Ile Ser Phe Asp Gly Ser Asn Lys 
1               5               


<210>  4361
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4361

Ala Arg Asp Leu Ser Thr Thr Trp Tyr Leu Glu Met Trp Gly Pro Asp 
1               5                   10                  15      


Ala Phe Asp Ile 
            20  


<210>  4362
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4362

Gly Phe Thr Leu Ser Arg Tyr Ser 
1               5               


<210>  4363
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4363

Thr Ser Arg Ala Ala Asp Gly Lys 
1               5               


<210>  4364
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4364

Ala Arg Asp Ser Gly Leu Ala Arg Ala Phe Ser Tyr Asp Tyr 
1               5                   10                  


<210>  4365
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4365

Gly Tyr Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  4366
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4366

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  4367
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4367

Ala Arg Gly Leu Ile Ser Leu Phe Arg Gly Ala Ile Phe His Tyr Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4368
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4368

Gly Gly Ser Ile Ile Asp His Tyr 
1               5               


<210>  4369
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4369

Ile Tyr Ser Thr Gly Arg Thr 
1               5           


<210>  4370
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4370

Ala Arg Thr Pro Pro Arg Gly Gly Phe Asp Val 
1               5                   10      


<210>  4371
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4371

Gly Phe Thr Phe Arg Arg Tyr Gly 
1               5               


<210>  4372
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4372

Ile Ser Tyr Asp Gly Thr Asp Lys 
1               5               


<210>  4373
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4373

Ala Lys Lys Gly Gly Pro Tyr Cys Gly Gly Gly Asn Cys Tyr Ala Gly 
1               5                   10                  15      


Tyr Phe Asp Tyr 
            20  


<210>  4374
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4374

Gly Tyr Thr Phe Thr Asn Tyr Trp 
1               5               


<210>  4375
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4375

Ile Tyr Pro Asp Asp Ser Asp Thr 
1               5               


<210>  4376
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4376

Ala Arg Arg Asp Lys Val Gly Ala Leu Asp Ser 
1               5                   10      


<210>  4377
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4377

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4378
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4378

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4379
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4379

Ala Arg Asp Leu Asp Tyr Tyr Gly Leu Asp Val 
1               5                   10      


<210>  4380
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4380

Gly Gly Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  4381
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4381

Ile Ile Pro Ile Phe Gly Thr Ala 
1               5               


<210>  4382
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4382

Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  4383
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4383

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4384
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4384

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4385
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4385

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4386
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4386

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  4387
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4387

Ile His Tyr Ser Gly Ser Thr 
1               5           


<210>  4388
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4388

Val Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Gly 
1               5                   10                  15      


Pro Trp Phe Asp Pro 
            20      


<210>  4389
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4389

Gly Phe Thr Leu Ser Arg Tyr Ser 
1               5               


<210>  4390
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4390

Ile Tyr Ser Gly Gly Thr Thr 
1               5           


<210>  4391
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4391

Ala Arg Gly Gly Ser Ile Leu Trp Trp Leu Ile Asp Tyr 
1               5                   10              


<210>  4392
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4392

Gly Gly Ser Met Ser Gly Phe Phe 
1               5               


<210>  4393
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4393

Phe Tyr Ser Ser Ala Lys Thr 
1               5           


<210>  4394
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4394

Ala Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg 
1               5                   10                  15      


Tyr Pro Arg Pro Asn Ile Phe Asp Met 
            20                  25  


<210>  4395
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4395

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4396
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4396

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4397
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4397

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4398
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4398

Gly Gly Ser Phe Ser Ala Tyr Tyr 
1               5               


<210>  4399
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4399

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4400
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4400

Ala Arg Val Gly Tyr Ser Gln Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210>  4401
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4401

Gly Gly Ser Ile Ser Arg Tyr Tyr 
1               5               


<210>  4402
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4402

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4403
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4403

Ala Arg Tyr Gly Ile Gly Glu Trp Glu Leu Gln Tyr Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4404
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4404

Gly Phe Ile Phe Asp Asp Tyr Val 
1               5               


<210>  4405
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4405

Ile Thr Tyr Asn Gly Gly Ile Leu 
1               5               


<210>  4406
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4406

Ala Arg Asp Tyr Cys Ser Ser Thr Thr Cys Pro Ala Glu Thr Tyr Tyr 
1               5                   10                  15      


Tyr Met Asp Val 
            20  


<210>  4407
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4407

Glu Val Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4408
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4408

Ile Tyr Ser Gly Gly Thr Thr 
1               5           


<210>  4409
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4409

Ala Arg Asp Phe Leu Arg Trp His Asp Leu 
1               5                   10  


<210>  4410
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4410

Gly Phe Thr Phe Ser Ser Tyr Asp 
1               5               


<210>  4411
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4411

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  4412
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4412

Ala Arg Val Asp Phe Asp Ile Leu Thr Gly Tyr Tyr Ser Asn 
1               5                   10                  


<210>  4413
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4413

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4414
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4414

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4415
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4415

Ala Arg Ala Thr Thr Phe Phe Tyr Gly Met Asp Val 
1               5                   10          


<210>  4416
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4416

Gly Tyr Thr Phe Ala Ser Leu Asp 
1               5               


<210>  4417
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4417

Met Thr Pro Arg Asn Gly Asn Thr 
1               5               


<210>  4418
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4418

Ala Arg Gly Val Ala Ala Gly Val Asp Tyr 
1               5                   10  


<210>  4419
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4419

Gly Phe Thr Phe Ser Cys Cys Ala 
1               5               


<210>  4420
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4420

Ile His Asp Asp Gly Val Gly Thr 
1               5               


<210>  4421
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4421

Ala Lys Trp Ala Gly Pro Ile Val Met Lys Tyr Tyr Leu Gln Tyr 
1               5                   10                  15  


<210>  4422
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4422

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4423
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4423

Met Ser Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4424
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4424

Ala Arg Glu Thr Tyr Ser Ala Tyr Asp Met Pro Pro Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4425
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4425

Gly Phe Thr Phe Ser Ser Tyr Asp 
1               5               


<210>  4426
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4426

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  4427
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4427

Ala Arg Gly Gly Asp Ser Gly Tyr Asp Leu Gly Ala Trp Tyr Phe Asp 
1               5                   10                  15      


Leu 
    


<210>  4428
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4428

Gly Tyr Ser Phe Thr Asn Tyr Trp 
1               5               


<210>  4429
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4429

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4430
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4430

Ala Arg Thr Pro Thr Leu Tyr Asn Trp Phe His Pro 
1               5                   10          


<210>  4431
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4431

Gly Phe Ser Leu Ser Thr Ser Gly Leu Cys 
1               5                   10  


<210>  4432
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4432

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4433
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4433

Ala Arg Ala Thr Thr Phe Phe Tyr Gly Met Asp Val 
1               5                   10          


<210>  4434
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4434

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4435
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4435

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4436
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4436

Ala His Ala Gln Ser Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4437
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4437

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  4438
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4438

Ile Tyr Tyr Ser Gly Ile Thr 
1               5           


<210>  4439
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4439

Ala Arg His Gln Arg Tyr Cys Ser Ser Ser Ser Cys His Val Trp Asp 
1               5                   10                  15      


Tyr 
    


<210>  4440
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4440

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4441
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4441

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4442
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4442

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4443
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4443

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  4444
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4444

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  4445
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4445

Ala Arg Glu Val Val Gly Tyr Phe Asp Cys 
1               5                   10  


<210>  4446
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4446

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  4447
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4447

Ile Ser Trp Asn Ser Asp Ser Ile 
1               5               


<210>  4448
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4448

Ala Lys Gly Arg Gly Ala Gly Tyr Thr Ser Tyr Met Asp Val 
1               5                   10                  


<210>  4449
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4449

Gly Gly Ser Ile Ser Arg Tyr Tyr 
1               5               


<210>  4450
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4450

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  4451
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4451

Ala Arg Asp Leu Val Thr Tyr Gly Leu Asp Val 
1               5                   10      


<210>  4452
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4452

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4453
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4453

Ile Tyr Pro Gly Gly Ser Ala 
1               5           


<210>  4454
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4454

Ala Arg Ser Tyr Asp Ile Leu Thr Gly Tyr Arg Asp Ala Phe Asp Ile 
1               5                   10                  15      


<210>  4455
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4455

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4456
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4456

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4457
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4457

Ala Arg Asp Asp Asn Ser Pro Gln Gly Ser Gly Trp Tyr Phe Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Ala Met Asp Val 
            20          


<210>  4458
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4458

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4459
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4459

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4460
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4460

Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  4461
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4461

Gly Phe Ile Phe Ser Ser Tyr Ala 
1               5               


<210>  4462
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4462

Ile Ser Tyr Asp Gly Gly Asn Lys 
1               5               


<210>  4463
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4463

Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  4464
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4464

Gly Tyr Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  4465
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4465

Met Lys Ser Asn Ser Gly Asn Thr 
1               5               


<210>  4466
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4466

Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp His 
1               5                   10                  15      


<210>  4467
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4467

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  4468
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4468

Ile His Tyr Ser Gly Ser Thr 
1               5           


<210>  4469
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4469

Val Arg Asp Asn Tyr Phe Asp Asn Ser Gly Asn Pro Val Tyr Pro Val 
1               5                   10                  15      


Pro Trp Phe Asp Pro 
            20      


<210>  4470
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4470

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4471
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4471

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4472
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4472

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4473
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4473

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  4474
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4474

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  4475
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4475

Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr 
1               5                   10          


<210>  4476
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4476

Gly Phe Ser Leu Ser Asn Ala Arg Met Ser 
1               5                   10  


<210>  4477
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4477

Ile Phe Ser Asn Asp Glu Lys 
1               5           


<210>  4478
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4478

Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr 
1               5                   10              


<210>  4479
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4479

Gly Phe Thr Phe Ser Ser His Trp 
1               5               


<210>  4480
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4480

Ile Lys Glu Asp Gly Arg Glu Lys 
1               5               


<210>  4481
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4481

Ala Arg Val Val Val Glu Val Ala Thr Asn Lys Gly Ile His Gly Val 
1               5                   10                  15      


Asp Tyr Tyr Tyr Tyr Tyr Tyr Met Asp Val 
            20                  25      


<210>  4482
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4482

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4483
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4483

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4484
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4484

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  4485
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4485

Gly Tyr Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  4486
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4486

Ile Asn Pro Ser Ala Gly Ser Thr 
1               5               


<210>  4487
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4487

Ala Arg Asp Leu Val Thr Tyr Gly Leu Asp Val 
1               5                   10      


<210>  4488
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4488

Glu Val Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4489
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4489

Ile Tyr Ser Gly Gly Thr Thr 
1               5           


<210>  4490
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4490

Ala Arg His Gln Arg Tyr Cys Ser Ser Ser Ser Cys His Val Trp Asp 
1               5                   10                  15      


Tyr 
    


<210>  4491
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4491

Gly Leu Thr Val Arg Ser Asn Tyr 
1               5               


<210>  4492
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4492

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  4493
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4493

Ala Arg Asp Phe Leu Arg Trp His Asp Leu 
1               5                   10  


<210>  4494
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4494

Gly Asp Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  4495
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4495

Ile Asn Pro Ser Gly Gly Ser Arg 
1               5               


<210>  4496
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4496

Ala Arg Gly Tyr Gly Phe Val Pro Asn Val Leu Tyr Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4497
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4497

Gly Phe Ser Leu Ser Thr Ser Gly Leu Cys 
1               5                   10  


<210>  4498
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4498

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4499
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4499

Ala Arg Ala Thr Thr Phe Phe Tyr Val Met Asp Val 
1               5                   10          


<210>  4500
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4500

Gly Phe Thr Phe Arg Asp Tyr Ser 
1               5               


<210>  4501
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4501

Ile Ser Ser Gly Gly Ser Tyr Ile 
1               5               


<210>  4502
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4502

Ala Arg Gly Gly Ser Ile Leu Trp Trp Leu Ile Asp Tyr 
1               5                   10              


<210>  4503
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4503

Gly Asp Ser Ile Ser Ser Gly Arg Tyr Tyr 
1               5                   10  


<210>  4504
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4504

Val Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4505
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4505

Ala Arg Glu Thr Tyr Ser Ala Tyr Glu Met Pro Pro Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4506
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4506

Gly Phe Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  4507
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4507

Ile Ser Ile Ser Gly Gly Ser Thr 
1               5               


<210>  4508
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4508

Ala Lys Asp Ser Arg Ser Gly Ile Ala Gly Val Asp Ala Phe Asp Ile 
1               5                   10                  15      


<210>  4509
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4509

Gly Ala Ser Ile Ser Ser Ser Asn 
1               5               


<210>  4510
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4510

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4511
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4511

Ala Lys Asp Tyr Val Gly Ala Val Met Val Arg Gly Val Asn Tyr His 
1               5                   10                  15      


Tyr Tyr Gly Met Asp Val 
            20          


<210>  4512
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4512

Gly Leu Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4513
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4513

Ile Tyr Ala Gly Gly Asn Thr 
1               5           


<210>  4514
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4514

Ala Arg Gly Asp Gly Gly Tyr Tyr Ser Pro Phe Asp Tyr 
1               5                   10              


<210>  4515
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4515

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  4516
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4516

Ile Ser Ser Asp Gly Ser Asn Lys 
1               5               


<210>  4517
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4517

Ala Lys Asp Met Val Glu Pro Phe Phe Ser His Tyr Tyr Tyr Tyr Gly 
1               5                   10                  15      


Met Asp Val 
            


<210>  4518
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4518

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  4519
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4519

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4520
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4520

Ala His Arg Leu Pro Thr Pro Gln Leu Leu Pro Ser Phe Glu Asn Trp 
1               5                   10                  15      


Phe Asp Pro 
            


<210>  4521
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4521

Gly Leu Thr Val Gly Ser Asn Tyr 
1               5               


<210>  4522
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4522

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  4523
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4523

Ala Arg Glu Val Val Gly Tyr Phe Asp Cys 
1               5                   10  


<210>  4524
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4524

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4525
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4525

Ile Ser Asn Asp Gly Arg Asn Lys 
1               5               


<210>  4526
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4526

Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  4527
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4527

Gly Phe Thr Phe Met Ser Ser Ala 
1               5               


<210>  4528
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4528

Ile Val Ile Gly Ser Gly Asn Thr 
1               5               


<210>  4529
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4529

Ala Arg Glu Thr Tyr Ser Ala Tyr Glu Met Pro Pro Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4530

<400>  4530
000

<210>  4531

<400>  4531
000

<210>  4532

<400>  4532
000

<210>  4533
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4533

Gly Gly Ser Leu Ser Leu Tyr Tyr 
1               5               


<210>  4534
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4534

Ile Tyr Tyr Thr Gly Ser Thr 
1               5           


<210>  4535
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4535

Ala Arg Ile Pro Thr Gly Phe Pro Arg Cys Tyr Met Asp Val 
1               5                   10                  


<210>  4536
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4536

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4537
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4537

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4538
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4538

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4539
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4539

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  4540
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4540

Ile Tyr Tyr Thr Gly Ser Ser 
1               5           


<210>  4541
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4541

Ala Arg Leu Arg Trp Leu Arg Gly Gly Ile Asp Phe 
1               5                   10          


<210>  4542
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4542

Gly Asp Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  4543
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4543

Ile Asn Pro Ser Gly Gly Ser Arg 
1               5               


<210>  4544
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4544

Ala Arg Gly Tyr Gly Phe Val Pro Asn Val Leu Tyr Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4545
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4545

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4546
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4546

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4547
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4547

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4548
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4548

Gly Phe Ile Phe Ser Ser Tyr Ala 
1               5               


<210>  4549
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4549

Ile Ser Tyr Asp Gly Gly Asn Lys 
1               5               


<210>  4550
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4550

Ala Arg Ala Gln Gly Gly Asn Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  4551
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4551

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4552
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4552

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4553
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4553

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  4554
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4554

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Ser 
1               5                   10  


<210>  4555
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4555

Ile Tyr His Ser Gly Ser Thr 
1               5           


<210>  4556
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4556

Ala Arg Ser Gly Gly Val Lys Phe Asp Pro 
1               5                   10  


<210>  4557
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4557

Gly Phe Thr Leu Ser Arg Tyr Ser 
1               5               


<210>  4558
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4558

Thr Ser Arg Ala Ala Asp Gly Lys 
1               5               


<210>  4559
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4559

Ala Arg Asp Ser Gly Leu Ala Arg Ala Phe Ser Tyr Asp Tyr 
1               5                   10                  


<210>  4560
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4560

Gly Phe Thr Phe Ser Arg Tyr Ala 
1               5               


<210>  4561
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4561

Ile Ser Tyr Asp Gly Arg Asn Glu 
1               5               


<210>  4562
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4562

Ala Arg Asp Leu Ala Tyr His Pro Tyr Arg Asp Tyr Gly Asp Asp Asp 
1               5                   10                  15      


Tyr Tyr Tyr Tyr Tyr Gly Met Asp Val 
            20                  25  


<210>  4563
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4563

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4564
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4564

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4565
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4565

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4566
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4566

Gly Tyr Thr Phe Thr Asn Tyr Trp 
1               5               


<210>  4567
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4567

Ile Tyr Pro Asp Asp Ser Asp Thr 
1               5               


<210>  4568
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4568

Ala Arg Arg Asp Lys Val Gly Ala Leu Asp Ser 
1               5                   10      


<210>  4569
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4569

Gly Ala Ser Ile Ser Ser Ser Asn Tyr Tyr 
1               5                   10  


<210>  4570
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4570

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4571
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4571

Ala Arg Arg His His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe Ala 
1               5                   10                  15      


Tyr 
    


<210>  4572
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4572

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4573
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4573

Ile Ser Asn Asp Gly Arg Asn Lys 
1               5               


<210>  4574
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4574

Ala Arg Asp Gln Ser Gln Gly Ala Tyr Ile Leu Thr Gly Tyr Arg Gly 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4575
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4575

Gly Tyr Thr Phe Thr Ser Tyr Tyr 
1               5               


<210>  4576
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4576

Ile Asn Pro Gly Gly Gly Ser Thr 
1               5               


<210>  4577
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4577

Ala Arg Gly Ala Ile Pro Pro Asn Ser Arg Ala Glu Ile Asp Tyr 
1               5                   10                  15  


<210>  4578
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4578

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4579
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4579

Met Ser Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4580
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4580

Ala Arg Leu Ser Gly Ser Gly Trp Leu Gly Tyr Ala Met Asp Val 
1               5                   10                  15  


<210>  4581
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4581

Gly Tyr Thr Phe Ala Ser Leu Asp 
1               5               


<210>  4582
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4582

Met Asn Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4583
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4583

Ala Arg Gly Phe His Val Pro Ala Ala Leu Arg Asn Trp Phe Asp Pro 
1               5                   10                  15      


<210>  4584
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4584

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4585
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4585

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4586
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4586

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  4587
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4587

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  4588
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4588

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4589
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4589

Ala Arg Asp Leu His Gln Asp Trp Val Val Val Val Ala Ala Asn Val 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4590
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4590

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4591
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4591

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4592
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4592

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4593
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4593

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4594
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4594

Met Ser Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4595
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4595

Ala Arg Asp Phe Leu Arg Trp His Asp Leu 
1               5                   10  


<210>  4596
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4596

Gly Phe Ile Phe Ser Ser Tyr Trp 
1               5               


<210>  4597
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4597

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  4598
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4598

Ala Arg Asp Phe Leu Arg Trp His Asp Leu 
1               5                   10  


<210>  4599
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4599

Gly Gly Ser Val Ser Ser Arg Ser Tyr Tyr 
1               5                   10  


<210>  4600
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4600

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4601
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4601

Ala Arg His Thr Val Asp Cys Gly Gly Asp Cys Phe Pro Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  4602
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4602

Gly Gly Ser Val Ser Ser Arg Ser Tyr Tyr 
1               5                   10  


<210>  4603
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4603

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4604
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4604

Ala Arg His Thr Val Asp Cys Gly Gly Asp Cys Phe Pro Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  4605
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4605

Gly Tyr Thr Phe Thr Ser Tyr Tyr 
1               5               


<210>  4606
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4606

Ile Asn Pro Ser Gly Gly Ser Thr 
1               5               


<210>  4607
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4607

Ala Arg Glu Asn Asp Tyr Gly Asp Tyr Val Glu Pro Arg Asp Tyr Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4608
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4608

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Ser 
1               5                   10  


<210>  4609
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4609

Ile Tyr His Ser Gly Ser Thr 
1               5           


<210>  4610
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4610

Ala Arg Arg His His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe Ala 
1               5                   10                  15      


Tyr 
    


<210>  4611
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4611

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4612
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4612

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4613
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4613

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4614
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4614

Glu Tyr Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  4615
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4615

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  4616
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4616

Ala Arg Pro Gly Lys Ala Ala Ala Phe Asp Tyr 
1               5                   10      


<210>  4617
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4617

Gly Phe Thr Leu Ser Arg Tyr Ser 
1               5               


<210>  4618
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4618

Thr Ser Arg Ala Ala Asp Gly Lys 
1               5               


<210>  4619
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4619

Ala Arg Asp Ser Gly Leu Ala Arg Ala Phe Ser His Asp Tyr 
1               5                   10                  


<210>  4620
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4620

Gly Phe Ile Phe Ser Ser Tyr Ala 
1               5               


<210>  4621
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4621

Thr Ser Tyr Asp Gly Thr Asn Lys 
1               5               


<210>  4622
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4622

Ala Arg His Thr Val Asp Cys Gly Gly Asp Cys Phe Pro Asn Asp Ala 
1               5                   10                  15      


Phe Asp Ile 
            


<210>  4623
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4623

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  4624
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4624

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4625
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4625

Ala Lys Asp Gly Gly Asn Ala Tyr Ser Ser Gly Trp Tyr Arg Tyr Phe 
1               5                   10                  15      


Tyr His Met Asp Val 
            20      


<210>  4626
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4626

Gly Asp Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  4627
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4627

Ile Asn Pro Ser Gly Gly Ser Thr 
1               5               


<210>  4628
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4628

Ala Arg Gly Phe His Val Pro Ala Ala Leu Arg Asn Trp Phe Asp Pro 
1               5                   10                  15      


<210>  4629
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4629

Gly Phe Ser Leu Thr Thr Ser Gly Met Cys 
1               5                   10  


<210>  4630
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4630

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4631
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4631

Ala Arg Glu Thr Pro Val Thr Ala Ile Asp Tyr 
1               5                   10      


<210>  4632
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4632

Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210>  4633
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4633

Ile Trp Tyr Asp Gly Asn Lys Lys 
1               5               


<210>  4634
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4634

Ala Arg Glu Gly Pro Phe Gly Asp Arg Glu Ala Ser Gly Ala Phe Asp 
1               5                   10                  15      


Val 
    


<210>  4635
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4635

Gly Phe Thr Phe Ser Asp Tyr Tyr 
1               5               


<210>  4636
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4636

Ile Ser Ser Ser Gly Ile Thr Ile 
1               5               


<210>  4637
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4637

Thr Gly Val Val Ala Ala Pro Ala Glu Tyr Phe Gln His 
1               5                   10              


<210>  4638
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4638

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  4639
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4639

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4640
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4640

Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu Ile 
1               5                   10                  15      


Asp Ala Phe Asp Ile 
            20      


<210>  4641
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4641

Gly Phe Ser Leu Ser Thr Ser Gly Leu Cys 
1               5                   10  


<210>  4642
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4642

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4643
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4643

Ala Trp Ala Thr Thr Phe Phe Tyr Gly Met Asp Val 
1               5                   10          


<210>  4644
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4644

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  4645
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4645

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4646
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4646

Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu Ile 
1               5                   10                  15      


Asp Ala Phe Asp Ile 
            20      


<210>  4647
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4647

Gly Phe Ser Leu Thr Thr Ser Gly Met Cys 
1               5                   10  


<210>  4648
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4648

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4649
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4649

Ala Arg Glu Thr Pro Val Thr Ala Ile Asp Tyr 
1               5                   10      


<210>  4650
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4650

Gly Phe Thr Phe Ser Arg His Trp 
1               5               


<210>  4651
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4651

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  4652
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4652

Ala Arg Leu Gly Phe Tyr Tyr Gly Gly Ala Asp Tyr 
1               5                   10          


<210>  4653
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4653

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  4654
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4654

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4655
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4655

Ala Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Leu Asp Val 
1               5                   10                  15      


<210>  4656
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4656

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  4657
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4657

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4658
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4658

Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu Ile 
1               5                   10                  15      


Asp Ala Phe Asp Ile 
            20      


<210>  4659
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4659

Gly Ile Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4660
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4660

Ile Tyr Ala Gly Gly Ser Thr 
1               5           


<210>  4661
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4661

Ala Arg Asp Ala Leu Tyr Tyr Asn Gly Pro Gly Arg Asp Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  4662
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4662

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4663
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4663

Met Ser Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4664
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4664

Ala Arg Gly Val Ala Ala Gly Val Asp Tyr 
1               5                   10  


<210>  4665
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4665

Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210>  4666
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4666

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4667
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4667

Ala Lys Asp Gly Ser Ile Ala Ala Ala Asp Tyr 
1               5                   10      


<210>  4668
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4668

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  4669
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4669

Ile His Tyr Ser Gly Ser Thr 
1               5           


<210>  4670
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4670

Val Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val 
1               5                   10                  15      


Pro Trp Phe Asp Pro 
            20      


<210>  4671
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4671

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4672
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4672

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4673
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4673

Ala Ser Met Asn Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4674
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4674

Gly Gly Ser Val Ser Ser Gly Ala Tyr Tyr 
1               5                   10  


<210>  4675
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4675

Ile Tyr Thr Ser Gly Thr Thr 
1               5           


<210>  4676
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4676

Ala Arg Ala Arg Ser Ser Met Asp Asn Phe Tyr Tyr Phe Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  4677
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4677

Gly Tyr Thr Phe Thr Thr Tyr Tyr 
1               5               


<210>  4678
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4678

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  4679
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4679

Ala Arg Pro Gly Lys Ala Ala Ala Phe Asp Tyr 
1               5                   10      


<210>  4680
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4680

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4681
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4681

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4682
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4682

Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  4683
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4683

Gly Gly Ser Phe Ser Ala Tyr Tyr 
1               5               


<210>  4684
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4684

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4685
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4685

Ala Arg Val Gly Tyr Ser Gln Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210>  4686
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4686

Gly Gly Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  4687
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4687

Ile Ile Pro Ile Phe Gly Thr Ala 
1               5               


<210>  4688
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4688

Ala Ala Pro Tyr Cys Ser Ser Ile Ile Cys Asn Asp Gly Phe Asp Ile 
1               5                   10                  15      


<210>  4689
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4689

Gly Tyr Thr Phe Thr Ser Tyr Tyr 
1               5               


<210>  4690
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4690

Ile Asn Pro Ser Gly Gly Ser Thr 
1               5               


<210>  4691
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4691

Ala Arg Gly Ala Ala Val Pro Ala Ala Gly Glu Phe Asp Tyr 
1               5                   10                  


<210>  4692
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4692

Gly Gly Ser Phe Ser Ala Tyr Tyr 
1               5               


<210>  4693
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4693

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4694
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4694

Ala Arg Val Gly Tyr Ser Gln Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210>  4695
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4695

Gly Tyr Thr Phe Ala Ser Leu Asp 
1               5               


<210>  4696
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4696

Met Ser Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4697
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4697

Ala Arg Gly Val Ala Ala Gly Val Asp Tyr 
1               5                   10  


<210>  4698
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4698

Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210>  4699
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4699

Ile Ser Tyr Asp Gly Ile Asn Lys 
1               5               


<210>  4700
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4700

Ala Lys Gly Asp Gly Ser Tyr Leu Met Asp Tyr Phe Asp Tyr 
1               5                   10                  


<210>  4701
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4701

Gly Phe Thr Phe Ser Ser His Trp 
1               5               


<210>  4702
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4702

Ile Lys Glu Asp Gly Arg Glu Lys 
1               5               


<210>  4703
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4703

Ala Arg Leu Gly Phe Tyr Tyr Gly Gly Ala Asp Tyr 
1               5                   10          


<210>  4704
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4704

Gly Phe Thr Phe Ser Ser Phe Ala 
1               5               


<210>  4705
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4705

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4706
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4706

Ala Arg Glu Leu Met Ser Val Gly 
1               5               


<210>  4707
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4707

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4708
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4708

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4709
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4709

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4710
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4710

Gly Tyr Ser Phe Thr Ser Phe Gly 
1               5               


<210>  4711
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4711

Ile Ser Gly Tyr Asp Gly Asn Thr 
1               5               


<210>  4712
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4712

Ala Arg Arg Ile Arg Tyr Asn Asp Ser Gly Tyr Tyr His Tyr Tyr Met 
1               5                   10                  15      


Asp Ala 
        


<210>  4713
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4713

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  4714
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4714

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4715
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4715

Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu Ile 
1               5                   10                  15      


Asp Ala Phe Asp Ile 
            20      


<210>  4716
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4716

Gly Phe Ser Leu Ser Thr Ser Gly Leu Cys 
1               5                   10  


<210>  4717
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4717

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4718
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4718

Ala Arg Ala Thr Thr Phe Phe Tyr Gly Met Asp Val 
1               5                   10          


<210>  4719
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4719

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4720
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4720

Ile Tyr Pro Gly Gly Ser Ala 
1               5           


<210>  4721
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4721

Ala Arg Ser Tyr Asp Ile Leu Thr Gly Tyr Arg Asp Ala Phe Asp Ile 
1               5                   10                  15      


<210>  4722
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4722

Gly Phe Thr Leu Ser Arg Tyr Ser 
1               5               


<210>  4723
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4723

Thr Ser Arg Ala Ala Asp Gly Lys 
1               5               


<210>  4724
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4724

Ala Arg Asp Ser Gly Leu Ala Arg Ala Phe Ser Tyr Asp Tyr 
1               5                   10                  


<210>  4725
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4725

Gly Tyr Ser Phe Thr Ser Phe Gly 
1               5               


<210>  4726
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4726

Ile Ser Gly Tyr Asp Gly Asn Thr 
1               5               


<210>  4727
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4727

Ala Arg Arg Ile Arg Tyr Asn Asp Ser Gly Tyr Tyr His Tyr Tyr Met 
1               5                   10                  15      


Asp Ala 
        


<210>  4728
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4728

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  4729
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4729

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4730
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4730

Ala Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210>  4731
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4731

Gly Asp Ser Ile Ser Ser Gly Arg Tyr Tyr 
1               5                   10  


<210>  4732
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4732

Val Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4733
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4733

Ala Arg Glu Thr Tyr Ser Ala Tyr Glu Met Pro Pro Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  4734
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4734

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  4735
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4735

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4736
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4736

Ala Arg Leu Gly Ser Glu Ser Lys Ile Asp Tyr Tyr Tyr Tyr Gly Met 
1               5                   10                  15      


Asp Val 
        


<210>  4737
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4737

Gly Gly Ser Met Ser Gly Phe Phe 
1               5               


<210>  4738
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4738

Phe Tyr Ser Ser Ala Lys Thr 
1               5           


<210>  4739
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4739

Ala Arg Ala Gln Asn Tyr Tyr Arg Gly Asn Thr Tyr Tyr Ser Thr Arg 
1               5                   10                  15      


Tyr Pro Arg Pro Asp Ile Phe Asp Met 
            20                  25  


<210>  4740
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4740

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  4741
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4741

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4742
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4742

Ala Arg Arg Asp His Tyr Asn Thr Ala Trp Gly Ser Thr Tyr Phe Gly 
1               5                   10                  15      


Tyr 
    


<210>  4743
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4743

Gly Asp Thr Phe Ser Ser Tyr Thr 
1               5               


<210>  4744
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4744

Ile Ile Pro Ile Leu Gly Ile Pro 
1               5               


<210>  4745
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4745

Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  4746
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4746

Gly Gly Ser Phe Ser Ala Tyr Tyr 
1               5               


<210>  4747
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4747

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4748
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4748

Ala Arg Ser Gly Gly Val Lys Phe Asp Pro 
1               5                   10  


<210>  4749
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4749

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  4750
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4750

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4751
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4751

Ala Arg Met Ser Arg Gly Tyr Asn Tyr Ala Tyr Thr Phe Asp Ile 
1               5                   10                  15  


<210>  4752
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4752

Gly Tyr Ser Phe Thr Asn Tyr Trp 
1               5               


<210>  4753
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4753

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4754
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4754

Ala Arg Thr Pro Thr Leu Tyr Asn Trp Phe His Pro 
1               5                   10          


<210>  4755
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4755

Gly Phe Pro Phe Ser Ser Ser Ala 
1               5               


<210>  4756
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4756

Val Val Val Gly Ser Gly Asn Thr 
1               5               


<210>  4757
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4757

Ala Gln Arg Arg Gly Glu Ala Val Tyr Ser Asn Gly Trp Tyr Lys Tyr 
1               5                   10                  15      


Tyr Tyr Cys Met Asp Val 
            20          


<210>  4758
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4758

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4759
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4759

Met Ser Pro Asn Ser Gly Asn Thr 
1               5               


<210>  4760
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4760

Thr Arg Gly Glu Gly Val Leu Gly Pro Phe 
1               5                   10  


<210>  4761
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4761

Gly Tyr Thr Phe Thr Ser His Thr 
1               5               


<210>  4762
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4762

Met Asn Ser Asn Ser Gly Asn Thr 
1               5               


<210>  4763
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4763

Ala Ser Ser Ser Trp Leu Arg Gly Ala Phe Asp Ile 
1               5                   10          


<210>  4764
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4764

Gly Phe Ser Phe Gly Asp Tyr Ala 
1               5               


<210>  4765
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4765

Ile Arg Asn Lys Asp Tyr Gly Gly Thr Thr 
1               5                   10  


<210>  4766
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4766

Thr Arg Ser Leu Tyr Leu Arg Ala Phe Asp Phe 
1               5                   10      


<210>  4767
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4767

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  4768
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4768

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4769
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4769

Ala Arg Pro Asp Tyr Ser Ser Gly Trp Phe Ser Tyr Trp Tyr Phe Asp 
1               5                   10                  15      


Leu 
    


<210>  4770
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4770

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4771
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4771

Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               


<210>  4772
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4772

Ala Gln Arg Arg Gly Glu Ala Val Tyr Ser Asn Gly Trp Tyr Lys Tyr 
1               5                   10                  15      


Tyr Tyr Cys Met Asp Val 
            20          


<210>  4773
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4773

Gly Phe Thr Phe Ser Asp Tyr Trp 
1               5               


<210>  4774
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4774

Ile Lys Gln Asp Gly Ser Glu Thr 
1               5               


<210>  4775
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4775

Ala Arg Asp Trp Asn Glu Arg Asp Thr Asp Thr Tyr Gly Ala Asp 
1               5                   10                  15  


<210>  4776
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4776

Gly Tyr Thr Phe Thr Asn Tyr Asp 
1               5               


<210>  4777
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4777

Met Asn Ser Asn Ser Gly Asn Ala 
1               5               


<210>  4778
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4778

Ala Arg Met Arg Thr Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
1               5                   10                  15      


<210>  4779
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4779

Gly Gly Ser Ile Ser Ser Ser Thr Tyr Tyr 
1               5                   10  


<210>  4780
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4780

Ile Asn Tyr Ser Gly Ser Thr 
1               5           


<210>  4781
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4781

Ala Arg Leu Ala Pro Gly Tyr Asp Phe Trp Arg Ala Gly Glu Ser Tyr 
1               5                   10                  15      


Tyr Phe Asp Tyr 
            20  


<210>  4782
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4782

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Tyr 
1               5                   10  


<210>  4783
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4783

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4784
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4784

Ala Arg Val Ser Tyr Asp Phe Trp Ser Gly Tyr Trp Ala Phe Asp Pro 
1               5                   10                  15      


<210>  4785
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4785

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  4786
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4786

Ile His Tyr Ser Gly Ser Thr 
1               5           


<210>  4787
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4787

Ala Ala Pro His Cys Asn Arg Thr Ser Cys Tyr Asp Ala Phe Asp Leu 
1               5                   10                  15      


<210>  4788
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4788

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  4789
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4789

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  4790
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4790

Ala Arg Glu Gly Gln Trp Pro Asn Gln Ala Phe Asp Ile 
1               5                   10              


<210>  4791
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4791

Gly Tyr Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  4792
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4792

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  4793
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4793

Ala Arg Gly Arg Ser Tyr Gly Leu Ser Leu Gly Tyr 
1               5                   10          


<210>  4794
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4794

Gly Phe Thr Phe Ser Ser His Gly 
1               5               


<210>  4795
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4795

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4796
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4796

Ala Arg Glu Ser Ala Asp Ile Ser Ser Arg Leu Asp Tyr 
1               5                   10              


<210>  4797
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4797

Gly Phe Thr Phe Arg Thr Cys Ala 
1               5               


<210>  4798
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4798

Ile Thr Glu Ser Gly Asp Asp Thr 
1               5               


<210>  4799
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4799

Ala Val Ala Thr His Tyr Phe Asn Ser Gly Arg Ala Tyr 
1               5                   10              


<210>  4800
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4800

Gly Asp Thr Ser Ser Ser Tyr Thr 
1               5               


<210>  4801
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4801

Ile Ile Pro Ile Leu Gly Ile Ala 
1               5               


<210>  4802
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4802

Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro 
1               5                   10                  


<210>  4803
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4803

Gly Phe Ser Val Ser Thr Ser Gly Glu Gly 
1               5                   10  


<210>  4804
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4804

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4805
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4805

Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile 
1               5                   10          


<210>  4806
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4806

Gly Gly Ser Val Ser Ser Gly Ala Tyr Tyr 
1               5                   10  


<210>  4807
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4807

Ile Tyr Thr Ser Gly Thr Thr 
1               5           


<210>  4808
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4808

Ala Arg Ala Arg Ser Ser Met Asp Asn Phe Tyr Tyr Phe Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  4809
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4809

Gly Phe Ile Leu Ser Asp His Tyr 
1               5               


<210>  4810
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4810

Thr Arg Asn Lys Ala Asn Ser Tyr Thr Thr 
1               5                   10  


<210>  4811
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4811

Ala Ser Val Ile Thr Phe Gly Gly Val Ile Val Arg Ser Tyr 
1               5                   10                  


<210>  4812
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4812

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4813
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4813

Ile Ile Pro Val Phe Gly Thr Thr 
1               5               


<210>  4814
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4814

Ala Arg Val Ser Gly Tyr Gly Asp Tyr Gly Ala Tyr Ser Asp Tyr 
1               5                   10                  15  


<210>  4815
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4815

Glu Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  4816
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4816

Ile Asn Trp Asn Gly Gly Ser Thr 
1               5               


<210>  4817
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4817

Ala Ser Val Ile Thr Phe Gly Gly Val Ile Val Arg Ser Tyr 
1               5                   10                  


<210>  4818
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4818

Gly Phe Thr Phe Asn Asn Tyr Ala 
1               5               


<210>  4819
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4819

Ile Gly Gly Ser Gly Gly Ser Thr 
1               5               


<210>  4820
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4820

Ala Arg Val Glu Gly Asp Trp Leu Leu Gly Gly Pro Tyr Tyr His Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4821
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4821

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4822
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4822

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4823
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4823

Ala Arg Ala Asp Thr Met Val Arg Gly Thr Tyr Phe Glu Tyr 
1               5                   10                  


<210>  4824
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4824

Gly Phe Thr Phe Ser Ser Tyr Leu 
1               5               


<210>  4825
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4825

Ile Trp Ala Asn Gly Asn Arg 
1               5           


<210>  4826
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4826

Ala Arg Asp Tyr Cys Asn Gly Val Thr Cys Asn Ser Asn Tyr 
1               5                   10                  


<210>  4827
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4827

Gly Gly Ser Ile Ser Ser Ser Asn Trp 
1               5                   


<210>  4828
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4828

Ile Tyr His Ser Gly Ser Thr 
1               5           


<210>  4829
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4829

Ala Arg Gly Trp Tyr Phe Asp Tyr 
1               5               


<210>  4830
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4830

Gly Tyr Thr Phe Thr Ser Tyr Gly 
1               5               


<210>  4831
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4831

Ile Ser Ala Tyr Asn Gly Asn Thr 
1               5               


<210>  4832
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4832

Ala Arg Glu Gly Glu Glu Arg Ala Asn Val Asn Val Pro Met Ile Tyr 
1               5                   10                  15      


Gly Met Asp Val 
            20  


<210>  4833
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4833

Gly Gly Thr Phe His Asn Tyr Ala 
1               5               


<210>  4834
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4834

Phe Ile Pro Ile Leu Gly Thr Thr 
1               5               


<210>  4835
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4835

Ala Arg Val Glu Gly Glu Gly Val Asp Ser Tyr Tyr Tyr Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  4836
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4836

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Ser 
1               5                   10  


<210>  4837
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4837

Ile Tyr His Ser Gly Ser Thr 
1               5           


<210>  4838
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4838

Ala Arg Ser Gly Gly Leu Arg Phe Asp Ser 
1               5                   10  


<210>  4839
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4839

Gly Tyr Ser Phe Ser Gly Ser Gly 
1               5               


<210>  4840
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4840

Ile Gly Arg Asn Asn Val Gly Asp Arg Asp Val Asn Thr 
1               5                   10              


<210>  4841
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4841

Ala Arg Asp Trp Asp Cys Ser Gly Gly Ser Cys Thr Asp Cys Phe Asp 
1               5                   10                  15      


Pro 
    


<210>  4842
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4842

Gly Tyr Ser Phe Ser Asp Tyr Trp 
1               5               


<210>  4843
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4843

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4844
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4844

Ala Arg Leu Thr Phe Gly Gly Ser Gly Ser Tyr Tyr Phe Tyr Tyr Asn 
1               5                   10                  15      


Gly Met Asp Val 
            20  


<210>  4845
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4845

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  4846
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4846

Ile Ser Trp Asn Ser Gly Thr Ile 
1               5               


<210>  4847
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4847

Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val 
1               5                   10                  


<210>  4848
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4848

Gly Phe Thr Val Tyr Ser Asn His 
1               5               


<210>  4849
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4849

Ile Tyr Gly Asp Gly Tyr Val Asp Gly Gly Gly Thr 
1               5                   10          


<210>  4850
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4850

Ala Arg Arg Glu Ile Leu Gly Tyr Ile Asn Gly Val Gly Thr Ser Asn 
1               5                   10                  15      


Ile 
    


<210>  4851
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4851

Gly Phe Thr Phe Ser Ser Tyr Glu 
1               5               


<210>  4852
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4852

Ile Ser Ser Ser Gly Ser Thr Ile 
1               5               


<210>  4853
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4853

Ala Arg Trp Asp Tyr Tyr Gly Ser Gly Ser Tyr Tyr Asn Val Pro Ser 
1               5                   10                  15      


Tyr Tyr Tyr Tyr Tyr Gly Met Asp Val 
            20                  25  


<210>  4854
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4854

Gly Asp Pro Val Ile Asn Thr Asn Tyr Tyr 
1               5                   10  


<210>  4855
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4855

Leu Ser Tyr Ser Gly Gly Thr 
1               5           


<210>  4856
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4856

Ala Arg His Pro Val Asp Gly Tyr Asn Tyr Gly Tyr Ser Asp Leu 
1               5                   10                  15  


<210>  4857
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4857

Gly Tyr Thr Phe Thr Asp Tyr Tyr 
1               5               


<210>  4858
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4858

Ile Asn Pro Asn Ser Arg Gly Thr 
1               5               


<210>  4859
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4859

Ala Arg Val Val Val Leu Gly Tyr Gly Arg Pro Asn Asn Tyr Tyr Asp 
1               5                   10                  15      


Gly Arg Asn Val Trp Asp Tyr 
            20              


<210>  4860
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4860

Gly Tyr Thr Phe Pro Ser Tyr Ser 
1               5               


<210>  4861
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4861

Val Ser Ala Tyr Asn Gly Tyr Thr 
1               5               


<210>  4862
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4862

Ala Arg Arg Tyr Cys Ser Gly Gly Ile Ala Lys Cys Gly Phe His Pro 
1               5                   10                  15      


<210>  4863
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4863

Gly Phe Ser Leu Gly Thr Ser Gly Met Cys 
1               5                   10  


<210>  4864
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4864

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4865
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4865

Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile 
1               5                   10          


<210>  4866
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4866

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4867
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4867

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4868
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4868

Ala Arg Asp Gln Asp Ser Gly Tyr Pro Thr Tyr Tyr Tyr Tyr Ser Met 
1               5                   10                  15      


Asp Val 
        


<210>  4869
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4869

Gly Phe Ala Phe Ser Asn Tyr Ala 
1               5               


<210>  4870
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4870

Ile Ser Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  4871
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4871

Ala Arg Val Pro Val Met Val Arg Gly Val Tyr Phe Asp Tyr 
1               5                   10                  


<210>  4872
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4872

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4873
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4873

Ile Ile Pro Ile Phe Gly Ala Ala 
1               5               


<210>  4874
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4874

Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr 
1               5                   10                  15  


<210>  4875
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4875

Gly Phe Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  4876
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4876

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4877
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4877

Ala Lys Pro Tyr Gly Met Asp Val 
1               5               


<210>  4878
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4878

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4879
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4879

Ile Ser Tyr Asp Glu Ile Asn Lys 
1               5               


<210>  4880
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4880

Ala Arg Ala Gly Gly Gly Ser Tyr Arg Gly Pro Phe Asp Tyr 
1               5                   10                  


<210>  4881
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4881

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4882
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4882

Ile Val Pro Ile Phe Gly Thr Ala 
1               5               


<210>  4883
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4883

Ala Arg Glu Asp Tyr Tyr Gly Ser Gly Ser Leu Val Asp Pro Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Arg Met Asp Val 
            20          


<210>  4884
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4884

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  4885
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4885

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4886
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4886

Ala Lys Ser Tyr Asn Gly Asn Tyr Tyr Asp Ala Phe Asp Ile 
1               5                   10                  


<210>  4887
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4887

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4888
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4888

Ile Tyr Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4889
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4889

Ala Arg Glu Gly Gln Met Ala Ala Thr Thr Gly Ile Asp Tyr 
1               5                   10                  


<210>  4890
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4890

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4891
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4891

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4892
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4892

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4893
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4893

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4894
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4894

Ile Lys Ser Lys Ile Asp Gly Gly Thr Thr 
1               5                   10  


<210>  4895
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4895

Thr Thr Ala Gly Ser Tyr Tyr Tyr Asp Thr Val Gly Pro Gly Leu Pro 
1               5                   10                  15      


Glu Gly Lys Phe Asp Tyr 
            20          


<210>  4896
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4896

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  4897
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4897

Ile Ser Trp Asn Ser Asp Ser Ile 
1               5               


<210>  4898
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4898

Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr 
1               5                   10          


<210>  4899
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4899

Gly Phe Ser Leu Thr Thr Ser Gly Met Cys 
1               5                   10  


<210>  4900
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4900

Ile Phe Ser Asn Asp Glu Lys 
1               5           


<210>  4901
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4901

Val Arg Met Leu Trp Glu Asn Trp Ser Tyr Asp Asp Tyr 
1               5                   10              


<210>  4902
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4902

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4903
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4903

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4904
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4904

Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu Ile 
1               5                   10                  15      


Asp Ala Phe Asp Ile 
            20      


<210>  4905
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4905

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4906
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4906

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4907
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4907

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4908
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4908

Gly Phe Ser Leu Ser Thr Ser Gly Met Cys 
1               5                   10  


<210>  4909
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4909

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4910
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4910

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  4911
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4911

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  4912
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4912

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  4913
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4913

Ala Arg Asp Leu Asp Tyr Tyr Gly Leu Asp Val 
1               5                   10      


<210>  4914
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4914

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  4915
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4915

Met Lys Ser Asn Ser Gly Asn Thr 
1               5               


<210>  4916
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4916

Ala Arg Ile Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp Leu 
1               5                   10                  15      


<210>  4917
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4917

Gly Tyr Thr Phe Thr Asn Tyr Trp 
1               5               


<210>  4918
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4918

Ile Tyr Pro Asp Asp Ser Asp Thr 
1               5               


<210>  4919
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4919

Ala Arg Arg Asp Lys Val Gly Ala Leu Asp Ser 
1               5                   10      


<210>  4920
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4920

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4921
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4921

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4922
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4922

Ala Arg Glu Ile Pro Val Thr Ala Ile Asp Tyr 
1               5                   10      


<210>  4923
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4923

Gly Gly Ser Ile Ile Asp His Tyr 
1               5               


<210>  4924
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4924

Ile Tyr Ser Thr Gly Arg Thr 
1               5           


<210>  4925
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4925

Ala Arg Thr Pro His Arg Gly Gly Phe Asp Val 
1               5                   10      


<210>  4926
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4926

Gly Gly Ser Val Ser Ser Gly Ala Tyr Tyr 
1               5                   10  


<210>  4927
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4927

Ile Tyr Thr Ser Gly Thr Thr 
1               5           


<210>  4928
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4928

Ala Arg Ala Arg Ser Ser Met Asp Asn Phe Tyr Tyr Phe Ser Met Asp 
1               5                   10                  15      


Val 
    


<210>  4929
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4929

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  4930
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4930

Ile Gln Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4931
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4931

Ala Arg Asp Leu Ile Ile Glu Ser Thr Ile Ala Ala Arg Pro Gly Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4932
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4932

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4933
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4933

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4934
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4934

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4935
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4935

Gly Gly Ser Leu Ser Leu Tyr Tyr 
1               5               


<210>  4936
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4936

Ile Tyr Tyr Thr Gly Ser Thr 
1               5           


<210>  4937
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4937

Ala Arg Ile Pro Thr Gly Phe Pro Arg Cys Tyr Met Asp Val 
1               5                   10                  


<210>  4938
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4938

Gly Gly Ser Phe Ser Ala Tyr Tyr 
1               5               


<210>  4939
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4939

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  4940
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4940

Ala Arg Asp Phe Leu Arg Trp His Asp Leu 
1               5                   10  


<210>  4941
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4941

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  4942
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4942

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  4943
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4943

Ala Ser Met Thr Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  4944
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4944

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4945
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4945

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4946
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4946

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4947
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4947

Gly Gly Ser Phe Ser Ala Tyr Tyr 
1               5               


<210>  4948
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4948

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4949
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4949

Ala Arg Pro Ser Asn Trp Tyr Phe Asp Leu 
1               5                   10  


<210>  4950
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4950

Gly Phe Thr Phe Ser Tyr Tyr Pro 
1               5               


<210>  4951
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4951

Thr Ser Tyr Asp Gly Thr Asn Lys 
1               5               


<210>  4952
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4952

Ala Arg Gly Gly Ala Thr Asn Phe Asp Tyr 
1               5                   10  


<210>  4953
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4953

Glu Tyr Thr Phe Thr Ser Tyr Ala 
1               5               


<210>  4954
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4954

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  4955
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4955

Ala Arg Pro Gly Lys Ala Ala Ala Phe Asp Tyr 
1               5                   10      


<210>  4956
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4956

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  4957
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4957

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  4958
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4958

Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu Ile 
1               5                   10                  15      


Asp Ala Phe Asp Ile 
            20      


<210>  4959
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4959

Gly Phe Thr Phe Ser Asn Tyr Ala 
1               5               


<210>  4960
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4960

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  4961
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4961

Ala Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210>  4962
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4962

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  4963
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4963

Ile Gln Pro Gly Asp Ser Asp Thr 
1               5               


<210>  4964
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4964

Ala Arg Asp Leu Ile Ile Glu Ser Thr Ile Ala Ala Arg Pro Gly Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4965
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4965

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  4966
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4966

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4967
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4967

Ala Arg Gly Tyr Ser Ser Gly Trp Tyr Tyr Phe Asp Tyr 
1               5                   10              


<210>  4968
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4968

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  4969
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4969

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  4970
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4970

Ala Arg Asp Leu His Gln Asp Trp Val Val Val Val Ala Ala Asn Val 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4971
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4971

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4972
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4972

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4973
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4973

Ala His Leu Leu Arg Ile Gly Ser Gly Tyr Tyr Ser Pro Arg Leu Ile 
1               5                   10                  15      


Asp Ala Phe Asp Ile 
            20      


<210>  4974
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4974

Gly Phe Thr Phe Met Ser Ser Ala 
1               5               


<210>  4975
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4975

Ile Val Ile Gly Ser Gly Asn Thr 
1               5               


<210>  4976
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4976

Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
1               5                   10                  15      


<210>  4977
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4977

Gly Phe Ser Leu Ser Thr Ser Gly Leu Cys 
1               5                   10  


<210>  4978
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4978

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  4979
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4979

Ala Arg Ala Thr Thr Phe Phe Tyr Gly Met Asp Val 
1               5                   10          


<210>  4980
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4980

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4981
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4981

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4982
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4982

Ala His Ala Gln Thr Gly Thr Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4983
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4983

Gly Phe Thr Phe Arg Arg Tyr Gly 
1               5               


<210>  4984
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4984

Ile Ser Tyr Asp Gly Thr Asp Lys 
1               5               


<210>  4985
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4985

Ala Lys Lys Gly Gly Pro Tyr Cys Gly Gly Gly Asn Cys Tyr Ala Gly 
1               5                   10                  15      


Tyr Phe Asp Tyr 
            20  


<210>  4986
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4986

Gly Phe Thr Phe Glu Asp Tyr Ala 
1               5               


<210>  4987
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4987

Val Ser Trp Asn Ser Gly Ile Ile 
1               5               


<210>  4988
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4988

Ala Lys Leu Asp Val Gly Gly Tyr Asp Phe Val Ser Gly His Tyr Tyr 
1               5                   10                  15      


Ala Phe Asp Ile 
            20  


<210>  4989
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4989

Gly Phe Ser Leu Ser Thr Thr Arg Val Gly 
1               5                   10  


<210>  4990
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4990

Ile Tyr Trp Gly Asp Asp Lys 
1               5           


<210>  4991
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4991

Ala His Ala Gln Thr Gly Ser Pro Leu Tyr Asp Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4992
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4992

Gly Tyr Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  4993
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4993

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  4994
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4994

Ala Arg Gly Leu Ile Ser Leu Phe Arg Gly Ala Ile Phe His Tyr Tyr 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  4995
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4995

Gly Phe Thr Phe Met Ser Ser Ala 
1               5               


<210>  4996
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4996

Ile Val Ile Gly Ser Gly Asn Thr 
1               5               


<210>  4997
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4997

Ala Asp Gln Tyr Cys Ser Ile Ile Ser Cys Asn Asp Gly Phe Asp Ile 
1               5                   10                  15      


<210>  4998
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4998

Gly Gly Ser Val Ser Ser Asp Asp Phe Ser Ser Gly Asp Asn Tyr 
1               5                   10                  15  


<210>  4999
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4999

Ile Tyr Tyr Ser Gly Leu Thr 
1               5           


<210>  5000
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5000

Ala Ser Glu His Lys Thr His Tyr Tyr Asp Ser Ser Gly Tyr Tyr Ser 
1               5                   10                  15      


Asn Trp Phe Asp Pro 
            20      


<210>  5001
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5001

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  5002
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5002

Met Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  5003
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5003

Ala Arg Asp Asp Asn Ser Pro Gln Gly Ser Gly Trp Tyr Phe Tyr Tyr 
1               5                   10                  15      


Asp Tyr Ala Met Asp Val 
            20          


<210>  5004
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5004

Gly Phe Ser Leu Thr Thr Ser Gly Met Cys 
1               5                   10  


<210>  5005
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5005

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  5006
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5006

Ala Arg Thr Met Ala Thr Ile Asn Ala Phe Asp Ile 
1               5                   10          


<210>  5007

<400>  5007
000

<210>  5008

<400>  5008
000

<210>  5009

<400>  5009
000

<210>  5010
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5010

Gly Phe Ser Leu Ser Thr Lys Arg Val Gly 
1               5                   10  


<210>  5011
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5011

Ile Tyr Trp Asp Asp Asp Gln 
1               5           


<210>  5012
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5012

Ala His Ser Gly Pro Pro Asp Leu Ser Pro Val Leu Ser Gln Gly Trp 
1               5                   10                  15      


Phe Asp Pro 
            


<210>  5013
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5013

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  5014
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5014

Gly Lys Asn 
1           


<210>  5015
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5015

Gln Val Trp Asp Ser Ser Thr Val Val 
1               5                   


<210>  5016
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5016

Thr Ser Asp Val Gly Gly Tyr Asp Tyr 
1               5                   


<210>  5017
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5017

Glu Val Thr 
1           


<210>  5018
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5018

Cys Ser Tyr Ala Gly Asn Tyr Ile Arg Val 
1               5                   10  


<210>  5019
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5019

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5020
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5020

Gly Ala Ser 
1           


<210>  5021
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5021

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  5022
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5022

Gln Ser Val Pro Ser Thr Tyr 
1               5           


<210>  5023
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5023

Ala Ala Ser 
1           


<210>  5024
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5024

Gln His Tyr Gly Gly Ser Pro Arg Ile Ser 
1               5                   10  


<210>  5025
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5025

Asn Ile Gly Ser Lys Asn 
1               5       


<210>  5026
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5026

Asp Asp Ser 
1           


<210>  5027
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5027

Gln Val Trp Asp Ser Ser Tyr Tyr His Pro Val Val 
1               5                   10          


<210>  5028
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5028

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5029
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5029

Tyr Val Ser 
1           


<210>  5030
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5030

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Leu Tyr Val 
1               5                   10          


<210>  5031
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5031

Arg Ser Leu Leu Arg Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5032
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5032

Leu Gly Ser 
1           


<210>  5033
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5033

Met Gln Ala Leu Gln Thr Pro Leu Thr 
1               5                   


<210>  5034
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5034

Asn Ser Asn Ile Gly Ser Tyr Thr 
1               5               


<210>  5035
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5035

Asp Asn Asn 
1           


<210>  5036
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5036

Leu Val Trp Asp Asp Ser Leu Asn Gly Leu Val 
1               5                   10      


<210>  5037
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5037

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5038
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5038

Ile Asn Ser 
1           


<210>  5039
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5039

Leu Ser Tyr Asp Ser Ser Leu Gly Ala Leu 
1               5                   10  


<210>  5040
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5040

Gln Pro Ile Ser Asn Phe 
1               5       


<210>  5041
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5041

Ser Ala Ser 
1           


<210>  5042
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5042

His Gln Ser Tyr Phe Thr Pro Gln Thr 
1               5                   


<210>  5043
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5043

Ser Ser Asn Ile Gly Asn Asn Tyr 
1               5               


<210>  5044
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5044

Asp Asn Asn 
1           


<210>  5045
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5045

Gly Thr Trp Asp Ser Ser Leu Ser Ala Val Val 
1               5                   10      


<210>  5046
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5046

Glu Asp Ile Arg Asn Tyr 
1               5       


<210>  5047
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5047

Ala Ala Ser 
1           


<210>  5048
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5048

Gln Asn Tyr Ile Ser Ala Pro Gln Thr 
1               5                   


<210>  5049
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5049

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  5050
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5050

Glu Asp Asn 
1           


<210>  5051
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5051

Gln Ser Tyr Asp Ser Ser Asn His Val Val 
1               5                   10  


<210>  5052
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5052

Gln Ser Ile Asn Ser Trp 
1               5       


<210>  5053
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5053

Lys Ala Ser 
1           


<210>  5054
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5054

Gln Gln Tyr Ser Ile Tyr Ser Trp Thr 
1               5                   


<210>  5055
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5055

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5056
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5056

Asp Val Asn 
1           


<210>  5057
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5057

Cys Ser Tyr Ala Gly Ser Tyr Thr Leu Val 
1               5                   10  


<210>  5058
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5058

Gln Ser Val Ser Thr Trp 
1               5       


<210>  5059
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5059

Ala Ala Ser 
1           


<210>  5060
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5060

His Gln Ser Ser Ser Leu Pro Pro Thr 
1               5                   


<210>  5061
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5061

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  5062
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5062

Ala Ala Ser 
1           


<210>  5063
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5063

Gln Gln Ser Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  5064
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5064

Gln Gly Ile Ser Ser Trp 
1               5       


<210>  5065
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5065

Ala Ala Ser 
1           


<210>  5066
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5066

Gln Gln Ala Asn Ser Leu Pro Leu Thr 
1               5                   


<210>  5067
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5067

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5068
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5068

Leu Gly Ser 
1           


<210>  5069
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5069

Met Gln Ala Leu Gln Thr Pro Arg Thr 
1               5                   


<210>  5070
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5070

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5071
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5071

Gly Ala Ser 
1           


<210>  5072
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5072

Gln His Tyr Asn Asn Trp Pro Pro Tyr Thr 
1               5                   10  


<210>  5073
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5073

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5074
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5074

Asp Val Arg 
1           


<210>  5075
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5075

Ser Ser Phe Thr Ser Arg Gly Ala Leu Val Leu 
1               5                   10      


<210>  5076
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5076

Ser Ser Asn Ile Glu Ser Asn Ser 
1               5               


<210>  5077
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5077

Ser Asn Asn 
1           


<210>  5078
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5078

Ala Ala Trp Asp Asp Ser Leu Asn Gly Val Val 
1               5                   10      


<210>  5079
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5079

Thr Ser Asn Ile Gly Ser Asn Thr 
1               5               


<210>  5080
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5080

Ser Asn Asn 
1           


<210>  5081
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5081

Ala Ala Trp Asp Asp Ser Leu Asn Gly Trp Val 
1               5                   10      


<210>  5082
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5082

Gln Ser Leu Val Tyr Ser Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  5083
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5083

Lys Val Ser 
1           


<210>  5084
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5084

Met Gln Ala Leu Gln Thr Pro Leu Thr 
1               5                   


<210>  5085
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5085

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  5086
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5086

Gln Asp Ser 
1           


<210>  5087
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5087

Gln Ala Trp Asp Ser Ser Thr Ala Val 
1               5                   


<210>  5088
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5088

Gln Ser Val Arg Ser Asn 
1               5       


<210>  5089
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5089

Gly Ala Ser 
1           


<210>  5090
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5090

His Gln Tyr Asn Asn Trp Pro Gln Thr 
1               5                   


<210>  5091
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5091

Ala Leu Pro Asn Gln Tyr 
1               5       


<210>  5092
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5092

Lys Asp Ser 
1           


<210>  5093
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5093

Gln Ala Trp Asp Ser Ser Leu Val Val 
1               5                   


<210>  5094
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5094

Gln Ser Ile Ser Thr Tyr 
1               5       


<210>  5095
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5095

Ala Ala Ser 
1           


<210>  5096
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5096

Gln Gln Ser Tyr Ser Thr Leu Thr 
1               5               


<210>  5097
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5097

Asn Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5098
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5098

Asp Val Ile 
1           


<210>  5099
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5099

Cys Ser Tyr Ala Gly Thr His Val Ala 
1               5                   


<210>  5100
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5100

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  5101
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5101

Ala Ala Ser 
1           


<210>  5102
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5102

Gln Gln Ser Tyr Ser Thr Pro Thr 
1               5               


<210>  5103
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5103

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  5104
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5104

Asp Ala Ser 
1           


<210>  5105
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5105

Gln His Arg Ser Asn Trp Pro Pro Arg Leu Thr 
1               5                   10      


<210>  5106
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5106

Gln Ser Leu Leu His Ser Leu Gly Tyr Asn Ser 
1               5                   10      


<210>  5107
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5107

Leu Gly Ser 
1           


<210>  5108
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5108

Met Gln Ala Leu Gln Thr Pro Leu Thr 
1               5                   


<210>  5109
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5109

Gln Asn Val Gly Asn Tyr 
1               5       


<210>  5110
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5110

Gly Val Ser 
1           


<210>  5111
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5111

Gln Gln Arg Arg His Trp Arg Thr 
1               5               


<210>  5112
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5112

Ser Gly Tyr Ser Asn Tyr Lys 
1               5           


<210>  5113
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5113

Val Gly Thr Gly Gly Ile Val Gly 
1               5               


<210>  5114
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5114

Gly Ala Asp His Gly Ser Gly Ser Asn Phe Val Phe Val Val 
1               5                   10                  


<210>  5115
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5115

Ser Ser Asp Val Gly Gly Tyr Lys Tyr 
1               5                   


<210>  5116
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5116

Glu Val Asn 
1           


<210>  5117
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5117

Ser Ser Phe Ala Gly Ser Asn Ile Pro Tyr Val 
1               5                   10      


<210>  5118
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5118

Gln Ser Ile Ala Gly Tyr 
1               5       


<210>  5119
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5119

Gly Thr Thr 
1           


<210>  5120
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5120

Gln Gln Ser Tyr Ser Thr Pro Gly Thr 
1               5                   


<210>  5121
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5121

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5122
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5122

Ile Asn Ser 
1           


<210>  5123
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5123

Gln Ser Tyr Asp Arg Thr Leu Ser Val Val 
1               5                   10  


<210>  5124
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5124

Gln Ser Val Phe Asn Thr Val Asn His Arg Asp Tyr 
1               5                   10          


<210>  5125
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5125

Trp Ala Ser 
1           


<210>  5126
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5126

Gln Gln Tyr His Asn Met Val Thr 
1               5               


<210>  5127
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5127

Ser Gly Asp Ile Ala Arg Asn Ser 
1               5               


<210>  5128
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5128

Glu Asp Asp 
1           


<210>  5129
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5129

His Ser Tyr Asp Asp Asn Tyr Gln Ala Phe 
1               5                   10  


<210>  5130
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5130

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5131
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5131

Gly Ala Ser 
1           


<210>  5132
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5132

Gln Gln Tyr Gly Ser Ser Tyr Thr 
1               5               


<210>  5133
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5133

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5134
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5134

Gly Ala Ser 
1           


<210>  5135
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5135

Gln Gln Tyr Thr Asn Phe Leu Thr 
1               5               


<210>  5136
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5136

Gln Ser Val Asp Ser Tyr 
1               5       


<210>  5137
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5137

Asp Ala Ser 
1           


<210>  5138
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5138

Gln Gln Arg Ser Asn Trp Pro Pro Asp Thr 
1               5                   10  


<210>  5139
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5139

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  5140
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5140

Ala Ala Ser 
1           


<210>  5141
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5141

Gln Gln Thr Tyr Ser Thr Phe Trp Thr 
1               5                   


<210>  5142
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5142

Gln Ser Val Phe Tyr Ser Ser Asn Lys Lys Asn Tyr 
1               5                   10          


<210>  5143
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5143

Trp Ala Ser 
1           


<210>  5144
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5144

Gln Gln Tyr Tyr Ser Thr Pro Gln Thr 
1               5                   


<210>  5145
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5145

Lys Leu Gly Asp Lys Phe 
1               5       


<210>  5146
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5146

Glu Asp Phe 
1           


<210>  5147
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5147

Gln Ala Trp Asp Ser Ser Thr Gly Val 
1               5                   


<210>  5148
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5148

Lys Leu Gly His Lys Tyr 
1               5       


<210>  5149
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5149

Gln Asp Asp 
1           


<210>  5150
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5150

Gln Ala Trp Asp Asn Asp Ala Gly Val Val 
1               5                   10  


<210>  5151
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5151

Gln Gly Ile Ser Asn Tyr 
1               5       


<210>  5152
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5152

Ala Ala Ser 
1           


<210>  5153
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5153

Gln Gln Tyr Asn Ser His Pro Pro Thr 
1               5                   


<210>  5154
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5154

Ser Ser Asp Val Gly Thr Tyr Asn Tyr 
1               5                   


<210>  5155
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5155

Glu Val Ser 
1           


<210>  5156
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5156

Ser Ala Tyr Ala Gly Ser Asn Asn Leu Val 
1               5                   10  


<210>  5157
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5157

Ser Gly Tyr Ser Asn Tyr Lys 
1               5           


<210>  5158
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5158

Val Gly Thr Gly Gly Ile Val Gly 
1               5               


<210>  5159
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5159

Gly Ala Asp His Gly Ser Gly Ser Asn Phe Glu Tyr Val Val 
1               5                   10                  


<210>  5160
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5160

Gln Ser Val Leu His Arg Pro Asn Asn Met Asn Tyr 
1               5                   10          


<210>  5161
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5161

Trp Ala Ser 
1           


<210>  5162
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5162

Gln Gln Tyr Glu Ile Thr Pro Arg Thr 
1               5                   


<210>  5163
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5163

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  5164
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5164

Glu Val Ser 
1           


<210>  5165
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5165

Cys Ser Tyr Ala Gly Ile Val Leu 
1               5               


<210>  5166
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5166

Gln Ser Ile Ser Ser Trp 
1               5       


<210>  5167
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5167

Ala Ala Ser 
1           


<210>  5168
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5168

Gln Gln Tyr Asn Ser Tyr Ser Pro Asp Thr 
1               5                   10  


<210>  5169
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5169

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  5170
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5170

Lys Asp Ser 
1           


<210>  5171
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5171

Gln Ser Gly Asp Ser Ser Gly Thr Tyr Val Val 
1               5                   10      


<210>  5172
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5172

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  5173
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5173

Asp Ala Ser 
1           


<210>  5174
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5174

Gln Gln Arg Arg Ser Trp Pro Leu Thr 
1               5                   


<210>  5175
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5175

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5176
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5176

Trp Ala Ser 
1           


<210>  5177
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5177

Gln Gln Tyr Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  5178
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5178

Ala Leu Ser Lys Gln Tyr 
1               5       


<210>  5179
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5179

Lys Asp Ser 
1           


<210>  5180
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5180

Gln Ser Val Asp Arg Ser Gly Thr Tyr Phe Asn Trp Val 
1               5                   10              


<210>  5181
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5181

Gln Ser Leu Leu Arg Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5182
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5182

Leu Gly Ser 
1           


<210>  5183
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5183

Met Gln Ala Leu Arg Thr Pro Leu Thr 
1               5                   


<210>  5184
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5184

Gln Thr Ile Thr Asn Tyr 
1               5       


<210>  5185
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5185

Ala Ala Ser 
1           


<210>  5186
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5186

Gln Gln Ser Tyr Ser Thr Pro Tyr Thr 
1               5                   


<210>  5187
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5187

Ala Gly Ala Val Thr Ser Gly Tyr Tyr 
1               5                   


<210>  5188
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5188

Ser Thr Ala 
1           


<210>  5189
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5189

Leu Leu Tyr Tyr Gly Gly Ala Trp Val 
1               5                   


<210>  5190
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5190

Gln Ser Ile Gly Pro Trp 
1               5       


<210>  5191
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5191

Glu Thr Ser 
1           


<210>  5192
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5192

His Gln Tyr Met Ala Phe Trp Thr 
1               5               


<210>  5193
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5193

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  5194
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5194

Glu Asp Asn 
1           


<210>  5195
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5195

Gln Ser Tyr Asp Gly Ser Asn His Ala Val Val 
1               5                   10      


<210>  5196
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5196

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5197
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5197

Gly Ala Ser 
1           


<210>  5198
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5198

Gln Gln Ser Tyr Ser Thr Pro Gly Thr 
1               5                   


<210>  5199
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5199

Gln Ser Leu Leu Tyr Ser Ser Asp Asn Lys Asn Tyr 
1               5                   10          


<210>  5200
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5200

Trp Ala Ser 
1           


<210>  5201
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5201

Gln Gln Tyr Gly Arg Ser Pro Ile Thr 
1               5                   


<210>  5202
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5202

Asn Ile Gly Ser Lys Asn 
1               5       


<210>  5203
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5203

Asp Asp Ser 
1           


<210>  5204
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5204

Gln Val Trp Asp Ser Ser Ser Asp Pro Val Val 
1               5                   10      


<210>  5205
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5205

Gln Ser Leu Leu Asn Ser Asn Gly Leu Thr Tyr 
1               5                   10      


<210>  5206
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5206

Phe Val Ser 
1           


<210>  5207
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5207

Met Gln Ala Leu Gln Thr Pro Gln Thr 
1               5                   


<210>  5208
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5208

Gln Ser Ile Ser Ser Ser Tyr 
1               5           


<210>  5209
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5209

Gly Ala Ser 
1           


<210>  5210
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5210

Gln Gln Tyr Gly Gly Ser Leu Thr 
1               5               


<210>  5211
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5211

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  5212
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5212

Gln Asp Ser 
1           


<210>  5213
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5213

Gln Ala Trp Asp Ser Ser Thr His Val Val 
1               5                   10  


<210>  5214
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5214

Lys Met Gly Asp Lys Tyr 
1               5       


<210>  5215
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5215

Glu Asp Asn 
1           


<210>  5216
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5216

Gln Ala Trp Asp Ser Ser Leu Val Val 
1               5                   


<210>  5217
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5217

Gln Asp Ile Gly His Phe 
1               5       


<210>  5218
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5218

Ala Thr Ser 
1           


<210>  5219
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5219

Gln Gln Tyr Asp Ser Tyr Pro Trp Thr 
1               5                   


<210>  5220
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5220

Ser Ser Asp Val Gly Ser Tyr Asn Arg 
1               5                   


<210>  5221
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5221

Glu Val Ser 
1           


<210>  5222
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5222

Ser Ser Tyr Thr Ser Ser Ser Leu Arg Val 
1               5                   10  


<210>  5223
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5223

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  5224
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5224

Ala Ala Ser 
1           


<210>  5225
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5225

Gln Gln Leu Asn Ser Tyr Pro Val Thr 
1               5                   


<210>  5226
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5226

Gln Ser Leu Leu His Thr Ser Gly His Asn Leu 
1               5                   10      


<210>  5227
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5227

Leu Gly Ser 
1           


<210>  5228
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5228

Met Gln Ala Leu Gln Thr Pro Pro Thr 
1               5                   


<210>  5229
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5229

Asn Leu Gly Asp Arg Tyr 
1               5       


<210>  5230
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5230

Gln Asp Asn 
1           


<210>  5231
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5231

Gln Ala Trp Asp Gly Gly Thr Val Val 
1               5                   


<210>  5232
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5232

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5233
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5233

Asp Val Thr 
1           


<210>  5234
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5234

Cys Ser Tyr Ala Gly Ser Tyr Thr Tyr Val 
1               5                   10  


<210>  5235
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5235

Gln Arg Leu Ile Asn Asp Tyr Gly Arg Thr Phe 
1               5                   10      


<210>  5236
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5236

Glu Val Ser 
1           


<210>  5237
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5237

Met Gln Ser Ala Ser Leu Pro Thr 
1               5               


<210>  5238
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5238

Gly Ser Asp Val Gly Gly Ser Asn Tyr 
1               5                   


<210>  5239
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5239

Asp Val Ser 
1           


<210>  5240
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5240

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Val Leu 
1               5                   10      


<210>  5241
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5241

Gln Thr Ile Ala Asn Ser 
1               5       


<210>  5242
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5242

Leu Ser Ser 
1           


<210>  5243
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5243

Gln Gln Gly Ala Thr Thr Pro Gly Thr 
1               5                   


<210>  5244
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5244

Gln Ser Val Ser Ser Phe 
1               5       


<210>  5245
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5245

Asp Ala Ser 
1           


<210>  5246
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5246

Gln Gln Arg Ser Asn Trp Pro Pro Ser Tyr Thr 
1               5                   10      


<210>  5247
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5247

Thr Ser Asn Ile Gly Ser Gly Tyr His 
1               5                   


<210>  5248
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5248

Gly Asn Ser 
1           


<210>  5249
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5249

Gln Ser Tyr Asp Gly Tyr Leu Thr Ala Tyr Val 
1               5                   10      


<210>  5250
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5250

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5251
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5251

Ser Ala Ser 
1           


<210>  5252
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5252

Gln Gln Tyr Val Glu Pro Pro Phe Thr 
1               5                   


<210>  5253
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5253

Ser Ser Asp Ile Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5254
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5254

Asp Val Ser 
1           


<210>  5255
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5255

Ser Ser Tyr Thr Ser Ile Ser Thr Trp Val 
1               5                   10  


<210>  5256
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5256

Ala Leu Pro Lys Arg Tyr 
1               5       


<210>  5257
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5257

Glu Asp Ser 
1           


<210>  5258
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5258

Phe Ser Met Asp Ser Ser Gly Asp Leu Arg Val 
1               5                   10      


<210>  5259
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5259

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5260
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5260

Gly Asn Ser 
1           


<210>  5261
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5261

Gln Ser Tyr Asp Gly Ser Asn His Ala Val Val 
1               5                   10      


<210>  5262
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5262

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  5263
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5263

Lys Asp Thr 
1           


<210>  5264
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5264

Gln Ser Thr Asp Ser Ser Gly Val Tyr Arg Val 
1               5                   10      


<210>  5265
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5265

Gln Ser Ile Ser Thr Tyr 
1               5       


<210>  5266
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5266

Ala Ala Ser 
1           


<210>  5267
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5267

Gln Gln Ser Tyr Ser Thr Pro Gly Leu Thr 
1               5                   10  


<210>  5268
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5268

Gln Ser Ile Ala Gly Tyr 
1               5       


<210>  5269
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5269

Glu Ala Ser 
1           


<210>  5270
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5270

Gln Gln Ser Tyr Ser Thr Pro Gly Thr 
1               5                   


<210>  5271
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5271

Ser Gly His Thr Asn Tyr Ala 
1               5           


<210>  5272
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5272

Val Asn Ser Asp Gly Ser His 
1               5           


<210>  5273
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5273

Gln Thr Trp Gly Pro Gly Ile Arg Val 
1               5                   


<210>  5274
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5274

Gln Ser Val Gly Thr Phe 
1               5       


<210>  5275
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5275

Glu Gly Ser 
1           


<210>  5276
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5276

Gln Gln Arg Tyr Gly Trp Pro Pro Thr 
1               5                   


<210>  5277
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5277

Ser Ser Asp Val Val Gly Tyr Asn Tyr 
1               5                   


<210>  5278
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5278

Asp Val Arg 
1           


<210>  5279
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5279

Ile Ser Tyr Thr Ser Ser Arg Thr Leu Val 
1               5                   10  


<210>  5280
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5280

Gln Ser Val Phe Asn Ile His Asn Asn Arg Asp Tyr 
1               5                   10          


<210>  5281
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5281

Trp Ala Ser 
1           


<210>  5282
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5282

Gln Gln Met Tyr Ser Pro Pro Arg Thr 
1               5                   


<210>  5283
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5283

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5284
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5284

Gly Ala Ser 
1           


<210>  5285
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5285

Gln Gln Tyr Gly Ser Ser Pro Pro Tyr Thr 
1               5                   10  


<210>  5286
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5286

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5287
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5287

Asp Val Ser 
1           


<210>  5288
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5288

Cys Ser Tyr Ala Gly Ser Tyr Thr Leu Val 
1               5                   10  


<210>  5289
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5289

Arg Ser Leu Leu Ser Lys Asn Lys Asn Phe 
1               5                   10  


<210>  5290
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5290

Trp Ala Ser 
1           


<210>  5291
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5291

Gln Gln Tyr Tyr Ser Ser Pro Phe Thr 
1               5                   


<210>  5292
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5292

Gln Ser Val Ser Ser Gly Tyr 
1               5           


<210>  5293
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5293

Ala Ala Ser 
1           


<210>  5294
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5294

Gln Glu Tyr Gly Ser Ser Ala Ile Thr 
1               5                   


<210>  5295
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5295

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5296
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5296

Leu Gly Ser 
1           


<210>  5297
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5297

Met Gln Ala Leu Asp Thr Leu Phe Thr 
1               5                   


<210>  5298
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5298

Ser Gly Tyr Ser Asn Tyr Lys 
1               5           


<210>  5299
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5299

Val Gly Thr Gly Gly Ile Val Gly 
1               5               


<210>  5300
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5300

Gly Ala Asp His Gly Ser Gly Ser Asn Phe Val Tyr Val Val 
1               5                   10                  


<210>  5301
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5301

Gln Ser Leu Leu Tyr Ser Ser Asp Asn Lys Asn Tyr 
1               5                   10          


<210>  5302
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5302

Trp Ala Ser 
1           


<210>  5303
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5303

Gln Gln Tyr Tyr Gly Thr Pro Tyr Thr 
1               5                   


<210>  5304
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5304

Gln Ser Ile Ser Thr Tyr 
1               5       


<210>  5305
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5305

Ala Ala Ser 
1           


<210>  5306
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5306

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  5307

<400>  5307
000

<210>  5308

<400>  5308
000

<210>  5309

<400>  5309
000

<210>  5310
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5310

Thr Gly Ala Val Thr Ser Gly Tyr Phe 
1               5                   


<210>  5311
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5311

Ser Thr Asn 
1           


<210>  5312
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5312

Leu Leu Tyr Tyr Gly Gly Pro Trp Val 
1               5                   


<210>  5313
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5313

Gln Thr Leu Ser Ser Asn 
1               5       


<210>  5314
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5314

Gly Ala Ser 
1           


<210>  5315
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5315

Gln Gln Tyr Asn Asn Trp Pro Leu Ala 
1               5                   


<210>  5316
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5316

Ser Ser Asp Ile Gly Ser Tyr Asn Leu 
1               5                   


<210>  5317
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5317

Glu Val Ser 
1           


<210>  5318
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5318

Cys Ser Tyr Ala Gly Gly Asn Thr Phe Val Val 
1               5                   10      


<210>  5319
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5319

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  5320
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5320

Asp Lys Asn 
1           


<210>  5321
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5321

Tyr Ser Ala Ala Asp Asn Lys Gly Val 
1               5                   


<210>  5322
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5322

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5323
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5323

Gly Ala Ser 
1           


<210>  5324
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5324

Gln Gln Tyr Asn Asn Trp Pro Arg Thr 
1               5                   


<210>  5325
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5325

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5326
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5326

Asp Val Ser 
1           


<210>  5327
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5327

Ser Ser Tyr Thr Ser Ser Ser Thr Pro Val Val 
1               5                   10      


<210>  5328
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5328

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5329
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5329

Leu Gly Ser 
1           


<210>  5330
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5330

Met Gln Ala Leu Gln Thr Pro Arg Thr 
1               5                   


<210>  5331
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5331

Gln Asn Ile Ala Ser Tyr 
1               5       


<210>  5332
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5332

Ala Ala Ser 
1           


<210>  5333
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5333

Gln Gln Ser Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  5334
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5334

Gln Thr Val Phe Asn Ser Ala Asn His Arg Asn Tyr 
1               5                   10          


<210>  5335
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5335

Trp Ala Ser 
1           


<210>  5336
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5336

Gln Gln Tyr His Asn Met Val Thr 
1               5               


<210>  5337

<400>  5337
000

<210>  5338

<400>  5338
000

<210>  5339

<400>  5339
000

<210>  5340
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5340

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5341
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5341

Gly Ala Ser 
1           


<210>  5342
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5342

Gln Asn Tyr Ile Ser Ala Pro Gln Thr 
1               5                   


<210>  5343
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5343

Ala Leu Pro Asp Gln Tyr 
1               5       


<210>  5344
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5344

Lys Asp Thr 
1           


<210>  5345
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5345

Gln Ser Ala Asp Ser Ser Gly Thr Asn Pro Val Val 
1               5                   10          


<210>  5346
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5346

Gln Ser Val Ser Asn Asn 
1               5       


<210>  5347
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5347

Gly Ala Ser 
1           


<210>  5348
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5348

Gln Gln Cys Tyr Asn Trp Pro Pro Trp Thr 
1               5                   10  


<210>  5349
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5349

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5350
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5350

Gly Ala Ser 
1           


<210>  5351
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5351

Gln Gln Tyr Gly Ser Ser Leu Leu Thr 
1               5                   


<210>  5352
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5352

Gln Ser Val Ser Ser Asn Phe 
1               5           


<210>  5353
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5353

Gly Ala Ser 
1           


<210>  5354
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5354

Gln Gln Tyr Gly Arg Ser Ser Gly Thr 
1               5                   


<210>  5355
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5355

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  5356
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5356

Gln Asp Ser 
1           


<210>  5357
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5357

Gln Ala Trp Asp Ser Ser Thr Gly Val 
1               5                   


<210>  5358
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5358

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  5359
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5359

Glu Asp Ser 
1           


<210>  5360
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5360

Tyr Ser Thr Asp Ser Ser Gly Asp Gln Arg Val 
1               5                   10      


<210>  5361
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5361

Gln Asp Ile Ser Lys Tyr 
1               5       


<210>  5362
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5362

Asp Ala Ser 
1           


<210>  5363
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5363

Gln Gln Tyr His Asn Leu Pro Arg Thr 
1               5                   


<210>  5364
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5364

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  5365
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5365

Ala Ala Ser 
1           


<210>  5366
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5366

Gln Gln Leu Asn Ser Tyr Pro Phe Thr 
1               5                   


<210>  5367
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5367

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Ser 
1               5                   10          


<210>  5368
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5368

Trp Ala Ser 
1           


<210>  5369
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5369

Gln Gln Tyr Tyr Ser Ile Ser Trp Thr 
1               5                   


<210>  5370
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5370

Gln Ser Leu Val Tyr Ser Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  5371
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5371

Lys Val Ser 
1           


<210>  5372
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5372

Met Gln Ala Thr His Trp Pro Phe Thr 
1               5                   


<210>  5373
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5373

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5374
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5374

Asp Val Gly 
1           


<210>  5375
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5375

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Tyr Val 
1               5                   10      


<210>  5376
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5376

Ser Ser Asp Ile Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5377
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5377

Asp Val Ser 
1           


<210>  5378
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5378

Cys Ser Tyr Ala Gly Cys Tyr Thr Leu Val 
1               5                   10  


<210>  5379
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5379

Gln Gly Ile Ser Asn Tyr 
1               5       


<210>  5380
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5380

Ala Ala Ser 
1           


<210>  5381
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5381

Gln Lys Tyr Asn Ser Ala Pro Trp Thr 
1               5                   


<210>  5382
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5382

Lys Leu Gly Asp Lys Phe 
1               5       


<210>  5383
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5383

Gln Asp Asn 
1           


<210>  5384
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5384

Gln Ala Trp Asp Ser Ser Thr Gly Val 
1               5                   


<210>  5385
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5385

Gln Gly Ile Ser Ser Trp 
1               5       


<210>  5386
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5386

Lys Ala Ser 
1           


<210>  5387
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5387

Gln Gln Tyr Gly Ser Ser Pro Arg Leu Thr 
1               5                   10  


<210>  5388
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5388

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  5389
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5389

Ala Ala Ser 
1           


<210>  5390
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5390

Gln Gln Leu Asn Ser Tyr Pro Ile Thr 
1               5                   


<210>  5391
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5391

Thr Ser Asn Ile Gly Arg Asn Thr 
1               5               


<210>  5392
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5392

Ile Asn Asn 
1           


<210>  5393
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5393

Ala Ala Trp Asp Asp Val Leu Gln Gly Trp Val 
1               5                   10      


<210>  5394
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5394

Lys Leu Gly Asp Lys Phe 
1               5       


<210>  5395
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5395

Glu Asp Phe 
1           


<210>  5396
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5396

Gln Ala Trp Asp Ser Ser Asn Trp Val 
1               5                   


<210>  5397
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5397

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5398
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5398

Leu Gly Ser 
1           


<210>  5399
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5399

Met Gln Ala Leu Gln Thr Pro Thr 
1               5               


<210>  5400
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5400

Gln Thr Leu Leu Tyr Ser Ser Asn Asn Lys Ala Cys 
1               5                   10          


<210>  5401
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5401

Trp Ala Ser 
1           


<210>  5402
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5402

Gln Gln Tyr Cys Ser Ser Pro Arg Thr 
1               5                   


<210>  5403
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5403

Asn Ser Asn Ile Gly Ser Tyr Thr 
1               5               


<210>  5404
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5404

Asp Asn Asn 
1           


<210>  5405
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5405

Ala Val Trp Asp Asp Ser Leu Asn Gly Leu Val 
1               5                   10      


<210>  5406
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5406

Ala Leu Pro Asn Gln Tyr 
1               5       


<210>  5407
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5407

Lys Asp Ser 
1           


<210>  5408
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5408

Gln Ala Trp Asp Ser Ser Thr Gly Val 
1               5                   


<210>  5409
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5409

Ile Leu Thr Lys Lys Tyr 
1               5       


<210>  5410
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5410

Lys Asp Ser 
1           


<210>  5411
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5411

Tyr Ser Val Ala Asp Asn Asn Arg Val 
1               5                   


<210>  5412
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5412

Ser Ser Asn Ile Gly Asn Asn Ala 
1               5               


<210>  5413
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5413

Tyr Asp Asp 
1           


<210>  5414
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5414

Ala Ala Trp Asp Asp Ser Leu Asn Gly Val Val 
1               5                   10      


<210>  5415
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5415

Gln Ser Ile Thr Ser Tyr 
1               5       


<210>  5416
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5416

Ala Ala Ser 
1           


<210>  5417
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5417

Gln Gln Ser Tyr Thr Thr Leu Leu Thr 
1               5                   


<210>  5418
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5418

Gln Ser Leu Leu His Ser Asn Gly Tyr Tyr His 
1               5                   10      


<210>  5419
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5419

Leu Ala Ser 
1           


<210>  5420
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5420

Met Gln Ala Leu Gln Thr Pro Leu Thr 
1               5                   


<210>  5421
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5421

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5422
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5422

Gly Ala Ser 
1           


<210>  5423
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5423

Gln Gln Tyr Asn Asn Trp Pro Gly Thr 
1               5                   


<210>  5424
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5424

Val Leu Ala Lys Asn Tyr 
1               5       


<210>  5425
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5425

Lys Asp Ser 
1           


<210>  5426
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5426

Tyr Ser Ala Ala Asp Asn Asn Arg Val 
1               5                   


<210>  5427
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5427

Gln Ser Val Asn Gly Phe 
1               5       


<210>  5428
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5428

Asp Ala Ser 
1           


<210>  5429
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5429

Gln Gln Arg Ser Asn Trp Leu Tyr Thr 
1               5                   


<210>  5430
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5430

Ala Leu Pro Ser Gln Tyr 
1               5       


<210>  5431
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5431

Lys Asp Thr 
1           


<210>  5432
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5432

Gln Ser Ala Asp Ser Thr Gly Thr Phe Val Val 
1               5                   10      


<210>  5433
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5433

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  5434
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5434

Gly Ala Ser 
1           


<210>  5435
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5435

Gln Gln Ser Tyr Ser Thr Pro Thr 
1               5               


<210>  5436

<400>  5436
000

<210>  5437

<400>  5437
000

<210>  5438

<400>  5438
000

<210>  5439
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5439

Gln Asp Ile Ser Asn Ser 
1               5       


<210>  5440
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5440

Asp Ala Ser 
1           


<210>  5441
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5441

Gln Gln Tyr Asp Asn Leu Leu Leu Phe Thr 
1               5                   10  


<210>  5442
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5442

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  5443
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5443

Asp Ala Ser 
1           


<210>  5444
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5444

Gln Gln Arg Ser Asn Trp Pro Pro Arg Thr Trp Thr 
1               5                   10          


<210>  5445
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5445

Gln Ser Val Ser Ser Phe 
1               5       


<210>  5446
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5446

Asp Ala Ser 
1           


<210>  5447
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5447

His Tyr Arg Ser Asn Trp Pro Pro Val Leu Thr 
1               5                   10      


<210>  5448
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5448

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  5449
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5449

Asp Lys Asn 
1           


<210>  5450
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5450

Asn Ser Arg Asp Ser Ser Gly Asn Ala Val Val 
1               5                   10      


<210>  5451
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5451

Gln Ser Leu Leu Tyr Thr Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5452
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5452

Trp Ala Ser 
1           


<210>  5453
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5453

Gln Gln Tyr Tyr Ser Pro Pro Trp Thr 
1               5                   


<210>  5454
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5454

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  5455
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5455

Gly Lys Asn 
1           


<210>  5456
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5456

Asn Ser Arg Asp Ser Ser Gly Tyr Ile Trp Gly Trp Met 
1               5                   10              


<210>  5457
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5457

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  5458
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5458

Asp Asp Ser 
1           


<210>  5459
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5459

Gln Val Trp Asp Ser Ser Ser Asp His Trp Val 
1               5                   10      


<210>  5460
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5460

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5461
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5461

Gly Ala Ser 
1           


<210>  5462
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5462

Gln His Arg Ser Asn Trp Pro Pro Arg Leu Thr 
1               5                   10      


<210>  5463
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5463

Gln Ser Val Leu Asn Ser Gln Asn Asn Arg Asp Tyr 
1               5                   10          


<210>  5464
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5464

Trp Ala Ser 
1           


<210>  5465
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5465

Gln Gln Tyr Asn Asn Trp Trp Arg Thr 
1               5                   


<210>  5466
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5466

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5467
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5467

Ile Asn Ser 
1           


<210>  5468
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5468

Gln Ser Tyr Asp Ser Ser Leu Gly Ala Leu 
1               5                   10  


<210>  5469
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5469

Ser Gly His Thr Thr Tyr Ala 
1               5           


<210>  5470
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5470

Leu Asn Ser Asp Gly Ser His 
1               5           


<210>  5471
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5471

Gln Ser Trp Asp Thr Gly Ile Gly Val 
1               5                   


<210>  5472
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5472

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  5473
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5473

Gln Gly Ala 
1           


<210>  5474
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5474

Gln Ala Trp Asp Ser Ser Thr Val Val 
1               5                   


<210>  5475
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5475

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  5476
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5476

Glu Val Ser 
1           


<210>  5477
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5477

Cys Ser Tyr Val Gly Ser Ser Thr Tyr Val Val 
1               5                   10      


<210>  5478
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5478

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5479
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5479

Gly Ala Ser 
1           


<210>  5480
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5480

Gln Gln Met Tyr Ser Pro Pro Arg Thr 
1               5                   


<210>  5481
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5481

Ala Leu Ser Lys Gln Tyr 
1               5       


<210>  5482
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5482

Lys Asp Ser 
1           


<210>  5483
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5483

Gln Ser Ala Asp Ser Ser Ser His Trp Val 
1               5                   10  


<210>  5484
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5484

Ser Ser Asn Ile Gly Ile Asn Thr 
1               5               


<210>  5485
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5485

Ser Asn Asn 
1           


<210>  5486
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5486

Ala Ala Trp Asp Asp Ser Leu Asn Gly Pro Val 
1               5                   10      


<210>  5487
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5487

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  5488
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5488

Glu Asp Ser 
1           


<210>  5489
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5489

Gln Ser Phe Asp Ser Gly Asn Val Val 
1               5                   


<210>  5490
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5490

Ser Ser Asn Ile Gly Ser Asn Thr 
1               5               


<210>  5491
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5491

Asn Asn Asn 
1           


<210>  5492
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5492

Val Ala Trp Asp Asp Ser Arg Asn Gly Leu Val 
1               5                   10      


<210>  5493
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5493

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5494
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5494

Trp Ala Ser 
1           


<210>  5495
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5495

Gln Gln Tyr Tyr Ser Thr Arg Thr 
1               5               


<210>  5496
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5496

Gln Ser Val Phe Asn Ser Glu Asn His Tyr Asn Tyr 
1               5                   10          


<210>  5497
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5497

Trp Ala Ser 
1           


<210>  5498
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5498

Gln Gln Tyr Tyr Gly Ala Pro Arg Thr 
1               5                   


<210>  5499
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5499

Gln Asp Ile Lys Asn Phe 
1               5       


<210>  5500
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5500

Asp Ala Ser 
1           


<210>  5501
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5501

Gln Gln Tyr Asp Asn Leu Leu Phe Thr 
1               5                   


<210>  5502
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5502

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5503
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5503

Trp Ala Ser 
1           


<210>  5504
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5504

Gln Gln Tyr Tyr Ser Thr Pro Pro Tyr Thr 
1               5                   10  


<210>  5505
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5505

Gln Ser Val Phe Asn Trp Asp Asn His Arg Asp Tyr 
1               5                   10          


<210>  5506
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5506

Trp Ala Ser 
1           


<210>  5507
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5507

Gln His Arg Ser Asn Trp Pro Pro Arg Leu Thr 
1               5                   10      


<210>  5508
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5508

Ser Gly Ile Asp Ile Lys Met Tyr Arg 
1               5                   


<210>  5509
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5509

Tyr Lys Ser Asp Ser Asp Lys 
1               5           


<210>  5510
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5510

Leu Ile Trp His Ile Asn Ala Tyr Val 
1               5                   


<210>  5511
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5511

Asn Ser Asn Ile Gly Ser Tyr Thr 
1               5               


<210>  5512
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5512

Asp Asn Asn 
1           


<210>  5513
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5513

Leu Ala Trp Asp Asp Ser Leu Asn Gly Leu Val 
1               5                   10      


<210>  5514
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5514

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  5515
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5515

Asp Lys Asn 
1           


<210>  5516
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5516

Asn Ser Arg Asp Ser Ser Gly Asn Ala Val Val 
1               5                   10      


<210>  5517
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5517

Ser Pro Asn Ile Gly Ser Ser Thr 
1               5               


<210>  5518
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5518

Ser Asn Asn 
1           


<210>  5519
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5519

Ala Ser Trp Asp Asp Ser Leu Asn Gly His Val Val 
1               5                   10          


<210>  5520
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5520

Ser Gly His Arg Ser Tyr Ala 
1               5           


<210>  5521
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5521

Ile Thr Thr Asp Gly Arg His 
1               5           


<210>  5522
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5522

Gln Thr Trp Gly Thr 
1               5   


<210>  5523
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5523

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  5524
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5524

Asp Lys Asn 
1           


<210>  5525
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5525

Tyr Ser Thr Asp Ser Ser Gly Asn Val 
1               5                   


<210>  5526
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5526

Arg Asp Asp Val Gly Arg Tyr Asn His 
1               5                   


<210>  5527
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5527

Asp Val Asn 
1           


<210>  5528
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5528

Cys Ser Tyr Ala Glu Gly Tyr Ile Leu Val 
1               5                   10  


<210>  5529
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5529

Ser Ser Asn Ile Gly Ser Asn Tyr 
1               5               


<210>  5530
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5530

Ser Ser Asn 
1           


<210>  5531
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5531

Ala Ala Trp Asp Ala Ser Leu Ser Gly Trp Val 
1               5                   10      


<210>  5532
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5532

Ala Leu Pro Lys His Tyr 
1               5       


<210>  5533
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5533

Lys Asp Ile 
1           


<210>  5534
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5534

Gln Ser Val Asp Gly Ser Gly Ser Ser Val Val 
1               5                   10      


<210>  5535
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5535

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5536
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5536

Gly Ala Ser 
1           


<210>  5537
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5537

Gln Gln Tyr Asn Asn Trp Pro Pro Trp Thr 
1               5                   10  


<210>  5538
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5538

Ser Gly Ile Asn Val Glu Thr Tyr Pro 
1               5                   


<210>  5539
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5539

Tyr Asn Ser Asp Ser His Lys 
1               5           


<210>  5540
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5540

Met Ile Trp His Asn Asp Ala Ala Val 
1               5                   


<210>  5541
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5541

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  5542
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5542

Gln Asp Ser 
1           


<210>  5543
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5543

Gln Ala Trp Asp Ser Ser Thr His Val Val 
1               5                   10  


<210>  5544
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5544

Gln Ser Ile Ala Gly Tyr 
1               5       


<210>  5545
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5545

Ala Ala Ser 
1           


<210>  5546
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5546

Gln Leu Tyr Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  5547
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5547

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5548
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5548

Asp Val Ser 
1           


<210>  5549
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5549

Ser Ser Tyr Thr Ser Ser Ser Thr Pro Phe Val 
1               5                   10      


<210>  5550
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5550

Ser Gly His Ser Ser Tyr Ile 
1               5           


<210>  5551
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5551

Leu Glu Gly Ser Gly Ser Tyr 
1               5           


<210>  5552
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5552

Glu Thr Trp Asp Ser Asn Thr Arg Val 
1               5                   


<210>  5553
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5553

Gln Ser Ile Asn Ser Trp 
1               5       


<210>  5554
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5554

Lys Ala Ser 
1           


<210>  5555
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5555

Gln Gln Tyr Gly Ser Ser Pro Arg Leu Thr 
1               5                   10  


<210>  5556
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5556

Ala Leu Pro Asn Gln Tyr 
1               5       


<210>  5557
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5557

Lys Asp Ser 
1           


<210>  5558
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5558

Gln Ser Ala Asp Ser Ser Gly Tyr Val 
1               5                   


<210>  5559
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5559

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5560
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5560

Asp Val Ser 
1           


<210>  5561
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5561

Ser Ser Tyr Thr Ser Ser Ser Ile Pro Tyr Val 
1               5                   10      


<210>  5562
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5562

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  5563
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5563

Asp Thr Ser 
1           


<210>  5564
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5564

Gln Gln Arg Gly Asn Trp Trp Thr 
1               5               


<210>  5565
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5565

Gln Asp Ile Thr Asn Tyr 
1               5       


<210>  5566
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5566

Asp Ala Ser 
1           


<210>  5567
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5567

His Gln Tyr Asp Tyr Leu Pro Tyr Thr 
1               5                   


<210>  5568
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5568

Ser Ser Asp Val Gly Gly Tyr Lys Tyr 
1               5                   


<210>  5569
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5569

Glu Val Asn 
1           


<210>  5570
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5570

Ser Ser Tyr Thr Ser Ser Ser Thr Pro Phe Val 
1               5                   10      


<210>  5571
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5571

Gln Asn Val Phe Asn Ser His Asn Asn Arg Asp Tyr 
1               5                   10          


<210>  5572
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5572

Trp Ala Ser 
1           


<210>  5573
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5573

Gln Gln Tyr His Ala Ala Pro Arg Thr 
1               5                   


<210>  5574
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5574

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5575
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5575

Leu Gly Ser 
1           


<210>  5576
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5576

Met Gln Ala Leu Gln Thr Pro Phe Thr 
1               5                   


<210>  5577
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5577

Gln Thr Ile Ser Asn Phe 
1               5       


<210>  5578
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5578

Ala Ala Ser 
1           


<210>  5579
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5579

Gln Gln Thr Tyr Thr Asp Thr Trp Thr 
1               5                   


<210>  5580
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5580

Lys Ile Gly Arg Ile His 
1               5       


<210>  5581
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5581

Arg Asp Ser 
1           


<210>  5582
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5582

Gln Val Trp Asp Ser Ser Thr Val Val 
1               5                   


<210>  5583
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5583

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  5584
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5584

Glu Asp Ser 
1           


<210>  5585
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5585

Tyr Ser Thr Asp Thr Ser Gly Asn His Trp Val 
1               5                   10      


<210>  5586
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5586

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  5587
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5587

Glu Asp Ser 
1           


<210>  5588
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5588

Tyr Ser Thr Asp Ser Ser Gly Asn His Arg Val 
1               5                   10      


<210>  5589
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5589

Ala Val Pro Thr Gln Phe 
1               5       


<210>  5590
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5590

Lys Asp Thr 
1           


<210>  5591
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5591

Gln Ser Ala Asp Thr Ser Asp Thr Tyr Trp Val 
1               5                   10      


<210>  5592
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5592

Gln Ser Val Leu Phe Ser Thr Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5593
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5593

Trp Ala Ser 
1           


<210>  5594
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5594

Gln Gln Met Tyr Ser Pro Pro Arg Thr 
1               5                   


<210>  5595
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5595

Ser Leu Arg Asp Phe Tyr 
1               5       


<210>  5596
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5596

Gly Lys Asn 
1           


<210>  5597
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5597

Ile Cys Arg Asp Asn Ser Gly Asp His Pro Val 
1               5                   10      


<210>  5598
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5598

Gln Ser Val Ser Ser Thr Phe 
1               5           


<210>  5599
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5599

Gly Ala Ser 
1           


<210>  5600
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5600

His Gln Tyr Gly Thr Ser Pro Tyr Thr 
1               5                   


<210>  5601
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5601

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5602
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5602

Gly Ala Ser 
1           


<210>  5603
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5603

Gln Gln Tyr Asn Asn Phe Leu Thr 
1               5               


<210>  5604
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5604

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5605
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5605

Asp Val Ser 
1           


<210>  5606
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5606

Cys Ser Tyr Ala Gly Ser Tyr Thr Leu Val 
1               5                   10  


<210>  5607
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5607

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5608
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5608

Trp Ala Ser 
1           


<210>  5609
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5609

Gln Gln Tyr Tyr Ser Thr Pro Gly 
1               5               


<210>  5610
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5610

Gln Ser Val Thr Ser Ser Tyr 
1               5           


<210>  5611
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5611

Gly Ala Ser 
1           


<210>  5612
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5612

Gln Leu Tyr Gly Ser Ser Pro Leu Tyr Thr 
1               5                   10  


<210>  5613
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5613

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5614
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5614

Asp Val Asp 
1           


<210>  5615
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5615

Cys Ser Tyr Ala Gly Ser Tyr Thr Leu Val 
1               5                   10  


<210>  5616
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5616

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  5617
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5617

Asp Ala Ser 
1           


<210>  5618
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5618

Gln Leu Tyr Gly Ser Ser Pro Leu Tyr Thr 
1               5                   10  


<210>  5619
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5619

Asn Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5620
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5620

Gly Asn Ser 
1           


<210>  5621
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5621

Gln Ser Tyr Asp Ser Ser Leu Ser Asp Ser Val 
1               5                   10      


<210>  5622
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5622

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5623
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5623

Gly Asp Ser 
1           


<210>  5624
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5624

Gln Ser Tyr Asp Ser Ser Leu Ser Val Val 
1               5                   10  


<210>  5625
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5625

Gln Ser Val Arg Lys Ser Tyr 
1               5           


<210>  5626
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5626

Gly Ala Ser 
1           


<210>  5627
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5627

Gln Gln Tyr Gly Ser Ser Pro Leu Thr 
1               5                   


<210>  5628
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5628

Ala Leu Pro Asn Gln Tyr 
1               5       


<210>  5629
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5629

Lys Asp Ser 
1           


<210>  5630
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5630

Gln Ser Ala Asp Ser Ser Gly Thr Ser Trp Val 
1               5                   10      


<210>  5631
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5631

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5632
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5632

Gly Ala Ser 
1           


<210>  5633
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5633

Gln Gln Tyr Gly Ser Ser Pro Phe Thr 
1               5                   


<210>  5634
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5634

Gln Ser Ile Ser Ser Trp 
1               5       


<210>  5635
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5635

Lys Ala Ser 
1           


<210>  5636
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5636

Gln Gln Tyr Asn Ser Tyr Ser Leu Thr 
1               5                   


<210>  5637
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5637

Ser Arg Asp Phe Gly Ala His Asp Tyr 
1               5                   


<210>  5638
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5638

Lys Val Tyr 
1           


<210>  5639
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5639

Ser Thr Ala Pro Gly Ala Leu Ile Leu Leu 
1               5                   10  


<210>  5640
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5640

Ser Pro Asn Ile Gly Ser Asn Ser 
1               5               


<210>  5641
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5641

Thr Asp Asn 
1           


<210>  5642
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5642

Ser Ala Trp Asp Asp Ser Leu Ser Gly Trp Val 
1               5                   10      


<210>  5643
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5643

Ser Gly His Ile Thr Asn Ala 
1               5           


<210>  5644
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5644

Ile Asn Ser Asp Gly Thr His 
1               5           


<210>  5645
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5645

Leu Thr Trp Gly Ser Gly Ser Trp Val 
1               5                   


<210>  5646
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5646

Gln Ser Leu Phe Tyr Ser Ser Asn Ser Lys Asn Tyr 
1               5                   10          


<210>  5647
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5647

Trp Ala Ser 
1           


<210>  5648
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5648

Gln Gln Tyr Tyr Gly Thr Pro Tyr Thr 
1               5                   


<210>  5649
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5649

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5650
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5650

Gly Ala Ser 
1           


<210>  5651
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5651

Gln Gln Tyr Asn Asn Trp Trp Arg Thr 
1               5                   


<210>  5652
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5652

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  5653
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5653

Glu Asp Ser 
1           


<210>  5654
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5654

Tyr Ser Thr Asp Ser Ser Gly Asn His Trp Val 
1               5                   10      


<210>  5655
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5655

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5656
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5656

Gly Ala Ser 
1           


<210>  5657
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5657

Gln Gln Tyr Gly Ser Ser Pro Trp Thr 
1               5                   


<210>  5658
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5658

Gln Ser Ile Ser Ser Phe 
1               5       


<210>  5659
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5659

Ala Ala Phe 
1           


<210>  5660
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5660

Gln Gln Ser Tyr Asn Thr Pro Tyr Thr 
1               5                   


<210>  5661
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5661

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  5662
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5662

Gly Lys Asn 
1           


<210>  5663
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5663

Asn Phe Arg Asp Ser Ser Gly His His Pro Val 
1               5                   10      


<210>  5664
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5664

Gln Ser Val Leu Asn Ser Gln Asn Asn Arg Asp Tyr 
1               5                   10          


<210>  5665
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5665

Trp Ala Ser 
1           


<210>  5666
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5666

Gln Gln Leu Tyr Ser Pro Pro Arg Thr 
1               5                   


<210>  5667
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5667

Gln Thr Ile Lys Thr Phe 
1               5       


<210>  5668
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5668

Ser Ala Ser 
1           


<210>  5669
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5669

Gln Gln Tyr Asp Asn Leu Leu Phe Thr 
1               5                   


<210>  5670
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5670

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5671
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5671

Leu Gly Ser 
1           


<210>  5672
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5672

Met Gln Ala Leu Gln Thr Pro Phe Thr 
1               5                   


<210>  5673
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5673

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5674
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5674

Gly Asn Asn 
1           


<210>  5675
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5675

Gln Ser Tyr Asp Arg Ser Leu Ser Gly Val Val 
1               5                   10      


<210>  5676
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5676

Ser Ser Asn Ile Gly Ser Asn Thr 
1               5               


<210>  5677
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5677

Ser Asn Asn 
1           


<210>  5678
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5678

Ala Ala Trp Asp Asp Ser Leu Asn Ala Leu Val 
1               5                   10      


<210>  5679
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5679

Ser Ser Asn Ile Gly Ser Asn Thr 
1               5               


<210>  5680
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5680

Ser Asn Asn 
1           


<210>  5681
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5681

Ala Ala Trp Asp Asp Ser Leu Asn Gly Leu Tyr Val 
1               5                   10          


<210>  5682
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5682

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5683
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5683

Gly Asn Ser 
1           


<210>  5684
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5684

Gln Ser Tyr Asp Arg Thr Leu Ser Val Val 
1               5                   10  


<210>  5685
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5685

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  5686
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5686

Ala Ala Ser 
1           


<210>  5687
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5687

Gln His Leu Asn Ser Tyr Pro Phe 
1               5               


<210>  5688
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5688

Ser Ser Asp Val Gly Gly Tyr Asn Phe 
1               5                   


<210>  5689
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5689

Asp Val Ser 
1           


<210>  5690
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5690

Ser Ser Tyr Thr Ser Thr Ser Thr Pro Trp Val 
1               5                   10      


<210>  5691
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5691

Gln Asp Ile Val Ile Trp 
1               5       


<210>  5692
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5692

Gly Ala Ser 
1           


<210>  5693
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5693

Gln Gln Ala Asn Ser Val Pro Phe Thr 
1               5                   


<210>  5694
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5694

Gln Ser Leu Ser Ser His 
1               5       


<210>  5695
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5695

Gly Val Ser 
1           


<210>  5696
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5696

Gln Gln Tyr His Val Trp Pro Pro Ile Thr 
1               5                   10  


<210>  5697
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5697

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5698
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5698

Leu Gly Ser 
1           


<210>  5699
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5699

Gln Gln Tyr Asn Asn Trp Trp Arg Thr 
1               5                   


<210>  5700
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5700

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5701
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5701

Trp Ala Ser 
1           


<210>  5702
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5702

Gln Gln Tyr Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  5703
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5703

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5704
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5704

Trp Ala Ser 
1           


<210>  5705
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5705

Gln Gln Tyr Tyr Ser Thr Pro Tyr Thr 
1               5                   


<210>  5706
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5706

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5707
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5707

Ser Ala Ser 
1           


<210>  5708
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5708

Leu His Tyr Gly Asp Ser Pro Phe Thr 
1               5                   


<210>  5709
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5709

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  5710
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5710

Ala Ala Ser 
1           


<210>  5711
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5711

Gln Gln Thr Tyr Thr Asp Thr Trp Thr 
1               5                   


<210>  5712
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5712

Gln Ser Ile Ser Arg Trp 
1               5       


<210>  5713
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5713

Lys Ala Ser 
1           


<210>  5714
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5714

Gln Gln Tyr Asn Ser Tyr Ser Glu Thr 
1               5                   


<210>  5715
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5715

Gln Gly Ile Ser Ser Trp 
1               5       


<210>  5716
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5716

Ala Ala Ser 
1           


<210>  5717
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5717

Gln Gln Gly Asn Ser Phe Pro Leu Thr 
1               5                   


<210>  5718
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5718

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5719
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5719

Gly Asn Asn 
1           


<210>  5720
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5720

Gln Ser Tyr Asp Ser Ser Leu Ser Ala Trp Val 
1               5                   10      


<210>  5721
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5721

His Ser Ile Ser Ser Trp 
1               5       


<210>  5722
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5722

Lys Ala Ser 
1           


<210>  5723
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5723

Gln Gln Tyr Asn Thr Tyr Ser Gln Thr 
1               5                   


<210>  5724
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5724

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  5725
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5725

Asp Ala Ser 
1           


<210>  5726
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5726

Gln Gln Arg Ser Asn Trp Pro Pro Gly Val Thr 
1               5                   10      


<210>  5727
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5727

Ser Ser Asp Ile Gly Ser Tyr Asn Arg 
1               5                   


<210>  5728
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5728

Glu Val Thr 
1           


<210>  5729
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5729

Ser Ser Tyr Thr Ser Gly Ser Thr Val Ile 
1               5                   10  


<210>  5730
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5730

His Ser Ile Gly Thr Tyr 
1               5       


<210>  5731
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5731

Ala Ala Ser 
1           


<210>  5732
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5732

His Gln Ser Tyr Thr Thr Pro Arg Thr 
1               5                   


<210>  5733
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5733

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5734
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5734

Leu Gly Ser 
1           


<210>  5735
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5735

Met Gln Ser Ile Gln Pro Pro Leu Thr 
1               5                   


<210>  5736
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5736

Gln Asp Ile Arg Asn Tyr 
1               5       


<210>  5737
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5737

Asp Ala Ser 
1           


<210>  5738
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5738

His Gln Tyr Asp Tyr Leu Pro Tyr Thr 
1               5                   


<210>  5739
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5739

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  5740
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5740

Asp Ala Ser 
1           


<210>  5741
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5741

Gln Gln Arg Arg Ser Trp Pro Leu Thr 
1               5                   


<210>  5742
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5742

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5743
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5743

Ser Ala Ser 
1           


<210>  5744
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5744

Gln Gln Tyr Thr Asn Phe Leu Thr 
1               5               


<210>  5745
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5745

Ser Ser Asp Val Gly Ser Arg Asp Leu 
1               5                   


<210>  5746
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5746

Glu Val Thr 
1           


<210>  5747
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5747

Cys Ser Tyr Ser Gly Ser Ser Ile Phe Gly Val 
1               5                   10      


<210>  5748
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5748

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  5749
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5749

Ala Ala Thr 
1           


<210>  5750
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5750

Gln Gln Thr Tyr Ser Thr Pro Leu Tyr Thr 
1               5                   10  


<210>  5751
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5751

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  5752
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5752

Glu Asp Asn 
1           


<210>  5753
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5753

Gln Ser Tyr Asp Ser Ser Asn Val Val 
1               5                   


<210>  5754
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5754

Ser Ser Asn Val Glu Asn His Tyr 
1               5               


<210>  5755
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5755

Met Asn Asp 
1           


<210>  5756
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5756

Ala Ala Trp Asp Val Ser Leu Thr Gly Pro Val 
1               5                   10      


<210>  5757
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5757

Gln Ser Val Ser Ser Phe 
1               5       


<210>  5758
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5758

Asp Ala Ser 
1           


<210>  5759
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5759

Gln His Arg Thr Asn Trp Pro Pro Leu Phe Thr 
1               5                   10      


<210>  5760
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5760

Glu Asp Ile Arg Asn Tyr 
1               5       


<210>  5761
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5761

Ala Ala Ser 
1           


<210>  5762
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5762

Gln Gln Ser Tyr Ser Thr Pro Thr 
1               5               


<210>  5763
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5763

Gln Ser Leu Leu His Thr Asp Gly Lys Thr Tyr 
1               5                   10      


<210>  5764
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5764

Glu Val Ser 
1           


<210>  5765
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5765

Met Glu Gly Arg His Phe Pro Leu Phe Ser 
1               5                   10  


<210>  5766
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5766

Ala Leu Pro Asn Gln Tyr 
1               5       


<210>  5767
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5767

Lys Asp Ser 
1           


<210>  5768
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5768

Gln Ser Ala Asp Ser Ser Gly Thr Tyr Val Val 
1               5                   10      


<210>  5769
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5769

Gln Ser Val Ser Thr Trp 
1               5       


<210>  5770
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5770

Glu Ala Ser 
1           


<210>  5771
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5771

Gln Gln Tyr Asn Thr Tyr Ser Gly Thr 
1               5                   


<210>  5772
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5772

Ser Gly Tyr Ser Asn Tyr Lys 
1               5           


<210>  5773
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5773

Val Gly Thr Gly Gly Ile Val Gly 
1               5               


<210>  5774
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5774

Gly Ala Asp His Gly Ser Gly Ser Asn Phe Val Phe Val Val 
1               5                   10                  


<210>  5775
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5775

Gln Thr Ile Lys Thr Phe 
1               5       


<210>  5776
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5776

Ala Ala Ser 
1           


<210>  5777
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5777

Gln Gln Ser Tyr Ser Ile Pro Pro Thr 
1               5                   


<210>  5778
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5778

Gln Ser Val Leu His Arg Pro Asn Asn Met Asn Tyr 
1               5                   10          


<210>  5779
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5779

Trp Ala Ser 
1           


<210>  5780
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5780

Gln Gln Tyr Glu Val Thr Pro Arg Thr 
1               5                   


<210>  5781
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5781

Gln Ser Leu Leu Tyr Thr Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5782
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5782

Trp Ala Ser 
1           


<210>  5783
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5783

Gln Gln Tyr Tyr Ser Pro Pro Trp Thr 
1               5                   


<210>  5784
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5784

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  5785
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5785

Asp Ala Ser 
1           


<210>  5786
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5786

Gln Gln Tyr His Asn Leu Pro Pro Ile Thr 
1               5                   10  


<210>  5787
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5787

Lys Leu Gly Glu Thr Tyr 
1               5       


<210>  5788
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5788

Glu Asp Ser 
1           


<210>  5789
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5789

Gln Ala Trp Asp Ser Ser Thr Gly Gly Val 
1               5                   10  


<210>  5790
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5790

Gly Leu Ser Lys Gln Tyr 
1               5       


<210>  5791
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5791

Lys Asp Thr 
1           


<210>  5792
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5792

Gln Ser Thr Asp Gly Gly Gly Gly Phe Gln Gly Ile 
1               5                   10          


<210>  5793
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5793

Leu Asp Ile Ser Lys Tyr 
1               5       


<210>  5794
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5794

Asp Ala Phe 
1           


<210>  5795
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5795

Gln Gln Tyr Asp Asn Leu Pro Pro Gly Val Ser Thr Thr 
1               5                   10              


<210>  5796
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5796

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  5797
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5797

Glu Asp Ser 
1           


<210>  5798
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5798

Cys Ser Thr Asp Ser Ser Gly Asn Gln Arg Val 
1               5                   10      


<210>  5799
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5799

Ser Ser Asp Ile Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5800
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5800

Asp Val Ser 
1           


<210>  5801
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5801

Ser Ser Tyr Thr Ser Ser Ser Thr His Val Val 
1               5                   10      


<210>  5802
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5802

Ser Gly Asp Ile Ala Arg Asn Ser 
1               5               


<210>  5803
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5803

Glu Asp Asp 
1           


<210>  5804
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5804

His Ser Tyr Asp Asp Asn Tyr Gln Ala Phe 
1               5                   10  


<210>  5805
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5805

Ser Gly His Thr Thr Tyr Ala 
1               5           


<210>  5806
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5806

Leu Asn Ser Asp Gly Ser His 
1               5           


<210>  5807
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5807

Gln Ser Trp Asp Thr Gly Ile Gly Val 
1               5                   


<210>  5808
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5808

Ala Leu Pro Arg Gln Tyr 
1               5       


<210>  5809
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5809

Lys Asp Ser 
1           


<210>  5810
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5810

Gln Ser Ala Asp Thr Ile Gly Thr Tyr Trp Val 
1               5                   10      


<210>  5811
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5811

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5812
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5812

Gly Ala Ser 
1           


<210>  5813
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5813

Gln Gln Tyr Asn Asn Trp Pro Pro Met Tyr Thr 
1               5                   10      


<210>  5814
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5814

Ser Ile Gly Asn Lys Asn 
1               5       


<210>  5815
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5815

Asp Asp Ser 
1           


<210>  5816
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5816

Gln Leu Trp Asp Asp Asp Ser Asp Arg Val Val 
1               5                   10      


<210>  5817
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5817

Gln Asp Ile Thr Asn Tyr 
1               5       


<210>  5818
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5818

Asp Ala Ser 
1           


<210>  5819
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5819

Gln Gln Tyr Asp Asn Leu Tyr Ser Val His 
1               5                   10  


<210>  5820
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5820

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  5821
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5821

Ala Ala Ser 
1           


<210>  5822
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5822

Gln Gln Ser Tyr Glu Met Pro Pro Trp Thr 
1               5                   10  


<210>  5823
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5823

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5824
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5824

Gly Ala Ser 
1           


<210>  5825
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5825

Gln Leu Tyr Gly Ser Ser Pro Leu Tyr Thr 
1               5                   10  


<210>  5826
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5826

Ser Ser Asn Ile Gly Ser Asn Tyr 
1               5               


<210>  5827
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5827

Arg Asn Asn 
1           


<210>  5828
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5828

Ala Ala Trp Asp Asp Ser Leu Ser Ser Trp Val 
1               5                   10      


<210>  5829
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5829

Val Leu Ala Lys Lys Tyr 
1               5       


<210>  5830
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5830

Lys Asp Ser 
1           


<210>  5831
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5831

Tyr Ser Ala Ala Asp Asn Asn Leu Val 
1               5                   


<210>  5832
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5832

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  5833
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5833

Glu Asp Asn 
1           


<210>  5834
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5834

Gln Ser Tyr Asp Ser Gly Asn Pro Ile 
1               5                   


<210>  5835
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5835

Gln Ser Val Leu Asn Ser Gln Asn Asn Arg Asp Tyr 
1               5                   10          


<210>  5836
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5836

Trp Ala Ser 
1           


<210>  5837
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5837

Gln Gln Leu Tyr Ser Ala Pro Arg Thr 
1               5                   


<210>  5838
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5838

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  5839
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5839

Glu Asp Thr 
1           


<210>  5840
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5840

Gln Ala Trp Ser Ser Ser Thr Ala Val 
1               5                   


<210>  5841
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5841

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  5842
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5842

Glu Asp Asn 
1           


<210>  5843
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5843

Gln Ala Trp Asp Ser Val Thr Val Val 
1               5                   


<210>  5844
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5844

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  5845
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5845

Tyr Val Ser 
1           


<210>  5846
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5846

Ser Ser Tyr Thr Ser Ser Thr Leu Asn Val Leu 
1               5                   10      


<210>  5847
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5847

Ser Ser Asp Val Gly Ala Phe Asp Tyr 
1               5                   


<210>  5848
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5848

Asp Val Val 
1           


<210>  5849
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5849

Cys Ser Tyr Ala Gly Thr His Val Ala 
1               5                   


<210>  5850
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5850

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  5851
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5851

Ala Ala Ser 
1           


<210>  5852
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5852

Gln Gln Ser Tyr Ser Thr Pro Gly Thr 
1               5                   


<210>  5853
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5853

Gln Ser Val Asp Ser Asn Phe 
1               5           


<210>  5854
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5854

Asp Ala Ser 
1           


<210>  5855
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5855

Gln Gln Tyr Ser Ser Trp Pro Phe Ser 
1               5                   


<210>  5856
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5856

Ser Ser Asp Val Gly Ala Phe Asp Tyr 
1               5                   


<210>  5857
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5857

Asp Val Val 
1           


<210>  5858
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5858

Ser Ser Tyr Pro Cys Thr Tyr Thr Cys Gln Val Ile 
1               5                   10          


<210>  5859
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5859

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  5860
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5860

Gly Asn Ser 
1           


<210>  5861
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5861

Gln Ser Tyr Asp Ser Ser Leu Ser Gly Trp Ser Val 
1               5                   10          


<210>  5862
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5862

Ser Ser Asp Val Gly Asp Tyr Asn Tyr 
1               5                   


<210>  5863
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5863

Asp Val Ser 
1           


<210>  5864
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5864

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Leu Tyr Val 
1               5                   10          


<210>  5865
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5865

Gln Ser Ile Ser Ile Tyr 
1               5       


<210>  5866
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5866

Ala Ala Ser 
1           


<210>  5867
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5867

Gln Gln Ser Tyr Ser Thr His Met Ser Thr 
1               5                   10  


<210>  5868
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5868

Glu Thr Leu Leu His Ser Asp Gly Lys Thr Tyr 
1               5                   10      


<210>  5869
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5869

Glu Val Ser 
1           


<210>  5870
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5870

Met Gln Ser Ile Gln Leu Ala 
1               5           


<210>  5871
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5871

Gln Ser Leu Val Tyr Glu Asp Gly Lys Thr Tyr 
1               5                   10      


<210>  5872
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5872

Lys Val Ser 
1           


<210>  5873
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5873

Met Gln Gly Thr Arg Trp Pro Tyr Thr 
1               5                   


<210>  5874
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5874

Gln Ser Leu Leu Tyr Ser Ser Asp Asn Lys Asn Tyr 
1               5                   10          


<210>  5875
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5875

Trp Ala Ser 
1           


<210>  5876
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5876

Gln Gln Tyr Tyr Gly Val Leu Leu Thr 
1               5                   


<210>  5877
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5877

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5878
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5878

Gly Ala Ser 
1           


<210>  5879
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5879

Gln Gln Tyr Asn Tyr Trp Pro Pro Leu Thr 
1               5                   10  


<210>  5880
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5880

Glu Ser Leu Val Tyr Arg Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  5881
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5881

Met Val Ser 
1           


<210>  5882
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5882

Met Gln Ala Thr Gln Tyr Pro Tyr Thr 
1               5                   


<210>  5883
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5883

Arg Ser Asp Val Gly Gly Tyr Thr Tyr 
1               5                   


<210>  5884
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5884

His Val Ser 
1           


<210>  5885
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5885

Cys Ser Tyr Ala Gly Ser Tyr Ala Phe Ala Leu 
1               5                   10      


<210>  5886
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5886

Gln Ser Leu Leu Arg Ser Ser Gly Tyr Asn Tyr 
1               5                   10      


<210>  5887
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5887

Leu Gly Ser 
1           


<210>  5888
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5888

Met Gln Ala Leu Arg Thr Pro Leu Thr 
1               5                   


<210>  5889
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5889

Ser Ser Asn Ile Gly Asn Asn Tyr 
1               5               


<210>  5890
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5890

Lys Asn Ile 
1           


<210>  5891
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5891

Ala Thr Trp Asp Asp Ser Leu Ser Gly Arg Val 
1               5                   10      


<210>  5892
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5892

Ser Leu Arg Ser His Tyr 
1               5       


<210>  5893
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5893

Gly Arg Asn 
1           


<210>  5894
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5894

Ser Ser Gly Asp Ser Ser Thr Asp His His Val Val 
1               5                   10          


<210>  5895
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5895

Gln Ser Ile Ser Thr Tyr 
1               5       


<210>  5896
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5896

Ser Ala Ser 
1           


<210>  5897
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5897

His Gln Ser Tyr Gly Val Pro Ile Thr 
1               5                   


<210>  5898
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5898

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5899
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5899

Gly Ala Ser 
1           


<210>  5900
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5900

Gln Gln Tyr Asn Asn Trp Pro Pro Met Tyr Thr 
1               5                   10      


<210>  5901
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5901

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  5902
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5902

Glu Asp Asn 
1           


<210>  5903
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5903

Gln Ser Tyr Asp Ser Ser Lys Tyr Val Val 
1               5                   10  


<210>  5904

<400>  5904
000

<210>  5905

<400>  5905
000

<210>  5906

<400>  5906
000

<210>  5907
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5907

Gln Ser Leu Leu Gln Ser His Gly Tyr Asn Phe 
1               5                   10      


<210>  5908
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5908

Leu Gly Ser 
1           


<210>  5909
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5909

Met Gln Ala Gln Gln Thr Pro His Thr 
1               5                   


<210>  5910
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5910

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  5911
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5911

Leu Gly Ser 
1           


<210>  5912
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5912

Met Gln Ala Leu Gln Thr Pro Leu Tyr Thr 
1               5                   10  


<210>  5913
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5913

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  5914
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5914

Ala Ala Ser 
1           


<210>  5915
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5915

Gln Gln Ser Tyr Ser Ser Leu Ser Ile Thr 
1               5                   10  


<210>  5916
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5916

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  5917
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5917

Ser Ala Ser 
1           


<210>  5918
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5918

Gln Gln Tyr Thr Asn Phe Leu Thr 
1               5               


<210>  5919
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5919

Ser Ser Asp Val Gly Glu Tyr Asn Leu 
1               5                   


<210>  5920
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5920

Val Val Ser 
1           


<210>  5921
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5921

Leu Ser Tyr Ala Gly Gly Gly Arg Gly Phe 
1               5                   10  


<210>  5922
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5922

Ala Leu Pro Arg Gln Phe 
1               5       


<210>  5923
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5923

Lys Asp Ser 
1           


<210>  5924
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5924

Gln Ser Ala Asp Thr Ile Gly Thr Tyr Trp Val 
1               5                   10      


<210>  5925
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5925

Gln Ser Leu Val Tyr Ser Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  5926
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5926

Lys Val Ser 
1           


<210>  5927
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5927

Met Gln Gly Thr His Trp Pro Asn Thr 
1               5                   


<210>  5928
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5928

Gln Ser Val Asn Thr Ala Ser 
1               5           


<210>  5929
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5929

Gly Thr Ser 
1           


<210>  5930
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5930

Gln Gln Tyr Asp Ile Ser Pro Gly Thr 
1               5                   


<210>  5931
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5931

Ser Ser Asn Ile Gly Ser Asn Tyr 
1               5               


<210>  5932
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5932

Arg Asn Asn 
1           


<210>  5933
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5933

Val Ala Trp Asp Asp Ser Leu Ser Gly Val Val 
1               5                   10      


<210>  5934
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5934

Gln Tyr Phe Gly Arg Trp 
1               5       


<210>  5935
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5935

Glu Ala Ser 
1           


<210>  5936
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5936

Gln Arg Tyr Asp Gly Pro 
1               5       


<210>  5937
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5937

Ser Ala Ser Val Ser Thr Ser Tyr Tyr 
1               5                   


<210>  5938
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5938

Ser Thr Asn 
1           


<210>  5939
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5939

Val Leu Tyr Met Gly Ser Gly Ile Ser Ile 
1               5                   10  


<210>  5940
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5940

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  5941
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5941

Asp Ala Ser 
1           


<210>  5942
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5942

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  5943
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5943

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  5944
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5944

Lys Asp Thr 
1           


<210>  5945
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5945

Gln Ser Thr Ala Ser Ser Gly Thr Tyr Val Val 
1               5                   10      


<210>  5946
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5946

Gln Ser Ile Ser Ser Trp 
1               5       


<210>  5947
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5947

Lys Ala Ser 
1           


<210>  5948
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5948

Gln Gln Tyr Asn Ser Tyr Ser Pro Thr 
1               5                   


<210>  5949
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5949

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  5950
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5950

Glu Asp Asn 
1           


<210>  5951
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5951

Gln Ser Tyr Asp Gly Ile Asn Arg Trp Leu Val 
1               5                   10      


<210>  5952
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5952

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5953
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5953

Gly Ala Ser 
1           


<210>  5954
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5954

Gln Gln Tyr Asn Asn Trp Pro Gly Thr 
1               5                   


<210>  5955
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5955

Gln Ser Val Leu Phe Ser Thr Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  5956
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5956

Trp Ala Ser 
1           


<210>  5957
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5957

Gln Gln Tyr Tyr Ser Asn Pro Leu Trp Thr 
1               5                   10  


<210>  5958
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5958

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  5959
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5959

Ala Ala Ser 
1           


<210>  5960
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5960

Gln Gln Ser Tyr Ser Thr Pro Met His Thr 
1               5                   10  


<210>  5961
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5961

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  5962
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5962

Ala Ala Ser 
1           


<210>  5963
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5963

Gln Gln Leu Asn Ser Tyr Leu Gly Thr 
1               5                   


<210>  5964
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5964

Gln Gly Ile Ser Ser Trp 
1               5       


<210>  5965
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5965

Ala Ala Ser 
1           


<210>  5966
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5966

Gln Gln Ser Tyr Ser Ile Pro Pro Thr 
1               5                   


<210>  5967
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5967

Gln Ser Leu Ser Arg Thr Tyr 
1               5           


<210>  5968
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5968

Asn Ala Ser 
1           


<210>  5969
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5969

Gln Gln Tyr Asp Thr Ser Pro Trp Thr 
1               5                   


<210>  5970
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5970

Ala Leu Ala Lys Gln Tyr 
1               5       


<210>  5971
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5971

Glu Asp Arg 
1           


<210>  5972
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5972

Phe Ser Ala Asp Ser Leu Gly Gly His Arg Met 
1               5                   10      


<210>  5973
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5973

Gln Gly Ile Ser Ser Trp 
1               5       


<210>  5974
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5974

Asp Ala Ser 
1           


<210>  5975
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5975

Gln Gln Ala Asn Ser Phe Pro Pro Thr 
1               5                   


<210>  5976
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5976

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  5977
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5977

Val Ala Ser 
1           


<210>  5978
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5978

Gln Lys Tyr Asp Ser Val Pro Leu Thr 
1               5                   


<210>  5979
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5979

Gln Ser Val Ser Thr Trp 
1               5       


<210>  5980
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5980

Glu Ala Ser 
1           


<210>  5981
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5981

His Gln Tyr Gly Ile Ser Pro Phe Thr 
1               5                   


<210>  5982
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5982

Gln Ser Leu Leu His Ser Asn Gly Asn Asn Tyr 
1               5                   10      


<210>  5983
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5983

Leu Val Ser 
1           


<210>  5984
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5984

Met Gln Ala Leu Gln Thr Pro Pro Thr 
1               5                   


<210>  5985
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5985

Asn Ser Asn Ile Gly Ser Tyr Thr 
1               5               


<210>  5986
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5986

Asp Asn Asn 
1           


<210>  5987
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5987

Leu Val Trp Asp Asp Ser Leu Asn Gly Leu Val 
1               5                   10      


<210>  5988
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5988

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  5989
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5989

Glu Val Ser 
1           


<210>  5990
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5990

Cys Ser Tyr Ala Gly Ser Ser Thr Trp Gly 
1               5                   10  


<210>  5991
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5991

Asn Ile Gly Thr Lys Gly 
1               5       


<210>  5992
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5992

Asp Asp Ser 
1           


<210>  5993
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5993

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  5994
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5994

Gln Ser Leu Leu His Ser Asp Gly Tyr Thr Tyr 
1               5                   10      


<210>  5995
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5995

Leu Gly Ser 
1           


<210>  5996
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5996

Met Gln Ala Leu Gln Thr Pro Leu Thr 
1               5                   


<210>  5997
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5997

Gln Ser Val Ser Ser Asn 
1               5       


<210>  5998
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5998

Gly Ala Ser 
1           


<210>  5999
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5999

Gln Gln Tyr Asn Asn Trp Trp Arg Thr 
1               5                   


<210>  6000
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6000

Gln Asp Ile Lys Lys Tyr 
1               5       


<210>  6001
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6001

Asp Thr Ser 
1           


<210>  6002
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6002

Gln Gln Tyr Asp Asn Leu Pro Phe Thr 
1               5                   


<210>  6003
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6003

Ser Leu Arg Lys Tyr Tyr 
1               5       


<210>  6004
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6004

Gly Lys Asn 
1           


<210>  6005
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6005

Tyr Ser Arg Asp Arg Ser Gly Asn Arg Trp Val 
1               5                   10      


<210>  6006
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6006

Gln Gly Ile Ser Asn Tyr 
1               5       


<210>  6007
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6007

Ala Ala Ser 
1           


<210>  6008
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6008

Gln Gln Tyr Tyr Ser Phe Pro Tyr Thr 
1               5                   


<210>  6009
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6009

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6010
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6010

Gly Ala Ser 
1           


<210>  6011
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6011

Gln Gln Tyr Asn Asn Trp Pro Pro Met Tyr Thr 
1               5                   10      


<210>  6012
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6012

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6013
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6013

Gly Ala Ser 
1           


<210>  6014
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6014

Gln Gln Tyr Asn Asn Trp Pro Arg Thr 
1               5                   


<210>  6015
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6015

Thr Gly Ser Val Thr Ser Gly His Tyr 
1               5                   


<210>  6016
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6016

Asp Thr Ser 
1           


<210>  6017
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6017

Leu Leu Thr Tyr Ile Val Thr His Thr Ala Thr Arg Val 
1               5                   10              


<210>  6018
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6018

Val Leu Pro Lys Gln Tyr 
1               5       


<210>  6019
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6019

Lys Asp Thr 
1           


<210>  6020
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6020

Gln Ser Ala Asp Ser Ser Gly Val Tyr Leu Asn Trp Val 
1               5                   10              


<210>  6021
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6021

Ser Gly His Arg Ser Tyr Ala 
1               5           


<210>  6022
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6022

Ile Thr Thr Asp Gly Arg His 
1               5           


<210>  6023
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6023

Gln Thr Trp Gly Thr 
1               5   


<210>  6024
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6024

Thr Gly Thr Val Thr Arg Asp His Tyr 
1               5                   


<210>  6025
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6025

Asp Thr Ser 
1           


<210>  6026
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6026

Leu Leu Thr Tyr Gly Gly Gly Arg Val 
1               5                   


<210>  6027
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6027

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  6028
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6028

Val Ala Ser 
1           


<210>  6029
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6029

Gln Glu Tyr Gly Ser Ser Ala Ile Thr 
1               5                   


<210>  6030
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6030

Gln Asn Val Asn Asn Met 
1               5       


<210>  6031
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6031

Ser Thr Ser 
1           


<210>  6032
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6032

Gln His His Asp Thr Trp Pro Tyr Ala 
1               5                   


<210>  6033
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6033

Gln Ser Ile Leu His Ser Pro Asn Ser Gln Asn Tyr 
1               5                   10          


<210>  6034
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6034

Trp Ala Ser 
1           


<210>  6035
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6035

Gln Gln Tyr Tyr Thr Pro Pro Arg Thr 
1               5                   


<210>  6036
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6036

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6037
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6037

Gly Asn Ser 
1           


<210>  6038
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6038

Gln Ser Tyr Asp Arg Ser Leu Ser Gly Val Val 
1               5                   10      


<210>  6039
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6039

Gln Ser Leu Val His Gly Ser Gly Asn Thr Tyr 
1               5                   10      


<210>  6040
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6040

Lys Val Ser 
1           


<210>  6041
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6041

Met Gln Ala Thr Tyr Trp Pro Tyr Thr 
1               5                   


<210>  6042
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6042

Gln Thr Thr Gly Glu Trp 
1               5       


<210>  6043
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6043

Lys Thr Ser 
1           


<210>  6044
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6044

Gln Gln Tyr Gly Ala Tyr Pro Trp Thr 
1               5                   


<210>  6045
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6045

Gln Ser Leu Leu His Ser Asp Gly Lys Thr Tyr 
1               5                   10      


<210>  6046
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6046

Glu Val Ser 
1           


<210>  6047
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6047

Met Gln Ser Ile Gln Pro Pro Leu Thr 
1               5                   


<210>  6048
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6048

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  6049
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6049

Trp Ala Ser 
1           


<210>  6050
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6050

Gln Gln Tyr Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  6051
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6051

Ile Ser Asp Val Gly Gly Trp Asn Tyr 
1               5                   


<210>  6052
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6052

Asp Val Arg 
1           


<210>  6053
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6053

Ser Ser Phe Thr Ser Arg Gly Ala Leu Val Leu 
1               5                   10      


<210>  6054
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6054

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6055
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6055

Asp Val Ser 
1           


<210>  6056
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6056

Cys Ser Tyr Ala Gly Ile Trp Val 
1               5               


<210>  6057
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6057

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6058
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6058

Gly Ala Ser 
1           


<210>  6059
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6059

Gln His Tyr Gly Ser Ser Arg Ser Thr 
1               5                   


<210>  6060
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6060

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  6061
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6061

Ala Ala Ser 
1           


<210>  6062
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6062

Gln Gln Ser Tyr Ser Thr Pro Thr 
1               5               


<210>  6063
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6063

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6064
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6064

Gly Ala Ser 
1           


<210>  6065
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6065

Gln Gln Tyr Asn Asn Trp Pro Leu Thr 
1               5                   


<210>  6066
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6066

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6067
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6067

Ala Ala Ser 
1           


<210>  6068
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6068

Gln Gln Ser Tyr Ser Thr Pro Tyr Thr 
1               5                   


<210>  6069
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6069

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6070
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6070

Gly Asn Asn 
1           


<210>  6071
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6071

Asn Ser Arg Asp Ser Ser Gly Asn His Leu Arg Val 
1               5                   10          


<210>  6072
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6072

Gln Ser Ile Gly Pro Trp 
1               5       


<210>  6073
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6073

Glu Thr Ser 
1           


<210>  6074
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6074

His Gln Tyr Met Ala Phe Trp Thr 
1               5               


<210>  6075
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6075

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6076
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6076

Asp Val Ser 
1           


<210>  6077
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6077

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Val Val 
1               5                   10      


<210>  6078
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6078

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6079
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6079

Gly Ala Ser 
1           


<210>  6080
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6080

Leu His Tyr Gly Asp Ser Pro Phe Thr 
1               5                   


<210>  6081
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6081

Ser Arg Asp Phe Gly Ala His Asp Tyr 
1               5                   


<210>  6082
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6082

Lys Val Tyr 
1           


<210>  6083
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6083

Ser Thr Ala Pro Gly Ala Leu Ile Leu Leu 
1               5                   10  


<210>  6084
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6084

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6085
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6085

Lys Asp Ser 
1           


<210>  6086
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6086

Gln Ala Trp Asp Ser Ser Thr Gly Val 
1               5                   


<210>  6087
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6087

Ser Ser Asn Ile Glu Ser Asn Ser 
1               5               


<210>  6088
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6088

Ser Asn Asn 
1           


<210>  6089
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6089

Ala Ala Trp Asp Asp Ser Leu Asn Gly Tyr Val 
1               5                   10      


<210>  6090
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6090

Ala Leu Pro Lys His Tyr 
1               5       


<210>  6091
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6091

Lys Asp Ile 
1           


<210>  6092
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6092

Gln Ala Trp Asp Ser Ser Thr Pro Tyr Val 
1               5                   10  


<210>  6093
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6093

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6094
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6094

Ala Ala Ser 
1           


<210>  6095
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6095

Gln Gln Ser Tyr Ser Thr Pro Gly Thr 
1               5                   


<210>  6096
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6096

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  6097
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6097

Val Ala Ser 
1           


<210>  6098
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6098

Gln Lys Tyr Asp Ser Val Pro Leu Thr 
1               5                   


<210>  6099
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6099

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6100
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6100

Lys Asp Ser 
1           


<210>  6101
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6101

Tyr Ser Thr Asp Ser Ser Gly Asn Val 
1               5                   


<210>  6102
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6102

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6103
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6103

Glu Val Ser 
1           


<210>  6104
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6104

Cys Ser Tyr Ala Gly Thr Ser 
1               5           


<210>  6105
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6105

Gln Ser Ile Gly Pro Trp 
1               5       


<210>  6106
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6106

Gly Thr Thr 
1           


<210>  6107
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6107

Gln Gln Tyr Asn Asn Trp Pro Pro Met Tyr Thr 
1               5                   10      


<210>  6108
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6108

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6109
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6109

Asp Lys Asn 
1           


<210>  6110
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6110

Asn Ser Arg Asp Ser Ser Gly Asn Ala Val Val 
1               5                   10      


<210>  6111
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6111

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6112
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6112

Tyr Val Ser 
1           


<210>  6113
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6113

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Tyr Val 
1               5                   10      


<210>  6114
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6114

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  6115
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6115

Glu Asp Ser 
1           


<210>  6116
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6116

Cys Ser Thr Asp Ser Ser Gly Asn Gln Arg Val 
1               5                   10      


<210>  6117
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6117

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6118
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6118

Gly Ala Ser 
1           


<210>  6119
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6119

Gln Gln Tyr Asn Ser Tyr Ser Pro Asp Thr 
1               5                   10  


<210>  6120
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6120

Ser Ser Asn Ile Gly His Asn Thr 
1               5               


<210>  6121
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6121

Arg Asn Asn 
1           


<210>  6122
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6122

Ala Ala Trp Asp Asp Ser Leu Asn Gly Pro Val 
1               5                   10      


<210>  6123
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6123

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6124
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6124

Gly Ala Ser 
1           


<210>  6125
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6125

Gln Gln Tyr Asn Asn Trp Pro Gly Thr 
1               5                   


<210>  6126
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6126

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  6127
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6127

Gln Gly Ala 
1           


<210>  6128
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6128

Gln Ala Trp Asp Ser Ser Thr Val Val 
1               5                   


<210>  6129
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6129

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  6130
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6130

Leu Gly Ser 
1           


<210>  6131
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6131

Met Gln Ala Leu Gln Thr Pro Phe Thr 
1               5                   


<210>  6132
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6132

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6133
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6133

Gly Ala Ser 
1           


<210>  6134
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6134

Gln Gln Tyr Gly Arg Ser Ser Gly Thr 
1               5                   


<210>  6135
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6135

Gln Ser Val Ser Thr Trp 
1               5       


<210>  6136
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6136

Ala Ala Phe 
1           


<210>  6137
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6137

Gln Gln Tyr Tyr Ser Tyr Pro Pro Asn Thr 
1               5                   10  


<210>  6138
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6138

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6139
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6139

Gly Asp Ser 
1           


<210>  6140
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6140

Ala Ala Trp Asp Asp Ser Leu Ser Ser Trp Val 
1               5                   10      


<210>  6141
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6141

Gln Thr Ile Ala Asn Ser 
1               5       


<210>  6142
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6142

Leu Ser Ser 
1           


<210>  6143
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6143

Gln Gln Tyr Asp Asn Leu Tyr Ser Val His 
1               5                   10  


<210>  6144
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6144

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6145
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6145

Gly Ala Ser 
1           


<210>  6146
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6146

Gln Gln Tyr Gly Ser Ser Pro Leu Ile Thr 
1               5                   10  


<210>  6147
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6147

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6148
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6148

Ala Ala Ser 
1           


<210>  6149
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6149

His Gln Ser Tyr Gly Val Pro Ile Thr 
1               5                   


<210>  6150
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6150

Ser Gly Tyr Ser Asn Tyr Lys 
1               5           


<210>  6151
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6151

Val Gly Thr Gly Gly Ile Val Gly 
1               5               


<210>  6152
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6152

Gly Ala Asp His Gly Ser Gly Ser Asn Phe Val Tyr Val Val 
1               5                   10                  


<210>  6153
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6153

Gln Asp Ile Lys Lys Tyr 
1               5       


<210>  6154
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6154

Asp Thr Ser 
1           


<210>  6155
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6155

Gln Gln Tyr Asp Asn Leu Pro Phe Thr 
1               5                   


<210>  6156
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6156

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6157
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6157

Lys Asp Ser 
1           


<210>  6158
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6158

Gln Ala Trp Asp Ser Ser Thr His Val Val 
1               5                   10  


<210>  6159
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6159

Thr Leu Pro Lys Gln Tyr 
1               5       


<210>  6160
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6160

Lys Asp Ser 
1           


<210>  6161
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6161

Gln Ser Gly Asp Tyr Ser Gly Thr Trp Val 
1               5                   10  


<210>  6162
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6162

Ser Pro Asn Ile Gly Ser Asn Ser 
1               5               


<210>  6163
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6163

Thr Asp Asn 
1           


<210>  6164
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6164

Ser Ala Trp Asp Asp Ser Leu Ser Gly Trp Val 
1               5                   10      


<210>  6165
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6165

Gln Ser Val Arg Lys Ser Tyr 
1               5           


<210>  6166
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6166

Gly Ala Ser 
1           


<210>  6167
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6167

Gln Gln Tyr Gly Ser Ser Pro Thr 
1               5               


<210>  6168
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6168

Gln Ser Val Asp Ser Asn Phe 
1               5           


<210>  6169
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6169

Asp Ala Ser 
1           


<210>  6170
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6170

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  6171
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6171

Gln Ser Val Leu Tyr Thr Pro Lys Asn Lys Asn Tyr 
1               5                   10          


<210>  6172
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6172

Trp Ala Ser 
1           


<210>  6173
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6173

Gln Gln Tyr Tyr Thr Ala Pro Leu Thr 
1               5                   


<210>  6174
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6174

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  6175
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6175

Glu Asp Ser 
1           


<210>  6176
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6176

Cys Ser Thr Asp Ser Ser Gly Asn Gln Arg Val 
1               5                   10      


<210>  6177
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6177

Ser Leu Arg Arg Tyr Tyr 
1               5       


<210>  6178
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6178

Asp Lys Asn 
1           


<210>  6179
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6179

Ser Ser Arg Asp Ser Ser Gly Asn His Leu Phe Val 
1               5                   10          


<210>  6180
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6180

Gln Ser Ile Arg Arg His 
1               5       


<210>  6181
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6181

Ala Ala Ser 
1           


<210>  6182
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6182

Gln Gln Ser Tyr Ser Val Ser Pro Tyr Thr 
1               5                   10  


<210>  6183
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6183

Ala Gly Ala Val Thr Ser Gly Tyr Tyr 
1               5                   


<210>  6184
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6184

Ser Thr Ala 
1           


<210>  6185
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6185

Leu Leu Tyr Tyr Gly Gly Ala Trp Val 
1               5                   


<210>  6186
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6186

Gln Ser Val Asn Lys Tyr 
1               5       


<210>  6187
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6187

Asp Ala Ser 
1           


<210>  6188
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6188

Gln Gln Arg Phe Gln Trp Pro Pro Gly Thr 
1               5                   10  


<210>  6189
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6189

Gln Asn Ile Gly Ser Ser 
1               5       


<210>  6190
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6190

Tyr Ala Ser 
1           


<210>  6191
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6191

His Gln Ser Ser Ser Leu Pro Pro Thr 
1               5                   


<210>  6192
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6192

Gln Ser Ile Ser Ser Phe 
1               5       


<210>  6193
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6193

Asp Ala Ser 
1           


<210>  6194
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6194

Gln Arg Arg Ser Asn Trp Pro Pro Phe Thr 
1               5                   10  


<210>  6195
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6195

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  6196
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6196

Glu Asp Asn 
1           


<210>  6197
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6197

Gln Ser Tyr Asp Ser Ser Asn Tyr Trp Val 
1               5                   10  


<210>  6198
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6198

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6199
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6199

Asp Lys Asn 
1           


<210>  6200
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6200

Asn Ser Arg Asp Ser Ser Gly Asn Ala Val Val 
1               5                   10      


<210>  6201
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6201

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  6202
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6202

Asp Ala Ser 
1           


<210>  6203
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6203

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  6204
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6204

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6205
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6205

Gly Ala Ser 
1           


<210>  6206
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6206

Gln Gln Tyr Gly Ser Ser Pro Leu Thr 
1               5                   


<210>  6207
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6207

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  6208
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6208

Trp Ala Ser 
1           


<210>  6209
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6209

Gln Gln Tyr Tyr Ser Ser Pro Tyr Thr 
1               5                   


<210>  6210
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6210

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  6211
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6211

Glu Asp Asn 
1           


<210>  6212
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6212

Gln Ser Tyr Asp Ser Ser Asn His Val Val 
1               5                   10  


<210>  6213
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6213

Gln Ser Val Leu Tyr Ser Ser Asn Ser Lys His Tyr 
1               5                   10          


<210>  6214
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6214

Trp Ala Ser 
1           


<210>  6215
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6215

Gln Gln Tyr Tyr Thr Thr Pro Asn Thr 
1               5                   


<210>  6216
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6216

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6217
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6217

Gly Ala Ser 
1           


<210>  6218
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6218

Gln Gln Tyr Asn Asn Trp Trp Arg Thr 
1               5                   


<210>  6219
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6219

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6220
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6220

Gly Ala Ser 
1           


<210>  6221
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6221

Gln Gln Tyr Gly Ser Ser Pro Arg Leu Thr 
1               5                   10  


<210>  6222
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6222

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  6223
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6223

Ala Ala Ser 
1           


<210>  6224
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6224

Gln Gln Ser Tyr Ser Ser Leu Ser Ile Thr 
1               5                   10  


<210>  6225
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6225

Gln Ser Leu Leu His Ser Asp Gly Lys Thr Tyr 
1               5                   10      


<210>  6226
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6226

Glu Val Ser 
1           


<210>  6227
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6227

Met Gln Ser Ile Gln Pro Pro Leu Thr 
1               5                   


<210>  6228
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6228

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6229
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6229

Asp Val Ser 
1           


<210>  6230
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6230

Cys Ser Tyr Ala Ser Ser Ser Ile Val Val 
1               5                   10  


<210>  6231
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6231

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6232
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6232

Gly Lys Asn 
1           


<210>  6233
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6233

Gln Ser Val Asp Ser Ser Gly Thr Tyr Pro His Val Ile 
1               5                   10              


<210>  6234
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6234

Gln Asp Ile Asn Asn Tyr 
1               5       


<210>  6235
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6235

Asp Ala Ser 
1           


<210>  6236
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6236

Gln Gln Tyr Asp Asn Leu Pro Tyr Thr 
1               5                   


<210>  6237
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6237

Gln Asn Ile Arg Ser Tyr 
1               5       


<210>  6238
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6238

Ala Ala Ser 
1           


<210>  6239
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6239

Gln Gln Ser Ser Ser Ser Pro Ile Thr 
1               5                   


<210>  6240
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6240

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  6241
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6241

Asp Asp Ser 
1           


<210>  6242
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6242

Gln Val Trp Asp Ser Ser Ser Asp His Pro Gly Val 
1               5                   10          


<210>  6243
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6243

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6244
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6244

Lys Asp Thr 
1           


<210>  6245
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6245

Gln Ser Ala Asp Ser Ser Gly Ser Arg 
1               5                   


<210>  6246
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6246

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6247
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6247

Gly Ala Ser 
1           


<210>  6248
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6248

Gln Gln Tyr Asn Asn Trp Pro Tyr Thr 
1               5                   


<210>  6249
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6249

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6250
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6250

Asp Asp Ser 
1           


<210>  6251
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6251

Gln Val Trp Asp Ser Gly Ser Asp His Val Val 
1               5                   10      


<210>  6252
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6252

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6253
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6253

Ala Ala Ser 
1           


<210>  6254
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6254

Gln Gln Ser Tyr Glu Ile Pro Pro Trp Thr 
1               5                   10  


<210>  6255
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6255

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  6256
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6256

Asp Asp Ser 
1           


<210>  6257
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6257

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6258
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6258

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6259
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6259

Glu Gly Ser 
1           


<210>  6260
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6260

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  6261
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6261

Ser Ser Asn Ile Gly Ser Asn Thr 
1               5               


<210>  6262
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6262

Asn Asn Asn 
1           


<210>  6263
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6263

Ala Thr Trp Asp Asp Ser Leu Asn Gly Pro Val 
1               5                   10      


<210>  6264
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6264

Ser Ser Asn Ile Gly Ser Gly Ser Asp 
1               5                   


<210>  6265
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6265

Gly Asn Thr 
1           


<210>  6266
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6266

Gln Ser Tyr Asp Ser Arg Leu Ser Gly Phe Val Val 
1               5                   10          


<210>  6267
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6267

Ala Leu Pro Asn Glu Tyr 
1               5       


<210>  6268
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6268

Lys Asp Ser 
1           


<210>  6269
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6269

Gln Ser Glu Asp Ser Ser Gly Thr Tyr Pro His Val Ile 
1               5                   10              


<210>  6270
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6270

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6271
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6271

Asp Asp Ser 
1           


<210>  6272
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6272

Gln Val Trp Asp Ser Ser Ser Asp Pro Phe Tyr Val 
1               5                   10          


<210>  6273
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6273

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  6274
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6274

Ala Ala Ser 
1           


<210>  6275
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6275

Gln Gln Ser Tyr Ser Met Pro Pro Ile Thr 
1               5                   10  


<210>  6276
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6276

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6277
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6277

Lys Asp Ser 
1           


<210>  6278
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6278

Gln Ser Ala Asp Ser Ser Gly Thr Ser Val Leu 
1               5                   10      


<210>  6279
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6279

Ser Gly His Thr Ser Asn Ala 
1               5           


<210>  6280
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6280

Ile Asn Ser Asp Gly Ser His 
1               5           


<210>  6281
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6281

Leu Thr Trp Val Thr Gly Ser Trp Val 
1               5                   


<210>  6282
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6282

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6283
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6283

Glu Gly Ser 
1           


<210>  6284
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6284

Cys Ser Tyr Ala Arg Ser Ser Thr Arg Val 
1               5                   10  


<210>  6285
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6285

Ala Phe Pro Lys Gln Tyr 
1               5       


<210>  6286
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6286

Lys Asp Ser 
1           


<210>  6287
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6287

Gln Ser Ala Asp Ser Arg Gly Ala Val 
1               5                   


<210>  6288
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6288

Gln Asp Ile Asn His Tyr 
1               5       


<210>  6289
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6289

Ala Ala Ser 
1           


<210>  6290
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6290

Gln Gln Tyr Asp Asn Leu Pro Pro Val 
1               5                   


<210>  6291
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6291

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6292
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6292

Gly Ala Ser 
1           


<210>  6293
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6293

Gln Gln Tyr Asp Asn Leu Pro Arg Thr 
1               5                   


<210>  6294
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6294

Ser Ser Asn Ile Gly Ser Asn Tyr 
1               5               


<210>  6295
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6295

Arg Asn Asn 
1           


<210>  6296
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6296

Ala Ala Trp Asp Asp Ser Leu Ser Ala Trp Val 
1               5                   10      


<210>  6297
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6297

Ser Ser Asn Ile Gly Asn Asn Lys 
1               5               


<210>  6298
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6298

Asn Ser Asn 
1           


<210>  6299
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6299

Ala Val Trp Asp Asp Ser Leu His Ser Tyr Val 
1               5                   10      


<210>  6300
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6300

Gln Arg Leu Ala Pro Thr Leu 
1               5           


<210>  6301
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6301

Ala Ala Ser 
1           


<210>  6302
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6302

Gln Gln Ser Phe Ser Thr Pro Arg Thr 
1               5                   


<210>  6303
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6303

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6304
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6304

Glu Val Ser 
1           


<210>  6305
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6305

Ser Ser Tyr Arg Ser Val Ser Thr Val Val 
1               5                   10  


<210>  6306
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6306

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6307
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6307

Lys Asp Ser 
1           


<210>  6308
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6308

Gln Ala Trp Gly Ser Ser Arg Gly Val 
1               5                   


<210>  6309
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6309

Gln Ser Val Leu His Ser Ser Asn Asn Lys Asp Ser 
1               5                   10          


<210>  6310
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6310

Trp Ala Ser 
1           


<210>  6311
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6311

Gln Gln Tyr Asn Ser Tyr Pro Ile Thr 
1               5                   


<210>  6312
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6312

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  6313
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6313

Ala Asn Ser 
1           


<210>  6314
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6314

Gln Ser Tyr Asp Ser Ser Leu Asn Gly Asp Val 
1               5                   10      


<210>  6315
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6315

Gln Ser Ile Ser Arg Tyr 
1               5       


<210>  6316
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6316

Thr Ala Ser 
1           


<210>  6317
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6317

Gln Gln Ser Tyr Ser Thr Pro Arg Thr 
1               5                   


<210>  6318
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6318

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  6319
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6319

Asp Ala Ser 
1           


<210>  6320
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6320

Gln Gln Tyr Asp Asn Leu Pro Leu Ala 
1               5                   


<210>  6321
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6321

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  6322
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6322

Ala Ala Ser 
1           


<210>  6323
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6323

Gln Gln Ser Tyr Thr Thr Leu Leu Thr 
1               5                   


<210>  6324
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6324

Gln Arg Leu Ala Pro Thr Leu 
1               5           


<210>  6325
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6325

Ala Ala Ser 
1           


<210>  6326
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6326

His Gln Tyr Gly Ile Ser Pro Phe Thr 
1               5                   


<210>  6327
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6327

Ser Ser Asn Ile Gly Ala Arg Tyr Asp 
1               5                   


<210>  6328
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6328

Gly Asn Asn 
1           


<210>  6329
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6329

Gln Ser Tyr Asp Ser Ser Leu Ser Gly Trp Val 
1               5                   10      


<210>  6330
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6330

Gln Asp Ile Asn Lys Tyr 
1               5       


<210>  6331
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6331

Asp Ala Ser 
1           


<210>  6332
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6332

Gln Gln Tyr Ala Asn Leu Pro Phe Thr 
1               5                   


<210>  6333
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6333

Gln Asp Ile Asn Lys Tyr 
1               5       


<210>  6334
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6334

Asp Ala Ser 
1           


<210>  6335
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6335

Gln Gln Tyr Asp Asn Leu Pro Arg Thr 
1               5                   


<210>  6336
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6336

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6337
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6337

Gly Asn Ser 
1           


<210>  6338
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6338

Gln Ser Tyr Asp Ser Ser Leu Ser Gly Tyr Val 
1               5                   10      


<210>  6339
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6339

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6340
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6340

Gly Lys Asn 
1           


<210>  6341
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6341

Asn Val Arg Asp Ser Ser Gly His His Pro Val 
1               5                   10      


<210>  6342
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6342

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6343
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6343

Glu Val Ile 
1           


<210>  6344
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6344

Cys Ser Tyr Ala Val Ser Thr Thr Tyr Val Ile 
1               5                   10      


<210>  6345
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6345

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6346
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6346

Ala Ala Ser 
1           


<210>  6347
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6347

Gln Gln Ser Tyr Ser Asn Pro Ser Tyr Thr 
1               5                   10  


<210>  6348
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6348

Gln Ser Val Ala Ser Ser Tyr 
1               5           


<210>  6349
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6349

Gly Ala Ser 
1           


<210>  6350
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6350

Gln Gln Tyr Gly Ser Ser Pro Pro Arg Tyr Thr 
1               5                   10      


<210>  6351
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6351

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6352
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6352

Ala Ala Ser 
1           


<210>  6353
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6353

Gln Gln Ser Tyr Ser Thr Leu Leu Tyr Thr 
1               5                   10  


<210>  6354
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6354

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  6355
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6355

Leu Gly Ser 
1           


<210>  6356
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6356

Met Gln Ala Leu Gln Thr Pro Phe Thr 
1               5                   


<210>  6357
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6357

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6358
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6358

Tyr Asp Ser 
1           


<210>  6359
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6359

Gln Val Trp Asp Ser Ser Ser Asp Arg Leu Tyr Val 
1               5                   10          


<210>  6360
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6360

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  6361
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6361

Ala Ala Ser 
1           


<210>  6362
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6362

Gln Gln Ser Tyr Ser Asn Pro Ser Tyr Thr 
1               5                   10  


<210>  6363
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6363

Gln Ser Leu Leu Tyr Ser Asp Gly Tyr Asn Tyr 
1               5                   10      


<210>  6364
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6364

Leu Gly Ser 
1           


<210>  6365
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6365

Met Gln Ala Leu Glu Val Pro His Thr 
1               5                   


<210>  6366
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6366

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  6367
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6367

Asp Asp Asn 
1           


<210>  6368
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6368

Gln Ala Trp Gly Ser Ser Arg Gly Val 
1               5                   


<210>  6369
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6369

Ser Gly Ile Asp Val Gly Thr Tyr Arg 
1               5                   


<210>  6370
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6370

Tyr Lys Ser Asp Ser Asp Lys 
1               5           


<210>  6371
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6371

Leu Ile Trp His Ile Asn Ala Tyr Val 
1               5                   


<210>  6372

<400>  6372
000

<210>  6373
<211>  0
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6373
000
<210>  6374

<400>  6374
000

<210>  6375
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6375

Asn Ile Gly Arg Lys Ser 
1               5       


<210>  6376
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6376

Asp Asp Ser 
1           


<210>  6377
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6377

Gln Val Trp Asp Ser Ser Ser Asp His Pro Gly Val 
1               5                   10          


<210>  6378
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6378

Asn Ser Asn Ile Gly Ser Tyr Thr 
1               5               


<210>  6379
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6379

Asp Asn Asn 
1           


<210>  6380
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6380

Ala Val Trp Asp Asp Ser Leu Asn Gly Leu Val 
1               5                   10      


<210>  6381
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6381

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6382
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6382

Gly Asn Thr 
1           


<210>  6383
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6383

Gln Ser Tyr Asp Ser Ser Leu Asn Gly Asp Val 
1               5                   10      


<210>  6384
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6384

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  6385
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6385

Trp Ala Ser 
1           


<210>  6386
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6386

Gln Gln Tyr Ser Ser Thr Pro Trp Thr 
1               5                   


<210>  6387
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6387

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  6388
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6388

Leu Gly Ser 
1           


<210>  6389
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6389

Gln Gln Ser Tyr Thr Thr Leu Leu Thr 
1               5                   


<210>  6390
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6390

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  6391
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6391

Asp Ala Tyr 
1           


<210>  6392
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6392

Gln Gln Arg Ser Asn Trp Pro Leu Ile Phe Thr 
1               5                   10      


<210>  6393
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6393

Ser Leu Arg Arg Tyr Tyr 
1               5       


<210>  6394
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6394

Gly Lys Asn 
1           


<210>  6395
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6395

Asn Ser Arg Asp Ser Ser Gly Ser Tyr Val 
1               5                   10  


<210>  6396
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6396

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  6397
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6397

Thr Ala Ser 
1           


<210>  6398
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6398

Gln Gln Tyr Gly Ser Leu Ser Phe Thr 
1               5                   


<210>  6399
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6399

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  6400
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6400

Gly Asn Asn 
1           


<210>  6401
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6401

Gln Ser Tyr Asp Ser Ser Leu Ser Gly Tyr Val 
1               5                   10      


<210>  6402
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6402

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6403
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6403

Gly Ala Ser 
1           


<210>  6404
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6404

Gln Gln Ser Tyr Ser Thr Pro Arg Thr 
1               5                   


<210>  6405
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6405

Asn Ile Gly Arg Lys Ser 
1               5       


<210>  6406
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6406

Asp Asp Ser 
1           


<210>  6407
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6407

Gln Val Trp Asp Ser Ser Ser Asp His Pro Gly Val 
1               5                   10          


<210>  6408
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6408

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6409
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6409

Asp Ala Ser 
1           


<210>  6410
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6410

Gln Gln Ser Tyr Ser Thr Pro Pro Ile Thr 
1               5                   10  


<210>  6411
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6411

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6412
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6412

Glu Gly Ser 
1           


<210>  6413
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6413

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  6414
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6414

Gln Ser Ile Arg Ser Tyr 
1               5       


<210>  6415
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6415

Val Ala Ser 
1           


<210>  6416
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6416

Gln Gln Ser Tyr Ser Thr Pro Pro Trp Thr 
1               5                   10  


<210>  6417
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6417

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  6418
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6418

Trp Ala Ser 
1           


<210>  6419
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6419

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  6420
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6420

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6421
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6421

Asp Asp Ser 
1           


<210>  6422
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6422

Gln Val Trp Asp Ser Ser Ser Asp His Pro Glu Trp Val 
1               5                   10              


<210>  6423
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6423

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6424
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6424

Gly Ala Ser 
1           


<210>  6425
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6425

Gln His Tyr Gly Ser Ser Arg Gly Trp Thr 
1               5                   10  


<210>  6426
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6426

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  6427
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6427

Asp Ala Ser 
1           


<210>  6428
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6428

Gln Gln Tyr Ala Asn Leu Pro Phe Thr 
1               5                   


<210>  6429
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6429

Asn Ser Asn Ile Gly Ser Tyr Thr 
1               5               


<210>  6430
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6430

Gly Asn Asn 
1           


<210>  6431
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6431

Val Ala Trp Asp Asp Ser Arg Asn Gly Leu Val 
1               5                   10      


<210>  6432
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6432

Gln Asp Ile Asn His Tyr 
1               5       


<210>  6433
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6433

Asp Ala Ser 
1           


<210>  6434
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6434

Gln Gln Ser Asp Asn Leu Pro Met Tyr Thr 
1               5                   10  


<210>  6435
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6435

Gln Gly Ile Asn Ser Trp 
1               5       


<210>  6436
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6436

Ala Ala Ser 
1           


<210>  6437
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6437

Gln Gln Ala Asn Ser Phe Pro Pro Thr 
1               5                   


<210>  6438
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6438

Ala Leu Pro Asn Glu Tyr 
1               5       


<210>  6439
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6439

Lys Asp Ser 
1           


<210>  6440
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6440

Gln Ser Val Asp Ser Ser Gly Thr Tyr Pro His Val Ile 
1               5                   10              


<210>  6441
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6441

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6442
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6442

Gly Ala Ser 
1           


<210>  6443
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6443

His Gln Tyr Gly Ile Ser Pro Phe Thr 
1               5                   


<210>  6444
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6444

Asn Ile Gly Arg Lys Ser 
1               5       


<210>  6445
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6445

Asp Asp Ser 
1           


<210>  6446
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6446

Gln Ser Val Asp Ser Ser Gly Thr Tyr Pro His Val Ile 
1               5                   10              


<210>  6447
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6447

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  6448
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6448

Gly Asn Asn 
1           


<210>  6449
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6449

Gln Ser Phe Asp Ile Gly Arg Gly Gly Trp Ile 
1               5                   10      


<210>  6450
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6450

Gln Ser Ile Ile Ser Tyr 
1               5       


<210>  6451
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6451

Ala Ala Ser 
1           


<210>  6452
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6452

Gln Gln Ser Tyr Ser Thr Pro Tyr Thr 
1               5                   


<210>  6453
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6453

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  6454
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6454

Ala Ala Ser 
1           


<210>  6455
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6455

Gln Gln Leu Asn Ser Tyr Pro Leu Thr 
1               5                   


<210>  6456
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6456

Gln Gly Ile Ser Asn Tyr 
1               5       


<210>  6457
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6457

Ala Ala Ser 
1           


<210>  6458
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6458

Gln Gln Ser Ser Ser Ser Pro Ile Thr 
1               5                   


<210>  6459
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6459

Gln Asp Ile Asn Asn Tyr 
1               5       


<210>  6460
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6460

Asp Ala Ser 
1           


<210>  6461
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6461

Gln Gln Ser Asp Asn Leu Pro Met Tyr Thr 
1               5                   10  


<210>  6462
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6462

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6463
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6463

Asp Asp Ser 
1           


<210>  6464
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6464

Gln Val Trp Asp Ser Ser Ser Asp His Pro Glu Trp Val 
1               5                   10              


<210>  6465
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6465

Ser Ser Asp Val Gly Gly Tyr Asn Phe 
1               5                   


<210>  6466
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6466

Asp Val Ser 
1           


<210>  6467
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6467

Thr Ser Tyr Thr Ser Ser Ser Thr Leu Asn Val Val 
1               5                   10          


<210>  6468
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6468

Gln Asp Ile Asn His Tyr 
1               5       


<210>  6469
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6469

Asp Ala Ser 
1           


<210>  6470
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6470

Gln Gln Tyr Asp Asn Leu Pro Pro Val 
1               5                   


<210>  6471
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6471

Gln Asp Ile Asn Asn Tyr 
1               5       


<210>  6472
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6472

Asp Ala Ser 
1           


<210>  6473
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6473

Gln Leu Leu Asn Ser His Pro Leu Thr 
1               5                   


<210>  6474
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6474

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6475
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6475

Asp Val Ser 
1           


<210>  6476
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6476

Ser Ser Tyr Thr Ser Arg Ser Thr Leu Val 
1               5                   10  


<210>  6477
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6477

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6478
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6478

Glu Val Ser 
1           


<210>  6479
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6479

Cys Ser Tyr Ala Ser Ser Ser Ile Val Val 
1               5                   10  


<210>  6480
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6480

Ser Gly Ile Asp Val Gly Thr Tyr Arg 
1               5                   


<210>  6481
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6481

Tyr Lys Ser Asp Ser Asp Lys 
1               5           


<210>  6482
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6482

Leu Ile Trp His Ile Asn Ala Tyr Val 
1               5                   


<210>  6483
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6483

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6484
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6484

Gly Ala Ser 
1           


<210>  6485
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6485

Gln Gln Thr His Ser Pro Leu Asp Ser 
1               5                   


<210>  6486
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6486

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6487
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6487

Gly Lys Asn 
1           


<210>  6488
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6488

Asn Ser Arg Asp Asn Ser Gly Asn Leu Asn Trp Val 
1               5                   10          


<210>  6489
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6489

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6490
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6490

Ala Ala Ser 
1           


<210>  6491
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6491

Gln Gln Ser Tyr Ser Thr Pro Pro Trp Thr 
1               5                   10  


<210>  6492
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6492

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6493
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6493

Ala Ala Ser 
1           


<210>  6494
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6494

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  6495
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6495

Asn Ile Gly Ser Lys Asn 
1               5       


<210>  6496
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6496

His Asp Gly 
1           


<210>  6497
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6497

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6498
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6498

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  6499
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6499

Ala Ala Ser 
1           


<210>  6500
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6500

Gln Gln Leu Asn Ser Tyr Ser Phe Glu Thr 
1               5                   10  


<210>  6501
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6501

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  6502
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6502

Glu Asp Asn 
1           


<210>  6503
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6503

Gln Ser Tyr Asp Gly Ile Asn Arg Trp Leu Val 
1               5                   10      


<210>  6504
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6504

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  6505
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6505

Gln Asp Ser 
1           


<210>  6506
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6506

Gln Ala Trp Asp Ser Ser Thr Ala Val 
1               5                   


<210>  6507
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6507

Gln Ser Ile Ser Ser Trp 
1               5       


<210>  6508
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6508

Lys Ala Ser 
1           


<210>  6509
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6509

Gln Gln Tyr Asn Ser Tyr Pro Tyr Thr 
1               5                   


<210>  6510
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6510

Gln Ser Val Ser Thr Phe 
1               5       


<210>  6511
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6511

Ala Ala Ser 
1           


<210>  6512
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6512

Gln Gln Thr His Ser Pro Leu Asp Ser 
1               5                   


<210>  6513
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6513

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6514
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6514

Ala Ala Ser 
1           


<210>  6515
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6515

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  6516
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6516

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6517
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6517

Gly Lys Asn 
1           


<210>  6518
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6518

Leu Thr Trp Val Thr Gly Ser Trp Val 
1               5                   


<210>  6519
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6519

Gln Asn Ile Arg Ser Tyr 
1               5       


<210>  6520
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6520

Ala Ala Ser 
1           


<210>  6521
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6521

Gln Gln Ser Ser Ser Ser Pro Ile Thr 
1               5                   


<210>  6522
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6522

Gln Ser Ile Gly Ser Ser Tyr 
1               5           


<210>  6523
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6523

Gly Ala Ser 
1           


<210>  6524
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6524

Gln Gln His Ala Gly Ser Pro Arg Thr 
1               5                   


<210>  6525
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6525

Ala Leu Pro Asn Glu Tyr 
1               5       


<210>  6526
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6526

Lys Asp Ser 
1           


<210>  6527
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6527

Gln Ser Val Asp Ser Ser Gly Thr Tyr Pro His Val Ile 
1               5                   10              


<210>  6528
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6528

Ser Ser Asn Ile Gly Ala Arg Tyr Asp 
1               5                   


<210>  6529
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6529

Ala Asn Ser 
1           


<210>  6530
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6530

Cys Ser Tyr Ala Arg Ser Ser Thr Arg Val 
1               5                   10  


<210>  6531
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6531

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6532
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6532

Asp Asp Ser 
1           


<210>  6533
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6533

Gln Val Trp Asp Ser Ser Ser Asp His Pro Gly Val 
1               5                   10          


<210>  6534
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6534

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  6535
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6535

Trp Ala Ser 
1           


<210>  6536
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6536

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  6537
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6537

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  6538
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6538

Asp Ala Ser 
1           


<210>  6539
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6539

Gln Gln Tyr Ala Asn Leu Pro Phe Thr 
1               5                   


<210>  6540
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6540

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6541
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6541

Gly Ala Ser 
1           


<210>  6542
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6542

Gln Gln Cys Ser Asp Trp Pro Thr 
1               5               


<210>  6543
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6543

Asn Phe Ala Thr Lys Ser 
1               5       


<210>  6544
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6544

Asp Asp Asn 
1           


<210>  6545
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6545

Gln Val Trp Asp Ser Arg Ser Gly His Phe Val Val 
1               5                   10          


<210>  6546
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6546

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  6547
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6547

Ala Ala Ser 
1           


<210>  6548
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6548

Gln Gln Ser Tyr Thr Thr Leu Leu Thr 
1               5                   


<210>  6549
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6549

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6550
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6550

Glu Gly Ser 
1           


<210>  6551
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6551

Cys Ser Tyr Val Gly Tyr Arg Thr Val Val 
1               5                   10  


<210>  6552
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6552

Tyr Ile Gly Arg Lys Asn 
1               5       


<210>  6553
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6553

Asp Asp Ser 
1           


<210>  6554
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6554

Gln Val Trp Asp Gly Ile Asn Asp Arg Val Val 
1               5                   10      


<210>  6555
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6555

Gln Asp Ile Asn Asn Tyr 
1               5       


<210>  6556
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6556

Asp Ala Ser 
1           


<210>  6557
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6557

Gln Gln Tyr Asp Asn Leu Pro Pro Val 
1               5                   


<210>  6558
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6558

Gln Ser Ile Ser Thr Tyr 
1               5       


<210>  6559
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6559

Ala Ala Ser 
1           


<210>  6560
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6560

Gln Gln Ser Tyr Ser Ser Glu Trp Thr 
1               5                   


<210>  6561
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6561

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6562
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6562

Glu Gly Ser 
1           


<210>  6563
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6563

Cys Ser Tyr Ala Arg Ser Ser Thr Arg Val 
1               5                   10  


<210>  6564
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6564

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6565
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6565

Lys Asp Ser 
1           


<210>  6566
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6566

Gln Val Trp Asp Ser Ser Ser Asp His Pro Glu Trp Val 
1               5                   10              


<210>  6567
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6567

Thr Ser Asn Ile Gly Ala Gly Ser Asp 
1               5                   


<210>  6568
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6568

Tyr Asn Thr 
1           


<210>  6569
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6569

Gln Ser Tyr Asp Ile Ser Leu Gly Gly Trp Val 
1               5                   10      


<210>  6570
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6570

Gln Ser Val Ser Asn Asn Tyr 
1               5           


<210>  6571
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6571

Gly Ala Ser 
1           


<210>  6572
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6572

Gln Gln His Ala Gly Ser Pro Arg Thr 
1               5                   


<210>  6573
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6573

Gln Ser Val Ser Ile Tyr 
1               5       


<210>  6574
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6574

Ala Ala Ser 
1           


<210>  6575
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6575

Gln Gln Ser Tyr Ser Met Pro Pro Ile Thr 
1               5                   10  


<210>  6576
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6576

Ser Ser Asn Ile Gly Ser Asn Ser 
1               5               


<210>  6577
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6577

Ser Asn Asn 
1           


<210>  6578
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6578

Ala Ala Trp Asp Asp Ser Leu Asn Gly Ser Trp Val 
1               5                   10          


<210>  6579
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6579

Arg Tyr Asn Ile Gly Ser Asn Tyr 
1               5               


<210>  6580
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6580

Ser Asn Asn 
1           


<210>  6581
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6581

Ala Ala Trp Asp Asp Ser Leu Ser Gly Leu Ile 
1               5                   10      


<210>  6582
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6582

Ser Gly Ser Ile Ala Ser Ser Tyr 
1               5               


<210>  6583
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6583

Glu Asp Asn 
1           


<210>  6584
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6584

Gln Ser Tyr Asp Gly Ile Asn Arg Ala Trp Val 
1               5                   10      


<210>  6585
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6585

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6586
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6586

Glu Gly Ser 
1           


<210>  6587
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6587

Cys Ser Tyr Ala Gly Ser Ser Thr Trp Leu 
1               5                   10  


<210>  6588
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6588

Gln Thr Ile Phe Ser Thr Tyr 
1               5           


<210>  6589
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6589

Gly Thr Ser 
1           


<210>  6590
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6590

Gln Gln Tyr Tyr Asn Tyr Val Thr 
1               5               


<210>  6591
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6591

Ala Leu Pro Asn Glu Tyr 
1               5       


<210>  6592
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6592

Lys Asp Ser 
1           


<210>  6593
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6593

Gln Ser Val Asp Ser Ser Gly Thr Tyr Pro His Val Ile 
1               5                   10              


<210>  6594
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6594

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6595
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6595

Asp Asp Ser 
1           


<210>  6596
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6596

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6597
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6597

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6598
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6598

Asp Val Ser 
1           


<210>  6599
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6599

Cys Ser Tyr Ala Arg Ser Ser Thr Arg Val 
1               5                   10  


<210>  6600
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6600

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6601
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6601

Ala Asn Ser 
1           


<210>  6602
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6602

Val Ala Trp Asp Asp Ser Arg Asn Gly Leu Val 
1               5                   10      


<210>  6603
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6603

Ser Ser Asn Ile Gly Asn Asn Tyr 
1               5               


<210>  6604
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6604

Asp Asn Asn 
1           


<210>  6605
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6605

Gly Thr Trp Asp Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210>  6606
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6606

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  6607
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6607

Asp Asp Ser 
1           


<210>  6608
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6608

Gln Val Trp Asp Ser Ser Ser Asp His Pro Gly Val 
1               5                   10          


<210>  6609
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6609

Asn Ile Gly Ser Lys Asn 
1               5       


<210>  6610
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6610

His Asp Gly 
1           


<210>  6611
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6611

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6612
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6612

Gln Ser Ile Ile Ser Tyr 
1               5       


<210>  6613
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6613

Ala Ala Ser 
1           


<210>  6614
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6614

Gln Gln Ser Asp Asn Leu Pro Met Tyr Thr 
1               5                   10  


<210>  6615
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6615

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  6616
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6616

Trp Ala Ser 
1           


<210>  6617
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6617

Leu Leu Phe Gly Cys Ser Arg Gly Trp Lys 
1               5                   10  


<210>  6618
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6618

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  6619
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6619

Lys Asp Ser 
1           


<210>  6620
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6620

Gln Ser Val Asp Ser Ser Gly Thr Tyr Pro His Val Ile 
1               5                   10              


<210>  6621
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6621

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  6622
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6622

Gln Asp Thr 
1           


<210>  6623
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6623

Gln Ala Trp Gly Ser Ser Arg Gly Val 
1               5                   


<210>  6624
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6624

Asn Phe Ala Thr Lys Ser 
1               5       


<210>  6625
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6625

Asp Asp Ser 
1           


<210>  6626
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6626

Gln Val Trp Asp Ser Gly Ser Asp His Val Val 
1               5                   10      


<210>  6627
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6627

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6628
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6628

Gly Lys Asn 
1           


<210>  6629
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6629

Asn Ser Arg Asp Asn Ser Gly Asn Leu Asn Trp Val 
1               5                   10          


<210>  6630
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6630

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6631
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6631

Lys Asp Ser 
1           


<210>  6632
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6632

Gln Val Trp Asp Ser Ser Ser Asp His Pro Glu Trp Val 
1               5                   10              


<210>  6633
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6633

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6634
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6634

Asp Asp Ser 
1           


<210>  6635
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6635

Gln Val Trp Asp Ser Gly Ser Asp His Val Val 
1               5                   10      


<210>  6636
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6636

Ser Ser Asp Val Gly Gly Tyr Thr Tyr 
1               5                   


<210>  6637
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6637

Asp Val Asn 
1           


<210>  6638
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6638

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  6639
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6639

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  6640
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6640

Trp Ala Ser 
1           


<210>  6641
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6641

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  6642
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6642

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6643
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6643

Glu Gly Ser 
1           


<210>  6644
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6644

Cys Ser Tyr Ala Gly Ser Ser Thr Trp Leu 
1               5                   10  


<210>  6645
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6645

Ser Ser Asn Ile Gly Ala Arg Tyr Asp 
1               5                   


<210>  6646
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6646

Gly Asn Asn 
1           


<210>  6647
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6647

Cys Ser Tyr Ala Ser Ser Ser Ile Val Val 
1               5                   10  


<210>  6648
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6648

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  6649
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6649

Glu Asp Asn 
1           


<210>  6650
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6650

Gln Ser Tyr Asp Ser Thr Ser Arg Val Val 
1               5                   10  


<210>  6651
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6651

Gln Ser Leu Val His Ser Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  6652
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6652

Lys Val Ser 
1           


<210>  6653
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6653

Met Gln Gly Thr His Trp Pro 
1               5           


<210>  6654
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6654

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6655
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6655

Asp Asp Ser 
1           


<210>  6656
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6656

Gln Val Trp Asp Ser Gly Ser Asp His Val Val 
1               5                   10      


<210>  6657
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6657

Gln Asp Ile Asn Lys Tyr 
1               5       


<210>  6658
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6658

Asp Ala Ser 
1           


<210>  6659
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6659

Gln Gln Tyr Asp Asn Leu Pro Pro Val 
1               5                   


<210>  6660
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6660

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6661
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6661

Ala Ala Ser 
1           


<210>  6662
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6662

Gln Gln Ser Tyr Ser Thr Pro Gln Thr 
1               5                   


<210>  6663
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6663

Ser Ser Asp Val Gly Gly Tyr Thr Tyr 
1               5                   


<210>  6664
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6664

Asp Val Asn 
1           


<210>  6665
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6665

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  6666
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6666

Ser Ser Asn Ile Gly Asn Asn Ala 
1               5               


<210>  6667
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6667

Tyr Asp Asp 
1           


<210>  6668
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6668

Ala Ser Trp Asp Asp Ser Leu Ile Gly Pro Val 
1               5                   10      


<210>  6669
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6669

Gln Gly Ile Ser Thr Tyr 
1               5       


<210>  6670
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6670

Ala Ala Ser 
1           


<210>  6671
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6671

Gln Gln Leu Asn Ser Tyr Pro Gly Tyr Thr 
1               5                   10  


<210>  6672
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6672

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6673
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6673

Glu Val Ser 
1           


<210>  6674
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6674

Cys Ser Tyr Ala Ser Ser Ser Ile Val Val 
1               5                   10  


<210>  6675
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6675

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6676
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6676

Gly Lys Asn 
1           


<210>  6677
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6677

Asn Ser Arg Asp Asn Ser Gly Asn Leu Asn Trp Val 
1               5                   10          


<210>  6678

<400>  6678
000

<210>  6679

<400>  6679
000

<210>  6680

<400>  6680
000

<210>  6681
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6681

Gln Asn Ile Arg Ser Tyr 
1               5       


<210>  6682
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6682

Ala Ala Ser 
1           


<210>  6683
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6683

Gln Gln Ser Ser Ser Ser Pro Ile Thr 
1               5                   


<210>  6684
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6684

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6685
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6685

Asp Val Ser 
1           


<210>  6686
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6686

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  6687
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6687

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  6688
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6688

Glu Asp Asn 
1           


<210>  6689
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6689

Gln Ser Tyr Asp Ser Asn Asn Gln Val 
1               5                   


<210>  6690
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6690

Ser Gly Ser Ile Ala Ser Ser Tyr 
1               5               


<210>  6691
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6691

Glu Asp Asn 
1           


<210>  6692
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6692

Gln Ser Tyr Asp Ser Ser Asp Val Val 
1               5                   


<210>  6693
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6693

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  6694
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6694

Glu Asp Asn 
1           


<210>  6695
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6695

Gln Ser Tyr Asp Gly Ile Asn Arg Ala Trp Val 
1               5                   10      


<210>  6696
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6696

Asn Ile Gly Ser Lys Asn 
1               5       


<210>  6697
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6697

His Asp Gly 
1           


<210>  6698
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6698

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6699
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6699

Gln Arg Leu Ala Pro Thr Leu 
1               5           


<210>  6700
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6700

Ala Ala Ser 
1           


<210>  6701
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6701

Gln Gln Ser Tyr Ser Thr Leu Leu Tyr Thr 
1               5                   10  


<210>  6702
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6702

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6703
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6703

Asp Val Ser 
1           


<210>  6704
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6704

Cys Ser Tyr Ala Asp Asn Tyr Thr Tyr Asn Tyr Val 
1               5                   10          


<210>  6705
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6705

Gln Asn Ile Arg Ser Tyr 
1               5       


<210>  6706
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6706

Ala Ala Ser 
1           


<210>  6707
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6707

Gln Gln Ser Ser Ser Ser Pro Ile Thr 
1               5                   


<210>  6708
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6708

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6709
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6709

Lys Asp Ser 
1           


<210>  6710
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6710

Gln Ser Ala Asp Ser Ser Gly Thr Tyr Arg Val 
1               5                   10      


<210>  6711
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6711

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  6712
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6712

Leu Gly Ser 
1           


<210>  6713
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6713

Leu Gln Ala Leu Gln Phe Pro Tyr Thr 
1               5                   


<210>  6714
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6714

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  6715
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6715

Asp Ala Ser 
1           


<210>  6716
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6716

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  6717
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6717

Gln Ser Ile Ser Ser Trp 
1               5       


<210>  6718
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6718

Lys Ala Ser 
1           


<210>  6719
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6719

Gln Gln Tyr Asn Ser Tyr Pro Ile Thr 
1               5                   


<210>  6720
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6720

Gln Ser Ile Thr Thr Tyr 
1               5       


<210>  6721
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6721

Ala Val Ser 
1           


<210>  6722
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6722

Gln Gln Tyr Ala Asn Leu Pro Phe Thr 
1               5                   


<210>  6723
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6723

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6724
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6724

Gly Ala Ser 
1           


<210>  6725
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6725

Gln Gln Tyr Tyr Asn Trp Pro Leu Thr 
1               5                   


<210>  6726
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6726

Ala Leu Pro Asn Glu Tyr 
1               5       


<210>  6727
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6727

Lys Asp Ser 
1           


<210>  6728
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6728

Gln Ser Val Asp Ser Ser Gly Thr Tyr Pro His Val Ile 
1               5                   10              


<210>  6729
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6729

Asn Phe Ala Thr Lys Ser 
1               5       


<210>  6730
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6730

Asp Asp Asn 
1           


<210>  6731
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6731

Gln Val Trp Asp Ser Arg Ser Gly His Phe Val Val 
1               5                   10          


<210>  6732
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6732

Gln Asp Ile Asn Asn Tyr 
1               5       


<210>  6733
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6733

Asp Ala Ser 
1           


<210>  6734
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6734

Gln Gln Tyr Ala Asn Leu Thr Leu Thr 
1               5                   


<210>  6735
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6735

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6736
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6736

Gly Asn Thr 
1           


<210>  6737
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6737

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  6738
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6738

Asn Phe Ala Thr Lys Ser 
1               5       


<210>  6739
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6739

Asp Asp Asn 
1           


<210>  6740
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6740

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6741
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6741

Gln Ser Val Ala Ser Ser Tyr 
1               5           


<210>  6742
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6742

Gly Ala Ser 
1           


<210>  6743
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6743

Gln Gln Tyr Gly Ser Ser Pro Pro Arg Tyr Thr 
1               5                   10      


<210>  6744
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6744

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6745
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6745

Lys Asp Ser 
1           


<210>  6746
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6746

Gln Ser Ala Asp Ser Ser Gly Thr Ser Val Leu 
1               5                   10      


<210>  6747
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6747

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  6748
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6748

Gln Asp Thr 
1           


<210>  6749
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6749

Gln Val Trp Asp Ser Ser Ser Asp His Pro Glu Trp Val 
1               5                   10              


<210>  6750
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6750

Gln Ser Val Ala Ser Ser Tyr 
1               5           


<210>  6751
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6751

Gly Ala Ser 
1           


<210>  6752
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6752

His Gln Tyr Gly Ile Ser Pro Phe Thr 
1               5                   


<210>  6753
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6753

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6754
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6754

Lys Asp Ser 
1           


<210>  6755
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6755

Gln Ser Ala Asp Ser Ser Ala Ala Tyr Val Val 
1               5                   10      


<210>  6756
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6756

Ser Leu Arg Ser His Tyr 
1               5       


<210>  6757
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6757

Gly Arg Asn 
1           


<210>  6758
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6758

Gln Ser Tyr Asp Ser Ser Leu Asn Gly Asp Val 
1               5                   10      


<210>  6759
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6759

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6760
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6760

Asp Asp Ser 
1           


<210>  6761
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6761

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6762
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6762

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6763
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6763

Gly Ala Ser 
1           


<210>  6764
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6764

Gln Gln Tyr Gly Ser Ser Pro Pro Arg Tyr Thr 
1               5                   10      


<210>  6765
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6765

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6766
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6766

Glu Gly Ser 
1           


<210>  6767
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6767

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  6768
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6768

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6769
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6769

Gly Ala Ser 
1           


<210>  6770
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6770

Gln Gln Tyr Gly Ser Ser Pro Pro Arg Tyr Thr 
1               5                   10      


<210>  6771
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6771

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  6772
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6772

Asp Asp Ser 
1           


<210>  6773
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6773

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6774
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6774

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  6775
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6775

Leu Gly Ser 
1           


<210>  6776
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6776

Met Gln Gly Thr His Trp Pro 
1               5           


<210>  6777
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6777

Asn Ile Gly Ser Lys Asn 
1               5       


<210>  6778
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6778

His Asp Gly 
1           


<210>  6779
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6779

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6780
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6780

Ala Leu Pro Lys Lys Tyr 
1               5       


<210>  6781
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6781

Glu Asp Ser 
1           


<210>  6782
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6782

Tyr Ser Thr Asp Ser Ser Gly Lys Gly Val 
1               5                   10  


<210>  6783
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6783

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  6784
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6784

Asp Asp Ser 
1           


<210>  6785
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6785

Gln Val Trp Asp Ser Ser Ser Asp Pro Phe Tyr Val 
1               5                   10          


<210>  6786
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6786

Gln Thr Ile Phe Ser Thr Tyr 
1               5           


<210>  6787
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6787

Gly Ala Ser 
1           


<210>  6788
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6788

Gln Gln Tyr Asp Asp Trp Pro Pro Glu Val Thr 
1               5                   10      


<210>  6789
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6789

Tyr Ile Gly Arg Lys Asn 
1               5       


<210>  6790
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6790

Asp Asp Ser 
1           


<210>  6791
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6791

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  6792
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6792

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  6793
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6793

Lys Asp Ser 
1           


<210>  6794
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6794

Gln Ser Ala Asp Ser Arg Gly Ala Val 
1               5                   


<210>  6795
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6795

Gln Arg Leu Ala Pro Thr Leu 
1               5           


<210>  6796
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6796

Ala Ala Ser 
1           


<210>  6797
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6797

His Gln Tyr Gly Ile Ser Pro Phe Thr 
1               5                   


<210>  6798
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6798

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  6799
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6799

Glu Asp Asn 
1           


<210>  6800
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6800

Gln Ser Tyr Asp Gly Ile Asn Arg Ala Trp Val 
1               5                   10      


<210>  6801
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6801

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6802
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6802

Ala Asn Ser 
1           


<210>  6803
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6803

Ala Ala Trp Asp Asp Ser Leu Asn Gly Ser Trp Val 
1               5                   10          


<210>  6804
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6804

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6805
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6805

Asp Lys Asn 
1           


<210>  6806
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6806

Asn Ser Arg Asp Ser Ser Gly Asn Ala Val Val 
1               5                   10      


<210>  6807
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6807

Ala Phe Pro Lys Gln Tyr 
1               5       


<210>  6808
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6808

Asp Asp Ser 
1           


<210>  6809
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6809

Gln Val Trp Asp Ser Ser Ser Asp Arg Leu Tyr Val 
1               5                   10          


<210>  6810
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6810

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6811
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6811

Gly Ala Ser 
1           


<210>  6812
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6812

Gln Gln Ser Ser Ser Ser Pro Ile Thr 
1               5                   


<210>  6813
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6813

Gln Ser Val Leu His Ser Ser Asn Asn Lys Asp Ser 
1               5                   10          


<210>  6814
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6814

Trp Ala Ser 
1           


<210>  6815
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6815

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  6816
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6816

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  6817
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6817

Gly Asn Asn 
1           


<210>  6818
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6818

Gln Ser Tyr Asp Ser Ser Leu Ser Gly Ser Val 
1               5                   10      


<210>  6819
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6819

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  6820
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6820

Asp Ala Ser 
1           


<210>  6821
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6821

Gln Gln Tyr Asp Lys Leu Thr 
1               5           


<210>  6822
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6822

Gln Asn Ile Lys Asn Thr Tyr 
1               5           


<210>  6823
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6823

Gly Ala Ser 
1           


<210>  6824
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6824

Leu Gln Asp Tyr Asn Leu Pro Trp Thr 
1               5                   


<210>  6825
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6825

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6826
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6826

Gly Ala Ser 
1           


<210>  6827
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6827

Gln Gln Tyr Tyr Asn Trp Pro Leu Thr 
1               5                   


<210>  6828
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6828

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6829
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6829

Lys Asp Thr 
1           


<210>  6830
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6830

Gln Ala Trp Gly Ser Ser Arg Gly Val 
1               5                   


<210>  6831
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6831

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  6832
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6832

Gly Asn Asn 
1           


<210>  6833
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6833

Gln Ser Phe Asp Ile Gly Arg Gly Gly Trp Ile 
1               5                   10      


<210>  6834
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6834

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6835
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6835

Glu Gly Ser 
1           


<210>  6836
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6836

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  6837
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6837

Gln Ser Ile Ser Ser Trp 
1               5       


<210>  6838
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6838

Lys Ala Ser 
1           


<210>  6839
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6839

Gln Gln Tyr Asn Ser Tyr Ser Tyr Thr 
1               5                   


<210>  6840
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6840

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6841
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6841

Glu Gly Ser 
1           


<210>  6842
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6842

Cys Ser Tyr Ala Arg Ser Ser Thr Arg Val 
1               5                   10  


<210>  6843
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6843

Gln Ser Val Leu His Ser Ser Asn Asn Lys Asp Ser 
1               5                   10          


<210>  6844
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6844

Trp Ala Ser 
1           


<210>  6845
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6845

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  6846
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6846

Gln Ser Val Ser Asn Asn 
1               5       


<210>  6847
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6847

Gly Ala Ser 
1           


<210>  6848
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6848

Gln Gln Tyr Asp Asp Trp Pro Pro Glu Val Thr 
1               5                   10      


<210>  6849
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6849

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  6850
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6850

Gly Lys Asn 
1           


<210>  6851
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6851

Asn Ser Arg Asp Asn Ser Gly Asn Leu Asn Trp Val 
1               5                   10          


<210>  6852
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6852

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr 
1               5                   10          


<210>  6853
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6853

Trp Ala Ser 
1           


<210>  6854
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6854

Gln Gln Tyr Tyr Ser Thr Leu Ala 
1               5               


<210>  6855
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6855

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  6856
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6856

Gly Asn Asn 
1           


<210>  6857
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6857

Gln Ser Phe Asp Ile Gly Arg Gly Gly Trp Ile 
1               5                   10      


<210>  6858
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6858

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6859
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6859

Lys Asp Ser 
1           


<210>  6860
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6860

Gln Val Trp Asp Gly Ile Asn Asp Arg Val Val 
1               5                   10      


<210>  6861
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6861

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  6862
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6862

Leu Gly Ser 
1           


<210>  6863
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6863

Gln Gln Tyr Gly Ser Ser Leu Phe Thr 
1               5                   


<210>  6864
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6864

Gln Ser Leu Val His Ser Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  6865
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6865

Lys Val Ser 
1           


<210>  6866
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6866

Met Gln Gly Thr Pro Trp Pro 
1               5           


<210>  6867
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6867

Ser Ser Asn Ile Gly Ser Gly Ser Asp 
1               5                   


<210>  6868
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6868

Gly Asn Thr 
1           


<210>  6869
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6869

Val Ala Trp Asp Asp Ser Arg Asn Gly Leu Val 
1               5                   10      


<210>  6870
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6870

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  6871
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6871

Glu Asp Asn 
1           


<210>  6872
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6872

Gln Ser Tyr Asp Ser Ser Ser Val Val 
1               5                   


<210>  6873
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6873

Glu Ser Val Arg Arg Asn 
1               5       


<210>  6874
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6874

Gly Ala Ser 
1           


<210>  6875
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6875

Gln Gln Cys Ser Asp Trp Pro Thr 
1               5               


<210>  6876
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6876

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  6877
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6877

Gly Asn Asn 
1           


<210>  6878
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6878

Gln Ser Phe Asp Ile Gly Arg Gly Gly Trp Ile 
1               5                   10      


<210>  6879
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6879

Gln Asn Ile Arg Ser Tyr 
1               5       


<210>  6880
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6880

Asp Ala Ser 
1           


<210>  6881
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6881

Gln Gln Tyr Asp Asn Leu Pro Leu Ala 
1               5                   


<210>  6882
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6882

Gln Ser Ile Thr Thr Tyr 
1               5       


<210>  6883
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6883

Ala Val Ser 
1           


<210>  6884
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6884

Gln Gln Ser Tyr Ser Thr Pro Pro Thr 
1               5                   


<210>  6885
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6885

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6886
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6886

Glu Gly Ser 
1           


<210>  6887
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6887

Val Ala Trp Asp Asp Ser Arg Asn Gly Leu Val 
1               5                   10      


<210>  6888
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6888

Thr Ser Asn Ile Gly Ala Gly Ser Asp 
1               5                   


<210>  6889
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6889

Gly Asn Asn 
1           


<210>  6890
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6890

Gln Ser Phe Asp Ile Gly Arg Gly Gly Trp Ile 
1               5                   10      


<210>  6891
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6891

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6892
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6892

Ala Asn Ser 
1           


<210>  6893
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6893

Gln Ser Tyr Asp Ser Ser Leu Ser Gly Ser Val 
1               5                   10      


<210>  6894
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6894

Gln Ser Val Ala Ser Ser Tyr 
1               5           


<210>  6895
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6895

Gly Ala Ser 
1           


<210>  6896
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6896

Met Gln Ala Leu Gln Thr Pro Trp Thr 
1               5                   


<210>  6897
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6897

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6898
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6898

Glu Gly Ser 
1           


<210>  6899
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6899

Cys Ser Tyr Ala Gly Ser Val Leu 
1               5               


<210>  6900
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6900

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  6901
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6901

Gly Asn Asn 
1           


<210>  6902
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6902

Gln Ser Phe Asp Ile Gly Arg Gly Gly Trp Ile 
1               5                   10      


<210>  6903
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6903

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  6904
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6904

Lys Ala Ser 
1           


<210>  6905
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6905

Gln Gln Ser Tyr Ser Thr Pro Thr 
1               5               


<210>  6906
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6906

Gln Ser Val Asn His Gly Tyr 
1               5           


<210>  6907
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6907

Gly Ala Ser 
1           


<210>  6908
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6908

His Gln Tyr Asp Ser Ser Gln Gly Tyr Thr 
1               5                   10  


<210>  6909
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6909

Gln Ser Ile Ala Gly Tyr 
1               5       


<210>  6910
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6910

Gly Thr Thr 
1           


<210>  6911
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6911

Gln Gln Tyr Asp Asn Leu Leu Leu Phe Thr 
1               5                   10  


<210>  6912
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6912

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6913
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6913

Asp Val Ser 
1           


<210>  6914
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6914

Ser Ser Tyr Arg Ser Val Ser Thr Val Val 
1               5                   10  


<210>  6915
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6915

Gln Ser Val Ser Ser Asn Phe 
1               5           


<210>  6916
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6916

Gly Ala Ser 
1           


<210>  6917
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6917

Gln Gln Tyr Gly Arg Ser Pro Ile Thr 
1               5                   


<210>  6918
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6918

Gln Ser Ile Ala Gly Tyr 
1               5       


<210>  6919
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6919

Gly Thr Thr 
1           


<210>  6920
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6920

Gln Arg Tyr Asn Ser Tyr Ser Leu Thr 
1               5                   


<210>  6921
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6921

Glu Asp Leu Leu Tyr Thr Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  6922
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6922

Lys Val Ser 
1           


<210>  6923
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6923

Met Gln Gly Thr Arg Trp Pro Trp Thr 
1               5                   


<210>  6924
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6924

His Ser Ile Gly Thr Tyr 
1               5       


<210>  6925
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6925

Ala Ala Ser 
1           


<210>  6926
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6926

Gln Gln Tyr Tyr Ser Tyr Ser Trp Thr 
1               5                   


<210>  6927
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6927

Gln Ser Leu Val Tyr Ser Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  6928
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6928

Lys Val Ser 
1           


<210>  6929
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6929

Met Gln Gly Thr His Trp Pro Ile Thr 
1               5                   


<210>  6930
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6930

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  6931
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6931

Gly Asn Asn 
1           


<210>  6932
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6932

Gln Ser Tyr Asp Arg Thr Leu Ser Val Val 
1               5                   10  


<210>  6933
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6933

Gln Ser Val Phe Asn Trp Asp Asn His Arg Asp Tyr 
1               5                   10          


<210>  6934
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6934

Trp Ala Ser 
1           


<210>  6935
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6935

Gln Gln Tyr Asn Asn Trp Pro Leu Thr 
1               5                   


<210>  6936
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6936

Ala Leu Pro Lys His Tyr 
1               5       


<210>  6937
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6937

Lys Asp Ile 
1           


<210>  6938
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6938

Gln Ala Trp Asp Ser Ser Thr Ala Val 
1               5                   


<210>  6939
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6939

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  6940
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6940

Ala Ala Ser 
1           


<210>  6941
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6941

Gln Gln Tyr Asp Asn Leu Leu Gln Phe Thr 
1               5                   10  


<210>  6942
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6942

Ala Leu Pro Thr Lys Tyr 
1               5       


<210>  6943
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6943

Asp Asp Ser 
1           


<210>  6944
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6944

Tyr Ser Thr Asp Ser Ser Gly Asn Val 
1               5                   


<210>  6945
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6945

Gln Ser Leu Leu His Ser Asn Gly Asp Thr Tyr 
1               5                   10      


<210>  6946
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6946

Lys Ile Ser 
1           


<210>  6947
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6947

Met Gln Ala Thr Gln Phe Pro Arg Thr 
1               5                   


<210>  6948
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6948

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6949
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6949

Gly Ala Ser 
1           


<210>  6950
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6950

Gln Gln Tyr Asn Asn Trp Pro Pro Met Tyr Thr 
1               5                   10      


<210>  6951
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6951

Gln Ser Ile Ser Ser Asn 
1               5       


<210>  6952
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6952

Gly Ala Ser 
1           


<210>  6953
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6953

Gln Gln Tyr Asn Ser Tyr Ser Leu Thr 
1               5                   


<210>  6954
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6954

Gln Asn Ile Lys Asn Thr Tyr 
1               5           


<210>  6955
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6955

Gly Ala Ser 
1           


<210>  6956
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6956

Leu Gln Asp Tyr Asn Leu Pro Trp Thr 
1               5                   


<210>  6957
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6957

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6958
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6958

Gly Ala Ser 
1           


<210>  6959
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6959

Gln Tyr Tyr Gly Ser Ser Pro Phe Gly 
1               5                   


<210>  6960
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6960

Gln Ser Val Ser Arg Phe 
1               5       


<210>  6961
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6961

Asp Ala Ser 
1           


<210>  6962
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6962

Gln Gln Arg Ser Asn Trp Pro Pro Arg Leu Thr 
1               5                   10      


<210>  6963
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6963

Ser Ser Asn Ile Gly Ser Asn Thr 
1               5               


<210>  6964
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6964

Ser Asn Asn 
1           


<210>  6965
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6965

Ala Val Trp Asp Asp Ser Leu Asn Gly Val Val 
1               5                   10      


<210>  6966
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6966

Ser Ser Asn Ile Gly Ser Asn Tyr 
1               5               


<210>  6967
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6967

Arg Asn Asn 
1           


<210>  6968
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6968

Leu Val Trp Asp Asp Ser Leu Asn Gly Leu Val 
1               5                   10      


<210>  6969
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6969

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  6970
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6970

Asp Val Ser 
1           


<210>  6971
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6971

Ser Ser Tyr Thr Ser Ser Arg Ala Val Leu 
1               5                   10  


<210>  6972
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6972

Gln Ser Val Leu Asp Asn Ser Ser Asn Lys Asn His 
1               5                   10          


<210>  6973
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6973

Trp Ala Ser 
1           


<210>  6974
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6974

Gln Gln Tyr Tyr Ser Ser His Trp Thr 
1               5                   


<210>  6975
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6975

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  6976
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6976

Glu Val Ser 
1           


<210>  6977
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6977

Tyr Ser Tyr Ala Gly Ser Ser Thr Trp Val 
1               5                   10  


<210>  6978
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6978

Gln Ser Val Ser Ser Asn 
1               5       


<210>  6979
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6979

Gly Ala Ser 
1           


<210>  6980
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6980

Gln Gln Tyr Asn Asn Trp Pro Pro Met Tyr Thr 
1               5                   10      


<210>  6981
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6981

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  6982
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6982

Lys Asp Ser 
1           


<210>  6983
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6983

Gln Ser Thr Asp Ser Ser Gly Ser Tyr Val Val 
1               5                   10      


<210>  6984
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6984

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  6985
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6985

Leu Ser Ser 
1           


<210>  6986
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6986

Gln Gln Ser Tyr Ser Ile Pro Pro Thr 
1               5                   


<210>  6987
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6987

Ser Gly His Thr Asn Tyr Ala 
1               5           


<210>  6988
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6988

Val Asn Ser Asp Gly Ser His 
1               5           


<210>  6989
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6989

Gln Thr Trp Gly Pro Gly Ile Arg Val 
1               5                   


<210>  6990
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6990

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  6991
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6991

Gly Ala Ser 
1           


<210>  6992
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6992

Gln Gln Tyr Gly Ser Ser Pro Leu Thr 
1               5                   


<210>  6993
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6993

Gln Asn Ile Ala Ser Tyr 
1               5       


<210>  6994
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6994

Ala Ala Ser 
1           


<210>  6995
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6995

His Gln Ser Tyr Phe Thr Pro Gln Thr 
1               5                   


<210>  6996
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6996

Arg Ser Val Arg Asn Asn 
1               5       


<210>  6997
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6997

Asp Ala Ser 
1           


<210>  6998
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6998

Gln Gln Tyr Asp Asp Trp Pro Trp Thr 
1               5                   


<210>  6999
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6999

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  7000
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7000

Ala Ala Ser 
1           


<210>  7001
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7001

Gln Gln Tyr Tyr Ser Tyr Pro Pro Asn Thr 
1               5                   10  


<210>  7002
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7002

Gln Arg Val Ser Ser Asp Tyr 
1               5           


<210>  7003
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7003

His Gly Ser 
1           


<210>  7004
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7004

Gln Gln Tyr Gly Asn Ser Pro Phe Thr 
1               5                   


<210>  7005
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7005

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  7006
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7006

Ser Ala Ser 
1           


<210>  7007
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7007

Gln Gln Tyr Val Glu Pro Pro Phe Thr 
1               5                   


<210>  7008
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7008

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  7009
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7009

Ala Ala Ser 
1           


<210>  7010
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7010

Gln Gln Tyr Tyr Ser Ile Ser Trp Thr 
1               5                   


<210>  7011
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7011

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  7012
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7012

Asp Lys Asn 
1           


<210>  7013
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7013

Gln Ser Trp Asp Thr Gly Ile Gly Val 
1               5                   


<210>  7014
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7014

Gln Ser Val Thr Ser Ser Tyr 
1               5           


<210>  7015
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7015

Gly Ala Ser 
1           


<210>  7016
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7016

Gln Gln Tyr Val Glu Pro Pro Phe Thr 
1               5                   


<210>  7017
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7017

Ser Ser Asp Val Val Gly Tyr Asn Tyr 
1               5                   


<210>  7018
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7018

Asp Val Arg 
1           


<210>  7019
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7019

Ser Ser Tyr Thr Ser Ser Ser Thr Pro Phe Val 
1               5                   10      


<210>  7020
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7020

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  7021
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7021

Asp Ala Ser 
1           


<210>  7022
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7022

Gln Gln Tyr Asn Asn Trp Trp Arg Thr 
1               5                   


<210>  7023
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7023

Gln Ser Val Phe Asn Thr Val Asn His Arg Asp Tyr 
1               5                   10          


<210>  7024
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7024

Trp Ala Ser 
1           


<210>  7025
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7025

Gln Gln Tyr Tyr Ser Thr Pro Leu Thr 
1               5                   


<210>  7026
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7026

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  7027
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7027

Asp Val Ser 
1           


<210>  7028
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7028

Ser Ala Tyr Ala Gly Ser Asn Asn Leu Val 
1               5                   10  


<210>  7029
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7029

Gln Ser Val Ser Ser Asn 
1               5       


<210>  7030
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7030

Asp Ala Ser 
1           


<210>  7031
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7031

Gln Gln Tyr Val Glu Pro Pro Phe Thr 
1               5                   


<210>  7032
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7032

Gln Thr Val Ser Ser Ser Tyr 
1               5           


<210>  7033
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7033

Gly Ala Ser 
1           


<210>  7034
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7034

Gln Gln Tyr Gly Ser Ser Tyr Thr 
1               5               


<210>  7035
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7035

Ser Gly His Thr Thr Tyr Ala 
1               5           


<210>  7036
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7036

Leu Asn Ser Asp Gly Ser His 
1               5           


<210>  7037
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7037

Tyr Ser Arg Asp Arg Ser Gly Asn Arg Trp Val 
1               5                   10      


<210>  7038
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7038

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  7039
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7039

Asp Val Ser 
1           


<210>  7040
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7040

Thr Ser Tyr Thr Ser Ser Ser Thr Leu Asn Val Val 
1               5                   10          


<210>  7041
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7041

Gln Ser Val Ser Ser Asn 
1               5       


<210>  7042
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7042

Gly Ala Ser 
1           


<210>  7043
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7043

Gln Gln Tyr Tyr Asn Trp Pro Leu Thr 
1               5                   


<210>  7044
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7044

Gln Ser Ile Ser Arg Tyr 
1               5       


<210>  7045
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7045

Asp Ala Ser 
1           


<210>  7046
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7046

Gln Gln Ser Ser Ser Ser Pro Ile Thr 
1               5                   


<210>  7047
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7047

Ser Gly Ile Asp Val Gly Thr Tyr Arg 
1               5                   


<210>  7048
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7048

Tyr Lys Ser Asp Ser Asp Lys 
1               5           


<210>  7049
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7049

Leu Ile Trp His Ile Asn Ala Tyr Val 
1               5                   


<210>  7050
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7050

Gln Ser Val Ser Ser Asn 
1               5       


<210>  7051
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7051

Gly Ala Ser 
1           


<210>  7052
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7052

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  7053
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7053

Gln Ser Leu Leu Arg Ser Asp Ser Lys Thr Tyr 
1               5                   10      


<210>  7054
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7054

Glu Val Ser 
1           


<210>  7055
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7055

Met Gln Ala Leu Gln Thr Pro Trp Thr 
1               5                   


<210>  7056
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7056

Gln Ser Ile Arg Tyr Tyr 
1               5       


<210>  7057
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7057

Ala Ala Ser 
1           


<210>  7058
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7058

Gln Gln Ser Phe Ser Thr Pro Arg Thr 
1               5                   


<210>  7059
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7059

Gln Ser Val Ser Ser Asn 
1               5       


<210>  7060
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7060

Gly Ala Ser 
1           


<210>  7061
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7061

Gln Gln Tyr Asn Asn Trp Pro His Thr 
1               5                   


<210>  7062
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7062

Ser Ser Asn Ile Gly Asn Asn Tyr 
1               5               


<210>  7063
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7063

Asp Asn Asn 
1           


<210>  7064
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7064

Gly Thr Trp Asp Ser Ser Leu Ser Ala Tyr Val 
1               5                   10      


<210>  7065
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7065

Gln Ser Val Leu His Ser Ser Asn Asn Lys Asp Ser 
1               5                   10          


<210>  7066
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7066

Trp Ala Ser 
1           


<210>  7067
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7067

Gln Gln Tyr Gly Ser Ser Pro Pro Arg Tyr Thr 
1               5                   10      


<210>  7068
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7068

Ser Ser Asn Ile Gly Asn Asn Lys 
1               5               


<210>  7069
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7069

Asn Asn Asn 
1           


<210>  7070
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7070

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  7071
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7071

Glu Ser Leu Leu His Ser Asp Gly His Asn Tyr 
1               5                   10      


<210>  7072
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7072

Phe Gly Ser 
1           


<210>  7073
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7073

Leu Gln Ala Leu Gln Phe Pro Tyr Thr 
1               5                   


<210>  7074
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7074

Gln Arg Leu Ala Pro Thr Leu 
1               5           


<210>  7075
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7075

Ala Ala Ser 
1           


<210>  7076
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7076

His Gln Tyr Gly Ile Ser Pro Phe Thr 
1               5                   


<210>  7077
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7077

Gln Ser Ile Ser Arg Tyr 
1               5       


<210>  7078
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7078

Asp Ala Ser 
1           


<210>  7079
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7079

Gln Gln Tyr Asp Asn Leu Pro Arg Thr 
1               5                   


<210>  7080
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7080

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  7081
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7081

Asp Ala Ser 
1           


<210>  7082
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7082

Gln Gln Ser Tyr Ser Thr Pro Pro Thr Thr 
1               5                   10  


<210>  7083
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7083

Gln Asn Ile Arg Ser Tyr 
1               5       


<210>  7084
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7084

Ala Ala Ser 
1           


<210>  7085
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7085

Gln Gln Ser Tyr Ser Thr Pro Arg Thr 
1               5                   


<210>  7086
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7086

Gln Ser Val Ser Thr Phe 
1               5       


<210>  7087
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7087

Ala Ala Ser 
1           


<210>  7088
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7088

Gln Gln Ser Ser Ser Ser Pro Ile Thr 
1               5                   


<210>  7089
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7089

Gln Asp Ile Asn Asn Tyr 
1               5       


<210>  7090
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7090

Ala Ala Ser 
1           


<210>  7091
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7091

Gln Gln Thr His Ser Pro Leu Asp Ser 
1               5                   


<210>  7092
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7092

Gln Asp Ile Asn Lys Tyr 
1               5       


<210>  7093
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7093

Asp Ala Ser 
1           


<210>  7094
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7094

Gln Gln Tyr Asp Asn Leu Pro Arg Thr 
1               5                   


<210>  7095
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7095

Gln Ser Val Ser Ser Asn 
1               5       


<210>  7096
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7096

Gly Ala Ser 
1           


<210>  7097
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7097

Gln Gln Tyr Tyr Asn Trp Pro Leu Thr 
1               5                   


<210>  7098
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7098

Asn Ile Gly Arg Lys Ser 
1               5       


<210>  7099
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7099

Asp Asp Ser 
1           


<210>  7100
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7100

Gln Val Trp Asp Ser Ser Ser Asp His Pro Glu Trp Val 
1               5                   10              


<210>  7101
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7101

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Phe 
1               5                   10      


<210>  7102
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7102

Leu Gly Ser 
1           


<210>  7103
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7103

Met Gln Ala Leu Gln Thr Pro Trp Thr 
1               5                   


<210>  7104
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7104

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  7105
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7105

Asp Asp Ser 
1           


<210>  7106
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7106

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  7107
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7107

Asn Ser Asn Ile Gly Ser Tyr Thr 
1               5               


<210>  7108
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7108

Gly Asn Asn 
1           


<210>  7109
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7109

Ala Ala Trp Asp Asp Ser Leu Asn Gly Pro Val 
1               5                   10      


<210>  7110
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7110

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  7111
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7111

Asp Ala Ser 
1           


<210>  7112
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7112

Gln Gln Ser Asp Asn Leu Pro Met Tyr Thr 
1               5                   10  


<210>  7113
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7113

Gln Ser Val Ser Ser Asn 
1               5       


<210>  7114
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7114

Gly Ala Ser 
1           


<210>  7115
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7115

Gln Gln Tyr Asn Asn Trp Pro His Thr 
1               5                   


<210>  7116
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7116

Ser Leu Arg Arg Tyr Tyr 
1               5       


<210>  7117
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7117

Gly Lys Asn 
1           


<210>  7118
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7118

Asn Ser Arg Asp Ser Ser Gly Asn Pro Arg Trp 
1               5                   10      


<210>  7119
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7119

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  7120
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7120

Asp Asp Ser 
1           


<210>  7121
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7121

Gln Val Trp Asp Ser Gly Ser Asp His Val Val 
1               5                   10      


<210>  7122
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7122

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  7123
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7123

Gly Ala Ser 
1           


<210>  7124
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7124

Gln Gln Tyr Gly Ser Ser Pro Pro Arg Tyr Thr 
1               5                   10      


<210>  7125
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7125

Ala Leu Pro Asn Glu Tyr 
1               5       


<210>  7126
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7126

Lys Asp Ser 
1           


<210>  7127
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7127

Gln Ser Val Asp Ser Ser Gly Thr Tyr Arg Val 
1               5                   10      


<210>  7128
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7128

Gln Ser Ile Ser Ser Trp 
1               5       


<210>  7129
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7129

Asp Ala Ser 
1           


<210>  7130
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7130

Gln Gln Tyr Ala Asn Leu Pro Phe Thr 
1               5                   


<210>  7131
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7131

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  7132
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7132

Asp Ala Ser 
1           


<210>  7133
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7133

Gln Gln Tyr Asp Asn Leu Pro Leu Ala 
1               5                   


<210>  7134
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7134

Gln Ser Leu Val Tyr Ser Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  7135
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7135

Lys Val Ser 
1           


<210>  7136
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7136

Met Gln Gly Thr His Trp Pro Tyr Thr 
1               5                   


<210>  7137
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7137

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  7138
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7138

Asp Asp Ser 
1           


<210>  7139
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7139

Gln Val Trp Asp Ser Gly Ser Asp His Val Val 
1               5                   10      


<210>  7140
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7140

Ser Ser Asp Val Gly Gly Tyr Thr Tyr 
1               5                   


<210>  7141
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7141

Asp Val Asn 
1           


<210>  7142
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7142

Cys Ser Tyr Ala Gly Arg Tyr Thr Trp Val 
1               5                   10  


<210>  7143
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7143

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  7144
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7144

Gly Ala Ser 
1           


<210>  7145
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7145

Gln Gln Ser Tyr Ser Thr Pro Gln Thr 
1               5                   


<210>  7146
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7146

Gln Asn Ile Arg Ser Tyr 
1               5       


<210>  7147
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7147

Asp Ala Ser 
1           


<210>  7148
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7148

Gln Gln Tyr Asp Asn Leu Pro Arg Thr 
1               5                   


<210>  7149
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7149

Gln Ser Ile Arg Ser Tyr 
1               5       


<210>  7150
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7150

Asp Ala Ser 
1           


<210>  7151
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7151

Gln Gln Tyr Ala Asn Leu Pro Phe Thr 
1               5                   


<210>  7152
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7152

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  7153
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7153

Glu Gly Ser 
1           


<210>  7154
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7154

Cys Ser Tyr Ala Ser Ser Ser Ile Val Val 
1               5                   10  


<210>  7155

<400>  7155
000

<210>  7156

<400>  7156
000

<210>  7157

<400>  7157
000

<210>  7158
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7158

Ala Leu Pro Lys Gln Tyr 
1               5       


<210>  7159
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7159

Arg Asp Ser 
1           


<210>  7160
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7160

Gln Ser Ala Asp Ser Thr Gly Trp Val 
1               5                   


